Gene1700T,PDB,UniProtID,tempFlag,ProteinName,Type,Cluster,ModelPDB,LIG,LigSuggested,PDB,STBCloudClass,inPBList,Replaced,STBClass,manager,first1700T,Title,ModelActionMode,AllostericOrthostericETC,isAssay,CRO,CROTarget,UniProt,Family,Subfamily,Class,AssayType,AssaySubtype,FunctionMode,DetectionMethod,AssayPossibility,RelatedDisease,internalProject
O15229_KMO_wild_cl1,KMO_5x68A_FAD,O15229,O15229wild,KMO,wild,cl1,5x68A,FAD,,5x68,2,1,,oxidoreductases ,,1,Structural Basis for inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase,Inhibitor,,1,BPSbio,KMO,O15229,Immunotherapy,Kynurenine 3-monooxygenase,_,Biochemical,Binding,_,_,,,
O60341_LSD1_wild_cl1,LSD1_2xaqA_M84,O60341,O60341wild,LSD1,wild,cl1,2xaqA,M84,,2xaq,2,1,,oxidoreductases ,,1,Biochemical_ Structural_ and Biological Evaluation of Tranylcypromine Derivatives as inhibitors of Histone Demethylases Lsd1 and Lsd2.,Inhibitor,,1,BPSbio,LSD1,O60341,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
O60341_LSD1_wild_cl1,LSD1_5lguA_6W1,O60341,O60341wild,LSD1,wild,cl1,5lguA,6W1,,5lgu,2,1,,oxidoreductases ,,1,Thieno[3_2-b]pyrrole-5-carboxamides as New Reversible inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship.,Inhibitor,,1,BPSbio,LSD1,O60341,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
O75164_KDM4A_wild_cl1,KDM4A_5f2sD_5TZ,O75164,O75164wild,KDM4A,wild,cl1,5f2sD,5TZ,,5f2s,1,1,,methylase,SooYongLee,1,8-Substituted Pyrido[3_4-d]pyrimidin-4(3H)-one Derivatives As Potent_ Cell Permeable_ KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase inhibitors.,Inhibitor,,1,BPSbio,KDM4A,O75164,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
O75164_KDM4A_wild_cl1,KDM4A_5f3iD_5UJ,O75164,O75164wild,KDM4A,wild,cl1,5f3iD,5UJ,,5f3i,1,1,,methylase,SooYongLee,1,8-Substituted Pyrido[3_4-d]pyrimidin-4(3H)-one Derivatives As Potent_ Cell Permeable_ KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase inhibitors.,Inhibitor,,1,BPSbio,KDM4A,O75164,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
O94953_KDM4B_wild_cl1,KDM4B_4lxlA_PD2,O94953,O94953wild,KDM4B,wild,cl1,4lxlA,PD2,,4lxl,2,1,,methylase,SooYongLee,1,Crystal structure of JMJD2B complexed with pyridine-2_4-dicarboxylic acid and H3K9me3,Binding,Peptide binding,1,BPSbio,KDM4B,O94953,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
O95271_TNKS1_wild_cl1,TNKS1_4i9iD_1DY,O95271,O95271wild,TNKS1,wild,cl1,4i9iD,1DY,,4i9i,1,1,,Transferase,,1,Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.,Inhibitor,,1,BPSbio,PARP5A,O95271,?ARTD,mono-ADP-ribosyltransferase?,Writer,Functional,Enzymatic,_,Chemiluminescent,,,
O95271_TNKS1_wild_cl1,TNKS1_4uuhA_T40,O95271,O95271wild,TNKS1,wild,cl1,4uuhA,T40,,4uuh,1,1,,Transferase,,1,Design and Discovery of 3-Aryl-5-Substituted-Isoquinolin-1- Ones as Potent and Selective Tankyrase inhibitors,Inhibitor,,1,BPSbio,PARP5A,O95271,?ARTD,mono-ADP-ribosyltransferase?,Writer,Functional,Enzymatic,_,Chemiluminescent,,,
P09958_FURIN_wild_cl1,FURIN_6yd2A_ON8,P09958,P09958wild,FURIN,wild,cl1,6yd2A,ON8,,6yd2,2,1,,Peptidase,,1,The Basicity Makes the Difference: Improved Canavanine-Derived inhibitors of the Proprotein Convertase Furin.,Inhibitor,,1,BPSbio,FURIN,P09958,Protease,Serine Proteases,_,Biochemical,Binding,_,_,,,
P09958_FURIN_wild_cl1,FURIN_6yd7A_2UE,P09958,P09958wild,FURIN,wild,cl1,6yd7A,2UE,,6yd7,2,1,,Peptidase,,1,The Basicity Makes the Difference: Improved Canavanine-Derived inhibitors of the Proprotein Convertase Furin.,Inhibitor,,1,BPSbio,FURIN,P09958,Protease,Serine Proteases,_,Biochemical,Binding,_,_,,,
P17752_TPH1_wild_cl1,TPH1_3hfbA_ML4,P17752,P17752wild,TPH1,wild,cl1,3hfbA,ML4,,3hfb,3,1,,oxidoreductases ,,1,Mechanism of inhibition of Novel Tryptophan Hydroxylase inhibitors Revealed by Co-crystal Structures and Kinetic Analysis.,Inhibitor,,1,BPSbio,TPH1,P17752,Immunotherapy,Tryptophan hydroxylase,_,Biochemical,Binding,_,_,,,
P17752_TPH1_wild_cl1,TPH1_5j6dB_6H5,P17752,P17752wild,TPH1,wild,cl1,5j6dB,6H5,,5j6d,3,1,,oxidoreductases ,,1,Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors.,Inhibitor,,1,BPSbio,TPH1,P17752,Immunotherapy,Tryptophan hydroxylase,_,Biochemical,Binding,_,_,,,
P26358_DNMT1_wild_cl1,DNMT1_3ptaA_SAH,P26358,P26358wild,DNMT1,wild,cl1,3ptaA,SAH,,3pta,2,1,,methylase,SooYongLee,1,Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation.,Inhibitor,,1,BPSbio,DNMT1,P26358,Epigenetic,Methyltransferase,Writer,Biochemical,Binding,_,_,,,
P26358_DNMT1_wild_cl1,DNMT1_3swrA_SFG,P26358,P26358wild,DNMT1,wild,cl1,3swrA,SFG,,3swr,2,1,,methylase,SooYongLee,1,Structure of human DNMT1 (residues 600-1600) in complex with Sinefungin,Inhibitor,,1,BPSbio,DNMT1,P26358,Epigenetic,Methyltransferase,Writer,Biochemical,Binding,_,_,,,
P31153_METK2_wild_cl1,METK2_4ktvC_POP,P31153,P31153wild,METK2,wild,cl1,4ktvC,POP,ADN,4ktv,3,1,,Synthase,,1,Structure and function study of the complex that synthesizes S-adenosylmethionine.,Inhibitor,,1,BPSbio,MAT2A,P31153 ,_,_,_,_,_,_,_,,,
P31153_METK2_wild_cl1,METK2_6fcbA_PPK,P31153,P31153wild,METK2,wild,cl1,6fcbA,PPK,SAM,6fcb,3,1,,Synthase,,1,Control and regulation of S-Adenosylmethionine biosynthesis by the regulatory beta subunit and quinolone-based compounds.,Inhibitor,,1,BPSbio,MAT2A,P31153 ,_,_,_,_,_,_,_,,,
Q13332_PTPRS_wild_cl1,PTPRS_2yd9A_B3P,Q13332,Q13332wild,PTPRS,wild,cl1,2yd9A,B3P,,2yd9,3,1,,phosphatase,SooYongLee,1,Proteoglycan-Specific Molecular Switch for Rptp Sigma Clustering and Neuronal Extension.,apo,,1,BPSbio,PTPRS,Q13332,Protein Tyrosine Phosphatase,Receptor,_,Biochemical,Binding,_,_,,,
Q6B0I6_KDM4D_wild_cl1,KDM4D_4d6qA_PD2,Q6B0I6,Q6B0I6wild,KDM4D,wild,cl1,4d6qA,PD2,,4d6q,1,1,,methylase,SooYongLee,1,Crystal Structure of Human Jmjd2D in Complex with 2_4-Pdca,Inhibitor,,1,BPSbio,KDM4D,Q6B0I6,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q6B0I6_KDM4D_wild_cl1,KDM4D_6f5sA_CQT,Q6B0I6,Q6B0I6wild,KDM4D,wild,cl1,6f5sA,CQT,,6f5s,1,1,,methylase,SooYongLee,1,Crystal Structure of KDM4D with tetrazole ligand GF049,Inhibitor,,1,BPSbio,KDM4D,Q6B0I6,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q6P2P2_PRMT9_wild_cl1,PRMT9_7rbqA_44T,Q6P2P2,Q6P2P2wild,PRMT9,wild,cl1,7rbqA,44T,,7rbq,3,1,,methylase,SooYongLee,1,Co-crystal structure of human PRMT9 in complex with MT556 inhibitor,Inhibitor,,1,BPSbio,PRMT9,Q6P2P2,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Binding,_,_,,,
Q6ZMT4_KDM7_wild_cl1,KDM7_3u78A_E67,Q6ZMT4,Q6ZMT4wild,KDM7,wild,cl1,3u78A,E67,,3u78,3,1,,methylase,SooYongLee,1,An Analog of BIX-01294 Selectively inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases.,Inhibitor,,1,BPSbio,KDM7,Q6ZMT4,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q8NB78_KDM1B_wild_cl1,KDM1B_4gusA_FAD,Q8NB78,Q8NB78wild,KDM1B,wild,cl1,4gusA,FAD,,4gus,1,1,,oxidoreductases ,,1,LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation,inhibitor,,1,BPSbio,KDM1B,Q8NB78,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q8NBP7_PCSK9_474_cl1,PCSK9_6u2pB_PUV,Q8NBP7,Q8NBP7474,PCSK9,474,cl1,6u2pB,PUV,,6u2p,2,1,,Peptidase,,1,From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.,inhibitor,,1,BPSbio,PCSK9,Q8NBP7,proprotein convertase,cholesterol metabolism,_,Biochemical,Binding,_,_,,,
Q8NBP7_PCSK9_474_cl1,PCSK9_6u3xB_PVV,Q8NBP7,Q8NBP7474,PCSK9,474,cl1,6u3xB,PVV,,6u3x,2,1,,Peptidase,,1,From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.,inhibitor,,1,BPSbio,PCSK9,Q8NBP7,proprotein convertase,cholesterol metabolism,_,Biochemical,Binding,_,_,,,
Q9H3R0_KDM4C_wild_cl1,KDM4C_5fjhA_MMK,Q9H3R0,Q9H3R0wild,KDM4C,wild,cl1,5fjhA,MMK,,5fjh,2,1,,methylase,SooYongLee,1,Crystal Structures of Human Jmjd2C Catalytic Domain Bound to inhibitors,Inhibitor,,1,BPSbio,KDM4C,Q9H3R0,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q9H3R0_KDM4C_wild_cl1,KDM4C_5fjkA_EM6,Q9H3R0,Q9H3R0wild,KDM4C,wild,cl1,5fjkA,EM6,,5fjk,2,1,,methylase,SooYongLee,1,Crystal Structures of Human Jmjd2C Catalytic Domain Bound to inhibitors,Inhibitor,,1,BPSbio,KDM4C,Q9H3R0,Epigenetic,Histone Demethylase,Writer,Biochemical,Binding,_,_,,,
Q9H7B4_SMYD3_wild_cl1,SMYD3_5ccmA_4ZX,Q9H7B4,Q9H7B4wild,SMYD3,wild,cl1,5ccmA,4ZX,,5ccm,2,2,,methylase,SooYongLee,1,Novel Oxindole Sulfonamides and Sulfamides: EPZ031686_ the First Orally Bioavailable Small Molecule SMYD3 inhibitor.,Inhibitor,,1,BPSbio,SMYD3,Q9H7B4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Binding,_,_,,,
Q9H7B4_SMYD3_wild_cl2,SMYD3_5ccmA_SAM,Q9H7B4,Q9H7B4wild,SMYD3,wild,cl2,5ccmA,SAM,,5ccm,2,2,,methylase,SooYongLee,1,Novel Oxindole Sulfonamides and Sulfamides: EPZ031686_ the First Orally Bioavailable Small Molecule SMYD3 inhibitor.,Inhibitor,,1,BPSbio,SMYD3,Q9H7B4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Binding,_,_,,,
Q9H7B4_SMYD3_wild_cl2,SMYD3_5hi7A_62X,Q9H7B4,Q9H7B4wild,SMYD3,wild,cl2,5hi7A,62X,,5hi7,2,2,,methylase,SooYongLee,1,Structure-Based Design of a Novel SMYD3 inhibitor that Bridges the SAM-and MEKK2-Binding Pockets.,Inhibitor,,1,BPSbio,SMYD3,Q9H7B4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Binding,_,_,,,
Q9HAN9_NMNA1_wild_cl1,NMNA1_1kqnB_NAD,Q9HAN9,Q9HAN9wild,NMNA1,wild,cl1,1kqnB,NAD,,1kqn,3,1,,Transferase,,1,Structure of Human Nicotinamide/Nicotonic Acid Mononucleotide Adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin.,Inhibitor,,1,BPSbio,NMNAT1,Q9HAN9,_,_,_,_,_,_,_,,,
Q9HAN9_NMNA1_wild_cl1,NMNA1_1kqoE_DND,Q9HAN9,Q9HAN9wild,NMNA1,wild,cl1,1kqoE,DND,,1kqo,3,1,,Transferase,,1,Structure of Hhuman of Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase.Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin.,inhibitor,,1,BPSbio,NMNAT1,Q9HAN9,_,_,_,_,_,_,_,,,
Q9UDY8_MALT1_wild_cl1,MALT1_6f7iB_CW5,Q9UDY8,Q9UDY8wild,MALT1,wild,cl1,6f7iB,CW5,,6f7i,2,1,,Peptidase,,1,An Allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient.,Inhibitor,allosteric,1,BPSbio,MALT1,Q9UDY8,Protease,Cysteine Proteases,_,Biochemical,Binding,_,_,,,
Q9UDY8_MALT1_wild_cl1,MALT1_7ak0B_RJK,Q9UDY8,Q9UDY8wild,MALT1,wild,cl1,7ak0B,RJK,,7ak0,2,1,,Peptidase,,1,Discovery of Potent_ Highly Selective_ and In Vivo Efficacious_ Allosteric MALT1 inhibitors by Iterative Scaffold Morphing.,Inhibitor,allosteric,1,BPSbio,MALT1,Q9UDY8,Protease,Cysteine Proteases,_,Biochemical,Binding,_,_,,,
Q9Y6F1_PARP3_wild_cl1,PARP3_3ce0A_P34,Q9Y6F1,Q9Y6F1wild,PARP3,wild,cl1,3ce0A,P34,,3ce0,1,1,,Transferase,,1,Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.,Inhibitor,,1,BPSbio,PARP3,Q9Y6F1,?ARTD,mono-ADP-ribosyltransferase?,Writer,Functional,Enzymatic,_,Chemiluminescent,,,
Q9Y6F1_PARP3_wild_cl1,PARP3_4gv2A_5ME,Q9Y6F1,Q9Y6F1wild,PARP3,wild,cl1,4gv2A,5ME,,4gv2,1,1,,Transferase,,1,PARP inhibitor with Selectivity Toward ADP-Ribosyltransferase ARTD3/PARP3,Inhibitor,,1,BPSbio,PARP3,Q9Y6F1,?ARTD,mono-ADP-ribosyltransferase?,Writer,Functional,Enzymatic,_,Chemiluminescent,,,
O00763_ACACB_wild_cl1,ACACB_3gidB_S1A,O00763,O00763wild,ACACB,wild,cl1,3gidB,S1A,,3gid,2,1,,0,JiYoonShin,1,Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylase.,Inhibitor,,1,BPSbio,ACC2,O00763,0,0,metabolic diseases including obesity and diabetes,Functional,Biochemical,inhibitor,ADP-Glo¢â reagents,,,
O00763_ACACB_wild_cl1,ACACB_5kknC_6U3,O00763,O00763wild,ACACB,wild,cl1,5kknC,6U3,,5kkn,2,1,,0,JiYoonShin,1,Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis_ improves insulin sensitivity_ and modulates dyslipidemia in rats.,Inhibitor,,1,BPSbio,ACC2,O00763,0,0,metabolic diseases including obesity and diabetes,Functional,Biochemical,inhibitor,ADP-Glo¢â reagents,,,
O60885_BRD4_wild_cl1,BRD4_4ogiB_R78,O60885,O60885wild,BRD4,wild,cl1,4ogiB,R78,,4ogi,1,1,,0,JiYoonShin,1,Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.,Inhibitor,,1,BPSbio,BRD4 (BD1 and/or BD2),O60885,0,0,0,Functional,Biochemical,inhibitor,0,,,
O60885_BRD4_wild_cl1,BRD4_6c7qA_EO1,O60885,O60885wild,BRD4,wild,cl1,6c7qA,EO1,,6c7q,1,1,,0,JiYoonShin,1,Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain inhibitor.,Inhibitor,,1,BPSbio,BRD4 (BD1 and/or BD2),O60885,0,0,0,Functional,Biochemical,inhibitor,0,,,
O94925_GLSK_wild_cl1,GLSK_3vp2A_BP0,O94925,O94925wild,GLSK,wild,cl1,3vp2A,BP0,,3vp2,2,1,,0,JiYoonShin,1,Structural basis for the Allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,Inhibitor,allosteric,1,BPSbio,GLS1,O94925,0,0,0,Functional,Biochemical,inhibitor,0,,,
O94925_GLSK_wild_cl1,GLSK_5fi6C_5XY,O94925,O94925wild,GLSK,wild,cl1,5fi6C,5XY,,5fi6,2,1,,0,JiYoonShin,1,Design and evaluation of novel glutaminase inhibitors.,Inhibitor,,1,BPSbio,GLS1,O94925,0,0,0,Functional,Biochemical,inhibitor,0,,,
O95696_BRD1_wild_cl2,BRD1_5pnyB_8S1,O95696,O95696wild,BRD1,wild,cl2,5pnyB,8S1,,5pny,1,2,,0,JiYoonShin,1,A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.,Inhibitor,Bromodomain,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
O95696_BRD1_wild_cl2,BRD1_5po5B_8SM,O95696,O95696wild,BRD1,wild,cl2,5po5B,8SM,,5po5,1,2,,0,JiYoonShin,1,A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.,Inhibitor,Bromodomain,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
O95696_BRD1_wild_cl1,BRD1_5pooA_8TS,O95696,O95696wild,BRD1,wild,cl1,5pooA,8TS,,5poo,1,2,,0,JiYoonShin,1,A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.,Inhibitor,Bromodomain,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
O95696_BRD1_wild_cl1,BRD1_5povA_8TJ,O95696,O95696wild,BRD1,wild,cl1,5povA,8TJ,,5pov,1,2,,0,JiYoonShin,1,A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.,Inhibitor,Bromodomain,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
P01375_TNFA_wild_cl1,TNFA_6x81B_UTJ,P01375,P01375wild,TNFA,wild,cl1,6x81B,UTJ,,6x81,2,1,,0,JiYoonShin,1,Development of Orally Efficacious Allosteric inhibitors of TNF alpha via Fragment-Based Drug Design.,Inhibitor,allosteric,1,BPSbio,TNFR2:TNFA,P01375,0,0,0,Functional,Biochemical,inhibitor,0,,,
P01375_TNFA_wild_cl1,TNFA_6x85B_UTV,P01375,P01375wild,TNFA,wild,cl1,6x85B,UTV,,6x85,2,1,,0,JiYoonShin,1,Development of Orally Efficacious Allosteric inhibitors of TNF alpha via Fragment-Based Drug Design.,Inhibitor,allosteric,1,BPSbio,TNFR2:TNFA,P01375,0,0,0,Functional,Biochemical,inhibitor,0,,,
P05089_ARGI1_wild_cl1,ARGI1_3kv2B_NNH,P05089,P05089wild,ARGI1,wild,cl1,3kv2B,NNH,,3kv2,2,1,,0,JiYoonShin,1,inhibition of human arginase I by substrate and product analogues.,Inhibitor,,1,BPSbio,ARG1,P05089,0,0,0,Functional,Biochemical,inhibitor,0,,,
P05089_ARGI1_wild_cl1,ARGI1_3sjtB_5AB,P05089,P05089wild,ARGI1,wild,cl1,3sjtB,5AB,,3sjt,2,1,,0,JiYoonShin,1,Binding of alpha_alpha-Disubstituted Amino Acids to Arginase Suggests New Avenues for inhibitor Design,Inhibitor,,1,BPSbio,ARG1,P05089,0,0,0,Functional,Biochemical,inhibitor,0,,,
P07900_HS90A_wild_cl1,HS90A_3k98B_1RC,P07900,P07900wild,HS90A,wild,cl1,3k98B,1RC,,3k98,1,1,,0,JiYoonShin,1,Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone.,Inhibitor,,1,BPSbio,HSP90a (N and/or C ter),P07900,0,0,0,Functional,Biochemical,inhibitor,0,,,
P07900_HS90A_wild_cl1,HS90A_4fcrA_0TM,P07900,P07900wild,HS90A,wild,cl1,4fcrA,0TM,,4fcr,1,1,,0,JiYoonShin,1,Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2_3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization.,Inhibitor,,1,BPSbio,HSP90a (N and/or C ter),P07900,0,0,0,Functional,Biochemical,inhibitor,0,,,
P08238_HS90B_wild_cl1,HS90B_5uchD_871,P08238,P08238wild,HS90B,wild,cl1,5uchD,871,,5uch,1,1,,0,JiYoonShin,1,Structure-guided design of an Hsp90 beta N-terminal isoform-selective inhibitor.,Inhibitor,,1,BPSbio,HSP90b (N and/or C ter),P08238,0,0,0,Functional,Biochemical,inhibitor,0,,,
P08238_HS90B_wild_cl1,HS90B_5uciD_874,P08238,P08238wild,HS90B,wild,cl1,5uciD,874,,5uci,1,1,,0,JiYoonShin,1,Structure-guided design of an Hsp90 beta N-terminal isoform-selective inhibitor.,Inhibitor,,1,BPSbio,HSP90b (N and/or C ter),P08238,0,0,0,Functional,Biochemical,inhibitor,0,,,
P10415_BCL2_wild_cl1,BCL2_2o2fA_LI0,P10415,P10415wild,BCL2,wild,cl1,2o2fA,LI0,,2o2f,2,1,,0,JiYoonShin,1,Studies Leading to Potent_ Dual inhibitors of Bcl-2 and Bcl-xL.,Inhibitor,,1,BPSbio,BCL-2,P10415,0,0,0,Functional,Biochemical,inhibitor,0,,,
P10415_BCL2_wild_cl1,BCL2_4lxdA_1XV,P10415,P10415wild,BCL2,wild,cl1,4lxdA,1XV,,4lxd,2,1,,0,JiYoonShin,1,ABT-199_ a potent and selective BCL-2 inhibitor_ achieves antitumor activity while sparing platelets.,Inhibitor,,1,BPSbio,BCL-2,P10415,0,0,0,Functional,Biochemical,inhibitor,0,,,
P28907_CD38_wild_cl1,CD38_4xjsA_733,P28907,P28907wild,CD38,wild,cl1,4xjsA,733,,4xjs,2,1,,cyclase,,1,Discovery of 4-Amino-8-quinoline Carboxamides as Novel_ Submicromolar inhibitors of NAD-Hydrolyzing Enzyme CD38.,Inhibitor,,1,BPSbio,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P28907_CD38_wild_cl1,CD38_4xjtA_41Z,P28907,P28907wild,CD38,wild,cl1,4xjtA,41Z,,4xjt,2,1,,cyclase,,1,Discovery of 4-Amino-8-quinoline Carboxamides as Novel_ Submicromolar inhibitors of NAD-Hydrolyzing Enzyme CD38.,Inhibitor,,1,BPSbio,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P43490_NAMPT_wild_cl1,NAMPT_4jnmB_1LJ,P43490,P43490wild,NAMPT,wild,cl1,4jnmB,1LJ,,4jnm,1,1,,0,JiYoonShin,1,Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties.,Inhibitor,,1,BPSbio,NAMPT,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P43490_NAMPT_wild_cl1,NAMPT_5upfB_8HV,P43490,P43490wild,NAMPT,wild,cl1,5upfB,8HV,,5upf,1,1,,0,JiYoonShin,1,SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT).,Inhibitor,,1,BPSbio,NAMPT,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P46531_NOTCH1_wild_cl1,NOTCH1_4cudA_FUC,P46531,P46531wild,NOTCH1,wild,cl1,4cudA,FUC,,4cud,3,1,,0,JiYoonShin,1,Fringe-Mediated Extension of O-Linked Fucose in the Ligand-Binding Region of Notch1 Increases Binding to Mammalian Notch Ligands.,Binding,Ligand binding,1,BPSbio,Notch/CSL pathway,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
P51531_SMCA2_wild_cl1,SMCA2_5dkcA_5BW,P51531,P51531wild,SMCA2,wild,cl1,5dkcA,5BW,,5dkc,2,1,,0,JiYoonShin,1,Crystal structure of the bromodomain of human BRM (SMARCA2) in complex with PFI-3 chemical probe,Binding,PROTAC,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
P51531_SMCA2_wild_cl1,SMCA2_6hazB_FX5,P51531,P51531wild,SMCA2,wild,cl1,6hazB,FX5,,6haz,2,1,,0,JiYoonShin,1,BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.,Binding,PROTAC,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
P51532_SMCA4_wild_cl1,SMCA4_5dkdB_5BW,P51532,P51532wild,SMCA4,wild,cl1,5dkdB,5BW,,5dkd,2,1,,0,JiYoonShin,1,Crystal structure of the bromodomain of human BRG1 (SMARCA4) in complex with PFI-3 chemical probe,Binding,PROTAC,1,BPSbio,SMARCA4/BRG1,P51532,0,0,0,Functional,Biochemical,inhibitor,0,,,
P51532_SMCA4_wild_cl1,SMCA4_6zs2B_FX5,P51532,P51532wild,SMCA4,wild,cl1,6zs2B,FX5,,6zs2,2,1,,0,JiYoonShin,1,Pan-SMARCA/PB1 Bromodomain inhibitors and Their Role in Regulating Adipogenesis.,Inhibitor,,1,BPSbio,SMARCA4/BRG1,P51532,0,0,0,Functional,Biochemical,inhibitor,0,,,
P51570_GALK1_wild_cl1,GALK1_1wuuD_ANP,P51570,P51570wild,GALK1,wild,cl1,1wuuD,ANP,,1wuu,2,1,,Kinase,HoYoungLee,1,Molecular Structure of Human Galactokinase: IMPLICATIONS FOR TYPE II GALACTOSEMIA,Inhibitor,,1,BPSbio,GALK1,P51570,Kinase,0,0,0,0,inhibitors,Kinase-Glo reagent,,,
P51570_GALK1_wild_cl1,GALK1_6zgxE_HFK,P51570,P51570wild,GALK1,wild,cl1,6zgxE,HFK,,6zgx,2,1,,Kinase,HoYoungLee,1,Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 inhibitors to Treat Classic Galactosemia.,Inhibitor,,1,BPSbio,GALK1,P51570,Kinase,0,0,0,0,inhibitors,Kinase-Glo reagent,,,
P54252_ATXN3_wild_cl1,ATXN3_4wthA_MAL,P54252,P54252wild,ATXN3,wild,cl1,4wthA,MAL,,4wth,3,1,,0,JiYoonShin,1,The 2.2-Angstrom resolution crystal structure of the carboxy-terminal region of ataxin-3.,Binding,Ligand binding,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
P78536_ADA17_wild_cl1,ADA17_1zxcB_IH6,P78536,P78536wild,ADA17,wild,cl1,1zxcB,IH6,,1zxc,1,2,,0,JiYoonShin,1,Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.,Inhibitor,,1,BPSbio,ADAM17,P78536,0,0,0,Functional,Biochemical,inhibitor,0,,,
P78536_ADA17_wild_cl1,ADA17_2fv5B_541,P78536,P78536wild,ADA17,wild,cl1,2fv5B,541,,2fv5,1,2,,0,JiYoonShin,1,IK682_ a tight binding inhibitor of TACE.,Inhibitor,,1,BPSbio,ADAM17,P78536,0,0,0,Functional,Biochemical,inhibitor,0,,,
P78540_ARGI2_wild_cl1,ARGI2_6q37C_HE8,P78540,P78540wild,ARGI2,wild,cl1,6q37C,HE8,,6q37,3,1,,0,JiYoonShin,1,Discovery ofN-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation inhibitors of Human Arginase I and II.,Inhibitor,,1,BPSbio,ARG2,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P78540_ARGI2_wild_cl1,ARGI2_6q39C_HDQ,P78540,P78540wild,ARGI2,wild,cl1,6q39C,HDQ,,6q39,3,1,,0,JiYoonShin,1,Discovery ofN-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation inhibitors of Human Arginase I and II.,Inhibitor,,1,BPSbio,ARG2,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q01973_ROR1_wild_cl1,ROR1_6tu9B_0LI,Q01973,Q01973wild,ROR1,wild,cl1,6tu9B,0LI,,6tu9,3,1,,Kinase,HoYoungLee,1,Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.,Inhibitor,,1,BPSbio,ROR1,Q01973,Kinase,0,CAR-T,0,0,0,0,,,
Q07820_MCL1_wild_cl1,MCL1_5if4B_6AK,Q07820,Q07820wild,MCL1,wild,cl1,5if4B,6AK,,5if4,1,1,,0,JiYoonShin,1,Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors.,Inhibitor,,1,BPSbio,MCL1,0,0,0,0,Binding,Biochemical,Binding,0,,,
Q07820_MCL1_wild_cl1,MCL1_6fs1B_E4Q,Q07820,Q07820wild,MCL1,wild,cl1,6fs1B,E4Q,,6fs1,1,1,,0,JiYoonShin,1,Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.,Inhibitor,,1,BPSbio,MCL1,0,0,0,0,Binding,Biochemical,Binding,0,,,
Q09472_EP300_wild_cl1,EP300_5lpkF_XDM,Q09472,Q09472wild,EP300,wild,cl1,5lpkF,XDM,,5lpk,2,1,,0,JiYoonShin,1,Beyond the BET Family: Targeting CBP/p300 with 4-Acyl Pyrroles.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q09472_EP300_wild_cl1,EP300_5nu5B_99E,Q09472,Q09472wild,EP300,wild,cl1,5nu5B,99E,,5nu5,2,1,,0,JiYoonShin,1,Beyond the BET Family: Targeting CBP/p300 with 4-Acyl Pyrroles.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q12830_BPTF_wild_cl1,BPTF_5r4iA_RUV,Q12830,Q12830wild,BPTF,wild,cl1,5r4iA,RUV,,5r4i,1,1,,0,JiYoonShin,1,PanDDA analysis group deposition,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q12830_BPTF_wild_cl1,BPTF_5r4nA_K3D,Q12830,Q12830wild,BPTF,wild,cl1,5r4nA,K3D,,5r4n,1,1,,0,JiYoonShin,1,PanDDA analysis group deposition,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q15059_BRD3_wild_cl1,BRD3_3s92A_JQ1,Q15059,Q15059wild,BRD3,wild,cl1,3s92A,JQ1,,3s92,2,1,,0,JiYoonShin,1,Crystal Structure of the second bromodomain of human BRD3 in complex with the inhibitor JQ1,Inhibitor,,1,BPSbio,BRD3 (BD1 and/or BD2),Q15059,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q15059_BRD3_wild_cl1,BRD3_6qjuA_J58,Q15059,Q15059wild,BRD3,wild,cl1,6qjuA,J58,,6qju,2,1,,0,JiYoonShin,1,Br-O-modomain (BRD3) halogen binding to a small molecule,Inhibitor,,1,BPSbio,BRD3 (BD1 and/or BD2),Q15059,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q15116_PDCD1_wild_cl1,PDCD1_7cu5Q_FUC,Q15116,Q15116wild,PDCD1,wild,cl1,7cu5Q,FUC,,7cu5,3,1,,0,JiYoonShin,1,N-glycosylation of PD-1 promotes binding of camrelizumab.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q15118_PDK1_wild_cl1,PDK1_2q8gA_AZX,Q15118,Q15118wild,PDK1,wild,cl1,2q8gA,AZX,,2q8g,2,1,,Kinase,HoYoungLee,1,Distinct Structural Mechanisms for inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545_ Dichloroacetate_ and Radicicol.,Inhibitor,,1,BPSbio,PDHK1 ,Q15118,Kinase,0,0,0,0,inhibitors,0,,,
Q15120_PDK3_wild_cl1,PDK3_1y8oA_ADP,Q15120,Q15120wild,PDK3,wild,cl1,1y8oA,ADP,,1y8o,2,1,,Kinase,HoYoungLee,1,Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.,Inhibitor,,1,BPSbio,PDK3,Q15120.1,Kinase,0,0,0,0,0,0,,,
Q15120_PDK3_wild_cl1,PDK3_2q8iA_RDC,Q15120,Q15120wild,PDK3,wild,cl1,2q8iA,RDC,,2q8i,2,1,,Kinase,HoYoungLee,1,Distinct Structural Mechanisms for inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545_ Dichloroacetate_ and Radicicol.,Inhibitor,,1,BPSbio,PDK3,Q15120.1,Kinase,0,0,0,0,0,0,,,
Q16719_KYNU_wild_cl1,KYNU_3e9kA_3XH,Q16719,Q16719wild,KYNU,wild,cl1,3e9kA,3XH,,3e9k,3,1,,0,JiYoonShin,1,Crystal structure of the Homo sapiens kynureninase-3-hydroxyhippuric acid inhibitor complex: insights into the molecular basis of kynureninase substrate specificity.,Inhibitor,,1,BPSbio,Kynureninase ,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q16719_KYNU_wild_cl1,KYNU_3e9kA_PLP,Q16719,Q16719wild,KYNU,wild,cl1,3e9kA,PLP,,3e9k,3,1,,0,JiYoonShin,1,Crystal structure of the Homo sapiens kynureninase-3-hydroxyhippuric acid inhibitor complex: insights into the molecular basis of kynureninase substrate specificity.,Inhibitor,,1,BPSbio,Kynureninase ,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q58F21_BRDT_wild_cl1,BRDT_4kcxB_1QK,Q58F21,Q58F21wild,BRDT,wild,cl1,4kcxB,1QK,,4kcx,2,1,,0,JiYoonShin,1,Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.,Inhibitor,,1,BPSbio,BRDT (BD1 and BD2),0,0,0,0,Binding,Biochemical,Binding,0,,,
Q58F21_BRDT_wild_cl1,BRDT_5vbrB_IBI,Q58F21,Q58F21wild,BRDT,wild,cl1,5vbrB,IBI,,5vbr,2,1,,0,JiYoonShin,1,Differential BET Bromodomain inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase inhibitors.,Inhibitor,,1,BPSbio,BRDT (BD1 and BD2),0,0,0,0,Binding,Biochemical,Binding,0,,,
Q6P6C2_ALKB5_wild_cl1,ALKB5_4nrmA_FLC,Q6P6C2,Q6P6C2wild,ALKB5,wild,cl1,4nrmA,FLC,,4nrm,3,1,,0,JiYoonShin,1,Crystal structures of the human RNA demethylase Alkbh5 reveal basis for substrate recognition,Inhibitor,RNA binding,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q6P6C2_ALKB5_wild_cl1,ALKB5_4o61B_CIT,Q6P6C2,Q6P6C2wild,ALKB5,wild,cl1,4o61B,CIT,,4o61,3,1,,0,JiYoonShin,1,Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation.,Inhibitor,RNA binding,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q6PL18_ATAD2_wild_cl1,ATAD2_5a81A_78J,Q6PL18,Q6PL18wild,ATAD2,wild,cl1,5a81A,78J,,5a81,2,1,,ATPase,,1,Structure-Based Optimization of Naphthyridones Into Potent Atad2 Bromodomain inhibitors.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q6PL18_ATAD2_wild_cl1,ATAD2_5lj0A_6XX,Q6PL18,Q6PL18wild,ATAD2,wild,cl1,5lj0A,6XX,,5lj0,2,1,,ATPase,,1,A Chemical Probe for the ATAD2 Bromodomain.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q86U44_MTA70_wild_cl1,MTA70_5k7uA_SAM,Q86U44,Q86U44wild,MTA70,wild,cl1,5k7uA,SAM,,5k7u,1,1,,0,JiYoonShin,1,Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases.,Inhibitor,,1,BPSbio,METTL3/METTL14,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q86U44_MTA70_wild_cl1,MTA70_6ttvA_NWW,Q86U44,Q86U44wild,MTA70,wild,cl1,6ttvA,NWW,,6ttv,1,1,,0,JiYoonShin,1,Small-Molecule inhibitors of METTL3_ the Major Human Epitranscriptomic Writer.,Inhibitor,,1,BPSbio,METTL3/METTL14,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8IXJ6_SIR2_wild_cl1,SIR2_5matA_7KJ,Q8IXJ6,Q8IXJ6wild,SIR2,wild,cl1,5matA,7KJ,,5mat,2,1,,0,JiYoonShin,1,Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective inhibitors Bind in the Ligand Induced Selectivity Pocket.,Inhibitor,,1,BPSbio,SIRT2,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8IXJ6_SIR2_wild_cl1,SIR2_5y0zB_8K9,Q8IXJ6,Q8IXJ6wild,SIR2,wild,cl1,5y0zB,8K9,,5y0z,2,1,,0,JiYoonShin,1,Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.,Inhibitor,,1,BPSbio,SIRT2,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8IZX4_TAF1L_wild_cl1,TAF1L_5iglA_BMF,Q8IZX4,Q8IZX4wild,TAF1L,wild,cl1,5iglA,BMF,,5igl,2,1,,0,JiYoonShin,1,Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.,Inhibitor,Kd 42.7nM,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q8N6T7_SIR6_wild_cl2,SIR6_3k35F_APR,Q8N6T7,Q8N6T7wild,SIR6,wild,cl2,3k35F,APR,,3k35,2,2,,0,JiYoonShin,1,Structure and biochemical functions of SIRT6.,Inhibitor,,1,BPSbio,SIRT6,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8N6T7_SIR6_wild_cl1,SIR6_5mfpA_7M5,Q8N6T7,Q8N6T7wild,SIR6,wild,cl1,5mfpA,7M5,,5mfp,2,2,,0,JiYoonShin,1,Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.,Activator,,1,BPSbio,SIRT6,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8N6T7_SIR6_wild_cl2,SIR6_5mfpB_AR6,Q8N6T7,Q8N6T7wild,SIR6,wild,cl2,5mfpB,AR6,,5mfp,2,2,,0,JiYoonShin,1,Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules.,Inhibitor,,1,BPSbio,SIRT6,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8N6T7_SIR6_wild_cl1,SIR6_6qceA_HW2,Q8N6T7,Q8N6T7wild,SIR6,wild,cl1,6qceA,HW2,,6qce,2,2,,0,JiYoonShin,1,Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives.,Activator,,1,BPSbio,SIRT6,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q8WWQ0_PHIP_wild_cl1,PHIP_5rjoA_1P8,Q8WWQ0,Q8WWQ0wild,PHIP,wild,cl1,5rjoA,1P8,,5rjo,2,1,,0,JiYoonShin,1,PanDDA analysis group deposition of ground-state model,Inhibitor,PPI,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q8WWQ0_PHIP_wild_cl1,PHIP_5enfA_5Q7,Q8WWQ0,Q8WWQ0wild,PHIP,wild,cl1,5enfA,5Q7,,5enf,2,1,,0,JiYoonShin,1,A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2)_ an atypical bromodomain.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q92793_CBP_wild_cl1,CBP_5ktxA_6XH,Q92793,Q92793wild,CBP,wild,cl1,5ktxA,6XH,,5ktx,1,1,,0,JiYoonShin,1,Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q92793_CBP_wild_cl1,CBP_5nlkA_92E,Q92793,Q92793wild,CBP,wild,cl1,5nlkA,92E,,5nlk,1,1,,0,JiYoonShin,1,Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q96EB6_SIR1_wild_cl1,SIR1_4i5iB_NAD,Q96EB6,Q96EB6wild,SIR1,wild,cl1,4i5iB,NAD,,4i5i,2,1,,0,JiYoonShin,1,The 2.5 angstrom crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q96EB6_SIR1_wild_cl1,SIR1_4zzjA_CNA,Q96EB6,Q96EB6wild,SIR1,wild,cl1,4zzjA,CNA,,4zzj,2,1,,0,JiYoonShin,1,Crystallographic structure of a small molecule SIRT1 activator-enzyme complex.,Activator,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q96F46_IL17RA_wild_cl1,IL17RA_4hsaC_FUC,Q96F46,Q96F46wild,IL17RA,wild,cl1,4hsaC,FUC,,4hsa,3,1,,0,JiYoonShin,1,Crystal structures of interleukin 17A and its complex with IL-17 receptor A.,Binding,Ligand binding,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q96KB5_TOPK_wild_cl1,TOPK_5j0aB_HC4,Q96KB5,Q96KB5wild,TOPK,wild,cl1,5j0aB,HC4,,5j0a,3,1,,Kinase,HoYoungLee,1,The crystal structure of an inactive dimer of PDZ-binding kinase,Inhibitor,,1,BPSbio,TOPK,Q96KB5,Kinase,0,Protein Ser/Thr,0,0,0,0,,,
Q9BXF3_CECR2_wild_cl1,CECR2_5v84D_96V,Q9BXF3,Q9BXF3wild,CECR2,wild,cl1,5v84D,96V,,5v84,2,1,,0,JiYoonShin,1,GNE-886: A Potent and Selective inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2).,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9C0B1_FTO_wild_cl1,FTO_3lfmA_3DT,Q9C0B1,Q9C0B1wild,FTO,wild,cl1,3lfmA,3DT,,3lfm,2,1,,0,JiYoonShin,1,Crystal structure of the FTO protein reveals basis for its substrate specificity,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9C0B1_FTO_wild_cl1,FTO_6ak4A_PD9,Q9C0B1,Q9C0B1wild,FTO,wild,cl1,6ak4A,PD9,,6ak4,2,1,,0,JiYoonShin,1,Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9H8M2_BRD9_wild_cl1,BRD9_5eu1B_5SW,Q9H8M2,Q9H8M2wild,BRD9,wild,cl1,5eu1B,5SW,,5eu1,1,1,,0,JiYoonShin,1,Structure-Based Design of an in Vivo Active Selective BRD9 inhibitor.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9H8M2_BRD9_wild_cl1,BRD9_5f1hB_5U6,Q9H8M2,Q9H8M2wild,BRD9,wild,cl1,5f1hB,5U6,,5f1h,1,1,,0,JiYoonShin,1,Structure-Based Design of an in Vivo Active Selective BRD9 inhibitor.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NTG7_SIRT3_wild_cl1,SIRT3_4jsrA_1NQ,Q9NTG7,Q9NTG7wild,SIRT3,wild,cl1,4jsrA,1NQ,,4jsr,2,1,,0,JiYoonShin,1,Discovery of Thieno[3_2-d]pyrimidine-6-carboxamides as Potent inhibitors of SIRT1_ SIRT2_ and SIRT3.,Inhibitor,,1,BPSbio,SIRT3,0,0,0,0,0,0,inhibitor,0,,,
Q9NTG7_SIRT3_wild_cl1,SIRT3_4jt9A_1NS,Q9NTG7,Q9NTG7wild,SIRT3,wild,cl1,4jt9A,1NS,,4jt9,2,1,,0,JiYoonShin,1,Discovery of Thieno[3_2-d]pyrimidine-6-carboxamides as Potent inhibitors of SIRT1_ SIRT2_ and SIRT3.,Inhibitor,,1,BPSbio,SIRT3,0,0,0,0,0,0,inhibitor,0,,,
Q9NXA8_SIR5_wild_cl1,SIR5_3rigB_NHE,Q9NXA8,Q9NXA8wild,SIR5,wild,cl1,3rigB,NHE,,3rig,2,1,,0,JiYoonShin,1,Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9NXA8_SIR5_wild_cl1,SIR5_3riyB_NAD,Q9NXA8,Q9NXA8wild,SIR5,wild,cl1,3riyB,NAD,,3riy,2,1,,0,JiYoonShin,1,Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9NYA1_SPHK1_wild_cl1,SPHK1_3vzdF_UUL,Q9NYA1,Q9NYA1wild,SPHK1,wild,cl1,3vzdF,UUL,,3vzd,2,1,,0,JiYoonShin,1,Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NYA1_SPHK1_wild_cl1,SPHK1_4l02C_1V2,Q9NYA1,Q9NYA1wild,SPHK1,wild,cl1,4l02C,1V2,,4l02,2,1,,0,JiYoonShin,1,Structure guided design of a series of sphingosine kinase (SphK) inhibitors.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NZQ7_PD1L1_wild_cl2,PD1L1_5j89B_6GX,Q9NZQ7,Q9NZQ7wild,PD1L1,wild,cl2,5j89B,6GX,,5j89,3,2,,0,JiYoonShin,1,Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NZQ7_PD1L1_wild_cl2,PD1L1_5j8oA_6GZ,Q9NZQ7,Q9NZQ7wild,PD1L1,wild,cl2,5j8oA,6GZ,,5j8o,3,2,,0,JiYoonShin,1,Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1).,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NZQ7_PD1L1_wild_cl1,PD1L1_5nixD_8YQ,Q9NZQ7,Q9NZQ7wild,PD1L1,wild,cl1,5nixD,8YQ,,5nix,3,2,6R3K_ Diff Lig,0,JiYoonShin,1,Terphenyl-Based Small-Molecule inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NZQ7_PD1L1_wild_cl1,PD1L1_6vqnC_R81,Q9NZQ7,Q9NZQ7wild,PD1L1,wild,cl1,6vqnC,R81,,6vqn,3,2,,0,JiYoonShin,1,Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1.,Inhibitor,,1,BPSbio,0,0,0,0,0,0,0,inhibitor,0,,,
Q9UIF8_BAZ2B_wild_cl1,BAZ2B_4ir5A_IR5,Q9UIF8,Q9UIF8wild,BAZ2B,wild,cl1,4ir5A,IR5,,4ir5,2,1,,0,JiYoonShin,1,Discovery and Characterization of GSK2801_ a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9UIF8_BAZ2B_wild_cl1,BAZ2B_4xubA_43D,Q9UIF8,Q9UIF8wild,BAZ2B,wild,cl1,4xubA,43D,,4xub,2,1,,0,JiYoonShin,1,Structure Enabled Design of BAZ2-ICR_ A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9ULI0_ATD2B_wild_cl1,ATD2B_6veoA_YD4,Q9ULI0,Q9ULI0wild,ATD2B,wild,cl1,6veoA,YD4,,6veo,3,1,,ATPase,,1,Structural Insights into the Recognition of Mono- and Diacetylated Histones by the ATAD2B Bromodomain.,inhibitor,,1,BPSbio,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q9Y275_TN13B_wild_cl1,TN13B_1kxgA_CIT,Q9Y275,Q9Y275wild,TN13B,wild,cl1,1kxgA,CIT,,1kxg,3,1,,0,JiYoonShin,1,Structural basis of BLyS receptor recognition.,apo,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9Y468_LMBTL_wild_cl1,LMBTL_2rhuA_PG4,Q9Y468,Q9Y468wild,LMBTL,wild,cl1,2rhuA,PG4,MLY,2rhu,2,2,,0,JiYoonShin,1,Structural Basis for Lower Lysine Methylation State-Specific Readout by MBT Repeats of L3MBTL1 and an Engineered PHD Finger.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9Y468_LMBTL_wild_cl1,LMBTL_2rhxA_PG4,Q9Y468,Q9Y468wild,LMBTL,wild,cl1,2rhxA,MLY,,2rhx,2,2,,0,JiYoonShin,1,Structural Basis for Lower Lysine Methylation State-Specific Readout by MBT Repeats of L3MBTL1 and an Engineered PHD Finger.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9Y468_LMBTL_wild_cl2,LMBTL_3p8hB_P8H,Q9Y468,Q9Y468wild,LMBTL,wild,cl2,3p8hB,P8H,,3p8h,2,2,,0,JiYoonShin,1,Small-molecule ligands of methyl-lysine binding proteins.,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
Q9Y468_LMBTL_wild_cl2,LMBTL_3uwnA_UWN,Q9Y468,Q9Y468wild,LMBTL,wild,cl2,3uwnA,UWN,,3uwn,2,2,,0,JiYoonShin,1,The 3-MBT repeat domain of L3MBTL1 in complex with a methyl-lysine mimic,inhibitor,,1,BPSbio,0,0,0,0,0,0,0,0,0,,,
O00141_SGK1_wild_cl1,SGK1_2r5tA_ANP,O00141,O00141wild,SGK1,wild,cl1,2r5tA,ANP,,2r5t,2,1,,Kinase,HoYoungLee,1,Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP.,Inhibitor,,1,CEREP,SGK1,O00141,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00141_SGK1_wild_cl1,SGK1_3hdmA_MMG,O00141,O00141wild,SGK1,wild,cl1,3hdmA,MMG,,3hdm,2,1,,Kinase,HoYoungLee,1,Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.,Inhibitor,,1,CEREP,SGK1,O00141,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00238_BMR1B_wild_cl1,BMR1B_3mdyC_LDN,O00238,O00238wild,BMR1B,wild,cl1,3mdyC,LDN,,3mdy,3,1,,Kinase,HoYoungLee,1,Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189,Inhibitor,,1,CEREP,ALK6,O00238,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00311_CDC7_wild_cl1,CDC7_6ya6A_0SX,O00311,O00311wild,CDC7,wild,cl1,6ya6A,0SX,,6ya6,2,1,,Kinase,HoYoungLee,1,Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase.,Inhibitor,,1,CEREP,CDC7,O00311,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00311_CDC7_wild_cl1,CDC7_6ya7A_ADP,O00311,O00311wild,CDC7,wild,cl1,6ya7A,ADP,,6ya7,2,1,,Kinase,HoYoungLee,1,Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase.,Inhibitor,,1,CEREP,CDC7,O00311,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00329_PK3CD_wild_cl1,PK3CD_5vlrA_9EM,O00329,O00329wild,PK3CD,wild,cl1,5vlrA,9EM,,5vlr,1,1,,Kinase,HoYoungLee,1,Identification of a Potent_ Selective_ and Efficacious Phosphatidylinositol 3-Kinase delta (PI3K delta ) inhibitor for the Treatment of Immunological Disorders.,Inhibitor,,1,CEREP,PI3Kdelta,O00329,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
O00329_PK3CD_wild_cl1,PK3CD_6pyuA_P5V,O00329,O00329wild,PK3CD,wild,cl1,6pyuA,P5V,,6pyu,1,1,,Kinase,HoYoungLee,1,Design of selective PI3K delta inhibitors using an iterative scaffold-hopping workflow.,Inhibitor,,1,CEREP,PI3Kdelta,O00329,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
O00443_PIK3C2A_wild_cl1,PIK3C2A_6btzB_O4B,O00443,O00443wild,PIK3C2A,wild,cl1,6btzB,O4B,,6btz,3,2,,Kinase,HoYoungLee,1,Molecular Basis for Membrane Recruitment by the PX and C2 Domains of Class II Phosphoinositide 3-Kinase-C2 alpha.,Inhibitor,,1,CEREP,PI3K-C2alpha,O00443,Kinase,PtdIns4P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
O00443_PIK3C2A_wild_cl1,PIK3C2A_6btzD_O4B,O00443,O00443wild,PIK3C2A,wild,cl1,6btzD,O4B,,6btz,3,2,,Kinase,HoYoungLee,1,Molecular Basis for Membrane Recruitment by the PX and C2 Domains of Class II Phosphoinositide 3-Kinase-C2 alpha.,Inhibitor,,1,CEREP,PI3K-C2alpha,O00443,Kinase,PtdIns4P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
O00443_PIK3C2A_wild_cl2,PIK3C2A_6bu0B_IHP,O00443,O00443wild,PIK3C2A,wild,cl2,6bu0B,IHP,,6bu0,3,2,,Kinase,HoYoungLee,1,Molecular Basis for Membrane Recruitment by the PX and C2 Domains of Class II Phosphoinositide 3-Kinase-C2 alpha.,Inhibitor,,1,CEREP,PI3K-C2alpha,O00443,Kinase,PtdIns4P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
O00444_PLK4_wild_cl1,PLK4_4jxfA_631,O00444,O00444wild,PLK4,wild,cl1,4jxfA,631,,4jxf,2,1,,Kinase,HoYoungLee,1,Crystal Structure of PLK4 Kinase with an inhibitor: 400631,Inhibitor,,1,CEREP,PLK4,O00444,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00444_PLK4_wild_cl1,PLK4_4yurA_4J7,O00444,O00444wild,PLK4,wild,cl1,4yurA,4J7,,4yur,2,1,,Kinase,HoYoungLee,1,Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4.,Inhibitor,,1,CEREP,PLK4,O00444,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O00506_STK25_wild_cl1,STK25_2xikA_J60,O00506,O00506wild,STK25,wild,cl1,2xikA,J60,,2xik,3,1,,Kinase,HoYoungLee,1,Structure of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1),Inhibitor,,1,CEREP,YSK1,O00506,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14744_ANM5_wild_cl1,ANM5_4x60A_3XV,O14744,O14744wild,ANM5,wild,cl1,4x60A,3XV,,4x60,2,1,,methylase,SooYongLee,1,A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.,Inhibitor,,1,CEREP,PRMT5,O14744,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14744_ANM5_wild_cl1,ANM5_5emkA_5QH,O14744,O14744wild,ANM5,wild,cl1,5emkA,5QH,,5emk,2,1,,methylase,SooYongLee,1,Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666.,Inhibitor,,1,CEREP,PRMT5,O14744,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14757_CHK1_wild_cl1,CHK1_2gdoA_12C,O14757,O14757wild,CHK1,wild,cl1,2gdoA,12C,,2gdo,1,1,,Kinase,HoYoungLee,1,4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors.,Inhibitor,,1,CEREP,CHK1,O14757,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14757_CHK1_wild_cl1,CHK1_4hyhA_1AM,O14757,O14757wild,CHK1,wild,cl1,4hyhA,1AM,,4hyh,1,1,,Kinase,HoYoungLee,1,Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.,Inhibitor,,1,CEREP,CHK1,O14757,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14842_FFAR1_88_cl1,FFAR1_4phuA_2YB,O14842,O1484288,FFAR1,88,cl1,4phuA,2YB,,4phu,2,2,,GPCR,,1,High-resolution structure of the human GPR40 receptor bound to Allosteric Agonist TAK-875.,Activator,allosteric,1,CEREP,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
O14842_FFAR1_88_cl1,FFAR1_5tzrA_MK6,O14842,O1484288,FFAR1,88,cl1,5tzrA,MK6,,5tzr,2,2,,GPCR,,1,Structural basis for the cooperative Allosteric activation of the free fatty acid receptor GPR40.,Activator,allosteric,1,CEREP,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
O14920_IKKB_wild_cl1,IKKB_4kikB_KSA,O14920,O14920wild,IKKB,wild,cl1,4kikB,KSA,,4kik,2,1,,Kinase,HoYoungLee,1,Crystal Structure of a Human I kappa B Kinase beta Asymmetric Dimer.,Inhibitor,,1,CEREP,IKBKB,O14920,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14965_STK6_wild_cl1,STK6_3mygA_EML,O14965,O14965wild,STK6,wild,cl1,3mygA,EML,,3myg,1,1,,Kinase,HoYoungLee,1,Discovery of a Potent_ Injectable inhibitor of Aurora Kinases Based on the Imidazo-[1_2-a]-Pyrazine Core.,Inhibitor,,1,CEREP,Aurora-A,O14965,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14965_STK6_wild_cl1,STK6_3vapA_0FY,O14965,O14965wild,STK6,wild,cl1,3vapA,0FY,,3vap,1,1,,Kinase,HoYoungLee,1,Synthesis and SAR studies of imidazo-[1_2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity.,Inhibitor,,1,CEREP,Aurora-A,O14965,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14976_GAK_wild_cl1,GAK_4c58A_824,O14976,O14976wild,GAK,wild,cl1,4c58A,824,,4c58,2,1,,Kinase,HoYoungLee,1,Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.,Inhibitor,,1,CEREP,GAK,O14976,Kinase,CAMK,Protein Serine/Threonine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14976_GAK_wild_cl1,GAK_5y7zB_IRE,O14976,O14976wild,GAK,wild,cl1,5y7zB,IRE,,5y7z,2,1,,Kinase,HoYoungLee,1,Structural Basis for the inhibition of Cyclin G-Associated Kinase by Gefitinib.,Inhibitor,,1,CEREP,GAK,O14976,Kinase,CAMK,Protein Serine/Threonine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O15054_KDM6B_wild_cl1,KDM6B_4askB_K0I,O15054,O15054wild,KDM6B,wild,cl1,4askB,K0I,,4ask,2,1,,0,JiYoonShin,1,A Selective Jumonji H3K27 Demethylase inhibitor Modulates the Proinflammatory Macrophage Response,Inhibitor,,1,CEREP,JMJD3,O15054,Epigenetic,Histone Demethylase,Eraser,Functional,Biochemical,inhibitor,0,,,
O15054_KDM6B_wild_cl1,KDM6B_5fp3B_3JI,O15054,O15054wild,KDM6B,wild,cl1,5fp3B,3JI,,5fp3,2,1,,0,JiYoonShin,1,Cell Penetrant inhibitors of the Kdm4 and Kdm5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-Pyridine Carboxylate Derivatives.,Inhibitor,,1,CEREP,JMJD3,O15054,Epigenetic,Histone Demethylase,Eraser,Functional,Biochemical,inhibitor,0,,,
O15264_MK13_wild_cl1,MK13_4eyjA_N61,O15264,O15264wild,MK13,wild,cl1,4eyjA,N61,,4eyj,2,1,,Kinase,HoYoungLee,1,IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.,Inhibitor,,1,CEREP,p38delta,O15264,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O15264_MK13_wild_cl1,MK13_5ekoA_N17,O15264,O15264wild,MK13,wild,cl1,5ekoA,N17,,5eko,2,1,,Kinase,HoYoungLee,1,First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.,Inhibitor,,1,CEREP,p38delta,O15264,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O15379_HDAC3_wild_cl1,HDAC3_4a69B_I0P,O15379,O15379wild,HDAC3,wild,cl1,4a69B,I0P,,4a69,3,1,,Acetylase,SooYongLee,1,Structure of Hdac3 Bound to Co-Repressor and Inositol Tetraphosphate.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O15530_PDPK1_wild_cl1,PDPK1_3qd0A_3Q4,O15530,O15530wild,PDPK1,wild,cl1,3qd0A,3Q4,,3qd0,1,1,,Kinase,HoYoungLee,1,Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) inhibitors.,Inhibitor,,1,CEREP,PDK1,O15530,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O15530_PDPK1_wild_cl1,PDPK1_3qd4A_3Q6,O15530,O15530wild,PDPK1,wild,cl1,3qd4A,3Q6,,3qd4,1,1,,Kinase,HoYoungLee,1,Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) inhibitors.,Inhibitor,,1,CEREP,PDK1,O15530,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O15550_KDM6A_wild_cl1,KDM6A_6fulA_E7Z,O15550,O15550wild,KDM6A,wild,cl1,6fulA,E7Z,,6ful,3,1,,0,JiYoonShin,1,In Silico Identification of JMJD3 Demethylase inhibitors.,Inhibitor,,1,CEREP,UTX,O15550,0,0,0,Functional,Biochemical,Inhibitor,0,,,
O15550_KDM6A_wild_cl1,KDM6A_6g8fA_K0I,O15550,O15550wild,KDM6A,wild,cl1,6g8fA,K0I,,6g8f,3,1,,0,JiYoonShin,1,In Silico Identification of JMJD3 Demethylase inhibitors.,Inhibitor,,1,CEREP,UTX,O15550,0,0,0,Functional,Biochemical,Inhibitor,0,,,
O43293_DAPK3_wild_cl1,DAPK3_3bhyA_7CP,O43293,O43293wild,DAPK3,wild,cl1,3bhyA,7CP,,3bhy,2,1,,Kinase,HoYoungLee,1,7_8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.,Inhibitor,,1,CEREP,DAPK3,O43293,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O43293_DAPK3_wild_cl1,DAPK3_5vjaD_DUK,O43293,O43293wild,DAPK3,wild,cl1,5vjaD,DUK,,5vja,2,1,,Kinase,HoYoungLee,1,Targeting Pim Kinases and DAPK3 to Control Hypertension.,Inhibitor,,1,CEREP,DAPK3,O43293,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O43318_MAP3K7_wild_cl1,MAP3K7_2yiyA_YIY,O43318,O43318wild,MAP3K7,wild,cl1,2yiyA,YIY,,2yiy,3,1,,Kinase,HoYoungLee,1,The Discovery and Synthesis of Selective Dfg-Out Tak-1 inhibitors,Inhibitor,,1,CEREP,TAK1,O43318,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O43353_RIPK2_wild_cl1,RIPK2_5ar5B_IQ7,O43353,O43353wild,RIPK2,wild,cl1,5ar5B,IQ7,,5ar5,1,1,,Kinase,HoYoungLee,1,Crystal Structures of Human Rip2 Kinase Catalytic Domain Complexed with ATP-Competitive inhibitors: Foundations for Understanding inhibitor Selectivity.,Inhibitor,,1,CEREP,RIPK2,O43353,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O43353_RIPK2_wild_cl1,RIPK2_5ar8A_XYW,O43353,O43353wild,RIPK2,wild,cl1,5ar8A,XYW,,5ar8,1,1,,Kinase,HoYoungLee,1,Crystal Structures of Human Rip2 Kinase Catalytic Domain Complexed with ATP-Competitive inhibitors: Foundations for Understanding inhibitor Selectivity.,Inhibitor,,1,CEREP,RIPK2,O43353,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O43613_OX1R_wild_cl1,OX1R_4zjcA_4OT,O43613,O43613wild,OX1R,wild,cl1,4zjcA,4OT,,4zjc,2,3,,GPCR,,1,Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O43613_OX1R_wild_cl1,OX1R_6tosA_NRE,O43613,O43613wild,OX1R,wild,cl1,6tosA,NRE,,6tos,2,3,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O43614_OX2R_wild_cl1,OX2R_6tpjB_SUV,O43614,O43614wild,OX2R,wild,cl1,6tpjB,SUV,,6tpj,2,2,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O43781_DYRK3_wild_cl1,DYRK3_5y86A_HRM,O43781,O43781wild,DYRK3,wild,cl1,5y86A,HRM,,5y86,3,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Dual-Specificity Tyrosine-Regulated Kinase 3 Reveals New Structural Features and Insights into its Auto-phosphorylation,Inhibitor,,1,CEREP,DYRK3,O43781,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O60674_JAK2_wild_cl1,JAK2_3kckA_3KC,O60674,O60674wild,JAK2,wild,cl1,3kckA,3KC,,3kck,2,2,,Kinase,HoYoungLee,1,A novel chemotype of kinase inhibitors: Discovery of 3_4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.,Inhibitor,,1,CEREP,JAK2,O60674,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O60674_JAK2_wild_cl1,JAK2_4jiaA_1K3,O60674,O60674wild,JAK2,wild,cl1,4jiaA,1K3,,4jia,2,2,,Kinase,HoYoungLee,1,2-Amino-[1_2_4]triazolo[1_5-a]pyridines as JAK2 inhibitors.,Inhibitor,,1,CEREP,JAK2,O60674,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O60678_ANM3_wild_cl1,ANM3_3smqA_TDU,O60678,O60678wild,ANM3,wild,cl1,3smqA,TDU,,3smq,2,2,,methylase,SooYongLee,1,An Allosteric inhibitor of protein arginine methyltransferase 3.,Inhibitor,allosteric,1,CEREP,PRMT3,O60678,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Functional,Cell Based Binding,Agonist,_,,,
O60678_ANM3_wild_cl2,ANM3_2fytA_SAH,O60678,O60678wild,ANM3,wild,cl2,2fytA,SAH,,2fyt,2,2,,methylase,SooYongLee,1,The Crystal Structure of Human HMT1 hnRNP methyltransferase-like 3 in complex with SAH.,Inhibitor,,1,CEREP,PRMT3,O60678,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Functional,Cell Based Binding,Agonist,_,,,
O75116_ROCK2_wild_cl1,ROCK2_5u7rD_81G,O75116,O75116wild,ROCK2,wild,cl1,5u7rD,81G,,5u7r,2,1,,Kinase,HoYoungLee,1,Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2_3-dihydrothieno[3_2-d]pyrimidin-4(1H)-ones.,Inhibitor,,1,CEREP,ROCK2,O75116,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75116_ROCK2_wild_cl1,ROCK2_7jntH_VFA,O75116,O75116wild,ROCK2,wild,cl1,7jntH,VFA,,7jnt,2,1,,Kinase,HoYoungLee,1,Identification of 5H-chromeno[3_4-c]pyridine and 6H-isochromeno[3_4-c]pyridine derivatives as potent and selective dual ROCK inhibitors.,Inhibitor,,1,CEREP,ROCK2,O75116,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75385_ULK1_wild_cl1,ULK1_4wnoA_3RF,O75385,O75385wild,ULK1,wild,cl1,4wnoA,3RF,,4wno,2,1,,Kinase,HoYoungLee,1,Structure of the Human Autophagy Initiating Kinase ULK1 in Complex with Potent inhibitors.,Inhibitor,,1,CEREP,ULK1,O75385,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75385_ULK1_wild_cl1,ULK1_6mnhA_JVD,O75385,O75385wild,ULK1,wild,cl1,6mnhA,JVD,,6mnh,2,1,,Kinase,HoYoungLee,1,Idea2Data: Toward a New Paradigm for Drug Discovery.,Inhibitor,,1,CEREP,ULK1,O75385,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75460_ERN1_wild_cl1,ERN1_4u6rA_3E4,O75460,O75460wild,ERN1,wild,cl1,4u6rA,30000,,4u6r,1,1,,Kinase,HoYoungLee,1,Unfolded Protein Response in Cancer: IRE1 alpha inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability.,Inhibitor,,1,CEREP,IRE1,O75460,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75460_ERN1_wild_cl1,ERN1_6urcB_QFV,O75460,O75460wild,ERN1,wild,cl1,6urcB,QFV,,6urc,1,1,,Kinase,HoYoungLee,1,Disruption of IRE1 alpha through its kinase domain attenuates multiple myeloma.,Inhibitor,,1,CEREP,IRE1,O75460,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75582_KS6A5_wild_cl1,KS6A5_3kn5B_ANP,O75582,O75582wild,KS6A5,wild,cl1,3kn5B,ANP,,3kn5,3,1,,Kinase,HoYoungLee,1,The crystal structure of the active form of the C-terminal kinase domain of mitogen- and stress-activated protein kinase 1.,Inhibitor,,1,CEREP,RPS6KA5,O75582,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O75914_PAK3_wild_cl1,PAK3_6fd3A_ADP,O75914,O75914wild,PAK3,wild,cl1,6fd3A,ADP,,6fd3,2,1,,Kinase,HoYoungLee,1,Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited incis.,Inhibitor,,1,CEREP,PAK3,O75914,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O76039_CDKL5_wild_cl1,CDKL5_4bgqA_38R,O76039,O76039wild,CDKL5,wild,cl1,4bgqA,38R,,4bgq,2,1,,Kinase,HoYoungLee,1,CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.,Inhibitor,,1,CEREP,CDKL5,O76039,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O94768_ST17B_wild_cl1,ST17B_6y6fA_OD2,O94768,O94768wild,ST17B,wild,cl1,6y6fA,OD2,,6y6f,1,1,,Kinase,HoYoungLee,1,A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.,Inhibitor,,1,CEREP,STK17B,O94768,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O94768_ST17B_wild_cl1,ST17B_6zjfA_QM2,O94768,O94768wild,ST17B,wild,cl1,6zjfA,QM2,,6zjf,1,1,,Kinase,HoYoungLee,1,A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.,Inhibitor,,1,CEREP,STK17B,O94768,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O94804_STK10_wild_cl1,STK10_5owqB_38O,O94804,O94804wild,STK10,wild,cl1,5owqB,38O,,5owq,2,1,,Kinase,HoYoungLee,1,Human STK10 bound to dovitinib,Inhibitor,,1,CEREP,STK10,O94804,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O94804_STK10_wild_cl1,STK10_5owrA_1N1,O94804,O94804wild,STK10,wild,cl1,5owrA,1N1,,5owr,2,1,,Kinase,HoYoungLee,1,Human STK10 bound to dasatinib,Inhibitor,,1,CEREP,STK10,O94804,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O95251_KAT7_wild_cl1,KAT7_6majA_JAV,O95251,O95251wild,KAT7,wild,cl1,6majA,JAV,,6maj,3,1,,0,JiYoonShin,1,HBO1 is required for the maintenance of leukaemia stem cells.,Inhibitor,,1,CEREP,MYST2,0,0,0,0,0,0,inhibitor,0,,,
O95747_OXSR1_wild_cl1,OXSR1_3dakD_ANP,O95747,O95747wild,OXSR1,wild,cl1,3dakD,ANP,,3dak,2,1,,Kinase,HoYoungLee,1,Crystal structure of domain-swapped STE20 OSR1 kinase domain.,Inhibitor,,1,CEREP,OXSR1,0,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,0,,,
O95800_GPR75_wild_cl1,GPR75_hml1A_LIG,O95800,O95800wild,GPR75,wild,cl1,hml1A,LIG,,hml1,1,1,STB-Model,GPCR,,1, ,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O95800_GPR75_wild_cl1,GPR75_hml2A_LIG,O95800,O95800wild,GPR75,wild,cl1,hml2A,LIG,,hml2,1,1,STB-Model,GPCR,,1, ,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
O95819_M4K4_wild_cl1,M4K4_4zk5A_4P4,O95819,O95819wild,M4K4,wild,cl1,4zk5A,4P4,,4zk5,1,1,,Kinase,HoYoungLee,1,Structure-Based Design of GNE-495_ a Potent and Selective MAP4K4 inhibitor with Efficacy in Retinal Angiogenesis.,Inhibitor,,1,CEREP,HGK,O95819,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O95819_M4K4_wild_cl1,M4K4_5w5qA_9X4,O95819,O95819wild,M4K4,wild,cl1,5w5qA,9X4,,5w5q,1,1,,Kinase,HoYoungLee,1,Structure Based Design of Potent Selective inhibitors of Protein Kinase D1 (PKD1).,Inhibitor,,1,CEREP,HGK,O95819,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96013_PAK4_wild_cl1,PAK4_2x4zA_X4Z,O96013,O96013wild,PAK4,wild,cl1,2x4zA,X4Z,,2x4z,2,1,,Kinase,HoYoungLee,1,Small-Molecule P21-Activated Kinase inhibitor Pf- 3758309 is a Potent inhibitor of Oncogenic Signaling and Tumor Growth.,Inhibitor,,1,CEREP,PAK4,O96013,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96013_PAK4_wild_cl1,PAK4_5bmsA_4T6,O96013,O96013wild,PAK4,wild,cl1,5bmsA,4T6,,5bms,2,1,,Kinase,HoYoungLee,1,Structure-Guided Design of Group I Selective p21-Activated Kinase inhibitors.,Inhibitor,,1,CEREP,PAK4,O96013,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96017_CHK2_wild_cl1,CHK2_2ycfA_YCF,O96017,O96017wild,CHK2,wild,cl1,2ycfA,YCF,,2ycf,1,1,,Kinase,HoYoungLee,1,Structural Characterization of inhibitor Complexes with Checkpoint Kinase 2 (Chk2)_ a Drug Target for Cancer Therapy.,Inhibitor,,1,CEREP,CHK2,O96017,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96017_CHK2_wild_cl1,CHK2_2yirA_YIR,O96017,O96017wild,CHK2,wild,cl1,2yirA,YIR,,2yir,1,1,,Kinase,HoYoungLee,1,X-Ray Structures of Checkpoint Kinase 2 in Complex with inhibitors that Target its Gatekeeper-Dependent Hydrophobic Pocket.,Inhibitor,,1,CEREP,CHK2,O96017,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96028_NSD2_wild_cl1,NSD2_6ue6H_Q5D,O96028,O96028wild,NSD2,wild,cl1,6ue6H,Q5D,,6ue6,2,1,,methylase,SooYongLee,1,Discovery of Small-Molecule antagonists of the PWWP Domain of NSD2.,Inhibitor,,1,CEREP,NSD2,O96028,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O96028_NSD2_wild_cl1,NSD2_6xcgC_V01,O96028,O96028wild,NSD2,wild,cl1,6xcgC,V01,,6xcg,2,1,,methylase,SooYongLee,1,Histone-lysine N-methyltransferase NSD2-PWWP1 with compound UNC6934,Inhibitor,,1,CEREP,NSD2,O96028,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00519_ABL1_wild_cl1,ABL1_3qriB_919,P00519,P00519wild,ABL1,wild,cl1,3qriB,919,,3qri,2,1,,Kinase,HoYoungLee,1,Conformational Control inhibition of the BCR-ABL1 Tyrosine Kinase_ Including the Gatekeeper T315I Mutant_ by the Switch-Control inhibitor DCC-2036.,Inhibitor,,1,CEREP,Abl,P00519,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00519_ABL1_wild_cl1,ABL1_4xeyA_1N1,P00519,P00519wild,ABL1,wild,cl1,4xeyA,1N1,,4xey,2,1,,Kinase,HoYoungLee,1,Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity.,Inhibitor,,1,CEREP,Abl,P00519,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_wild_cl1,EGFR_3pozA_03P,P00533,P00533wild,EGFR,wild,cl1,3pozA,03P,,3poz,1,3,,Kinase,HoYoungLee,1,Structural Analysis of the Mechanism of inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein.,Inhibitor,allosteric,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_wild_cl1,EGFR_1xkkA_FMM,P00533,P00533wild,EGFR,wild,cl1,1xkkA,FMM,,1xkk,1,3,,Kinase,HoYoungLee,1,A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation_ inhibitor off-rate_ and receptor activity in tumor cells.,Inhibitor,,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_790p858_cl1,EGFR_5caqA_4ZJ,P00533,P00533790p858,EGFR,790p858,cl1,5caqA,4ZJ,,5caq,1,3,,Kinase,HoYoungLee,1,Noncovalent Mutant Selective Epidermal Growth Factor Receptor inhibitors: A Lead Optimization Case Study.,Inhibitor,,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_790p858_cl1,EGFR_5casA_4ZQ,P00533,P00533790p858,EGFR,790p858,cl1,5casA,4ZQ,,5cas,1,3,,Kinase,HoYoungLee,1,Noncovalent Mutant Selective Epidermal Growth Factor Receptor inhibitors: A Lead Optimization Case Study.,Inhibitor,,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_790_cl1,EGFR_5gmpA_F62,P00533,P00533790,EGFR,790,cl1,5gmpA,F62,,5gmp,1,3,,Kinase,HoYoungLee,1,A structure-guided optimization of pyrido[2_3-d]pyrimidin-7-ones as selective inhibitors of EGFR(L858R/T790M) mutant with improved pharmacokinetic properties.,Inhibitor,,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00533_EGFR_790_cl1,EGFR_5ug8A_8BP,P00533,P00533790,EGFR,790,cl1,5ug8A,8BP,,5ug8,1,3,,Kinase,HoYoungLee,1,Discovery of N-((3R_4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR.,Inhibitor,,1,CEREP,EGFR,P00533,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P00797_RENI_wild_cl1,RENI_3o9lC_LPN,P00797,P00797wild,RENI,wild,cl1,3o9lC,LPN,,3o9l,1,1,,Peptidase,,1,Design and optimization of new piperidines as renin inhibitors.,Inhibitor,,1,CEREP,Renin,P00797,Protease,Pepsin,Aspartic Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P00797_RENI_wild_cl1,RENI_5koqB_6VR,P00797,P00797wild,RENI,wild,cl1,5koqB,6VR,,5koq,1,1,,Peptidase,,1,Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors.,Inhibitor,,1,CEREP,Renin,P00797,Protease,Pepsin,Aspartic Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P01111_RASN_wild_cl1,RASN_6zizB_EZZ,P01111,P01111wild,RASN,wild,cl1,6zizB,EZZ,,6ziz,3,2,,GTPase,,1,Drugging all RAS isoforms with one pocket.,Inhibitor,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P01111_RASN_wild_cl2,RASN_5uhvA_GNP,P01111,P01111wild,RASN,wild,cl2,5uhvA,GNP,,5uhv,3,2,,GTPase,,1,The small GTPases K-Ras_ N-Ras_ and H-Ras have distinct biochemical properties determined by Allosteric effects.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P01111_RASN_wild_cl2,RASN_6wghA_GDP,P01111,P01111wild,RASN,wild,cl2,6wghA,GDP,,6wgh,3,2,,GTPase,,1,RASinternal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P01116_RASK_39_cl1,RASK_4q01B_2XH,P01116,P0111639,RASK,39,cl1,4q01B,2XH,,4q01,2,2,,GTPase,,1,A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand.,Inhibitor,Covalent,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P01116_RASK_wild_cl1,RASK_5kykC_6ZD,P01116,P01116wild,RASK,wild,cl1,5kykC,6ZD,,5kyk,2,2,,GTPase,,1,Covalent Guanosine Mimetic inhibitors of G12C KRAS.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P01116_RASK_wild_cl1,RASK_6mtaC_GNP,P01116,P01116wild,RASK,wild,cl1,6mtaC,GNP,,6mta,2,2,,GTPase,,1,GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P03372_ESR1_wild_cl1,ESR1_1xp6A_AIU,P03372,P03372wild,ESR1,wild,cl1,1xp6A,AIU,,1xp6,1,1,,Receptor,,1,Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.,Inhibitor,IC50 0.4nM,1,CEREP,Eralpha,P03372,NHR,Estrogen,Steroid,Biochemical,Binding,_,Radiometric,,,
P03372_ESR1_wild_cl1,ESR1_2r6yB_LLC,P03372,P03372wild,ESR1,wild,cl1,2r6yB,LLC,,2r6y,1,1,,Receptor,,1,Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method.,Inhibitor,IC50 120nM,1,CEREP,Eralpha,P03372,NHR,Estrogen,Steroid,Biochemical,Binding,_,Radiometric,,,
P03956_MMP1_wild_cl1,MMP1_1cglB_0ED,P03956,P03956wild,MMP1,wild,cl1,1cglB,0ED,,1cgl,2,1,,Peptidase,,1,Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.,Inhibitor,,1,CEREP,MMP1,P03956,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P03956_MMP1_wild_cl1,MMP1_1hfcA_PLH,P03956,P03956wild,MMP1,wild,cl1,1hfcA,PLH,,1hfc,2,1,,Peptidase,,1,1.56 A structure of mature truncated human fibroblast collagenase.,inhibitor,,1,CEREP,MMP1,P03956,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P04049_RAF1_wild_cl1,RAF1_3omvB_SM5,P04049,P04049wild,RAF1,wild,cl1,3omvB,SM5,,3omv,3,1,,Kinase,HoYoungLee,1,RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.,Inhibitor,,1,CEREP,c-Raf,P04049,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P04626_ERBB2_wild_cl1,ERBB2_3rcdC_03P,P04626,P04626wild,ERBB2,wild,cl1,3rcdC,03P,,3rcd,2,2,,Kinase,HoYoungLee,1,Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual inhibitors Bearing a Pyrrolo[3_2-d]pyrimidine Scaffold.,Inhibitor,,1,CEREP,HER2,P04626,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P04629_NTRK1_wild_cl1,NTRK1_4pmpA_31W,P04629,P04629wild,NTRK1,wild,cl1,4pmpA,31W,,4pmp,3,1,,Kinase,HoYoungLee,1,Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.,Inhibitor,,1,CEREP,TRKA,P04629,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P04629_NTRK1_wild_cl1,NTRK1_5wr7A_RCH,P04629,P04629wild,NTRK1,wild,cl1,5wr7A,RCH,,5wr7,3,1,,Kinase,HoYoungLee,1,Selective TRK inhibitor CH7057288 against TRK Fusion-Driven Cancer.,Inhibitor,,1,CEREP,TRKA,P04629,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06213_INSR_wild_cl1,INSR_3eknA_GS3,P06213,P06213wild,INSR,wild,cl1,3eknA,GS3,,3ekn,2,1,,Kinase,HoYoungLee,1,Optimization of 4_6-bis-anilino-1H-pyrrolo[2_3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.,Inhibitor,,1,CEREP,IR,P06213,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06213_INSR_wild_cl1,INSR_5e1sA_5JA,P06213,P06213wild,INSR,wild,cl1,5e1sA,5JA,,5e1s,2,1,,Kinase,HoYoungLee,1,BI 885578_ a Novel IGF1R/INSR Tyrosine Kinase inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis.,Inhibitor,,1,CEREP,IR,P06213,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06239_LCK_wild_cl1,LCK_1qpeA_PP2,P06239,P06239wild,LCK,wild,cl1,1qpeA,PP2,,1qpe,2,1,,Kinase,HoYoungLee,1,Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.,Inhibitor,,1,CEREP,Lck,P06239,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06239_LCK_wild_cl1,LCK_3b2wA_9NH,P06239,P06239wild,LCK,wild,cl1,3b2wA,9NH,,3b2w,2,1,,Kinase,HoYoungLee,1,N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure_ synthesis and SAR.,Inhibitor,,1,CEREP,Lck,P06239,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06493_CDK1_wild_cl1,CDK1_6gu2A_F9Z,P06493,P06493wild,CDK1,wild,cl1,6gu2A,F9Z,,6gu2,2,1,,Kinase,HoYoungLee,1,Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK inhibition.,Inhibitor,,1,CEREP,CDK1,P06493,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P06493_CDK1_wild_cl1,CDK1_6gu6A_1QK,P06493,P06493wild,CDK1,wild,cl1,6gu6A,1QK,,6gu6,2,1,,Kinase,HoYoungLee,1,Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK inhibition.,Inhibitor,,1,CEREP,CDK1,P06493,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07332_FES_wild_cl1,FES_4e93A_GUI,P07332,P07332wild,FES,wild,cl1,4e93A,GUI,,4.00E+93,2,1,,Kinase,HoYoungLee,1,Small-Molecule inhibitors of the c-Fes Protein-Tyrosine Kinase.,Inhibitor,,1,CEREP,FES,P07332,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07332_FES_wild_cl1,FES_6jmfA_9FC,P07332,P07332wild,FES,wild,cl1,6jmfA,9FC,,6jmf,2,1,,Kinase,HoYoungLee,1,Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase inhibitors with Antitumor Activity.,Inhibitor,,1,CEREP,FES,P07332,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07333_CSF1R_wild_cl1,CSF1R_2i0vA_6C3,P07333,P07333wild,CSF1R,wild,cl1,2i0vA,6C3,,2i0v,2,2,,Kinase,HoYoungLee,1,Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.,Inhibitor,,1,CEREP,Fms,P07333,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07333_CSF1R_wild_cl1,CSF1R_2i0yA_5CN,P07333,P07333wild,CSF1R,wild,cl1,2i0yA,5CN,,2i0y,2,2,,Kinase,HoYoungLee,1,Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.,Inhibitor,,1,CEREP,Fms,P07333,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07948_LYN_wild_cl1,LYN_5xy1A_8H0,P07948,P07948wild,LYN,wild,cl1,5xy1A,8H0,,5xy1,2,1,,Kinase,HoYoungLee,1,Crystal structure of Lyn kinase domain in complex with N-(1H-indazol-6-yl)-8-(piperidin-4-yloxy)-6-propylquinazolin-2-amine,Inhibitor,,1,CEREP,LYN,P07948,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07949_RET_wild_cl1,RET_2x2mB_X2M,P07949,P07949wild,RET,wild,cl1,2x2mB,X2M,,2x2m,1,2,,Kinase,HoYoungLee,1,Synthesis_ structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.,Inhibitor,,1,CEREP,Ret,P07949,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07949_RET_804_cl1,RET_6i82B_H6W,P07949,P07949804,RET,804,cl1,6i82B,H6W,,6i82,1,2,,Kinase,HoYoungLee,1,Discovery and Optimization of wt-RET/KDR-Selective inhibitors of RETV804MKinase.,Inhibitor,,1,CEREP,Ret,P07949,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07949_RET_804_cl1,RET_6i83A_H72,P07949,P07949804,RET,804,cl1,6i83A,H72,,6i83,1,2,,Kinase,HoYoungLee,1,Discovery and Optimization of wt-RET/KDR-Selective inhibitors of RETV804MKinase.,Inhibitor,,1,CEREP,Ret,P07949,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P07949_RET_wild_cl1,RET_7ju6B_Q6G,P07949,P07949wild,RET,wild,cl1,7ju6B,Q6G,,7ju6,1,2,,Kinase,HoYoungLee,1,Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.,Inhibitor,,1,CEREP,Ret,P07949,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08069_IGF1R_wild_cl1,IGF1R_3lvpD_PDR,P08069,P08069wild,IGF1R,wild,cl1,3lvpD,PDR,,3lvp,1,1,,Kinase,HoYoungLee,1,Design of Potent IGF1-R inhibitors Related to Bis-azaindoles,Inhibitor,,1,CEREP,IGF1R,P08069,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08069_IGF1R_wild_cl1,IGF1R_5fxqA_GD5,P08069,P08069wild,IGF1R,wild,cl1,5fxqA,GD5,,5fxq,1,1,,Kinase,HoYoungLee,1,Discovery of a Potent_ Selective_ Orally Bioavailable_ and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R).,Inhibitor,,1,CEREP,IGF1R,P08069,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08172_ACM2_wild_cl1,ACM2_4mqtA_2CU,P08172,P08172wild,ACM2,wild,cl1,4mqtA,2CU,,4mqt,2,1,,GPCR,,1,Activation and Allosteric modulation of a muscarinic acetylcholine receptor.,Activator,allosteric,1,CEREP,0,0,0,0,0,Functional,Biochemical,Inhibitor,0,,,
P08172_ACM2_wild_cl1,ACM2_5yc8A_3C0,P08172,P08172wild,ACM2,wild,cl1,5yc8A,3C0,,5yc8,2,1,,GPCR,,1,Structural insights into the subtype-selective antagonist binding to the M2muscarinic receptor,Inhibitor,,1,CEREP,0,0,0,0,0,Functional,Biochemical,Inhibitor,0,,,
P08173_CHRM4_wild_cl1,CHRM4_5dsgA_0HK,P08173,P08173wild,CHRM4,wild,cl1,5dsgA,0HK,,5dsg,3,1,,GPCR,,1,Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P08253_MMP2_wild_cl1,MMP2_1hovA_I52,P08253,P08253wild,MMP2,wild,cl1,1hovA,I52,,1hov,3,1,,Peptidase,,1,Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor,Inhibitor,,1,CEREP,MMP2,P08253,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P08254_MMP3_wild_cl1,MMP3_1d8fB_SPI,P08254,P08254wild,MMP3,wild,cl1,1d8fB,SPI,,1d8f,1,1,,Peptidase,,1,Design and synthesis of piperazine-based matrix metalloproteinase inhibitors.,Inhibitor,,1,CEREP,MMP3,P08254,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P08254_MMP3_wild_cl1,MMP3_1d8mB_BBH,P08254,P08254wild,MMP3,wild,cl1,1d8mB,BBH,,1d8m,1,1,,Peptidase,,1,Heterocycle-based MMP inhibitors with P2' substituents.,Inhibitor,,1,CEREP,MMP3,P08254,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P08581_MET_wild_cl1,MET_4deiA_0JL,P08581,P08581wild,MET,wild,cl1,4deiA,0JL,,4dei,1,1,,Kinase,HoYoungLee,1,Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors.,Inhibitor,,1,CEREP,Met,P08581,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08581_MET_wild_cl1,MET_4gg5A_0J3,P08581,P08581wild,MET,wild,cl1,4gg5A,0J3,,4gg5,1,1,,Kinase,HoYoungLee,1,Multisubstituted quinoxalines and pyrido[2_3-d]pyrimidines: Synthesis and SAR study as tyrosine kinase c-Met inhibitors.,Inhibitor,,1,CEREP,Met,P08581,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08631_HCK_wild_cl1,HCK_2hk5A_1BM,P08631,P08631wild,HCK,wild,cl1,2hk5A,1BM,,2hk5,2,1,,Kinase,HoYoungLee,1,The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).,Inhibitor,,1,CEREP,HCK,P08631,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08631_HCK_wild_cl1,HCK_3vryB_B43,P08631,P08631wild,HCK,wild,cl1,3vryB,B43,,3vry,2,1,,Kinase,HoYoungLee,1,A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo,Inhibitor,,1,CEREP,HCK,P08631,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08912_CHRM5_wild_cl1,CHRM5_6ol9A_0HK,P08912,P08912wild,CHRM5,wild,cl1,6ol9A,0HK,,6ol9,3,1,,GPCR,,1,Crystal structure of the M5muscarinic acetylcholine receptor.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P08913_ADA2A_wild_cl1,ADA2A_6kuxA_E3F,P08913,P08913wild,ADA2A,wild,cl1,6kuxA,E3F,,6kux,2,1,,GPCR,,1,Crystal structures of the alpha2A adrenergic receptor in complex with  an antagonist RSC.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P08922_ROS1_wild_cl1,ROS1_3zbfA_VGH,P08922,P08922wild,ROS1,wild,cl1,3zbfA,VGH,,3zbf,2,1,,Kinase,HoYoungLee,1,Acquired Resistance to Crizotinib from a Mutation in Cd74-Ros1,Inhibitor,,1,CEREP,Ros,P08922,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P08922_ROS1_wild_cl1,ROS1_4uxlA_5P8,P08922,P08922wild,ROS1,wild,cl1,4uxlA,5P8,,4uxl,2,1,,Kinase,HoYoungLee,1,Pf-06463922 is a Potent and Selective Next-Generation Ros1/Alk inhibitor Capable of Blocking Crizotinib-Resistant Ros1 Mutations.,Inhibitor,,1,CEREP,Ros,P08922,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P09237_MMP7_wild_cl1,MMP7_1mmqA_RRS,P09237,P09237wild,MMP7,wild,cl1,1mmqA,RRS,,1mmq,2,1,,Peptidase,,1,Matrilysin-inhibitor complexes: common themes among metalloproteases.,Inhibitor,,1,CEREP,MMP7,P09237,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P09237_MMP7_wild_cl1,MMP7_2y6dA_TQJ,P09237,P09237wild,MMP7,wild,cl1,2y6dA,TQJ,,2y6d,2,1,,Peptidase,,1,The Discovery of Mmp7 inhibitors Exploiting a Novel Selectivity Trigger.,Inhibitor,,1,CEREP,MMP7,P09237,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P09238_MMP10_wild_cl1,MMP10_1q3aB_NGH,P09238,P09238wild,MMP10,wild,cl1,1q3aB,NGH,,1q3a,2,1,,Peptidase,,1,Crystal structure of the catalytic domain of human matrix metalloproteinase 10.,Inhibitor,,1,CEREP,Stromelysin-2,P09238,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P09874_PARP1_wild_cl1,PARP1_2rd6A_78P,P09874,P09874wild,PARP1,wild,cl1,2rd6A,78P,,2rd6,2,2,,Transferase,,1,PARP complexed with A861695,Inhibitor,IC50 335 nM,1,CEREP,PARP1,P09874,DNA Repair & Mitotic Regulation,_,Other,Biochemical,Enzymatic,_,Spectrophotometry,,,
P09874_PARP1_762_cl1,PARP1_4l6sB_1WQ,P09874,P09874762,PARP1,762,cl1,4l6sB,1WQ,,4l6s,2,2,,Transferase,,1,Discovery of novel benzo[b][1_4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors,Inhibitor,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
P09874_PARP1_wild_cl1,PARP1_5ha9B_TP0,P09874,P09874wild,PARP1,wild,cl1,5ha9B,TP0,,5ha9,2,2,,Transferase,,1,Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.,Inhibitor,,1,CEREP,PARP1,P09874,DNA Repair & Mitotic Regulation,_,Other,Biochemical,Enzymatic,_,Spectrophotometry,,,
P0C1S8_WEE2_wild_cl1,WEE2_5vdkA_8X7,P0C1S8,P0C1S8wild,WEE2,wild,cl1,5vdkA,8X7,,5vdk,3,1,,Kinase,HoYoungLee,1,Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule inhibitors.,Inhibitor,,1,CEREP,WEE1B,P0C1S8,Kinase,Other Protein Kinase,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P10275_ANDR_wild_cl1,ANDR_2hvcA_LGD,P10275,P10275wild,ANDR,wild,cl1,2hvcA,LGD,,2hvc,2,1,,Receptor,,1,Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226,Activator,,1,CEREP,AR,P10275,NHR,3-Ketosteroid,Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P10275_ANDR_wild_cl1,ANDR_5v8qA_97A,P10275,P10275wild,ANDR,wild,cl1,5v8qA,97A,,5v8q,2,1,,Receptor,,1,Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate.,Activator,,1,CEREP,AR,P10275,NHR,3-Ketosteroid,Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P10276_RARA_wild_cl1,RARA_1dkfB_BMS,P10276,P10276wild,RARA,wild,cl1,1dkfB,BMS,,1dkf,2,1,,Receptor,,1,Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.,Inhibitor,,1,CEREP,RARalpha,P10276,NHR,Retinoic Acid,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P10276_RARA_wild_cl1,RARA_3a9eB_REA,P10276,P10276wild,RARA,wild,cl1,3a9eB,REA,,3a9e,2,1,,Receptor,,1,The Phantom Effect of the Rexinoid LG100754: structural and functional insights,Activator,,1,CEREP,RARalpha,P10276,NHR,Retinoic Acid,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P10721_KIT_wild_cl1,KIT_3g0fB_B49,P10721,P10721wild,KIT,wild,cl1,3g0fB,B49,,3g0f,2,2,,Kinase,HoYoungLee,1,KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients.,Inhibitor,,1,CEREP,Kit,P10721,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P10721_KIT_wild_cl1,KIT_4u0iA_0LI,P10721,P10721wild,KIT,wild,cl1,4u0iA,0LI,,4u0i,2,2,,Kinase,HoYoungLee,1,Ponatinib inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients.,Inhibitor,,1,CEREP,Kit,P10721,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P10827_THA_wild_cl2,THA_4lnxA_T44,P10827,P10827wild,THA,wild,cl2,4lnxA,T44,,4lnx,3,2,,Receptor,,1,Identification of a new hormone-binding site on the surface of thyroid hormone receptor.,Inhibitor,PPI,1,CEREP,Tralpha,P10827,NHR,Thyroid Hormone,Non-Steroid,Functional,Cell Based,Agonist & Antagonist,_,,,
P10827_THA_wild_cl1,THA_1navA_IH5,P10827,P10827wild,THA,wild,cl1,1navA,IH5,,1nav,3,2,,Receptor,,1,Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.,Activator,,1,CEREP,Tralpha,P10827,NHR,Thyroid Hormone,Non-Steroid,Functional,Cell Based,Agonist & Antagonist,_,,,
P10828_THB_wild_cl1,THB_1r6gA_442,P10828,P10828wild,THB,wild,cl1,1r6gA,442,,1r6g,2,1,,Receptor,,1,Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.,Activator,,1,CEREP,TRbeta,P10828,NHR,Thyroid Hormone,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P10828_THB_wild_cl1,THB_3imyA_B72,P10828,P10828wild,THB,wild,cl1,3imyA,B72,,3imy,2,1,,Receptor,,1,Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms.,Activator,,1,CEREP,TRbeta,P10828,NHR,Thyroid Hormone,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P11086_PNMT_wild_cl1,PNMT_1yz3B_SKA,P11086,P11086wild,PNMT,wild,cl1,1yz3B,SKA,,1yz3,1,1,,methylase,SooYongLee,1,Structural_ mutagenic_ and kinetic analysis of the binding of substrates and inhibitors of human phenylethanolamine N-methyltransferase,Inhibitor,,1,CEREP,PNMT,P11086,Neurotransmitter Metabolism,Catecholamine Turnover,_,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11086_PNMT_wild_cl1,PNMT_3kr1B_VGD,P11086,P11086wild,PNMT,wild,cl1,3kr1B,VGD,,3kr1,1,1,,methylase,SooYongLee,1,Fragment-based screening by X-ray crystallography_ MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.,Inhibitor,,1,CEREP,PNMT,P11086,Neurotransmitter Metabolism,Catecholamine Turnover,_,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11309_PIM1_wild_cl1,PIM1_5dwrA_5H7,P11309,P11309wild,PIM1,wild,cl1,5dwrA,5H7,,5dwr,1,1,,Kinase,HoYoungLee,1,Identification of N-(4-((1R_3S_5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2_6-difluorophenyl)-5-fluoropicolinamide (PIM447)_ a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1_ 2_ and 3 Kinase inhibitor in Clinical Trials for Hematological Malignancies.,Inhibitor,,1,CEREP,Pim1,P11309,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11309_PIM1_wild_cl1,PIM1_5v82A_96Y,P11309,P11309wild,PIM1,wild,cl1,5v82A,96Y,,5v82,1,1,,Kinase,HoYoungLee,1,Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim inhibitor with Optimized Bioavailability.,Inhibitor,,1,CEREP,Pim1,P11309,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11362_FGFR1_wild_cl1,FGFR1_4f65B_0S9,P11362,P11362wild,FGFR1,wild,cl1,4f65B,0S9,,4f65,2,3,,Kinase,HoYoungLee,1,Protein-Ligand Crystal Structures Can Guide the Design of Selective inhibitors of the FGFR Tyrosine Kinase.,Inhibitor,,1,CEREP,FGFR1,P11362,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11362_FGFR1_wild_cl1,FGFR1_4nk9B_2K5,P11362,P11362wild,FGFR1,wild,cl1,4nk9B,2K5,,4nk9,2,3,,Kinase,HoYoungLee,1,FGFR1 Kinase inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures.,Inhibitor,,1,CEREP,FGFR1,P11362,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11362_FGFR1_561_cl1,FGFR1_5am7B_38O,P11362,P11362561,FGFR1,561,cl1,5am7B,38O,,5am7,2,3,,Kinase,HoYoungLee,1,The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study,Inhibitor,,1,CEREP,FGFR1,P11362,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P11474_ERR1_wild_cl1,ERR1_2pjlB_047,P11474,P11474wild,ERR1,wild,cl1,2pjlB,47,,2pjl,2,1,,Receptor,,1,Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse Agonist reveals its novel molecular mechanism.,Activator,,1,CEREP,ERRalpha,P11474,NHR,Estrogen-Related,Non-Steroid,Functional,Protein-Protein Interaction,Agonist,_,,,
P11474_ERR1_wild_cl1,ERR1_3k6pA_5FB,P11474,P11474wild,ERR1,wild,cl1,3k6pA,5FB,,3k6p,2,1,,Receptor,,1,Development of Diaryl Ether based ligands for Estrogen Related Receptor alpha as Potential Anti-Diabetic Agents.,Activator,,1,CEREP,ERRalpha,P11474,NHR,Estrogen-Related,Non-Steroid,Functional,Protein-Protein Interaction,Agonist,_,,,
P12931_SRC_wild_cl2,SRC_1o44A_852,P12931,P12931wild,SRC,wild,cl2,1o44A,852,,1o44,2,2,,Kinase,HoYoungLee,1,Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.,Inhibitor,,1,CEREP,Src,P12931,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P12931_SRC_wild_cl2,SRC_1o45A_687,P12931,P12931wild,SRC,wild,cl2,1o45A,687,,1o45,2,2,,Kinase,HoYoungLee,1,Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.,Inhibitor,,1,CEREP,Src,P12931,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P12931_SRC_wild_cl1,SRC_2bdfB_24A,P12931,P12931wild,SRC,wild,cl1,2bdfB,24A,,2bdf,2,2,,Kinase,HoYoungLee,1,Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.,Inhibitor,,1,CEREP,Src,P12931,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P12931_SRC_wild_cl1,SRC_2bdjA_HET,P12931,P12931wild,SRC,wild,cl1,2bdjA,HET,,2bdj,2,2,,Kinase,HoYoungLee,1,Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.,Inhibitor,,1,CEREP,Src,P12931,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P13569_CFTR_wild_cl1,CFTR_2bbtA_ATP,P13569,P13569wild,CFTR,wild,cl1,2bbtA,ATP,,2bbt,1,3,,Transporter,,1,Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.,Inhibitor,,1,CEREP,CFTR,P13569,Ion Channel,Chloride,Other,Functional,Cell Based,Agonist,_,,,
P13569_CFTR_494_cl1,CFTR_4wz6A_ATP,P13569,P13569494,CFTR,494,cl1,4wz6A,ATP,,4wz6,1,3,,Transporter,,1,Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.,Inhibitor,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
P13631_RARG1_wild_cl1,RARG1_1fcyA_564,P13631,P13631wild,RARG1,wild,cl1,1fcyA,564,,1fcy,2,1,,Receptor,,1,Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.,Activator,Kd 3 nM,1,CEREP,RARgamma,P13631,NHR,Retinoic Acid,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P13631_RARG1_wild_cl1,RARG1_1fcxA_184,P13631,P13631wild,RARG1,wild,cl1,1fcxA,184,,1fcx,2,1,,Receptor,,1,Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.,Activator,Kd 64 nM,1,CEREP,RARgamma,P13631,NHR,Retinoic Acid,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P14780_MMP9_wild_cl1,MMP9_4h3xB_10B,P14780,P14780wild,MMP9,wild,cl1,4h3xB,10B,,4h3x,1,2,,Peptidase,,1,Crystallization of bi-functional ligand protein complexes.,Inhibitor,,1,CEREP,MMP9,P14780,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P14780_MMP9_wild_cl1,MMP9_4wzvB_E40,P14780,P14780wild,MMP9,wild,cl1,4wzvB,E40,,4wzv,1,2,,Peptidase,,1,N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.,Inhibitor,,1,CEREP,MMP9,P14780,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P14780_MMP9_227_cl1,MMP9_6esmA_B9Z,P14780,P14780227,MMP9,227,cl1,6esmA,B9Z,,6esm,1,2,,Peptidase,,1,Development of Thioaryl-Based Matrix Metalloproteinase-12 inhibitors with Alternative Zinc-Binding Groups: Synthesis_ Potentiometric_ NMR_ and Crystallographic Studies.,Inhibitor,,1,CEREP,MMP9,P14780,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P14902_I23O_wild_cl1,I23O_4pk5A_PKJ,P14902,P14902wild,I23O,wild,cl1,4pk5A,PKJ,,4pk5,2,1,,oxidoreductases ,,1,Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 inhibitors.,Inhibitor,,1,CEREP,Indoleamine 2_3-dioxygenase 1,P14902,In Vitro Pharmacology,Dioxygenase,Protein (enzyme),Biochemical,Enzymatic,Antagonist,Absorbance,,,
P14902_I23O_wild_cl1,I23O_5wmvA_ZCW,P14902,P14902wild,I23O,wild,cl1,5wmvA,ZCW,,5wmv,2,1,,oxidoreductases ,,1,Structural insights into substrate and inhibitor binding sites in human indoleamine 2_3-dioxygenase 1.,Inhibitor,,1,CEREP,Indoleamine 2_3-dioxygenase 1,P14902,In Vitro Pharmacology,Dioxygenase,Protein (enzyme),Biochemical,Enzymatic,Antagonist,Absorbance,,,
P15056_BRAF_wild_cl1,BRAF_3ppkB_FNI,P15056,P15056wild,BRAF,wild,cl1,3ppkB,FNI,,3ppk,1,1,,Kinase,HoYoungLee,1,Non-oxime inhibitors of B-Raf(V600E) kinase.,Inhibitor,,1,CEREP,B-Raf,P15056,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P15056_BRAF_wild_cl1,BRAF_4yhtB_4EF,P15056,P15056wild,BRAF,wild,cl1,4yhtB,4EF,,4yht,1,1,,Kinase,HoYoungLee,1,GSK114: A selective inhibitor for elucidating the biological role of TNNI3K.,Inhibitor,,1,CEREP,B-Raf,P15056,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P15735_PHKG2_wild_cl1,PHKG2_2y7jB_B49,P15735,P15735wild,PHKG2,wild,cl1,2y7jB,B49,,2y7j,3,1,,Kinase,HoYoungLee,1,Structure of Human Phosphorylase Kinase_ Gamma 2,Inhibitor,,1,CEREP,PHKG2,P15735,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P16234_PGFRA_wild_cl1,PGFRA_5grnA_748,P16234,P16234wild,PGFRA,wild,cl1,5grnA,748,,5grn,2,1,,Kinase,HoYoungLee,1,Crystal Structure of PDGFRA in Complex with WQ-C-159,Inhibitor,,1,CEREP,PDGFRA,P16234,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P16234_PGFRA_wild_cl1,PGFRA_6joiA_6T2,P16234,P16234wild,PGFRA,wild,cl1,6joiA,6T2,,6joi,2,1,,Kinase,HoYoungLee,1,Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization,Inhibitor,,1,CEREP,PDGFRA,P16234,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P17252_PRKCA_wild_cl1,PRKCA_3iw4A_LW4,P17252,P17252wild,PRKCA,wild,cl1,3iw4A,LW4,,3iw4,3,1,,Kinase,HoYoungLee,1,Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2_5-dione (AEB071)_ a potent and selective inhibitor of protein kinase C isotypes,Inhibitor,,1,CEREP,PKCalpha,P17252,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P17252_PRKCA_wild_cl1,PRKCA_3iw4B_LW4,P17252,P17252wild,PRKCA,wild,cl1,3iw4B,LW4,,3iw4,3,1,,Kinase,HoYoungLee,1,Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2_5-dione (AEB071)_ a potent and selective inhibitor of protein kinase C isotypes,Inhibitor,,1,CEREP,PKCalpha,P17252,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P17612_KAPCA_wild_cl1,KAPCA_4uj2A_NVV,P17612,P17612wild,KAPCA,wild,cl1,4uj2A,NVV,,4uj2,1,3,,Kinase,HoYoungLee,1,Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: inhibition of Pka and a Pkb Mimic.,Inhibitor,,1,CEREP,PKACalpha,P17612,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P17612_KAPCA_wild_cl1,KAPCA_6c0uA_EE4,P17612,P17612wild,KAPCA,wild,cl1,6c0uA,EE4,,6c0u,1,3,,Kinase,HoYoungLee,1,Structural basis for selective inhibition of human PKG I alpha by the balanol-like compound N46.,Inhibitor,,1,CEREP,PKACalpha,P17612,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P17948_VGFR1_wild_cl1,VGFR1_3hngA_8ST,P17948,P17948wild,VGFR1,wild,cl1,3hngA,8ST,,3hng,3,1,,Kinase,HoYoungLee,1,Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide,Inhibitor,,1,CEREP,FLT1,P17948,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P18031_PTN1_wild_cl1,PTN1_2qbpA_527,P18031,P18031wild,PTN1,wild,cl1,2qbpA,527,,2qbp,2,1,,phosphatase,SooYongLee,1,Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.,Inhibitor,,1,CEREP,PTP1B,P18031,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P18031_PTN1_wild_cl1,PTN1_2zmmA_35B,P18031,P18031wild,PTN1,wild,cl1,2zmmA,35B,,2zmm,2,1,,phosphatase,SooYongLee,1,Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24,Inhibitor,,1,CEREP,PTP1B,P18031,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P19525_E2AK2_wild_cl1,E2AK2_2a19C_ANP,P19525,P19525wild,E2AK2,wild,cl1,2a19C,ANP,,2a19,2,1,,Kinase,HoYoungLee,1,Higher-Order Substrate Recognition of eIF2alpha by the RNA-Dependent Protein Kinase PKR.,Inhibitor,,1,CEREP,EIF2AK2,P19525,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P19525_E2AK2_wild_cl1,E2AK2_6d3kC_ADP,P19525,P19525wild,E2AK2,wild,cl1,6d3kC,ADP,,6d3k,2,1,,Kinase,HoYoungLee,1,Structural Basis of Protein Kinase R Autophosphorylation.,Inhibitor,,1,CEREP,EIF2AK2,P19525,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P19784_CSNK2A2_wild_cl1,CSNK2A2_6l20G_E3U,P19784,P19784wild,CSNK2A2,wild,cl1,6l20G,E3U,,6l20,1,1,,Kinase,HoYoungLee,1,Structural insights for producing CK2 alpha 1-specific inhibitors.,Inhibitor,,1,CEREP,CK2alpha2,P19784,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P19784_CSNK2A2_wild_cl1,CSNK2A2_7a22A_QWW,P19784,P19784wild,CSNK2A2,wild,cl1,7a22A,QWW,,7a22,1,1,,Kinase,HoYoungLee,1,Synthesis_ biological properties and structural study of new halogenated azolo[4_5-b]pyridines as inhibitors of CK2 kinase.,Inhibitor,,1,CEREP,CK2alpha2,P19784,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P19793_RXRA_wild_cl1,RXRA_1rdtA_L79,P19793,P19793wild,RXRA,wild,cl1,1rdtA,L79,,1rdt,2,1,,Receptor,,1,Structure-based design of potent retinoid X receptor alpha Agonists.,Activator,,1,CEREP,RXRalpha,P19793,NHR,Retinoid X,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P19793_RXRA_wild_cl1,RXRA_4m8eA_29V,P19793,P19793wild,RXRA,wild,cl1,4m8eA,29V,,4m8e,2,1,,Receptor,,1,Methyl-substituted conformationally constrained rexinoid Agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.,Activator,,1,CEREP,RXRalpha,P19793,NHR,Retinoid X,Non-Steroid,Biochemical,Binding,Agonist,Radiometric,,,
P21730_C5AR1_wild_cl1,C5AR1_6c1qB_9P2,P21730,P21730wild,C5AR1,wild,cl1,6c1qB,9P2,,6c1q,3,1,,GPCR,,1,Orthosteric and Allosteric action of the C5a receptor antagonists.,Inhibitor,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P21730_C5AR1_wild_cl1,C5AR1_5o9hA_9P2,P21730,P21730wild,C5AR1,wild,cl1,5o9hA,9P2,,5o9h,3,1,,GPCR,,1,Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P21731_TA2R_wild_cl1,TA2R_6iivA_A90,P21731,P21731wild,TA2R,wild,cl1,6iivA,A90,,6iiv,2,1,,GPCR,,1,Structural basis for ligand recognition of the human thromboxane A2receptor.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P21802_FGFR2_wild_cl1,FGFR2_1oecA_AA2,P21802,P21802wild,FGFR2,wild,cl1,1oecA,AA2,,1oec,1,2,,Kinase,HoYoungLee,1,The Crystal Structure of the Fgfr2 Tyrosine Kinase Domain in Complex with 4-Aryl-2-Phenylamino Pyrimidine Angiogenesis inhibitors,Inhibitor,,1,CEREP,FGFR2,P21802,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P21802_FGFR2_wild_cl1,FGFR2_7kieB_WF7,P21802,P21802wild,FGFR2,wild,cl1,7kieB,WF7,,7kie,1,2,,Kinase,HoYoungLee,1,Discovery of Aminopyrazole Derivatives as Potent inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3.,Inhibitor,,1,CEREP,FGFR2,P21802,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P21964_COMT_wild_cl1,COMT_4xucA_43G,P21964,P21964wild,COMT,wild,cl1,4xucA,43G,,4xuc,2,1,,methylase,SooYongLee,1,Synthesis and Evaluation of Heterocyclic Catechol Mimics as inhibitors of Catechol-O-methyltransferase (COMT).,Inhibitor,,1,CEREP,Catechol-O-Methyltransferase,P21964,Neurotransmitter,Catecholamine Turnover,Neurotransmitter,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P21964_COMT_wild_cl1,COMT_4xudA_43H,P21964,P21964wild,COMT,wild,cl1,4xudA,43H,,4xud,2,1,,methylase,SooYongLee,1,Synthesis and Evaluation of Heterocyclic Catechol Mimics as inhibitors of Catechol-O-methyltransferase (COMT).,Inhibitor,,1,CEREP,Catechol-O-Methyltransferase,P21964,Neurotransmitter,Catecholamine Turnover,Neurotransmitter,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P22455_FGFR4_wild_cl1,FGFR4_5nudB_99K,P22455,P22455wild,FGFR4,wild,cl1,5nudB,99K,,5nud,2,2,,Kinase,HoYoungLee,1,Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.,Inhibitor,,1,CEREP,FGFR4,P22455,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P22455_FGFR4_wild_cl1,FGFR4_5nwzB_9CT,P22455,P22455wild,FGFR4,wild,cl1,5nwzB,9CT,,5nwz,2,2,,Kinase,HoYoungLee,1,Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region.,Inhibitor,,1,CEREP,FGFR4,P22455,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P22607_FGFR3_482_cl1,FGFR3_6pnxB_ACP,P22607,P22607482,FGFR3,482,cl1,6pnxB,ACP,,6pnx,3,1,,Kinase,HoYoungLee,1,Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.,Inhibitor,,1,CEREP,FGFR3,P22607,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P22888_LHCGR_wild_cl1,LHCGR_7fihR_55Z,P22888,P22888wild,LHCGR,wild,cl1,7fihR,55Z,,7fih,3,1,,GPCR,,1,Structures of full-length glycoprotein hormone receptor signalling complexes.,Activator,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P22894_MMP8_wild_cl1,MMP8_1bzsA_BSI,P22894,P22894wild,MMP8,wild,cl1,1bzsA,BSI,,1bzs,1,1,,Peptidase,,1,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,Inhibitor,,1,CEREP,MMP8,P22894,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P22894_MMP8_wild_cl1,MMP8_1jj9A_BBT,P22894,P22894wild,MMP8,wild,cl1,1jj9A,BBT,,1jj9,1,1,,Peptidase,,1,The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.,Inhibitor,,1,CEREP,MMP8,P22894,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P23458_JAK1_wild_cl1,JAK1_4e4nB_0NL,P23458,P23458wild,JAK1,wild,cl1,4e4nB,0NL,,4e4n,1,1,,Kinase,HoYoungLee,1,Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 inhibitors.,Inhibitor,,1,CEREP,JAK1,P23458,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P23458_JAK1_wild_cl1,JAK1_4ivbB_1J5,P23458,P23458wild,JAK1,wild,cl1,4ivbB,1J5,,4ivb,1,1,,Kinase,HoYoungLee,1,Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2.,Inhibitor,,1,CEREP,JAK1,P23458,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P23467_PTPRB_wild_cl1,PTPRB_2i4gA_UA1,P23467,P23467wild,PTPRB,wild,cl1,2i4gA,UA1,,2i4g,2,1,,phosphatase,SooYongLee,1,Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.,Inhibitor,,1,CEREP,PTPbeta,P23467,Phosphatase,RTP,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P23467_PTPRB_wild_cl1,PTPRB_2i5xB_UA5,P23467,P23467wild,PTPRB,wild,cl1,2i5xB,UA5,,2i5x,2,1,,phosphatase,SooYongLee,1,Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.,Inhibitor,,1,CEREP,PTPbeta,P23467,Phosphatase,RTP,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P23470_PTPRG_wild_cl1,PTPRG_3qcgA_NX1,P23470,P23470wild,PTPRG,wild,cl1,3qcgA,NX1,,3qcg,1,1,,phosphatase,SooYongLee,1,Small molecule receptor protein tyrosine phosphatase [gamma](RPTP[gamma]) ligands  that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loop,Inhibitor,,1,CEREP,PTPgamma,P23470,Phosphatase,RTP,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P23470_PTPRG_wild_cl1,PTPRG_3qcjA_NX4,P23470,P23470wild,PTPRG,wild,cl1,3qcjA,NX4,,3qcj,1,1,,phosphatase,SooYongLee,1,Small molecule receptor protein tyrosine phosphatase [gamma](RPTP[gamma]) ligands  that inhibit phosphatase activity via perturbation of the tryptophan-proline-aspartate (WPD) loop,Inhibitor,,1,CEREP,PTPgamma,P23470,Phosphatase,RTP,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P24723_PRKCH_wild_cl1,PRKCH_3txoA_07U,P24723,P24723wild,PRKCH,wild,cl1,3txoA,07U,,3txo,3,1,,Kinase,HoYoungLee,1,2_6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.,Inhibitor,,1,CEREP,PKCeta,P24723,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P24941_CDK2_wild_cl1,CDK2_2fvdA_LIA,P24941,P24941wild,CDK2,wild,cl1,2fvdA,LIA,,2fvd,1,1,,Kinase,HoYoungLee,1,Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2_3-difluoro-6- methoxyphenyl)methanone (R547)_ a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity.,Inhibitor,,1,CEREP,CDK2,P24941,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P24941_CDK2_wild_cl1,CDK2_2uueC_MTZ,P24941,P24941wild,CDK2,wild,cl1,2uueC,MTZ,,2uue,1,1,,Kinase,HoYoungLee,1,Replace: A Strategy for Iterative Design of Cyclin- Binding Groove inhibitors,Inhibitor,,1,CEREP,CDK2,P24941,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P25098_ARBK1_wild_cl1,ARBK1_5ukkA_8DJ,P25098,P25098wild,ARBK1,wild,cl1,5ukkA,8DJ,,5ukk,1,1,,Kinase,HoYoungLee,1,Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 inhibitors Based on Paroxetine.,Inhibitor,,1,CEREP,GRK2,P25098,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P25098_ARBK1_wild_cl1,ARBK1_6c2yA_EJS,P25098,P25098wild,ARBK1,wild,cl1,6c2yA,EJS,,6c2y,1,1,,Kinase,HoYoungLee,1,Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.,Inhibitor,,1,CEREP,GRK2,P25098,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P25105_PTAFR_289_cl1,PTAFR_5zkpA_FMN,P25105,P25105289,PTAFR,289,cl1,5zkpA,FMN,,5zkp,2,1,,GPCR,,1,Structural basis for signal recognition and transduction by platelet-activating-factor receptor.,Activator,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P25105_PTAFR_289_cl1,PTAFR_5zkpA_FMN,P25105,P25105289,PTAFR,289,cl1,5zkpA,,9ER,5zkp,,,,,,,Structural basis for signal recognition and transduction by platelet-activating-factor receptor.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P25116_PAR1_wild_cl1,PAR1_3vw7A_VPX,P25116,P25116wild,PAR1,wild,cl1,3vw7A,VPX,,3vw7,2,1,,GPCR,,1,High-resolution crystal structure of human protease-activated receptor 1,inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P25929_NPY1R_wild_cl1,NPY1R_5zbhA_9AF,P25929,P25929wild,NPY1R,wild,cl1,5zbhA,9AF,,5zbh,2,1,,GPCR,,1,Structural basis of ligand binding modes at the neuropeptide Y Y1receptor,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P25929_NPY1R_wild_cl1,NPY1R_5zbqA_9AO,P25929,P25929wild,NPY1R,wild,cl1,5zbqA,9AO,,5zbq,2,1,,GPCR,,1,Structural basis of ligand binding modes at the neuropeptide Y Y1receptor,inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P27037_AVR2A_wild_cl1,AVR2A_4asxB_6OJ,P27037,P27037wild,AVR2A,wild,cl1,4asxB,6OJ,,4asx,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Activin Receptor Type-Iia (Acvr2A) Kinase Domain in Complex with a Beta- Carboline inhibitor,Inhibitor,,1,CEREP,ActR2,P27037,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P27361_MK03_wild_cl1,MK03_4qtbB_38Z,P27361,P27361wild,MK03,wild,cl1,4qtbB,38Z,,4qtb,2,1,,Kinase,HoYoungLee,1,A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics.,Inhibitor,,1,CEREP,ERK1,P27361,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P27361_MK03_wild_cl1,MK03_6gesB_6H3,P27361,P27361wild,MK03,wild,cl1,6gesB,6H3,,6ges,2,1,,Kinase,HoYoungLee,1,Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome.,Inhibitor,,1,CEREP,ERK1,P27361,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P27448_MARK3_wild_cl1,MARK3_7p1lB_V5E,P27448,P27448wild,MARK3,wild,cl1,7p1lB,V5E,,7p1l,3,1,,Kinase,HoYoungLee,1,Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration.,Inhibitor,,1,CEREP,MARK3,P27448,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P28482_MK01_wild_cl1,MK01_3i5zA_Z48,P28482,P28482wild,MK01,wild,cl1,3i5zA,Z48,,3i5z,1,1,,Kinase,HoYoungLee,1,Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.,Inhibitor,,1,CEREP,ERK2,P28482,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P28482_MK01_wild_cl1,MK01_3i60A_E86,P28482,P28482wild,MK01,wild,cl1,3i60A,E86,,3i60,1,1,,Kinase,HoYoungLee,1,Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.,Inhibitor,,1,CEREP,ERK2,P28482,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29317_EPHA2_wild_cl1,EPHA2_5i9yA_1N1,P29317,P29317wild,EPHA2,wild,cl1,5i9yA,1N1,,5i9y,1,1,,Kinase,HoYoungLee,1,Chemical Proteomics and Structural Biology Define EPHA2 inhibition by Clinical Kinase Drugs.,Inhibitor,,1,CEREP,EphA2,P29317,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29317_EPHA2_wild_cl1,EPHA2_5nkcA_90T,P29317,P29317wild,EPHA2,wild,cl1,5nkcA,90T,,5nkc,1,1,,Kinase,HoYoungLee,1,Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 inhibitors.,Inhibitor,,1,CEREP,EphA2,P29317,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29320_EPHA3_wild_cl1,EPHA3_4p5qA_Q0B,P29320,P29320wild,EPHA3,wild,cl1,4p5qA,Q0B,,4p5q,3,1,,Kinase,HoYoungLee,1,Pyrrolo[3_2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase inhibitors: Structure-Based Design_ Synthesis_ and in Vivo Validation.,Inhibitor,,1,CEREP,EphA3,P29320,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29320_EPHA3_wild_cl1,EPHA3_4p5zA_Q7M,P29320,P29320wild,EPHA3,wild,cl1,4p5zA,Q7M,,4p5z,3,1,,Kinase,HoYoungLee,1,Pyrrolo[3_2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase inhibitors: Structure-Based Design_ Synthesis_ and in Vivo Validation.,Inhibitor,,1,CEREP,EphA3,P29320,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29375_KDM5A_wild_cl1,KDM5A_6bgwA_DKS,P29375,P29375wild,KDM5A,wild,cl1,6bgwA,DKS,,6bgw,1,1,,methylase,SooYongLee,1,Insights into the Action of inhibitor Enantiomers against Histone Lysine Demethylase 5A.,Inhibitor,,1,CEREP,JARID1A,P29375,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
P29375_KDM5A_wild_cl1,KDM5A_6bgyA_DLJ,P29375,P29375wild,KDM5A,wild,cl1,6bgyA,DLJ,,6bgy,1,1,,methylase,SooYongLee,1,Insights into the Action of inhibitor Enantiomers against Histone Lysine Demethylase 5A.,Inhibitor,,1,CEREP,JARID1A,P29375,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
P29597_TYK2_wild_cl1,TYK2_4wovB_3SM,P29597,P29597wild,TYK2,wild,cl1,4wovB,3SM,,4wov,2,2,,Kinase,HoYoungLee,1,Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.,Inhibitor,,1,CEREP,Tyk2,P29597,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P29597_TYK2_wild_cl1,TYK2_5f1zA_5U3,P29597,P29597wild,TYK2,wild,cl1,5f1zA,5U3,,5f1z,2,2,,Kinase,HoYoungLee,1,Structure-Based Design and Synthesis of 3-Amino-1_5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 inhibitors.,Inhibitor,,1,CEREP,Tyk2,P29597,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P30291_WEE1_wild_cl1,WEE1_1x8bA_824,P30291,P30291wild,WEE1,wild,cl1,1x8bA,824,,1x8b,1,1,,Kinase,HoYoungLee,1,Structure and inhibition of the human cell cycle checkpoint kinase_ Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation,Inhibitor,,1,CEREP,Wee1,P30291,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P30291_WEE1_wild_cl1,WEE1_2io6A_330,P30291,P30291wild,WEE1,wild,cl1,2io6A,330,,2io6,1,1,,Kinase,HoYoungLee,1,Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3_4-c]carbazole-1_3(2H_6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.,Inhibitor,,1,CEREP,Wee1,P30291,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P30305_MPIP2_wild_cl1,MPIP2_4wh9A_3M8,P30305,P30305wild,MPIP2,wild,cl1,4wh9A,3M8,,4wh9,2,1,,phosphatase,SooYongLee,1,inhibition of CDC25B Phosphatase Through Disruption of Protein-Protein Interaction.,Inhibitor,,1,CEREP,CDC25B,P30305,Phosphatase,Dual Specificity,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P30530_UFO_wild_cl1,UFO_5u6bD_7YS,P30530,P30530wild,UFO,wild,cl1,5u6bD,7YS,,5u6b,2,1,,Kinase,HoYoungLee,1,The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase.,Inhibitor,,1,CEREP,AXL,P30530,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31749_AKT1_wild_cl1,AKT1_5kcvA_6S1,P31749,P31749wild,AKT1,wild,cl1,5kcvA,6S1,,5kcv,3,2,,Kinase,HoYoungLee,1,Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4_5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable_ Selective_ and Potent Allosteric AKT inhibitor.,Inhibitor,allosteric,1,CEREP,Akt1,P31749,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31749_AKT1_wild_cl2,AKT1_3qkmA_SM9,P31749,P31749wild,AKT1,wild,cl2,3qkmA,SM9,,3qkm,3,2,,Kinase,HoYoungLee,1,Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.,Inhibitor,,1,CEREP,Akt1,P31749,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31749_AKT1_wild_cl1,AKT1_4ejnA_0R4,P31749,P31749wild,AKT1,wild,cl1,4ejnA,0R4,,4ejn,3,2,,Kinase,HoYoungLee,1,Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4_5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable_ selective_ and potent ATP-independent Akt inhibitors.,Inhibitor,,1,CEREP,Akt1,P31749,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31749_AKT1_wild_cl2,AKT1_4eklA_0RF,P31749,P31749wild,AKT1,wild,cl2,4eklA,0RF,,4ekl,3,2,,Kinase,HoYoungLee,1,An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt.,Inhibitor,,1,CEREP,Akt1,P31749,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31751_AKT2_wild_cl1,AKT2_2uw9A_GVP,P31751,P31751wild,AKT2,wild,cl1,2uw9A,GVP,,2uw9,1,1,,Kinase,HoYoungLee,1,Identification of inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery.,Inhibitor,,1,CEREP,Akt2,P31751,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P31751_AKT2_wild_cl1,AKT2_3e88B_G96,P31751,P31751wild,AKT2,wild,cl1,3e88B,G96,,3.00E+88,1,1,,Kinase,HoYoungLee,1,Aminofurazans as potent inhibitors of AKT kinase,Inhibitor,,1,CEREP,Akt2,P31751,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P32298_GRK4_wild_cl1,GRK4_4yhjB_AN2,P32298,P32298wild,GRK4,wild,cl1,4yhjB,AN2,,4yhj,2,1,,Kinase,HoYoungLee,1,Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4.,Inhibitor,,1,CEREP,GRK4,P32298,Kinase,AGC,Protein Serine/Threonine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P33981_TTK_wild_cl1,TTK_3wyyA_O17,P33981,P33981wild,TTK,wild,cl1,3wyyA,O17,,3wyy,3,1,,Kinase,HoYoungLee,1,A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity.,Inhibitor,,1,CEREP,TTK,P33981,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P33981_TTK_wild_cl1,TTK_4c4jA_X21,P33981,P33981wild,TTK,wild,cl1,4c4jA,X21,,4c4j,3,1,,Kinase,HoYoungLee,1,Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3_ 2-C]Pyridine inhibitors of the Mitotic Kinase Monopolar Spindle 1 (Mps1).,Inhibitor,,1,CEREP,TTK,P33981,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P34947_GRK5_wild_cl1,GRK5_4tndA_ANP,P34947,P34947wild,GRK5,wild,cl1,4tndA,ANP,,4tnd,2,1,,Kinase,HoYoungLee,1,Atomic Structure of G Protein-Coupled Receptor Kinase 5 (GRK5) Reveals Distinct Structural Features Novel for GRKs.,Inhibitor,,1,CEREP,GRK5,P34947,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P34947_GRK5_wild_cl1,GRK5_6pjxA_SGV,P34947,P34947wild,GRK5,wild,cl1,6pjxA,SGV,,6pjx,2,1,,Kinase,HoYoungLee,1,Structure of a GRK5-Calmodulin Complex Reveals Molecular Mechanism of GRK Activation and Substrate Targeting.,Inhibitor,,1,CEREP,GRK5,P34947,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P34998_CRFR1_wild_cl1,CRFR1_4z9gC_1Q5,P34998,P34998wild,CRFR1,wild,cl1,4z9gC,1Q5,,4z9g,2,1,,GPCR,,1,Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P35236_PTN7_wild_cl1,PTN7_3d42A_TAR,P35236,P35236wild,PTN7,wild,cl1,3d42A,TAR,,3d42,2,1,,phosphatase,SooYongLee,1,Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.,apo,,1,CEREP,HePTP,P35236,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P35236_PTN7_wild_cl1,PTN7_3o4tA_TAR,P35236,P35236wild,PTN7,wild,cl1,3o4tA,TAR,,3o4t,2,1,,phosphatase,SooYongLee,1,Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop.,apo,,1,CEREP,HePTP,P35236,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P35354_PGH2_wild_cl2,PGH2_5f1aA_COH,P35354,P35354wild,PGH2,wild,cl2,5f1aA,COH,SAL,5f1a,2,2,,Synthase,,1,Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.,Inhibitor,,1,CEREP,COX2,P35354,Lipid Metabolism,Eicosanoid Turnover,Cyclooxygenase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P35354_PGH2_wild_cl1,PGH2_5ikqB_JMS,P35354,P35354wild,PGH2,wild,cl1,5ikqB,JMS,,5ikq,2,2,,Synthase,,1,Substrate-selective inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.,Inhibitor,,1,CEREP,COX2,P35354,Lipid Metabolism,Eicosanoid Turnover,Cyclooxygenase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P35354_PGH2_wild_cl2,PGH2_5ikrB_COH,P35354,P35354wild,PGH2,wild,cl2,5ikrB,COH,,5ikr,2,2,,Synthase,,1,Substrate-selective inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.,Inhibitor,,1,CEREP,COX2,P35354,Lipid Metabolism,Eicosanoid Turnover,Cyclooxygenase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P35354_PGH2_wild_cl1,PGH2_5ikvA_FLF,P35354,P35354wild,PGH2,wild,cl1,5ikvA,FLF,,5ikv,2,2,,Synthase,,1,Substrate-selective inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.,Inhibitor,,1,CEREP,COX2,P35354,Lipid Metabolism,Eicosanoid Turnover,Cyclooxygenase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P35367_HRH1_wild_cl1,HRH1_3rzeA_5EH,P35367,P35367wild,HRH1,wild,cl1,3rzeA,5EH,,3rze,3,1,,GPCR,,1,Structure of the human histamine H1 receptor complex with doxepin.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P35408_PE2R4_wild_cl1,PE2R4_7d7mA_P2E,P35408,P35408wild,PE2R4,wild,cl1,7d7mA,P2E,,7d7m,3,1,,GPCR,,1,Cryo-EM Structure of the Prostaglandin E Receptor EP4 Coupled to G Protein.,Activator,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P35462_DRD3_wild_cl1,DRD3_3pblB_ETQ,P35462,P35462wild,DRD3,wild,cl1,3pblB,ETQ,,3pbl,2,1,,GPCR,,1,Structure of the human dopamine d3 receptor in complex with a d2/d3 selective antagonist.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P35968_VGFR2_wild_cl1,VGFR2_3b8qB_900,P35968,P35968wild,VGFR2,wild,cl1,3b8qB,900,,3b8q,1,1,,Kinase,HoYoungLee,1,Naphthamides as Novel and Potent Vascular Endothelial Growth Factor  Receptor Tyrosine Kinase inhibitors: Design_ Synthesis and Evaluation,Inhibitor,,1,CEREP,KDR ,P35968,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P35968_VGFR2_wild_cl1,VGFR2_4aseA_AV9,P35968,P35968wild,VGFR2,wild,cl1,4aseA,AV9,,4ase,1,1,,Kinase,HoYoungLee,1,Molecular Conformations_ Interactions_ and Properties Associated with Drug Efficiency and Clinical Performance Among Vegfr Tk inhibitors.,Inhibitor,,1,CEREP,KDR ,P35968,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P36507_MP2K2_wild_cl1,MP2K2_1s9iB_ATP,P36507,P36507wild,MP2K2,wild,cl1,1s9iB,ATP,,1s9i,2,1,,Kinase,HoYoungLee,1,Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.,Inhibitor,,1,CEREP,MEK2,P36507,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P36639_8ODP_wild_cl1,8ODP_5nhyB_8XT,P36639,P36639wild,8ODP,wild,cl1,5nhyB,8XT,,5nhy,1,1,,hydrolase,,1,Novel Class of Potent and Cellularly Active inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P36639_8ODP_wild_cl1,8ODP_6f22B_C9B,P36639,P36639wild,8ODP,wild,cl1,6f22B,C9B,,6f22,1,1,,hydrolase,,1,Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) inhibitors Using Fragment-Based Screening and Structure-Based Drug Design.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P36888_FLT3_wild_cl1,FLT3_4xufA_P30,P36888,P36888wild,FLT3,wild,cl1,4xufA,P30,,4xuf,3,1,,Kinase,HoYoungLee,1,Crystal Structure of the FLT3 Kinase Domain Bound to the inhibitor Quizartinib (AC220).,Inhibitor,,1,CEREP,FLT3,P36888,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P36888_FLT3_wild_cl1,FLT3_5x02A_F6M,P36888,P36888wild,FLT3,wild,cl1,5x02A,F6M,,5x02,3,1,,Kinase,HoYoungLee,1,A novel irreversible FLT3 inhibitor_ FF-10101_ shows excellent efficacy against AML cells withFLT3mutations.,Inhibitor,,1,CEREP,FLT3,P36888,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P36897_TGFR1_wild_cl1,TGFR1_3kcfE_JZO,P36897,P36897wild,TGFR1,wild,cl1,3kcfE,JZO,,3kcf,1,1,,Kinase,HoYoungLee,1,Pyrazolone based TGFbetaR1 kinase inhibitors.,Inhibitor,,1,CEREP,TGFBR1,P36897,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P36897_TGFR1_wild_cl1,TGFR1_5qilA_J2V,P36897,P36897wild,TGFR1,wild,cl1,5qilA,J2V,,5qil,1,1,,Kinase,HoYoungLee,1,Discovery of 4-Azaindole inhibitors of TGF beta RI as Immuno-oncology Agents.,Inhibitor,,1,CEREP,TGFBR1,P36897,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P37023_ACVL1_wild_cl1,ACVL1_3my0A_LDN,P37023,P37023wild,ACVL1,wild,cl1,3my0A,LDN,,3my0,3,1,,Kinase,HoYoungLee,1,A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.,Inhibitor,,1,CEREP,ALK1,P37023,Kinase,RSTK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P37173_TGFR2_wild_cl1,TGFR2_5e91A_5L4,P37173,P37173wild,TGFR2,wild,cl1,5e91A,5L4,,5.00E+91,2,2,,Kinase,HoYoungLee,1,Crystal structures of apo and inhibitor-bound TGF beta R2 kinase domain: insights into TGF beta R isoform selectivity.,Inhibitor,,1,CEREP,TGFBR2,P37173,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P37173_TGFR2_wild_cl1,TGFR2_5qinA_J2V,P37173,P37173wild,TGFR2,wild,cl1,5qinA,J2V,,5qin,2,2,,Kinase,HoYoungLee,1,Discovery of 4-Azaindole inhibitors of TGF beta RI as Immuno-oncology Agents.,Inhibitor,,1,CEREP,TGFBR2,P37173,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P37231_PPARG_wild_cl1,PPARG_3ia6B_UNT,P37231,P37231wild,PPARG,wild,cl1,3ia6B,UNT,,3ia6,2,1,,Receptor,,1,Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual Agonists.,Activator,,1,CEREP,PPARgamma,P37231,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional,Protein-Protein Interaction,Agonist & Antagonist,AlphaScreen,,,
P37231_PPARG_wild_cl1,PPARG_5twoA_7MV,P37231,P37231wild,PPARG,wild,cl1,5twoA,7MV,,5two,2,1,,Receptor,,1,Identification of a novel selective PPAR gamma ligand with a unique binding mode and improved therapeutic profile in vitro.,Activator,,1,CEREP,PPARgamma,P37231,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional,Protein-Protein Interaction,Agonist & Antagonist,AlphaScreen,,,
P39900_MMP12_wild_cl1,MMP12_1rosB_DEO,P39900,P39900wild,MMP12,wild,cl1,1rosB,DEO,,1ros,1,2,,Peptidase,,1,Crystal structures of novel non-peptidic_ non-zinc chelating inhibitors bound to MMP-12.,Inhibitor,,1,CEREP,MMP12,P39900,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P39900_MMP12_wild_cl1,MMP12_2w0dD_CGS,P39900,P39900wild,MMP12,wild,cl1,2w0dD,CGS,,2w0d,1,2,,Peptidase,,1,Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? a Case Study of Metalloproteinases.,Inhibitor,,1,CEREP,MMP12,P39900,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P39900_MMP12_171_cl1,MMP12_3likA_EEG,P39900,P39900171,MMP12,171,cl1,3likA,EEG,,3lik,1,2,,Peptidase,,1,Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1' loop canonical conformation.,Inhibitor,,1,CEREP,MMP12,P39900,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P39900_MMP12_171_cl1,MMP12_6eknA_B9N,P39900,P39900171,MMP12,171,cl1,6eknA,B9N,,6ekn,1,2,,Peptidase,,1,Development of Thioaryl-Based Matrix Metalloproteinase-12 inhibitors with Alternative Zinc-Binding Groups: Synthesis_ Potentiometric_ NMR_ and Crystallographic Studies.,Inhibitor,,1,CEREP,MMP12,P39900,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
P40261_NNMT_wild_cl1,NNMT_6b1aC_C8J,P40261,P40261wild,NNMT,wild,cl1,6b1aC,C8J,,6b1a,3,1,6CHH_ Diff lig,methylase,SooYongLee,1,Structure of human NNMT in complex with bisubstrate inhibitor MS2756,Inhibitor,,1,CEREP,Nicotinamide N-Methyltransferase,P40261,Epigenetic,Small Molecule Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,HPLC-MS,,,
P40261_NNMT_wild_cl1,NNMT_6chhA_F0P,P40261,P40261wild,NNMT,wild,cl1,6chhA,F0P,,6chh,3,1,,methylase,SooYongLee,1,Discovery of Bisubstrate inhibitors of Nicotinamide N-Methyltransferase (NNMT).,Inhibitor,,1,CEREP,Nicotinamide N-Methyltransferase,P40261,Epigenetic,Small Molecule Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,HPLC-MS,,,
P41143_OPRD_wild_cl1,OPRD_4n6hA_EJ4,P41143,P41143wild,OPRD,wild,cl1,4n6hA,EJ4,,4n6h,2,1,,GPCR,,1,Molecular control of delta-opioid receptor signalling.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41145_OPRK_135_cl1,OPRK_6vi4B_JDC,P41145,P41145135,OPRK,135,cl1,6vi4B,JDC,,6vi4,2,2,,GPCR,,1,Nanobody-enabled monitoring of kappa opioid receptor states.,Activator,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41145_OPRK_135_cl1,OPRK_4djhA_JDC,P41145,P41145135,OPRK,135,cl1,4djhA,JDC,,4djh,2,2,,GPCR,,1,tructure of the human kappa-opioid receptor in complex with JDTic,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41145_OPRK_wild_cl1,OPRK_4djhB_JDC,P41145,P41145wild,OPRK,wild,cl1,4djhB,JDC,,4djh,2,2,,GPCR,,1,tructure of the human kappa-opioid receptor in complex with JDTic,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41145_OPRK_wild_cl1,OPRK_6b73B_CVV,P41145,P41145wild,OPRK,wild,cl1,6b73B,CVV,,6b73,2,2,,GPCR,,1,Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.,Activator,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41146_OPRX_wild_cl1,OPRX_4ea3B_0NN,P41146,P41146wild,OPRX,wild,cl1,4ea3B,0NN,,4ea3,2,1,,GPCR,,1,Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41146_OPRX_wild_cl1,OPRX_5dhhB_DGW,P41146,P41146wild,OPRX,wild,cl1,5dhhB,DGW,,5dhh,2,1,,GPCR,,1,The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41229_KDM5C_wild_cl1,KDM5C_5fwjB_MMK,P41229,P41229wild,KDM5C,wild,cl1,5fwjB,MMK,,5fwj,2,1,,methylase,SooYongLee,1,Structural Analysis of Human Kdm5B Guides Histone Demethylase inhibitor Development.,Inhibitor,,1,CEREP,JARID1C,P41229,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
P41240_CSK_wild_cl1,CSK_3d7tA_STU,P41240,P41240wild,CSK,wild,cl1,3d7tA,STU,,3d7t,3,1,,Kinase,HoYoungLee,1,Structural basis for the recognition of c-Src by its inactivator Csk.,Inhibitor,,1,CEREP,CSK,P41240,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P41279_M3K8_wild_cl1,M3K8_5iu2A_6DA,P41279,P41279wild,M3K8,wild,cl1,5iu2A,6DA,,5iu2,3,1,,Kinase,HoYoungLee,1,Discovery of Imidazoquinolines as a Novel Class of Potent_ Selective_ and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase inhibitors.,Inhibitor,,1,CEREP,COT,P41279,Kinase,STE,Protein Serine/Threonine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P41586_ADCYAP1R1_wild_cl1,ADCYAP1R1_3n94A_MAL,P41586,P41586wild,ADCYAP1R1,wild,cl1,3n94A,MAL,,3n94,3,1,,GPCR,,1,Crystal Structure of the PAC1R Extracellular Domain Unifies a Consensus Fold for Hormone Recognition by Class B G-Protein Coupled Receptors.,Binding,Peptide binding,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41594_GRM5_wild_cl1,GRM5_5cgcA_51D,P41594,P41594wild,GRM5,wild,cl1,5cgcA,51D,,5cgc,2,1,,GPCR,,1,Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).,Inhibitor,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41594_GRM5_wild_cl1,GRM5_5cgdA_51E,P41594,P41594wild,GRM5,wild,cl1,5cgdA,51E,,5cgd,2,1,,GPCR,,1,Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).,inhibitor,allosteric,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P41743_KPCI_wild_cl1,KPCI_5li1A_ANP,P41743,P41743wild,KPCI,wild,cl1,5li1A,ANP,,5li1,2,1,,Kinase,HoYoungLee,1,aPKC inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization.,Inhibitor,,1,CEREP,PKCiota,P41743,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P41743_KPCI_wild_cl1,KPCI_5li9A_ACP,P41743,P41743wild,KPCI,wild,cl1,5li9A,ACP,,5li9,2,1,,Kinase,HoYoungLee,1,aPKC inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization.,Inhibitor,,1,CEREP,PKCiota,P41743,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P42574_CASP3_wild_cl1,CASP3_1re1A_NA3,P42574,P42574wild,CASP3,wild,cl1,1re1A,NA3,,1re1,2,1,,Peptidase,,1,Reducing the Peptidyl Features of Caspase-3 inhibitors: A Structural Analysis,Inhibitor,,1,CEREP,Caspase 3,P42574,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P42574_CASP3_wild_cl1,CASP3_3gjrC_DZE,P42574,P42574wild,CASP3,wild,cl1,3gjrC,DZE,,3gjr,2,1,,Peptidase,,1,Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.,Inhibitor,,1,CEREP,Caspase 3,P42574,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P42684_ABL2_wild_cl1,ABL2_3hmiA_DKI,P42684,P42684wild,ABL2,wild,cl1,3hmiA,DKI,,3hmi,2,1,,Kinase,HoYoungLee,1,The crystal structure of human ABL2 in complex with 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2_6-DIFLUOROPHENYL)-1H-1_2_4-TRIAZOLE-1-CARBOTHIOAMIDE,Inhibitor,,1,CEREP,ABL2,P42684,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43250_GRK6_wild_cl1,GRK6_3nynB_SGV,P43250,P43250wild,GRK6,wild,cl1,3nynB,SGV,,3nyn,2,1,,Kinase,HoYoungLee,1,Molecular basis for activation of G protein-coupled receptor kinases.,Inhibitor,,1,CEREP,GRK6,P43250,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43250_GRK6_wild_cl1,GRK6_3nyoB_AMP,P43250,P43250wild,GRK6,wild,cl1,3nyoB,AMP,,3nyo,2,1,,Kinase,HoYoungLee,1,Molecular basis for activation of G protein-coupled receptor kinases.,Inhibitor,,1,CEREP,GRK6,P43250,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43403_ZAP70_wild_cl1,ZAP70_4xz0A_4N5,P43403,P43403wild,ZAP70,wild,cl1,4xz0A,4N5,,4xz0,3,2,,Kinase,HoYoungLee,1,Modification by covalent reaction or oxidation of cysteine residues in the tandem-SH2 domains of ZAP-70 and Syk can block phosphopeptide binding.,Inhibitor,allosteric_ Covalent,1,CEREP,ZAP70,P43403,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43403_ZAP70_wild_cl1,ZAP70_1u59A_STU,P43403,P43403wild,ZAP70,wild,cl1,1u59A,STU,,1u59,3,2,,Kinase,HoYoungLee,1,The Three-dimensional Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine: IMPLICATIONS FOR THE DESIGN OF SELECTIVE inhibitorS,Inhibitor,,1,CEREP,ZAP70,P43403,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43405_KSYK_wild_cl1,KSYK_4rssA_4MG,P43405,P43405wild,KSYK,wild,cl1,4rssA,4MG,,4rss,1,1,,Kinase,HoYoungLee,1,Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors.,Inhibitor,,1,CEREP,Syk,P43405,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P43405_KSYK_wild_cl1,KSYK_5cxhA_55M,P43405,P43405wild,KSYK,wild,cl1,5cxhA,55M,,5cxh,1,1,,Kinase,HoYoungLee,1,Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.,Inhibitor,,1,CEREP,Syk,P43405,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45452_MMP13_wild_cl1,MMP13_1ztqD_033,P45452,P45452wild,MMP13,wild,cl1,1ztqD,33,,1ztq,1,1,,Peptidase,,1,Identification of potent and selective MMP-13 inhibitors,Inhibitor,,1,CEREP,MMP13,P45452,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P45452_MMP13_wild_cl1,MMP13_456cB_CBP,P45452,P45452wild,MMP13,wild,cl1,456cB,CBP,,456c,1,1,,Peptidase,,1,Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.,Inhibitor,,1,CEREP,MMP13,P45452,Protease,Matrix Metallopeptidase,Metallo Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P45983_MK08_wild_cl1,MK08_3v3vA_MYU,P45983,P45983wild,MK08,wild,cl1,3v3vA,MYU,,3v3v,2,1,,Kinase,HoYoungLee,1,Structural and Functional Analysis of the Natural JNK1 inhibitor Quercetagetin.,Inhibitor,,1,CEREP,JNK1,P45983,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45983_MK08_wild_cl1,MK08_4l7fA_1V5,P45983,P45983wild,MK08,wild,cl1,4l7fA,1V5,,4l7f,2,1,,Kinase,HoYoungLee,1,Hit-to-lead optimization and kinase selectivity of imidazo[1_2-a]quinoxalin-4-amine derived JNK1 inhibitors.,Inhibitor,,1,CEREP,JNK1,P45983,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45984_MK09_wild_cl1,MK09_3e7oB_35F,P45984,P45984wild,MK09,wild,cl1,3e7oB,35F,,3e7o,2,1,,Kinase,HoYoungLee,1,The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.,Inhibitor,,1,CEREP,JNK2,P45984,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45984_MK09_wild_cl1,MK09_3npcB_B96,P45984,P45984wild,MK09,wild,cl1,3npcB,B96,,3npc,2,1,,Kinase,HoYoungLee,1,X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitors.,Inhibitor,,1,CEREP,JNK2,P45984,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45985_MAP2K4_wild_cl1,MAP2K4_3alnB_ANP,P45985,P45985wild,MAP2K4,wild,cl1,3alnB,ANP,,3aln,2,1,,Kinase,HoYoungLee,1,Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an Allosteric site and induces an auto-inhibition state,Inhibitor,allosteric,1,CEREP,MKK4,P45985,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P45985_MAP2K4_wild_cl1,MAP2K4_3aloA_ANP,P45985,P45985wild,MAP2K4,wild,cl1,3aloA,ANP,,3alo,2,1,,Kinase,HoYoungLee,1,Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an Allosteric site and induces an auto-inhibition state,Inhibitor,allosteric,1,CEREP,MKK4,P45985,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P48426_PI42A_wild_cl1,PI42A_6ospA_N51,P48426,P48426wild,PI42A,wild,cl1,6ospA,N51,,6osp,3,1,,0,JiYoonShin,1,Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent inhibitors.,Inhibitor,,1,CEREP,PIP4K2alpha,P48426,0,0,0,Functional,Biochemical,inhibitor,0,,,
P48443_RXRG_wild_cl1,RXRG_7a79A_PLM,P48443,P48443wild,RXRG,wild,cl1,7a79A,PLM,,7a79,2,1,,Receptor,,1,Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms.,Binding,Peptide binding,1,CEREP,RXRgamma,P48443,NHR,Retinoid X,Non-Steroid,Functional,Cell Based,Agonist & Antagonist,_,,,
P48729_KC1A_wild_cl1,KC1A_6gzdA_LCI,P48729,P48729wild,KC1A,wild,cl1,6gzdA,LCI,,6gzd,2,1,,Kinase,HoYoungLee,1,Small Molecules Co-targeting CKI alpha and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.,Inhibitor,,1,CEREP,CSNK1A1,P48729,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P48730_KC1D_wild_cl1,KC1D_3uzpB_0CK,P48730,P48730wild,KC1D,wild,cl1,3uzpB,0CK,,3uzp,1,2,,Kinase,HoYoungLee,1,Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.,Inhibitor,,1,CEREP,CK1delta,P48730,Kinase,CK1,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P48730_KC1D_wild_cl1,KC1D_4kbcB_1QJ,P48730,P48730wild,KC1D,wild,cl1,4kbcB,1QJ,,4kbc,1,2,,Kinase,HoYoungLee,1,Ligand-protein interactions of selective casein kinase 1 delta inhibitors.,Inhibitor,,1,CEREP,CK1delta,P48730,Kinase,CK1,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P48736_PK3CG_wild_cl1,PK3CG_3sd5A_SD5,P48736,P48736wild,PK3CG,wild,cl1,3sd5A,SD5,,3sd5,1,1,,Kinase,HoYoungLee,1,Identification and Characterization of NVP-BKM120_ an Orally Available Pan-Class I PI3-Kinase inhibitor.,Inhibitor,,1,CEREP,PI3Kgamma,P48736,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
P48736_PK3CG_wild_cl1,PK3CG_4ps3A_2WH,P48736,P48736wild,PK3CG,wild,cl1,4ps3A,2WH,,4ps3,1,1,,Kinase,HoYoungLee,1,Structural Basis for Isoform Selectivity in a Class of Benzothiazole inhibitors of Phosphoinositide 3-Kinase gamma.,Inhibitor,,1,CEREP,PI3Kgamma,P48736,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Enzymatic,Antagonist,HTRF,,,
P49137_MAPK2_wild_cl1,MAPK2_3kgaA_LX9,P49137,P49137wild,MAPK2,wild,cl1,3kgaA,LX9,,3kga,2,1,,Kinase,HoYoungLee,1,Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.,Inhibitor,,1,CEREP,MAPKAPK2,P49137,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49137_MAPK2_wild_cl1,MAPK2_3r2yA_P4O,P49137,P49137wild,MAPK2,wild,cl1,3r2yA,P4O,,3r2y,2,1,,Kinase,HoYoungLee,1,Structure-based lead identification of ATP-competitive MK2 inhibitors.,Inhibitor,,1,CEREP,MAPKAPK2,P49137,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49674_KC1E_wild_cl1,KC1E_4hniA_16W,P49674,P49674wild,KC1E,wild,cl1,4hniA,16W,,4hni,2,1,,Kinase,HoYoungLee,1,Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.,Inhibitor,,1,CEREP,CK1epsilon,P49674,Kinase,CK1,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49759_CLK1_wild_cl1,CLK1_5x8iA_SQZ,P49759,P49759wild,CLK1,wild,cl1,5x8iA,SQZ,,5x8i,1,1,,Kinase,HoYoungLee,1,Discovery of Potent and Selective inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers,Inhibitor,,1,CEREP,CLK1,P49759,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49759_CLK1_wild_cl1,CLK1_6khdC_3NG,P49759,P49759wild,CLK1,wild,cl1,6khdC,3NG,,6khd,1,1,,Kinase,HoYoungLee,1,Structural Basis for the Selective inhibition of Cdc2-Like Kinases by CX-4945.,Inhibitor,,1,CEREP,CLK1,P49759,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49760_CLK2_wild_cl1,CLK2_5unpB_8FY,P49760,P49760wild,CLK2,wild,cl1,5unpB,8FY,,5unp,2,1,,Kinase,HoYoungLee,1,A novel CLK inhibitor exhibits anti-tumor efficacies via modulating pre-mRNA splicing and targeting a MYC-dependent vulnerability,Inhibitor,,1,CEREP,CLK2,P49760,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49760_CLK2_wild_cl1,CLK2_6fykC_EAZ,P49760,P49760wild,CLK2,wild,cl1,6fykC,EAZ,,6fyk,2,1,,Kinase,HoYoungLee,1,X-ray Structures and Feasibility Assessment of CLK2 inhibitors for Phelan-McDermid Syndrome.,Inhibitor,,1,CEREP,CLK2,P49760,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49761_CLK3_wild_cl1,CLK3_2wu6A_DKI,P49761,P49761wild,CLK3,wild,cl1,2wu6A,DKI,,2wu6,2,1,,Kinase,HoYoungLee,1,Specific Clk inhibitors from a Novel Chemotype for Regulation of Alternative Splicing.,Inhibitor,,1,CEREP,CLK3,P49761,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49761_CLK3_wild_cl1,CLK3_6fypA_3NG,P49761,P49761wild,CLK3,wild,cl1,6fypA,3NG,,6fyp,2,1,,Kinase,HoYoungLee,1,X-ray Structures and Feasibility Assessment of CLK2 inhibitors for Phelan-McDermid Syndrome.,Inhibitor,,1,CEREP,CLK3,P49761,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49841_GSK3B_wild_cl1,GSK3B_4acdB_GR9,P49841,P49841wild,GSK3B,wild,cl1,4acdB,GR9,,4acd,1,1,,Kinase,HoYoungLee,1,Discovery of novel potent and highly selective glycogen synthase kinase-3 beta (GSK3 beta ) inhibitors for Alzheimer's disease: design_ synthesis_ and characterization of pyrazines.,Inhibitor,,1,CEREP,GSK3beta,P49841,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P49841_GSK3B_wild_cl1,GSK3B_5f94B_3UO,P49841,P49841wild,GSK3B,wild,cl1,5f94B,3UO,,5f94,1,1,,Kinase,HoYoungLee,1,Discovery of Isonicotinamides as Highly Selective_ Brain Penetrable_ and Orally Active Glycogen Synthase Kinase-3 inhibitors.,Inhibitor,,1,CEREP,GSK3beta,P49841,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P50613_CDK7_wild_cl1,CDK7_7b5oJ_I74,P50613,P50613wild,CDK7,wild,cl1,7b5oJ,I74,,7b5o,2,1,,Kinase,HoYoungLee,1,2.5 angstrom -resolution structure of human CDK-activating kinase bound to the clinical inhibitor ICEC0942.,Inhibitor,,1,CEREP,CDK7,P50613,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P50750_CDK9_wild_cl1,CDK9_4imyA_AMP,P50750,P50750wild,CDK9,wild,cl1,4imyA,AMP,,4imy,1,1,,Kinase,HoYoungLee,1,The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat.,Inhibitor,,1,CEREP,CDK9,P50750,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P50750_CDK9_wild_cl1,CDK9_4ogrE_ADN,P50750,P50750wild,CDK9,wild,cl1,4ogrE,ADN,,4ogr,1,1,,Kinase,HoYoungLee,1,AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter.,Inhibitor,,1,CEREP,CDK9,P50750,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P51617_IRAK1_wild_cl1,IRAK1_6bfnB_DL1,P51617,P51617wild,IRAK1,wild,cl1,6bfnB,DL1,,6bfn,3,1,,Kinase,HoYoungLee,1,Crystal structure of human IRAK1.,Inhibitor,,1,CEREP,IRAK1,P51617,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P51812_KS6A3_wild_cl1,KS6A3_4d9uA_0JH,P51812,P51812wild,KS6A3,wild,cl1,4d9uA,0JH,,4d9u,1,2,,Kinase,HoYoungLee,1,Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles.,Inhibitor,,1,CEREP,RSK2,P51812,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P51812_KS6A3_wild_cl1,KS6A3_5d9kB_584,P51812,P51812wild,KS6A3,wild,cl1,5d9kB,584,,5d9k,1,2,,Kinase,HoYoungLee,1,Discovery of Potent and Selective RSK inhibitors as Biological Probes.,Inhibitor,,1,CEREP,RSK2,P51812,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P51955_NEK2_wild_cl1,NEK2_2xnmA_WGZ,P51955,P51955wild,NEK2,wild,cl1,2xnmA,WGZ,,2xnm,1,1,,Kinase,HoYoungLee,1,Benzimidazole inhibitors Induce a Dfg-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure-Activity Relationship.,Inhibitor,,1,CEREP,NEK2,P51955,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P51955_NEK2_wild_cl1,NEK2_4afeA_GGY,P51955,P51955wild,NEK2,wild,cl1,4afeA,GGY,,4afe,1,1,,Kinase,HoYoungLee,1,Design of Potent and Selective Hybrid inhibitors of the Mitotic Kinase Nek2: Structure-Activity Relationship_ Structural Biology_ and Cellular Activity.,Inhibitor,,1,CEREP,NEK2,P51955,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P52333_JAK3_wild_cl1,JAK3_4rioA_3QX,P52333,P52333wild,JAK3,wild,cl1,4rioA,3QX,,4rio,1,1,,Kinase,HoYoungLee,1,Discovery of pyrrolo[1_2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors.,Inhibitor,,1,CEREP,JAK3,P52333,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P52333_JAK3_wild_cl1,JAK3_5lwmA_79T,P52333,P52333wild,JAK3,wild,cl1,5lwmA,79T,,5lwm,1,1,,Kinase,HoYoungLee,1,Selective JAK3 inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket.,Inhibitor,,1,CEREP,JAK3,P52333,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P52564_MP2K6_wild_cl1,MP2K6_3fmeA_STU,P52564,P52564wild,MP2K6,wild,cl1,3fmeA,STU,,3fme,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Mitogen-Activated Protein Kinase Kinase 6 (MEK6) Activated Mutant (S207D_ T211D),Inhibitor,,1,CEREP,MKK6,P52564,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P52564_MP2K6_wild_cl1,MP2K6_3vn9A_ANK,P52564,P52564wild,MP2K6,wild,cl1,3vn9A,ANK,,3vn9,2,1,,Kinase,HoYoungLee,1,Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state,Inhibitor,,1,CEREP,MKK6,P52564,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53350_PLK1_wild_cl1,PLK1_3fc2A_IBI,P53350,P53350wild,PLK1,wild,cl1,3fc2A,IBI,,3fc2,1,1,,Kinase,HoYoungLee,1,BI 6727_ A Polo-like Kinase inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity.,Inhibitor,,1,CEREP,PLK1,P53350,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53350_PLK1_wild_cl1,PLK1_4a4lA_939,P53350,P53350wild,PLK1,wild,cl1,4a4lA,939,,4a4l,1,1,,Kinase,HoYoungLee,1,5-(2-Amino-Pyrimidin-4-Yl)-1H-Pyrrole and 2-(2-Amino-Pyrimidin-4-Yl)-1_5_6_7-Tetrahydro-Pyrrolo[3_2-C]Pyridin-4-One Derivatives as New Classes of Selective and Orally Available Polo-Like Kinase 1 inhibitors.,Inhibitor,,1,CEREP,PLK1,P53350,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53355_DAPK1_wild_cl1,DAPK1_2yakA_OSV,P53355,P53355wild,DAPK1,wild,cl1,2yakA,OSV,,2yak,2,1,,Kinase,HoYoungLee,1,Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase inhibitors.,Inhibitor,,1,CEREP,DAPK1,P53355,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53355_DAPK1_wild_cl1,DAPK1_4txcA_38G,P53355,P53355wild,DAPK1,wild,cl1,4txcA,38G,,4txc,2,1,,Kinase,HoYoungLee,1,Identification and characterization of a small-molecule inhibitor of death-associated protein kinase 1.,Inhibitor,,1,CEREP,DAPK1,P53355,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53667_LIMK1_wild_cl1,LIMK1_3s95B_STU,P53667,P53667wild,LIMK1,wild,cl1,3s95B,STU,,3s95,2,1,,Kinase,HoYoungLee,1,Crystal structure of the human LIMK1 kinase domain in complex with staurosporine,Inhibitor,,1,CEREP,LIMK1,P53667,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53667_LIMK1_wild_cl1,LIMK1_5nxcL_9DB,P53667,P53667wild,LIMK1,wild,cl1,5nxcL,9DB,,5nxc,2,1,,Kinase,HoYoungLee,1,LIM Domain Kinase (LIMK1) In Complex With PF-00477736,Inhibitor,,1,CEREP,LIMK1,P53667,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53778_MAPK12_wild_cl1,MAPK12_1cm8A_ANP,P53778,P53778wild,MAPK12,wild,cl1,1cm8A,ANP,,1cm8,3,1,,Kinase,HoYoungLee,1,The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.,Inhibitor,,1,CEREP,MAPK12,P53778,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53779_MK10_wild_cl1,MK10_3rtpA_34I,P53779,P53779wild,MK10,wild,cl1,3rtpA,34I,,3rtp,1,1,,Kinase,HoYoungLee,1,Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.,Inhibitor,,1,CEREP,JNK3,P53779,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P53779_MK10_wild_cl1,MK10_4z9lA_880,P53779,P53779wild,MK10,wild,cl1,4z9lA,880,,4z9l,1,1,,Kinase,HoYoungLee,1,The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity.,Inhibitor,,1,CEREP,JNK3,P53779,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54646_AAPK2_wild_cl1,AAPK2_4zhxC_C1V,P54646,P54646wild,AAPK2,wild,cl1,4zhxC,C1V,,4zhx,2,1,,Kinase,HoYoungLee,1,Structural basis of Allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding.,Inhibitor,allosteric,1,CEREP,PRKAA2,P54646,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54646_AAPK2_wild_cl1,AAPK2_6b1uC_CG7,P54646,P54646wild,AAPK2,wild,cl1,6b1uC,CG7,,6b1u,2,1,,Kinase,HoYoungLee,1,Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK alpha 2 beta 2 gamma 1 by the Glucose Importagog SC4.,Inhibitor,,1,CEREP,PRKAA2,P54646,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54753_EPHB3_wild_cl1,EPHB3_5l6oA_6P6,P54753,P54753wild,EPHB3,wild,cl1,5l6oA,6P6,,5l6o,3,1,,Kinase,HoYoungLee,1,Development of Specific_ Irreversible inhibitors for a Receptor Tyrosine Kinase EphB3.,Inhibitor,,1,CEREP,EphB3,P54753,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54753_EPHB3_wild_cl1,EPHB3_5l6pA_6P8,P54753,P54753wild,EPHB3,wild,cl1,5l6pA,6P8,,5l6p,3,1,,Kinase,HoYoungLee,1,Development of Specific_ Irreversible inhibitors for a Receptor Tyrosine Kinase EphB3.,Inhibitor,,1,CEREP,EphB3,P54753,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54760_EPHB4_wild_cl1,EPHB4_2vwxA_7X4,P54760,P54760wild,EPHB4,wild,cl1,2vwxA,7X4,,2vwx,1,1,,Kinase,HoYoungLee,1,inhibitors of the Tyrosine Kinase Ephb4. Part 2: Structure-Based Discovery and Optimisation of 3_5-Bis Substituted Anilinopyrimidines.,Inhibitor,,1,CEREP,EphB4,P54760,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54760_EPHB4_wild_cl1,EPHB4_6fnmA_1N1,P54760,P54760wild,EPHB4,wild,cl1,6fnmA,1N1,,6fnm,1,1,,Kinase,HoYoungLee,1,NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.,Inhibitor,,1,CEREP,EphB4,P54760,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54762_EPHB1_wild_cl1,EPHB1_5mjbB_7O3,P54762,P54762wild,EPHB1,wild,cl1,5mjbB,7O3,,5mjb,3,1,,Kinase,HoYoungLee,1,A Chemical-Genetic Approach to Generate Selective Covalent inhibitors of Protein Kinases.,Inhibitor,,1,CEREP,EphB1,P54762,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54764_EPHA4_wild_cl1,EPHA4_4w50A_BU2,P54764,P54764wild,EPHA4,wild,cl1,4w50A,BU2,,4w50,3,1,,Kinase,HoYoungLee,1,Development and Structural Analysis of a Nanomolar Cyclic Peptide antagonist for the EphA4 Receptor.,Inhibitor,,1,CEREP,EphA4,P54764,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P54764_EPHA4_wild_cl1,EPHA4_4w50B_BU2,P54764,P54764wild,EPHA4,wild,cl1,4w50B,BU2,,4w50,3,1,,Kinase,HoYoungLee,1,Development and Structural Analysis of a Nanomolar Cyclic Peptide antagonist for the EphA4 Receptor.,Inhibitor,,1,CEREP,EphA4,P54764,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P55055_NR1H2_wild_cl1,NR1H2_5i4vE_67S,P55055,P55055wild,NR1H2,wild,cl1,5i4vE,67S,,5i4v,1,2,,Receptor,,1,Discovery of a Novel_ Orally Efficacious Liver X Receptor (LXR) beta Agonist.,Activator,,1,CEREP,LXRbeta,P55055,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
P55055_NR1H2_264_cl1,NR1H2_5kyaE_6Y4,P55055,P55055264,NR1H2,264,cl1,5kyaE,6Y4,,5kya,1,2,,Receptor,,1,Brain penetrant liver X receptor (LXR) modulators based on a 2_4_5_6-tetrahydropyrrolo[3_4-c]pyrazole core.,Activator,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
P55055_NR1H2_wild_cl1,NR1H2_5kyjE_6Y8,P55055,P55055wild,NR1H2,wild,cl1,5kyjE,6Y8,,5kyj,1,2,,Receptor,,1,Brain penetrant liver X receptor (LXR) modulators based on a 2_4_5_6-tetrahydropyrrolo[3_4-c]pyrazole core.,Activator,,1,CEREP,LXRbeta,P55055,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
P55210_CASP7_wild_cl1,CASP7_1shjB_NXN,P55210,P55210wild,CASP7,wild,cl1,1shjB,NXN,,1shj,3,1,,Peptidase,,1,Discovery of an Allosteric site in the caspases,Inhibitor,allosteric,1,CEREP,Caspase 7,P55210,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P55210_CASP7_wild_cl1,CASP7_5v6zB_8YJ,P55210,P55210wild,CASP7,wild,cl1,5v6zB,8YJ,,5v6z,3,1,,Peptidase,,1,Crystal structure of human caspase-7 soaked with Allosteric inhibitor,Inhibitor,allosteric,1,CEREP,Caspase 7,P55210,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P55212_CASP6_wild_cl1,CASP6_4n5dA_2FQ,P55212,P55212wild,CASP6,wild,cl1,4n5dA,2FQ,,4n5d,2,2,,Peptidase,,1,Tailoring small molecules for an Allosteric site on procaspase-6.,Inhibitor,allosteric,1,CEREP,Caspase 6,P55212,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P55212_CASP6_wild_cl1,CASP6_4n6gB_2GQ,P55212,P55212wild,CASP6,wild,cl1,4n6gB,2GQ,,4n6g,2,2,,Peptidase,,1,Tailoring small molecules for an Allosteric site on procaspase-6.,Inhibitor,allosteric,1,CEREP,Caspase 6,P55212,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P55212_CASP6_163_cl1,CASP6_4nblA_2J6,P55212,P55212163,CASP6,163,cl1,4nblA,2J6,,4nbl,2,2,,Peptidase,,1,Tailoring small molecules for an Allosteric site on procaspase-6.,Inhibitor,allosteric,1,CEREP,_,_,_,_,_,_,_,_,_,,,
P55212_CASP6_163_cl1,CASP6_4nbnB_2J7,P55212,P55212163,CASP6,163,cl1,4nbnB,2J7,,4nbn,2,2,,Peptidase,,1,Tailoring small molecules for an Allosteric site on procaspase-6.,Inhibitor,allosteric,1,CEREP,_,_,_,_,_,_,_,_,_,,,
P56524_HDAC4_wild_cl1,HDAC4_2vqvB_HA3,P56524,P56524wild,HDAC4,wild,cl1,2vqvB,HA3,,2vqv,2,1,,Acetylase,SooYongLee,1,Structural and Functional Analysis of the Human Hdac4 Catalytic Domain Reveals a Regulatory Structural Zinc-Binding Domain.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P56524_HDAC4_wild_cl1,HDAC4_4cbyD_KEE,P56524,P56524wild,HDAC4,wild,cl1,4cbyD,KEE,,4cby,2,1,,Acetylase,SooYongLee,1,Design_ synthesis_ and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
P56817_BACE1_wild_cl1,BACE1_4rcdA_3LL,P56817,P56817wild,BACE1,wild,cl1,4rcdA,3LL,,4rcd,1,1,,Peptidase,,1,inhibitors of beta-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2_3-b]pyridine-5_4'-oxazol]-2'-amine (AMG-8718).,Inhibitor,,1,CEREP,beta-Secretase 1,P56817,Protease,Pepsin,Aspartic Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P56817_BACE1_wild_cl1,BACE1_5i3yA_68K,P56817,P56817wild,BACE1,wild,cl1,5i3yA,68K,,5i3y,1,1,,Peptidase,,1,Fragment-Linking Approach Using (19)F NMR Spectroscopy To Obtain Highly Potent and Selective inhibitors of beta-Secretase.,Inhibitor,,1,CEREP,beta-Secretase 1,P56817,Protease,Pepsin,Aspartic Peptidase,Biochemical,Enzymatic,Antagonist,Fluorimetry,,,
P68400_CSK21_wild_cl1,CSK21_5h8bB_5Y2,P68400,P68400wild,CSK21,wild,cl1,5h8bB,5Y2,,5h8b,1,1,,Kinase,HoYoungLee,1,Potent and Selective CK2 Kinase inhibitors with Effects on Wnt Pathway Signaling in Vivo.,Inhibitor,,1,CEREP,CK2alpha1,P68400,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P68400_CSK21_wild_cl1,CSK21_5h8eB_5Y3,P68400,P68400wild,CSK21,wild,cl1,5h8eB,5Y3,,5h8e,1,1,,Kinase,HoYoungLee,1,Potent and Selective CK2 Kinase inhibitors with Effects on Wnt Pathway Signaling in Vivo.,Inhibitor,,1,CEREP,CK2alpha1,P68400,Kinase,Other Protein Kinase,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P78362_SRPK2_wild_cl1,SRPK2_2x7gA_PVB,P78362,P78362wild,SRPK2,wild,cl1,2x7gA,PVB,,2x7g,3,1,,Kinase,HoYoungLee,1,Structure of Human Serine-Arginine-Rich Protein- Specific Kinase 2 (Srpk2) Bound to Purvalanol B,Inhibitor,,1,CEREP,SRPK2,P78362,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P78362_SRPK2_wild_cl1,SRPK2_5myvC_W4A,P78362,P78362wild,SRPK2,wild,cl1,5myvC,W4A,,5myv,3,1,,Kinase,HoYoungLee,1,Development of Potent_ Selective SRPK1 inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.,Inhibitor,,1,CEREP,SRPK2,P78362,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P78368_CSNK1G2_wild_cl1,CSNK1G2_2c47B_5ID,P78368,P78368wild,CSNK1G2,wild,cl1,2c47B,5ID,,2c47,3,1,,Kinase,HoYoungLee,1,The Structure of Casein Kinase 1 Gamma 2,Inhibitor,,1,CEREP,CSNK1G2,P78368,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P78368_CSNK1G2_wild_cl1,CSNK1G2_2c47C_5ID,P78368,P78368wild,CSNK1G2,wild,cl1,2c47C,5ID,,2c47,3,1,,Kinase,HoYoungLee,1,The Structure of Casein Kinase 1 Gamma 2,Inhibitor,,1,CEREP,CSNK1G2,P78368,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
P80192_MAP3K9_wild_cl1,MAP3K9_3dtcA_VIN,P80192,P80192wild,MAP3K9,wild,cl1,3dtcA,VIN,,3dtc,3,1,,Kinase,HoYoungLee,1,Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3_4-a]pyrrolo[3_4-c]carbazole-5-ones: optimization_ mixed-lineage kinase 1 crystallography_ and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.,Inhibitor,,1,CEREP,MAP3K9,P80192,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00532_CDKL1_wild_cl1,CDKL1_4aguC_D15,Q00532,Q00532wild,CDKL1,wild,cl1,4aguC,D15,,4agu,3,1,,Kinase,HoYoungLee,1,CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.,Inhibitor,,1,CEREP,CDKL1,Q00532,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00534_CDK6_wild_cl1,CDK6_2f2cB_AP9,Q00534,Q00534wild,CDK6,wild,cl1,2f2cB,AP9,,2f2c,1,1,,Kinase,HoYoungLee,1,Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.,Inhibitor,,1,CEREP,CDK6,Q00534,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00534_CDK6_wild_cl1,CDK6_6oqoA_N1J,Q00534,Q00534wild,CDK6,wild,cl1,6oqoA,N1J,,6oqo,1,1,,Kinase,HoYoungLee,1,Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.,Inhibitor,,1,CEREP,CDK6,Q00534,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00535_CDK5_wild_cl1,CDK5_4au8B_Z3R,Q00535,Q00535wild,CDK5,wild,cl1,4au8B,Z3R,,4au8,2,1,,Kinase,HoYoungLee,1,Synthesis and Structure-Activity Relationship of 4-(1_3-Benzothiazol-2-Yl)-Thiophene-2-Sulfonamides as Cyclin-Dependent Kinase 5 (Cdk5)/P25 inhibitors.,Inhibitor,,1,CEREP,CDK5,Q00535,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00536_CDK16_wild_cl1,CDK16_3mtlA_FEF,Q00536,Q00536wild,CDK16,wild,cl1,3mtlA,FEF,,3mtl,2,1,,Kinase,HoYoungLee,1,Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804,Inhibitor,,1,CEREP,CDK16 (PCTK1),Q00536,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q00536_CDK16_wild_cl1,CDK16_5g6vB_919,Q00536,Q00536wild,CDK16,wild,cl1,5g6vB,919,,5g6v,2,1,,Kinase,HoYoungLee,1,Structure of the Pctaire1 Kinase in Complex with inhibitor,Inhibitor,,1,CEREP,CDK16 (PCTK1),Q00536,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q01344_IL5RA_wild_cl1,IL5RA_3qt2B_BGC,Q01344,Q01344wild,IL5RA,wild,cl1,3qt2B,BGC,,3qt2,3,1,,Receptor,,1,Structure Analysis of the IL-5 Ligand-Receptor Complex Reveals a Wrench-like Architecture for IL-5Ralpha.,Binding,Ligand binding,1,CEREP,IL5RA,Q01344,Cell Surface (Other),Cytokine,IL-3,Functional,Cell Based,Agonist,_,,,
Q02750_MP2K1_wild_cl1,MP2K1_3eqgA_4BM,Q02750,Q02750wild,MP2K1,wild,cl1,3eqgA,4BM,,3eqg,1,3,,Kinase,HoYoungLee,1,Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and inhibitors.,Inhibitor,,1,CEREP,MEK1,Q02750,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q02750_MP2K1_wild_cl1,MP2K1_3mblA_LSG,Q02750,Q02750wild,MP2K1,wild,cl1,3mblA,LSG,,3mbl,1,3,,Kinase,HoYoungLee,1,Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.,Inhibitor,,1,CEREP,MEK1,Q02750,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q02763_TIE2_wild_cl1,TIE2_2oscA_MUH,Q02763,Q02763wild,TIE2,wild,cl1,2oscA,MUH,,2osc,3,2,,Kinase,HoYoungLee,1,Synthesis_ structural analysis_ and SAR studies of triazine derivatives as potent_ selective Tie-2 inhibitors.,Inhibitor,,1,CEREP,TIE2,Q02763,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q02763_TIE2_wild_cl1,TIE2_2p4iB_MR9,Q02763,Q02763wild,TIE2,wild,cl1,2p4iB,MR9,,2p4i,3,2,,Kinase,HoYoungLee,1,Evolution of a highly selective and potent 2-(pyridin-2-yl)-1_3_5-triazine Tie-2 kinase inhibitor.,Inhibitor,,1,CEREP,TIE2,Q02763,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q03164_KMT2A_wild_cl1,KMT2A_5f5eA_SAH,Q03164,Q03164wild,KMT2A,wild,cl1,5f5eA,SAH,,5f5e,1,1,,methylase,SooYongLee,1,Structural basis for activity regulation of MLL family methyltransferases.,Inhibitor,,1,CEREP,MLL1,Q03164,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q03164_KMT2A_wild_cl1,KMT2A_6kivK_SAH,Q03164,Q03164wild,KMT2A,wild,cl1,6kivK,SAH,,6kiv,1,1,,methylase,SooYongLee,1,Structural basis of nucleosome recognition and modification by MLL methyltransferases.,Inhibitor,,1,CEREP,MLL1,Q03164,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q03181_PPARD_wild_cl2,PPARD_5u3qB_7UJ,Q03181,Q03181wild,PPARD,wild,cl2,5u3qB,7UJ,,5u3q,1,2,,Receptor,,1,Structural basis for specific ligation of the peroxisome proliferator-activated receptor delta.,Activator,,1,CEREP,PPARdelta,Q03181,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional (E-coli),Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q03181_PPARD_wild_cl3,PPARD_5u3qB_B7G,Q03181,Q03181wild,PPARD,wild,cl3,5u3qB,B7G,7UJ,5u3q,1,2,,Receptor,,1,Structural basis for specific ligation of the peroxisome proliferator-activated receptor delta.,Activator,,1,CEREP,PPARdelta,Q03181,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional (E-coli),Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q03181_PPARD_wild_cl2,PPARD_5u41B_7UG,Q03181,Q03181wild,PPARD,wild,cl2,5u41B,7UG,,5u41,1,2,,Receptor,,1,Structural basis for specific ligation of the peroxisome proliferator-activated receptor delta.,Activator,,1,CEREP,PPARdelta,Q03181,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional (E-coli),Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q03181_PPARD_wild_cl3,PPARD_5y7xA_JZR,Q03181,Q03181wild,PPARD,wild,cl3,5y7xA,JZR,,5y7x,1,2,,Receptor,,1,Design_ synthesis_ and the X-ray co-crystal structure of Highly Potent_ Selective_ and Orally Bioavailable_ Novel Peroxisome Proliferator-Activated Receptor delta Agonists,Activator,,1,CEREP,PPARdelta,Q03181,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional (E-coli),Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q03431_PTH1R_wild_cl1,PTH1R_3c4mA_MAL,Q03431,Q03431wild,PTH1R,wild,cl1,3c4mA,MAL,,3c4m,3,1,,GPCR,,1,Molecular recognition of parathyroid hormone by its G protein-coupled receptor.,Binding,Ligand binding,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q04759_KPCT_wild_cl1,KPCT_4q9zB_PZW,Q04759,Q04759wild,KPCT,wild,cl1,4q9zB,PZW,,4q9z,2,1,,Kinase,HoYoungLee,1,Discovery of Selective and Orally Bioavailable Protein Kinase C theta (PKC theta ) inhibitors from a Fragment Hit.,Inhibitor,,1,CEREP,PKCtheta,Q04759,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q04759_KPCT_wild_cl1,KPCT_5f9eB_5VS,Q04759,Q04759wild,KPCT,wild,cl1,5f9eB,5VS,,5f9e,2,1,,Kinase,HoYoungLee,1,Discovery and optimization of 1_7-disubstituted-2_2-dimethyl-2_3-dihydroquinazolin-4(1H)-ones as potent and selective PKC theta inhibitors.,Inhibitor,,1,CEREP,PKCtheta,Q04759,Kinase,PKC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q04771_ACVR1_wild_cl1,ACVR1_5oxgD_B4B,Q04771,Q04771wild,ACVR1,wild,cl1,5oxgD,B4B,,5oxg,2,1,,Kinase,HoYoungLee,1,Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.,Inhibitor,,1,CEREP,ALK2,Q04771,Kinase,RSTK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q04771_ACVR1_wild_cl1,ACVR1_6ginB_IR2,Q04771,Q04771wild,ACVR1,wild,cl1,6ginB,IR2,,6gin,2,1,,Kinase,HoYoungLee,1,Novel Quinazolinone inhibitors of ALK2 Flip between Alternate Binding Modes: Structure-Activity Relationship_ Structural Characterization_ Kinase Profiling_ and Cellular Proof of Concept.,Inhibitor,,1,CEREP,ALK2,Q04771,Kinase,RSTK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q04912_RON_wild_cl1,RON_3plsA_ANP,Q04912,Q04912wild,RON,wild,cl1,3plsA,ANP,,3pls,3,1,,Kinase,HoYoungLee,1,The Crystal Structure of a Constitutively Active Mutant RON Kinase Suggests an Intramolecular Autophosphorylation Hypothesis,Inhibitor,,1,CEREP,MST1R,Q04912,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q05397_FAK1_wild_cl1,FAK1_4i4eA_1BQ,Q05397,Q05397wild,FAK1,wild,cl1,4i4eA,1BQ,,4i4e,1,1,,Kinase,HoYoungLee,1,Structure-based discovery of cellular-active Allosteric inhibitors of FAK.,Inhibitor,allosteric,1,CEREP,FAK,Q05397,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q05397_FAK1_wild_cl1,FAK1_4kaoB_KAO,Q05397,Q05397wild,FAK1,wild,cl1,4kaoB,KAO,,4kao,1,1,,Kinase,HoYoungLee,1,Fragment-based discovery of focal adhesion kinase inhibitors.,Inhibitor,,1,CEREP,FAK,Q05397,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q06124_PTN11_wild_cl1,PTN11_6cmsA_5OD,Q06124,Q06124wild,PTN11,wild,cl1,6cmsA,5OD,,6cms,2,1,,phosphatase,SooYongLee,1,Mechanism of activating mutations and Allosteric drug inhibition of the phosphatase SHP2.,Inhibitor,allosteric,1,CEREP,SHP2,Q06124,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
Q06187_BTK_wild_cl1,BTK_5fboA_5WH,Q06187,Q06187wild,BTK,wild,cl1,5fboA,5WH,,5fbo,1,1,,Kinase,HoYoungLee,1,Discovery of 8-Amino-imidazo[1_5-a]pyrazines as Reversible BTK inhibitors for the Treatment of Rheumatoid Arthritis.,Inhibitor,,1,CEREP,BTK,Q06187,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q06187_BTK_wild_cl1,BTK_5t18A_73T,Q06187,Q06187wild,BTK,wild,cl1,5t18A,73T,,5t18,1,1,,Kinase,HoYoungLee,1,Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2_4-dioxo-1_2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2_3_4_9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers.,Inhibitor,,1,CEREP,BTK,Q06187,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q06418_TYRO3_wild_cl1,TYRO3_1rhfB_EPE,Q06418,Q06418wild,TYRO3,wild,cl1,1rhfB,EPE,,1rhf,3,1,,Kinase,HoYoungLee,1,Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.,Binding,Ligand binding,1,CEREP,TYRO3,Q06418,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q07869_PPARA_wild_cl1,PPARA_3kdtB_7HA,Q07869,Q07869wild,PPARA,wild,cl1,3kdtB,7HA,,3kdt,1,1,,Receptor,,1,Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective Agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).,Activator,,1,CEREP,PPARalpha,Q07869,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional,Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q07869_PPARA_wild_cl1,PPARA_6kb0A_ITY,Q07869,Q07869wild,PPARA,wild,cl1,6kb0A,ITY,,6kb0,1,1,,Receptor,,1,PPAR alpha Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates.,Inhibitor,,1,CEREP,PPARalpha,Q07869,NHR,Peroxisome Proliferator-Activated,Non-Steroid,Functional,Protein-Protein Interaction,Agonist & Antagonist,Alphascreen,,,
Q07912_ACK1_wild_cl1,ACK1_1u4dB_DBQ,Q07912,Q07912wild,ACK1,wild,cl1,1u4dB,DBQ,,1u4d,1,1,,Kinase,HoYoungLee,1,Crystal Structures of the Phosphorylated and Unphosphorylated Kinase Domains of the Cdc42-associated Tyrosine Kinase ACK1.,Inhibitor,,1,CEREP,ACK1,Q07912,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q07912_ACK1_wild_cl1,ACK1_4id7A_1G0,Q07912,Q07912wild,ACK1,wild,cl1,4id7A,1G0,,4id7,1,1,,Kinase,HoYoungLee,1,Discovery of potent_ selective and orally bioavailable imidazo[1_5-a]pyrazine derived ACK1 inhibitors.,Inhibitor,,1,CEREP,ACK1,Q07912,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q08345_DDR1_wild_cl1,DDR1_4bkjB_STI,Q08345,Q08345wild,DDR1,wild,cl1,4bkjB,STI,,4bkj,1,1,,Kinase,HoYoungLee,1,Structural Mechanisms Determining inhibition of the Collagen Receptor Ddr1 by Selective and Multi-Targeted Type II Kinase inhibitors,Inhibitor,,1,CEREP,DDR1,Q08345,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q08345_DDR1_wild_cl1,DDR1_6fexA_D6Z,Q08345,Q08345wild,DDR1,wild,cl1,6fexA,D6Z,,6fex,1,1,,Kinase,HoYoungLee,1,DNA-Encoded Library-Derived DDR1 inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.,Inhibitor,,1,CEREP,DDR1,Q08345,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q08881_ITK_wild_cl1,ITK_3v8tB_477,Q08881,Q08881wild,ITK,wild,cl1,3v8tB,477,,3v8t,1,2,,Kinase,HoYoungLee,1,X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase.,Inhibitor,,1,CEREP,ITK,Q08881,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q08881_ITK_wild_cl1,ITK_4ppbB_2VV,Q08881,Q08881wild,ITK,wild,cl1,4ppbB,2VV,,4ppb,1,2,,Kinase,HoYoungLee,1,Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.,Inhibitor,,1,CEREP,ITK,Q08881,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q09013_DMPK_wild_cl1,DMPK_2vd5B_BI8,Q09013,Q09013wild,DMPK,wild,cl1,2vd5B,BI8,,2vd5,3,1,,Kinase,HoYoungLee,1,Structure of Dystrophia Myotonica Protein Kinase.,Inhibitor,,1,CEREP,DMPK,Q09013,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q12866_MERTK_wild_cl1,MERTK_4mhaB_4MH,Q12866,Q12866wild,MERTK,wild,cl1,4mhaB,4MH,,4mha,1,1,,Kinase,HoYoungLee,1,Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.,Inhibitor,,1,CEREP,Mer,Q12866,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q12866_MERTK_wild_cl1,MERTK_5k0xB_K0X,Q12866,Q12866wild,MERTK,wild,cl1,5k0xB,K0X,,5k0x,1,1,,Kinase,HoYoungLee,1,Discovery of Macrocyclic Pyrimidines as MerTK-Specific inhibitors.,Inhibitor,,1,CEREP,Mer,Q12866,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13043_STK4_wild_cl1,STK4_6yatB_OJ5,Q13043,Q13043wild,STK4,wild,cl1,6yatB,OJ5,,6yat,2,1,,Kinase,HoYoungLee,1,inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia.,Inhibitor,,1,CEREP,MST1,Q13043,Kinase,STE,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13133_NR1H3_wild_cl1,NR1H3_3ipqA_965,Q13133,Q13133wild,NR1H3,wild,cl1,3ipqA,965,,3ipq,1,1,,Receptor,,1,X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.,Activator,,1,CEREP,LXRalpha,Q13133,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
Q13133_NR1H3_wild_cl1,NR1H3_3ipsB_O90,Q13133,Q13133wild,NR1H3,wild,cl1,3ipsB,O90,,3ips,1,1,,Receptor,,1,X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.,Activator,,1,CEREP,LXRalpha,Q13133,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
Q13237_KGP2_wild_cl1,KGP2_5jixA_6J7,Q13237,Q13237wild,KGP2,wild,cl1,5jixA,6J7,,5jix,2,1,,Kinase,HoYoungLee,1,Structural Basis of Analog Specificity in PKG I and II.,Inhibitor,,1,CEREP,PRKG2,Q13237,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13237_KGP2_wild_cl1,KGP2_6bq8A_6FW,Q13237,Q13237wild,KGP2,wild,cl1,6bq8A,6FW,,6bq8,2,1,,Kinase,HoYoungLee,1,Neutron Crystallography Detects Differences in Protein Dynamics: Structure of the PKG II Cyclic Nucleotide Binding Domain in Complex with an Activator.,Inhibitor,,1,CEREP,PRKG2,Q13237,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13464_ROCK1_wild_cl1,ROCK1_3d9vB_H52,Q13464,Q13464wild,ROCK1,wild,cl1,3d9vB,H52,,3d9v,1,1,,Kinase,HoYoungLee,1,The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.,Inhibitor,,1,CEREP,ROCK1,Q13464,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13464_ROCK1_wild_cl1,ROCK1_3twjC_07R,Q13464,Q13464wild,ROCK1,wild,cl1,3twjC,07R,,3twj,1,1,,Kinase,HoYoungLee,1,RKI-1447 Is a Potent inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer.,Inhibitor,,1,CEREP,ROCK1,Q13464,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13523_PRP4B_wild_cl1,PRP4B_6cnhA_919,Q13523,Q13523wild,PRP4B,wild,cl1,6cnhA,919,,6cnh,2,1,,Kinase,HoYoungLee,1,Crystal structure of the human PRPF4B in complex with Rebastinib,Inhibitor,,1,CEREP,PRPF4B,Q13523,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13523_PRP4B_wild_cl1,PRP4B_6pjjD_OCJ,Q13523,Q13523wild,PRP4B,wild,cl1,6pjjD,OCJ,,6pjj,2,1,,Kinase,HoYoungLee,1,to be published,Inhibitor,,1,CEREP,PRPF4B,Q13523,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13546_RIPK1_wild_cl1,RIPK1_4itjB_1HX,Q13546,Q13546wild,RIPK1,wild,cl1,4itjB,1HX,,4itj,2,4,,Kinase,HoYoungLee,1,Structural Basis of RIP1 inhibition by Necrostatins.,Inhibitor,,1,CEREP,RIPK1,Q13546,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13546_RIPK1_wild_cl1,RIPK1_6c4dD_EJP,Q13546,Q13546wild,RIPK1,wild,cl1,6c4dD,EJP,,6c4d,2,4,,Kinase,HoYoungLee,1,Discovery of 7-Oxo-2_4_5_7-tetrahydro-6 H-pyrazolo[3_4- c]pyridine Derivatives as Potent_ Orally Available_ and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase inhibitors: Analysis of Structure-Kinetic Relationships.,Inhibitor,,1,CEREP,RIPK1,Q13546,Kinase,TKL,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13554_KCC2B_wild_cl1,KCC2B_3bhhB_5CP,Q13554,Q13554wild,KCC2B,wild,cl1,3bhhB,5CP,,3bhh,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Calcium/Calmodulin-Dependent Protein Kinase IIB Isoform 1 (CAMK2B).,Inhibitor,,1,CEREP,CAMK2B,Q13554,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13555_KCC2G_wild_cl1,KCC2G_2v7oA_DRN,Q13555,Q13555wild,KCC2G,wild,cl1,2v7oA,DRN,,2v7o,2,1,,Kinase,HoYoungLee,1,Structure of the Camkiidelta/Calmodulin Complex Reveals the Molecular Mechanism of Camkii Kinase Activation.,Inhibitor,,1,CEREP,CAMK2G,Q13555,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13557_KCC2D_wild_cl1,KCC2D_2welA_K88,Q13557,Q13557wild,KCC2D,wild,cl1,2welA,K88,,2wel,2,1,,Kinase,HoYoungLee,1,Structure of the Camkiidelta/Calmodulin Complex Reveals the Molecular Mechanism of Camkii Kinase Activation.,Inhibitor,,1,CEREP,CaMK2delta,Q13557,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13557_KCC2D_wild_cl1,KCC2D_5vloB_9EJ,Q13557,Q13557wild,KCC2D,wild,cl1,5vloB,9EJ,,5vlo,2,1,,Kinase,HoYoungLee,1,inhibitors of CamKII,Inhibitor,,1,CEREP,CaMK2delta,Q13557,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13627_DYR1A_wild_cl1,DYR1A_6eifD_B5T,Q13627,Q13627wild,DYR1A,wild,cl1,6eifD,B5T,,6eif,2,1,,Kinase,HoYoungLee,1,Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) inhibitors.,Inhibitor,,1,CEREP,DYRK1A,Q13627,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13627_DYR1A_wild_cl1,DYR1A_6eisD_B6N,Q13627,Q13627wild,DYR1A,wild,cl1,6eisD,B6N,,6eis,2,1,,Kinase,HoYoungLee,1,Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) inhibitors.,Inhibitor,,1,CEREP,DYRK1A,Q13627,Kinase,CMGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13873_BMPR2_wild_cl1,BMPR2_3g2fB_ADP,Q13873,Q13873wild,BMPR2,wild,cl1,3g2fB,ADP,,3g2f,3,1,,Kinase,HoYoungLee,1,Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertension.,Inhibitor,,1,CEREP,BMPR2,Q13873,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13882_PTK6_wild_cl1,PTK6_5h2uD_1N1,Q13882,Q13882wild,PTK6,wild,cl1,5h2uD,1N1,,5h2u,2,1,,Kinase,HoYoungLee,1,Co-crystal structures of PTK6: With Dasatinib at 2.24 angstrom _ with novel imidazo[1_2-a]pyrazin-8-amine derivative inhibitor at 1.70 angstrom resolution,Inhibitor,,1,CEREP,Brk (PTK6),Q13882,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13882_PTK6_wild_cl1,PTK6_6cz4A_FKY,Q13882,Q13882wild,PTK6,wild,cl1,6cz4A,FKY,,6cz4,2,1,,Kinase,HoYoungLee,1,Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.,Inhibitor,,1,CEREP,Brk (PTK6),Q13882,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13976_KGP1_wild_cl1,KGP1_5j48B_6FW,Q13976,Q13976wild,KGP1,wild,cl1,5j48B,6FW,,5j48,2,1,,Kinase,HoYoungLee,1,Structural Basis of Analog Specificity in PKG I and II.,Inhibitor,,1,CEREP,PRKG1,Q13976,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q13976_KGP1_wild_cl1,KGP1_5l0nA_6ZA,Q13976,Q13976wild,KGP1,wild,cl1,5l0nA,6ZA,,5l0n,2,1,,Kinase,HoYoungLee,1,Structure of PKG I CNB-B bound to RP-cGMP,Inhibitor,,1,CEREP,PRKG1,Q13976,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14012_KCC1A_wild_cl1,KCC1A_4fg7A_ATP,Q14012,Q14012wild,KCC1A,wild,cl1,4fg7A,ATP,,4fg7,2,1,,Kinase,HoYoungLee,1,Crystal structures of human CaMKIalpha reveal insights into the regulation mechanism of CaMKI.,Inhibitor,,1,CEREP,CAMK1,Q14012,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14012_KCC1A_wild_cl1,KCC1A_4fg8B_ATP,Q14012,Q14012wild,KCC1A,wild,cl1,4fg8B,ATP,,4fg8,2,1,,Kinase,HoYoungLee,1,Crystal structures of human CaMKIalpha reveal insights into the regulation mechanism of CaMKI.,Inhibitor,,1,CEREP,CAMK1,Q14012,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14289_FAK2_wild_cl1,FAK2_3fztA_4JZ,Q14289,Q14289wild,FAK2,wild,cl1,3fztA,4JZ,,3fzt,3,1,,Kinase,HoYoungLee,1,Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.,Inhibitor,,1,CEREP,PYK2,Q14289,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14289_FAK2_wild_cl1,FAK2_4h1jA_0YH,Q14289,Q14289wild,FAK2,wild,cl1,4h1jA,0YH,,4h1j,3,1,,Kinase,HoYoungLee,1,Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.,Inhibitor,,1,CEREP,PYK2,Q14289,Kinase,TK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14680_MELK_wild_cl1,MELK_4bkzA_1WS,Q14680,Q14680wild,MELK,wild,cl1,4bkzA,1WS,,4bkz,1,1,,Kinase,HoYoungLee,1,Structural Insight Into Maternal Embryonic Leucine Zipper Kinase (Melk) Conformation and inhibition Towards Structure- Based Drug Design.,Inhibitor,,1,CEREP,MELK,Q14680,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14680_MELK_wild_cl1,MELK_4umtA_47W,Q14680,Q14680wild,MELK,wild,cl1,4umtA,47W,,4umt,1,1,,Kinase,HoYoungLee,1,Structure-Based Design of Type II inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.,Inhibitor,,1,CEREP,MELK,Q14680,Kinase,CAMK,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q14790_CASP8_wild_cl1,CASP8_2c2zB_DTD,Q14790,Q14790wild,CASP8,wild,cl1,2c2zB,DTD,,2c2z,2,1,,Peptidase,,1,Design_ Synthesis_ and Evaluation of Aza-Peptide Michael Acceptors as Selective and Potent inhibitors of Caspases-2_ -3_ -6_ -7_ -8_ -9_ and - 10.,Inhibitor,,1,CEREP,Caspase 8,Q14790,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Spectrophotometric,,,
Q14790_CASP8_wild_cl1,CASP8_4ps1D_DTT,Q14790,Q14790wild,CASP8,wild,cl1,4ps1D,DTT,,4ps1,2,1,,Peptidase,,1,Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acids.,Inhibitor,,1,CEREP,Caspase 8,Q14790,Protease,Caspase,Cysteine Peptidase,Biochemical,Enzymatic,Antagonist,Spectrophotometric,,,
Q15047_SETB1_wild_cl1,SETB1_5kchA_6RN,Q15047,Q15047wild,SETB1,wild,cl1,5kchA,6RN,,5kch,2,2,,methylase,SooYongLee,1,SETDB1 in complex with an early stage_ low affinity fragment candidate modelled at reduced occupancy,Inhibitor,,1,CEREP,SETDB1,Q15047,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15047_SETB1_wild_cl2,SETB1_5ke2A_6S4,Q15047,Q15047wild,SETB1,wild,cl2,5ke2A,6S4,,5ke2,2,2,,methylase,SooYongLee,1,Crystal structure of SETDB1 Tudor domain in complex with inhibitor xst06472a,Inhibitor,,1,CEREP,SETDB1,Q15047,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15047_SETB1_wild_cl2,SETB1_5ke3A_6S5,Q15047,Q15047wild,SETB1,wild,cl2,5ke3A,6S5,,5ke3,2,2,,methylase,SooYongLee,1,Crystal structure of SETDB1 Tudor domain in complex with fragment MRT0181a,Inhibitor,,1,CEREP,SETDB1,Q15047,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15047_SETB1_wild_cl1,SETB1_5qt1A_DSJ,Q15047,Q15047wild,SETB1,wild,cl1,5qt1A,DSJ,,5qt1,2,2,,methylase,SooYongLee,1,PanDDA analysis group deposition,Inhibitor,,1,CEREP,SETDB1,Q15047,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15208_STK38_wild_cl1,STK38_6bxiB_ANP,Q15208,Q15208wild,STK38,wild,cl1,6bxiB,ANP,,6bxi,2,1,,Kinase,HoYoungLee,1,Structural Basis for Auto-inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment.,Inhibitor,,1,CEREP,NDR1,Q15208,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,0,,,
Q15303_ERBB4_wild_cl1,ERBB4_2r4bB_GW7,Q15303,Q15303wild,ERBB4,wild,cl1,2r4bB,GW7,,2r4b,2,1,,Kinase,HoYoungLee,1,6-Ethynylthieno[3_2-d]- and 6-ethynylthieno[2_3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.,Inhibitor,,1,CEREP,HER4,Q15303,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15303_ERBB4_wild_cl1,ERBB4_3bbtD_FMM,Q15303,Q15303wild,ERBB4,wild,cl1,3bbtD,FMM,,3bbt,2,1,,Kinase,HoYoungLee,1,Mechanism of Activation and inhibition of the HER4/ErbB4 Kinase.,Inhibitor,,1,CEREP,HER4,Q15303,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15375_EPHA7_wild_cl1,EPHA7_3dkoA_IHZ,Q15375,Q15375wild,EPHA7,wild,cl1,3dkoA,IHZ,,3dko,2,1,,Kinase,HoYoungLee,1,Kinase domain of human ephrin type-a receptor 7 (epha7) in complex with ALW-II-49-7,Inhibitor,,1,CEREP,EPHA7,Q15375,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15418_KS6A1_wild_cl1,KS6A1_2z7qA_ACP,Q15418,Q15418wild,KS6A1,wild,cl1,2z7qA,ACP,,2z7q,2,1,,Kinase,HoYoungLee,1,Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.,Inhibitor,,1,CEREP,RSK1,Q15418,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15418_KS6A1_wild_cl1,KS6A1_2z7rA_STU,Q15418,Q15418wild,KS6A1,wild,cl1,2z7rA,STU,,2z7r,2,1,,Kinase,HoYoungLee,1,Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.,Inhibitor,,1,CEREP,RSK1,Q15418,Kinase,AGC,Protein Ser/thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15722_LT4R1_wild_cl1,LT4R1_7k15A_VRJ,Q15722,Q15722wild,LT4R1,wild,cl1,7k15A,VRJ,,7k15,2,1,,GPCR,,1,Structural insights on ligand recognition at the human leukotriene B4 receptor 1.,Inhibitor,,1,CEREP,BLT1,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q15759_MK11_wild_cl1,MK11_3gc8B_B45,Q15759,Q15759wild,MK11,wild,cl1,3gc8B,B45,,3gc8,2,1,,Kinase,HoYoungLee,1,The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.,Inhibitor,,1,CEREP,MAPK11,Q15759,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15759_MK11_wild_cl1,MK11_3gp0A_NIL,Q15759,Q15759wild,MK11,wild,cl1,3gp0A,NIL,,3gp0,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Mitogen Activated Protein Kinase 11 (p38 beta) in complex with Nilotinib,Inhibitor,,1,CEREP,MAPK11,Q15759,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15831_STK11_wild_cl1,STK11_2wtkF_ANP,Q15831,Q15831wild,STK11,wild,cl1,2wtkF,ANP,,2wtk,3,1,,Kinase,HoYoungLee,1,Structure of the Lkb1-Strad-Mo25 Complex Reveals an Allosteric Mechanism of Kinase Activation.,Inhibitor,allosteric,1,CEREP,STK11,Q15831,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15910_EZH2_wild_cl1,EZH2_5ij7A_6BN,Q15910,Q15910wild,EZH2,wild,cl1,5ij7A,6BN,,5ij7,3,1,,methylase,SooYongLee,1,Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.,Inhibitor,,1,CEREP,EZH2,Q15910,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q15910_EZH2_wild_cl1,EZH2_5ls6A_74D,Q15910,Q15910wild,EZH2,wild,cl1,5ls6A,74D,,5ls6,3,1,,methylase,SooYongLee,1,Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1_2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2_2_2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205)_ a Potent and Selective inhibitor of Histone Methyltransferase EZH2_ Suitable for Phase I Clinical Trials for B-Cell Lymphomas.,Inhibitor,,1,CEREP,EZH2,Q15910,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16288_NTRK3_wild_cl1,NTRK3_6kzcA_DZC,Q16288,Q16288wild,NTRK3,wild,cl1,6kzcA,DZC,,6kzc,2,1,,Kinase,HoYoungLee,1,Design_ synthesis and biological evaluation of 3-(imidazo[1_2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors.,Inhibitor,,1,CEREP,NTRK3,Q16288,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16288_NTRK3_wild_cl1,NTRK3_6kzdA_DZ6,Q16288,Q16288wild,NTRK3,wild,cl1,6kzdA,DZ6,,6kzd,2,1,,Kinase,HoYoungLee,1,Design_ synthesis and biological evaluation of 3-(imidazo[1_2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors.,Inhibitor,,1,CEREP,NTRK3,Q16288,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16512_PKN1_wild_cl1,PKN1_4othA_DRN,Q16512,Q16512wild,PKN1,wild,cl1,4othA,DRN,,4oth,2,1,,Kinase,HoYoungLee,1,Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes.,Inhibitor,,1,CEREP,PKN1,Q16512,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16512_PKN1_wild_cl1,PKN1_4otiA_MI1,Q16512,Q16512wild,PKN1,wild,cl1,4otiA,MI1,,4oti,2,1,,Kinase,HoYoungLee,1,Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes.,Inhibitor,,1,CEREP,PKN1,Q16512,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16513_PKN2_wild_cl1,PKN2_4crsA_AGS,Q16513,Q16513wild,PKN2,wild,cl1,4crsA,AGS,,4crs,3,1,,Kinase,HoYoungLee,1,Structure of Pkn2,Inhibitor,,1,CEREP,PKN2,Q16513,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16539_MK14_wild_cl1,MK14_3bv2A_P38,Q16539,Q16539wild,MK14,wild,cl1,3bv2A,P38,,3bv2,1,1,,Kinase,HoYoungLee,1,Synthesis and SAR of new pyrrolo[2_1-f][1_2_4]triazines as potent p38 alpha MAP kinase inhibitors.,Inhibitor,,1,CEREP,MAPK14,Q16539,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16539_MK14_wild_cl1,MK14_3gc7A_B45,Q16539,Q16539wild,MK14,wild,cl1,3gc7A,B45,,3gc7,1,1,,Kinase,HoYoungLee,1,The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.,Inhibitor,,1,CEREP,MAPK14,Q16539,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16566_KCC4_wild_cl1,KCC4_2w4oA_DKI,Q16566,Q16566wild,KCC4,wild,cl1,2w4oA,DKI,,2w4o,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Camk4 in Complex with 4-Amino(Sulfamoyl-Phenylamino)-Triazole- Carbothioic Acid (2_6-Difluoro-Phenyl)-Amide),Inhibitor,,1,CEREP,CAMK4,Q16566,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16620_NTRK2_wild_cl1,NTRK2_4at3A_LTI,Q16620,Q16620wild,NTRK2,wild,cl1,4at3A,LTI,,4at3,2,1,,Kinase,HoYoungLee,1,The Crystal Structures of Trka and Trkb Suggest Key Regions for Achieving Selective inhibition.,Inhibitor,,1,CEREP,NTRK2,Q16620,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16620_NTRK2_wild_cl1,NTRK2_4at4A_T6E,Q16620,Q16620wild,NTRK2,wild,cl1,4at4A,T6E,,4at4,2,1,,Kinase,HoYoungLee,1,The Crystal Structures of Trka and Trkb Suggest Key Regions for Achieving Selective inhibition.,Inhibitor,,1,CEREP,NTRK2,Q16620,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16644_MAPK3_wild_cl1,MAPK3_3fxwA_F10,Q16644,Q16644wild,MAPK3,wild,cl1,3fxwA,F10,,3fxw,2,1,,Kinase,HoYoungLee,1,High resolution crystal structure of mitogen-activated protein kinase-activated protein kinase 3/inhibitor 2 complex,Inhibitor,,1,CEREP,MAPK3,P27361,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16644_MAPK3_wild_cl1,MAPK3_3r1nA_05B,Q16644,Q16644wild,MAPK3,wild,cl1,3r1nA,05B,,3r1n,2,1,,Kinase,HoYoungLee,1,Structure-based lead identification of ATP-competitive MK2 inhibitors.,Inhibitor,,1,CEREP,MAPK3,P27361,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16654_PDK4_wild_cl1,PDK4_2zdxB_P4A,Q16654,Q16654wild,PDK4,wild,cl1,2zdxB,P4A,,2zdx,2,1,,Kinase,HoYoungLee,1,inhibitor-bound structures of human pyruvate dehydrogenase kinase 4.,Inhibitor,,1,CEREP,PDK4,Q16654,Kinase,PDHK,Atypical,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16654_PDK4_wild_cl1,PDK4_3d2rB_ADP,Q16654,Q16654wild,PDK4,wild,cl1,3d2rB,ADP,,3d2r,2,1,,Kinase,HoYoungLee,1,Pyruvate Dehydrogenase Kinase-4 Structures Reveal a Metastable Open Conformation Fostering Robust Core-free Basal Activity.,Inhibitor,,1,CEREP,PDK4,Q16654,Kinase,PDHK,Atypical,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q16659_MK06_wild_cl1,MK06_6yllA_OYB,Q16659,Q16659wild,MK06,wild,cl1,6yllA,OYB,,6yll,2,1,,Kinase,HoYoungLee,1,Biochemical_ cellular and structural characterization of novel and selective ERK3 inhibitors.,Inhibitor,,1,CEREP,MAPK6,Q16659,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q16832_DDR2_wild_cl1,DDR2_7aymA_4VD,Q16832,Q16832wild,DDR2,wild,cl1,7aymA,4VD,,7aym,2,1,,Kinase,HoYoungLee,1,Structure of DDR2 Kinase domain in complex with IBZ3,Inhibitor,,1,CEREP,DDR2,Q16832,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q2M2I8_AAK1_wild_cl1,AAK1_4wsqB_KSA,Q2M2I8,Q2M2I8wild,AAK1,wild,cl1,4wsqB,KSA,,4wsq,2,1,,Kinase,HoYoungLee,1,Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.,Inhibitor,,1,CEREP,AAK1,Q2M2I8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q2M2I8_AAK1_wild_cl1,AAK1_5l4qB_LKB,Q2M2I8,Q2M2I8wild,AAK1,wild,cl1,5l4qB,LKB,,5l4q,2,1,,Kinase,HoYoungLee,1,Synthesis and Structure-Activity Relationships of 3_5-Disubstituted-pyrrolo[2_3- b]pyridines as inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.,Inhibitor,,1,CEREP,AAK1,Q2M2I8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q59H18_TNI3K_wild_cl1,TNI3K_4yffD_4CV,Q59H18,Q59H18wild,TNI3K,wild,cl1,4yffD,4CV,,4yff,3,1,,Kinase,HoYoungLee,1,Identification of Purines and 7-Deazapurines as Potent and Selective Type I inhibitors of Troponin I-Interacting Kinase (TNNI3K).,Inhibitor,,1,CEREP,TNNI3K,Q59H18,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q59H18_TNI3K_wild_cl1,TNI3K_6b5jD_CV4,Q59H18,Q59H18wild,TNI3K,wild,cl1,6b5jD,CV4,,6b5j,3,1,,Kinase,HoYoungLee,1,4_6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) inhibitors.,Inhibitor,,1,CEREP,TNNI3K,Q59H18,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q5S007_LRRK2_wild_cl2,LRRK2_2zejA_GDP,Q5S007,Q5S007wild,LRRK2,wild,cl2,2zejA,GDP,,2zej,2,2,,Kinase,HoYoungLee,1,Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase,Inhibitor,GPTase,1,CEREP,LRRK2,Q5S007,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q5S007_LRRK2_wild_cl2,LRRK2_2zejB_GDP,Q5S007,Q5S007wild,LRRK2,wild,cl2,2zejB,GDP,,2zej,2,2,,Kinase,HoYoungLee,1,Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase,Inhibitor,GPTase,1,CEREP,LRRK2,Q5S007,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q5S007_LRRK2_wild_cl1,LRRK2_3d6tB_GDP,Q5S007,Q5S007wild,LRRK2,wild,cl1,3d6tB,GDP,,3d6t,2,2,,Kinase,HoYoungLee,1,Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase,Inhibitor,GPTase,1,CEREP,LRRK2,Q5S007,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q5S007_LRRK2_wild_cl1,LRRK2_6xafA_GDP,Q5S007,Q5S007wild,LRRK2,wild,cl1,6xafA,GDP,,6xaf,2,2,,Kinase,HoYoungLee,1,Structural basis for conformational plasticity in the GTPase domain of the Parkinson's disease-associated protein LRRK2,Inhibitor,GPTase,1,CEREP,LRRK2,Q5S007,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q5TCY1_TTBK1_wild_cl1,TTBK1_4btjB_ATP,Q5TCY1,Q5TCY1wild,TTBK1,wild,cl1,4btjB,ATP,,4btj,2,1,,Kinase,HoYoungLee,1,X-Ray Structural Analysis of Tau-Tubulin Kinase 1 and its Interactions with Small Molecular inhibitors.,Inhibitor,,1,CEREP,TTBK1,Q5TCY1,Kinase,CK1,0,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q5TCY1_TTBK1_wild_cl1,TTBK1_4nfnA_2KC,Q5TCY1,Q5TCY1wild,TTBK1,wild,cl1,4nfnA,2KC,,4nfn,2,1,,Kinase,HoYoungLee,1,The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor.,Inhibitor,,1,CEREP,TTBK1,Q5TCY1,Kinase,CK1,0,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q6IQ55_TTBK2_wild_cl1,TTBK2_6u0kA_DTQ,Q6IQ55,Q6IQ55wild,TTBK2,wild,cl1,6u0kA,DTQ,,6u0k,3,1,,Kinase,HoYoungLee,1,The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor,Inhibitor,,1,CEREP,TTBK2,Q6IQ55,Kinase,CK1,0,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q6IQ55_TTBK2_wild_cl1,TTBK2_6vrfB_ADP,Q6IQ55,Q6IQ55wild,TTBK2,wild,cl1,6vrfB,ADP,,6vrf,3,1,,Kinase,HoYoungLee,1,Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.,Inhibitor,,1,CEREP,TTBK2,Q6IQ55,Kinase,CK1,0,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q6PHR2_ULK3_wild_cl1,ULK3_6fdzU_C87,Q6PHR2,Q6PHR2wild,ULK3,wild,cl1,6fdzU,C87,,6fdz,2,1,,Kinase,HoYoungLee,1,Unc-51-Like Kinase 3 (ULK3) In Complex With Momelotinib,Inhibitor,,1,CEREP,ULK3,Q6PHR2,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q7KZI7_MARK2_wild_cl1,MARK2_5kz7B_6Z2,Q7KZI7,Q7KZI7wild,MARK2,wild,cl1,5kz7B,6Z2,,5kz7,2,1,,Kinase,HoYoungLee,1,Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.,Inhibitor,,1,CEREP,MARK2,Q7KZI7,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q7KZI7_MARK2_wild_cl1,MARK2_5kz8B_6Z5,Q7KZI7,Q7KZI7wild,MARK2,wild,cl1,5kz8B,6Z5,,5kz8,2,1,,Kinase,HoYoungLee,1,Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.,Inhibitor,,1,CEREP,MARK2,Q7KZI7,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q7LBC6_KDM3B_wild_cl2,KDM3B_5rabA_S4Y,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl2,5rabA,S4Y,,5rab,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl3,KDM3B_5radA_AYJ,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl3,5radA,AYJ,,5rad,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl5,KDM3B_5rahA_GX4,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl5,5rahA,GX4,,5rah,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl5,KDM3B_5rajA_W77,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl5,5rajA,W77,,5raj,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl6,KDM3B_5raoA_S3S,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl6,5raoA,S3S,,5rao,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl1,KDM3B_5rapA_S64,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl1,5rapA,S64,,5rap,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl4,KDM3B_5rasB_S3J,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl4,5rasB,S3J,,5ras,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl3,KDM3B_5ravA_S9G,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl3,5ravA,S9G,,5rav,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl2,KDM3B_5rawA_JJ7,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl2,5rawA,JJ7,,5raw,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl4,KDM3B_5raxB_S9J,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl4,5raxB,S9J,,5rax,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl1,KDM3B_5rayA_S9M,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl1,5rayA,S9M,,5ray,3,6,,methylase,SooYongLee,1,PanDDA analysis group deposition of Human JMJD1B screened against the DSPL Fragment Library,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q7LBC6_KDM3B_wild_cl6,KDM3B_6rbjB_JX8,Q7LBC6,Q7LBC6wild,KDM3B,wild,cl6,6rbjB,JX8,,6rbj,3,6,,methylase,SooYongLee,1,Crystal structure of KDM3B in complex with 5-(1H-tetrazol-5-yl)quinolin-8-ol,Inhibitor,,1,CEREP,JMJD1B,Q7LBC6,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q86UE8_TLK2_wild_cl1,TLK2_5o0yA_AGS,Q86UE8,Q86UE8wild,TLK2,wild,cl1,5o0yA,AGS,,5o0y,3,1,,Kinase,HoYoungLee,1,Molecular basis of Tousled-Like Kinase 2 activation.,Inhibitor,,1,CEREP,TLK2,Q86UE8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q86Y07_VRK2_wild_cl1,VRK2_5uu1A_7DZ,Q86Y07,Q86Y07wild,VRK2,wild,cl1,5uu1A,7DZ,,5uu1,3,1,,Kinase,HoYoungLee,1,Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations.,Inhibitor,,1,CEREP,VRK2,Q86Y07,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q86Y07_VRK2_wild_cl1,VRK2_6ncgB_KJD,Q86Y07,Q86Y07wild,VRK2,wild,cl1,6ncgB,KJD,,6ncg,3,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor,Inhibitor,,1,CEREP,VRK2,Q86Y07,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8IU85_KCC1D_wild_cl1,KCC1D_2jc6C_QPP,Q8IU85,Q8IU85wild,KCC1D,wild,cl1,2jc6C,QPP,,2jc6,3,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Calmodulin-Dependent Protein Kinase 1D,Inhibitor,,1,CEREP,CAMK1D,Q8IU85,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8IU85_KCC1D_wild_cl1,KCC1D_6t6fB_MMW,Q8IU85,Q8IU85wild,KCC1D,wild,cl1,6t6fB,MMW,,6t6f,3,1,,Kinase,HoYoungLee,1,CAMK1D bound to CS275,Inhibitor,,1,CEREP,CAMK1D,Q8IU85,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8IVH8_M4K3_wild_cl1,M4K3_5j5tA_6G2,Q8IVH8,Q8IVH8wild,M4K3,wild,cl1,5j5tA,6G2,,5j5t,2,1,,Kinase,HoYoungLee,1,Germinal-center kinase-like kinase co-crystal structure reveals a swapped activation loop and C-terminal extension.,Inhibitor,,1,CEREP,MAP4K3,Q8IVH8,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8IYT8_ULK2_wild_cl1,ULK2_6qavD_HVH,Q8IYT8,Q8IYT8wild,ULK2,wild,cl1,6qavD,HVH,,6qav,2,1,,Kinase,HoYoungLee,1,Conservation of structure_ function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2).,Inhibitor,,1,CEREP,ULK2,Q8IYT8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8IYT8_ULK2_wild_cl1,ULK2_6yidD_EDJ,Q8IYT8,Q8IYT8wild,ULK2,wild,cl1,6yidD,EDJ,,6yid,2,1,,Kinase,HoYoungLee,1,Design_ Synthesis_ and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy inhibitor that Synergizes with the PARP inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer.,Inhibitor,,1,CEREP,ULK2,Q8IYT8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8N5S9_KKCC1_wild_cl1,KKCC1_6ccfB_H1N,Q8N5S9,Q8N5S9wild,KKCC1,wild,cl1,6ccfB,H1N,,6ccf,3,1,,Kinase,HoYoungLee,1,Crystal Structure of the Human CAMKK1A in complex with Hesperadin,Inhibitor,,1,CEREP,CAMKK1,Q8N5S9,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8N5S9_KKCC1_wild_cl1,KKCC1_6cd6D_DXV,Q8N5S9,Q8N5S9wild,KKCC1,wild,cl1,6cd6D,DXV,,6cd6,3,1,,Kinase,HoYoungLee,1,Crystal Structure of the Human CAMKK1A in complex with GSK650394,Inhibitor,,1,CEREP,CAMKK1,Q8N5S9,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8NEZ4_KMT2C_wild_cl1,KMT2C_5f59A_SAH,Q8NEZ4,Q8NEZ4wild,KMT2C,wild,cl1,5f59A,SAH,,5f59,3,1,,methylase,SooYongLee,1,Structural basis for activity regulation of MLL family methyltransferases.,Inhibitor,,1,CEREP,MLL3,Q8NEZ4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TDX7_NEK7_wild_cl1,NEK7_2wqnA_ADP,Q8TDX7,Q8TDX7wild,NEK7,wild,cl1,2wqnA,ADP,,2wqn,2,1,,Kinase,HoYoungLee,1,An Autoinhibitory Tyrosine Motif in the Cell-Cycle- Regulated Nek7 Kinase is Released Through Binding of Nek9.,Inhibitor,,1,CEREP,NEK7,Q8TDX7,Kinase,Other Protein,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TDX7_NEK7_wild_cl1,NEK7_6s75C_F9N,Q8TDX7,Q8TDX7wild,NEK7,wild,cl1,6s75C,F9N,,6s75,2,1,,Kinase,HoYoungLee,1,Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine.,Inhibitor,,1,CEREP,NEK7,Q8TDX7,Kinase,Other Protein,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TEK3_DOT1L_wild_cl1,DOT1L_4ekiA_0QK,Q8TEK3,Q8TEK3wild,DOT1L,wild,cl1,4ekiA,0QK,,4eki,2,1,,methylase,SooYongLee,1,Conformational adaptation drives potent_ selective and durable inhibition of the human protein methyltransferase DOT1L.,Inhibitor,,1,CEREP,DOT1L,Q8TEK3,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TEK3_DOT1L_wild_cl1,DOT1L_5mw3B_5JT,Q8TEK3,Q8TEK3wild,DOT1L,wild,cl1,5mw3B,5JT,,5mw3,2,1,,methylase,SooYongLee,1,Discovery of Potent_ Selective_ and Structurally Novel Dot1L inhibitors by a Fragment Linking Approach.,Inhibitor,,1,CEREP,DOT1L,Q8TEK3,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TF76_HASP_wild_cl1,HASP_6g37A_FTU,Q8TF76,Q8TF76wild,HASP,wild,cl1,6g37A,FTU,,6g37,2,1,,Kinase,HoYoungLee,1,Halogen-Aromatic pi Interactions Modulate inhibitor Residence Times.,Inhibitor,,1,CEREP,GSG2,Q8TF76,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8TF76_HASP_wild_cl1,HASP_6g38A_TBN,Q8TF76,Q8TF76wild,HASP,wild,cl1,6g38A,TBN,,6g38,2,1,,Kinase,HoYoungLee,1,Halogen-Aromatic pi Interactions Modulate inhibitor Residence Times.,Inhibitor,,1,CEREP,GSG2,Q8TF76,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8WTS6_SETD7_wild_cl1,SETD7_3vuzA_K15,Q8WTS6,Q8WTS6wild,SETD7,wild,cl1,3vuzA,K15,,3vuz,1,1,,methylase,SooYongLee,1,Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives,Inhibitor,,1,CEREP,SETD7/ SET9,Q8WTS6,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8WTS6_SETD7_wild_cl1,SETD7_4jdsD_1L4,Q8WTS6,Q8WTS6wild,SETD7,wild,cl1,4jdsD,1L4,,4jds,1,1,,methylase,SooYongLee,1,SETD7 in complex with inhibitor PF-5426 and S-adenosyl-methionine,Inhibitor,,1,CEREP,SETD7/ SET9,Q8WTS6,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8WU08_STK32A_wild_cl1,STK32A_4fr4D_STU,Q8WU08,Q8WU08wild,STK32A,wild,cl1,4fr4D,STU,,4fr4,3,1,,Kinase,HoYoungLee,1,Crystal structure of human serine/threonine-protein kinase 32A (YANK1),Inhibitor,,1,CEREP,STK32A,Q8WU08,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q8WU08_STK32A_wild_cl1,STK32A_4fr4E_STU,Q8WU08,Q8WU08wild,STK32A,wild,cl1,4fr4E,STU,,4fr4,3,1,,Kinase,HoYoungLee,1,Crystal structure of human serine/threonine-protein kinase 32A (YANK1),Inhibitor,,1,CEREP,STK32A,Q8WU08,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q92630_DYRK2_wild_cl1,DYRK2_6hdpA_FZ5,Q92630,Q92630wild,DYRK2,wild,cl1,6hdpA,FZ5,,6hdp,2,1,,Kinase,HoYoungLee,1,DYRK2 bound to Scorzodihydrostilbene A,Inhibitor,,1,CEREP,DYRK2,Q92630,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q92630_DYRK2_wild_cl1,DYRK2_6hdrA_CC9,Q92630,Q92630wild,DYRK2,wild,cl1,6hdrA,CC9,,6hdr,2,1,,Kinase,HoYoungLee,1,DYRK2 bound to Curcumin,Inhibitor,,1,CEREP,DYRK2,Q92630,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q92633_LPAR1_wild_cl1,LPAR1_4z34A_ON7,Q92633,Q92633wild,LPAR1,wild,cl1,4z34A,ON7,,4z34,2,1,,GPCR,,1,Crystal Structure of antagonist Bound Human Lysophosphatidic Acid Receptor 1.,Inhibitor,,1,CEREP,LPA1,0,0,0,0,Biochemical,Enzymatic,Activator,0,,,
Q92633_LPAR1_wild_cl1,LPAR1_4z35A_ON9,Q92633,Q92633wild,LPAR1,wild,cl1,4z35A,ON9,,4z35,2,1,,GPCR,,1,Crystal Structure of antagonist Bound Human Lysophosphatidic Acid Receptor 1.,Inhibitor,,1,CEREP,LPA1,0,0,0,0,Biochemical,Enzymatic,Activator,0,,,
Q92769_HDAC2_wild_cl1,HDAC2_5iwgC_IWX,Q92769,Q92769wild,HDAC2,wild,cl1,5iwgC,IWX,,5iwg,2,1,,Acetylase,SooYongLee,1,Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1_ 2) inhibitors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92769_HDAC2_wild_cl1,HDAC2_5ix0C_6EZ,Q92769,Q92769wild,HDAC2,wild,cl1,5ix0C,6EZ,,5ix0,2,1,,Acetylase,SooYongLee,1,Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1_ 2) inhibitors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92830_KAT2A_wild_cl1,KAT2A_5mljB_9ST,Q92830,Q92830wild,KAT2A,wild,cl1,5mljB,9ST,,5mlj,2,1,,Acetylase,SooYongLee,1,Discovery of a Potent_ Cell Penetrant_ and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92830_KAT2A_wild_cl1,KAT2A_6j3pB_B8O,Q92830,Q92830wild,KAT2A,wild,cl1,6j3pB,B8O,,6j3p,2,1,,Acetylase,SooYongLee,1,Discovery of Pyrrolo[3_2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active inhibitors of P300/CBP-Associated Factor Bromodomain.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92831_KAT2B_wild_cl1,KAT2B_5fe3B_5WX,Q92831,Q92831wild,KAT2B,wild,cl1,5fe3B,5WX,,5fe3,1,1,,Acetylase,SooYongLee,1,Structure-Based Identification of inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92831_KAT2B_wild_cl1,KAT2B_5fe4B_5WY,Q92831,Q92831wild,KAT2B,wild,cl1,5fe4B,5WY,,5fe4,1,1,,Acetylase,SooYongLee,1,Structure-Based Identification of inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q92918_M4K1_wild_cl1,M4K1_6cqfA_F97,Q92918,Q92918wild,M4K1,wild,cl1,6cqfA,F97,,6cqf,2,1,,Kinase,HoYoungLee,1,Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.,Inhibitor,,1,CEREP,MAP4K1,Q92918,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q92918_M4K1_wild_cl1,M4K1_6nfyB_B49,Q92918,Q92918wild,M4K1,wild,cl1,6nfyB,B49,,6nfy,2,1,,Kinase,HoYoungLee,1,Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation.,Inhibitor,,1,CEREP,MAP4K1,Q92918,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q92993_KAT5_wild_cl1,KAT5_2ou2A_ACO,Q92993,Q92993wild,KAT5,wild,cl1,2ou2A,ACO,,2ou2,3,1,,0,JiYoonShin,1,The Crystal Structure of acetyltransferase domain of Human HIV-1 Tat interacting protein in complex with acetylcoenzyme A.,inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q96GD4_AURKB_wild_cl1,AURKB_4af3A_VX6,Q96GD4,Q96GD4wild,AURKB,wild,cl1,4af3A,VX6,,4af3,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Aurora B in Complex with Incenp and Vx-680.,Inhibitor,,1,CEREP,AURKB,Q96GD4,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96KQ7_EHMT2_wild_cl1,EHMT2_3k5kB_DXQ,Q96KQ7,Q96KQ7wild,EHMT2,wild,cl1,3k5kB,DXQ,,3k5k,2,1,,methylase,SooYongLee,1,Discovery of a 2_4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.,Inhibitor,,1,CEREP,G9A,Q96KQ7,Epigenetic,Histone Methyltransferase,Writer,Functional,Cell Based Binding,Agonist,_,,,
Q96KQ7_EHMT2_wild_cl1,EHMT2_5v9iD_90P,Q96KQ7,Q96KQ7wild,EHMT2,wild,cl1,5v9iD,90P,,5v9i,2,1,,methylase,SooYongLee,1,Crystal structure of catalytic domain of G9a with MS0105,Inhibitor,,1,CEREP,G9A,Q96KQ7,Epigenetic,Histone Methyltransferase,Writer,Functional,Cell Based Binding,Agonist,_,,,
Q96L34_MARK4_wild_cl1,MARK4_5es1A_5RC,Q96L34,Q96L34wild,MARK4,wild,cl1,5es1A,5RC,,5es1,2,1,,Kinase,HoYoungLee,1,Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor.,Inhibitor,,1,CEREP,MARK4,Q96L34,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96L73_NSD1_wild_cl1,NSD1_6kqpA_SAM,Q96L73,Q96L73wild,NSD1,wild,cl1,6kqpA,SAM,,6kqp,3,1,,methylase,SooYongLee,1,Covalent inhibition of NSD1 histone methyltransferase.,Inhibitor,,1,CEREP,NSD1,Q96L73,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96LA8_ANM6_wild_cl1,ANM6_4qppC_36S,Q96LA8,Q96LA8wild,ANM6,wild,cl1,4qppC,36S,,4qpp,2,2,,methylase,SooYongLee,1,The Crystal Structure of Human HMT1 hnRNP methyltransferase-like protein 6 in complex with compound DS-421,Inhibitor,,1,CEREP,PRMT6,Q96LA8,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96LA8_ANM6_wild_cl2,ANM6_4y30B_49L,Q96LA8,Q96LA8wild,ANM6,wild,cl2,4y30B,49L,,4y30,2,2,,methylase,SooYongLee,1,Aryl Pyrazoles as Potent inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound.,Inhibitor,,1,CEREP,PRMT6,Q96LA8,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96LA8_ANM6_wild_cl1,ANM6_5wcfA_A0S,Q96LA8,Q96LA8wild,ANM6,wild,cl1,5wcfA,A0S,,5wcf,2,2,,methylase,SooYongLee,1,The Crystal Structure of Human HMT1 hnRNP methyltransferase-like protein 6 in complex with MTLLE1441,Inhibitor,,1,CEREP,PRMT6,Q96LA8,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96LA8_ANM6_wild_cl2,ANM6_6p7iC_O3P,Q96LA8,Q96LA8wild,ANM6,wild,cl2,6p7iC,O3P,,6p7i,2,2,,methylase,SooYongLee,1,Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent inhibitor,Inhibitor,,1,CEREP,PRMT6,Q96LA8,Epigenetic,Protein Arginine N-Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96NX5_KCC1G_wild_cl1,KCC1G_2jamA_J60,Q96NX5,Q96NX5wild,KCC1G,wild,cl1,2jamA,J60,,2jam,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Calmodulin-Dependent Protein Kinase I G,Inhibitor,,1,CEREP,CAMK1G,Q96NX5,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96PY6_NEK1_wild_cl1,NEK1_4b9dB_CK7,Q96PY6,Q96PY6wild,NEK1,wild,cl1,4b9dB,CK7,,4b9d,2,1,,Kinase,HoYoungLee,1,NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.,Inhibitor,,1,CEREP,NEK1,Q96PY6,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96RG2_PASK_wild_cl1,PASK_3dlsE_ADP,Q96RG2,Q96RG2wild,PASK,wild,cl1,3dlsE,ADP,,3dls,3,1,,Kinase,HoYoungLee,1,Structural bases of PAS domain-regulated kinase (PASK) activation in the absence of activation loop phosphorylation.,Inhibitor,,1,CEREP,PASK,Q96RG2,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96RI1_NR1H4_wild_cl1,NR1H4_5q14C_9MM,Q96RI1,Q96RI1wild,NR1H4,wild,cl1,5q14C,9MM,,5q14,1,2,,Receptor,,1,D3R Grand Challenge 2: blind prediction of protein-ligand poses_ affinity rankings_ and relative binding free energies.,inhibitor,IC50 21 nM,1,CEREP,FXR,Q96RI1,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
Q96RI1_NR1H4_wild_cl1,NR1H4_5q1cC_9NA,Q96RI1,Q96RI1wild,NR1H4,wild,cl1,5q1cC,9NA,,5q1c,1,2,,Receptor,,1,D3R Grand Challenge 2: blind prediction of protein-ligand poses_ affinity rankings_ and relative binding free energies.,inhibitor,IC50 8.4 nM,1,CEREP,FXR,Q96RI1,NHR,Liver X Receptor-Like,Non-Steroid,Functional,Cell Based,Agonist,_,,,
Q96RI1_NR1H4_281p354_cl1,NR1H4_3olfC_OLF,Q96RI1,Q96RI1281p354,NR1H4,281p354,cl1,3olfC,OLF,,3olf,1,2,,Receptor,,1,Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) Agonists to improve physicochemical and ADME properties,Activator,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
Q96RI1_NR1H4_281p354_cl1,NR1H4_3ookC_OOK,Q96RI1,Q96RI1281p354,NR1H4,281p354,cl1,3ookC,OOK,,3ook,1,2,,Receptor,,1,Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) Agonists to improve physicochemical and ADME properties,Activator,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
Q96RR4_KKCC2_wild_cl1,KKCC2_6cmjB_F6J,Q96RR4,Q96RR4wild,KKCC2,wild,cl1,6cmjB,F6J,,6cmj,2,1,,Kinase,HoYoungLee,1,An orally available_ brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model.,Inhibitor,,1,CEREP,CAMKK2,Q96RR4,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96SB4_SRPK1_wild_cl1,SRPK1_5mxxA_W4A,Q96SB4,Q96SB4wild,SRPK1,wild,cl1,5mxxA,W4A,,5mxx,2,1,,Kinase,HoYoungLee,1,Development of Potent_ Selective SRPK1 inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.,Inhibitor,,1,CEREP,SRPK1,Q96SB4,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q96SB4_SRPK1_wild_cl1,SRPK1_5my8A_RXZ,Q96SB4,Q96SB4wild,SRPK1,wild,cl1,5my8A,RXZ,,5my8,2,1,,Kinase,HoYoungLee,1,Development of Potent_ Selective SRPK1 inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.,Inhibitor,,1,CEREP,SRPK1,Q96SB4,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q99683_M3K5_wild_cl1,M3K5_3vw6B_IM6,Q99683,Q99683wild,M3K5,wild,cl1,3vw6B,IM6,,3vw6,1,1,,Kinase,HoYoungLee,1,Design and biological evaluation of imidazo[1_2-a]pyridines as novel and potent ASK1 inhibitors.,Inhibitor,,1,CEREP,MAP3K5,Q99683,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q99683_M3K5_wild_cl1,M3K5_6e2nB_KK8,Q99683,Q99683wild,M3K5,wild,cl1,6e2nB,KK8,,6e2n,1,1,,Kinase,HoYoungLee,1,ASK1 contributes to fibrosis and dysfunction in models of kidney disease.,Inhibitor,,1,CEREP,MAP3K5,Q99683,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q99986_VRK1_wild_cl1,VRK1_6bruD_E5M,Q99986,Q99986wild,VRK1,wild,cl1,6bruD,E5M,,6bru,1,1,,Kinase,HoYoungLee,1,Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor,Inhibitor,,1,CEREP,VRK1,0,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q99986_VRK1_wild_cl1,VRK1_6cqhA_F8Y,Q99986,Q99986wild,VRK1,wild,cl1,6cqhA,F8Y,,6cqh,1,1,,Kinase,HoYoungLee,1,Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor,Inhibitor,,1,CEREP,VRK1,0,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BVS4_RIOK2_wild_cl1,RIOK2_6fdmC_ANP,Q9BVS4,Q9BVS4wild,RIOK2,wild,cl1,6fdmC,ANP,,6fdm,2,1,,Kinase,HoYoungLee,1,In vitro dimerization of human RIO2 kinase.,Inhibitor,,1,CEREP,RIOK2,Q9BVS4,Kinase,RIO,Atypical,Biochemical,Binding,0,0,,,
Q9BVS4_RIOK2_wild_cl1,RIOK2_6hk6J_G8H,Q9BVS4,Q9BVS4wild,RIOK2,wild,cl1,6hk6J,G8H,,6hk6,2,1,,Kinase,HoYoungLee,1,Crystal structure of human RIOK2 bound to a specific inhibitor.,Inhibitor,,1,CEREP,RIOK2,Q9BVS4,Kinase,RIO,Atypical,Biochemical,Binding,0,0,,,
Q9BY41_HDAC8_wild_cl1,HDAC8_3f07B_AGE,Q9BY41,Q9BY41wild,HDAC8,wild,cl1,3f07B,AGE,,3f07,1,1,,Acetylase,SooYongLee,1,Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q9BY41_HDAC8_wild_cl1,HDAC8_3sffA_0DI,Q9BY41,Q9BY41wild,HDAC8,wild,cl1,3sffA,0DI,,3sff,1,1,,Acetylase,SooYongLee,1,Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q9BYP7_WNK3_wild_cl1,WNK3_5o26B_ANP,Q9BYP7,Q9BYP7wild,WNK3,wild,cl1,5o26B,ANP,,5o26,3,1,,Kinase,HoYoungLee,1,Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+,Inhibitor,,1,CEREP,WNK3,Q9BYP7,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BYP7_WNK3_wild_cl1,WNK3_5o2bB_KS1,Q9BYP7,Q9BYP7wild,WNK3,wild,cl1,5o2bB,KS1,,5o2b,3,1,,Kinase,HoYoungLee,1,Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121,Inhibitor,,1,CEREP,WNK3,Q9BYP7,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BYW2_SETD2_wild_cl1,SETD2_4fmuA_0UM,Q9BYW2,Q9BYW2wild,SETD2,wild,cl1,4fmuA,0UM,,4fmu,1,1,,methylase,SooYongLee,1,Sinefungin Derivatives as inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2.,Inhibitor,,1,CEREP,SETD2,Q9BYW2,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BYW2_SETD2_wild_cl1,SETD2_6j9jA_SAH,Q9BYW2,Q9BYW2wild,SETD2,wild,cl1,6j9jA,SAH,,6j9j,1,1,,methylase,SooYongLee,1,Histone H3.3 phosphorylation amplifies stimulation-induced transcription.,Inhibitor,,1,CEREP,SETD2,Q9BYW2,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl3,NSD3_5updA_SAM,Q9BZ95,Q9BZ95wild,NSD3,wild,cl3,5updA,SAM,,5upd,3,3,,methylase,SooYongLee,1,Methyltransferase domain of human Wolf-Hirschhorn Syndrome Candidate 1-Like protein 1 (WHSC1L1),Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl3,NSD3_6g25A_EHQ,Q9BZ95,Q9BZ95wild,NSD3,wild,cl3,6g25A,EHQ,,6g25,3,3,,methylase,SooYongLee,1,Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.,Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl2,NSD3_6g27A_EHE,Q9BZ95,Q9BZ95wild,NSD3,wild,cl2,6g27A,EHE,,6g27,3,3,,methylase,SooYongLee,1,Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.,Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl1,NSD3_6g2bA_EH8,Q9BZ95,Q9BZ95wild,NSD3,wild,cl1,6g2bA,EH8,,6g2b,3,3,,methylase,SooYongLee,1,Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.,Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl1,NSD3_6g2cA_EHT,Q9BZ95,Q9BZ95wild,NSD3,wild,cl1,6g2cA,EHT,,6g2c,3,3,,methylase,SooYongLee,1,Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.,Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9BZ95_NSD3_wild_cl2,NSD3_6g2fA_EHW,Q9BZ95,Q9BZ95wild,NSD3,wild,cl2,6g2fA,EHW,,6g2f,3,3,,methylase,SooYongLee,1,Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.,Inhibitor,,1,CEREP,NSD3,Q9BZ95,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H2G2_SLK_wild_cl1,SLK_2uv2A_GVD,Q9H2G2,Q9H2G2wild,SLK,wild,cl1,2uv2A,GVD,,2uv2,2,1,,Kinase,HoYoungLee,1,Activation Segment Dimerization: A Mechanism for Kinase Autophosphorylation of Non-Consensus Sites.,Inhibitor,,1,CEREP,SLK,Q9H2G2,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H2G2_SLK_wild_cl1,SLK_6hvdA_GUQ,Q9H2G2,Q9H2G2wild,SLK,wild,cl1,6hvdA,GUQ,,6hvd,2,1,,Kinase,HoYoungLee,1,Human SLK bound to a maleimide inhibitor,Inhibitor,,1,CEREP,SLK,Q9H2G2,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H2K8_TAOK3_wild_cl1,TAOK3_6bdnA_ADP,Q9H2K8,Q9H2K8wild,TAOK3,wild,cl1,6bdnA,ADP,,6bdn,2,1,,Kinase,HoYoungLee,1,Crystal structure of human TAO3 kinase  binding ADP,Inhibitor,,1,CEREP,TAOK3,Q9H2K8,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H2X6_HIPK2_wild_cl1,HIPK2_6p5sA_3NG,Q9H2X6,Q9H2X6wild,HIPK2,wild,cl1,6p5sA,3NG,,6p5s,2,1,,Kinase,HoYoungLee,1,The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.,Inhibitor,,1,CEREP,HIPK2,Q9H2X6,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H422_HIPK3_wild_cl1,HIPK3_7o7jA_6ZV,Q9H422,Q9H422wild,HIPK3,wild,cl1,7o7jA,6ZV,,7o7j,3,1,,Kinase,HoYoungLee,1,Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.,Inhibitor,,1,CEREP,HIPK3,Q9H422,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H4B4_PLK3_wild_cl1,PLK3_4b6lA_9ZP,Q9H4B4,Q9H4B4wild,PLK3,wild,cl1,4b6lA,9ZP,,4b6l,2,1,,Kinase,HoYoungLee,1,Discovery of Oral Polo-Like Kinase (Plk) inhibitors with Enhanced Selectivity Profile Using Residue Targeted Drug Design,Inhibitor,,1,CEREP,PLK3,Q9H4B4,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H5I1_SUV92_wild_cl1,SUV92_2r3aA_SAM,Q9H5I1,Q9H5I1wild,SUV92,wild,cl1,2r3aA,SAM,,2r3a,3,1,,methylase,SooYongLee,1,Structural biology of human H3K9 methyltransferases,Inhibitor,,1,CEREP,SUV39H2,Q9H5I1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H5I1_SUV92_wild_cl1,SUV92_6p0rB_NM4,Q9H5I1,Q9H5I1wild,SUV92,wild,cl1,6p0rB,NM4,,6p0r,3,1,,methylase,SooYongLee,1,Methyltransferase domain of human suppressor of variegation 3-9 homolog 2 (SUV39H2) in complex with OTS186935 inhibitor,Inhibitor,,1,CEREP,SUV39H2,Q9H5I1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H9B1_EHMT1_wild_cl1,EHMT1_3mo2D_E67,Q9H9B1,Q9H9B1wild,EHMT1,wild,cl1,3mo2D,E67,,3mo2,2,1,,methylase,SooYongLee,1,Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.,Inhibitor,,1,CEREP,EHMT1,Q9H9B1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9H9B1_EHMT1_wild_cl1,EHMT1_5ttgB_7KZ,Q9H9B1,Q9H9B1wild,EHMT1,wild,cl1,5ttgB,7KZ,,5ttg,2,1,,methylase,SooYongLee,1,Discovery of Potent and Selective inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.,Inhibitor,,1,CEREP,EHMT1,Q9H9B1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9HAZ1_CLK4_wild_cl1,CLK4_6fyvA_3NG,Q9HAZ1,Q9HAZ1wild,CLK4,wild,cl1,6fyvA,3NG,,6fyv,2,1,,Kinase,HoYoungLee,1,X-ray Structures and Feasibility Assessment of CLK2 inhibitors for Phelan-McDermid Syndrome.,Inhibitor,,1,CEREP,CLK4,Q9HAZ1,Kinase,CMGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9HBH9_MKNK2_wild_cl1,MKNK2_2hw7A_STU,Q9HBH9,Q9HBH9wild,MKNK2,wild,cl1,2hw7A,STU,,2hw7,2,2,,Kinase,HoYoungLee,1,Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment.,Inhibitor,,1,CEREP,MKNK2,Q9HBH9,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9HBH9_MKNK2_wild_cl1,MKNK2_6cj5A_F4G,Q9HBH9,Q9HBH9wild,MKNK2,wild,cl1,6cj5A,F4G,,6cj5,2,2,,Kinase,HoYoungLee,1,Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) inhibition.,Inhibitor,,1,CEREP,MKNK2,Q9HBH9,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9HCP0_CSNK1G1_wild_cl1,CSNK1G1_2cmwA_OLP,Q9HCP0,Q9HCP0wild,CSNK1G1,wild,cl1,2cmwA,OLP,,2cmw,3,1,,Kinase,HoYoungLee,1,Structure of Human Casein Kinase 1 Gamma-1 in Complex with 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9-Isopropylpurine (Casp Target),Inhibitor,,1,CEREP,CSNK1G1,Q9HCP0,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQR1_KMT5A_343_cl1,KMT5A_4ij8B_SAM,Q9NQR1,Q9NQR1343,KMT5A,343,cl1,4ij8B,SAM,,4ij8,2,2,,methylase,SooYongLee,1,Crystal structure of the complex of SETD8 with SAM,Inhibitor,,1,CEREP,_,_,_,_,_,_,_,_,_,,,
Q9NQR1_KMT5A_wild_cl1,KMT5A_5t5gA_75P,Q9NQR1,Q9NQR1wild,KMT5A,wild,cl1,5t5gA,75P,,5t5g,2,2,,methylase,SooYongLee,1,Structure-Based Design of a Covalent inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase.,Inhibitor,,1,CEREP,PR-SET7 (SETD8),Q9NQR1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQR1_KMT5A_wild_cl1,KMT5A_5w1yB_9SV,Q9NQR1,Q9NQR1wild,KMT5A,wild,cl1,5w1yB,9SV,,5w1y,2,2,,methylase,SooYongLee,1,SETD8 in complex with a covalent inhibitor,Inhibitor,,1,CEREP,PR-SET7 (SETD8),Q9NQR1,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQU5_PAK6_wild_cl1,PAK6_4ks7A_X4Z,Q9NQU5,Q9NQU5wild,PAK6,wild,cl1,4ks7A,X4Z,,4ks7,2,1,,Kinase,HoYoungLee,1,Substrate and inhibitor Specificity of the Type II p21-Activated Kinase_ PAK6.,Inhibitor,,1,CEREP,PAK6,Q9NQU5,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQU5_PAK6_wild_cl1,PAK6_4ks8A_B49,Q9NQU5,Q9NQU5wild,PAK6,wild,cl1,4ks8A,B49,,4ks8,2,1,,Kinase,HoYoungLee,1,Substrate and inhibitor Specificity of the Type II p21-Activated Kinase_ PAK6.,Inhibitor,,1,CEREP,PAK6,Q9NQU5,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQV7_PRDM9_wild_cl1,PRDM9_6nm4B_KS7,Q9NQV7,Q9NQV7wild,PRDM9,wild,cl1,6nm4B,KS7,,6nm4,3,1,,methylase,SooYongLee,1,Discovery of a chemical probe for PRDM9.,Inhibitor,,1,CEREP,PRDM9,Q9NQV7,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NQV7_PRDM9_wild_cl1,PRDM9_6nm4B_SAM,Q9NQV7,Q9NQV7wild,PRDM9,wild,cl1,6nm4B,SAM,,6nm4,3,1,,methylase,SooYongLee,1,Discovery of a chemical probe for PRDM9.,Inhibitor,,1,CEREP,PRDM9,Q9NQV7,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NRG4_SMYD2_wild_cl1,SMYD2_4wuyA_3UJ,Q9NRG4,Q9NRG4wild,SMYD2,wild,cl1,4wuyA,3UJ,,4wuy,1,1,,methylase,SooYongLee,1,LLY-507_ a Cell-active_ Potent_ and Selective inhibitor of Protein-lysine Methyltransferase SMYD2.,Inhibitor,,1,CEREP,SMYD2,Q9NRG4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NRG4_SMYD2_wild_cl1,SMYD2_5argA_H41,Q9NRG4,Q9NRG4wild,SMYD2,wild,cl1,5argA,H41,,5arg,1,1,,methylase,SooYongLee,1,Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (Bay-598) for the Protein Lysine Methyltransferase Smyd2.,Inhibitor,,1,CEREP,SMYD2,Q9NRG4,Epigenetic,Histone Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NRW4_DUS22_88_cl1,DUS22_4wohA_4NP,Q9NRW4,Q9NRW488,DUS22,88,cl1,4wohA,4NP,,4woh,3,1,,phosphatase,SooYongLee,1,Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.,inhibitor,,1,CEREP,DUSP22,Q9NRW4,Phosphatase,Non-Receptor,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Spectrofluorimetric,,,
Q9NS75_CLTR2_wild_cl1,CLTR2_6rz6A_KNW,Q9NS75,Q9NS75wild,CLTR2,wild,cl1,6rz6A,KNW,,6rz6,2,1,,GPCR,,1,Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.,inhibitor,,1,CEREP,0,0,0,0,0,0,Enzymatic,Agonist,0,,,
Q9NSY1_BMP2K_wild_cl1,BMP2K_4w9xA_3JW,Q9NSY1,Q9NSY1wild,BMP2K,wild,cl1,4w9xA,3JW,,4w9x,2,1,,Kinase,HoYoungLee,1,Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.,Inhibitor,,1,CEREP,BMP2K,Q9NSY1,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NSY1_BMP2K_wild_cl1,BMP2K_5i3oB_IDV,Q9NSY1,Q9NSY1wild,BMP2K,wild,cl1,5i3oB,IDV,,5i3o,2,1,,Kinase,HoYoungLee,1,Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor,Inhibitor,,1,CEREP,BMP2K,Q9NSY1,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NWZ3_IRAK4_wild_cl1,IRAK4_4y73D_XPY,Q9NWZ3,Q9NWZ3wild,IRAK4,wild,cl1,4y73D,XPY,,4y73,1,1,,Kinase,HoYoungLee,1,Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1_5-a]pyrimidine-3-carboxamide inhibitors of IRAK4.,Inhibitor,,1,CEREP,IRAK4,Q9NWZ3,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NWZ3_IRAK4_wild_cl1,IRAK4_6f3dB_CJT,Q9NWZ3,Q9NWZ3wild,IRAK4,wild,cl1,6f3dB,CJT,,6f3d,1,1,,Kinase,HoYoungLee,1,Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4.,Inhibitor,,1,CEREP,IRAK4,Q9NWZ3,Kinase,TKL,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NZJ5_E2AK3_wild_cl1,E2AK3_4g31A_0WH,Q9NZJ5,Q9NZJ5wild,E2AK3,wild,cl1,4g31A,0WH,,4g31,2,2,,Kinase,HoYoungLee,1,Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2_3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2_3-d]pyrimidin-4-amine (GSK2606414)_ a Potent and Selective First-in-Class inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK).,Inhibitor,,1,CEREP,EIF2AK3,Q9NZJ5,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9NZJ5_E2AK3_wild_cl1,E2AK3_4m7iA_27D,Q9NZJ5,Q9NZJ5wild,E2AK3,wild,cl1,4m7iA,27D,,4m7i,2,2,,Kinase,HoYoungLee,1,Discovery of 5-{4-fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2_3-dihydro-1H-indol-5-yl}-7-methyl-7H-pyrrolo[2_3-d]pyrimidin-4-amine (GSK2656157)_ a Potent and Selective PERK inhibitor Selected for Preclinical Development,Inhibitor,,1,CEREP,EIF2AK3,Q9NZJ5,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P1W9_PIM2_wild_cl1,PIM2_2iwiB_HB1,Q9P1W9,Q9P1W9wild,PIM2,wild,cl1,2iwiB,HB1,,2iwi,2,1,,Kinase,HoYoungLee,1,Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.,Inhibitor,,1,CEREP,PIM2,Q9P1W9,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P1W9_PIM2_wild_cl1,PIM2_4x7qA_3YR,Q9P1W9,Q9P1W9wild,PIM2,wild,cl1,4x7qA,3YR,,4x7q,2,1,,Kinase,HoYoungLee,1,Structure-based design of low-nanomolar PIM kinase inhibitors.,Inhibitor,,1,CEREP,PIM2,Q9P1W9,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P286_PAK7_wild_cl1,PAK7_2f57B_23D,Q9P286,Q9P286wild,PAK7,wild,cl1,2f57B,23D,,2f57,2,1,,Kinase,HoYoungLee,1,Crystal Structures of the p21-activated kinases PAK4_ PAK5_ and PAK6 reveal catalytic domain plasticity of active group II PAKs.,Inhibitor,Orthosteric,1,CEREP,PAK5,Q9P286,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P289_MST4_wild_cl1,MST4_7b36C_59T,Q9P289,Q9P289wild,MST4,wild,cl1,7b36C,59T,,7b36,2,1,,Kinase,HoYoungLee,1,Structure-Based Design of Selective Salt-Inducible Kinase inhibitors.,Inhibitor,,1,CEREP,STK26,Q9P289,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P2K8_E2AK4_807p848_cl1,E2AK4_6n3lA_KAV,Q9P2K8,Q9P2K8807p848,E2AK4,807p848,cl1,6n3lA,KAV,,6n3l,3,1,,Kinase,HoYoungLee,1,Identification of Novel_ Potent_ and Orally Available GCN2 inhibitors with Type I Half Binding Mode.,Inhibitor,,1,CEREP,EIF2AK4,Q9P2K8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9P2K8_E2AK4_807p848_cl1,E2AK4_6n3nA_KA4,Q9P2K8,Q9P2K8807p848,E2AK4,807p848,cl1,6n3nA,KA4,,6n3n,3,1,,Kinase,HoYoungLee,1,Identification of Novel_ Potent_ and Orally Available GCN2 inhibitors with Type I Half Binding Mode.,Inhibitor,,1,CEREP,EIF2AK4,Q9P2K8,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UBC3_DNM3B_wild_cl1,DNM3B_6kdpD_SAH,Q9UBC3,Q9UBC3wild,DNM3B,wild,cl1,6kdpD,SAH,,6kdp,2,1,,methylase,SooYongLee,1,Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B.,Inhibitor,,1,CEREP,DNMT3B,Q9UBC3,Epigenetic,DNA Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UBC3_DNM3B_wild_cl1,DNM3B_6kdtA_SAH,Q9UBC3,Q9UBC3wild,DNM3B,wild,cl1,6kdtA,SAH,,6kdt,2,1,,methylase,SooYongLee,1,Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B.,Inhibitor,,1,CEREP,DNMT3B,Q9UBC3,Epigenetic,DNA Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UBN7_HDAC6_wild_cl1,HDAC6_5wbnA_9ZV,Q9UBN7,Q9UBN7wild,HDAC6,wild,cl1,5wbnA,9ZV,,5wbn,2,1,,Acetylase,SooYongLee,1,Crystal structure of fragment 3-(3-Benzyl-2-oxo-2H-[1_2_4]triazino[2_3-c]quinazolin-6-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q9UBN7_HDAC6_wild_cl1,HDAC6_6ce6A_EYP,Q9UBN7,Q9UBN7wild,HDAC6,wild,cl1,6ce6A,EYP,,6ce6,2,1,,Acetylase,SooYongLee,1,Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain inhibitors.,Inhibitor,,1,CEREP,0,0,0,0,0,0,0,0,0,,,
Q9UBS5_GABR1_wild_cl1,GABR1_4ms1A_381,Q9UBS5,Q9UBS5wild,GABR1,wild,cl1,4ms1A,381,,4ms1,3,1,,GPCR,,1,Structural mechanism of ligand activation in human GABA(B) receptor.,Inhibitor,,1,CEREP,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q9UEE5_STK17A_wild_cl1,STK17A_7queA_F7I,Q9UEE5,Q9UEE5wild,STK17A,wild,cl1,7queA,F7I,,7que,2,1,,Kinase,HoYoungLee,1,Illuminating the Dark: Highly Selective inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1_5- a ]pyrimidine-Based Macrocycles.,Inhibitor,,1,CEREP,STK17A,Q9UEE5,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9UEE5_STK17A_wild_cl1,STK17A_7queB_F7I,Q9UEE5,Q9UEE5wild,STK17A,wild,cl1,7queB,F7I,,7que,2,1,,Kinase,HoYoungLee,1,Illuminating the Dark: Highly Selective inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1_5- a ]pyrimidine-Based Macrocycles.,Inhibitor,,1,CEREP,STK17A,Q9UEE5,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9UGL1_KDM5B_wild_cl1,KDM5B_5a3nA_LQT,Q9UGL1,Q9UGL1wild,KDM5B,wild,cl1,5a3nA,LQT,,5a3n,2,1,,methylase,SooYongLee,1,Potent and Selective KDM5 inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.,Inhibitor,,1,CEREP,JARID1B,Q9UGL1,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9UGL1_KDM5B_wild_cl1,KDM5B_5fpuA_K0I,Q9UGL1,Q9UGL1wild,KDM5B,wild,cl1,5fpuA,K0I,,5fpu,2,1,,methylase,SooYongLee,1,Structural Analysis of Human Kdm5B Guides Histone Demethylase inhibitor Development.,Inhibitor,,1,CEREP,JARID1B,Q9UGL1,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9UGN5_PARP2_wild_cl1,PARP2_3kjdB_78P,Q9UGN5,Q9UGN5wild,PARP2,wild,cl1,3kjdB,78P,,3kjd,3,1,,Transferase,,1,Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.,Inhibitor,,1,CEREP,PARP2,Q9UGN5,DNA Repair & Mitotic Regulation,_,Other,Biochemical,Enzymatic,_,Spectrophotometry,,,
Q9UGN5_PARP2_wild_cl1,PARP2_4zzxB_FSU,Q9UGN5,Q9UGN5wild,PARP2,wild,cl1,4zzxB,FSU,,4zzx,3,1,,Transferase,,1,Discovery of 2-[1-(4_4-Difluorocyclohexyl)Piperidin-4-Yl]-6-Fluoro-3-Oxo-2_3-Dihydro-1H-Isoindole-4-Carboxamide (Nms-P118): A Potent_ Orally Available and Highly Selective Parp- 1 inhibitor for Cancer Therapy.,Inhibitor,,1,CEREP,PARP2,Q9UGN5,DNA Repair & Mitotic Regulation,_,Other,Biochemical,Enzymatic,_,Spectrophotometry,,,
Q9UHD2_TBK1_wild_cl1,TBK1_4iwoA_1H4,Q9UHD2,Q9UHD2wild,TBK1,wild,cl1,4iwoA,1H4,,4iwo,2,2,,Kinase,HoYoungLee,1,Crystal structure and mechanism of activation of TANK-binding kinase 1.,Inhibitor,,1,CEREP,TBK1,Q9UHD2,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UHD2_TBK1_wild_cl1,TBK1_5w5vA_ANW,Q9UHD2,Q9UHD2wild,TBK1,wild,cl1,5w5vA,ANW,,5w5v,2,2,,Kinase,HoYoungLee,1,Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKepsilonand Reveal Mechanisms for Selective inhibition.,Inhibitor,,1,CEREP,TBK1,Q9UHD2,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UIK4_DAPK2_wild_cl1,DAPK2_2ckeD_IQU,Q9UIK4,Q9UIK4wild,DAPK2,wild,cl1,2ckeD,IQU,,2cke,2,1,,Kinase,HoYoungLee,1,Crystal Structure of Human Drp-1 Complexed with an inhibitor,Inhibitor,,1,CEREP,DAPK2,Q9UIK4,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UK32_KS6A6_wild_cl1,KS6A6_6g78B_ANP,Q9UK32,Q9UK32wild,KS6A6,wild,cl1,6g78B,ANP,,6g78,2,1,,Kinase,HoYoungLee,1,Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.,Inhibitor,,1,CEREP,RPS6KA6,Q9UK32,Kinase,AGC,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UKE5_TNIK_wild_cl1,TNIK_2x7fE_824,Q9UKE5,Q9UKE5wild,TNIK,wild,cl1,2x7fE,824,,2x7f,2,1,,Kinase,HoYoungLee,1,Crystal Structure of the Kinase Domain of Human Traf2- and Nck-Interacting Kinase with Wee1Chk1 inhibitor,Inhibitor,,1,CEREP,TNIK,Q9UKE5,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UKE5_TNIK_wild_cl1,TNIK_6ra7A_JWK,Q9UKE5,Q9UKE5wild,TNIK,wild,cl1,6ra7A,JWK,,6ra7,2,1,,Kinase,HoYoungLee,1,Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase,Inhibitor,,1,CEREP,TNIK,Q9UKE5,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UM73_ALK_wild_cl1,ALK_4fodA_0UV,Q9UM73,Q9UM73wild,ALK,wild,cl1,4fodA,0UV,,4fod,1,2,,Kinase,HoYoungLee,1,The Discovery and Optimization of a Novel Class of Potent_ Selective_ and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) inhibitors with Potential Utility for the Treatment of Cancer.,Inhibitor,,1,CEREP,ALK,Q9UM73,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UM73_ALK_wild_cl1,ALK_5ftoA_YMX,Q9UM73,Q9UM73wild,ALK,wild,cl1,5ftoA,YMX,,5fto,1,2,,Kinase,HoYoungLee,1,Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (Alk)_ C-Ros Oncogene 1 Kinase (Ros1)_ and Pan-Tropomyosin Receptor Kinases (Pan-Trks) inhibitor.,Inhibitor,,1,CEREP,ALK,Q9UM73,Kinase,RTK,Protein Tyrosine,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UPP1_PHF8_wild_cl1,PHF8_4do0A_DZA,Q9UPP1,Q9UPP1wild,PHF8,wild,cl1,4do0A,DZA,,4do0,3,1,,methylase,SooYongLee,1,Crystal Structure of human PHF8 in complex with Daminozide,Inhibitor,,1,CEREP,PHF8,Q9UPP1,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9UQB9_AURKC_wild_cl1,AURKC_6gr8A_F8Z,Q9UQB9,Q9UQB9wild,AURKC,wild,cl1,6gr8A,F8Z,,6gr8,2,1,,Kinase,HoYoungLee,1,AURKC INCENP complex bound to BRD-7880,Inhibitor,,1,CEREP,AURKC,Q9UQB9,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UQB9_AURKC_wild_cl1,AURKC_6gr9A_VX6,Q9UQB9,Q9UQB9wild,AURKC,wild,cl1,6gr9A,VX6,,6gr9,2,1,,Kinase,HoYoungLee,1,AURKC INCENP complex bound to BRD-7880,Inhibitor,,1,CEREP,AURKC,Q9UQB9,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UQM7_KCC2A_wild_cl1,KCC2A_7kl0B_UZD,Q9UQM7,Q9UQM7wild,KCC2A,wild,cl1,7kl0B,UZD,,7kl0,2,2,,Kinase,HoYoungLee,1,CaMKII binds both substrates and activators at the active site.,Inhibitor,,1,CEREP,CAMK2A,Q9UQM7,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9UQM7_KCC2A_wild_cl1,KCC2A_7kl1B_ATP,Q9UQM7,Q9UQM7wild,KCC2A,wild,cl1,7kl1B,ATP,,7kl1,2,2,,Kinase,HoYoungLee,1,CaMKII binds both substrates and activators at the active site.,Inhibitor,,1,CEREP,CAMK2A,Q9UQM7,Kinase,CAMK,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y2K7_KDM2A_wild_cl1,KDM2A_2yu1A_AKG,Q9Y2K7,Q9Y2K7wild,KDM2A,wild,cl1,2yu1A,AKG,,2yu1,3,1,,methylase,SooYongLee,1,Structural basis for histone demethylation by JHDM1,Inhibitor,,1,CEREP,FBXL11,Q9Y2K7,Epigenetic,Histone Demethylase,Eraser,Biochemical,Enzymatic,Antagonist,LANCE,,,
Q9Y6E0_STK24_wild_cl1,STK24_4qmmA_35R,Q9Y6E0,Q9Y6E0wild,STK24,wild,cl1,4qmmA,35R,,4qmm,1,1,,Kinase,HoYoungLee,1,Discovery of Diverse Small-Molecule inhibitors of Mammalian Sterile20-like Kinase 3 (MST3).,Inhibitor,,1,CEREP,STK24,Q9Y6E0,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y6E0_STK24_wild_cl1,STK24_4qo9B_627,Q9Y6E0,Q9Y6E0wild,STK24,wild,cl1,4qo9B,627,,4qo9,1,1,,Kinase,HoYoungLee,1,Discovery of Diverse Small-Molecule inhibitors of Mammalian Sterile20-like Kinase 3 (MST3).,Inhibitor,,1,CEREP,STK24,Q9Y6E0,Kinase,STE,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y6K1_DNM3A_wild_cl1,DNM3A_4u7pA_SAH,Q9Y6K1,Q9Y6K1wild,DNM3A,wild,cl1,4u7pA,SAH,,4u7p,1,1,,methylase,SooYongLee,1,Structural insight into autoinhibition and histone H3-induced activation of DNMT3A,Inhibitor,,1,CEREP,DNMT3A,Q9Y6K1,Epigenetic,DNA Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y6K1_DNM3A_wild_cl1,DNM3A_6w89A_SAH,Q9Y6K1,Q9Y6K1wild,DNM3A,wild,cl1,6w89A,SAH,,6w89,1,1,,methylase,SooYongLee,1,Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation.,Inhibitor,,1,CEREP,DNMT3A,Q9Y6K1,Epigenetic,DNA Methyltransferase,Writer,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y6M4_KC1G3_wild_cl1,KC1G3_2izsA_BRQ,Q9Y6M4,Q9Y6M4wild,KC1G3,wild,cl1,2izsA,BRQ,,2izs,1,1,,Kinase,HoYoungLee,1,inhibitor Binding by Casein Kinases,Inhibitor,,1,CEREP,CSNK1G3,Q9Y6M4,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
Q9Y6M4_KC1G3_wild_cl1,KC1G3_4hgsA_15G,Q9Y6M4,Q9Y6M4wild,KC1G3,wild,cl1,4hgsA,15G,,4hgs,1,1,,Kinase,HoYoungLee,1,Crystal structure of ck1gs with compound 13,Inhibitor,,1,CEREP,CSNK1G3,Q9Y6M4,Kinase,CK1,Protein Ser/Thr,Biochemical,Enzymatic,Antagonist,Radiometric,,,
O14733_MAP2K7_wild_cl2,MAP2K7_6yg2A_1E8,O14733,O14733wild,MAP2K7,wild,cl2,6yg2A,1.00E+08,,6yg2,1,2,,Kinase,HoYoungLee,1,Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.,Inhibitor,allosteric,1,DiscoverX,MKK7,O14733,Kinase,STE,Protein Ser/thr,Biochemical,Binding,0,0,,,
O14733_MAP2K7_wild_cl1,MAP2K7_6qftA_J0B,O14733,O14733wild,MAP2K7,wild,cl1,6qftA,J0B,,6qft,1,2,,Kinase,HoYoungLee,1,Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).,Inhibitor,,1,DiscoverX,MKK7,O14733,Kinase,STE,Protein Ser/thr,Biochemical,Binding,0,0,,,
O14733_MAP2K7_wild_cl1,MAP2K7_6qg7A_6HL,O14733,O14733wild,MAP2K7,wild,cl1,6qg7A,6HL,,6qg7,1,2,,Kinase,HoYoungLee,1,Characterization of Covalent Pyrazolopyrimidine-MKK7 Complexes and a Report on a Unique DFG-in/Leu-in Conformation of Mitogen-Activated Protein Kinase Kinase 7 (MKK7).,Inhibitor,,1,DiscoverX,MKK7,O14733,Kinase,STE,Protein Ser/thr,Biochemical,Binding,0,0,,,
O14936_CSKP_wild_cl1,CSKP_3c0gB_3AM,O14936,O14936wild,CSKP,wild,cl1,3c0gB,3AM,,3c0g,2,1,,Kinase,HoYoungLee,1,CASK Functions as a Mg2+-independent neurexin kinase,Inhibitor,,1,DiscoverX,CASK,O14936,Kinase,CAMK,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O14936_CSKP_wild_cl1,CSKP_3mfrA_ANP,O14936,O14936wild,CSKP,wild,cl1,3mfrA,ANP,,3mfr,2,1,,Kinase,HoYoungLee,1,Evolution of CASK into a Mg2+-sensitive kinase.,Inhibitor,,1,DiscoverX,CASK,O14936,Kinase,CAMK,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O15075_DCLK1_wild_cl1,DCLK1_5jzjB_AN2,O15075,O15075wild,DCLK1,wild,cl1,5jzjB,AN2,,5jzj,2,1,,Kinase,HoYoungLee,1,Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.,Inhibitor,,1,DiscoverX,DCLK1,O15075,Kinase,CAMK,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O15075_DCLK1_wild_cl1,DCLK1_5jznB_GUI,O15075,O15075wild,DCLK1,wild,cl1,5jznB,GUI,,5jzn,2,1,,Kinase,HoYoungLee,1,Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.,Inhibitor,,1,DiscoverX,DCLK1,O15075,Kinase,CAMK,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O15164_TIF1A_wild_cl1,TIF1A_4yatB_4A8,O15164,O15164wild,TIF1A,wild,cl1,4yatB,4A8,,4yat,1,1,,0,JiYoonShin,1,Structure-Guided Design of IACS-9571_ a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain inhibitor.,Inhibitor,,1,DiscoverX,TRIM24,O15164,0,0,0,Binding,Biochemical,Binding,0,,,
O15164_TIF1A_wild_cl1,TIF1A_4ybsA_4BK,O15164,O15164wild,TIF1A,wild,cl1,4ybsA,4BK,,4ybs,1,1,,0,JiYoonShin,1,Structure-Guided Design of IACS-9571_ a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain inhibitor.,Inhibitor,,1,DiscoverX,TRIM24,O15164,0,0,0,Binding,Biochemical,Binding,0,,,
O43683_BUB1_wild_cl1,BUB1_4r8qA_ADP,O43683,O43683wild,BUB1,wild,cl1,4r8qA,ADP,,4r8q,2,1,,Kinase,HoYoungLee,1,Structure and substrate recruitment of the human spindle checkpoint kinase Bub1.,Inhibitor,,1,DiscoverX,BUB1,O43683,Kinase,BUB,Protein Ser/thr,Biochemical,Binding,0,0,,,
O43683_BUB1_wild_cl1,BUB1_6f7bA_CVQ,O43683,O43683wild,BUB1,wild,cl1,6f7bA,CVQ,,6f7b,2,1,,Kinase,HoYoungLee,1,inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes_ ATR_ and PARP inhibitorsIn VitroandIn Vivo.,Inhibitor,,1,DiscoverX,BUB1,O43683,Kinase,BUB,Protein Ser/thr,Biochemical,Binding,0,0,,,
O75716_STK16_wild_cl1,STK16_2bujB_STU,O75716,O75716wild,STK16,wild,cl1,2bujB,STU,,2buj,3,1,,Kinase,HoYoungLee,1,Crystal Structure of the Human Serine-Threonine Kinase 16 in Complex with Staurosporine,Inhibitor,,1,DiscoverX,STK16,O75716,Kinase,Other Protein Kinase,Protein Ser/Thr,Biochemical,Binding,0,0,,,
P14416_DRD2_wild_cl1,DRD2_7dfpA_SIP,P14416,P14416wild,DRD2,wild,cl1,7dfpA,SIP,,7dfp,3,1,,GPCR,,1,Structure of the dopamine D 2 receptor in complex with the antipsychotic drug spiperone.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P15153_RAC2_wild_cl1,RAC2_2w2vD_GTP,P15153,P15153wild,RAC2,wild,cl1,2w2vD,GTP,,2w2v,3,1,,GTPase,,1,Structural Insights Into Formation of an Active Signaling Complex between Rac and Phospholipase C Gamma 2.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P15153_RAC2_wild_cl1,RAC2_2w2xB_GSP,P15153,P15153wild,RAC2,wild,cl1,2w2xB,GSP,,2w2x,3,1,,GTPase,,1,Structural Insights Into Formation of an Active Signaling Complex between Rac and Phospholipase C Gamma 2.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P18089_ADRA2B_wild_cl1,ADRA2B_6k41R_CZX,P18089,P18089wild,ADRA2B,wild,cl1,6k41R,CZX,,6k41,3,1,,GPCR,,1,Activation of the alpha2Badrenoceptor by the sedative sympatholytic dexmedetomidine.,Binding,Protein binding,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P21675_TAF1_wild_cl1,TAF1_6p39A_NQY,P21675,P21675wild,TAF1,wild,cl1,6p39A,NQY,,6p39,2,1,,0,JiYoonShin,1,Crystal Structure Analysis of TAF1 Bromodomain,Inhibitor,IC50 0.063 uM,1,DiscoverX,TAF1,0,0,0,0,Binding,Biochemical,Binding,0,,,
P21675_TAF1_wild_cl1,TAF1_5mg2A_7M8,P21675,P21675wild,TAF1,wild,cl1,5mg2A,7M8,,5mg2,2,1,,0,JiYoonShin,1,Benzoisoquinolinediones as Potent and Selective inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.,Inhibitor,,1,DiscoverX,TAF1,0,0,0,0,Binding,Biochemical,Binding,0,,,
P21860_ERBB3_wild_cl1,ERBB3_3kexB_ANP,P21860,P21860wild,ERBB3,wild,cl1,3kexB,ANP,,3kex,2,1,,Kinase,HoYoungLee,1,Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.,Inhibitor,,1,DiscoverX,ERBB3,P21860,Kinase,RTK,Protein Tyrosine,Biochemical,Binding,0,0,,,
P21860_ERBB3_wild_cl1,ERBB3_4otwA_DB8,P21860,P21860wild,ERBB3,wild,cl1,4otwA,DB8,,4otw,2,1,6OP9,Kinase,HoYoungLee,1,Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.,Inhibitor,,1,DiscoverX,ERBB3,P21860,Kinase,RTK,Protein Tyrosine,Biochemical,Binding,0,0,,,
P21917_DRD4_wild_cl1,DRD4_5wivA_AQD,P21917,P21917wild,DRD4,wild,cl1,5wivA,AQD,,5wiv,2,1,,GPCR,,1,D4 dopamine receptor high-resolution structures enable the discovery of selective Agonists.,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
P23443_KS6B1_wild_cl1,KS6B1_3wf5A_FZ8,P23443,P23443wild,KS6B1,wild,cl1,3wf5A,FZ8,,3wf5,1,1,,Kinase,HoYoungLee,1,Crystal structures of the S6K1 kinase domain in complexes with inhibitors,Inhibitor,,1,DiscoverX,p70S6K,P23443,Kinase,AGC,Protein Ser/thr,Biochemical,Binding,0,0,,,
P23443_KS6B1_wild_cl1,KS6B1_4rloA_3T3,P23443,P23443wild,KS6B1,wild,cl1,4rloA,3T3,,4rlo,1,1,,Kinase,HoYoungLee,1,Development of Organometallic S6K1 inhibitors.,Inhibitor,,1,DiscoverX,p70S6K,P23443,Kinase,AGC,Protein Ser/thr,Biochemical,Binding,0,0,,,
P23945_FSHR_wild_cl1,FSHR_4mqwZ_JEF,P23945,P23945wild,FSHR,wild,cl1,4mqwZ,JEF,,4mqw,3,1,,GPCR,,1,Evidence for Follicle-stimulating Hormone Receptor as a Functional Trimer.,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
P25025_CXCR2_wild_cl1,CXCR2_6lflA_EBX,P25025,P25025wild,CXCR2,wild,cl1,6lflA,EBX,,6lfl,3,1,,GPCR,,1,Structural basis of CXC chemokine receptor 2 activation and signalling.,Activator,allosteric,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P25103_NK1R_wild_cl1,NK1R_6hloA_GBQ,P25103,P25103wild,NK1R,wild,cl1,6hloA,GBQ,,6hlo,2,1,,GPCR,,1,Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P25440_BRD2_wild_cl1,BRD2_2ydwC_WSH,P25440,P25440wild,BRD2,wild,cl1,2ydwC,WSH,,2ydw,1,1,,0,JiYoonShin,1,Discovery and Characterization of Small Molecule inhibitors of the Bet Family Bromodomains.,Inhibitor,,1,DiscoverX,BRD2 (BD1 and/or BD2),0,0,0,0,Binding,Biochemical,Binding,0,,,
P25440_BRD2_wild_cl1,BRD2_5ek9B_5P4,P25440,P25440wild,BRD2,wild,cl1,5ek9B,5P4,,5ek9,1,1,,0,JiYoonShin,1,Exploiting a water network to achieve enthalpy-driven_ bromodomain-selective BET inhibitors.,Inhibitor,,1,DiscoverX,BRD2 (BD1 and/or BD2),0,0,0,0,Binding,Biochemical,Binding,0,,,
P29274_AA2AR_wild_cl1,AA2AR_4ug2B_NGI,P29274,P29274wild,AA2AR,wild,cl1,4ug2B,NGI,,4ug2,2,8,,GPCR,,1,Molecular Determinants of Cgs21680 Binding to the Human Adenosine A2A Receptor.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P29274_AA2AR_wild_cl1,AA2AR_5g53B_NEC,P29274,P29274wild,AA2AR,wild,cl1,5g53B,NEC,,5g53,2,8,,GPCR,,1,Structure of the Adenosine A2A Receptor Bound to an Engineered G Protein,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P30518_AVPR2_wild_cl1,AVPR2_6u1nR_2CU,P30518,P30518wild,AVPR2,wild,cl1,6u1nR,2CU,,6u1n,3,1,,GPCR,,1,Structure of the M2 muscarinic receptor-beta-arrestin complex in a lipid nanodisc.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P30542_ADORA1_wild_cl2,ADORA1_7ld3R_XTD,P30542,P30542wild,ADORA1,wild,cl2,7ld3R,XTD,,7ld3,3,2,,GPCR,,1,Positive Allosteric mechanisms of adenosine A 1 receptor-mediated analgesia.,Activator,allosteric,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P30542_ADORA1_wild_cl1,ADORA1_5n2sA_8K8,P30542,P30542wild,ADORA1,wild,cl1,5n2sA,8K8,,5n2s,3,2,,GPCR,,1,Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P30542_ADORA1_wild_cl1,ADORA1_6d9hR_ADN,P30542,P30542wild,ADORA1,wild,cl1,6d9hR,ADN,,6d9h,3,2,,GPCR,,1,Structure of the adenosine-bound human adenosine A1receptor-Gicomplex.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P30556_AGTR1_wild_cl1,AGTR1_4yayA_ZD7,P30556,P30556wild,AGTR1,wild,cl1,4yayA,ZD7,,4yay,3,1,,GPCR,,1,Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P35222_CTNB1_wild_cl1,CTNB1_7afwA_R9Q,P35222,P35222wild,CTNB1,wild,cl1,7afwA,R9Q,,7afw,2,1,,0,JiYoonShin,1,Getting a Grip on the Undrugged: Targeting beta-Catenin with Fragment-Based Methods.,Inhibitor,PPI,1,DiscoverX,beta batenin WNT-Frz pathway,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
P41597_CCR2_wild_cl1,CCR2_5t1aA_VT5,P41597,P41597wild,CCR2,wild,cl1,5t1aA,VT5,,5t1a,3,1,,GPCR,,1,Structure of CC chemokine receptor 2 with orthosteric and Allosteric antagonists.,Inhibitor,allosteric,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P42336_PK3CA_wild_cl1,PK3CA_4tv3A_ML9,P42336,P42336wild,PK3CA,wild,cl1,4tv3A,ML9,,4tv3,1,2,,Kinase,HoYoungLee,1,Engineering of an isolated p110 alpha subunit of PI3K alpha permits crystallization and provides a platform for structure-based drug design.,Inhibitor,,1,DiscoverX,PI3Kalpha,P42336,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Binding,0,0,,,
P42336_PK3CA_wild_cl1,PK3CA_5dxhD_5H2,P42336,P42336wild,PK3CA,wild,cl1,5dxhD,5H2,,5dxh,1,2,,Kinase,HoYoungLee,1,The Rational Design of Selective Benzoxazepin inhibitors of the alpha-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1_2_4-triazol-5-yl)-5_6-dihydrobenzo[f]imidazo[1_2-d][1_4]oxazepin-9-yl)oxy)propanamide (GDC-0326).,Inhibitor,,1,DiscoverX,PI3Kalpha,P42336,Kinase,PtdIns(4_5)P 3-Kinase,Lipid,Biochemical,Binding,0,0,,,
P47900_P2RY1_wild_cl2,P2RY1_4xnvA_BUR,P47900,P47900wild,P2RY1,wild,cl2,4xnvA,BUR,,4xnv,3,3,,GPCR,,1,Two disparate ligand-binding sites in the human P2Y1 receptor,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P47900_P2RY1_wild_cl3,P2RY1_4xnvA_Y01,P47900,P47900wild,P2RY1,wild,cl3,4xnvA,Y01,,4xnv,3,3,,GPCR,,1,Two disparate ligand-binding sites in the human P2Y1 receptor,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P47900_P2RY1_wild_cl1,P2RY1_4xnwA_2ID,P47900,P47900wild,P2RY1,wild,cl1,4xnwA,2ID,,4xnw,3,3,,GPCR,,1,Two disparate ligand-binding sites in the human P2Y1 receptor,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P48039_MTR1A_wild_cl1,MTR1A_6me3A_JEY,P48039,P48039wild,MTR1A,wild,cl1,6me3A,JEY,,6me3,2,2,,GPCR,,1,Structural basis of ligand recognition at the human MT1melatonin receptor.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P49146_NPY2R_wild_cl1,NPY2R_7ddzA_H46,P49146,P49146wild,NPY2R,wild,cl1,7ddzA,H46,,7ddz,3,1,,GPCR,,1,Structural basis for ligand recognition of the neuropeptide Y Y 2 receptor.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P49286_MTNR1B_wild_cl1,MTNR1B_6me6A_JEY,P49286,P49286wild,MTNR1B,wild,cl1,6me6A,JEY,,6me6,2,1,,GPCR,,1,XFEL structures of the human MT2melatonin receptor reveal the basis of subtype selectivity.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P49286_MTNR1B_wild_cl1,MTNR1B_6me9A_JEV,P49286,P49286wild,MTNR1B,wild,cl1,6me9A,JEV,,6me9,2,1,,GPCR,,1,XFEL structures of the human MT2melatonin receptor reveal the basis of subtype selectivity.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P49336_CDK8_wild_cl1,CDK8_5fgkA_5XG,P49336,P49336wild,CDK8,wild,cl1,5fgkA,5XG,,5fgk,1,1,,Kinase,HoYoungLee,1,Discovery of Potent_ Selective_ and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19.,Inhibitor,,1,DiscoverX,CDK8,P49336,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
P49336_CDK8_wild_cl1,CDK8_5hbeA_5Y6,P49336,P49336wild,CDK8,wild,cl1,5hbeA,5Y6,,5hbe,1,1,,Kinase,HoYoungLee,1,Discovery of Potent_ Selective_ and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19.,Inhibitor,,1,DiscoverX,CDK8,P49336,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
P51681_CCR5_163_cl1,CCR5_4mbsB_MRV,P51681,P51681163,CCR5,163,cl1,4mbsB,MRV,,4mbs,2,1,,GPCR,,1,Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P51681_CCR5_163_cl1,CCR5_6akxB_A4R,P51681,P51681163,CCR5,163,cl1,6akxB,A4R,,6akx,2,1,,GPCR,,1,Structure-Based Design of 1-Heteroaryl-1_3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 antagonists.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P53671_LIMK2_wild_cl1,LIMK2_4tptB_35H,P53671,P53671wild,LIMK2,wild,cl1,4tptB,35H,,4tpt,2,1,,Kinase,HoYoungLee,1,Discovery of a Type III inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.,Inhibitor,,1,DiscoverX,LIMK2,P53671,Kinase,TKL,Protein Ser/thr,Biochemical,Binding,0,0,,,
P53671_LIMK2_wild_cl1,LIMK2_5nxdB_9D8,P53671,P53671wild,LIMK2,wild,cl1,5nxdB,9D8,,5nxd,2,1,,Kinase,HoYoungLee,1,LIM Domain Kinase 2 (LIMK2)In Complex With TH-300,Inhibitor,,1,DiscoverX,LIMK2,P53671,Kinase,TKL,Protein Ser/thr,Biochemical,Binding,0,0,,,
P55085_PAR2_wild_cl1,PAR2_5nddA_8TZ,P55085,P55085wild,PAR2,wild,cl1,5nddA,8TZ,,5ndd,2,2,,GPCR,,1,Structural insight into Allosteric modulation of protease-activated receptor 2.,Inhibitor,allosteric,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P55085_PAR2_wild_cl2,PAR2_5ndzA_8UN,P55085,P55085wild,PAR2,wild,cl2,5ndzA,8UN,,5ndz,2,2,,GPCR,,1,Structural insight into Allosteric modulation of protease-activated receptor 2.,Inhibitor,allosteric,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P61073_CXCR4_wild_cl1,CXCR4_3oe8B_ITD,P61073,P61073wild,CXCR4,wild,cl1,3oe8B,ITD,,3oe8,2,1,,GPCR,,1,Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P61073_CXCR4_wild_cl1,CXCR4_3oe8C_ITD,P61073,P61073wild,CXCR4,wild,cl1,3oe8C,ITD,,3oe8,2,1,,GPCR,,1,Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
P78356_PI42B_wild_cl1,PI42B_3x02B_5GP,P78356,P78356wild,PI42B,wild,cl1,3x02B,5GP,,3x02,2,1,,0,JiYoonShin,1,The Lipid Kinase PI5P4K beta Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,inhibitor,0,,,
P78356_PI42B_wild_cl1,PI42B_6k4gB_GNP,P78356,P78356wild,PI42B,wild,cl1,6k4gB,GNP,,6k4g,2,1,,0,JiYoonShin,1,The GTP responsiveness of PI5P4K beta evolved from a compromised trade-off between activity and specificity.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,inhibitor,0,,,
Q08722_CD47_wild_cl1,CD47_5iwlC_PGE,Q08722,Q08722wild,CD47,wild,cl1,5iwlC,PGE,,5iwl,3,1,,0,JiYoonShin,1,CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.,Binding,Antibody binding,1,DiscoverX,SIRPA:CD47,P78324,Cell Surface,Immune Checkpoint,CD Molecules,Functional,Cell based,Activator_ inhibitor,0,,,
Q13164_MK07_wild_cl1,MK07_4zsgA_4QX,Q13164,Q13164wild,MK07,wild,cl1,4zsgA,4QX,,4zsg,2,1,,Kinase,HoYoungLee,1,Discovery of a novel Allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.,Inhibitor,allosteric,1,DiscoverX,ERK5,Q13164,Kinase,CMGC,Protein Ser/thr,Biochemical,Binding,0,0,,,
Q13164_MK07_wild_cl1,MK07_4zsjA_4R0,Q13164,Q13164wild,MK07,wild,cl1,4zsjA,4R0,,4zsj,2,1,,Kinase,HoYoungLee,1,Discovery of a novel Allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.,Inhibitor,allosteric,1,DiscoverX,ERK5,Q13164,Kinase,CMGC,Protein Ser/thr,Biochemical,Binding,0,0,,,
Q13255_GRM1_wild_cl1,GRM1_3ks9B_Z99,Q13255,Q13255wild,GRM1,wild,cl1,3ks9B,Z99,,3ks9,2,1,,GPCR,,1,Metabotropic glutamate receptor mglur1 complexed with LY341495 antagonist,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q13705_ACVR2B_wild_cl1,ACVR2B_2qluA_ADE,Q13705,Q13705wild,ACVR2B,wild,cl1,2qluA,ADE,,2qlu,3,1,,Kinase,HoYoungLee,1,Crystal structure of activin receptor type IIB kinase domain from human at 2.0 Angstrom resolution,Inhibitor,,1,DiscoverX,ACVR2B,Q13705,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q14004_CDK13_wild_cl1,CDK13_5efqC_ADP,Q14004,Q14004wild,CDK13,wild,cl1,5efqC,ADP,,5efq,2,1,,Kinase,HoYoungLee,1,Structural and Functional Analysis of the Cdk13/Cyclin K Complex.,Inhibitor,,1,DiscoverX,CDK13,Q14004,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q14832_GRM3_wild_cl1,GRM3_4xarA_40F,Q14832,Q14832wild,GRM3,wild,cl1,4xarA,40F,,4xar,2,1,,GPCR,,1,Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1S_2S_5R_6S-2-Aminobicyclo[3.1.0]hexane-2_6-dicarboxylate: Identification of a Potent_ Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures.,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q16602_CALRL_wild_cl1,CALRL_3n7rB_N7R,Q16602,Q16602wild,CALRL,wild,cl1,3n7rB,N7R,,3n7r,2,1,,GPCR,,1,Crystal Structure of the Ectodomain Complex of the CGRP Receptor_ a Class-B GPCR_ Reveals the Site of Drug antagonism.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q6DWJ6_GPR139_wild_cl1,GPR139_7vuiR_7ZQ,Q6DWJ6,Q6DWJ6wild,GPR139,wild,cl1,7vuiR,7ZQ,,7vui,2,1,,GPCR,,1,Molecular insights into ligand recognition and G protein coupling of the neuromodulatory orphan receptor GPR139.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q86U86_PB1_wild_cl1,PB1_5fh7B_5XL,Q86U86,Q86U86wild,PB1,wild,cl1,5fh7B,5XL,,5fh7,2,1,,0,JiYoonShin,1,Identification and Development of 2_3-Dihydropyrrolo[1_2-a]quinazolin-5(1H)-one inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.,Inhibitor,,1,DiscoverX,PB1 (2 of 5),0,0,0,0,Binding,Biochemical,Binding,0,,,
Q86U86_PB1_wild_cl1,PB1_5ii1B_6BL,Q86U86,Q86U86wild,PB1,wild,cl1,5ii1B,6BL,,5ii1,2,1,,0,JiYoonShin,1,Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.,Inhibitor,,1,DiscoverX,PB1 (2 of 5),0,0,0,0,Binding,Biochemical,Binding,0,,,
Q86YV6_MYLK4_wild_cl1,MYLK4_2x4fB_16X,Q86YV6,Q86YV6wild,MYLK4,wild,cl1,2x4fB,16X,,2x4f,2,1,,Kinase,HoYoungLee,1,The Crystal Structure of the Human Myosin Light Chain Kinase Loc340156,Inhibitor,,1,DiscoverX,MYLK4,Q86YV6,Kinase,CAMK,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q8NB16_MLKL_wild_cl1,MLKL_5knjB_6UX,Q8NB16,Q8NB16wild,MLKL,wild,cl1,5knjB,6UX,,5knj,3,1,,Kinase,HoYoungLee,1,ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.,Inhibitor,,1,DiscoverX,MLKL,Q8NB16,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q8NB16_MLKL_wild_cl1,MLKL_5ko1A_6UY,Q8NB16,Q8NB16wild,MLKL,wild,cl1,5ko1A,6UY,,5ko1,3,1,,Kinase,HoYoungLee,1,ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.,Inhibitor,,1,DiscoverX,MLKL,Q8NB16,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q8NEB9_PK3C3_wild_cl1,PK3C3_3ls8B_AJZ,Q8NEB9,Q8NEB9wild,PK3C3,wild,cl1,3ls8B,AJZ,,3ls8,1,2,,Kinase,HoYoungLee,1,Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3_2-d]pyrimidin-2-yl]-phenol,Inhibitor,,1,DiscoverX,PIK3C3,Q8NEB9,Kinase,PtdIns 3-Kinase,Lipid,Biochemical,Binding,0,0,,,
Q8NEB9_PK3C3_wild_cl1,PK3C3_4oysA_1TT,Q8NEB9,Q8NEB9wild,PK3C3,wild,cl1,4oysA,1TT,,4oys,1,2,,Kinase,HoYoungLee,1,A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.,Inhibitor,,1,DiscoverX,PIK3C3,Q8NEB9,Kinase,PtdIns 3-Kinase,Lipid,Biochemical,Binding,0,0,,,
Q8NI60_ADCK3_wild_cl1,ADCK3_5i35A_ANP,Q8NI60,Q8NI60wild,ADCK3,wild,cl1,5i35A,ANP,,5i35,2,1,,Kinase,HoYoungLee,1,Cerebellar Ataxia and Coenzyme Q Deficiency through Loss of Unorthodox Kinase Activity.,Inhibitor,,1,DiscoverX,COQ8A,Q8NI60,Kinase,ABC1,Atypical,Biochemical,Binding,0,0,,,
Q8TDQ0_HAVCR2_wild_cl1,HAVCR2_7m3yB_YQ7,Q8TDQ0,Q8TDQ0wild,HAVCR2,wild,cl1,7m3yB,YQ7,,7m3y,3,1,,0,JiYoonShin,1,Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3).,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q92772_CDKL2_wild_cl1,CDKL2_4aaaA_DKI,Q92772,Q92772wild,CDKL2,wild,cl1,4aaaA,DKI,,4aaa,2,1,,Kinase,HoYoungLee,1,CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.,Inhibitor,,1,DiscoverX,CDKL2,Q92772,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q92772_CDKL2_wild_cl1,CDKL2_4bbmB_TC0,Q92772,Q92772wild,CDKL2,wild,cl1,4bbmB,TC0,,4bbm,2,1,,Kinase,HoYoungLee,1,CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.,Inhibitor,,1,DiscoverX,CDKL2,Q92772,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q92843_B2CL2_wild_cl1,B2CL2_2y6wB_PGE,Q92843,Q92843wild,B2CL2,wild,cl1,2y6wB,PGE,,2y6w,3,1,,0,JiYoonShin,1,Crystal Structure of a Bcl-W Domain-Swapped Dimer: Implications for the Function of Bcl-2 Family Proteins.,apo,Dimer,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q96LA9_MRGPRX4_wild_cl1,MRGPRX4_7s8pR_8IX,Q96LA9,Q96LA9wild,MRGPRX4,wild,cl1,7s8pR,8IX,,7s8p,3,1,,GPCR,,1,Structure_ function and pharmacology of human itch GPCRs.,Activator,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q96LB1_MRGPRX2_wild_cl1,MRGPRX2_7s8nR_8IU,Q96LB1,Q96LB1wild,MRGPRX2,wild,cl1,7s8nR,8IU,,7s8n,3,1,,GPCR,,1,Structure_ function and pharmacology of human itch GPCRs.,Activator,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q96LB1_MRGPRX2_wild_cl1,MRGPRX2_7vv6R_6IB,Q96LB1,Q96LB1wild,MRGPRX2,wild,cl1,7vv6R,6IB,,7vv6,3,1,,GPCR,,1,Structure_ function and pharmacology of human itch receptor complexes.,Activator,,1,DiscoverX,0,0,0,0,0,0,Cell based,Activator_ inhibitor,0,,,
Q99500_S1PR3_wild_cl1,S1PR3_7c4sB_S1P,Q99500,Q99500wild,S1PR3,wild,cl1,7c4sB,S1P,,7c4s,2,1,,GPCR,,1,Endogenous Agonist-bound S1PR3 structure reveals determinants of G protein-subtype bias.,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q99500_S1PR3_wild_cl1,S1PR3_7ew2R_J89,Q99500,Q99500wild,S1PR3,wild,cl1,7ew2R,J89,,7ew2,2,1,,GPCR,,1,Structural insights into sphingosine-1-phosphate recognition and ligand selectivity of S1PR3-Gi signaling complexes.,inhibitor,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q99558_M3K14_wild_cl1,M3K14_4idtB_T28,Q99558,Q99558wild,M3K14,wild,cl1,4idtB,T28,,4idt,2,1,,Kinase,HoYoungLee,1,inhibiting NF-KB-inducing kinase (NIK): Discovery_ structure-based design_ synthesis_ structure activity relationship_ and co-crystal structures,Inhibitor,,1,DiscoverX,MAP3K14,Q99558,Kinase,STE,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q99558_M3K14_wild_cl1,M3K14_6wppB_PZ4,Q99558,Q99558wild,M3K14,wild,cl1,6wppB,PZ4,,6wpp,2,1,,Kinase,HoYoungLee,1,Impact of Protein Preparation on Resulting Accuracy of FEP Calculations.,Inhibitor,,1,DiscoverX,MAP3K14,Q99558,Kinase,STE,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q99640_PMYT1_wild_cl1,PMYT1_5vcvA_1N1,Q99640,Q99640wild,PMYT1,wild,cl1,5vcvA,1N1,,5vcv,1,1,,Kinase,HoYoungLee,1,Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule inhibitors.,Inhibitor,,1,DiscoverX,PKMYT1,Q99640,Kinase,Other Protein Kinase,Protein Tyrosine,Biochemical,Binding,0,0,,,
Q99640_PMYT1_wild_cl1,PMYT1_5vd3A_H8H,Q99640,Q99640wild,PMYT1,wild,cl1,5vd3A,H8H,,5vd3,1,1,,Kinase,HoYoungLee,1,Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule inhibitors.,Inhibitor,,1,DiscoverX,PKMYT1,Q99640,Kinase,Other Protein Kinase,Protein Tyrosine,Biochemical,Binding,0,0,,,
Q99835_SMO_wild_cl1,SMO_4n4wA_SNT,Q99835,Q99835wild,SMO,wild,cl1,4n4wA,SNT,,4n4w,3,1,,GPCR,,1,Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Agonist,0,,,
Q99835_SMO_wild_cl1,SMO_5v56B_836,Q99835,Q99835wild,SMO,wild,cl1,5v56B,836,,5v56,3,1,,GPCR,,1,Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,Cell based,Agonist,0,,,
Q9BRS2_RIOK1_wild_cl1,RIOK1_6zxhz_ATP,Q9BRS2,Q9BRS2wild,RIOK1,wild,cl1,6zxhz,ATP,,6zxh,2,1,,Kinase,HoYoungLee,1,Structural basis for the final steps of human 40S ribosome maturation.,Inhibitor,Orthosteric,1,DiscoverX,RIOK1,Q9BRS2,Kinase,RIO,Atypical,Biochemical,Binding,0,0,,,
Q9BRS2_RIOK1_wild_cl1,RIOK1_4otpA_ADP,Q9BRS2,Q9BRS2wild,RIOK1,wild,cl1,4otpA,ADP,,4otp,2,1,,Kinase,HoYoungLee,1,Dominant Rio1 kinase/ATPase catalytic mutant induces trapping of late pre-40S biogenesis factors in 80S-like ribosomes.,Inhibitor,,1,DiscoverX,RIOK1,Q9BRS2,Kinase,RIO,Atypical,Biochemical,Binding,0,0,,,
Q9H244_P2Y12_wild_cl1,P2Y12_4pxzA_6AD,Q9H244,Q9H244wild,P2Y12,wild,cl1,4pxzA,6AD,,4pxz,2,1,,GPCR,,1,Agonist-bound structure of the human P2Y12 receptor,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q9H244_P2Y12_wild_cl1,P2Y12_4py0A_6AT,Q9H244,Q9H244wild,P2Y12,wild,cl1,4py0A,6AT,,4py0,2,1,,GPCR,,1,Agonist-bound structure of the human P2Y12 receptor,Activator,,1,DiscoverX,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q9NPI1_BRD7_wild_cl1,BRD7_6v0qD_EAE,Q9NPI1,Q9NPI1wild,BRD7,wild,cl1,6v0qD,EAE,,6v0q,2,1,,0,JiYoonShin,1,Structural Basis of inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NPI1_BRD7_wild_cl1,BRD7_6v17B_H1B,Q9NPI1,Q9NPI1wild,BRD7,wild,cl1,6v17B,H1B,,6v17,2,1,,0,JiYoonShin,1,Structural Basis of inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.,Inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,inhibitor,0,,,
Q9NYL2_MLTK_wild_cl1,MLTK_5hesA_032,Q9NYL2,Q9NYL2wild,MLTK,wild,cl1,5hesA,32,,5hes,2,1,,Kinase,HoYoungLee,1,Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.,Inhibitor,,1,DiscoverX,ZAK,Q9NYL2,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9NYL2_MLTK_wild_cl1,MLTK_5x5oA_7Z0,Q9NYL2,Q9NYL2wild,MLTK,wild,cl1,5x5oA,7Z0,,5x5o,2,1,,Kinase,HoYoungLee,1,Structure Based Design of N-(3-((1H-Pyrazolo[3_4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-alpha Motif Kinase (ZAK) inhibitors.,Inhibitor,,1,DiscoverX,ZAK,Q9NYL2,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9NYV4_CDK12_wild_cl1,CDK12_5acbD_5I1,Q9NYV4,Q9NYV4wild,CDK12,wild,cl1,5acbD,5I1,,5acb,1,1,,Kinase,HoYoungLee,1,Covalent Targeting of Remote Cysteine Residues to Develop Cdk12 and Cdk13 inhibitors.,Inhibitor,,1,DiscoverX,CDK12,Q9NYV4,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9NYV4_CDK12_wild_cl1,CDK12_6ckxA_8M1,Q9NYV4,Q9NYV4wild,CDK12,wild,cl1,6ckxA,8M1,,6ckx,1,1,,Kinase,HoYoungLee,1,Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) inhibitors.,Inhibitor,,1,DiscoverX,CDK12,Q9NYV4,Kinase,CMGC,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9UBF8_PI4KB_wild_cl1,PI4KB_5fbqA_5W6,Q9UBF8,Q9UBF8wild,PI4KB,wild,cl1,5fbqA,5W6,,5fbq,1,2,,Kinase,HoYoungLee,1,PI4KB in complex with Rab11 and the MI358 inhibitor,Inhibitor,,1,DiscoverX,PI4KB,Q9UBF8,Kinase,1-PtdIns 4-Kinase,Lipid,Biochemical,Binding,0,0,,,
Q9UBF8_PI4KB_wild_cl1,PI4KB_5fbvA_5W3,Q9UBF8,Q9UBF8wild,PI4KB,wild,cl1,5fbvA,5W3,,5fbv,1,2,,Kinase,HoYoungLee,1,PI4KB in complex with Rab11 and the MI364 inhibitor,Inhibitor,,1,DiscoverX,PI4KB,Q9UBF8,Kinase,1-PtdIns 4-Kinase,Lipid,Biochemical,Binding,0,0,,,
Q9UIF9_BAZ2A_wild_cl2,BAZ2A_6fapC_D3H,Q9UIF9,Q9UIF9wild,BAZ2A,wild,cl2,6fapC,D3H,,6fap,1,2,,0,JiYoonShin,1,Targeting Ligandable Pockets on Plant Homeodomain (PHD) Zinc Finger Domains by a Fragment-Based Approach.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q9UIF9_BAZ2A_wild_cl1,BAZ2A_6fgfA_EN2,Q9UIF9,Q9UIF9wild,BAZ2A,wild,cl1,6fgfA,EN2,,6fgf,1,2,,0,JiYoonShin,1,Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q9UIF9_BAZ2A_wild_cl1,BAZ2A_6fgvA_D9T,Q9UIF9,Q9UIF9wild,BAZ2A,wild,cl1,6fgvA,D9T,,6fgv,1,2,,0,JiYoonShin,1,Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q9UIF9_BAZ2A_wild_cl2,BAZ2A_6fi0C_DEW,Q9UIF9,Q9UIF9wild,BAZ2A,wild,cl2,6fi0C,DEW,,6fi0,1,2,,0,JiYoonShin,1,Targeting Ligandable Pockets on Plant Homeodomain (PHD) Zinc Finger Domains by a Fragment-Based Approach.,inhibitor,,1,DiscoverX,0,0,0,0,0,0,0,0,0,,,
Q9UM73_ALK_1196_cl1,ALK_4cd0A_AWJ,Q9UM73,Q9UM731196,ALK,1196,cl1,4cd0A,AWJ,,4cd0,1,2,,Kinase,HoYoungLee,1,The Design of Potent and Selective inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib.,Inhibitor,,1,DiscoverX,ALK,Q9UM73,Kinase,RTK,Protein Tyrosine,Biochemical,Binding,0,0,,,
Q9UM73_ALK_1196_cl1,ALK_4cljA_5P8,Q9UM73,Q9UM731196,ALK,1196,cl1,4cljA,5P8,,4clj,1,2,,Kinase,HoYoungLee,1,Discovery of (10R)-7-Amino-12-Fluoro-2_10_16-Trimethyl-15-Oxo-10_15_16_17-Tetrahydro-2H-8_4-(Metheno)Pyrazolo[4_3-H][2_5_11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf-06463922)_ a Macrocyclic inhibitor of Alk/Ros1 with Pre-Clinical Brain Exposure and Broad Spectrum Potency Against Alk-Resistant Mutations.,Inhibitor,,1,DiscoverX,ALK,Q9UM73,Kinase,RTK,Protein Tyrosine,Biochemical,Binding,0,0,,,
Q9Y2T5_GPR52_wild_cl1,GPR52_6li0A_EN6,Q9Y2T5,Q9Y2T5wild,GPR52,wild,cl1,6li0A,EN6,,6li0,2,1,,GPCR,,1,Structural basis of ligand recognition and self-activation of orphan GPR52.,Activator,,1,DiscoverX,0,0,0,0,0,0,Cell based,Agonist,0,,,
Q9Y572_RIPK3_wild_cl1,RIPK3_7monB_ZL1,Q9Y572,Q9Y572wild,RIPK3,wild,cl1,7monB,ZL1,,7mon,2,1,,Kinase,HoYoungLee,1,Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.,Inhibitor,,1,DiscoverX,RIPK3,Q9Y572,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9Y572_RIPK3_wild_cl1,RIPK3_7mx3D_ZOV,Q9Y572,Q9Y572wild,RIPK3,wild,cl1,7mx3D,ZOV,,7mx3,2,1,,Kinase,HoYoungLee,1,Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.,Inhibitor,,1,DiscoverX,RIPK3,Q9Y572,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
Q9Y616_IRAK3_wild_cl1,IRAK3_6ziwI_AGS,Q9Y616,Q9Y616wild,IRAK3,wild,cl1,6ziwI,AGS,,6ziw,2,1,,Kinase,HoYoungLee,1,The IRAK3 Pseudokinase Domain Bound To ATPgammaS,Inhibitor,,1,DiscoverX,IRAK3,Q9Y616,Kinase,TKL,Protein Ser/Thr,Biochemical,Binding,0,0,,,
O00408_PDE2A_wild_cl1,PDE2A_5vp0C_9GJ,O00408,O00408wild,PDE2A,wild,cl1,5vp0C,9GJ,,5vp0,1,1,,esterase,,1,Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2_3-dihydropyrido[2_3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent_ Selective_ and Brain-Penetrating Phosphodiesterase 2A inhibitor for the Treatment of Cognitive Disorders.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O00408_PDE2A_wild_cl1,PDE2A_6c7fC_EOS,O00408,O00408wild,PDE2A,wild,cl1,6c7fC,EOS,,6c7f,1,1,,esterase,,1,Mathematical and Structural Characterization of Strong Nonadditive Structure-Activity Relationship Caused by Protein Conformational Changes.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O60658_PDE8A_wild_cl1,PDE8A_3ecnA_IBM,O60658,O60658wild,PDE8A,wild,cl1,3ecnA,IBM,,3ecn,3,1,,esterase,,1,Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O76074_PDE5A_wild_cl1,PDE5A_1xp0A_VDN,O76074,O76074wild,PDE5A,wild,cl1,1xp0A,VDN,,1xp0,1,1,,esterase,,1,Structural Basis for the Activity of Drugs that inhibit Phosphodiesterases.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O76074_PDE5A_wild_cl1,PDE5A_5zz2A_9M0,O76074,O76074wild,PDE5A,wild,cl1,5zz2A,9M0,,5zz2,1,1,,esterase,,1,Optimization of Chromeno[2_3- c]pyrrol-9(2 H)-ones as Highly Potent_ Selective_ and Orally Bioavailable PDE5 inhibitors: Structure-Activity Relationship_ X-ray Crystal Structure_ and Pharmacodynamic Effect on Pulmonary Arterial Hypertension.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O76083_PDE9A_wild_cl1,PDE9A_3jswB_JAR,O76083,O76083wild,PDE9A,wild,cl1,3jswB,JAR,,3jsw,2,1,,esterase,,1,Identification of a Brain Penetrant PDE9A inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
O76083_PDE9A_wild_cl1,PDE9A_4e90B_7RG,O76083,O76083wild,PDE9A,wild,cl1,4e90B,7RG,,4.00E+90,2,1,,esterase,,1,Application of structure-based drug design and parallel chemistry to identify selective_ brain penetrant_ in vivo active phosphodiesterase 9A inhibitors.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P00915_CAH1_wild_cl1,CAH1_1azmA_AZM,P00915,P00915wild,CAH1,wild,cl1,1azmA,AZM,,1azm,1,1,,anhydrase,SooYongLee,1,Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P00915_CAH1_wild_cl1,CAH1_2nn7B_M29,P00915,P00915wild,CAH1,wild,cl1,2nn7B,M29,,2nn7,1,1,,anhydrase,SooYongLee,1,Structural Analysis of Charge Discrimination in the Binding of inhibitors to Human Carbonic Anhydrases I and II.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P00918_CAH2_wild_cl1,CAH2_1bntA_AL2,P00918,P00918wild,CAH2,wild,cl1,1bntA,AL2,,1bnt,1,1,,anhydrase,SooYongLee,1,Structural analysis of inhibitor binding to human carbonic anhydrase II.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P00918_CAH2_wild_cl1,CAH2_5llhA_V49,P00918,P00918wild,CAH2,wild,cl1,5llhA,V49,,5llh,1,1,,anhydrase,SooYongLee,1,Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P07550_ADRB2_96p98p187_cl1,ADRB2_6e67B_P0G,P07550,P0755096p98p187,ADRB2,96p98p187,cl1,6e67B,P0G,,6.00E+67,1,2,,GPCR,,1,Structural Insights into the Process of GPCR-G Protein Complex Formation.,Inhibitor,EC50 0.1nM,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P07550_ADRB2_wild_cl1,ADRB2_6ps0A_CAU,P07550,P07550wild,ADRB2,wild,cl1,6ps0A,CAU,,6ps0,1,2,,GPCR,,1,Toward G protein-coupled receptor structure-based drug design using X-ray lasers.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P07550_ADRB2_wild_cl1,ADRB2_6ps5A_SNP,P07550,P07550wild,ADRB2,wild,cl1,6ps5A,SNP,,6ps5,1,2,,GPCR,,1,Toward G protein-coupled receptor structure-based drug design using X-ray lasers.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P08134_RHOC_wild_cl1,RHOC_2gcoB_GNP,P08134,P08134wild,RHOC,wild,cl1,2gcoB,GNP,,2gco,3,1,,GTPase,,1,X-ray Crystal Structures Reveal Two Activated States for RhoC.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P08134_RHOC_wild_cl1,RHOC_2gcpA_GSP,P08134,P08134wild,RHOC,wild,cl1,2gcpA,GSP,,2gcp,3,1,,GTPase,,1,X-ray Crystal Structures Reveal Two Activated States for RhoC.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P21453_S1PR1_wild_cl1,S1PR1_3v2yA_ML5,P21453,P21453wild,S1PR1,wild,cl1,3v2yA,ML5,,3v2y,2,1,,GPCR,,1,Crystal structure of a lipid G protein-coupled receptor.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P21554_CNR1_wild_cl1,CNR1_5xr8A_8D0,P21554,P21554wild,CNR1,wild,cl1,5xr8A,8D0,,5xr8,2,2,,GPCR,,1,Crystal structures of Agonist-bound human cannabinoid receptor CB1.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P21554_CNR1_wild_cl1,CNR1_5xraA_8D3,P21554,P21554wild,CNR1,wild,cl1,5xraA,8D3,,5xra,2,2,,GPCR,,1,Crystal structures of Agonist-bound human cannabinoid receptor CB1,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P21554_CNR1_273p283_cl1,CNR1_6kpgR_8D0,P21554,P21554273p283,CNR1,273p283,cl1,6kpgR,8D0,,6kpg,2,2,,GPCR,,1,Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-GiComplex Structures.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P25090_FPR2_wild_cl1,FPR2_7t6sR_FUI,P25090,P25090wild,FPR2,wild,cl1,7t6sR,FUI,,7t6s,3,1,,GPCR,,1,Molecular recognition of formylpeptides and diverse Agonists by the formylpeptide receptors FPR1 and FPR2.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,Activator_ inhibitor,0,,,
P27815_PDE4A_wild_cl1,PDE4A_3i8vA_0MO,P27815,P27815wild,PDE4A,wild,cl1,3i8vA,0MO,,3i8v,2,1,,esterase,,1,Crystal structure of human PDE4a with 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone,Inhibitor,IC50 4.3 uM,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P27815_PDE4A_wild_cl1,PDE4A_3tvxB_PNX,P27815,P27815wild,PDE4A,wild,cl1,3tvxB,PNX,,3tvx,2,1,,esterase,,1,Fragment-Based Screening for inhibitors of PDE4A Using Enthalpy Arrays and X-ray Crystallography.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P28222_5HT1B_wild_cl1,5HT1B_4iaqA_2GM,P28222,P28222wild,5HT1B,wild,cl1,4iaqA,2GM,,4iaq,2,2,,GPCR,,1,Structural basis for molecular recognition at serotonin receptors.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28222_5HT1B_138_cl1,5HT1B_5v54B_89F,P28222,P28222138,5HT1B,138,cl1,5v54B,89F,,5v54,2,2,,GPCR,,1,A common antagonistic mechanism for class A GPCRs revealed by the structure of the human 5-HT1B serotonin receptor bound to an antagonist,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28222_5HT1B_wild_cl1,5HT1B_6g79S_EP5,P28222,P28222wild,5HT1B,wild,cl1,6g79S,EP5,,6g79,2,2,,GPCR,,1,Cryo-EM structure of the serotonin 5-HT1Breceptor coupled to heterotrimeric Go.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28223_HTR2A_wild_cl1,HTR2A_6a93B_8NU,P28223,P28223wild,HTR2A,wild,cl1,6a93B,8NU,,6a93,2,1,,GPCR,,1,Structures of the 5-HT2Areceptor in complex with the antipsychotics risperidone and zotepine.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28223_HTR2A_wild_cl1,HTR2A_7voeA_9SC,P28223,P28223wild,HTR2A,wild,cl1,7voeA,9SC,,7voe,2,1,,GPCR,,1,Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28335_5HT2C_wild_cl1,5HT2C_6bqgA_ERM,P28335,P28335wild,5HT2C,wild,cl1,6bqgA,ERM,,6bqg,2,1,,GPCR,,1,5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P28335_5HT2C_wild_cl1,5HT2C_6bqhA_E2J,P28335,P28335wild,5HT2C,wild,cl1,6bqhA,E2J,,6bqh,2,1,,GPCR,,1,5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P29274_AA2AR_65p89_cl1,AA2AR_2ydoA_ADN,P29274,P2927465p89,AA2AR,65p89,cl1,2ydoA,ADN,,2ydo,2,8,,GPCR,,1,Agonist-Bound Adenosine A(2A) Receptor Structures Reveal Common Features of Gpcr Activation.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,Activator,0,,,
P29274_AA2AR_65p89_cl1,AA2AR_4ug2A_NGI,P29274,P2927465p89,AA2AR,65p89,cl1,4ug2A,NGI,,4ug2,2,8,,GPCR,,1,Molecular Determinants of Cgs21680 Binding to the Human Adenosine A2A Receptor.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,Activator,0,,,
P30559_OXTR_wild_cl1,OXTR_6tpkA_NU2,P30559,P30559wild,OXTR,wild,cl1,6tpkA,NU2,,6tpk,3,1,,GPCR,,1,Crystal structure of the human oxytocin receptor.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30939_HTR1F_wild_cl1,HTR1F_7exdR_05X,P30939,P30939wild,HTR1F,wild,cl1,7exdR,05X,,7exd,3,1,,GPCR,,1,Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT 1F -G protein complex.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30968_GNRHR_wild_cl1,GNRHR_7br3A_F5O,P30968,P30968wild,GNRHR,wild,cl1,7br3A,F5O,,7br3,3,1,,GPCR,,1,Structure of the human gonadotropin-releasing hormone receptor GnRH1R reveals an unusual ligand binding mode.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30988_CALCR_wild_cl2,CALCR_7tynR_P42,P30988,P30988wild,CALCR,wild,cl2,7tynR,P42,,7tyn,3,2,,GPCR,,1,A structural basis for amylin receptor phenotype.,Binding,Peptide binding,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30988_CALCR_wild_cl1,CALCR_7tyoR_Y01,P30988,P30988wild,CALCR,wild,cl1,7tyoR,Y01,,7tyo,3,2,,GPCR,,1,A structural basis for amylin receptor phenotype.,Binding,Peptide binding,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30988_CALCR_wild_cl1,CALCR_7tywR_Y01,P30988,P30988wild,CALCR,wild,cl1,7tywR,Y01,,7tyw,3,2,,GPCR,,1,A structural basis for amylin receptor phenotype.,Binding,Peptide binding,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P30988_CALCR_wild_cl2,CALCR_7tzfR_P42,P30988,P30988wild,CALCR,wild,cl2,7tzfR,P42,,7tzf,3,2,,GPCR,,1,A structural basis for amylin receptor phenotype.,Binding,Peptide binding,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P32238_CCKAR_wild_cl1,CCKAR_7f8yA_1OZ,P32238,P32238wild,CCKAR,wild,cl1,7f8yA,1OZ,,7f8y,3,1,,GPCR,,1,Structures of the human cholecystokinin receptors bound to agonists and antagonists.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P32245_MC4R_wild_cl1,MC4R_7f58R_1I8,P32245,P32245wild,MC4R,wild,cl1,7f58R,1I8,,7f58,3,1,,GPCR,,1,Structural insights into ligand recognition and activation of the melanocortin-4 receptor.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P34972_CNR2_wild_cl1,CNR2_6kpfR_8D0,P34972,P34972wild,CNR2,wild,cl1,6kpfR,8D0,E3R,6kpf,2,2,,GPCR,,1,Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-GiComplex Structures.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P34972_CNR2_wild_cl1,CNR2_6pt0R_WI5,P34972,P34972wild,CNR2,wild,cl1,6pt0R,WI5,,6pt0,2,2,,GPCR,,1,Cryo-EM Structure of the Human Cannabinoid Receptor CB2-GiSignaling Complex.,Activator,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
P41595_5HT2B_wild_cl1,5HT2B_4nc3A_ERM,P41595,P41595wild,5HT2B,wild,cl1,4nc3A,ERM,,4nc3,2,2,,GPCR,,1,Serial femtosecond crystallography of G protein-coupled receptors.,Activator,,1,PanLab,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
P41595_5HT2B_wild_cl1,5HT2B_6dryA_H8D,P41595,P41595wild,5HT2B,wild,cl1,6dryA,H8D,,6dry,2,2,,GPCR,,1,Structural determinants of 5-HT2Breceptor activation and biased Agonism.,Activator,,1,PanLab,0,0,0,0,0,Functional,Cell based,Activator_ inhibitor,0,,,
Q01064_PDE1B_wild_cl1,PDE1B_4npvA_0NK,Q01064,Q01064wild,PDE1B,wild,cl1,4npvA,0NK,,4npv,2,1,,esterase,,1,Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q01064_PDE1B_wild_cl1,PDE1B_5b25D_4QJ,Q01064,Q01064wild,PDE1B,wild,cl1,5b25D,4QJ,,5b25,2,1,,esterase,,1,Discovery of Potent and Selective inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q07343_PDE4B_wild_cl1,PDE4B_1xmuB_ROF,Q07343,Q07343wild,PDE4B,wild,cl1,1xmuB,ROF,,1xmu,2,1,,esterase,,1,Structural Basis for the Activity of Drugs that inhibit Phosphodiesterases.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q07343_PDE4B_wild_cl1,PDE4B_3gwtA_066,Q07343,Q07343wild,PDE4B,wild,cl1,3gwtA,66,,3gwt,2,1,,esterase,,1,Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q08499_PDE4D_wild_cl1,PDE4D_3iadD_15X,Q08499,Q08499wild,PDE4D,wild,cl1,3iadD,15X,,3iad,1,1,,esterase,,1,Design of phosphodiesterase 4D (PDE4D) Allosteric modulators for enhancing cognition with improved safety.,Inhibitor,allosteric,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q08499_PDE4D_wild_cl1,PDE4D_3v9bD_IHM,Q08499,Q08499wild,PDE4D,wild,cl1,3v9bD,IHM,,3v9b,1,1,,esterase,,1,Stereoselective synthesis of novel pyrazole derivatives using tert-butansulfonamide as a chiral auxiliary,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q13370_CN3B_wild_cl1,CN3B_1so2D_666,Q13370,Q13370wild,CN3B,wild,cl1,1so2D,666,,1so2,2,1,,esterase,,1,Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and inhibitor Specificity,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q13370_CN3B_wild_cl1,CN3B_1sojL_IBM,Q13370,Q13370wild,CN3B,wild,cl1,1sojL,IBM,,1soj,2,1,,esterase,,1,Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and inhibitor Specificity,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q13946_PDE7A_wild_cl1,PDE7A_1zklA_IBM,Q13946,Q13946wild,PDE7A,wild,cl1,1zklA,IBM,,1zkl,2,1,,esterase,,1,Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q13946_PDE7A_wild_cl1,PDE7A_4pm0A_32V,Q13946,Q13946wild,PDE7A,wild,cl1,4pm0A,32V,,4pm0,2,1,,esterase,,1,Discovery of 2-(Cyclopentylamino)thieno[3_2-d]pyrimidin-4(3H)-one Derivatives as a New Series of Potent Phosphodiesterase 7 inhibitors.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q14416_GRM2_wild_cl1,GRM2_4xaqB_40F,Q14416,Q14416wild,GRM2,wild,cl1,4xaqB,40F,,4xaq,2,1,,GPCR,,1,Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1S_2S_5R_6S-2-Aminobicyclo[3.1.0]hexane-2_6-dicarboxylate: Identification of a Potent_ Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,Activator_ inhibitor,0,,,
Q14416_GRM2_wild_cl1,GRM2_4xasB_40H,Q14416,Q14416wild,GRM2,wild,cl1,4xasB,40H,,4xas,2,1,,GPCR,,1,Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1S_2S_5R_6S-2-Aminobicyclo[3.1.0]hexane-2_6-dicarboxylate: Identification of a Potent_ Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures.,Activator,,1,PanLab,0,0,0,0,0,Functional,Biochemical,Activator_ inhibitor,0,,,
Q14432_PDE3A_wild_cl1,PDE3A_7kweA_X5M,Q14432,Q14432wild,PDE3A,wild,cl1,7kweA,X5M,,7kwe,1,1,,esterase,,1,Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q14432_PDE3A_wild_cl1,PDE3A_7l28D_XKG,Q14432,Q14432wild,PDE3A,wild,cl1,7l28D,XKG,,7l28,1,1,,esterase,,1,Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q16790_CAH9_wild_cl1,CAH9_6fe1D_V14,Q16790,Q16790wild,CAH9,wild,cl1,6fe1D,V14,,6fe1,1,1,,anhydrase,SooYongLee,1,Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells.,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
Q16790_CAH9_wild_cl1,CAH9_6tl5D_MKQ,Q16790,Q16790wild,CAH9,wild,cl1,6tl5D,MKQ,,6tl5,1,1,,anhydrase,SooYongLee,1,Three dimensional structure of human carbonic anhydrase IX in complex with sulfonamide,Inhibitor,,1,PanLab,0,0,0,0,0,0,0,0,0,,,
Q92847_GHSR_wild_cl1,GHSR_6ko5A_8QX,Q92847,Q92847wild,GHSR,wild,cl1,6ko5A,8QX,,6ko5,3,1,,GPCR,,1,Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode.,Inhibitor,,1,PanLab,0,0,0,0,0,Biochemical,Enzymatic,Activator,0,,,
Q9Y233_PDE10_wild_cl1,PDE10_5b4kB_6DT,Q9Y233,Q9Y233wild,PDE10,wild,cl1,5b4kB,6DT,,5b4k,1,1,,esterase,,1,Design and synthesis of potent and selective pyridazin-4(1H)-one-based PDE10A inhibitors interacting with Tyr683 in the PDE10A selectivity pocket,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q9Y233_PDE10_wild_cl1,PDE10_5c2hB_4XU,Q9Y233,Q9Y233wild,PDE10,wild,cl1,5c2hB,4XU,,5c2h,1,1,,esterase,,1,Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) inhibitors through Fragment Screening_ Structure-Based Design_ and Parallel Synthesis.,Inhibitor,,1,PanLab,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
Q9Y5Y4_PD2R2_wild_cl1,PD2R2_6d26A_FSY,Q9Y5Y4,Q9Y5Y4wild,PD2R2,wild,cl1,6d26A,FSY,,6d26,2,1,,GPCR,,1,Structures of the Human PGD2Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition.,Inhibitor,,1,PanLab,0,0,0,0,0,0,Enzymatic,Agonist,0,,,
Q9Y5Y4_PD2R2_wild_cl1,PD2R2_6d27A_FT4,Q9Y5Y4,Q9Y5Y4wild,PD2R2,wild,cl1,6d27A,FT4,,6d27,2,1,,GPCR,,1,Structures of the Human PGD2Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition.,Inhibitor,,1,PanLab,0,0,0,0,0,0,Enzymatic,Agonist,0,,,
P0DTD1_R1AB_wild_cl1,R1AB_5rl9B_UR7,P0DTD1,P0DTD1wild,R1AB,wild,cl1,5rl9B,UR7,,5rl9,2,3,,0,JiYoonShin,1,Structure_ mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.,Inhibitor,NSP13 helicase,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P0DTD1_R1AB_wild_cl2,R1AB_5rm7B_N0E,P0DTD1,P0DTD1wild,R1AB,wild,cl2,5rm7B,N0E,,5rm7,2,3,,0,JiYoonShin,1,Structure_ mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.,Inhibitor,NSP13 helicase,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P0DTD1_R1AB_wild_cl1,R1AB_5rsmA_4SO,P0DTD1,P0DTD1wild,R1AB,wild,cl1,5rsmA,4SO,,5rsm,2,3,,0,JiYoonShin,1,Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.,Inhibitor,NSP3,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P0DTD1_R1AB_wild_cl2,R1AB_7cjmB_TTT,P0DTD1,P0DTD1wild,R1AB,wild,cl2,7cjmB,TTT,,7cjm,2,3,,0,JiYoonShin,1,The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.,Inhibitor,Plpro,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P0DTD1_R1AB_wild_cl3,R1AB_6xhmB_V2M,P0DTD1,P0DTD1wild,R1AB,wild,cl3,6xhmB,V2M,,6xhm,2,3,,0,JiYoonShin,1,Discovery of Ketone-Based Covalent inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.,Inhibitor,,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P0DTD1_R1AB_wild_cl3,R1AB_7jkvA_V7G,P0DTD1,P0DTD1wild,R1AB,wild,cl3,7jkvA,V7G,,7jkv,2,3,,0,JiYoonShin,1,A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.,Inhibitor,,1,°¡´É,0,0,0,0,0,Functional,Biochemical,inhibitor,0,,,
P13569_CFTR_470_cl1,CFTR_5tfaA_DUT,P13569,P13569470_ F508del,CFTR,470_ F508del,cl1,5tfaA,DUT,,5tfa,1,3,,Transporter,,1,Thermodynamic correction of F508del-CFTR by ligand binding to a remote site in the mutated domain,Inhibitor,,,,,,,,,,,,,,,
P13569_CFTR_470_cl1,CFTR_5tfiA_DGT,P13569,P13569470_ F508del,CFTR,470_ F508del,cl1,5tfiA,DGT,,5tfi,1,3,,Transporter,,1,Thermodynamic correction of F508del-CFTR by ligand binding to a remote site in the mutated domain,Inhibitor,,,,,,,,,,,,,,,
Q9H2K2_TNKS2_wild_cl1,TNKS2_4bs4B_A64,Q9H2K2,Q9H2K2wild,TNKS2,wild,cl1,4bs4B,A64,,4bs4,1,1,,Transferase,,1,Discovery of Tankyrase inhibiting Flavones with Increased Potency and Isoenzyme Selectivity.,Inhibitor,,,,,,,,,,,,,,,
Q9H2K2_TNKS2_wild_cl1,TNKS2_4l33B_F70,Q9H2K2,Q9H2K2wild,TNKS2,wild,cl1,4l33B,F70,,4l33,1,1,,Transferase,,1,Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.,Inhibitor,,,,,,,,,,,,,,,
B2RXH2_KD4DL_wild_cl1,KD4DL_2w2iA_PD2,B2RXH2,B2RXH2wild,KD4DL,wild,cl1,2w2iA,PD2,,2w2i,2,1,,methylase,SooYongLee,1,Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human Kdm4 Histone Demethylase Family.,Inhibitor,,,,,,,,,,,,,,,
O14842_FFAR1_88p103_cl1,FFAR1_5kw2A_6XQ,O14842,O1484288p103,FFAR1,88p103,cl1,5kw2A,6XQ,,5kw2,2,2,,GPCR,,1,Structural basis for GPR40 Allosteric Agonism and incretin stimulation.,Activator,allosteric,,,,,,,,,,,,,,
O15357_SHIP2_wild_cl1,SHIP2_5okmA_B3P,O15357,O15357wild,SHIP2,wild,cl1,5okmA,B3P,,5okm,2,1,,phosphatase,SooYongLee,1,Structural basis for interdomain communication in SHIP2 providing high phosphatase activity.,apo,,,,,,,,,,,,,,,
O43613_OX1R_95_cl1,OX1R_6tosB_NRE,O43613,O4361395,OX1R,95,cl1,6tosB,NRE,,6tos,2,3,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,,,,,,,,,,,,,,
O43613_OX1R_95p339_cl1,OX1R_6totB_NRK,O43613,O4361395p339,OX1R,95p339,cl1,6totB,NRK,,6tot,2,3,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,,,,,,,,,,,,,,
O43613_OX1R_95_cl1,OX1R_6tq6B_NVH,O43613,O4361395,OX1R,95,cl1,6tq6B,NVH,,6tq6,2,3,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,,,,,,,,,,,,,,
O43614_OX2R_28p91p100_cl1,OX2R_6tpgA_7MA,O43614,O4361428p91p100,OX2R,28p91p100,cl1,6tpgA,7MA,,6tpg,2,2,,GPCR,,1,Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.,Inhibitor,,,,,,,,,,,,,,,
O60674_JAK2_943_cl1,JAK2_3zmmB_F9J,O60674,O60674943,JAK2,943,cl1,3zmmB,F9J,,3zmm,2,2,,Kinase,HoYoungLee,1,Discovery of Novel Jak2-Stat Pathway inhibitors with Extended Residence Time on Target.,Inhibitor,,,,,,,,,,,,,,,
O75604_UBP2_wild_cl1,UBP2_5xu8A_DX4,O75604,O75604wild,UBP2,wild,cl1,5xu8A,DX4,,5xu8,3,1,,Peptidase,,1,6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2,Inhibitor,,,,,,,,,,,,,,,
O75874_IDHC_wild_cl1,IDHC_6bl1A_DWG,O75874,O75874wild,IDHC,wild,cl1,6bl1A,DWG,,6bl1,3,1,,oxidoreductases ,,1,Novel Modes of inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.,Inhibitor,,,,,,,,,,,,,,,
O75874_IDHC_wild_cl1,IDHC_6bl2C_DWS,O75874,O75874wild,IDHC,wild,cl1,6bl2C,DWS,,6bl2,3,1,,oxidoreductases ,,1,Novel Modes of inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl1,GSHR_1bwcA_FAD,P00390,P00390wild,GSHR,wild,cl1,1bwcA,FAD,,1bwc,2,4,,oxidoreductases ,,1,Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic_ kinetic_ and spectroscopic studies.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl1,GSHR_1dncA_FAD,P00390,P00390wild,GSHR,wild,cl1,1dncA,FAD,,1dnc,2,4,,oxidoreductases ,,1,Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl4,GSHR_1grbA_NAD,P00390,P00390wild,GSHR,wild,cl4,1grbA,NAD,,1grb,2,4,,oxidoreductases ,,1,Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl2,GSHR_1gsnA_GSH,P00390,P00390wild,GSHR,wild,cl2,1gsnA,GSH,,1gsn,2,4,,oxidoreductases ,,1,Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl3,GSHR_1xanA_HXP,P00390,P00390wild,GSHR,wild,cl3,1xanA,HXP,,1xan,2,4,,oxidoreductases ,,1,Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl2,GSHR_2grtA_GDS,P00390,P00390wild,GSHR,wild,cl2,2grtA,GDS,,2grt,2,4,,oxidoreductases ,,1,Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.,inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl4,GSHR_3dk4A_NDP,P00390,P00390wild,GSHR,wild,cl4,3dk4A,NDP,,3dk4,2,4,,oxidoreductases ,,1,Catalytic cycle of human glutathione reductase near 1 A resolution.,Inhibitor,,,,,,,,,,,,,,,
P00390_GSHR_wild_cl3,GSHR_3sqpB_3J8,P00390,P00390wild,GSHR,wild,cl3,3sqpB,3J8,,3sqp,2,4,,oxidoreductases ,,1,The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue.,inhibitor,,,,,,,,,,,,,,,
P04626_ERBB2_712_cl1,ERBB2_3pp0B_03Q,P04626,P04626712,ERBB2,712,cl1,3pp0B,03Q,,3pp0,2,2,,Kinase,HoYoungLee,1,Structural Analysis of the Mechanism of inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein.,Inhibitor,allosteric,,,,,,,,,,,,,,
P04637_P53_220_cl1,P53_4agqB_P96,P04637,P04637220,P53,220,cl1,4agqB,P96,,4agq,2,1,,0,JiYoonShin,1,Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant P53.,Y220C mutant specific stabilizer,Y220C mutant specific stabilizer,,,,,,,,,,,,,,
P04637_P53_220_cl1,P53_5o1iA_9GH,P04637,P04637220,P53,220,cl1,5o1iA,9GH,,5o1i,2,1,,0,JiYoonShin,1,Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.,Y220C mutant specific stabilizer,Y220C mutant specific stabilizer,,,,,,,,,,,,,,
P07333_CSF1R_667_cl1,CSF1R_4hw7A_64M,P07333,P07333667,CSF1R,667,cl1,4hw7A,64M,,4hw7,2,2,,Kinase,HoYoungLee,1,Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.,Inhibitor,,,,,,,,,,,,,,,
P08754_GNAI3_wild_cl1,GNAI3_4g5sB_GDP,P08754,P08754wild,GNAI3,wild,cl1,4g5sB,GDP,,4g5s,3,1,,0,JiYoonShin,1,Crystal Structures of the scaffolding protein LGN reveal the general mechanism by which GoLoco binding motifs inhibit the release of GDP from Galphai subunits in G-coupled heterotrimeric proteins,Inhibitor,,,,,,,,,,,,,,,
P10721_KIT_651_cl1,KIT_4hvsA_647,P10721,P10721651,KIT,651,cl1,4hvsA,647,,4hvs,2,2,,Kinase,HoYoungLee,1,Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.,Inhibitor,,,,,,,,,,,,,,,
P10826_RARB_wild_cl1,RARB_4jyiB_JYI,P10826,P10826wild,RARB,wild,cl1,4jyiB,JYI,,4jyi,2,1,,Receptor,,1,An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor beta (RAR beta _ NR1B2) Selective Agonist.,Activator,,,,,,,,,,,,,,,
P10826_RARB_wild_cl1,RARB_5uanB_REA,P10826,P10826wild,RARB,wild,cl1,5uanB,REA,,5uan,2,1,,Receptor,,1,The quaternary architecture of RAR beta-RXR alpha heterodimer facilitates domain-domain signal transmission.,Activator,,,,,,,,,,,,,,,
P11274_BCR_wild_cl1,BCR_5oc7D_IP2,P11274,P11274wild,BCR,wild,cl1,5oc7D,IP2,,5oc7,3,1,,0,JiYoonShin,1,Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase.,Binding,Antibody binding,,,,,,,,,,,,,,
P11362_FGFR1_488_cl1,FGFR1_4zsaB_4UT,P11362,P11362488,FGFR1,488,cl1,4zsaB,4UT,,4zsa,2,3,,Kinase,HoYoungLee,1,Design_ synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold.,Inhibitor,,,,,,,,,,,,,,,
P11362_FGFR1_488_cl1,FGFR1_5a4cB_XOJ,P11362,P11362488,FGFR1,488,cl1,5a4cB,XOJ,,5a4c,2,3,,Kinase,HoYoungLee,1,Structural and Dynamic Insights Into the Energetics of Activation Loop Rearrangement in Fgfr1 Kinase.,Inhibitor,,,,,,,,,,,,,,,
P11766_ADHX_wild_cl1,ADHX_1ma0B_DAO,P11766,P11766wild,ADHX,wild,cl1,1ma0B,DAO,,1ma0,3,1,,oxidoreductases ,,1,Human glutathione-dependent formaldehyde dehydrogenase. Structures of apo_ binary_ and inhibitory ternary complexes.,Inhibitor,,,,,,,,,,,,,,,
P11766_ADHX_wild_cl1,ADHX_1mc5A_AHE,P11766,P11766wild,ADHX,wild,cl1,1mc5A,AHE,,1mc5,3,1,,oxidoreductases ,,1,Human glutathione-dependent formaldehyde dehydrogenase.Structural changes associated with Ternary Complex formation,Inhibitor,,,,,,,,,,,,,,,
P14618_KPYM_wild_cl2,KPYM_4g1nA_NZT,P14618,P14618wild,KPYM,wild,cl2,4g1nA,NZT,,4g1n,2,2,,Kinase,HoYoungLee,1,Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy.,Activator,,,,,,,,,,,,,,,
P14618_KPYM_wild_cl1,KPYM_4rppC_FBP,P14618,P14618wild,KPYM,wild,cl1,4rppC,FBP,,4rpp,2,2,,Kinase,HoYoungLee,1,Structural insight into mechanisms for dynamic regulation of PKM2.,Inhibitor,,,,,,,,,,,,,,,
P14618_KPYM_wild_cl2,KPYM_5x1wC_7Y0,P14618,P14618wild,KPYM,wild,cl2,5x1wC,7Y0,,5x1w,2,2,,Kinase,HoYoungLee,1,Discovery and structure-guided fragment-linking of 4-(2_3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator,Activator,,,,,,,,,,,,,,,
P14618_KPYM_wild_cl1,KPYM_6tthA_FBP,P14618,P14618wild,KPYM,wild,cl1,6tthA,FBP,,6tth,2,2,,Kinase,HoYoungLee,1,Fragment-based drug discovery using cryo-EM.,Activator,,,,,,,,,,,,,,,
P14784_IL2RB_wild_cl2,IL2RB_2erjB_FUC,P14784,P14784wild,IL2RB,wild,cl2,2erjB,FUC,,2erj,3,3,,Receptor,,1,Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.,Binding,ligand binding,,,,,,,,,,,,,,
P14784_IL2RB_wild_cl3,IL2RB_5m5eB_CYS,P14784,P14784wild,IL2RB,wild,cl3,5m5eB,CYS,,5m5e,3,3,,Receptor,,1,Cergutuzumab amunaleukin (CEA-IL2v)_ a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.,Binding,ligand binding,,,,,,,,,,,,,,
P14784_IL2RB_wild_cl2,IL2RB_5m5eB_FUC,P14784,P14784wild,IL2RB,wild,cl2,5m5eB,FUC,,5m5e,3,3,,Receptor,,1,Cergutuzumab amunaleukin (CEA-IL2v)_ a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.,Binding,ligand binding,,,,,,,,,,,,,,
P14784_IL2RB_wild_cl1,IL2RB_7s2sB_FUC,P14784,P14784wild,IL2RB,wild,cl1,7s2sB,FUC,,7s2s,3,3,,Receptor,,1,Facile discovery of surrogate cytokine Agonists.,Activator,,,,,,,,,,,,,,,
P14784_IL2RB_wild_cl1,IL2RB_7s2sD_FUC,P14784,P14784wild,IL2RB,wild,cl1,7s2sD,FUC,,7s2s,3,3,,Receptor,,1,Facile discovery of surrogate cytokine Agonists.,Activator,,,,,,,,,,,,,,,
P17612_KAPCA_120p123p183_cl1,KAPCA_3amaA_SKE,P17612,P17612120p123p183,KAPCA,120p123p183,cl1,3amaA,SKE,,3ama,1,3,,Kinase,HoYoungLee,1,Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase,Inhibitor,,,,,,,,,,,,,,,
P17612_KAPCA_120p123p183_cl1,KAPCA_3ambA_VX6,P17612,P17612120p123p183,KAPCA,120p123p183,cl1,3ambA,VX6,,3amb,1,3,,Kinase,HoYoungLee,1,Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase,Inhibitor,,,,,,,,,,,,,,,
P17612_KAPCA_123p173p181_cl1,KAPCA_3l9nA_L9N,P17612,P17612123p173p181,KAPCA,123p173p181,cl1,3l9nA,L9N,,3l9n,1,3,,Kinase,HoYoungLee,1,Azole-based inhibitors of AKT/PKB for the treatment of cancer.,Inhibitor,,,,,,,,,,,,,,,
P20138_CD33_wild_cl1,CD33_5j06B_SIA,P20138,P20138wild,CD33,wild,cl1,5j06B,SIA,,5j06,3,1,,0,JiYoonShin,1,STRUCTURE OF LIGAND BOUND CD33 RECEPTOR ASSOCIATED WITH ALZHEIMER'S DISEASE,Binding,Ligand binding,,,,,,,,,,,,,,
P21589_5NTD_wild_cl1,5NTD_6s7fA_KYK,P21589,P21589wild,5NTD,wild,cl1,6s7fA,KYK,,6s7f,1,1,,nucleotidase,,1,X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) inhibitors for Cancer Immunotherapy,Inhibitor,,,,,,,,,,,,,,,
P21589_5NTD_wild_cl1,5NTD_6z9bA_QCQ,P21589,P21589wild,5NTD,wild,cl1,6z9bA,QCQ,,6z9b,1,1,,nucleotidase,,1,Discovery of AB680: A Potent and Selective inhibitor of CD73.,Inhibitor,,,,,,,,,,,,,,,
P21802_FGFR2_564_cl1,FGFR2_7kiaB_WFD,P21802,P21802564,FGFR2,564,cl1,7kiaB,WFD,,7kia,1,2,,Kinase,HoYoungLee,1,Discovery of Aminopyrazole Derivatives as Potent inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3.,Inhibitor,,,,,,,,,,,,,,,
P21802_FGFR2_564_cl1,FGFR2_7kieA_WF7,P21802,P21802564,FGFR2,564,cl1,7kieA,WF7,,7kie,1,2,,Kinase,HoYoungLee,1,Discovery of Aminopyrazole Derivatives as Potent inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3.,Inhibitor,,,,,,,,,,,,,,,
P22455_FGFR4_550_cl1,FGFR4_4r6vA_FI3,P22455,P22455550,FGFR4,550,cl1,4r6vA,FI3,,4r6v,2,2,,Kinase,HoYoungLee,1,Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.,Inhibitor,,,,,,,,,,,,,,,
P23469_PTPRE_457p597_cl1,PTPRE_6d4fA_1PE,P23469,P23469457p597,PTPRE,457p597,cl1,6d4fA,1PE,,6d4f,3,1,,phosphatase,SooYongLee,1,High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.,apo,,,,,,,,,,,,,,,
P23471_PTPRZ_wild_cl1,PTPRZ_5h08A_7WL,P23471,P23471wild,PTPRZ,wild,cl1,5h08A,7WL,,5h08,3,1,,phosphatase,SooYongLee,1,Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_91_cl1,AA2AR_5wf6A_UKA,P29274,P2927491,AA2AR,91,cl1,5wf6A,UKA,,5wf6,2,8,,GPCR,,1,Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.,Activator,allosteric,,,,,,,,,,,,,,
P29274_AA2AR_88p277_cl1,AA2AR_3rfmA_CFF,P29274,P2927488p277,AA2AR,88p277,cl1,3rfmA,CFF,,3rfm,2,8,,GPCR,,1,Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine,Activator,,,,,,,,,,,,,,,
P29274_AA2AR_88p277_cl1,AA2AR_3uzaA_T4G,P29274,P2927488p277,AA2AR,88p277,cl1,3uzaA,T4G,,3uza,2,8,,GPCR,,1,Discovery of 1_2_4-Triazine Derivatives as Adenosine A(2A) antagonists using Structure Based Drug Design,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_54p88p277_cl1,AA2AR_3uzcA_T4E,P29274,P2927454p88p277,AA2AR,54p88p277,cl1,3uzcA,T4E,,3uzc,2,8,,GPCR,,1,Discovery of 1_2_4-Triazine Derivatives as Adenosine A(2A) antagonists using Structure Based Drug Design,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_88p154_cl1,AA2AR_5iu7A_6DY,P29274,P2927488p154,AA2AR,88p154,cl1,5iu7A,6DY,,5iu7,2,8,,GPCR,,1,Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_88p154_cl1,AA2AR_5iuaA_6DX,P29274,P2927488p154,AA2AR,88p154,cl1,5iuaA,6DX,,5iua,2,8,,GPCR,,1,Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_154_cl1,AA2AR_5iubA_6DV,P29274,P29274154,AA2AR,154,cl1,5iubA,6DV,,5iub,2,8,,GPCR,,1,Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.,Inhibitor,,,,,,,,,,,,,,,
P29274_AA2AR_88_cl1,AA2AR_5olzA_T4E,P29274,P2927488,AA2AR,88,cl1,5olzA,T4E,,5olz,2,8,,GPCR,,1,Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals.,Activator,,,,,,,,,,,,,,,
P29274_AA2AR_88_cl1,AA2AR_6gt3A_F9Q,P29274,P2927488,AA2AR,88,cl1,6gt3A,F9Q,,6gt3,2,8,,GPCR,,1,Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity,Inhibitor,,,,,,,,,,,,,,,
P29597_TYK2_1023_cl1,TYK2_3nyxA_TZ1,P29597,P295971023,TYK2,1023,cl1,3nyxA,TZ1,,3nyx,2,2,,Kinase,HoYoungLee,1,A new regulatory switch in a JAK protein kinase.,Inhibitor,,,,,,,,,,,,,,,
P29597_TYK2_1023_cl1,TYK2_4gihA_0X5,P29597,P295971023,TYK2,1023,cl1,4gihA,0X5,,4gih,2,2,,Kinase,HoYoungLee,1,Lead identification of novel and selective TYK2 inhibitors.,Inhibitor,,,,,,,,,,,,,,,
P30613_KPYR_wild_cl1,KPYR_2vgbB_PGA,P30613,P30613wild,KPYR,wild,cl1,2vgbB,PGA,,2vgb,3,1,,Kinase,HoYoungLee,1,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia.,Inhibitor,,,,,,,,,,,,,,,
P30613_KPYR_wild_cl1,KPYR_2vggD_PGA,P30613,P30613wild,KPYR,wild,cl1,2vggD,PGA,,2vgg,3,1,,Kinase,HoYoungLee,1,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia.,Inhibitor,,,,,,,,,,,,,,,
P33176_KIF5B_wild_cl1,KIF5B_1bg2A_ADP,P33176,P33176wild,KIF5B,wild,cl1,1bg2A,ADP,,1bg2,3,1,,ATPase,,1,Crystal structure of the kinesin motor domain reveals a structural similarity to myosin.,Inhibitor,,,,,,,,,,,,,,,
P33176_KIF5B_wild_cl1,KIF5B_3j8yK_ATP,P33176,P33176wild,KIF5B,wild,cl1,3j8yK,ATP,,3j8y,3,1,,ATPase,,1,High-resolution structures of kinesin on microtubules provide a basis for nucleotide-gated force-generation.,Inhibitor,,,,,,,,,,,,,,,
P34972_CNR2_78_cl1,CNR2_5ztyA_9JU,P34972,P3497278,CNR2,78,cl1,5ztyA,9JU,,5zty,2,2,,GPCR,,1,Crystal Structure of the Human Cannabinoid Receptor CB2,Inhibitor,,,,,,,,,,,,,,,
P34972_CNR2_78_cl1,CNR2_6kpcA_8D0,P34972,P3497278,CNR2,78,cl1,6kpcA,8D0,E3R,6kpc,2,2,,GPCR,,1,Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-GiComplex Structures.,Activator,,,,,,,,,,,,,,,
P37173_TGFR2_97_cl1,TGFR2_4p7uA_1PS,P37173,P3717397,TGFR2,97,cl1,4p7uA,1PS,,4p7u,2,2,,Kinase,HoYoungLee,1,The non-detergent sulfobetaine-201 acts as a pharmacological chaperone to promote folding and crystallization of the type II TGF-beta receptor extracellular domain.,Inhibitor,PPI,,,,,,,,,,,,,,
P37173_TGFR2_97_cl1,TGFR2_4xjjA_41D,P37173,P3717397,TGFR2,97,cl1,4xjjA,41D,,4xjj,2,2,,Kinase,HoYoungLee,1,Extracellular domain of type II Transforming Growth Factor Beta receptor in complex with 2-(2-Hydroxyethyl)NDSB-201,Inhibitor,PPI,,,,,,,,,,,,,,
P41595_5HT2B_144_cl1,5HT2B_5tvnA_7LD,P41595,P41595144,5HT2B,144,cl1,5tvnA,7LD,,5tvn,2,2,,GPCR,,1,Crystal Structure of an LSD-Bound Human Serotonin Receptor.,Activator,,,,,,,,,,,,,,,
P41595_5HT2B_144_cl1,5HT2B_6drxA_H8G,P41595,P41595144,5HT2B,144,cl1,6drxA,H8G,,6drx,2,2,,GPCR,,1,Structural determinants of 5-HT2Breceptor activation and biased Agonism.,Activator,,,,,,,,,,,,,,,
P42336_PK3CA_770p780p798p800p850p930_cl1,PK3CA_5ukjA_3K6,P42336,P42336770p780p798p800p850p930,PK3CA,770p780p798p800p850p930,cl1,5ukjA,3K6,,5ukj,1,2,,Kinase,HoYoungLee,1,Rationally Designed PI3K alpha Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR inhibitors.,Inhibitor,,,,,,,,,,,,,,,
P42336_PK3CA_770p780p798p800p850p930_cl1,PK3CA_5ul1A_8DY,P42336,P42336770p780p798p800p850p930,PK3CA,770p780p798p800p850p930,cl1,5ul1A,8DY,,5ul1,1,2,,Kinase,HoYoungLee,1,Rationally Designed PI3K alpha Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR inhibitors.,Inhibitor,,,,,,,,,,,,,,,
P42356_PI4KA_wild_cl1,PI4KA_6bq1E_E4S,P42356,P42356wild,PI4KA,wild,cl1,6bq1E,E4S,,6bq1,3,1,,Kinase,HoYoungLee,1,Architecture of the human PI4KIII alpha lipid kinase complex.,Inhibitor,,,,,,,,,,,,,,,
P43403_ZAP70_461_cl1,ZAP70_4k2rA_ANP,P43403,P43403461,ZAP70,461,cl1,4k2rA,ANP,,4k2r,3,2,,Kinase,HoYoungLee,1,Structural Basis for Activation of ZAP-70 by Phosphorylation of the SH2-Kinase Linker.,Inhibitor,,,,,,,,,,,,,,,
P45974_UBP5_wild_cl1,UBP5_6dxhA_HH4,P45974,P45974wild,UBP5,wild,cl1,6dxhA,HH4,,6dxh,2,1,,Peptidase,,1,Discovery of Small Molecule antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.,Inhibitor,,,,,,,,,,,,,,,
P45974_UBP5_wild_cl1,UBP5_6p9gA_O4Y,P45974,P45974wild,UBP5,wild,cl1,6p9gA,O4Y,,6p9g,2,1,,Peptidase,,1,Discovery of Small Molecule antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.,Inhibitor,,,,,,,,,,,,,,,
P48039_MTR1A_95_cl1,MTR1A_6me2A_JEV,P48039,P4803995,MTR1A,95,cl1,6me2A,JEV,,6me2,2,2,,GPCR,,1,Structural basis of ligand recognition at the human MT1melatonin receptor.,Activator,,,,,,,,,,,,,,,
P48039_MTR1A_95_cl1,MTR1A_6me4A_ML2,P48039,P4803995,MTR1A,95,cl1,6me4A,ML2,,6me4,2,2,,GPCR,,1,Structural basis of ligand recognition at the human MT1melatonin receptor.,Activator,,,,,,,,,,,,,,,
P48730_KC1D_13_cl1,KC1D_6gzmB_LCI,P48730,P4873013,KC1D,13,cl1,6gzmB,LCI,,6gzm,1,2,,Kinase,HoYoungLee,1,Small Molecules Co-targeting CKI alpha and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_wild_cl1,IDHP_5svnA_NDP,P48735,P48735wild,IDHP,wild,cl1,5svnA,NDP,,5svn,2,5,,oxidoreductases ,,1,Allosteric Mutant IDH1 inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity.,Inhibitor,allosteric,,,,,,,,,,,,,,
P48735_IDHP_140_cl1,IDHP_5svoB_NAP,P48735,P48735140,IDHP,140,cl1,5svoB,NAP,,5svo,2,5,,oxidoreductases ,,1,Allosteric Mutant IDH1 inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity.,Inhibitor,allosteric,,,,,,,,,,,,,,
P48735_IDHP_140_cl2,IDHP_5i96B_69Q,P48735,P48735140,IDHP,140,cl2,5i96B,69Q,,5i96,2,5,,oxidoreductases ,,1,AG-221_ a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_wild_cl3,IDHP_5i96B_69Q,P48735,P48735wild,IDHP,wild,cl3,5i96B,69Q,,5i96,2,5,,oxidoreductases ,,1,AG-221_ a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_140_cl2,IDHP_6adiA_9UO,P48735,P48735140,IDHP,140,cl2,6adiA,9UO,,6adi,2,5,,oxidoreductases ,,1,Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_wild_cl3,IDHP_6adiA_9UO,P48735,P48735wild,IDHP,wild,cl3,6adiA,9UO,,6adi,2,5,,oxidoreductases ,,1,Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_140_cl1,IDHP_6adiB_NDP,P48735,P48735140,IDHP,140,cl1,6adiB,NDP,,6adi,2,5,,oxidoreductases ,,1,Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2,Inhibitor,,,,,,,,,,,,,,,
P48735_IDHP_wild_cl2,IDHP_6vfzA_9UO,P48735,P48735wild,IDHP,wild,cl2,6vfzA,9UO,,6vfz,2,5,,oxidoreductases ,,1,Vorasidenib (AG-881): A First-in-Class_ Brain-Penetrant Dual inhibitor of Mutant IDH1 and 2 for Treatment of Glioma.,Inhibitor,,,,,,,,,,,,,,,
P51812_KS6A3_493_cl1,KS6A3_4jg8A_1LE,P51812,P51812493,KS6A3,493,cl1,4jg8A,1LE,,4jg8,1,2,,Kinase,HoYoungLee,1,Electrophilic fragment-based design of reversible covalent kinase inhibitors.,Inhibitor,,,,,,,,,,,,,,,
P51813_BMX_432_cl1,BMX_3sxrB_1N1,P51813,P51813432,BMX,432,cl1,3sxrB,1N1,,3sxr,2,1,,Kinase,HoYoungLee,1,X-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinase.,Inhibitor,,,,,,,,,,,,,,,
P51813_BMX_432_cl1,BMX_3sxsA_PP2,P51813,P51813432,BMX,432,cl1,3sxsA,PP2,,3sxs,2,1,,Kinase,HoYoungLee,1,X-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinase.,Inhibitor,,,,,,,,,,,,,,,
P54578_UBP14_wild_cl1,UBP14_6iikB_IU1,P54578,P54578wild,UBP14,wild,cl1,6iikB,IU1,,6iik,3,1,,Peptidase,,1,Small molecule inhibitors reveal Allosteric regulation of USP14 via steric blockade.,Inhibitor,allosteric,,,,,,,,,,,,,,
P55072_TERA_wild_cl1,TERA_4kodL_ADP,P55072,P55072wild,TERA,wild,cl1,4kodL,ADP,,4kod,2,2,,ATPase,,1,Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants.,Inhibitor,,,,,,,,,,,,,,,
P55072_TERA_wild_cl1,TERA_5kiwB_ANP,P55072,P55072wild,TERA,wild,cl1,5kiwB,ANP,,5kiw,2,2,,ATPase,,1,Structural basis for nucleotide-modulated p97 association with the ER membrane.,Inhibitor,,,,,,,,,,,,,,,
P55072_TERA_wild_cl2,TERA_6g2wA_AWD,P55072,P55072wild,TERA,wild,cl2,6g2wA,AWD,,6g2w,2,2,,ATPase,,1,Crystal structure of the catalytic D2 domain of the AAA+ ATPase p97 reveals a putative helical split-washer-type mechanism for substrate unfolding.,Inhibitor,,,,,,,,,,,,,,,
P55072_TERA_wild_cl2,TERA_6g2zA_EJW,P55072,P55072wild,TERA,wild,cl2,6g2zA,EJW,,6g2z,2,2,,ATPase,,1,Crystal structure of the catalytic D2 domain of the AAA+ ATPase p97 reveals a putative helical split-washer-type mechanism for substrate unfolding.,Inhibitor,,,,,,,,,,,,,,,
P55085_PAR2_176p268_cl1,PAR2_5nddA_8TZ,P55085,P55085176p268,PAR2,176p268,cl1,5nddA,8TZ,,5ndd,2,2,,GPCR,,1,Structural insight into Allosteric modulation of protease-activated receptor 2.,Inhibitor,allosteric,,,,,,,,,,,,,,
P55085_PAR2_268_cl1,PAR2_5ndzA_8UN,P55085,P55085268,PAR2,268,cl1,5ndzA,8UN,,5ndz,2,2,,GPCR,,1,Structural insight into Allosteric modulation of protease-activated receptor 2.,Inhibitor,allosteric,,,,,,,,,,,,,,
P55201_BRPF1_wild_cl1,BRPF1_5mygD_LS8,P55201,P55201wild,BRPF1,wild,cl1,5mygD,LS8,,5myg,1,1,,0,JiYoonShin,1,Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.,Inhibitor,,,,,,,,,,,,,,,
P55201_BRPF1_wild_cl1,BRPF1_5t4vA_N48,P55201,P55201wild,BRPF1,wild,cl1,5t4vA,N48,,5t4v,1,1,,0,JiYoonShin,1,Design of a Biased Potent Small Molecule inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.,Inhibitor,,,,,,,,,,,,,,,
P60763_RAC3_wild_cl1,RAC3_2ic5A_GNP,P60763,P60763wild,RAC3,wild,cl1,2ic5A,GNP,,2ic5,3,1,,GTPase,,1,Crystal structure of human RAC3 grown in the presence of Gpp(NH)p.,Inhibitor,,,,,,,,,,,,,,,
P60763_RAC3_wild_cl1,RAC3_2ov2G_GCP,P60763,P60763wild,RAC3,wild,cl1,2ov2G,GCP,,2ov2,3,1,,GTPase,,1,The crystal structure of the human RAC3 in complex with the CRIB domain of human p21-activated kinase 4 (PAK4),Inhibitor,,,,,,,,,,,,,,,
P60953_CDC42_wild_cl2,CDC42_1a4rB_GNH,P60953,P60953wild,CDC42,wild,cl2,1a4rB,GNH,,1a4r,2,1,,GTPase,,1,Nucleotide binding to the G12V-mutant of Cdc42 investigated by X-ray diffraction and fluorescence spectroscopy: two different nucleotide states in one crystal.,Inhibitor,,,,,,,,,,,,,,,
P60953_CDC42_wild_cl2,CDC42_1am4D_GNP,P60953,P60953wild,CDC42,wild,cl2,1am4D,GNP,,1am4,2,1,,GTPase,,1,Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP.,Inhibitor,,,,,,,,,,,,,,,
P61077_UB2D3_wild_cl1,UB2D3_6t7fB_LWZ,P61077,P61077wild,UB2D3,wild,cl1,6t7fB,LWZ,,6t7f,3,1,,Ubiquitin,,1,Structural basis for RING-Cys-Relay E3 ligase activity and its role in axon integrity.,Binding,PROTAC,,,,,,,,,,,,,,
P61586_RHOA_wild_cl1,RHOA_1s1cB_GNP,P61586,P61586wild,RHOA,wild,cl1,1s1cB,GNP,,1s1c,2,1,,GTPase,,1,Structural Insights into the Interaction of ROCKI with the Switch Regions of RhoA.,Inhibitor,,,,,,,,,,,,,,,
P61586_RHOA_wild_cl1,RHOA_4xshA_GSP,P61586,P61586wild,RHOA,wild,cl1,4xshA,GSP,,4xsh,2,1,,GTPase,,1,Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.,Inhibitor,,,,,,,,,,,,,,,
P62140_PP1B_wild_cl1,PP1B_1s70A_PGE,P62140,P62140wild,PP1B,wild,cl1,1s70A,PGE,,1s70,3,1,,phosphatase,SooYongLee,1,Structural basis of protein phosphatase 1 regulation,apo,,,,,,,,,,,,,,,
P63000_RAC1_wild_cl1,RAC1_1mh1A_GNP,P63000,P63000wild,RAC1,wild,cl1,1mh1A,GNP,,1mh1,2,1,,GTPase,,1,The crystal structure of human rac1_ a member of the rho-family complexed with a GTP analogue.,Inhibitor,,,,,,,,,,,,,,,
P63000_RAC1_wild_cl1,RAC1_4gzmB_GSP,P63000,P63000wild,RAC1,wild,cl1,4gzmB,GSP,,4gzm,2,1,,GTPase,,1,RAC1P29S is a spontaneously activating cancer-associated GTPase.,Inhibitor,,,,,,,,,,,,,,,
P63092_GNAS_wild_cl1,GNAS_6eg8I_GDP,P63092,P63092wild,GNAS,wild,cl1,6eg8I,GDP,,6eg8,3,1,,0,JiYoonShin,1,Structural Insights into the Process of GPCR-G Protein Complex Formation.,Inhibitor,,,,,,,,,,,,,,,
P63092_GNAS_wild_cl1,GNAS_7vuiA_GTP,P63092,P63092wild,GNAS,wild,cl1,7vuiA,GTP,,7vui,3,1,,0,JiYoonShin,1,Molecular insights into ligand recognition and G protein coupling of the neuromodulatory orphan receptor GPR139.,Inhibitor,,,,,,,,,,,,,,,
P63096_GNAI1_wild_cl1,GNAI1_1kjyA_GDP,P63096,P63096wild,GNAI1,wild,cl1,1kjyA,GDP,,1kjy,2,1,,0,JiYoonShin,1,Structural determinants for GoLoco-induced inhibition of nucleotide release by Galpha subunits.,Inhibitor,,,,,,,,,,,,,,,
P63096_GNAI1_wild_cl1,GNAI1_5tdhH_GDP,P63096,P63096wild,GNAI1,wild,cl1,5tdhH,GDP,,5tdh,2,1,,0,JiYoonShin,1,The structural basis of the dominant negative phenotype of the G alpha i1 beta 1 gamma 2 G203A/A326S heterotrimer,Inhibitor,,,,,,,,,,,,,,,
P78536_ADA17_353_cl1,ADA17_3o64B_786,P78536,P78536353,ADA17,353,cl1,3o64B,786,,3o64,1,2,,0,JiYoonShin,1,2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent_ selective and orally bioavailable TACE inhibitors.,Inhibitor,,,,,,,,,,,,,,,
Q02750_MP2K1_218p222_cl1,MP2K1_4an3A_5Y0,Q02750,Q02750218p222,MP2K1,218p222,cl1,4an3A,5Y0,,4an3,1,3,,Kinase,HoYoungLee,1,Novel Carboxamide-Based Allosteric Mek inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Inhibitor,allosteric,,,,,,,,,,,,,,
Q02750_MP2K1_218_cl1,MP2K1_4anbA_YQY,Q02750,Q02750218,MP2K1,218,cl1,4anbA,YQY,,4anb,1,3,,Kinase,HoYoungLee,1,Novel Carboxamide-Based Allosteric Mek inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Inhibitor,allosteric,,,,,,,,,,,,,,
Q02750_MP2K1_218p222_cl1,MP2K1_6v32B_3EW,Q02750,Q02750218p222,MP2K1,218p222,cl1,6v32B,3EW,,6v32,1,3,7M0T,Kinase,HoYoungLee,1,Allosteric MEK inhibitors act on BRAF/MEK complexes to block MEK activation.,Inhibitor,allosteric,,,,,,,,,,,,,,
Q02763_TIE2_964_cl1,TIE2_2wqbA_QQ1,Q02763,Q02763964,TIE2,964,cl1,2wqbA,QQ1,,2wqb,3,2,,Kinase,HoYoungLee,1,Novel Thienopyrimidine and Thiazolopyrimidine Kinase inhibitors with Activity Against Tie-2 in Vitro and in Vivo.,Inhibitor,,,,,,,,,,,,,,,
Q02763_TIE2_964_cl1,TIE2_4x3jA_3WR,Q02763,Q02763964,TIE2,964,cl1,4x3jA,3WR,,4x3j,3,2,,Kinase,HoYoungLee,1,Selection of fragments for kinase inhibitor design: decoration is key.,Inhibitor,,,,,,,,,,,,,,,
Q08881_ITK_435_cl1,ITK_3t9tA_IAQ,Q08881,Q08881435,ITK,435,cl1,3t9tA,IAQ,,3t9t,1,2,,Kinase,HoYoungLee,1,Imidazo[1_5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.,Inhibitor,,,,,,,,,,,,,,,
Q12923_PTN13_wild_cl1,PTN13_2m0zA_33B,Q12923,Q12923wild,PTN13,wild,cl1,2m0zA,33B,,2m0z,3,1,,phosphatase,SooYongLee,1,Kinetic response of a photoperturbed Allosteric protein.,Inhibitor,allosteric_ Covalent,,,,,,,,,,,,,,
Q13126_MTAP_wild_cl1,MTAP_1k27A_MTM,Q13126,Q13126wild,MTAP,wild,cl1,1k27A,MTM,,1k27,2,1,,0,JiYoonShin,1,Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A,Inhibitor,,,,,,,,,,,,,,,
Q13188_STK3_146_cl1,STK3_6ao5A_ANP,Q13188,Q13188146,STK3,146,cl1,6ao5A,ANP,,6ao5,2,1,,Kinase,HoYoungLee,1,SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.,Inhibitor,,,,,,,,,,,,,,,
Q13546_RIPK1_127_cl1,RIPK1_4itiB_1HW,Q13546,Q13546127,RIPK1,127,cl1,4itiB,1HW,,4iti,2,4,,Kinase,HoYoungLee,1,Structural Basis of RIP1 inhibition by Necrostatins.,Inhibitor,,,,,,,,,,,,,,,
Q13546_RIPK1_34p127_cl1,RIPK1_5hx6B_65U,Q13546,Q1354634p127,RIPK1,34p127,cl1,5hx6B,65U,,5hx6,2,4,,Kinase,HoYoungLee,1,DNA-Encoded Library Screening Identifies Benzo[b][1_4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase inhibitors.,Inhibitor,,,,,,,,,,,,,,,
Q13546_RIPK1_34_cl1,RIPK1_5tx5B_7MJ,Q13546,Q1354634,RIPK1,34,cl1,5tx5B,7MJ,,5tx5,2,4,,Kinase,HoYoungLee,1,Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases.,Inhibitor,,,,,,,,,,,,,,,
Q13635_PTC1_wild_cl1,PTC1_6rtwA_Y01,Q13635,Q13635wild,PTC1,wild,cl1,6rtwA,Y01,,6rtw,3,1,,0,JiYoonShin,1,The morphogen Sonic hedgehog inhibits its receptor Patched by a pincer grasp mechanism.,Inhibitor,,,,,,,,,,,,,,,
Q15119_PDK2_wild_cl1,PDK2_4mp7A_PFT,Q15119,Q15119wild,PDK2,wild,cl1,4mp7A,PFT,,4mp7,2,1,,Kinase,HoYoungLee,1,Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase inhibitors Targeting the ATP-binding Pocket.,Inhibitor,,,,,,,,,,,,,,,
Q15119_PDK2_wild_cl1,PDK2_5j6aA_P46,Q15119,Q15119wild,PDK2,wild,cl1,5j6aA,P46,,5j6a,2,1,,Kinase,HoYoungLee,1,Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase inhibitors.,Inhibitor,,,,,,,,,,,,,,,
Q16740_CLPP_wild_cl1,CLPP_6dl7G_ONC,Q16740,Q16740wild,CLPP,wild,cl1,6dl7G,ONC,,6dl7,3,1,,Peptidase,,1,Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.,Activator,,,,,,,,,,,,,,,
Q460N3_PAR15_wild_cl1,PAR15_6ek3B_OUL,Q460N3,Q460N3wild,PAR15,wild,cl1,6ek3B,OUL,,6ek3,2,1,,Transferase,,1,4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10.,Inhibitor,,,,,,,,,,,,,,,
Q460N3_PAR15_wild_cl1,PAR15_6ry4A_KMW,Q460N3,Q460N3wild,PAR15,wild,cl1,6ry4A,KMW,,6ry4,2,1,,Transferase,,1,Evaluation of 3- and 4-Phenoxybenzamides as Selective inhibitors of the Mono-ADP-Ribosyltransferase PARP10.,Inhibitor,,,,,,,,,,,,,,,
Q460N5_PAR14_wild_cl1,PAR14_5o2dA_9HH,Q460N5,Q460N5wild,PAR14,wild,cl1,5o2dA,9HH,,5o2d,2,2,,Transferase,,1,Discovery of a Selective Allosteric inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.,Inhibitor,allosteric,,,,,,,,,,,,,,
Q460N5_PAR14_wild_cl1,PAR14_3q71A_AR6,Q460N5,Q460N5wild,PAR14,wild,cl1,3q71A,AR6,,3q71,2,2,,Transferase,,1,Recognition of Mono-ADP-Ribosylated ARTD10 Substrates by ARTD8 Macrodomains.,inhibitor,,,,,,,,,,,,,,,
Q460N5_PAR14_wild_cl2,PAR14_4f1lD_0RY,Q460N5,Q460N5wild,PAR14,wild,cl2,4f1lD,0RY,,4f1l,2,2,,Transferase,,1,Discovery of Ligands for ADP-Ribosyltransferases via Docking-Based Virtual Screening.,inhibitor,,,,,,,,,,,,,,,
Q460N5_PAR14_wild_cl2,PAR14_5v7wB_91J,Q460N5,Q460N5wild,PAR14,wild,cl2,5v7wB,91J,,5v7w,2,2,,Transferase,,1,Identification of PARP14 inhibitors using novel methods for detecting auto-ribosylation.,Inhibitor,,,,,,,,,,,,,,,
Q4FZB7_SV421_wild_cl1,SV421_5cprB_539,Q4FZB7,Q4FZB7wild,SV421,wild,cl1,5cprB,539,,5cpr,3,1,,methylase,SooYongLee,1,The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.,Inhibitor,,,,,,,,,,,,,,,
Q4FZB7_SV421_wild_cl1,SV421_5wbvB_9ZY,Q4FZB7,Q4FZB7wild,SV421,wild,cl1,5wbvB,9ZY,,5wbv,3,1,,methylase,SooYongLee,1,Crystal Structure of the SET Domain of Human SUV420H1 In Complex With inhibitor,Inhibitor,,,,,,,,,,,,,,,
Q53GL7_PAR10_wild_cl1,PAR10_6fxiB_CIT,Q53GL7,Q53GL7wild,PAR10,wild,cl1,6fxiB,CIT,,6fxi,2,1,,Transferase,,1,Human PARP10 (ARTD10)_ catalytic fragment in complex with 3-aminobenzamide and citrate,-,-,,,,,,,,,,,,,,
Q53GL7_PAR10_wild_cl1,PAR10_5lx6A_78P,Q53GL7,Q53GL7wild,PAR10,wild,cl1,5lx6A,78P,,5lx6,2,1,,Transferase,,1,Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase inhibitors.,Inhibitor,,,,,,,,,,,,,,,
Q5TCX8_M3KL4_307_cl1,M3KL4_4uyaA_AGS,Q5TCX8,Q5TCX8307,M3KL4,307,cl1,4uyaA,AGS,,4uya,3,1,,Kinase,HoYoungLee,1,Recurrent Mlk4 Loss-of-Function Mutations Suppress Jnk Signaling to Promote Colon Tumorigenesis.,Inhibitor,,,,,,,,,,,,,,,
Q6VAB6_KSR2_wild_cl1,KSR2_7juqB_ADP,Q6VAB6,Q6VAB6wild,KSR2,wild,cl1,7juqB,ADP,,7juq,3,1,,Kinase,HoYoungLee,1,Structural basis for the action of the drug trametinib at KSR-bound MEK.,Inhibitor,,,,,,,,,,,,,,,
Q6VAB6_KSR2_wild_cl1,KSR2_7jusB_ANP,Q6VAB6,Q6VAB6wild,KSR2,wild,cl1,7jusB,ANP,,7jus,3,1,,Kinase,HoYoungLee,1,Structural basis for the action of the drug trametinib at KSR-bound MEK.,Inhibitor,,,,,,,,,,,,,,,
Q86X55_CARM1_wild_cl1,CARM1_2y1wD_849,Q86X55,Q86X55wild,CARM1,wild,cl1,2y1wD,849,,2y1w,2,1,,methylase,SooYongLee,1,Structural Basis for Carm1 inhibition by Indole and Pyrazole inhibitors,Inhibitor,,,,,,,,,,,,,,,
Q86X55_CARM1_wild_cl1,CARM1_6arjD_BW4,Q86X55,Q86X55wild,CARM1,wild,cl1,6arjD,BW4,,6arj,2,1,,methylase,SooYongLee,1,Identification of a CARM1 inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma.,Inhibitor,,,,,,,,,,,,,,,
Q8IVT5_KSR1_wild_cl1,KSR1_7jv0A_ANP,Q8IVT5,Q8IVT5wild,KSR1,wild,cl1,7jv0A,ANP,,7jv0,3,1,,Kinase,HoYoungLee,1,Structural basis for the action of the drug trametinib at KSR-bound MEK.,Inhibitor,,,,,,,,,,,,,,,
Q8IVW4_CDKL3_158p160_cl1,CDKL3_3zduA_38R,Q8IVW4,Q8IVW4158p160,CDKL3,158p160,cl1,3zduA,38R,,3zdu,3,1,,Kinase,HoYoungLee,1,CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.,Inhibitor,,,,,,,,,,,,,,,
Q8NEB9_PK3C3_612p616p634p682p684_cl1,PK3C3_6i3uA_H2E,Q8NEB9,Q8NEB9612p616p634p682p684,PK3C3,612p616p634p682p684,cl1,6i3uA,H2E,,6i3u,1,2,,Kinase,HoYoungLee,1,Optimization of Potent and Selective Ataxia Telangiectasia-Mutated inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models.,Inhibitor,,,,,,,,,,,,,,,
Q8TBK2_SETD6_wild_cl1,SETD6_3rc0B_SAM,Q8TBK2,Q8TBK2wild,SETD6,wild,cl1,3rc0B,SAM,,3rc0,3,1,,methylase,SooYongLee,1,Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling.,Inhibitor,,,,,,,,,,,,,,,
Q8TCG2_PI4K2B_wild_cl1,PI4K2B_4wtvB_ATP,Q8TCG2,Q8TCG2wild,PI4K2B,wild,cl1,4wtvB,ATP,,4wtv,3,1,,Kinase,HoYoungLee,1,The high-resolution crystal structure of phosphatidylinositol 4-kinase II beta and the crystal structure of phosphatidylinositol 4-kinase II alpha containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design.,Inhibitor,,,,,,,,,,,,,,,
Q92835_SHIP1_wild_cl1,SHIP1_5rwoA_AXG,Q92835,Q92835wild,SHIP1,wild,cl1,5rwoA,AXG,,5rwo,2,2,,phosphatase,SooYongLee,1,INPP5D PanDDA analysis group deposition,-,,,,,,,,,,,,,,,
Q92835_SHIP1_wild_cl1,SHIP1_5rxmA_GWV,Q92835,Q92835wild,SHIP1,wild,cl1,5rxmA,GWV,,5rxm,2,2,,phosphatase,SooYongLee,1,INPP5D PanDDA analysis group deposition,-,,,,,,,,,,,,,,,
Q92835_SHIP1_wild_cl2,SHIP1_5rxpA_AWD,Q92835,Q92835wild,SHIP1,wild,cl2,5rxpA,AWD,,5rxp,2,2,,phosphatase,SooYongLee,1,INPP5D PanDDA analysis group deposition,-,,,,,,,,,,,,,,,
Q92835_SHIP1_wild_cl2,SHIP1_5ry3A_WKA,Q92835,Q92835wild,SHIP1,wild,cl2,5ry3A,WKA,,5ry3,2,2,,phosphatase,SooYongLee,1,INPP5D PanDDA analysis group deposition,-,,,,,,,,,,,,,,,
Q93009_UBP7_wild_cl1,UBP7_5n9rB_8RN,Q93009,Q93009wild,UBP7,wild,cl1,5n9rB,8RN,,5n9r,1,2,,Peptidase,,1,Discovery and characterization of highly potent and selective Allosteric USP7 inhibitors.,Inhibitor,allosteric,,,,,,,,,,,,,,
Q93009_UBP7_wild_cl1,UBP7_5ngfB_8WN,Q93009,Q93009wild,UBP7,wild,cl1,5ngfB,8WN,,5ngf,1,2,,Peptidase,,1,Molecular basis of USP7 inhibition by selective small-molecule inhibitors.,Inhibitor,,,,,,,,,,,,,,,
Q93009_UBP7_wild_cl2,UBP7_5uqvB_8JM,Q93009,Q93009wild,UBP7,wild,cl2,5uqvB,8JM,,5uqv,1,2,,Peptidase,,1,USP7 small-molecule inhibitors interfere with ubiquitin binding.,Inhibitor,,,,,,,,,,,,,,,
Q93009_UBP7_wild_cl2,UBP7_5uqxB_8JP,Q93009,Q93009wild,UBP7,wild,cl2,5uqxB,8JP,,5uqx,1,2,,Peptidase,,1,USP7 small-molecule inhibitors interfere with ubiquitin binding.,Inhibitor,,,,,,,,,,,,,,,
Q93096_TP4A1_wild_cl1,TP4A1_5bx1A_4XA,Q93096,Q93096wild,TP4A1,wild,cl1,5bx1A,4XA,,5bx1,3,1,,phosphatase,SooYongLee,1,Crystal Structure of PRL-1 complex with compound analogy 3,Inhibitor,,,,,,,,,,,,,,,
Q96DC9_OTUB2_wild_cl1,OTUB2_5qiqA_J5A,Q96DC9,Q96DC9wild,OTUB2,wild,cl1,5qiqA,J5A,,5qiq,3,1,,Peptidase,,1,Covalent fragment group deposition,inhibitor,Covalent,,,,,,,,,,,,,,
Q96DC9_OTUB2_wild_cl1,OTUB2_5qirA_J5D,Q96DC9,Q96DC9wild,OTUB2,wild,cl1,5qirA,J5D,,5qir,3,1,,Peptidase,,1,Covalent fragment group deposition,inhibitor,Covalent,,,,,,,,,,,,,,
Q96GX5_GWL_wild_cl1,GWL_5lohB_STU,Q96GX5,Q96GX5wild,GWL,wild,cl1,5lohB,STU,,5loh,3,1,,Kinase,HoYoungLee,1,A first generation inhibitor of human Greatwall kinase_ enabled by structural and functional characterisation of a minimal kinase domain construct.,Inhibitor,,,,,,,,,,,,,,,
Q96QZ7_MAGI1_wild_cl1,MAGI1_2r4hA_HIS,Q96QZ7,Q96QZ7wild,MAGI1,wild,cl1,2r4hA,HIS,,2r4h,3,1,,0,JiYoonShin,1,Crystal structure of a C1190S mutant of the 6th PDZ domain of human membrane associated guanylate kinase.,apo,,,,,,,,,,,,,,,
Q9BTU6_PI4K2A_wild_cl1,PI4K2A_4hneB_ADP,Q9BTU6,Q9BTU6wild,PI4K2A,wild,cl1,4hneB,ADP,,4hne,3,2,,Kinase,HoYoungLee,1,Molecular insights into the membrane-associated phosphatidylinositol 4-kinase II alpha.,Inhibitor,Orthosteric,,,,,,,,,,,,,,
Q9BTU6_PI4K2A_wild_cl2,PI4K2A_4yc4A_ADP,Q9BTU6,Q9BTU6wild,PI4K2A,wild,cl2,4yc4A,ADP,,4yc4,3,2,,Kinase,HoYoungLee,1,The high-resolution crystal structure of phosphatidylinositol 4-kinase II beta and the crystal structure of phosphatidylinositol 4-kinase II alpha containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design.,Inhibitor,,,,,,,,,,,,,,,
Q9BTU6_PI4K2A_wild_cl1,PI4K2A_5i0nA_ATP,Q9BTU6,Q9BTU6wild,PI4K2A,wild,cl1,5i0nA,ATP,,5i0n,3,2,,Kinase,HoYoungLee,1,PI4K IIalpha bound to calcium,Inhibitor,,,,,,,,,,,,,,,
Q9H0J9_PAR12_570p573p577p607_cl1,PAR12_6v3wA_QO4,Q9H0J9,Q9H0J9570p573p577p607,PAR12,570p573p577p607,cl1,6v3wA,QO4,,6v3w,3,1,,Transferase,,1,PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.,Inhibitor,,,,,,,,,,,,,,,
Q9H4A3_WNK1_378_cl1,WNK1_5we8B_A7Y,Q9H4A3,Q9H4A3378,WNK1,378,cl1,5we8B,A7Y,,5we8,3,1,,Kinase,HoYoungLee,1,Optimization of Allosteric With-No-Lysine (WNK) Kinase inhibitors and Efficacy in Rodent Hypertension Models.,Inhibitor,allosteric,,,,,,,,,,,,,,
Q9HBH9_MKNK2_228_cl1,MKNK2_6ck6A_N45,Q9HBH9,Q9HBH9228,MKNK2,228,cl1,6ck6A,N45,,6ck6,2,2,,Kinase,HoYoungLee,1,Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) inhibition.,Inhibitor,,,,,,,,,,,,,,,
Q9HBH9_MKNK2_228_cl1,MKNK2_6ckiA_FZJ,Q9HBH9,Q9HBH9228,MKNK2,228,cl1,6ckiA,FZJ,,6cki,2,2,,Kinase,HoYoungLee,1,Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) inhibition.,Inhibitor,,,,,,,,,,,,,,,
Q9HD26_GOPC_wild_cl1,GOPC_5ic3A_PQR,Q9HD26,Q9HD26wild,GOPC,wild,cl1,5ic3A,PQR,,5ic3,3,3,,0,JiYoonShin,1,CAL PDZ domain with peptide and inhibitor,Inhibitor,,,,,,,,,,,,,,,
Q9HD26_GOPC_wild_cl2,GOPC_7jzoB_QTU,Q9HD26,Q9HD26wild,GOPC,wild,cl2,7jzoB,QTU,,7jzo,3,3,,0,JiYoonShin,1,CFTR Associated Ligand (CAL) PDZ domain bound to peptidomimetic LyCALTPP,inhibitor,,,,,,,,,,,,,,,
Q9HD26_GOPC_wild_cl3,GOPC_7jzqA_VU1,Q9HD26,Q9HD26wild,GOPC,wild,cl3,7jzqA,VU1,,7jzq,3,3,,0,JiYoonShin,1,CFTR Associated Ligand (CAL) PDZ domain bound to peptidomimetic LyCALPMB,inhibitor,,,,,,,,,,,,,,,
Q9NR22_ANM8_wild_cl1,ANM8_4x41A_SAH,Q9NR22,Q9NR22wild,ANM8,wild,cl1,4x41A,SAH,,4x41,2,1,,methylase,SooYongLee,1,Protein Arginine Methyltransferase 8: Tetrameric Structure and Protein Substrate Specificity,Inhibitor,,,,,,,,,,,,,,,
Q9NR22_ANM8_wild_cl1,ANM8_5dstM_SAH,Q9NR22,Q9NR22wild,ANM8,wild,cl1,5dstM,SAH,,5dst,2,1,,methylase,SooYongLee,1,Novel helical assembly in arginine methyltransferase 8,Inhibitor,,,,,,,,,,,,,,,
Q9NYY3_PLK2_87_cl1,PLK2_4i6fA_1C7,Q9NYY3,Q9NYY387,PLK2,87,cl1,4i6fA,1C7,,4i6f,2,1,,Kinase,HoYoungLee,1,Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce alpha-synuclein phosphorylation in rat brain.,Inhibitor,,,,,,,,,,,,,,,
Q9NYY3_PLK2_87_cl1,PLK2_4i6hA_1C8,Q9NYY3,Q9NYY387,PLK2,87,cl1,4i6hA,1C8,,4i6h,2,1,,Kinase,HoYoungLee,1,Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) inhibitors that Reduce   alpha-Synuclein Phosphorylation in Rat Brain,Inhibitor,,,,,,,,,,,,,,,
Q9NZJ5_E2AK3_937_cl1,E2AK3_4x7kA_3Z3,Q9NZJ5,Q9NZJ5937,E2AK3,937,cl1,4x7kA,3Z3,,4x7k,2,2,,Kinase,HoYoungLee,1,Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK).,Inhibitor,,,,,,,,,,,,,,,
Q9NZJ5_E2AK3_937_cl1,E2AK3_4x7lA_3Z4,Q9NZJ5,Q9NZJ5937,E2AK3,937,cl1,4x7lA,3Z4,,4x7l,2,2,,Kinase,HoYoungLee,1,Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK).,Inhibitor,,,,,,,,,,,,,,,
Q9UBF8_PI4KB_294_cl1,PI4KB_5euqE_5S8,Q9UBF8,Q9UBF8294,PI4KB,294,cl1,5euqE,5S8,,5euq,1,2,,Kinase,HoYoungLee,1,Design and Structural Characterization of Potent and Selective inhibitors of Phosphatidylinositol 4 Kinase III beta.,Inhibitor,,,,,,,,,,,,,,,
Q9UHD2_TBK1_135_cl1,TBK1_4im0A_1FV,Q9UHD2,Q9UHD2135,TBK1,135,cl1,4im0A,1FV,,4im0,2,2,,Kinase,HoYoungLee,1,Structure and ubiquitination-dependent activation of TANK-binding kinase 1.,Inhibitor,,,,,,,,,,,,,,,
Q9UHD2_TBK1_135_cl1,TBK1_4iw0A_BX7,Q9UHD2,Q9UHD2135,TBK1,135,cl1,4iw0A,BX7,,4iw0,2,2,,Kinase,HoYoungLee,1,Crystal structure and mechanism of activation of TANK-binding kinase 1.,Inhibitor,,,,,,,,,,,,,,,
Q9UHL4_DPP2_wild_cl1,DPP2_3n0tB_OPY,Q9UHL4,Q9UHL4wild,DPP2,wild,cl1,3n0tB,OPY,,3n0t,2,1,,Peptidase,,1,Human dipeptidyl peptidase DPP7,inhibitor,,,,,,,,,,,,,,,
Q9UIC8_LCMT1_wild_cl1,LCMT1_3ieiH_SAH,Q9UIC8,Q9UIC8wild,LCMT1,wild,cl1,3ieiH,SAH,,3iei,3,1,,methylase,SooYongLee,1,Structural Insights into Novel Functions of a pro-survival PP2A-specific Methyltransferase,Inhibitor,,,,,,,,,,,,,,,
Q9UIC8_LCMT1_wild_cl1,LCMT1_3o7wA_SAM,Q9UIC8,Q9UIC8wild,LCMT1,wild,cl1,3o7wA,SAM,,3o7w,3,1,,methylase,SooYongLee,1,The structure of human leucine carboxyl methyltransferase 1 that regulates protein phosphatase PP2A,Inhibitor,,,,,,,,,,,,,,,
Q9UQM7_KCC2A_135_cl1,KCC2A_6vzkA_HC4,Q9UQM7,Q9UQM7135,KCC2A,135,cl1,6vzkA,HC4,,6vzk,2,2,,Kinase,HoYoungLee,1,Characterization of CaMKII alpha holoenzyme stability.,Inhibitor,,,,,,,,,,,,,,,
Q9UQM7_KCC2A_135_cl1,KCC2A_6x5gA_BCN,Q9UQM7,Q9UQM7135,KCC2A,135,cl1,6x5gA,BCN,,6x5g,2,2,,Kinase,HoYoungLee,1,CaMKII binds both substrates and activators at the active site.,Inhibitor,,,,,,,,,,,,,,,
Q9Y4E8_UBP15_wild_cl1,UBP15_6gh9A_MIX,Q9Y4E8,Q9Y4E8wild,UBP15,wild,cl1,6gh9A,MIX,,6gh9,3,1,,Peptidase,,1,The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel.,inhibitor,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
P11177_PDHB_wild_cl1,PDHB_3exfD_TPP,P11177,,PDHB,wild,cl1,3exfD,TPP,,3exf,3,1,,0,,,Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.,?,Apo protein,0,,,,,,,,,,,,,
O00481_BTN3A1_wild_cl2,BTN3A1_4jkwA_IPE,O00481,,BTN3A1,wild,cl2,4jkwA,IPE,,4jkw,2,2,,0,,,Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gamma delta T cells.,agonist,,0,,,,,,,,,,,,,
O00481_BTN3A1_wild_cl2,BTN3A1_4k55A_H6P,O00481,,BTN3A1,wild,cl2,4k55A,H6P,,4k55,2,2,,0,,,Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gamma delta T cells.,agonist,,0,,,,,,,,,,,,,
O00571_DDX3X_wild_cl1,DDX3X_4px9B_ADP,O00571,,DDX3X,wild,cl1,4px9B,ADP,,4px9,2,2,,0,,,Cancer-Associated Mutants of RNA Helicase DDX3X Are Defective in RNA-stimulated ATP Hydrolysis.,agonist,,0,,,,,,,,,,,,,
P07148_FABP1_wild_cl1,FABP1_6drgA_2VN,P07148,,FABP1,wild,cl1,6drgA,2VN,,6drg,2,1,,0,,,A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor alpha Agonists.,agonist,,0,,,,,,,,,,,,,
A0A6M4NAY4_A0A6M4NAY4_wild_cl1,A0A6M4NAY4_7b83A_PK8,A0A6M4NAY4,,A0A6M4NAY4,wild,cl1,7b83A,PK8,,7b83,3,1,,0,,,X-ray screening identifies active site and Allosteric inhibitors of SARS-CoV-2 main protease.,inhibitor,allosteric,0,,,,,,,,,,,,,
O00255_MEN1_wild_cl2,MEN1_6e1aA_7PR,O00255,,MEN1,wild,cl2,6e1aA,7PR,,6e1a,3,2,,0,,,Structure-Based Discovery of M-89 as a Highly Potent inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction.,inhibitor,,0,,,,,,,,,,,,,
O00571_DDX3X_wild_cl1,DDX3X_5e7mA_ANP,O00571,,DDX3X,wild,cl1,5e7mA,ANP,,5e7m,2,2,,0,,,Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.,inhibitor,,0,,,,,,,,,,,,,
O00625_PIR_wild_cl1,PIR_3aclA_3F1,O00625,,PIR,wild,cl1,3aclA,3F1,,3acl,2,1,,0,,,A small-molecule inhibitor shows that pirin regulates migration of melanoma cells,inhibitor,,0,,,,,,,,,,,,,
O14640_DVL1_wild_cl1,DVL1_6lcbA_E83,O14640,,DVL1,wild,cl1,6lcbA,E83,,6lcb,3,1,,0,,,Crystal structure of human Dishevelled1 PDZ domain with its inhibitor NPL3009,inhibitor,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl3,PTGES_4yk5A_JZR,O14684,,PTGES,wild,cl3,4yk5A,JZR,,4yk5,3,4,,0,,,Crystal Structures of mPGES-1 inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics.,inhibitor,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl2,PTGES_5tl9A_7DN,O14684,,PTGES,wild,cl2,5tl9A,7DN,,5tl9,3,4,,0,,,Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1.,inhibitor,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl3,PTGES_5tl9A_JZR,O14684,,PTGES,wild,cl3,5tl9A,JZR,,5tl9,3,4,,0,,,Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1.,inhibitor,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl1,PTGES_5bqgA_4UJ,O14684,,PTGES,wild,cl1,5bqgA,4UJ,,5bqg,3,4,,0,,,Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl4,PTGES_5bqhA_1KA,O14684,,PTGES,wild,cl4,5bqhA,1KA,,5bqh,3,4,,0,,,Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O14786_NRP1_wild_cl1,NRP1_3i97A_8DR,O14786,,NRP1,wild,cl1,3i97A,8DR,,3i97,2,1,,0,,,Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.,inhibitor,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl3,MDM4_7kjnA_DLE,O15151,,MDM4,wild,cl3,7kjnA,DLE,,7kjn,1,7,,0,,,CRYSTAL STRUCTURE OF HUMAN MDMX IN COMPLEX WITH D-PEPTIDE inhibitor(DPMI-OMEGA),inhibitor,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl5,MDM4_7kjnA_DTY,O15151,,MDM4,wild,cl5,7kjnA,DTY,,7kjn,1,7,,0,,,CRYSTAL STRUCTURE OF HUMAN MDMX IN COMPLEX WITH D-PEPTIDE inhibitor(DPMI-OMEGA),inhibitor,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl1,MDM4_3lbjE_WW8,O15151,,MDM4,wild,cl1,3lbjE,WW8,,3lbj,1,7,,0,,,Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery,inhibitor,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl2,GMDS_5in4B_6CK,O60547,,GMDS,wild,cl2,5in4B,6CK,,5in4,3,5,,0,,,Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin inhibitors and Cocrystal Structure with GDP-Mannose 4_6-Dehydratase.,inhibitor,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl2,GMDS_5in5B_GFB,O60547,,GMDS,wild,cl2,5in5B,GFB,,5in5,3,5,,0,,,Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin inhibitors and Cocrystal Structure with GDP-Mannose 4_6-Dehydratase.,inhibitor,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl5,GMDS_5in4A_6CK,O60547,,GMDS,wild,cl5,5in4A,6CK,,5in4,3,5,,0,,,Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin inhibitors and Cocrystal Structure with GDP-Mannose 4_6-Dehydratase.,inhibitor,,0,,,,,,,,,,,,,
O60760_HPGDS_wild_cl1,HPGDS_5aisC_CWC,O60760,,HPGDS,wild,cl1,5aisC,CWC,,5ais,1,1,,0,,,Identification of Indole inhibitors of Human Hematopoietic Prostaglandin D2 Synthase (Hh-Pgds).,inhibitor,,0,,,,,,,,,,,,,
O60760_HPGDS_wild_cl1,HPGDS_5aixC_KRX,O60760,,HPGDS,wild,cl1,5aixC,KRX,,5aix,1,1,,0,,,Identification of Indole inhibitors of Human Hematopoietic Prostaglandin D2 Synthase (Hh-Pgds).,inhibitor,,0,,,,,,,,,,,,,
O60825_PFKFB2_wild_cl1,PFKFB2_5htkA_ATP,O60825,,PFKFB2,wild,cl1,5htkA,ATP,,5htk,3,1,,0,,,Crystal structure of heart 6-phosphofructo-2-kinase/fructose-2_6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding.,inhibitor,,0,,,,,,,,,,,,,
O75530_EED_wild_cl1,EED_6sfcA_L9W,O75530,,EED,wild,cl1,6sfcA,L9W,,6sfc,1,3,,0,,,Rapid Identification of Novel Allosteric PRC2 inhibitors.,inhibitor,allosteric,0,,,,,,,,,,,,,
O75530_EED_wild_cl1,EED_5h14A_LQB,O75530,,EED,wild,cl1,5h14A,LQB,,5h14,1,3,,0,,,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 inhibitors Recognition by EED,inhibitor,,0,,,,,,,,,,,,,
O75530_EED_wild_cl3,EED_6w7gA_Q3A,O75530,,EED,wild,cl3,6w7gA,Q3A,,6w7g,1,3,,0,,,EEDi-5285: An Exceptionally Potent_ Efficacious_ and Orally Active Small-Molecule inhibitor of Embryonic Ectoderm Development.,inhibitor,,0,,,,,,,,,,,,,
O75530_EED_wild_cl2,EED_5ij7E_6BN,O75530,,EED,wild,cl2,5ij7E,6BN,,5ij7,1,3,,0,,,Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.,inhibitor,,0,,,,,,,,,,,,,
O75581_LRP6_wild_cl2,LRP6_6l6rB_FUC,O75581,,LRP6,wild,cl2,6l6rB,FUC,,6l6r,3,2,,0,,,Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains.,inhibitor,,0,,,,,,,,,,,,,
O75581_LRP6_wild_cl1,LRP6_3s2kA_FUC,O75581,,LRP6,wild,cl1,3s2kA,FUC,,3s2k,3,2,,0,,,Structural Basis of Wnt Signaling inhibition by Dickkopf Binding to LRP5/6.,inhibitor,,0,,,,,,,,,,,,,
O75936_BBOX1_wild_cl1,BBOX1_4bgkA_RTK,O75936,,BBOX1,wild,cl1,4bgkA,RTK,,4bgk,1,2,,0,,,Targeting Carnitine Biosynthesis: Discovery of New inhibitors Against Gamma-Butyrobetaine Hydroxylase.,inhibitor,,0,,,,,,,,,,,,,
O75936_BBOX1_wild_cl1,BBOX1_4bhiA_RUJ,O75936,,BBOX1,wild,cl1,4bhiA,RUJ,,4bhi,1,2,,0,,,Targeting Carnitine Biosynthesis: Discovery of New inhibitors Against Gamma-Butyrobetaine Hydroxylase.,inhibitor,,0,,,,,,,,,,,,,
O75936_BBOX1_wild_cl2,BBOX1_4c5wA_16D,O75936,,BBOX1,wild,cl2,4c5wA,16D,,4c5w,1,2,,0,,,Targeting Carnitine Biosynthesis: Discovery of New inhibitors Against Gamma-Butyrobetaine Hydroxylase.,inhibitor,,0,,,,,,,,,,,,,
O94760_DDAH1_wild_cl1,DDAH1_3p8eA_LN7,O94760,,DDAH1,wild,cl1,3p8eA,LN7,,3p8e,2,1,,0,,,Characterization of C-Alkyl Amidines as Bioavailable Covalent Reversible inhibitors of Human DDAH-1.,inhibitor,,0,,,,,,,,,,,,,
O94760_DDAH1_wild_cl1,DDAH1_6szpA_M3B,O94760,,DDAH1,wild,cl1,6szpA,M3B,,6szp,2,1,,0,,,Discovery ofN-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective_ Nonamino Acid_ Catalytic Site inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1).,inhibitor,,0,,,,,,,,,,,,,
O95470_SGPL1_wild_cl1,SGPL1_4q6rA_30J,O95470,,SGPL1,wild,cl1,4q6rA,30J,,4q6r,3,2,,0,,,Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis.,inhibitor,,0,,,,,,,,,,,,,
O95470_SGPL1_wild_cl1,SGPL1_4q6rB_30J,O95470,,SGPL1,wild,cl1,4q6rB,30J,,4q6r,3,2,,0,,,Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis.,inhibitor,,0,,,,,,,,,,,,,
O95470_SGPL1_wild_cl2,SGPL1_4q6rA_30J,O95470,,SGPL1,wild,cl2,4q6rA,30J,,4q6r,3,2,,0,,,Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis.,inhibitor,,0,,,,,,,,,,,,,
O95551_TDP2_wild_cl1,TDP2_5j3sA_6FQ,O95551,,TDP2,wild,cl1,5j3sA,6FQ,,5j3s,3,1,,0,,,Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2.,inhibitor,,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl2,LDHA_6sbvC_L5K,P00338,,LDHA,wild,cl2,6sbvC,L5K,,6sbv,1,5,,0,,,Structural Evidence for Isoform-Selective Allosteric inhibition of Lactate Dehydrogenase A.,inhibitor,allosteric,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl2,LDHA_6sbuA_L5N,P00338,,LDHA,wild,cl2,6sbuA,L5N,,6sbu,1,5,,0,,,Structural Evidence for Isoform-Selective Allosteric inhibition of Lactate Dehydrogenase A.,inhibitor,allosteric,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl3,LDHA_6sbuD_L5N,P00338,,LDHA,wild,cl3,6sbuD,L5N,,6sbu,1,5,,0,,,Structural Evidence for Isoform-Selective Allosteric inhibition of Lactate Dehydrogenase A.,inhibitor,allosteric,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl3,LDHA_6sbvA_L5K,P00338,,LDHA,wild,cl3,6sbvA,L5K,,6sbv,1,5,,0,,,Structural Evidence for Isoform-Selective Allosteric inhibition of Lactate Dehydrogenase A.,inhibitor,allosteric,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl5,LDHA_5w8hB_9Y1,P00338,,LDHA,wild,cl5,5w8hB,9Y1,,5w8h,1,5,,0,,,Discovery and Optimization of Potent_ Cell-Active Pyrazole-Based inhibitors of Lactate Dehydrogenase (LDH).,inhibitor,,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl4,LDHA_5zjfA_9G9,P00338,,LDHA,wild,cl4,5zjfA,9G9,,5zjf,1,5,,0,,,Machilin A inhibits Tumor Growth and Macrophage M2 Polarization Through the Reduction of Lactic Acid.,inhibitor,,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl4,LDHA_5zjfC_9G9,P00338,,LDHA,wild,cl4,5zjfC,9G9,,5zjf,1,5,,0,,,Machilin A inhibits Tumor Growth and Macrophage M2 Polarization Through the Reduction of Lactic Acid.,inhibitor,,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl1,LDHA_6bazC_NAD,P00338,,LDHA,wild,cl1,6bazC,NAD,,6baz,1,5,,0,,,Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam inhibitors of Human Lactate Dehydrogenase,inhibitor,,0,,,,,,,,,,,,,
P00338_LDHA_wild_cl1,LDHA_6bb0D_NAD,P00338,,LDHA,wild,cl1,6bb0D,NAD,,6bb0,1,5,,0,,,Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam inhibitors of Human Lactate Dehydrogenase,inhibitor,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl1,IL1B_5r8mA_S8G,P01584,,IL1B,wild,cl1,5r8mA,S8G,,5r8m,1,3,,0,,,Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.,inhibitor,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl1,IL1B_5r8eA_S7S,P01584,,IL1B,wild,cl1,5r8eA,S7S,,5r8e,1,3,,0,,,Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.,inhibitor,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl2,IL1B_5r8kA_S8D,P01584,,IL1B,wild,cl2,5r8kA,S8D,,5r8k,1,3,,0,,,Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.,inhibitor,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl2,IL1B_5r8fA_K3Y,P01584,,IL1B,wild,cl2,5r8fA,K3Y,,5r8f,1,3,,0,,,Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.,inhibitor,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl3,IL1B_5r86A_GT4,P01584,,IL1B,wild,cl3,5r86A,GT4,,5r86,1,3,,0,,,Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein inhibitors: Two Test Cases Illustrated by IL1 beta-IL1R and p38 alpha-TAB1 Complexes.,inhibitor,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl1,TTR_4ky2A_1W3,P02766,,TTR,wild,cl1,4ky2A,1W3,,4ky2,1,5,,0,,,Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors.,inhibitor,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl4,TTR_6imyA_AJU,P02766,,TTR,wild,cl4,6imyA,AJU,,6imy,1,5,,0,,,Crown Ethers as Transthyretin Amyloidogenesis inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl5,TTR_6imyB_AJU,P02766,,TTR,wild,cl5,6imyB,AJU,,6imy,1,5,,0,,,Crown Ethers as Transthyretin Amyloidogenesis inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P04040_CAT_wild_cl1,CAT_1dgbA_NDP,P04040,,CAT,wild,cl1,1dgbA,NDP,,1dgb,3,2,,0,,,Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism.,inhibitor,,0,,,,,,,,,,,,,
P04040_CAT_wild_cl1,CAT_1dgbC_NDP,P04040,,CAT,wild,cl1,1dgbC,NDP,,1dgb,3,2,,0,,,Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism.,inhibitor,,0,,,,,,,,,,,,,
P04040_CAT_wild_cl2,CAT_1dgfA_HEM,P04040,,CAT,wild,cl2,1dgfA,HEM,,1dgf,3,2,,0,,,Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism.,inhibitor,,0,,,,,,,,,,,,,
P05121_SERPINE1_wild_cl2,SERPINE1_1a7cA_RIP,P05121,,SERPINE1,wild,cl2,1a7cA,RIP,,1a7c,2,3,,0,,,Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide,inhibitor,,0,,,,,,,,,,,,,
P05121_SERPINE1_wild_cl3,SERPINE1_4g8oD_96P,P05121,,SERPINE1,wild,cl3,4g8oD,96P,,4g8o,2,3,,0,,,Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.,inhibitor,,0,,,,,,,,,,,,,
P05413_FABP3_wild_cl1,FABP3_5hz9D_5M8,P05413,,FABP3,wild,cl1,5hz9D,5M8,,5hz9,1,2,,0,,,Design and synthesis of selective_ dual fatty acid binding protein 4 and 5 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P06744_GPI_wild_cl1,GPI_1iriD_E4P,P06744,,GPI,wild,cl1,1iriD,E4P,,1iri,3,1,,0,,,inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.,inhibitor,,0,,,,,,,,,,,,,
P06744_GPI_wild_cl1,GPI_6xuhC_PA5,P06744,,GPI,wild,cl1,6xuhC,PA5,,6xuh,3,1,,0,,,Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis_ structure-activity relationship and crystallographic studies.,inhibitor,,0,,,,,,,,,,,,,
P08243_ASNS_wild_cl1,ASNS_6gq3A_ONL,P08243,,ASNS,wild,cl1,6gq3A,ONL,,6gq3,3,1,,0,,,High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity.,inhibitor,,0,,,,,,,,,,,,,
P08514_ITGA2B_wild_cl1,ITGA2B_3t3mA_RC2,P08514,,ITGA2B,wild,cl1,3t3mA,RC2,,3t3m,3,1,,0,,,Structure-Guided Design of a High-Affinity Platelet  Integrin alphaIIbbeta3 Receptor antagonist That Disrupts  Mg2+ Binding to the MIDAS,inhibitor,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl3,GSTP1_5jcwA_GSH,P09211,,GSTP1,wild,cl3,5jcwA,GSH,,5jcw,1,4,,0,,,Irreversible inhibition of Glutathione S-Transferase by Phenethyl Isothiocyanate (PEITC)_ a Dietary Cancer Chemopreventive Phytochemical.,inhibitor,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl3,GSTP1_5jcwB_GSH,P09211,,GSTP1,wild,cl3,5jcwB,GSH,,5jcw,1,4,,0,,,Irreversible inhibition of Glutathione S-Transferase by Phenethyl Isothiocyanate (PEITC)_ a Dietary Cancer Chemopreventive Phytochemical.,inhibitor,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl2,GSTP1_1aqxD_MES,P09211,,GSTP1,wild,cl2,1aqxD,MES,,1aqx,1,4,,0,,,Structures of class pi glutathione S-transferase from human placenta in complex with substrate_ transition-state analogue and inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl2,GSTP1_1aqwA_MES,P09211,,GSTP1,wild,cl2,1aqwA,MES,,1aqw,1,4,,0,,,Structures of class pi glutathione S-transferase from human placenta in complex with substrate_ transition-state analogue and inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl1,FBP1_2wbdE_RO5,P09467,,FBP1,wild,cl1,2wbdE,RO5,,2wbd,1,3,,0,,,Sulfonylureido Thiazoles as Fructose-1_6-Bisphosphatase inhibitors for the Treatment of Type-2 Diabetes.,inhibitor,,0,,,,,,,,,,,,,
P09601_HMOX1_wild_cl1,HMOX1_6ehaA_B5B,P09601,,HMOX1,wild,cl1,6ehaA,B5B,,6eha,3,2,,0,,,Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.,inhibitor,,0,,,,,,,,,,,,,
P0DTC1_R1A_wild_cl1,R1A_7jitA_Y95,P0DTC1,,R1A,wild,cl1,7jitA,Y95,,7jit,3,1,,0,,,Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P10153_RNASE2_wild_cl1,RNASE2_2bzzA_AP5,P10153,,RNASE2,wild,cl1,2bzzA,AP5,,2bzz,3,1,,0,,,Crystal Structures of Eosinophil-Derived Neurotoxin (Edn) in Complex with the inhibitors 5'- ATP_ Ap(3)A_ Ap(4)A_ and Ap(5)A.,inhibitor,,0,,,,,,,,,,,,,
P10153_RNASE2_wild_cl1,RNASE2_1hi3A_A2P,P10153,,RNASE2,wild,cl1,1hi3A,A2P,,1hi3,3,1,,0,,,Mapping the Ribonucleolytic Active Site of Eosinophil-Derived Neurotoxin (Edn): High Resolution Crystal Structures of Edn Complexes with Adenylic Nucleotide inhibitors,inhibitor,,0,,,,,,,,,,,,,
P11142_HSPA8_wild_cl1,HSPA8_5aqkA_GDP,P11142,,HSPA8,wild,cl1,5aqkA,GDP,,5aqk,1,3,,0,,,A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms.,inhibitor,,0,,,,,,,,,,,,,
P11142_HSPA8_wild_cl1,HSPA8_5aqfA_ADN,P11142,,HSPA8,wild,cl1,5aqfA,ADN,,5aqf,1,3,,0,,,A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms.,inhibitor,,0,,,,,,,,,,,,,
P11142_HSPA8_wild_cl2,HSPA8_4h5rB_GOL,P11142,,HSPA8,wild,cl2,4h5rB,GOL,,4h5r,1,3,,0,,,New crystal structures of HSC-70 ATP binding domain confirm the role of individual binding pockets and suggest a new method of inhibition.,inhibitor,,0,,,,,,,,,,,,,
P11142_HSPA8_wild_cl3,HSPA8_4h5rA_GOL,P11142,,HSPA8,wild,cl3,4h5rA,GOL,,4h5r,1,3,,0,,,New crystal structures of HSC-70 ATP binding domain confirm the role of individual binding pockets and suggest a new method of inhibition.,inhibitor,,0,,,,,,,,,,,,,
P11215_ITGAM_wild_cl1,ITGAM_4xw2A_SIM,P11215,,ITGAM,wild,cl1,4xw2A,SIM,,4xw2,3,1,,0,,,Structural Basis for Simvastatin Competitive antagonism of Complement Receptor 3.,inhibitor,,0,,,,,,,,,,,,,
P11387_TOP1_wild_cl1,TOP1_1tl8A_AI3,P11387,,TOP1,wild,cl1,1tl8A,AI3,,1tl8,3,1,,0,,,Synthesis and Mechanism of Action Studies of a Series of Norindenoisoquinoline Topoisomerase I Poisons Reveal an inhibitor with a Flipped Orientation in the Ternary DNA-Enzyme-inhibitor Complex As Determined by X-ray Crystallographic Analysis,inhibitor,,0,,,,,,,,,,,,,
P11597_CETP_wild_cl1,CETP_4ewsA_DLP,P11597,,CETP,wild,cl1,4ewsA,DLP,,4ews,3,3,,0,,,Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P11597_CETP_wild_cl2,CETP_4ewsA_0RP,P11597,,CETP,wild,cl2,4ewsA,0RP,,4ews,3,3,,0,,,Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P11597_CETP_wild_cl2,CETP_4f2aA_0SF,P11597,,CETP,wild,cl2,4f2aA,0SF,,4f2a,3,3,,0,,,Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P11597_CETP_wild_cl3,CETP_4ewsA_FUC,P11597,,CETP,wild,cl3,4ewsA,FUC,,4ews,3,3,,0,,,Crystal structures of cholesteryl ester transfer protein in complex with inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P11926_ODC1_wild_cl2,ODC1_2oo0A_XAP,P11926,,ODC1,wild,cl2,2oo0A,XAP,,2oo0,1,2,,0,,,A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.,inhibitor,,0,,,,,,,,,,,,,
P11926_ODC1_wild_cl2,ODC1_2oo0B_XAP,P11926,,ODC1,wild,cl2,2oo0B,XAP,,2oo0,1,2,,0,,,A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane.,inhibitor,,0,,,,,,,,,,,,,
P11926_ODC1_wild_cl1,ODC1_7s3fA_XAP,P11926,,ODC1,wild,cl1,7s3fA,XAP,,7s3f,1,2,,0,,,Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane.,inhibitor,,0,,,,,,,,,,,,,
P11926_ODC1_wild_cl1,ODC1_7s3fA_PLP,P11926,,ODC1,wild,cl1,7s3fA,PLP,,7s3f,1,2,,0,,,Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane.,inhibitor,,0,,,,,,,,,,,,,
P12004_PCNA_wild_cl1,PCNA_3vkxA_T3,P12004,,PCNA,wild,cl1,3vkxA,T3,,3vkx,3,1,,0,,,Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication,inhibitor,,0,,,,,,,,,,,,,
P12830_CDH1_wild_cl1,CDH1_4zteA_4RL,P12830,,CDH1,wild,cl1,4zteA,4RL,,4zte,3,1,,0,,,Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive inhibitor of Cadherin Homophilic Interaction.,inhibitor,,0,,,,,,,,,,,,,
P12830_CDH1_wild_cl1,CDH1_4zteB_4RL,P12830,,CDH1,wild,cl1,4zteB,4RL,,4zte,3,1,,0,,,Crystal Structure of Human E-Cadherin-EC1EC2 in Complex with a Peptidomimetic Competitive inhibitor of Cadherin Homophilic Interaction.,inhibitor,,0,,,,,,,,,,,,,
P13497_BMP1_wild_cl1,BMP1_6btoA_E8P,P13497,,BMP1,wild,cl1,6btoA,E8P,,6bto,2,1,,0,,,Reverse Hydroxamate inhibitors of Bone Morphogenetic Protein 1.,inhibitor,,0,,,,,,,,,,,,,
P13497_BMP1_wild_cl1,BMP1_6btpA_E8J,P13497,,BMP1,wild,cl1,6btpA,E8J,,6btp,2,1,,0,,,Reverse Hydroxamate inhibitors of Bone Morphogenetic Protein 1.,inhibitor,,0,,,,,,,,,,,,,
P14174_MIF_wild_cl1,MIF_1gczC_YZ9,P14174,,MIF,wild,cl1,1gczC,YZ9,,1gcz,1,2,,0,,,Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.,inhibitor,,0,,,,,,,,,,,,,
P14174_MIF_wild_cl1,MIF_1ca7A_ENO,P14174,,MIF,wild,cl1,1ca7A,ENO,,1ca7,1,2,,0,,,Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.,inhibitor,,0,,,,,,,,,,,,,
P14174_MIF_wild_cl2,MIF_1ca7A_ENO,P14174,,MIF,wild,cl2,1ca7A,ENO,,1ca7,1,2,,0,,,Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.,inhibitor,,0,,,,,,,,,,,,,
P14625_HSP90B1_wild_cl1,HSP90B1_4nh9A_2LC,P14625,,HSP90B1,wild,cl1,4nh9A,2LC,,4nh9,3,1,,0,,,Correlation between chemotype-dependent binding conformations of HSP90 alpha / beta and isoform selectivity-Implications for the structure-based design of HSP90 alpha / beta selective inhibitors for treating neurodegenerative diseases.,inhibitor,,0,,,,,,,,,,,,,
P14920_DAO_wild_cl2,DAO_3w4kC_3LD,P14920,,DAO,wild,cl2,3w4kC,3LD,,3w4k,1,2,,0,,,4-Hydroxypyridazin-3(2H)-one Derivatives as Novel d-Amino Acid Oxidase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P15090_FABP4_wild_cl1,FABP4_1towA_CRZ,P15090,,FABP4,wild,cl1,1towA,CRZ,,1tow,1,1,,0,,,Discovery of inhibitors of human adipocyte fatty acid-binding protein_ a potential type 2 diabetes target.,inhibitor,,0,,,,,,,,,,,,,
P15090_FABP4_wild_cl1,FABP4_4nntA_76D,P15090,,FABP4,wild,cl1,4nntA,76D,,4nnt,1,1,,0,,,The complex structure of FABP4 with novel inhibitors,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl2,AMD1_3dz2B_A8M,P17707,,AMD1,wild,cl2,3dz2B,A8M,,3dz2,3,5,,0,,,New Insights into the Design of inhibitors of Human S-Adenosylmethionine Decarboxylase: Studies of Adenine C8 Substitution in Structural Analogues of S-Adenosylmethionine,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl2,AMD1_3dz7B_O8M,P17707,,AMD1,wild,cl2,3dz7B,O8M,,3dz7,3,5,,0,,,New Insights into the Design of inhibitors of Human S-Adenosylmethionine Decarboxylase: Studies of Adenine C8 Substitution in Structural Analogues of S-Adenosylmethionine,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl1,AMD1_1i7mC_CG,P17707,,AMD1,wild,cl1,1i7mC,CG,,1i7m,3,5,,0,,,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl1,AMD1_1i7cA_MGB,P17707,,AMD1,wild,cl1,1i7cA,MGB,,1i7c,3,5,,0,,,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl3,AMD1_1i72A_PUT,P17707,,AMD1,wild,cl3,1i72A,PUT,,1i72,3,5,,0,,,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl4,AMD1_1i72B_PUT,P17707,,AMD1,wild,cl4,1i72B,PUT,,1i72,3,5,,0,,,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,inhibitor,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl5,AMD1_1i7mD_CG,P17707,,AMD1,wild,cl5,1i7mD,CG,,1i7m,3,5,,0,,,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,inhibitor,,0,,,,,,,,,,,,,
P18669_PGAM1_wild_cl1,PGAM1_5y2iB_8KX,P18669,,PGAM1,wild,cl1,5y2iB,8KX,,5y2i,1,1,,0,,,Phosphoglycerate mutase 1 (PGAM1) complexed with its inhibitor PGMI-004A,inhibitor,,0,,,,,,,,,,,,,
P19438_TNFRSF1A_wild_cl1,TNFRSF1A_1ft4A_703,P19438,,TNFRSF1A,wild,cl1,1ft4A,703,,1ft4,3,1,,0,,,Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.,inhibitor,,0,,,,,,,,,,,,,
P19971_TYMP_wild_cl1,TYMP_2j0fA_TDR,P19971,,TYMP,wild,cl1,2j0fA,TDR,,2j0f,2,1,,0,,,Structural Basis for Non-Competitive Product inhibition in Human Thymidine Phosphorylase: Implications for Drug Design.,inhibitor,,0,,,,,,,,,,,,,
P20248_CCNA2_wild_cl2,CCNA2_2uueB_GVC,P20248,,CCNA2,wild,cl2,2uueB,GVC,,2uue,3,2,,0,,,Replace: A Strategy for Iterative Design of Cyclin- Binding Groove inhibitors,inhibitor,,0,,,,,,,,,,,,,
P20248_CCNA2_wild_cl1,CCNA2_5lqeB_72L,P20248,,CCNA2,wild,cl1,5lqeB,72L,,5lqe,3,2,5NEV,0,,,Cyclin-Dependent Kinase (CDK) inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines,inhibitor,,0,,,,,,,,,,,,,
P20292_ALOX5AP_wild_cl1,ALOX5AP_2q7mC_2CS,P20292,,ALOX5AP,wild,cl1,2q7mC,2CS,,2q7m,3,2,,0,,,Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.,inhibitor,,0,,,,,,,,,,,,,
P20292_ALOX5AP_wild_cl2,ALOX5AP_2q7rA_3CS,P20292,,ALOX5AP,wild,cl2,2q7rA,3CS,,2q7r,3,2,,0,,,Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.,inhibitor,,0,,,,,,,,,,,,,
P20292_ALOX5AP_wild_cl1,ALOX5AP_6vgcA_QY1,P20292,,ALOX5AP,wild,cl1,6vgcA,QY1,,6vgc,3,2,,0,,,Structure-based_ multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP).,inhibitor,,0,,,,,,,,,,,,,
P20292_ALOX5AP_wild_cl2,ALOX5AP_6vgcD_QY1,P20292,,ALOX5AP,wild,cl2,6vgcD,QY1,,6vgc,3,2,,0,,,Structure-based_ multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP).,inhibitor,,0,,,,,,,,,,,,,
P20701_ITGAL_wild_cl1,ITGAL_1rd4C_L08,P20701,,ITGAL,wild,cl1,1rd4C,L08,,1rd4,1,2,,0,,,Structure of an Allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography_ NMR_ and calorimetry,inhibitor,allosteric,0,,,,,,,,,,,,,
P20701_ITGAL_wild_cl1,ITGAL_1rd4A_L08,P20701,,ITGAL,wild,cl1,1rd4A,L08,,1rd4,1,2,,0,,,Structure of an Allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography_ NMR_ and calorimetry,inhibitor,allosteric,0,,,,,,,,,,,,,
P20701_ITGAL_wild_cl2,ITGAL_3bqnC_BQN,P20701,,ITGAL,wild,cl2,3bqnC,BQN,,3bqn,1,2,,0,,,Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors,inhibitor,,0,,,,,,,,,,,,,
P22830_FECH_wild_cl2,FECH_3w1wA_SAL,P22830,,FECH,wild,cl2,3w1wA,SAL,,3w1w,3,2,,0,,,Salicylic Acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity,inhibitor,,0,,,,,,,,,,,,,
P26447_S100A4_wild_cl1,S100A4_3ko0I_TFP,P26447,,S100A4,wild,cl1,3ko0I,TFP,,3ko0,3,3,,0,,,Phenothiazines inhibit S100A4 function by inducing protein oligomerization.,inhibitor,,0,,,,,,,,,,,,,
P26447_S100A4_wild_cl2,S100A4_3ko0A_TFP,P26447,,S100A4,wild,cl2,3ko0A,TFP,,3ko0,3,3,,0,,,Phenothiazines inhibit S100A4 function by inducing protein oligomerization.,inhibitor,,0,,,,,,,,,,,,,
P26447_S100A4_wild_cl2,S100A4_3ko0B_TFP,P26447,,S100A4,wild,cl2,3ko0B,TFP,,3ko0,3,3,,0,,,Phenothiazines inhibit S100A4 function by inducing protein oligomerization.,inhibitor,,0,,,,,,,,,,,,,
P27694_RPA1_wild_cl1,RPA1_4r4qA_3HZ,P27694,,RPA1,wild,cl1,4r4qA,3HZ,,4r4q,1,1,,0,,,Diphenylpyrazoles as replication protein a inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P27694_RPA1_wild_cl1,RPA1_4luzA_1XT,P27694,,RPA1,wild,cl1,4luzA,1XT,,4luz,1,1,,0,,,Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.,inhibitor,,0,,,,,,,,,,,,,
P27707_DCK_wild_cl1,DCK_4q18A_2XJ,P27707,,DCK,wild,cl1,4q18A,2XJ,,4q18,1,2,,0,,,Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability.,inhibitor,,0,,,,,,,,,,,,,
P27707_DCK_wild_cl1,DCK_4q1eA_2Y8,P27707,,DCK,wild,cl1,4q1eA,2Y8,,4q1e,1,2,,0,,,Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability.,inhibitor,,0,,,,,,,,,,,,,
P28347_TEAD1_wild_cl1,TEAD1_7cmmC_KK9,P28347,,TEAD1,wild,cl1,7cmmC,KK9,,7cmm,3,1,,0,,,The novel potent TEAD inhibitor_ K-975_ inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.,inhibitor,,0,,,,,,,,,,,,,
P28347_TEAD1_wild_cl1,TEAD1_7cmmA_KK9,P28347,,TEAD1,wild,cl1,7cmmA,KK9,,7cmm,3,1,,0,,,The novel potent TEAD inhibitor_ K-975_ inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl1,NOS3_6pouF_HEM,P29474,,NOS3,wild,cl1,6pouF,HEM,,6pou,3,4,,0,,,First Contact: 7-Phenyl-2-Aminoquinolines_ Potent and Selective Neuronal Nitric Oxide Synthase inhibitors That Target an Isoform-Specific Aspartate.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl4,NOS3_5vvcC_BTB,P29474,,NOS3,wild,cl4,5vvcC,BTB,,5vvc,3,4,,0,,,Hydrophilic_ Potent_ and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl1,NOS3_5uo9D_8J4,P29474,,NOS3,wild,cl1,5uo9D,8J4,,5uo9,3,4,,0,,,Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl2,NOS3_5uo9A_BTB,P29474,,NOS3,wild,cl2,5uo9A,BTB,,5uo9,3,4,,0,,,Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl2,NOS3_5uo9B_BTB,P29474,,NOS3,wild,cl2,5uo9B,BTB,,5uo9,3,4,,0,,,Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl3,NOS3_5uoaA_8EY,P29474,,NOS3,wild,cl3,5uoaA,8EY,,5uoa,3,4,,0,,,Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29474_NOS3_wild_cl3,NOS3_5uocA_H4B,P29474,,NOS3,wild,cl3,5uocA,H4B,,5uoc,3,4,,0,,,Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29475_NOS1_wild_cl2,NOS1_6poaB_OUS,P29475,,NOS1,wild,cl2,6poaB,OUS,,6poa,3,2,,0,,,First Contact: 7-Phenyl-2-Aminoquinolines_ Potent and Selective Neuronal Nitric Oxide Synthase inhibitors That Target an Isoform-Specific Aspartate.,inhibitor,,0,,,,,,,,,,,,,
P29475_NOS1_wild_cl2,NOS1_6pocA_OU4,P29475,,NOS1,wild,cl2,6pocA,OU4,,6poc,3,2,,0,,,First Contact: 7-Phenyl-2-Aminoquinolines_ Potent and Selective Neuronal Nitric Oxide Synthase inhibitors That Target an Isoform-Specific Aspartate.,inhibitor,,0,,,,,,,,,,,,,
P29475_NOS1_wild_cl1,NOS1_5vuxA_9P1,P29475,,NOS1,wild,cl1,5vuxA,9P1,,5vux,3,2,,0,,,Hydrophilic_ Potent_ and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P29475_NOS1_wild_cl1,NOS1_6av1A_HEM,P29475,,NOS1,wild,cl1,6av1A,HEM,,6av1,3,2,,0,,,Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.,inhibitor,,0,,,,,,,,,,,,,
P29965_CD40LG_wild_cl1,CD40LG_3lkjA_LKJ,P29965,,CD40LG,wild,cl1,3lkjA,LKJ,,3lkj,3,1,,0,,,Small Molecule inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture Mechanism.,inhibitor,,0,,,,,,,,,,,,,
P29965_CD40LG_wild_cl1,CD40LG_3lkjB_LKJ,P29965,,CD40LG,wild,cl1,3lkjB,LKJ,,3lkj,3,1,,0,,,Small Molecule inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture Mechanism.,inhibitor,,0,,,,,,,,,,,,,
P30086_PEBP1_wild_cl1,PEBP1_2qyqA_PTR,P30086,,PEBP1,wild,cl1,2qyqA,PTR,,2qyq,3,1,,0,,,Phosphotyrosine recognition by the Raf Kinase inhibitor Protein,inhibitor,,0,,,,,,,,,,,,,
P30405_PPIF_wild_cl1,PPIF_6r8lA_JUZ,P30405,,PPIF,wild,cl1,6r8lA,JUZ,,6r8l,1,1,,0,,,Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.,inhibitor,,0,,,,,,,,,,,,,
P30419_NMT1_wild_cl2,NMT1_5o6jB_9M8,P30419,,NMT1,wild,cl2,5o6jB,9M8,,5o6j,1,2,,0,,,Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus.,inhibitor,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl1,ATIC_5uy8A_8UM,P31939,,ATIC,wild,cl1,5uy8A,8UM,,5uy8,3,3,,0,,,Discovery of N-(6-Fluoro-1-oxo-1_2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128)_ a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model.,inhibitor,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl3,ATIC_5uy8A_AMZ,P31939,,ATIC,wild,cl3,5uy8A,AMZ,,5uy8,3,3,,0,,,Discovery of N-(6-Fluoro-1-oxo-1_2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128)_ a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model.,inhibitor,,0,,,,,,,,,,,,,
P32320_CDA_wild_cl1,CDA_1mq0A_BRD,P32320,,CDA,wild,cl1,1mq0A,BRD,,1mq0,3,2,,0,,,Structure of human cytidine deaminase bound to a potent inhibitor,inhibitor,,0,,,,,,,,,,,,,
P32320_CDA_wild_cl1,CDA_1mq0B_BRD,P32320,,CDA,wild,cl1,1mq0B,BRD,,1mq0,3,2,,0,,,Structure of human cytidine deaminase bound to a potent inhibitor,inhibitor,,0,,,,,,,,,,,,,
P32320_CDA_wild_cl2,CDA_1mq0A_BRD,P32320,,CDA,wild,cl2,1mq0A,BRD,,1mq0,3,2,,0,,,Structure of human cytidine deaminase bound to a potent inhibitor,inhibitor,,0,,,,,,,,,,,,,
P32929_CTH_wild_cl1,CTH_6nbaA_P1T,P32929,,CTH,wild,cl1,6nbaA,P1T,,6nba,3,2,,0,,,S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine gamma-lyase-dependent hydrogen sulfide synthesis.,inhibitor,,0,,,,,,,,,,,,,
P32929_CTH_wild_cl1,CTH_2nmpA_PLP,P32929,,CTH,wild,cl1,2nmpA,PLP,,2nmp,3,2,,0,,,Structural basis for the inhibition mechanism of human cystathionine gamma-lyase_ an enzyme responsible for the production of H(2)S,inhibitor,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl1,DUT_3araA_MKH,P33316,,DUT,wild,cl1,3araA,MKH,,3ara,2,3,,0,,,Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors,inhibitor,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl2,DUT_3araA_MKH,P33316,,DUT,wild,cl2,3araA,MKH,,3ara,2,3,,0,,,Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors,inhibitor,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl1,DUT_5h4jA_FKM,P33316,,DUT,wild,cl1,5h4jA,FKM,,5h4j,2,3,,0,,,TAS-114_ a First-in-Class Dual dUTPase/DPD inhibitor_ Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.,inhibitor,,0,,,,,,,,,,,,,
P34896_SHMT1_wild_cl1,SHMT1_6m5wA_PLP,P34896,,SHMT1,wild,cl1,6m5wA,PLP,,6m5w,3,1,,0,,,Structural basis for selective inhibition of human serine hydroxymethyltransferase by secondary bile acid conjugate.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl1,SHMT2_5v7iA_8Z1,P34897,,SHMT2,wild,cl1,5v7iA,8Z1,,5v7i,3,4,,0,,,Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl1,SHMT2_6m5oA_DXC,P34897,,SHMT2,wild,cl1,6m5oA,DXC,,6m5o,3,4,,0,,,Structural basis for selective inhibition of human serine hydroxymethyltransferase by secondary bile acid conjugate.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl2,SHMT2_6qvlB_4DW,P34897,,SHMT2,wild,cl2,6qvlB,4DW,,6qvl,3,4,,0,,,Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl2,SHMT2_6qvgA_DDF,P34897,,SHMT2,wild,cl2,6qvgA,DDF,,6qvg,3,4,,0,,,Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl3,SHMT2_6qvgA_PLP,P34897,,SHMT2,wild,cl3,6qvgA,PLP,,6qvg,3,4,,0,,,Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.,inhibitor,,0,,,,,,,,,,,,,
P34897_SHMT2_wild_cl4,SHMT2_6qvgA_PLP,P34897,,SHMT2,wild,cl4,6qvgA,PLP,,6qvg,3,4,,0,,,Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.,inhibitor,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl1,NOS2_3ej8A_HEC,P35228,,NOS2,wild,cl1,3ej8A,HEC,,3ej8,3,3,,0,,,Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,inhibitor,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl1,NOS2_3ej8C_HEC,P35228,,NOS2,wild,cl1,3ej8C,HEC,,3ej8,3,3,,0,,,Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,inhibitor,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl2,NOS2_3ej8D_H4B,P35228,,NOS2,wild,cl2,3ej8D,H4B,,3ej8,3,3,,0,,,Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.,inhibitor,,0,,,,,,,,,,,,,
P38919_EIF4A3_wild_cl1,EIF4A3_3ex7H_ADP,P38919,,EIF4A3,wild,cl1,3ex7H,ADP,,3ex7,2,1,,0,,,Mechanism of ATP turnover inhibition in the EJC,inhibitor,,0,,,,,,,,,,,,,
P39748_FEN1_wild_cl1,FEN1_5fv7B_R3Z,P39748,,FEN1,wild,cl1,5fv7B,R3Z,,5fv7,3,1,,0,,,Cellular Active N-Hydroxyurea Fen1 inhibitors Block Substrate Entry to the Active Site,inhibitor,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl4,BCL6_3lbzA_Z88,P41182,,BCL6,wild,cl4,3lbzA,Z88,,3lbz,2,6,,0,,,A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.,inhibitor,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl5,BCL6_3lbzB_Z88,P41182,,BCL6,wild,cl5,3lbzB,Z88,,3lbz,2,6,,0,,,A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.,inhibitor,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl6,BCL6_3lbzB_Z89,P41182,,BCL6,wild,cl6,3lbzB,Z89,,3lbz,2,6,,0,,,A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.,inhibitor,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl1,BCL6_5n21A_8HN,P41182,,BCL6,wild,cl1,5n21A,8HN,,5n21,2,6,,0,,,Discovery of Pyrazolo[1_5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P42568_MLLT3_wild_cl1,MLLT3_5yyfA_FOA,P42568,,MLLT3,wild,cl1,5yyfA,FOA,,5yyf,3,1,,0,,,Structure-guided development of YEATS domain inhibitors by targeting pi-pi-pi stacking.,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl5,FASN_4w9nB_TCL,P49327,,FASN,wild,cl5,4w9nB,TCL,,4w9n,2,7,,0,,,Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals Allosteric protein-protein interface inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49327_FASN_wild_cl5,FASN_4w9nD_TCL,P49327,,FASN,wild,cl5,4w9nD,TCL,,4w9n,2,7,,0,,,Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals Allosteric protein-protein interface inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49327_FASN_wild_cl7,FASN_4w9nA_TCL,P49327,,FASN,wild,cl7,4w9nA,TCL,,4w9n,2,7,,0,,,Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals Allosteric protein-protein interface inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49327_FASN_wild_cl4,FASN_3tjmA_7FA,P49327,,FASN,wild,cl4,3tjmA,7FA,,3tjm,2,7,,0,,,Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid.,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl4,FASN_2px6B_DH9,P49327,,FASN,wild,cl4,2px6B,DH9,,2px6,2,7,,0,,,Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl1,FASN_5c37C_NDP,P49327,,FASN,wild,cl1,5c37C,NDP,,5c37,2,7,,0,,,Design and Synthesis of a Series of Bioavailable Fatty Acid Synthase (FASN) KR Domain inhibitors for Cancer Therapy,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl2,FASN_5c37C_4XN,P49327,,FASN,wild,cl2,5c37C,4XN,,5c37,2,7,,0,,,Design and Synthesis of a Series of Bioavailable Fatty Acid Synthase (FASN) KR Domain inhibitors for Cancer Therapy,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl1,FASN_6nnaA_NDP,P49327,,FASN,wild,cl1,6nnaA,NDP,,6nna,2,7,,0,,,Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).,inhibitor,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl2,FASN_6nnaA_KUA,P49327,,FASN,wild,cl2,6nnaA,KUA,,6nna,2,7,,0,,,Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).,inhibitor,,0,,,,,,,,,,,,,
P49773_HINT1_wild_cl2,HINT1_5i2eB_67D,P49773,,HINT1,wild,cl2,5i2eB,67D,,5i2e,3,2,,0,,,Design_ Synthesis_ and Characterization of Sulfamide and Sulfamate Nucleotidomimetic inhibitors of hHint1.,inhibitor,,0,,,,,,,,,,,,,
P54132_BLM_wild_cl1,BLM_7audB_ADP,P54132,,BLM,wild,cl1,7audB,ADP,,7aud,2,2,,0,,,Uncovering an Allosteric mode of action for a selective inhibitor of human Bloom syndrome protein.,inhibitor,allosteric,0,,,,,,,,,,,,,
P54132_BLM_wild_cl2,BLM_7audA_RY8,P54132,,BLM,wild,cl2,7audA,RY8,,7aud,2,2,,0,,,Uncovering an Allosteric mode of action for a selective inhibitor of human Bloom syndrome protein.,inhibitor,allosteric,0,,,,,,,,,,,,,
P54132_BLM_wild_cl2,BLM_7audC_RY8,P54132,,BLM,wild,cl2,7audC,RY8,,7aud,2,2,,0,,,Uncovering an Allosteric mode of action for a selective inhibitor of human Bloom syndrome protein.,inhibitor,allosteric,0,,,,,,,,,,,,,
P60842_EIF4A1_wild_cl1,EIF4A1_5zbzA_SAU,P60842,,EIF4A1,wild,cl1,5zbzA,SAU,,5zbz,3,1,,0,,,Targeting the N Terminus of eIF4AI for inhibition of Its Catalytic Recycling.,inhibitor,,0,,,,,,,,,,,,,
P60842_EIF4A1_wild_cl1,EIF4A1_5zc9A_ANP,P60842,,EIF4A1,wild,cl1,5zc9A,ANP,,5zc9,3,1,,0,,,The Translation inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.,inhibitor,,0,,,,,,,,,,,,,
P62937_PPIA_wild_cl1,PPIA_6gjiA_F1E,P62937,,PPIA,wild,cl1,6gjiA,F1E,,6gji,1,1,,0,,,A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P62937_PPIA_wild_cl1,PPIA_6gjnA_F0Q,P62937,,PPIA,wild,cl1,6gjnA,F0Q,,6gjn,1,1,,0,,,A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P62993_GRB2_wild_cl1,GRB2_7mphC_ZLY,P62993,,GRB2,wild,cl1,7mphC,ZLY,,7mph,1,2,,0,,,Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain.,inhibitor,,0,,,,,,,,,,,,,
P78380_OLR1_wild_cl1,OLR1_6tl9B_NJT,P78380,,OLR1,wild,cl1,6tl9B,NJT,,6tl9,3,2,,0,,,A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state,inhibitor,,0,,,,,,,,,,,,,
P78380_OLR1_wild_cl1,OLR1_6tl9C_NJT,P78380,,OLR1,wild,cl1,6tl9C,NJT,,6tl9,3,2,,0,,,A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state,inhibitor,,0,,,,,,,,,,,,,
P78417_GSTO1_wild_cl1,GSTO1_4yquA_4GB,P78417,,GSTO1,wild,cl1,4yquA,4GB,,4yqu,3,1,,0,,,Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor.,inhibitor,,0,,,,,,,,,,,,,
Q00610_CLTC_wild_cl1,CLTC_6e4lA_HRS,Q00610,,CLTC,wild,cl1,6e4lA,HRS,,6e4l,3,1,,0,,,Disruption of endocytosis through chemical inhibition of clathrin heavy chain function.,inhibitor,,0,,,,,,,,,,,,,
Q00610_CLTC_wild_cl1,CLTC_4g55A_VH2,Q00610,,CLTC,wild,cl1,4g55A,VH2,,4g55,3,1,,0,,,Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition.,inhibitor,,0,,,,,,,,,,,,,
Q00987_MDM2_wild_cl1,MDM2_5j7fD_6GG,Q00987,,MDM2,wild,cl1,5j7fD,6GG,,5j7f,3,1,,0,,,1_4_5-Trisubstituted Imidazole-Based p53-MDM2/MDMX antagonists with Aliphatic Linkers for Conjugation with Biological Carriers.,inhibitor,,0,,,,,,,,,,,,,
Q00987_MDM2_wild_cl1,MDM2_4ereA_0R2,Q00987,,MDM2,wild,cl1,4ereA,0R2,,4ere,3,1,,0,,,Structure-based design of novel inhibitors of the MDM2-p53 interaction.,inhibitor,,0,,,,,,,,,,,,,
Q02790_FKBP4_wild_cl1,FKBP4_4tw8A_37M,Q02790,,FKBP4,wild,cl1,4tw8A,37M,,4tw8,3,1,,0,,,Selective inhibitors of the FK506-binding protein 51 by induced fit.,inhibitor,,0,,,,,,,,,,,,,
Q03111_MLLT1_wild_cl1,MLLT1_6hpyA_GKN,Q03111,,MLLT1,wild,cl1,6hpyA,GKN,,6hpy,2,1,,0,,,Structure-Based Approach toward Identification of inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL).,inhibitor,,0,,,,,,,,,,,,,
Q03405_PLAUR_wild_cl1,PLAUR_1ywhI_FUC,Q03405,,PLAUR,wild,cl1,1ywhI,FUC,,1ywh,3,1,,0,,,Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide,inhibitor,,0,,,,,,,,,,,,,
Q03405_PLAUR_wild_cl1,PLAUR_1ywhC_FUC,Q03405,,PLAUR,wild,cl1,1ywhC,FUC,,1ywh,3,1,,0,,,Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide,inhibitor,,0,,,,,,,,,,,,,
Q04760_GLO1_wild_cl1,GLO1_3w0tA_HPU,Q04760,,GLO1,wild,cl1,3w0tA,HPU,,3w0t,3,2,,0,,,N-Hydroxypyridone-based glyoxalase I inhibitors mimicking binding interactions of the substrate,inhibitor,,0,,,,,,,,,,,,,
Q04760_GLO1_wild_cl2,GLO1_3w0tD_HPU,Q04760,,GLO1,wild,cl2,3w0tD,HPU,,3w0t,3,2,,0,,,N-Hydroxypyridone-based glyoxalase I inhibitors mimicking binding interactions of the substrate,inhibitor,,0,,,,,,,,,,,,,
Q04760_GLO1_wild_cl2,GLO1_3w0tA_HPU,Q04760,,GLO1,wild,cl2,3w0tA,HPU,,3w0t,3,2,,0,,,N-Hydroxypyridone-based glyoxalase I inhibitors mimicking binding interactions of the substrate,inhibitor,,0,,,,,,,,,,,,,
Q07817_B2CL1_wild_cl1,B2CL1_4c52B_X0D,Q07817,,B2CL1,wild,cl1,4c52B,X0D,,4c52,2,1,,0,,,De-Novo Designed Library of Benzoylureas as inhibitors of Bcl-Xl: Synthesis_ Structural and Biochemical Characterization.,inhibitor,,0,,,,,,,,,,,,,
Q07817_B2CL1_wild_cl1,B2CL1_3zloA_X8U,Q07817,,B2CL1,wild,cl1,3zloA,X8U,,3zlo,2,1,,0,,,Structure-Guided Design of a Selective Bcl-Xl inhibitor,inhibitor,,0,,,,,,,,,,,,,
Q07889_SOS1_wild_cl1,SOS1_4urvS_UMK,Q07889,,SOS1,wild,cl1,4urvS,UMK,,4urv,1,3,,0,,,Small Molecule Binding Sites on the Ras:SOS Complex Can be Exploited for inhibition of Ras Activation.,inhibitor,,0,,,,,,,,,,,,,
Q07889_SOS1_wild_cl2,SOS1_4uryS_RV1,Q07889,,SOS1,wild,cl2,4uryS,RV1,,4ury,1,3,,0,,,Small Molecule Binding Sites on the Ras:SOS Complex Can be Exploited for inhibition of Ras Activation.,inhibitor,,0,,,,,,,,,,,,,
Q07889_SOS1_wild_cl3,SOS1_4uryS_RV1,Q07889,,SOS1,wild,cl3,4uryS,RV1,,4ury,1,3,,0,,,Small Molecule Binding Sites on the Ras:SOS Complex Can be Exploited for inhibition of Ras Activation.,inhibitor,,0,,,,,,,,,,,,,
Q12834_CDC20_wild_cl1,CDC20_4n14A_WR7,Q12834,,CDC20,wild,cl1,4n14A,WR7,,4n14,3,1,,0,,,Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.,inhibitor,,0,,,,,,,,,,,,,
Q12931_TRAP1_wild_cl1,TRAP1_4z1iC_ANP,Q12931,,TRAP1,wild,cl1,4z1iC,ANP,,4z1i,1,1,,0,,,Development of a Mitochondria-Targeted Hsp90 inhibitor Based on the Crystal Structures of Human TRAP1,inhibitor,,0,,,,,,,,,,,,,
Q13451_FKBP5_wild_cl2,FKBP5_7apsB_RR5,Q13451,,FKBP5,wild,cl2,7apsB,RR5,,7aps,1,2,,0,,,Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides.,inhibitor,,0,,,,,,,,,,,,,
Q13490_BIRC2_wild_cl1,BIRC2_4lgeA_1Y0,Q13490,,BIRC2,wild,cl1,4lgeA,1Y0,,4lge,3,1,,0,,,Design_ stereoselective synthesis_ and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.,inhibitor,,0,,,,,,,,,,,,,
Q13510_ASAH1_wild_cl1,ASAH1_6mhmD_JRY,Q13510,,ASAH1,wild,cl1,6mhmD,JRY,,6mhm,3,1,,0,,,Molecular Mechanism of inhibition of Acid Ceramidase by Carmofur.,inhibitor,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl1,PIN1_3ikgA_J8Z,Q13526,,PIN1,wild,cl1,3ikgA,J8Z,,3ikg,1,4,,0,,,Structure-based design of novel human Pin1 inhibitors (I).,inhibitor,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl1,PIN1_3ikdA_J9Z,Q13526,,PIN1,wild,cl1,3ikdA,J9Z,,3ikd,1,4,,0,,,Structure-based design of novel human Pin1 inhibitors (I).,inhibitor,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl3,PIN1_3i6cA_GIA,Q13526,,PIN1,wild,cl3,3i6cA,GIA,,3i6c,1,4,,0,,,Structure-based design of novel human Pin1 inhibitors (II).,inhibitor,,0,,,,,,,,,,,,,
Q14145_KEAP1_wild_cl1,KEAP1_4l7bB_1VV,Q14145,,KEAP1,wild,cl1,4l7bB,1VV,,4l7b,1,1,,0,,,Binding Mode and Structure-Activity Relationships around Direct inhibitors of the Nrf2-Keap1 Complex.,inhibitor,,0,,,,,,,,,,,,,
Q14145_KEAP1_wild_cl1,KEAP1_6sp1A_LQ8,Q14145,,KEAP1,wild,cl1,6sp1A,LQ8,,6sp1,1,1,,0,,,Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ inhibitors of the KEAP1/NRF2 Interaction.,inhibitor,,0,,,,,,,,,,,,,
Q14534_SQLE_wild_cl1,SQLE_6c6pA_EMV,Q14534,,SQLE,wild,cl1,6c6pA,EMV,,6c6p,2,2,,0,,,Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.,inhibitor,,0,,,,,,,,,,,,,
Q14534_SQLE_wild_cl1,SQLE_6c6nA_EKV,Q14534,,SQLE,wild,cl1,6c6nA,EKV,,6c6n,2,2,,0,,,Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.,inhibitor,,0,,,,,,,,,,,,,
Q14534_SQLE_wild_cl2,SQLE_6c6pB_FAD,Q14534,,SQLE,wild,cl2,6c6pB,FAD,,6c6p,2,2,,0,,,Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl1,AGER_6xq8A_V6M,Q15109,,AGER,wild,cl1,6xq8A,V6M,,6xq8,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl1,AGER_6xq3B_V6Y,Q15109,,AGER,wild,cl1,6xq3B,V6Y,,6xq3,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl2,AGER_6xq7A_V6V,Q15109,,AGER,wild,cl2,6xq7A,V6V,,6xq7,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl2,AGER_6xq9B_V6S,Q15109,,AGER,wild,cl2,6xq9B,V6S,,6xq9,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl3,AGER_7lmwA_Y6P,Q15109,,AGER,wild,cl3,7lmwA,Y6P,,7lmw,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl3,AGER_7lmwB_Y6P,Q15109,,AGER,wild,cl3,7lmwB,Y6P,,7lmw,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15109_AGER_wild_cl4,AGER_6xq7B_V6V,Q15109,,AGER,wild,cl4,6xq7B,V6V,,6xq7,1,4,,0,,,A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15562_TEAD2_wild_cl2,TEAD2_6s60B_KX8,Q15562,,TEAD2,wild,cl2,6s60B,KX8,,6s60,3,2,,0,,,Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15562_TEAD2_wild_cl2,TEAD2_6s69B_KX5,Q15562,,TEAD2,wild,cl2,6s69B,KX5,,6s69,3,2,,0,,,Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q15562_TEAD2_wild_cl1,TEAD2_6uycA_QLV,Q15562,,TEAD2,wild,cl1,6uycA,QLV,,6uyc,3,2,,0,,,Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative inhibition of Hippo Pathway Signaling.,inhibitor,,0,,,,,,,,,,,,,
Q15750_TAB1_wild_cl1,TAB1_5gjgA_6V5,Q15750,,TAB1,wild,cl1,5gjgA,6V5,,5gjg,1,1,,0,,,Development of a Method for Converting a TAK1 Type I inhibitor into a Type II or c-Helix-Out inhibitor by Structure-Based Drug Design (SBDD),inhibitor,,0,,,,,,,,,,,,,
Q15750_TAB1_wild_cl1,TAB1_5v5nA_EDH,Q15750,,TAB1,wild,cl1,5v5nA,EDH,,5v5n,1,1,,0,,,Takinib_ a Selective TAK1 inhibitor_ Broadens the Therapeutic Efficacy of TNF-alpha inhibition for Cancer and Autoimmune Disease.,inhibitor,,0,,,,,,,,,,,,,
Q16647_PTGIS_wild_cl1,PTGIS_3b6hA_MXD,Q16647,,PTGIS,wild,cl1,3b6hA,MXD,,3b6h,3,1,,0,,,Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and inhibitor Reveal a Ligand-specific Heme Conformation Change,inhibitor,,0,,,,,,,,,,,,,
Q16658_FSCN1_wild_cl1,FSCN1_6i11A_H0H,Q16658,,FSCN1,wild,cl1,6i11A,H0H,,6i11,1,2,,0,,,Structure-based design_ synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4_3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents.,inhibitor,,0,,,,,,,,,,,,,
Q16658_FSCN1_wild_cl1,FSCN1_6i17A_GZW,Q16658,,FSCN1,wild,cl1,6i17A,GZW,,6i17,1,2,,0,,,Structure-based design_ synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4_3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents.,inhibitor,,0,,,,,,,,,,,,,
Q16873_LTC4S_wild_cl1,LTC4S_6r7dE_JUQ,Q16873,,LTC4S,wild,cl1,6r7dE,JUQ,,6r7d,3,2,,0,,,Discovery of the Oral Leukotriene C4 Synthase inhibitor (1S_2S)-2-({5-[(5-Chloro-2_4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.,inhibitor,,0,,,,,,,,,,,,,
Q16873_LTC4S_wild_cl1,LTC4S_6r7dC_JUQ,Q16873,,LTC4S,wild,cl1,6r7dC,JUQ,,6r7d,3,2,,0,,,Discovery of the Oral Leukotriene C4 Synthase inhibitor (1S_2S)-2-({5-[(5-Chloro-2_4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.,inhibitor,,0,,,,,,,,,,,,,
Q16873_LTC4S_wild_cl2,LTC4S_6r7dH_JUQ,Q16873,,LTC4S,wild,cl2,6r7dH,JUQ,,6r7d,3,2,,0,,,Discovery of the Oral Leukotriene C4 Synthase inhibitor (1S_2S)-2-({5-[(5-Chloro-2_4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.,inhibitor,,0,,,,,,,,,,,,,
Q6L8Q7_PDE12_wild_cl1,PDE12_4z2bA_4LC,Q6L8Q7,,PDE12,wild,cl1,4z2bA,4LC,,4z2b,3,1,,0,,,The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl5,SARM1_6zfxA_S1N,Q6SZW1,,SARM1,wild,cl5,6zfxA,S1N,,6zfx,3,5,,0,,,Structural basis for SARM1 inhibition and activation under energetic stress.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl1,SARM1_7nakF_1QD,Q6SZW1,,SARM1,wild,cl1,7nakF,1QD,,7nak,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl1,SARM1_7nakB_1QD,Q6SZW1,,SARM1,wild,cl1,7nakB,1QD,,7nak,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl2,SARM1_7nakH_1QD,Q6SZW1,,SARM1,wild,cl2,7nakH,1QD,,7nak,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl2,SARM1_7nakB_1QD,Q6SZW1,,SARM1,wild,cl2,7nakB,1QD,,7nak,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl4,SARM1_7nalA_NMN,Q6SZW1,,SARM1,wild,cl4,7nalA,NMN,,7nal,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl4,SARM1_7nalB_NMN,Q6SZW1,,SARM1,wild,cl4,7nalB,NMN,,7nal,3,5,,0,,,Structural basis of SARM1 activation_ substrate recognition_ and inhibition by small molecules.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl3,SARM1_7cm6A_NAD,Q6SZW1,,SARM1,wild,cl3,7cm6A,NAD,,7cm6,3,5,,0,,,The NAD + -mediated self-inhibition mechanism of pro-neurodegenerative SARM1.,inhibitor,,0,,,,,,,,,,,,,
Q6SZW1_SARM1_wild_cl3,SARM1_7cm7A_NAD,Q6SZW1,,SARM1,wild,cl3,7cm7A,NAD,,7cm7,3,5,,0,,,The NAD + -mediated self-inhibition mechanism of pro-neurodegenerative SARM1.,inhibitor,,0,,,,,,,,,,,,,
Q7KZF4_SND1_wild_cl1,SND1_7knxA_QOV,Q7KZF4,,SND1,wild,cl1,7knxA,QOV,,7knx,3,1,,0,,,Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.,inhibitor,,0,,,,,,,,,,,,,
Q7KZF4_SND1_wild_cl1,SND1_7knxC_QOV,Q7KZF4,,SND1,wild,cl1,7knxC,QOV,,7knx,3,1,,0,,,Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.,inhibitor,,0,,,,,,,,,,,,,
Q7Z2E3_APTX_wild_cl1,APTX_6cvtA_AMP,Q7Z2E3,,APTX,wild,cl1,6cvtA,AMP,,6cvt,3,1,,0,,,Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease.,inhibitor,,0,,,,,,,,,,,,,
Q86WV6_STING1_wild_cl1,STING1_6cy7A_2BA,Q86WV6,,STING1,wild,cl1,6cy7A,2BA,,6cy7,3,2,,0,,,STING Polymer Structure Reveals Mechanisms for Activation_ Hyperactivation_ and inhibition.,inhibitor,,0,,,,,,,,,,,,,
Q8N884_CGAS_wild_cl1,CGAS_6lrjA_EQX,Q8N884,,CGAS,wild,cl1,6lrjA,EQX,,6lrj,1,1,,0,,,In Silico Screening-Based Discovery of Novel inhibitors of Human Cyclic GMP-AMP Synthase: A Cross-Validation Study of Molecular Docking and Experimental Testing.,inhibitor,,0,,,,,,,,,,,,,
Q8N884_CGAS_wild_cl1,CGAS_5v8hA_8ZJ,Q8N884,,CGAS,wild,cl1,5v8hA,8ZJ,,5v8h,1,1,6NFG_ Diff Lig ,0,,,CYCLIC GMP-AMP SYNTHASE in complex with compound 16 inhibitor: 7-hydroxy-N-methyl-5-phenylpyrazolo[1_5-a]pyrimidine-3-carboxamide,inhibitor,,0,,,,,,,,,,,,,
Q92997_DVL3_wild_cl1,DVL3_6zc8B_QEK,Q92997,,DVL3,wild,cl1,6zc8B,QEK,,6zc8,3,1,,0,,,Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling,inhibitor,,0,,,,,,,,,,,,,
Q96C86_DCPS_wild_cl1,DCPS_4qdeD_30S,Q96C86,,DCPS,wild,cl1,4qdeD,30S,,4qde,3,2,,0,,,Dcps in complex with covalent inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q96CA5_BIRC7_wild_cl1,BIRC7_3f7gE_389,Q96CA5,,BIRC7,wild,cl1,3f7gE,389,,3f7g,3,1,,0,,,Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold,inhibitor,,0,,,,,,,,,,,,,
Q96GG9_DCUN1D1_wild_cl1,DCUN1D1_5v88A_8ZD,Q96GG9,,DCUN1D1,wild,cl1,5v88A,8ZD,,5v88,1,1,,0,,,Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.,inhibitor,,0,,,,,,,,,,,,,
Q96GG9_DCUN1D1_wild_cl1,DCUN1D1_5v86A_8ZA,Q96GG9,,DCUN1D1,wild,cl1,5v86A,8ZA,,5v86,1,1,,0,,,Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.,inhibitor,,0,,,,,,,,,,,,,
Q96JM7_L3MBTL3_wild_cl1,L3MBTL3_4l59A_1VZ,Q96JM7,,L3MBTL3,wild,cl1,4l59A,1VZ,,4l59,3,1,,0,,,The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.,inhibitor,,0,,,,,,,,,,,,,
Q96KS0_EGLN2_wild_cl1,EGLN2_5v1bA_8UY,Q96KS0,,EGLN2,wild,cl1,5v1bA,8UY,,5v1b,3,1,,0,,,1_2_4-Triazolo-[1_5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) inhibitors With a Novel Monodentate Binding Interaction.,inhibitor,,0,,,,,,,,,,,,,
Q96LI5_CNOT6L_wild_cl1,CNOT6L_5dv4A_NMY,Q96LI5,,CNOT6L,wild,cl1,5dv4A,NMY,,5dv4,3,1,,0,,,Structural basis for inhibition of the deadenylase activity of human CNOT6L,inhibitor,,0,,,,,,,,,,,,,
Q99418_CYTH2_wild_cl1,CYTH2_4jwlA_HRC,Q99418,,CYTH2,wild,cl1,4jwlA,HRC,,4jwl,3,2,,0,,,Fragment-based identification of a locus in the Sec7 domain of Arno for the design of protein-protein interaction inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q99418_CYTH2_wild_cl1,CYTH2_4jxhA_HRC,Q99418,,CYTH2,wild,cl1,4jxhA,HRC,,4jxh,3,2,,0,,,Fragment-based identification of a locus in the Sec7 domain of Arno for the design of protein-protein interaction inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q99418_CYTH2_wild_cl2,CYTH2_1r8qE_AFB,Q99418,,CYTH2,wild,cl2,1r8qE,AFB,,1r8q,3,2,,0,,,Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor,inhibitor,,0,,,,,,,,,,,,,
Q99418_CYTH2_wild_cl2,CYTH2_1s9dE_AFB,Q99418,,CYTH2,wild,cl2,1s9dE,AFB,,1s9d,3,2,,0,,,Structural Snapshots of the Mechanism and inhibition of a Guanine Nucleotide Exchange Factor,inhibitor,,0,,,,,,,,,,,,,
Q99814_EPAS1_wild_cl1,EPAS1_4xt2A_43L,Q99814,,EPAS1,wild,cl1,4xt2A,43L,,4xt2,1,1,,0,,,Isoform-Selective and Stereoselective inhibition of Hypoxia Inducible Factor-2.,inhibitor,,0,,,,,,,,,,,,,
Q99814_EPAS1_wild_cl1,EPAS1_5ufpA_86D,Q99814,,EPAS1,wild,cl1,5ufpA,86D,,5ufp,1,1,,0,,,On-target efficacy of a HIF-2 alpha antagonist in preclinical kidney cancer models.,inhibitor,,0,,,,,,,,,,,,,
Q9GZT4_SRR_wild_cl1,SRR_5x2lA_PLP,Q9GZT4,,SRR,wild,cl1,5x2lA,PLP,,5x2l,3,1,,0,,,Design_ synthesis_ and evaluation of novel inhibitors for wild-type human serine racemase.,inhibitor,,0,,,,,,,,,,,,,
Q9GZT4_SRR_wild_cl1,SRR_3l6bA_PLP,Q9GZT4,,SRR,wild,cl1,3l6bA,PLP,,3l6b,3,1,,0,,,The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding.,inhibitor,,0,,,,,,,,,,,,,
Q9GZT9_EGLN1_wild_cl1,EGLN1_3ouiA_42Z,Q9GZT9,,EGLN1,wild,cl1,3ouiA,42Z,,3oui,1,1,,0,,,Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase inhibitors as Oral Erythropoietin Secretagogues.,inhibitor,,0,,,,,,,,,,,,,
Q9GZT9_EGLN1_wild_cl1,EGLN1_6qgvA_J2H,Q9GZT9,,EGLN1,wild,cl1,6qgvA,J2H,,6qgv,1,1,,0,,,Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q9GZU7_CTDSP1_wild_cl1,CTDSP1_3pglA_RZX,Q9GZU7,,CTDSP1,wild,cl1,3pglA,RZX,,3pgl,3,1,,0,,,Selective inactivation of a human neuronal silencing phosphatase by a small molecule inhibitor.,inhibitor,,0,,,,,,,,,,,,,
Q9H7Z6_KAT8_wild_cl1,KAT8_6pdeA_O9V,Q9H7Z6,,KAT8,wild,cl1,6pdeA,O9V,,6pde,1,1,,0,,,Discovery of Acylsulfonohydrazide-Derived inhibitors of the Lysine Acetyltransferase_ KAT6A_ as Potent Senescence-Inducing Anti-Cancer Agents.,inhibitor,,0,,,,,,,,,,,,,
Q9H7Z6_KAT8_wild_cl1,KAT8_6pdgA_O9A,Q9H7Z6,,KAT8,wild,cl1,6pdgA,O9A,,6pdg,1,1,,0,,,Discovery of Acylsulfonohydrazide-Derived inhibitors of the Lysine Acetyltransferase_ KAT6A_ as Potent Senescence-Inducing Anti-Cancer Agents.,inhibitor,,0,,,,,,,,,,,,,
Q9HC16_APOBEC3G_wild_cl1,APOBEC3G_3v4jB_PQR,Q9HC16,,APOBEC3G,wild,cl1,3v4jB,PQR,,3v4j,3,1,,0,,,First-In-Class Small Molecule inhibitors of the Single-Strand DNA Cytosine Deaminase APOBEC3G.,inhibitor,,0,,,,,,,,,,,,,
Q9NWT6_HIF1AN_wild_cl1,HIF1AN_7a1kA_QVZ,Q9NWT6,,HIF1AN,wild,cl1,7a1kA,QVZ,,7a1k,1,1,,0,,,2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases.,inhibitor,,0,,,,,,,,,,,,,
Q9NWT6_HIF1AN_wild_cl1,HIF1AN_2ydeA_S2G,Q9NWT6,,HIF1AN,wild,cl1,2ydeA,S2G,,2yde,1,1,,0,,,The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.,inhibitor,,0,,,,,,,,,,,,,
Q9UH17_APOBEC3B_wild_cl1,APOBEC3B_6nflA_L60,Q9UH17,,APOBEC3B,wild,cl1,6nflA,L60,,6nfl,3,2,,0,,,Active site plasticity and possible modes of chemical inhibition of the human DNA deaminase APOBEC3B,inhibitor,,0,,,,,,,,,,,,,
Q9UHI8_ADAMTS1_wild_cl1,ADAMTS1_3q2gB_QGF,Q9UHI8,,ADAMTS1,wild,cl1,3q2gB,QGF,,3q2g,3,1,,0,,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis,inhibitor,,0,,,,,,,,,,,,,
Q9UHI8_ADAMTS1_wild_cl1,ADAMTS1_3q2hA_QHF,Q9UHI8,,ADAMTS1,wild,cl1,3q2hA,QHF,,3q2h,3,1,,0,,,The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis,inhibitor,,0,,,,,,,,,,,,,
Q9UM07_PADI4_wild_cl1,PADI4_3b1tA_YCL,Q9UM07,,PADI4,wild,cl1,3b1tA,YCL,,3b1t,2,1,,0,,,The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl1,GNE_2yi1A_ADP,Q9Y223,,GNE,wild,cl1,2yi1A,ADP,,2yi1,3,4,,0,,,Crystal Structures of N-Acetylmannosamine Kinase Provide Insights Into Enzyme Specificity and inhibition,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl3,GNE_2yhwA_BM3,Q9Y223,,GNE,wild,cl3,2yhwA,BM3,,2yhw,3,4,,0,,,Crystal Structures of N-Acetylmannosamine Kinase Provide Insights Into Enzyme Specificity and inhibition,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl3,GNE_2yhyA_BM3,Q9Y223,,GNE,wild,cl3,2yhyA,BM3,,2yhy,3,4,,0,,,Crystal Structures of N-Acetylmannosamine Kinase Provide Insights Into Enzyme Specificity and inhibition,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl1,GNE_4zhtC_UDP,Q9Y223,,GNE,wild,cl1,4zhtC,UDP,,4zht,3,4,,0,,,Mechanism and inhibition of human UDP-GlcNAc 2-epimerase_ the key enzyme in sialic acid biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl2,GNE_4zhtA_NCC,Q9Y223,,GNE,wild,cl2,4zhtA,NCC,,4zht,3,4,,0,,,Mechanism and inhibition of human UDP-GlcNAc 2-epimerase_ the key enzyme in sialic acid biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl2,GNE_4zhtC_NCC,Q9Y223,,GNE,wild,cl2,4zhtC,NCC,,4zht,3,4,,0,,,Mechanism and inhibition of human UDP-GlcNAc 2-epimerase_ the key enzyme in sialic acid biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y223_GNE_wild_cl4,GNE_4zhtC_BM7,Q9Y223,,GNE,wild,cl4,4zhtC,BM7,,4zht,3,4,,0,,,Mechanism and inhibition of human UDP-GlcNAc 2-epimerase_ the key enzyme in sialic acid biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y286_SIGLEC7_wild_cl1,SIGLEC7_2df3A_SIA,Q9Y286,,SIGLEC7,wild,cl1,2df3A,SIA,,2df3,3,3,,0,,,The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design,inhibitor,,0,,,,,,,,,,,,,
Q9Y286_SIGLEC7_wild_cl3,SIGLEC7_2df3A_NAG,Q9Y286,,SIGLEC7,wild,cl3,2df3A,NAG,,2df3,3,3,,0,,,The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design,inhibitor,,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl4,SAMHD1_6txeK_DTP,Q9Y3Z3,,SAMHD1,wild,cl4,6txeK,DTP,,6txe,3,5,,0,,,Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y5P4_CERT1_wild_cl1,CERT1_5zylA_9MC,Q9Y5P4,,CERT1,wild,cl1,5zylA,9MC,,5zyl,1,1,,0,,,Natural ligand-nonmimetic inhibitors of the lipid-transfer protein CERT,inhibitor,,0,,,,,,,,,,,,,
Q9Y657_SPIN1_wild_cl1,SPIN1_5jsgA_6P9,Q9Y657,,SPIN1,wild,cl1,5jsgA,6P9,,5jsg,2,1,,0,,,Developing Spindlin1 small-molecule inhibitors by using protein microarrays,inhibitor,,0,,,,,,,,,,,,,
Q9Y6Y9_LY96_wild_cl1,LY96_2z65C_E55,Q9Y6Y9,,LY96,wild,cl1,2z65C,E55,,2z65,3,2,,0,,,Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin antagonist Eritoran,inhibitor,,0,,,,,,,,,,,,,
O00182_LGALS9_wild_cl1,LGALS9_3wv6B_GAL,O00182,,LGALS9,wild,cl1,3wv6B,GAL,,3wv6,3,1,,0,,,X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site,,,0,,,,,,,,,,,,,
O00214_LGALS8_wild_cl1,LGALS8_5t7sA_GOL,O00214,,LGALS8,wild,cl1,5t7sA,GOL,,5t7s,3,1,,0,,,Structure-based rationale for differential recognition of lacto- and neolacto- series glycosphingolipids by the N-terminal domain of human galectin-8.,,,0,,,,,,,,,,,,,
O00255_MEN1_wild_cl1,MEN1_3u88A_GGB,O00255,,MEN1,wild,cl1,3u88A,GGB,,3u88,3,2,,0,,,The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.,,,0,,,,,,,,,,,,,
O00264_PGRMC1_wild_cl1,PGRMC1_4x8yB_HEM,O00264,,PGRMC1,wild,cl1,4x8yB,HEM,,4x8y,3,1,,0,,,Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance,,,0,,,,,,,,,,,,,
O00481_BTN3A1_wild_cl1,BTN3A1_6j06A_99C,O00481,,BTN3A1,wild,cl1,6j06A,99C,,6j06,2,2,,0,,,A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated V gamma 9V delta 2 T Cell Activation.,,,0,,,,,,,,,,,,,
O00481_BTN3A1_wild_cl1,BTN3A1_5lykA_FLC,O00481,,BTN3A1,wild,cl1,5lykA,FLC,,5lyk,2,2,,0,,,BTN3A1 Discriminates gamma delta T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.,,,0,,,,,,,,,,,,,
O00560_SDCBP_wild_cl1,SDCBP_4z33A_IP2,O00560,,SDCBP,wild,cl1,4z33A,IP2,,4z33,3,1,,0,,,Crystal structure of the syntenin PDZ1 and PDZ2 tandem in complex with the Frizzled 7 C-terminal fragment and PIP2,,,0,,,,,,,,,,,,,
O00571_DDX3X_wild_cl2,DDX3X_2i4iA_AMP,O00571,,DDX3X,wild,cl2,2i4iA,AMP,,2i4i,2,2,,0,,,Crystal Structure of Conserved Domains 1 and 2 of the Human DEAD-box Helicase DDX3X in Complex with the Mononucleotide AMP,,,0,,,,,,,,,,,,,
O00625_PIR_wild_cl1,PIR_5jctA_6JQ,O00625,,PIR,wild,cl1,5jctA,6JQ,,5jct,2,1,,0,,,Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.,,,0,,,,,,,,,,,,,
O00767_SCD_wild_cl1,SCD_4zyoA_ST9,O00767,,SCD,wild,cl1,4zyoA,ST9,,4zyo,3,1,,0,,,Crystal structure of human stearoyl-coenzyme A desaturase in complex with substrate.,,,0,,,,,,,,,,,,,
O14656_TOR1A_wild_cl1,TOR1A_5j1sA_ATP,O14656,,TOR1A,wild,cl1,5j1sA,ATP,,5j1s,3,1,,0,,,Structures of TorsinA and its disease-mutant complexed with an activator reveal the molecular basis for primary dystonia.,,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl1,PTGES_4al0A_GSH,O14684,,PTGES,wild,cl1,4al0A,GSH,,4al0,3,4,,0,,,Crystal Structure of Microsomal Prostaglandin E2 Synthase Provides Insight Into Diversity in the Mapeg Superfamily.,,,0,,,,,,,,,,,,,
O14684_PTGES_wild_cl2,PTGES_3dwwC_GSH,O14684,,PTGES,wild,cl2,3dwwC,GSH,,3dww,3,4,,0,,,Structural basis for induced formation of the inflammatory mediator prostaglandin E2,,,0,,,,,,,,,,,,,
O14727_APAF1_wild_cl1,APAF1_1z6tA_ADP,O14727,,APAF1,wild,cl1,1z6tA,ADP,,1z6t,3,1,,0,,,Structure of the apoptotic protease-activating factor 1 bound to ADP,,,0,,,,,,,,,,,,,
O14786_NRP1_wild_cl1,NRP1_5iyyA_R40,O14786,,NRP1,wild,cl1,5iyyA,R40,,5iyy,2,1,,0,,,Architecture and hydration of the arginine-binding site of neuropilin-1.,,,0,,,,,,,,,,,,,
O14929_HAT1_wild_cl1,HAT1_2p0wA_ACO,O14929,,HAT1,wild,cl1,2p0wA,ACO,,2p0w,3,1,,0,,,The crystal structure of human histone acetyltransferase 1 (HAT1) in complex with acetylcoenzyme A and histone peptide H4,,,0,,,,,,,,,,,,,
O14929_HAT1_wild_cl1,HAT1_6uhdB_CO6,O14929,,HAT1,wild,cl1,6uhdB,CO6,,6uhd,3,1,6VO5,0,,,Crystal structure of Human histone acetytransferas 1 (HAT1) in complex with isobutryl-COA and K12A mutant variant of histone H4,,,0,,,,,,,,,,,,,
O15118_NPC1_wild_cl1,NPC1_3gkjA_HC3,O15118,,NPC1,wild,cl1,3gkjA,HC3,,3gkj,3,1,,0,,,Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl2,MDM4_7c3qA_O4B,O15151,,MDM4,wild,cl2,7c3qA,O4B,,7c3q,1,7,,0,,,Human MdmX protein in complex with Nutlin3a,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl1,MDM4_6q9sB_HRN,O15151,,MDM4,wild,cl1,6q9sB,HRN,,6q9s,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl2,MDM4_6q9wB_O4B,O15151,,MDM4,wild,cl2,6q9wB,O4B,,6q9w,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl3,MDM4_6q9sA_O4B,O15151,,MDM4,wild,cl3,6q9sA,O4B,,6q9s,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl4,MDM4_6q9uA_O4B,O15151,,MDM4,wild,cl4,6q9uA,O4B,,6q9u,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl6,MDM4_6q9sC_O4B,O15151,,MDM4,wild,cl6,6q9sC,O4B,,6q9s,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15151_MDM4_wild_cl7,MDM4_6q9qB_O4B,O15151,,MDM4,wild,cl7,6q9qB,O4B,,6q9q,1,7,,0,,,Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.,,,0,,,,,,,,,,,,,
O15217_GSTA4_wild_cl1,GSTA4_3ik7A_BOB,O15217,,GSTA4,wild,cl1,3ik7A,BOB,,3ik7,3,1,,0,,,Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal.,,,0,,,,,,,,,,,,,
O15217_GSTA4_wild_cl1,GSTA4_3ik7B_BOB,O15217,,GSTA4,wild,cl1,3ik7B,BOB,,3ik7,3,1,,0,,,Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal.,,,0,,,,,,,,,,,,,
O15305_PMM2_wild_cl1,PMM2_7o1bA_G16,O15305,,PMM2,wild,cl1,7o1bA,G16,,7o1b,3,1,,0,,,Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency_ provided by novel human phosphomannomutase 2 structures.,,,0,,,,,,,,,,,,,
O15527_OGG1_wild_cl1,OGG1_1hu0A_OXG,O15527,,OGG1,wild,cl1,1hu0A,OXG,,1hu0,3,1,,0,,,Product-Assisted Catalysis in base-excision DNA Repair,,,0,,,,,,,,,,,,,
O15527_OGG1_wild_cl1,OGG1_1m3qA_ANG,O15527,,OGG1,wild,cl1,1m3qA,ANG,,1m3q,3,1,,0,,,Structures of End Products Resulting from Lesion Processing by a DNA Glycosylase/Lyase,,,0,,,,,,,,,,,,,
O15540_FABP7_wild_cl1,FABP7_5uraD_8KS,O15540,,FABP7,wild,cl1,5uraD,8KS,,5ura,2,1,,0,,,The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.,,,0,,,,,,,,,,,,,
O15540_FABP7_wild_cl1,FABP7_5uraA_8KS,O15540,,FABP7,wild,cl1,5uraA,8KS,,5ura,2,1,,0,,,The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.,,,0,,,,,,,,,,,,,
O43169_CYB5B_wild_cl1,CYB5B_3nerB_HEM,O43169,,CYB5B,wild,cl1,3nerB,HEM,,3ner,3,1,,0,,,Accommodating a Non-Conservative Internal Mutation by Water-Mediated Hydrogen-Bonding Between beta-Sheet Strands: A Comparison of Human and Rat Type B (Mitochondrial) Cytochrome b5,,,0,,,,,,,,,,,,,
O43708_GSTZ1_wild_cl1,GSTZ1_1fw1A_GSH,O43708,,GSTZ1,wild,cl1,1fw1A,GSH,,1fw1,3,1,,0,,,Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity.,,,0,,,,,,,,,,,,,
O43739_CYTH3_wild_cl1,CYTH3_6u3eA_4IP,O43739,,CYTH3,wild,cl1,6u3eA,4IP,,6u3e,3,1,,0,,,Structural Organization and Dynamics of Homodimeric Cytohesin Family Arf GTPase Exchange Factors in Solution and on Membranes.,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl1,GMDS_6q94H_GDD,O60547,,GMDS,wild,cl1,6q94H,GDD,,6q94,3,5,,0,,,A Parsimonious Mechanism of Sugar Dehydration by Human GDP-Mannose-4_6-dehydratase.,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl3,GMDS_6q94B_NAP,O60547,,GMDS,wild,cl3,6q94B,NAP,,6q94,3,5,,0,,,A Parsimonious Mechanism of Sugar Dehydration by Human GDP-Mannose-4_6-dehydratase.,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl4,GMDS_6q94E_NAP,O60547,,GMDS,wild,cl4,6q94E,NAP,,6q94,3,5,,0,,,A Parsimonious Mechanism of Sugar Dehydration by Human GDP-Mannose-4_6-dehydratase.,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl1,GMDS_1t2aA_GDP,O60547,,GMDS,wild,cl1,1t2aA,GDP,,1t2a,3,5,,0,,,Crystal Structure and Biophysical Characterization of Human GDP-D-mannose 4_6-dehydratase,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl3,GMDS_1t2aA_NDP,O60547,,GMDS,wild,cl3,1t2aA,NDP,,1t2a,3,5,,0,,,Crystal Structure and Biophysical Characterization of Human GDP-D-mannose 4_6-dehydratase,,,0,,,,,,,,,,,,,
O60547_GMDS_wild_cl4,GMDS_1t2aA_NDP,O60547,,GMDS,wild,cl4,1t2aA,NDP,,1t2a,3,5,,0,,,Crystal Structure and Biophysical Characterization of Human GDP-D-mannose 4_6-dehydratase,,,0,,,,,,,,,,,,,
O60551_NMT2_wild_cl1,NMT2_4c2xA_NHW,O60551,,NMT2,wild,cl1,4c2xA,NHW,,4c2x,3,1,,0,,,Global Profiling of Co- and Post-Translationally N-Myristoylated Proteomes in Human Cells.,,,0,,,,,,,,,,,,,
O75173_ADAMTS4_wild_cl1,ADAMTS4_2rjpA_886,O75173,,ADAMTS4,wild,cl1,2rjpA,886,,2rjp,3,1,,0,,,Crystal structures of the two major aggrecan degrading enzymes_ ADAMTS4 and ADAMTS5.,,,0,,,,,,,,,,,,,
O75173_ADAMTS4_wild_cl1,ADAMTS4_2rjpD_886,O75173,,ADAMTS4,wild,cl1,2rjpD,886,,2rjp,3,1,,0,,,Crystal structures of the two major aggrecan degrading enzymes_ ADAMTS4 and ADAMTS5.,,,0,,,,,,,,,,,,,
O75306_NDUFS2_wild_cl1,NDUFS2_5xtdQ_PLX,O75306,,NDUFS2,wild,cl1,5xtdQ,PLX,,5xtd,3,1,,0,,,Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2.,,,0,,,,,,,,,,,,,
O75417_POLQ_wild_cl1,POLQ_4x0pA_DDS,O75417,,POLQ,wild,cl1,4x0pA,DDS,,4x0p,3,1,,0,,,Human DNA polymerase theta grasps the primer terminus to mediate DNA repair.,,,0,,,,,,,,,,,,,
O75417_POLQ_wild_cl1,POLQ_6xbuA_DG3,O75417,,POLQ,wild,cl1,6xbuA,DG3,,6xbu,3,1,,0,,,Pol theta reverse transcribes RNA and promotes RNA-templated DNA repair.,,,0,,,,,,,,,,,,,
O75475_PSIP1_wild_cl1,PSIP1_3u88C_GGB,O75475,,PSIP1,wild,cl1,3u88C,GGB,,3u88,3,1,,0,,,The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.,,,0,,,,,,,,,,,,,
O75884_RBBP9_wild_cl1,RBBP9_7oexA_PHE,O75884,,RBBP9,wild,cl1,7oexA,PHE,,7oex,3,1,,0,,,Mechanism-based traps enable protease and hydrolase substrate discovery.,,,0,,,,,,,,,,,,,
O75940_SMNDC1_wild_cl1,SMNDC1_4a4fA_2MR,O75940,,SMNDC1,wild,cl1,4a4fA,2MR,,4a4f,3,1,,0,,,Structural Basis for Dimethyl-Arginine Recognition by the Tudor Domains of Human Smn and Spf30 Proteins,,,0,,,,,,,,,,,,,
O95453_PARN_wild_cl1,PARN_3ctrA_MGP,O95453,,PARN,wild,cl1,3ctrA,MGP,,3ctr,3,1,,0,,,Crystal structure of the RRM domain of poly(A)-specific ribonuclease reveals a novel m(7)G-cap-binding mode.,,,0,,,,,,,,,,,,,
O95822_MLYCD_wild_cl1,MLYCD_4f0xB_0OR,O95822,,MLYCD,wild,cl1,4f0xB,0OR,,4f0x,2,1,,0,,,Structural Asymmetry and Disulfide Bridges among Subunits Modulate the Activity of Human Malonyl-CoA Decarboxylase.,,,0,,,,,,,,,,,,,
O95822_MLYCD_wild_cl1,MLYCD_4f0xE_0OR,O95822,,MLYCD,wild,cl1,4f0xE,0OR,,4f0x,2,1,,0,,,Structural Asymmetry and Disulfide Bridges among Subunits Modulate the Activity of Human Malonyl-CoA Decarboxylase.,,,0,,,,,,,,,,,,,
P00167_CYB5A_wild_cl1,CYB5A_2i96A_HEM,P00167,,CYB5A,wild,cl1,2i96A,HEM,,2i96,3,1,,0,,,Solution Structure of human cytochrome b5,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl3,SOD1_5ytoD_946,P00441,,SOD1,wild,cl3,5ytoD,946,,5yto,1,5,,0,,,Assessment of ligand binding at a site relevant to SOD1 oxidation and aggregation,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl1,SOD1_6spiF_LQW,P00441,,SOD1,wild,cl1,6spiF,LQW,,6spi,1,5,,0,,,Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy.,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl1,SOD1_6spiC_LQW,P00441,,SOD1,wild,cl1,6spiC,LQW,,6spi,1,5,,0,,,Ebselen as template for stabilization of A4V mutant dimer for motor neuron disease therapy.,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl2,SOD1_4a7uA_ALE,P00441,,SOD1,wild,cl2,4a7uA,ALE,,4a7u,1,5,,0,,,Ligand Binding and Aggregation of Pathogenic Sod1.,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl2,SOD1_4a7tA_5FW,P00441,,SOD1,wild,cl2,4a7tA,5FW,,4a7t,1,5,,0,,,Ligand Binding and Aggregation of Pathogenic Sod1.,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl4,SOD1_2wz0F_DSN,P00441,,SOD1,wild,cl4,2wz0F,DSN,,2wz0,1,5,,0,,,Structural Discovery of Small Molecule Binding Sites in Cu-Zn Human Superoxide Dismutase Familial Amyotrophic Lateral Sclerosis Mutants Provides Insights for Lead Optimization.,,,0,,,,,,,,,,,,,
P00441_SOD1_wild_cl5,SOD1_2wyzA_U5P,P00441,,SOD1,wild,cl5,2wyzA,U5P,,2wyz,1,5,,0,,,Structural Discovery of Small Molecule Binding Sites in Cu-Zn Human Superoxide Dismutase Familial Amyotrophic Lateral Sclerosis Mutants Provides Insights for Lead Optimization.,,,0,,,,,,,,,,,,,
P00491_PNP_wild_cl1,PNP_4eceA_GUN,P00491,,PNP,wild,cl1,4eceA,GUN,,4ece,1,1,,0,,,Catalytic Site Conformations in Human PNP by (19)F-NMR and Crystallography.,,,0,,,,,,,,,,,,,
P00491_PNP_wild_cl1,PNP_1rctE_NOS,P00491,,PNP,wild,cl1,1rctE,NOS,,1rct,1,1,,0,,,Structures of human purine nucleoside phosphorylase complexed with inosine and ddI,,,0,,,,,,,,,,,,,
P01008_SERPINC1_wild_cl1,SERPINC1_2b5tI_GU1,P01008,,SERPINC1,wild,cl1,2b5tI,GU1,,2b5t,3,2,,0,,,Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation.,,,0,,,,,,,,,,,,,
P01008_SERPINC1_wild_cl2,SERPINC1_1lk6I_GOL,P01008,,SERPINC1,wild,cl2,1lk6I,GOL,,1lk6,3,2,,0,,,Serpin Polymerization Is Prevented by a Hydrogen Bond Network That Is Centered on His-334 and Stabilized by Glycerol,,,0,,,,,,,,,,,,,
P01008_SERPINC1_wild_cl1,SERPINC1_1tb6I_GU2,P01008,,SERPINC1,wild,cl1,1tb6I,GU2,,1tb6,3,2,,0,,,Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.,,,0,,,,,,,,,,,,,
P01011_SERPINA3_wild_cl1,SERPINA3_6hgfA_HCY,P01011,,SERPINA3,wild,cl1,6hgfA,HCY,,6hgf,3,1,,0,,,NewBG: A surrogate corticosteroid-binding globulin with an unprecedentedly high ligand release efficacy.,,,0,,,,,,,,,,,,,
P01011_SERPINA3_wild_cl1,SERPINA3_6hgiA_C0R,P01011,,SERPINA3,wild,cl1,6hgiA,C0R,,6hgi,3,1,,0,,,NewBG: A surrogate corticosteroid-binding globulin with an unprecedentedly high ligand release efficacy.,,,0,,,,,,,,,,,,,
P01215_CGA_wild_cl1,CGA_1e9jA_NAG,P01215,,CGA,wild,cl1,1e9jA,NAG,,1e9j,3,1,,0,,,Effects of the N-linked glycans on the 3D structure of the free alpha-subunit of human chorionic gonadotropin.,,,0,,,,,,,,,,,,,
P01275_GCG_wild_cl1,GCG_2m5qA_GGL,P01275,,GCG,wild,cl1,2m5qA,GGL,,2m5q,3,2,,0,,,Structural Changes Associated with Peptide Lipidation Broaden Biological Function,,,0,,,,,,,,,,,,,
P01275_GCG_wild_cl2,GCG_2m5pA_GGL,P01275,,GCG,wild,cl2,2m5pA,GGL,,2m5p,3,2,,0,,,Structural Changes Associated with Peptide Lipidation Broaden Biological Function,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl3,INS_4gbcD_CRS,P01308,,INS,wild,cl3,4gbcD,CRS,,4gbc,3,4,,0,,,A T3R3 hexamer of the human insulin variant B28Asp.,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl1,INS_1zehD_CRS,P01308,,INS,wild,cl1,1zehD,CRS,,1zeh,3,4,,0,,,Interactions of phenol and m-cresol in the insulin hexamer_ and their effect on the association properties of B28 pro --> Asp insulin analogues.,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl2,INS_1zegD_IPH,P01308,,INS,wild,cl2,1zegD,IPH,,1zeg,3,4,,0,,,Interactions of phenol and m-cresol in the insulin hexamer_ and their effect on the association properties of B28 pro --> Asp insulin analogues.,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl4,INS_1zehB_CRS,P01308,,INS,wild,cl4,1zehB,CRS,,1zeh,3,4,,0,,,Interactions of phenol and m-cresol in the insulin hexamer_ and their effect on the association properties of B28 pro --> Asp insulin analogues.,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl1,INS_1qizB_RCO,P01308,,INS,wild,cl1,1qizB,RCO,,1qiz,3,4,,0,,,Structural Consequences of the B5 Histidine --> Tyrosine Mutation in Human Insulin Characterized by X-Ray Crystallography and Conformational Analysis.,,,0,,,,,,,,,,,,,
P01308_INS_wild_cl2,INS_1qizD_RCO,P01308,,INS,wild,cl2,1qizD,RCO,,1qiz,3,4,,0,,,Structural Consequences of the B5 Histidine --> Tyrosine Mutation in Human Insulin Characterized by X-Ray Crystallography and Conformational Analysis.,,,0,,,,,,,,,,,,,
P01574_IFNB1_wild_cl1,IFNB1_1au1A_BGC,P01574,,IFNB1,wild,cl1,1au1A,BGC,,1au1,3,1,,0,,,The crystal structure of human interferon beta at 2.2-A resolution.,,,0,,,,,,,,,,,,,
P01584_IL1B_wild_cl3,IL1B_6y8mA_SX2,P01584,,IL1B,wild,cl3,6y8mA,SX2,,6y8m,1,3,,0,,,Fragment bikinin bound to Interleukin 1 beta,,,0,,,,,,,,,,,,,
P01730_CD4_wild_cl1,CD4_2b4cC_FUC,P01730,,CD4,wild,cl1,2b4cC,FUC,,2b4c,3,1,,0,,,Structure of a V3-containing HIV-1 gp120 core.,,,0,,,,,,,,,,,,,
P02144_MB_wild_cl1,MB_3rgkA_HEM,P02144,,MB,wild,cl1,3rgkA,HEM,,3rgk,3,1,,0,,,X-ray crystal structure of a recombinant human myoglobin mutant at 2.8 A resolution,,,0,,,,,,,,,,,,,
P02647_APOA1_wild_cl2,APOA1_6w4eD_17F,P02647,,APOA1,wild,cl2,6w4eD,17F,,6w4e,3,1,,0,,,Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement.,,,0,,,,,,,,,,,,,
P02647_APOA1_wild_cl1,APOA1_2a01C_AC9,P02647,,APOA1,wild,cl1,2a01C,AC9,,2a01,3,1,removed ,0,,, ,,,0,,,,,,,,,,,,,
P02647_APOA1_wild_cl1,APOA1_2a01B_AC9,P02647,,APOA1,wild,cl1,2a01B,AC9,,2a01,3,1,removed ,0,,, ,,,0,,,,,,,,,,,,,
P02743_APCS_wild_cl1,APCS_1lgnE_DA,P02743,,APCS,wild,cl1,1lgnE,DA,,1lgn,3,3,,0,,,Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.,,,0,,,,,,,,,,,,,
P02743_APCS_wild_cl2,APCS_4avsE_NAG,P02743,,APCS,wild,cl2,4avsE,NAG,,4avs,3,3,,0,,,Interaction of Serum Amyloid P Component with Hexanoyl Bis(D-Proline) (Cphpc),,,0,,,,,,,,,,,,,
P02743_APCS_wild_cl2,APCS_4avsB_NAG,P02743,,APCS,wild,cl2,4avsB,NAG,,4avs,3,3,,0,,,Interaction of Serum Amyloid P Component with Hexanoyl Bis(D-Proline) (Cphpc),,,0,,,,,,,,,,,,,
P02743_APCS_wild_cl3,APCS_4avvB_SIA,P02743,,APCS,wild,cl3,4avvB,SIA,,4avv,3,3,,0,,,Interaction of Serum Amyloid P Component with Hexanoyl Bis(D-Proline) (Cphpc),,,0,,,,,,,,,,,,,
P02743_APCS_wild_cl1,APCS_2a3xI_CPK,P02743,,APCS,wild,cl1,2a3xI,CPK,,2a3x,3,3,,0,,,Ligand-assisted Aggregation of Proteins: DIMERIZATION OF SERUM AMYLOID P COMPONENT BY BIVALENT LIGANDS.,,,0,,,,,,,,,,,,,
P02753_RBP4_wild_cl1,RBP4_6qbaA_2T1,P02753,,RBP4,wild,cl1,6qbaA,2T1,,6qba,1,1,,0,,,A conformation-specific ON-switch for controlling CAR T cells with an orally available drug.,,,0,,,,,,,,,,,,,
P02753_RBP4_wild_cl1,RBP4_1rbpA_RTL,P02753,,RBP4,wild,cl1,1rbpA,RTL,,1rbp,1,1,,0,,,Crystallographic refinement of human serum retinol binding protein at 2A resolution.,,,0,,,,,,,,,,,,,
P02763_ORM1_wild_cl1,ORM1_3kq0A_JIM,P02763,,ORM1,wild,cl1,3kq0A,JIM,,3kq0,3,1,,0,,,The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin.,,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl3,TTR_3ng5A_KDH,P02766,,TTR,wild,cl3,3ng5A,KDH,,3ng5,1,5,,0,,,Crystal structure of green tea polyphenol(-)-epigallocatechin gallate (EGCG)-transthyretin complex reveals novel binding site distinct from thyroxine binding site,,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl3,TTR_3ng5B_KDH,P02766,,TTR,wild,cl3,3ng5B,KDH,,3ng5,1,5,,0,,,Crystal structure of green tea polyphenol(-)-epigallocatechin gallate (EGCG)-transthyretin complex reveals novel binding site distinct from thyroxine binding site,,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl2,TTR_3p3sA_3M2,P02766,,TTR,wild,cl2,3p3sA,3M2,,3p3s,1,5,,0,,,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl2,TTR_3p3sB_3M2,P02766,,TTR,wild,cl2,3p3sB,3M2,,3p3s,1,5,,0,,,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,,,0,,,,,,,,,,,,,
P02766_TTR_wild_cl1,TTR_4hjsA_18J,P02766,,TTR,wild,cl1,4hjsA,18J,,4hjs,1,5,,0,,,Stilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl4,ALB_1e7cA_MYR,P02768,,ALB,wild,cl4,1e7cA,MYR,,1e7c,1,8,,0,,,Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin. High Resolution Crystal Structures,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl2,ALB_5yoqA_CLT,P02768,,ALB,wild,cl2,5yoqA,CLT,,5yoq,1,8,,0,,,Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl3,ALB_1e7iA_STE,P02768,,ALB,wild,cl3,1e7iA,STE,,1e7i,1,8,,0,,,Crystallographic Analysis Reveals Common Modes of Binding of Medium and Long-Chain Fatty Acids to Human Serum Albumin,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl4,ALB_5gixA_PLM,P02768,,ALB,wild,cl4,5gixA,PLM,,5gix,1,8,,0,,,Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl6,ALB_6qioA_JG5,P02768,,ALB,wild,cl6,6qioA,JG5,,6qio,1,8,,0,,,Identification of Binding Sites on Human Serum Albumin for Somapacitan_ a Long-Acting Growth Hormone Derivative.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl6,ALB_6qipA_HDW,P02768,,ALB,wild,cl6,6qipA,HDW,,6qip,1,8,,0,,,Identification of Binding Sites on Human Serum Albumin for Somapacitan_ a Long-Acting Growth Hormone Derivative.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl5,ALB_6m5eA_M12,P02768,,ALB,wild,cl5,6m5eA,M12,,6m5e,1,8,,0,,,Structural Basis for the Binding Mechanism of Human Serum Albumin Complexed with Cyclic Peptide Dalbavancin.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl2,ALB_1hk5A_MYR,P02768,,ALB,wild,cl2,1hk5A,MYR,,1hk5,1,8,,0,,,Structural Basis of Albumin-Thyroxine Interactions and Familial Dysalbuminemic Hyperthyroxinemia,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl3,ALB_4z69A_F15,P02768,,ALB,wild,cl3,4z69A,F15,,4z69,1,8,,0,,,Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl1,ALB_2bxnA_IDB,P02768,,ALB,wild,cl1,2bxnA,IDB,,2bxn,1,8,,0,,,Structural Basis of the Drug-Binding Specificity of Human Serum Albumin.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl8,ALB_4lb9A_EVP,P02768,,ALB,wild,cl8,4lb9A,EVP,,4lb9,1,8,,0,,,Structural studies of several clinically important oncology drugs in complex with human serum albumin.,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl1,ALB_7eekA_J2O,P02768,,ALB,wild,cl1,7eekA,J2O,,7eek,1,8,,0,,,Structure of Human serum albumin-Au compound complex,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl5,ALB_5z0bC_OCA,P02768,,ALB,wild,cl5,5z0bC,OCA,,5z0b,1,8,,0,,,The crystal structure of plasma-derived human serum albumin,,,0,,,,,,,,,,,,,
P02768_ALB_wild_cl7,ALB_6yg9A_OQ5,P02768,,ALB,wild,cl7,6yg9A,OQ5,,6yg9,1,8,,0,,,Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis.,,,0,,,,,,,,,,,,,
P02774_GC_wild_cl1,GC_1j78B_VDY,P02774,,GC,wild,cl1,1j78B,VDY,,1j78,3,1,,0,,,A structural basis for the unique binding features of the human vitamin D-binding protein.,,,0,,,,,,,,,,,,,
P02774_GC_wild_cl1,GC_1j7eA_JY,P02774,,GC,wild,cl1,1j7eA,JY,,1j7e,3,1,,0,,,A structural basis for the unique binding features of the human vitamin D-binding protein.,,,0,,,,,,,,,,,,,
P02787_TF_wild_cl1,TF_5x5pA_NTA,P02787,,TF,wild,cl1,5x5pA,NTA,,5x5p,3,1,,0,,,Binding of ruthenium and osmium at non?iron sites of transferrin accounts for their iron-independent cellular uptake.,,,0,,,,,,,,,,,,,
P03950_ANG_wild_cl1,ANG_5m9vA_GSH,P03950,,ANG,wild,cl1,5m9vA,GSH,,5m9v,3,1,,0,,,Structural insights into human angiogenin variants implicated in Parkinson's disease and Amyotrophic Lateral Sclerosis.,,,0,,,,,,,,,,,,,
P04271_S100B_wild_cl1,S100B_3hcmB_S45,P04271,,S100B,wild,cl1,3hcmB,S45,,3hcm,3,1,,0,,,Fragmenting the S100B-p53 Interaction: Combined Virtual/Biophysical Screening Approaches to Identify Ligands,,,0,,,,,,,,,,,,,
P04278_SHBG_wild_cl1,SHBG_6pyfA_EST,P04278,,SHBG,wild,cl1,6pyfA,EST,,6pyf,1,1,,0,,,Molecular interactions between sex hormone-binding globulin and nonsteroidal ligands that enhance androgen activity.,,,0,,,,,,,,,,,,,
P04278_SHBG_wild_cl1,SHBG_6ulbA_QA1,P04278,,SHBG,wild,cl1,6ulbA,QA1,,6ulb,1,1,,0,,,Structural and biochemical analyses of danazol interactions with sex hormone-binding globulin and effects on androgen action,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl1,RPN1_6s7oE_EGY,P04843,,RPN1,wild,cl1,6s7oE,EGY,,6s7o,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl1,RPN1_6s7tE_EGY,P04843,,RPN1,wild,cl1,6s7tE,EGY,,6s7t,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl2,RPN1_6s7oE_KZB,P04843,,RPN1,wild,cl2,6s7oE,KZB,,6s7o,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl2,RPN1_6s7tE_KZB,P04843,,RPN1,wild,cl2,6s7tE,KZB,,6s7t,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl3,RPN1_6s7oE_EGY,P04843,,RPN1,wild,cl3,6s7oE,EGY,,6s7o,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P04843_RPN1_wild_cl4,RPN1_6s7oE_EGY,P04843,,RPN1,wild,cl4,6s7oE,EGY,,6s7o,3,4,,0,,,Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B.,,,0,,,,,,,,,,,,,
P05019_IGF1_wild_cl1,IGF1_1gzrB_C15,P05019,,IGF1,wild,cl1,1gzrB,C15,,1gzr,3,1,,0,,,Structural Origins of the Functional Divergence of Human Insulin-Like Growth Factor-I and Insulin,,,0,,,,,,,,,,,,,
P05019_IGF1_wild_cl1,IGF1_1gzyB_C15,P05019,,IGF1,wild,cl1,1gzyB,C15,,1gzy,3,1,,0,,,Structural Origins of the Functional Divergence of Human Insulin-Like Growth Factor-I and Insulin,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl3,APP_2m9rA_23Y,P05067,,APP,wild,cl3,2m9rA,23Y,,2m9r,2,4,,0,,,3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-viniferin glucoside: Implications in Alzheimer's disease.,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl4,APP_5buoA_SGN,P05067,,APP,wild,cl4,5buoA,SGN,,5buo,2,4,,0,,,NULL,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl1,APP_3ktmG_BU4,P05067,,APP,wild,cl1,3ktmG,BU4,,3ktm,2,4,,0,,,Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl1,APP_3ktmD_BU4,P05067,,APP,wild,cl1,3ktmD,BU4,,3ktm,2,4,,0,,,Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl2,APP_3ktmB_BU4,P05067,,APP,wild,cl2,3ktmB,BU4,,3ktm,2,4,,0,,,Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.,,,0,,,,,,,,,,,,,
P05067_APP_wild_cl2,APP_3ktmC_BU4,P05067,,APP,wild,cl2,3ktmC,BU4,,3ktm,2,4,,0,,,Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.,,,0,,,,,,,,,,,,,
P05121_SERPINE1_wild_cl1,SERPINE1_4ic0A_GDE,P05121,,SERPINE1,wild,cl1,4ic0A,GDE,,4ic0,2,3,,0,,,Crystal Structure of PAI-1 in Complex with Gallate,,,0,,,,,,,,,,,,,
P05121_SERPINE1_wild_cl1,SERPINE1_4ic0C_GDE,P05121,,SERPINE1,wild,cl1,4ic0C,GDE,,4ic0,2,3,,0,,,Crystal Structure of PAI-1 in Complex with Gallate,,,0,,,,,,,,,,,,,
P05121_SERPINE1_wild_cl2,SERPINE1_3r4lA_FUC,P05121,,SERPINE1,wild,cl2,3r4lA,FUC,,3r4l,2,3,,0,,,Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure.,,,0,,,,,,,,,,,,,
P05162_LGALS2_wild_cl1,LGALS2_1hlcA_GAL,P05162,,LGALS2,wild,cl1,1hlcA,GAL,,1hlc,3,1,,0,,,X-ray crystal structure of the human dimeric S-Lac lectin_ L-14-II_ in complex with lactose at 2.9-A resolution.,,,0,,,,,,,,,,,,,
P05162_LGALS2_wild_cl1,LGALS2_1hlcB_GAL,P05162,,LGALS2,wild,cl1,1hlcB,GAL,,1hlc,3,1,,0,,,X-ray crystal structure of the human dimeric S-Lac lectin_ L-14-II_ in complex with lactose at 2.9-A resolution.,,,0,,,,,,,,,,,,,
P05230_FGF1_wild_cl1,FGF1_1hknC_N2M,P05230,,FGF1,wild,cl1,1hknC,N2M,,1hkn,3,1,,0,,,Leads for Development of New Naphthalenesulfonate Derivatives with Enhanced Antiangiogenic Activity: Crystal Structure of Acidic Fibroblast Growth Factor in Complex with 5-Amino-2-Naphthalenesulfonate,,,0,,,,,,,,,,,,,
P05230_FGF1_wild_cl1,FGF1_1axmA_SGN,P05230,,FGF1,wild,cl1,1axmA,SGN,,1axm,3,1,,0,,,Structure of a heparin-linked biologically active dimer of fibroblast growth factor.,,,0,,,,,,,,,,,,,
P05362_ICAM1_wild_cl1,ICAM1_5mzaB_IHP,P05362,,ICAM1,wild,cl1,5mzaB,IHP,,5mza,3,1,,0,,,Structure-Guided Identification of a Family of Dual Receptor-Binding PfEMP1 that Is Associated with Cerebral Malaria.,,,0,,,,,,,,,,,,,
P05413_FABP3_wild_cl1,FABP3_3wbgC_2AN,P05413,,FABP3,wild,cl1,3wbgC,2AN,,3wbg,1,2,,0,,,Structure of the human-heart fatty-acid-binding protein 3 in complex with the fluorescent probe 1-anilinonaphthalene-8-sulphonic acid,,,0,,,,,,,,,,,,,
P05413_FABP3_wild_cl2,FABP3_4tkjA_GLP,P05413,,FABP3,wild,cl2,4tkjA,GLP,,4tkj,1,2,,0,,,Water-mediated recognition of simple alkyl chains by heart-type Fatty-Acid-binding protein,,,0,,,,,,,,,,,,,
P05543_SERPINA7_wild_cl1,SERPINA7_2xn7A_T44,P05543,,SERPINA7,wild,cl1,2xn7A,T44,,2xn7,3,2,,0,,,Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid Binding-Globulins.,,allosteric,0,,,,,,,,,,,,,
P05543_SERPINA7_wild_cl1,SERPINA7_2xn5A_FUN,P05543,,SERPINA7,wild,cl1,2xn5A,FUN,,2xn5,3,2,,0,,,Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid Binding-Globulins.,,allosteric,0,,,,,,,,,,,,,
P05543_SERPINA7_wild_cl2,SERPINA7_2xn5B_FUN,P05543,,SERPINA7,wild,cl2,2xn5B,FUN,,2xn5,3,2,,0,,,Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid Binding-Globulins.,,allosteric,0,,,,,,,,,,,,,
P05543_SERPINA7_wild_cl2,SERPINA7_4x30A_T44,P05543,,SERPINA7,wild,cl2,4x30A,T44,,4x30,3,2,,0,,,Crystal structure of human Thyroxine-binding globulin complexed with thyroine at 1.55 Angstrom resolution,,,0,,,,,,,,,,,,,
P06702_S100A9_wild_cl1,S100A9_1irjB_CPS,P06702,,S100A9,wild,cl1,1irjB,CPS,,1irj,3,1,,0,,,The crystal structure of human MRP14 (S100A9)_ a Ca(2+)-dependent regulator protein in inflammatory process.,,,0,,,,,,,,,,,,,
P06702_S100A9_wild_cl1,S100A9_1irjG_CPS,P06702,,S100A9,wild,cl1,1irjG,CPS,,1irj,3,1,,0,,,The crystal structure of human MRP14 (S100A9)_ a Ca(2+)-dependent regulator protein in inflammatory process.,,,0,,,,,,,,,,,,,
P06729_CD2_wild_cl1,CD2_1hnfA_NAG,P06729,,CD2,wild,cl1,1hnfA,NAG,,1hnf,3,1,,0,,,Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution.,,,0,,,,,,,,,,,,,
P06730_EIF4E_wild_cl1,EIF4E_4tpwA_MGP,P06730,,EIF4E,wild,cl1,4tpwA,MGP,,4tpw,1,3,,0,,,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an Allosteric mechanism for dissociating eIF4G.,,allosteric,0,,,,,,,,,,,,,
P06730_EIF4E_wild_cl2,EIF4E_4tqcA_34J,P06730,,EIF4E,wild,cl2,4tqcA,34J,,4tqc,1,3,,0,,,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an Allosteric mechanism for dissociating eIF4G.,,allosteric,0,,,,,,,,,,,,,
P06730_EIF4E_wild_cl2,EIF4E_4tpwA_33R,P06730,,EIF4E,wild,cl2,4tpwA,33R,,4tpw,1,3,,0,,,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an Allosteric mechanism for dissociating eIF4G.,,allosteric,0,,,,,,,,,,,,,
P06730_EIF4E_wild_cl3,EIF4E_2w97A_GOL,P06730,,EIF4E,wild,cl3,2w97A,GOL,,2w97,1,3,,0,,,Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site.,,,0,,,,,,,,,,,,,
P06730_EIF4E_wild_cl1,EIF4E_2v8xA_MGQ,P06730,,EIF4E,wild,cl1,2v8xA,MGQ,,2v8x,1,3,,0,,,Crystallographic and Mass Spectrometric Characterisation of Eif4E with N(7)-Alkylated CAP Derivatives.,,,0,,,,,,,,,,,,,
P06731_CEACAM5_wild_cl1,CEACAM5_2verN_MTN,P06731,,CEACAM5,wild,cl1,2verN,MTN,,2ver,3,1,,0,,,Binding of Dr Adhesins of Escherichia Coli to Carcinoembryonic Antigen Triggers Receptor Dissociation.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl2,POLB_7rboA_QPJ,P06746,,POLB,wild,cl2,7rboA,QPJ,,7rbo,1,4,,0,,,Interlocking activities of DNA polymerase beta in the base excision repair pathway.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl3,POLB_3rh4A_CTP,P06746,,POLB,wild,cl3,3rh4A,CTP,,3rh4,1,4,,0,,,Molecular insights into DNA polymerase deterrents for ribonucleotide insertion.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl3,POLB_3rh5A_DCP,P06746,,POLB,wild,cl3,3rh5A,DCP,,3rh5,1,4,,0,,,Molecular insights into DNA polymerase deterrents for ribonucleotide insertion.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl1,POLB_4klsA_DTP,P06746,,POLB,wild,cl1,4klsA,DTP,,4kls,1,4,,0,,,Observing a DNA polymerase choose right from wrong.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl2,POLB_4o9mA_2RW,P06746,,POLB,wild,cl2,4o9mA,2RW,,4o9m,1,4,,0,,,Role of polymerase beta in complementing aprataxin deficiency during abasic-site base excision repair.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl1,POLB_4ubbA_8DG,P06746,,POLB,wild,cl1,4ubbA,8DG,,4ubb,1,4,,0,,,Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide.,,,0,,,,,,,,,,,,,
P06746_POLB_wild_cl4,POLB_4rq0A_DCP,P06746,,POLB,wild,cl4,4rq0A,DCP,,4rq0,1,4,,0,,,Viewing Human DNA Polymerase beta Faithfully and Unfaithfully Bypass an Oxidative Lesion by Time-Dependent Crystallography.,,,0,,,,,,,,,,,,,
P07148_FABP1_wild_cl1,FABP1_3stkA_PLM,P07148,,FABP1,wild,cl1,3stkA,PLM,,3stk,2,1,,0,,,Fatty acid induced remodeling within the Human liver fatty acid binding protein,,,0,,,,,,,,,,,,,
P07195_LDHB_wild_cl1,LDHB_1t2fA_NAD,P07195,,LDHB,wild,cl1,1t2fA,NAD,,1t2f,2,2,,0,,,Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity.,,,0,,,,,,,,,,,,,
P07195_LDHB_wild_cl1,LDHB_1t2fC_NAD,P07195,,LDHB,wild,cl1,1t2fC,NAD,,1t2f,2,2,,0,,,Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity.,,,0,,,,,,,,,,,,,
P07195_LDHB_wild_cl2,LDHB_1t2fA_OXQ,P07195,,LDHB,wild,cl2,1t2fA,OXQ,,1t2f,2,2,,0,,,Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity.,,,0,,,,,,,,,,,,,
P07195_LDHB_wild_cl2,LDHB_1i0zA_OXM,P07195,,LDHB,wild,cl2,1i0zA,OXM,,1i0z,2,2,,0,,,Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase.,,,0,,,,,,,,,,,,,
P07306_ASGR1_wild_cl1,ASGR1_5jpvA_LBT,P07306,,ASGR1,wild,cl1,5jpvA,LBT,,5jpv,3,1,,0,,,Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.,,,0,,,,,,,,,,,,,
P07306_ASGR1_wild_cl1,ASGR1_6yauA_OJB,P07306,,ASGR1,wild,cl1,6yauA,OJB,,6yau,3,1,,0,,,Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis.,,,0,,,,,,,,,,,,,
P07355_ANXA2_wild_cl1,ANXA2_2hyuA_SGN,P07355,,ANXA2,wild,cl1,2hyuA,SGN,,2hyu,3,2,,0,,,Crystallographic Analysis of Calcium-dependent Heparin Binding to Annexin A2.,,,0,,,,,,,,,,,,,
P07355_ANXA2_wild_cl1,ANXA2_2hyvA_SGN,P07355,,ANXA2,wild,cl1,2hyvA,SGN,,2hyv,3,2,,0,,,Crystallographic analysis of calcium-dependent heparin binding to annexin A2.,,,0,,,,,,,,,,,,,
P07355_ANXA2_wild_cl2,ANXA2_2hyuA_UAP,P07355,,ANXA2,wild,cl2,2hyuA,UAP,,2hyu,3,2,,0,,,Crystallographic Analysis of Calcium-dependent Heparin Binding to Annexin A2.,,,0,,,,,,,,,,,,,
P07437_TUBB_wild_cl1,TUBB_6i2iB_G2P,P07437,,TUBB,wild,cl1,6i2iB,G2P,,6i2i,3,2,,0,,,Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression.,,,0,,,,,,,,,,,,,
P07437_TUBB_wild_cl1,TUBB_6qusU_GDP,P07437,,TUBB,wild,cl1,6qusU,GDP,,6qus,3,2,,0,,,Structural determinants of microtubule minus end preference in CAMSAP CKK domains.,,,0,,,,,,,,,,,,,
P07437_TUBB_wild_cl2,TUBB_6qvjS_TA1,P07437,,TUBB,wild,cl2,6qvjS,TA1,,6qvj,3,2,,0,,,Structural determinants of microtubule minus end preference in CAMSAP CKK domains.,,,0,,,,,,,,,,,,,
P07437_TUBB_wild_cl2,TUBB_6qusU_TA1,P07437,,TUBB,wild,cl2,6qusU,TA1,,6qus,3,2,,0,,,Structural determinants of microtubule minus end preference in CAMSAP CKK domains.,,,0,,,,,,,,,,,,,
P07602_PSAP_wild_cl1,PSAP_4v2oB_CLQ,P07602,,PSAP,wild,cl1,4v2oB,CLQ,,4v2o,3,1,,0,,,The Lysosomal Protein Saposin B Binds Chloroquine.,,,0,,,,,,,,,,,,,
P07602_PSAP_wild_cl1,PSAP_4v2oC_CLQ,P07602,,PSAP,wild,cl1,4v2oC,CLQ,,4v2o,3,1,,0,,,The Lysosomal Protein Saposin B Binds Chloroquine.,,,0,,,,,,,,,,,,,
P07996_THBS1_wild_cl2,THBS1_5foeB_GDP,P07996,,THBS1,wild,cl2,5foeB,GDP,,5foe,3,3,,0,,,A Proactive Role of Water Molecules in Acceptor Recognition of Thrombospondin Type 1 Repeats by Protein-O-Fucosyltransferase 2,,,0,,,,,,,,,,,,,
P07996_THBS1_wild_cl1,THBS1_1lslA_FUC,P07996,,THBS1,wild,cl1,1lslA,FUC,,1lsl,3,3,,0,,,Crystal structure of the TSP-1 type 1 repeats: a novel  layered fold and its biological implication.,,,0,,,,,,,,,,,,,
P07996_THBS1_wild_cl3,THBS1_1lslA_FUL,P07996,,THBS1,wild,cl3,1lslA,FUL,,1lsl,3,3,,0,,,Crystal structure of the TSP-1 type 1 repeats: a novel  layered fold and its biological implication.,,,0,,,,,,,,,,,,,
P08138_NGFR_wild_cl1,NGFR_5zggB_9F6,P08138,,NGFR,wild,cl1,5zggB,9F6,,5zgg,3,1,,0,,,A Small Molecule Targeting the Transmembrane Domain of Death Receptor p75NTRInduces Melanoma Cell Death and Reduces Tumor Growth.,,,0,,,,,,,,,,,,,
P08185_SERPINA6_wild_cl2,SERPINA6_4bb2B_STR,P08185,,SERPINA6,wild,cl2,4bb2B,STR,,4bb2,2,3,,0,,,Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences,,,0,,,,,,,,,,,,,
P08185_SERPINA6_wild_cl3,SERPINA6_4bb2A_CYS,P08185,,SERPINA6,wild,cl3,4bb2A,CYS,,4bb2,2,3,,0,,,Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences,,,0,,,,,,,,,,,,,
P08185_SERPINA6_wild_cl1,SERPINA6_2vdyA_HCY,P08185,,SERPINA6,wild,cl1,2vdyA,HCY,,2vdy,2,3,,0,,,The S-to-R Transition of Corticosteroid-Binding Globulin and the Mechanism of Hormone Release.,,,0,,,,,,,,,,,,,
P08185_SERPINA6_wild_cl1,SERPINA6_2vdyB_HCY,P08185,,SERPINA6,wild,cl1,2vdyB,HCY,,2vdy,2,3,,0,,,The S-to-R Transition of Corticosteroid-Binding Globulin and the Mechanism of Hormone Release.,,,0,,,,,,,,,,,,,
P08240_SRPRA_wild_cl1,SRPRA_5l3qB_GNP,P08240,,SRPRA,wild,cl1,5l3qB,GNP,,5l3q,3,1,,0,,,Structural Basis for Conserved Regulation and Adaptation of the Signal Recognition Particle Targeting Complex.,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl1,GSTA1_1k3lA_GTX,P08263,,GSTA1,wild,cl1,1k3lA,GTX,,1k3l,1,4,,0,,,1.3-A resolution structure of human glutathione S-transferase with S-hexyl  glutathione bound reveals possible extended ligandin binding site,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl4,GSTA1_1k3yA_GOL,P08263,,GSTA1,wild,cl4,1k3yA,GOL,,1k3y,1,4,,0,,,1.3-A resolution structure of human glutathione S-transferase with S-hexyl glutathione bound reveals possible extended ligandin binding site.,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl2,GSTA1_5lczB_GSH,P08263,,GSTA1,wild,cl2,5lczB,GSH,,5lcz,1,4,,0,,,Directed evolution of glutathione transferases towards a selective glutathione-binding site and improved oxidative stability.,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl1,GSTA1_1pl1A_ABY,P08263,,GSTA1,wild,cl1,1pl1A,ABY,,1pl1,1,4,,0,,,New crystal structures of human glutathione transferase A1-1 shed light on glutathione binding and the conformation of the C-terminal helix.,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl3,GSTA1_7bicB_9AI,P08263,,GSTA1,wild,cl3,7bicB,9AI,,7bic,1,4,,0,,,Role of human salivary enzymes in bitter taste perception.,,,0,,,,,,,,,,,,,
P08263_GSTA1_wild_cl2,GSTA1_1gseA_GSH,P08263,,GSTA1,wild,cl2,1gseA,GSH,,1gse,1,4,,0,,,Structural analysis of human alpha-class glutathione transferase A1-1 in the apo-form and in complexes with ethacrynic acid and its glutathione conjugate.,,,0,,,,,,,,,,,,,
P08397_HMBS_wild_cl1,HMBS_5m7fA_DPM,P08397,,HMBS,wild,cl1,5m7fA,DPM,,5m7f,3,1,,0,,,Structural basis of pyrrole polymerization in human porphobilinogen deaminase.,,,0,,,,,,,,,,,,,
P08397_HMBS_wild_cl1,HMBS_5m6rA_7J8,P08397,,HMBS,wild,cl1,5m6rA,7J8,,5m6r,3,1,,0,,,Structural basis of pyrrole polymerization in human porphobilinogen deaminase.,,,0,,,,,,,,,,,,,
P08476_INHBA_wild_cl1,INHBA_6y6nA_ODQ,P08476,,INHBA,wild,cl1,6y6nA,ODQ,,6y6n,3,1,,0,,,Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashion,,,0,,,,,,,,,,,,,
P08567_PLEK_wild_cl1,PLEK_2i5cB_IP5,P08567,,PLEK,wild,cl1,2i5cB,IP5,,2i5c,3,1,,0,,,Structural analysis of the carboxy terminal PH domain of pleckstrin bound to D-myo-inositol 1_2_3_5_6-pentakisphosphate.,,,0,,,,,,,,,,,,,
P08574_CYC1_wild_cl1,CYC1_5xteH_HEC,P08574,,CYC1,wild,cl1,5xteH,HEC,,5xte,3,1,,0,,,Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2.,,,0,,,,,,,,,,,,,
P08603_CFH_wild_cl1,CFH_4zh1F_SIA,P08603,,CFH,wild,cl1,4zh1F,SIA,,4zh1,3,2,,0,,,Complement Factor H and Simian Virus 40 bind the GM1 ganglioside in distinct conformations.,,,0,,,,,,,,,,,,,
P08603_CFH_wild_cl1,CFH_4zh1D_SIA,P08603,,CFH,wild,cl1,4zh1D,SIA,,4zh1,3,2,,0,,,Complement Factor H and Simian Virus 40 bind the GM1 ganglioside in distinct conformations.,,,0,,,,,,,,,,,,,
P08603_CFH_wild_cl2,CFH_2uwnA_SCR,P08603,,CFH,wild,cl2,2uwnA,SCR,,2uwn,3,2,,0,,,Structural Basis for Complement Factor H Linked Age-Related Macular Degeneration.,,,0,,,,,,,,,,,,,
P08603_CFH_wild_cl2,CFH_2v8eA_SCR,P08603,,CFH,wild,cl2,2v8eA,SCR,,2v8e,3,2,,0,,,Structural Basis for Complement Factor H Linked Age-Related Macular Degeneration.,,,0,,,,,,,,,,,,,
P08648_ITGA5_wild_cl1,ITGA5_3vi3C_MAN,P08648,,ITGA5,wild,cl1,3vi3C,MAN,,3vi3,3,1,,0,,,Crystal structure of alpha5beta1 integrin ectodomain: Atomic details of the fibronectin receptor,,,0,,,,,,,,,,,,,
P09038_FGF2_wild_cl1,FGF2_1fq9A_IDS,P09038,,FGF2,wild,cl1,1fq9A,IDS,,1fq9,1,2,,0,,,Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.,,,0,,,,,,,,,,,,,
P09038_FGF2_wild_cl1,FGF2_1bfbA_SGN,P09038,,FGF2,wild,cl1,1bfbA,SGN,,1bfb,1,2,,0,,,Heparin structure and interactions with basic fibroblast growth factor.,,,0,,,,,,,,,,,,,
P09038_FGF2_wild_cl2,FGF2_5x1oA_I3P,P09038,,FGF2,wild,cl2,5x1oA,I3P,,5x1o,1,2,,0,,,PI(4_5)P2 lipid binding induced a reorientation of FGF2 molecules near membrane surface to facilitate the unconventional oligomerization-dependent secretion process as revealed by a combined FTIR/NMR/X-ray study,,,0,,,,,,,,,,,,,
P09210_GSTA2_wild_cl1,GSTA2_2vctA_ASD,P09210,,GSTA2,wild,cl1,2vctA,ASD,,2vct,1,1,,0,,,Structural Basis for Featuring of Steroid Isomerase Activity in Alpha Class Glutathione Transferases.,,,0,,,,,,,,,,,,,
P09210_GSTA2_wild_cl1,GSTA2_2wjuA_GSH,P09210,,GSTA2,wild,cl1,2wjuA,GSH,,2wju,1,1,,0,,,Structural Basis for Featuring of Steroid Isomerase Activity in Alpha Class Glutathione Transferases.,,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl1,GSTP1_6ap9B_GSH,P09211,,GSTP1,wild,cl1,6ap9B,GSH,,6ap9,1,4,,0,,,Cysteine S-nitrosylation of hGSTP1-1 by nitric oxide (NO)-releasing prodrugs,,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl1,GSTP1_3km6A_EAA,P09211,,GSTP1,wild,cl1,3km6A,EAA,,3km6,1,4,,0,,,Diuretic drug binding to human glutathione transferase P1-1: potential role of Cys-101 revealed in the double mutant C47S/Y108V.,,,0,,,,,,,,,,,,,
P09211_GSTP1_wild_cl4,GSTP1_5ddlB_5AU,P09211,,GSTP1,wild,cl4,5ddlB,5AU,,5ddl,1,4,,0,,,Visualisation of Organoarsenic Human Glutathione Transferase P1-1 Complexes: Metabolism of Arsenic-based Therapeutics,,,0,,,,,,,,,,,,,
P09382_LGALS1_wild_cl2,LGALS1_7nmlB_I7B,P09382,,LGALS1,wild,cl2,7nmlB,I7B,,7nml,1,2,,0,,,Galectin-1 in complex with 4-Amino-6-chloro-1_3-benzenedisulfonamide,,,0,,,,,,,,,,,,,
P09382_LGALS1_wild_cl1,LGALS1_4q1pA_2XT,P09382,,LGALS1,wild,cl1,4q1pA,2XT,,4q1p,1,2,,0,,,Galectin-1 in Complex with Ligand NB169,,,0,,,,,,,,,,,,,
P09382_LGALS1_wild_cl1,LGALS1_1gzwA_GAL,P09382,,LGALS1,wild,cl1,1gzwA,GAL,,1gzw,1,2,,0,,,Growth-Regulatory Human Galectin-1: Crystallographic Characterisation of the Structural Changes Induced by Single-Site Mutations and Their Impact on the Thermodynamics of Ligand Binding,,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl1,FBP1_4mjoA_2C1,P09467,,FBP1,wild,cl1,4mjoA,2C1,,4mjo,1,3,,0,,,Determination of protein-ligand binding constants of a cooperatively regulated tetrameric enzyme using electrospray mass spectrometry.,,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl2,FBP1_7cvhC_GRG,P09467,,FBP1,wild,cl2,7cvhC,GRG,,7cvh,1,3,,0,,,The structural basis for GGPP activation on the enzymatic activities FBP1,,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl2,FBP1_7cvhD_GRG,P09467,,FBP1,wild,cl2,7cvhD,GRG,,7cvh,1,3,,0,,,The structural basis for GGPP activation on the enzymatic activities FBP1,,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl3,FBP1_7cvhB_FBP,P09467,,FBP1,wild,cl3,7cvhB,FBP,,7cvh,1,3,,0,,,The structural basis for GGPP activation on the enzymatic activities FBP1,,,0,,,,,,,,,,,,,
P09467_FBP1_wild_cl3,FBP1_7cvhC_FBP,P09467,,FBP1,wild,cl3,7cvhC,FBP,,7cvh,1,3,,0,,,The structural basis for GGPP activation on the enzymatic activities FBP1,,,0,,,,,,,,,,,,,
P09601_HMOX1_wild_cl2,HMOX1_1ni6C_TRE,P09601,,HMOX1,wild,cl2,1ni6C,TRE,,1ni6,3,2,,0,,,Comparison of the heme-free and -bound crystal structures of human heme oxygenase-1,,,0,,,,,,,,,,,,,
P09601_HMOX1_wild_cl1,HMOX1_1ozwB_HEM,P09601,,HMOX1,wild,cl1,1ozwB,HEM,,1ozw,3,2,,0,,,Crystal structures of the ferric_ ferrous_ and ferrous-NO forms of the Asp140Ala mutant of human heme oxygenase-1: catalytic implications,,,0,,,,,,,,,,,,,
P0CG29_GSTT2_wild_cl1,GSTT2_4mpgA_GSH,P0CG29,,GSTT2,wild,cl1,4mpgA,GSH,,4mpg,3,1,,0,,,Crystal Structure of Human Glutathione S-Transferase Theta-2 (Target EFI-507257),,,0,,,,,,,,,,,,,
P0DTC1_R1A_wild_cl1,R1A_7kojA_Y94,P0DTC1,,R1A,wild,cl1,7kojA,Y94,,7koj,3,1,,0,,,The crystal structure of Papain-Like Protease of SARS CoV-2_ C111S mutant_ in complex with PLP_Snyder494,,,0,,,,,,,,,,,,,
P0DTC3_AP3A_wild_cl1,AP3A_7kjrA_PEE,P0DTC3,,AP3A,wild,cl1,7kjrA,PEE,,7kjr,3,1,,0,,,Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs.,,,0,,,,,,,,,,,,,
P0DTC9_NCAP_wild_cl1,NCAP_6vyoB_MES,P0DTC9,,NCAP,wild,cl1,6vyoB,MES,,6vyo,3,1,,0,,,Crystal structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2,,,0,,,,,,,,,,,,,
P10599_TXN_wild_cl1,TXN_4pokA_COM,P10599,,TXN,wild,cl1,4pokA,COM,,4pok,3,1,,0,,,BNP7787 Forms Novel Covalent Adducts on Human Thioredoxin and Modulates Thioredoxin Activity,,,0,,,,,,,,,,,,,
P10599_TXN_wild_cl1,TXN_4polB_COM,P10599,,TXN,wild,cl1,4polB,COM,,4pol,3,1,,0,,,BNP7787 Forms Novel Covalent Adducts on Human Thioredoxin and Modulates Thioredoxin Activity,,,0,,,,,,,,,,,,,
P10809_HSPD1_wild_cl1,HSPD1_4pj1A_ADP,P10809,,HSPD1,wild,cl1,4pj1A,ADP,,4pj1,3,1,,0,,,Crystal structure of the human mitochondrial chaperonin symmetrical football complex.,,,0,,,,,,,,,,,,,
P10809_HSPD1_wild_cl1,HSPD1_6mrcH_ADP,P10809,,HSPD1,wild,cl1,6mrcH,ADP,,6mrc,3,1,,0,,,Structural basis for active single and double ring complexes in human mitochondrial Hsp60-Hsp10 chaperonin.,,,0,,,,,,,,,,,,,
P10997_IAPP_wild_cl1,IAPP_7bg0A_GLC,P10997,,IAPP,wild,cl1,7bg0A,GLC,,7bg0,3,1,,0,,,Development of Cagrilintide_ a Long-Acting Amylin Analogue.,,,0,,,,,,,,,,,,,
P10997_IAPP_wild_cl1,IAPP_7bg0E_GLC,P10997,,IAPP,wild,cl1,7bg0E,GLC,,7bg0,3,1,,0,,,Development of Cagrilintide_ a Long-Acting Amylin Analogue.,,,0,,,,,,,,,,,,,
P11021_HSPA5_wild_cl1,HSPA5_6do2A_H5V,P11021,,HSPA5,wild,cl1,6do2A,H5V,,6do2,1,2,,0,,,Crystal structure of human GRP78 in complex with 7-deaza-2'-C-methyladenosine,,,0,,,,,,,,,,,,,
P11021_HSPA5_wild_cl1,HSPA5_5evzA_ADP,P11021,,HSPA5,wild,cl1,5evzA,ADP,,5evz,1,2,,0,,,Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs.,,,0,,,,,,,,,,,,,
P11021_HSPA5_wild_cl2,HSPA5_5f0xB_DTP,P11021,,HSPA5,wild,cl2,5f0xB,DTP,,5f0x,1,2,,0,,,Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs.,,,0,,,,,,,,,,,,,
P11177_PDHB_wild_cl1,PDHB_6cerF_TDP,P11177,,PDHB,wild,cl1,6cerF,TDP,,6cer,3,1,,0,,,Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the alpha V138M variant of human pyruvate dehydrogenase.,,,0,,,,,,,,,,,,,
P11387_TOP1_wild_cl1,TOP1_1rrjA_TTG,P11387,,TOP1,wild,cl1,1rrjA,TTG,,1rrj,3,1,,0,,,Mechanisms of camptothecin resistance by human topoisomerase I mutations,,,0,,,,,,,,,,,,,
P11388_TOP2A_wild_cl1,TOP2A_1zxnA_ADP,P11388,,TOP2A,wild,cl1,1zxnA,ADP,,1zxn,2,1,,0,,,Nucleotide-dependent Domain Movement in the ATPase Domain of a Human Type IIA DNA Topoisomerase.,,,0,,,,,,,,,,,,,
P11388_TOP2A_wild_cl1,TOP2A_1zxmA_ANP,P11388,,TOP2A,wild,cl1,1zxmA,ANP,,1zxm,2,1,,0,,,Nucleotide-dependent Domain Movement in the ATPase Domain of a Human Type IIA DNA Topoisomerase.,,,0,,,,,,,,,,,,,
P11597_CETP_wild_cl1,CETP_2obdA_PCW,P11597,,CETP,wild,cl1,2obdA,PCW,,2obd,3,3,,0,,,Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules.,,,0,,,,,,,,,,,,,
P11836_MS4A1_wild_cl1,MS4A1_6vjaD_Y01,P11836,,MS4A1,wild,cl1,6vjaD,Y01,,6vja,3,1,,0,,,Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab.,,,0,,,,,,,,,,,,,
P11940_PABPC1_wild_cl1,PABPC1_1cvjA_A,P11940,,PABPC1,wild,cl1,1cvjA,A,,1cvj,3,1,,0,,,Recognition of polyadenylate RNA by the poly(A)-binding protein.,,,0,,,,,,,,,,,,,
P12104_FABP2_wild_cl1,FABP2_3akmA_11D,P12104,,FABP2,wild,cl1,3akmA,11D,,3akm,3,1,,0,,,Crystal structures of human and rat intestinal fatty acid binding proteins in complex with 11-(Dansylamino)undecanoic acid,,,0,,,,,,,,,,,,,
P12104_FABP2_wild_cl1,FABP2_3akmB_11D,P12104,,FABP2,wild,cl1,3akmB,11D,,3akm,3,1,,0,,,Crystal structures of human and rat intestinal fatty acid binding proteins in complex with 11-(Dansylamino)undecanoic acid,,,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl1,IMPDH2_6uajA_GTP,P12268,,IMPDH2,wild,cl1,6uajA,GTP,,6uaj,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl1,IMPDH2_6udqB_GTP,P12268,,IMPDH2,wild,cl1,6udqB,GTP,,6udq,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl2,IMPDH2_6ua5A_IMP,P12268,,IMPDH2,wild,cl2,6ua5A,IMP,,6ua5,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl2,IMPDH2_6udqG_IMP,P12268,,IMPDH2,wild,cl2,6udqG,IMP,,6udq,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl3,IMPDH2_6u8eA_NAD,P12268,,IMPDH2,wild,cl3,6u8eA,NAD,,6u8e,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl4,IMPDH2_6u8sF_NAD,P12268,,IMPDH2,wild,cl4,6u8sF,NAD,,6u8s,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl4,IMPDH2_6ua2B_NAD,P12268,,IMPDH2,wild,cl4,6ua2B,NAD,,6ua2,1,4,,0,,,Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P12268_IMPDH2_wild_cl3,IMPDH2_1nf7A_MYD,P12268,,IMPDH2,wild,cl3,1nf7A,MYD,,1nf7,1,4,,0,,,Crystal Structure of Human Inosine Monophosphate Dehydrogenase type II complexed with the MPA/NAD analog C2-MAD,,,0,,,,,,,,,,,,,
P12318_FCGR2A_wild_cl1,FCGR2A_3ry6C_FUL,P12318,,FCGR2A,wild,cl1,3ry6C,FUL,,3ry6,3,1,,0,,,Structural Basis for Fc{gamma}RIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl1,CCL5_5dnfG_BGC,P13501,,CCL5,wild,cl1,5dnfG,BGC,,5dnf,3,4,,0,,,Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl1,CCL5_5dnfI_GLA,P13501,,CCL5,wild,cl1,5dnfI,GLA,,5dnf,3,4,,0,,,Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl2,CCL5_5dnfC_IDS,P13501,,CCL5,wild,cl2,5dnfC,IDS,,5dnf,3,4,,0,,,Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl2,CCL5_5dnfD_SGN,P13501,,CCL5,wild,cl2,5dnfD,SGN,,5dnf,3,4,,0,,,Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl4,CCL5_5dnfG_BGC,P13501,,CCL5,wild,cl4,5dnfG,BGC,,5dnf,3,4,,0,,,Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.,,,0,,,,,,,,,,,,,
P13501_CCL5_wild_cl3,CCL5_1b3aA_AOP,P13501,,CCL5,wild,cl3,1b3aA,AOP,,1b3a,3,4,,0,,,Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES.,,,0,,,,,,,,,,,,,
P13612_ITGA4_wild_cl1,ITGA4_3v4vA_0DU,P13612,,ITGA4,wild,cl1,3v4vA,0DU,,3v4v,3,1,,0,,,Structural specializations of a4b7_ an Integrin that Mediates Rolling Adhesion,,,0,,,,,,,,,,,,,
P13716_ALAD_wild_cl1,ALAD_1pv8A_PB1,P13716,,ALAD,wild,cl1,1pv8A,PB1,,1pv8,3,1,,0,,,Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.,,,0,,,,,,,,,,,,,
P13716_ALAD_wild_cl1,ALAD_5hnrA_DAV,P13716,,ALAD,wild,cl1,5hnrA,DAV,,5hnr,3,1,,0,,,Structural studies of substrate and product complexes of 5-aminolaevulinic acid dehydratase from humans_ Escherichia coli and the hyperthermophile Pyrobaculum calidifontis.,,,0,,,,,,,,,,,,,
P13726_F3_wild_cl1,F3_3th3T_FUC,P13726,,F3,wild,cl1,3th3T,FUC,,3th3,3,1,,0,,,Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla)  Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+,,,0,,,,,,,,,,,,,
P14174_MIF_wild_cl2,MIF_4grqA_AVL,P14174,,MIF,wild,cl2,4grqA,AVL,,4grq,1,2,,0,,,Characterization of N- and C- terminus mutants of human MIF,,,0,,,,,,,,,,,,,
P14920_DAO_wild_cl1,DAO_2du8A_FAD,P14920,,DAO,wild,cl1,2du8A,FAD,,2du8,1,2,,0,,,Crystal structure of human D-amino acid oxidase: Context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring,,,0,,,,,,,,,,,,,
P14920_DAO_wild_cl1,DAO_2e48D_FAD,P14920,,DAO,wild,cl1,2e48D,FAD,,2.00E+48,1,2,,0,,,Structural basis of d-DOPA oxidation by d-amino acid oxidase: Alternative pathway for dopamine biosynthesis.,,,0,,,,,,,,,,,,,
P14920_DAO_wild_cl2,DAO_2e49D_MH6,P14920,,DAO,wild,cl2,2e49D,MH6,,2.00E+49,1,2,,0,,,Structural basis of d-DOPA oxidation by d-amino acid oxidase: Alternative pathway for dopamine biosynthesis.,,,0,,,,,,,,,,,,,
P15289_ARSA_wild_cl1,ARSA_1e2sP_CSN,P15289,,ARSA,wild,cl1,1e2sP,CSN,,1e2s,3,1,,0,,,Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.,,,0,,,,,,,,,,,,,
P15531_NME1_wild_cl1,NME1_5ui4B_A7Z,P15531,,NME1,wild,cl1,5ui4B,A7Z,,5ui4,3,1,,0,,,"""Inverse Drug Discovery"" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates.",,,0,,,,,,,,,,,,,
P15531_NME1_wild_cl1,NME1_1ucnB_ADP,P15531,,NME1,wild,cl1,1ucnB,ADP,,1ucn,3,1,,0,,,Nucleotide Binding to Nucleoside Diphosphate Kinases: X-ray Structure of Human NDPK-A in Complex with ADP and Comparison to Protein Kinases,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl4,CD1D_6v7zA_BGC,P15813,,CD1D,wild,cl4,6v7zA,BGC,,6v7z,3,4,,0,,,A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response.,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl1,CD1D_2po6E_AGH,P15813,,CD1D,wild,cl1,2po6E,AGH,,2po6,3,4,,0,,,CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl2,CD1D_3vwjA_NAG,P15813,,CD1D,wild,cl2,3vwjA,NAG,,3vwj,3,4,,0,,,Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl2,CD1D_3vwkA_NAG,P15813,,CD1D,wild,cl2,3vwkA,NAG,,3vwk,3,4,,0,,,Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl1,CD1D_3tzvC_LSC,P15813,,CD1D,wild,cl1,3tzvC,LSC,,3tzv,3,4,,0,,,Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.,,,0,,,,,,,,,,,,,
P15813_CD1D_wild_cl3,CD1D_4wo4A_FUC,P15813,,CD1D,wild,cl3,4wo4A,FUC,,4wo4,3,4,,0,,,The molecular bases of delta / alpha beta T cell-mediated antigen recognition.,,,0,,,,,,,,,,,,,
P16109_SELP_wild_cl1,SELP_1g1rD_FUC,P16109,,SELP,wild,cl1,1g1rD,FUC,,1g1r,3,1,,0,,,Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.,,,0,,,,,,,,,,,,,
P16109_SELP_wild_cl1,SELP_1g1rA_FUC,P16109,,SELP,wild,cl1,1g1rA,FUC,,1g1r,3,1,,0,,,Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.,,,0,,,,,,,,,,,,,
P16118_PFKFB1_wild_cl1,PFKFB1_1k6mB_AGS,P16118,,PFKFB1,wild,cl1,1k6mB,AGS,,1k6m,3,1,,0,,,Tissue-specific structure/function differentiation of the liver isoform of 6-phosphofructo-2-kinase/fructose-2_6-bisphosphatase.,,,0,,,,,,,,,,,,,
P16581_SELE_wild_cl1,SELE_4c16A_4WC,P16581,,SELE,wild,cl1,4c16A,4WC,,4c16,2,1,,0,,,E-Selectin Ligand Complexes Adopt an Extended High-Affinity Conformation.,,,0,,,,,,,,,,,,,
P16581_SELE_wild_cl1,SELE_4c16A_FUC,P16581,,SELE,wild,cl1,4c16A,FUC,,4c16,2,1,,0,,,E-Selectin Ligand Complexes Adopt an Extended High-Affinity Conformation.,,,0,,,,,,,,,,,,,
P17066_HSPA6_wild_cl1,HSPA6_3fe1A_ADP,P17066,,HSPA6,wild,cl1,3fe1A,ADP,,3fe1,3,1,,0,,,Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom_ HSPA2/Hsp70-2_ HSPA6/Hsp70B'_ and HSPA5/BiP/GRP78,,,0,,,,,,,,,,,,,
P17405_SMPD1_wild_cl1,SMPD1_5i85A_PC,P17405,,SMPD1,wild,cl1,5i85A,PC,,5i85,3,1,,0,,,Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.,,,0,,,,,,,,,,,,,
P17707_AMD1_wild_cl3,AMD1_3epbA_PUT,P17707,,AMD1,wild,cl3,3epbA,PUT,,3epb,3,5,,0,,,Structural Basis for Putrescine Activation of Human S-Adenosylmethionine Decarboxylase.,,,0,,,,,,,,,,,,,
P17813_ENG_wild_cl1,ENG_5hzvA_MAL,P17813,,ENG,wild,cl1,5hzvA,MAL,,5hzv,3,1,,0,,,Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1.,,,0,,,,,,,,,,,,,
P17844_DDX5_wild_cl1,DDX5_3fe2A_ADP,P17844,,DDX5,wild,cl1,3fe2A,ADP,,3fe2,3,1,,0,,,Comparative Structural Analysis of Human DEAD-Box RNA Helicases,,,0,,,,,,,,,,,,,
P17931_LGALS3_wild_cl1,LGALS3_4bm8A_A6J,P17931,,LGALS3,wild,cl1,4bm8A,A6J,,4bm8,1,2,,0,,,Controlling Protein Conformation Through Electronic Fine-Tuning of Arginine-Arene Interactions: Synthetic_ Structural_ and Biological Studies,,,0,,,,,,,,,,,,,
P17931_LGALS3_wild_cl2,LGALS3_6fofC_LAT,P17931,,LGALS3,wild,cl2,6fofC,LAT,,6fof,1,2,,0,,,Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail.,,,0,,,,,,,,,,,,,
P17931_LGALS3_wild_cl2,LGALS3_6fofD_LAT,P17931,,LGALS3,wild,cl2,6fofD,LAT,,6fof,1,2,,0,,,Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail.,,,0,,,,,,,,,,,,,
P17931_LGALS3_wild_cl1,LGALS3_6rzjA_KPB,P17931,,LGALS3,wild,cl1,6rzjA,KPB,,6rzj,1,2,,0,,,Thermodynamic studies of halogen-bond interactions in galectin-3,,,0,,,,,,,,,,,,,
P18669_PGAM1_wild_cl1,PGAM1_1yfkA_CIT,P18669,,PGAM1,wild,cl1,1yfkA,CIT,,1yfk,1,1,,0,,,Crystal structure of human B-type phosphoglycerate mutase bound with citrate.,,,0,,,,,,,,,,,,,
P18858_LIG1_wild_cl1,LIG1_1x9nA_AMP,P18858,,LIG1,wild,cl1,1x9nA,AMP,,1x9n,3,1,,0,,,Human DNA ligase I completely encircles and partially unwinds nicked DNA.,,,0,,,,,,,,,,,,,
P19113_HDC_wild_cl1,HDC_4e1oA_PLP,P19113,,HDC,wild,cl1,4e1oA,PLP,,4e1o,3,1,,0,,,Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase,,,0,,,,,,,,,,,,,
P19113_HDC_wild_cl1,HDC_4e1oA_PVH,P19113,,HDC,wild,cl1,4e1oA,PVH,,4e1o,3,1,,0,,,Structural study reveals that Ser-354 determines substrate specificity on human histidine decarboxylase,,,0,,,,,,,,,,,,,
P19652_ORM2_wild_cl1,ORM2_3apxA_Z80,P19652,,ORM2,wild,cl1,3apxA,Z80,,3apx,3,1,,0,,,Structural insights into differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants_ the A and F1*S forms.,,,0,,,,,,,,,,,,,
P19652_ORM2_wild_cl1,ORM2_3apwB_DP0,P19652,,ORM2,wild,cl1,3apwB,DP0,,3apw,3,1,,0,,,Structural insights into differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants_ the A and F1*S forms.,,,0,,,,,,,,,,,,,
P19971_TYMP_wild_cl1,TYMP_2wk6B_IUR,P19971,,TYMP,wild,cl1,2wk6B,IUR,,2wk6,2,1,,0,,,Structures of Native Human Thymidine Phosphorylase and in Complex with 5-Iodouracil.,,,0,,,,,,,,,,,,,
P20273_CD22_wild_cl1,CD22_5vkmA_GAL,P20273,,CD22,wild,cl1,5vkmA,GAL,,5vkm,3,1,,0,,,Molecular basis of human CD22 function and therapeutic targeting.,,,0,,,,,,,,,,,,,
P20711_DDC_wild_cl1,DDC_3rbfA_PLP,P20711,,DDC,wild,cl1,3rbfA,PLP,,3rbf,3,1,,0,,,Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases.,,,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl1,IMPDH1_7rfeF_GTP,P20839,,IMPDH1,wild,cl1,7rfeF,GTP,,7rfe,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl1,IMPDH1_7rfeD_GTP,P20839,,IMPDH1,wild,cl1,7rfeD,GTP,,7rfe,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl2,IMPDH1_7rerA_NAD,P20839,,IMPDH1,wild,cl2,7rerA,NAD,,7rer,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl2,IMPDH1_7rgqB_NAD,P20839,,IMPDH1,wild,cl2,7rgqB,NAD,,7rgq,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl3,IMPDH1_7rgiC_NAD,P20839,,IMPDH1,wild,cl3,7rgiC,NAD,,7rgi,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl3,IMPDH1_7rgdF_NAD,P20839,,IMPDH1,wild,cl3,7rgdF,NAD,,7rgd,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl4,IMPDH1_7rgqC_IMP,P20839,,IMPDH1,wild,cl4,7rgqC,IMP,,7rgq,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl4,IMPDH1_7rgiA_IMP,P20839,,IMPDH1,wild,cl4,7rgiA,IMP,,7rgi,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl5,IMPDH1_7rfhE_ATP,P20839,,IMPDH1,wild,cl5,7rfhE,ATP,,7rfh,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl5,IMPDH1_7rgmD_ATP,P20839,,IMPDH1,wild,cl5,7rgmD,ATP,,7rgm,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl6,IMPDH1_7rfiA_GTP,P20839,,IMPDH1,wild,cl6,7rfiA,GTP,,7rfi,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl6,IMPDH1_7rfiC_GTP,P20839,,IMPDH1,wild,cl6,7rfiC,GTP,,7rfi,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl7,IMPDH1_7resA_ATP,P20839,,IMPDH1,wild,cl7,7resA,ATP,,7res,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P20839_IMPDH1_wild_cl7,IMPDH1_7rfhC_ATP,P20839,,IMPDH1,wild,cl7,7rfhC,ATP,,7rfh,1,7,,0,,,IMPDH1 retinal variants control filament architecture to tune Allosteric regulation.,,allosteric,0,,,,,,,,,,,,,
P22830_FECH_wild_cl1,FECH_2qd5A_PP9,P22830,,FECH,wild,cl1,2qd5A,PP9,,2qd5,3,2,,0,,,A pi-Helix Switch Selective for Porphyrin Deprotonation and Product Release in Human Ferrochelatase.,,,0,,,,,,,,,,,,,
P22830_FECH_wild_cl1,FECH_2qd1D_PP9,P22830,,FECH,wild,cl1,2qd1D,PP9,,2qd1,3,2,,0,,,A pi-Helix Switch Selective for Porphyrin Deprotonation and Product Release in Human Ferrochelatase.,,,0,,,,,,,,,,,,,
P22897_MRC1_wild_cl1,MRC1_7jufA_MAN,P22897,,MRC1,wild,cl1,7jufA,MAN,,7juf,3,1,,0,,,Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206.,,,0,,,,,,,,,,,,,
P22897_MRC1_wild_cl1,MRC1_7jubA_MMA,P22897,,MRC1,wild,cl1,7jubA,MMA,,7jub,3,1,,0,,,Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206.,,,0,,,,,,,,,,,,,
P23528_CFL1_wild_cl1,CFL1_5hvkD_ANP,P23528,,CFL1,wild,cl1,5hvkD,ANP,,5hvk,3,1,,0,,,Structural Basis for Noncanonical Substrate Recognition of Cofilin/ADF Proteins by LIM Kinases.,,,0,,,,,,,,,,,,,
P24752_ACAT1_wild_cl1,ACAT1_2ibuA_COA,P24752,,ACAT1,wild,cl1,2ibuA,COA,,2ibu,3,1,,0,,,Crystallographic and Kinetic Studies of Human Mitochondrial Acetoacetyl-CoA Thiolase: The Importance of Potassium and Chloride Ions for Its Structure and Function,,,0,,,,,,,,,,,,,
P24752_ACAT1_wild_cl1,ACAT1_2ibuB_COA,P24752,,ACAT1,wild,cl1,2ibuB,COA,,2ibu,3,1,,0,,,Crystallographic and Kinetic Studies of Human Mitochondrial Acetoacetyl-CoA Thiolase: The Importance of Potassium and Chloride Ions for Its Structure and Function,,,0,,,,,,,,,,,,,
P25205_MCM3_wild_cl1,MCM3_6xtx3_AGS,P25205,,MCM3,wild,cl1,6xtx3,AGS,,6xtx,3,1,,0,,,CryoEM structures of human CMG-ATP gamma S-DNA and CMG-AND-1 complexes.,,,0,,,,,,,,,,,,,
P26010_ITGB7_wild_cl1,ITGB7_3v4vD_0DU,P26010,,ITGB7,wild,cl1,3v4vD,0DU,,3v4v,3,1,,0,,,Structural specializations of a4b7_ an Integrin that Mediates Rolling Adhesion,,,0,,,,,,,,,,,,,
P26447_S100A4_wild_cl1,S100A4_3m0wE_P77,P26447,,S100A4,wild,cl1,3m0wE,P77,,3m0w,3,3,,0,,,Structure of S100A4 with PCP,,,0,,,,,,,,,,,,,
P26447_S100A4_wild_cl3,S100A4_3m0wH_P77,P26447,,S100A4,wild,cl3,3m0wH,P77,,3m0w,3,3,,0,,,Structure of S100A4 with PCP,,,0,,,,,,,,,,,,,
P27695_APEX1_wild_cl1,APEX1_5wn2A_PGA,P27695,,APEX1,wild,cl1,5wn2A,PGA,,5wn2,3,1,,0,,,Molecular snapshots of APE1 proofreading mismatches and removing DNA damage.,,,0,,,,,,,,,,,,,
P27707_DCK_wild_cl2,DCK_2zi9B_ADP,P27707,,DCK,wild,cl2,2zi9B,ADP,,2zi9,1,2,,0,,,Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase,,,0,,,,,,,,,,,,,
P27707_DCK_wild_cl2,DCK_1p60A_ADP,P27707,,DCK,wild,cl2,1p60A,ADP,,1p60,1,2,,0,,,Structure of human dCK suggests strategies to improve anticancer and antiviral therapy,,,0,,,,,,,,,,,,,
P29373_CRABP2_wild_cl1,CRABP2_6hkrA_G9Q,P29373,,CRABP2,wild,cl1,6hkrA,G9Q,,6hkr,1,1,,0,,,Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.,,,0,,,,,,,,,,,,,
P29373_CRABP2_wild_cl1,CRABP2_4i9sA_RET,P29373,,CRABP2,wild,cl1,4i9sA,RET,,4i9s,1,1,,0,,,Rational Design of a Colorimetric pH Sensor from a Soluble Retinoic Acid Chaperone.,,,0,,,,,,,,,,,,,
P29401_TKT_wild_cl2,TKT_3ooyA_TDP,P29401,,TKT,wild,cl2,3ooyA,TDP,,3ooy,2,2,,0,,,Crystal structure of human Transketolase (TKT),,,0,,,,,,,,,,,,,
P29401_TKT_wild_cl1,TKT_4kxyA_1U0,P29401,,TKT,wild,cl1,4kxyA,1U0,,4kxy,2,2,,0,,,Sub-angstrom-resolution crystallography reveals physical distortions that enhance reactivity of a covalent enzymatic intermediate.,,,0,,,,,,,,,,,,,
P29401_TKT_wild_cl2,TKT_4kxyA_1U0,P29401,,TKT,wild,cl2,4kxyA,1U0,,4kxy,2,2,,0,,,Sub-angstrom-resolution crystallography reveals physical distortions that enhance reactivity of a covalent enzymatic intermediate.,,,0,,,,,,,,,,,,,
P29401_TKT_wild_cl1,TKT_3mosA_TPP,P29401,,TKT,wild,cl1,3mosA,TPP,,3mos,2,2,,0,,,The crystal structure of human transketolase and new insights into its mode of action.,,,0,,,,,,,,,,,,,
P30044_PRDX5_wild_cl2,PRDX5_4mmmE_BP7,P30044,,PRDX5,wild,cl2,4mmmE,BP7,,4mmm,3,2,,0,,,Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5,,,0,,,,,,,,,,,,,
P30044_PRDX5_wild_cl1,PRDX5_1h4oA_BEZ,P30044,,PRDX5,wild,cl1,1h4oA,BEZ,,1h4o,3,2,,0,,,Crystal Structure of Human Peroxiredoxin 5_ a Novel Type of Mammalian Peroxiredoxin at 1.5 A Resolution,,,0,,,,,,,,,,,,,
P30044_PRDX5_wild_cl1,PRDX5_1h4oC_BEZ,P30044,,PRDX5,wild,cl1,1h4oC,BEZ,,1h4o,3,2,,0,,,Crystal Structure of Human Peroxiredoxin 5_ a Novel Type of Mammalian Peroxiredoxin at 1.5 A Resolution,,,0,,,,,,,,,,,,,
P30084_ECHS1_wild_cl1,ECHS1_2hw5C_COO,P30084,,ECHS1,wild,cl1,2hw5C,COO,,2hw5,3,1,,0,,,The crystal structure of human enoyl-coenzyme A (CoA) hydratase short chain 1_ ECHS1,,,0,,,,,,,,,,,,,
P30405_PPIF_wild_cl1,PPIF_6gjxA_F2E,P30405,,PPIF,wild,cl1,6gjxA,F2E,,6gjx,1,1,6YBM,0,,,Scaffold-ligand complex with ligand unmodelled.,,,0,,,,,,,,,,,,,
P30419_NMT1_wild_cl2,NMT1_4c2zA_646,P30419,,NMT1,wild,cl2,4c2zA,646,,4c2z,1,2,,0,,,Chemical Proteomics Defines the Mammalian N- Myristoylated Proteome in Live Cells Global Profiling of Co- and Post-Translationally N-Myristoylated Proteomes in Human Cells.,,,0,,,,,,,,,,,,,
P30419_NMT1_wild_cl1,NMT1_6ehjA_MYA,P30419,,NMT1,wild,cl1,6ehjA,MYA,,6ehj,1,2,,0,,,High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation.,,,0,,,,,,,,,,,,,
P30419_NMT1_wild_cl1,NMT1_6sk8A_MYA,P30419,,NMT1,wild,cl1,6sk8A,MYA,,6sk8,1,2,,0,,,High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation.,,,0,,,,,,,,,,,,,
P30519_HMOX2_wild_cl1,HMOX2_2qppA_HEM,P30519,,HMOX2,wild,cl1,2qppA,HEM,,2qpp,3,1,,0,,,Comparison of Apo- and Heme-bound Crystal Structures of a Truncated Human Heme Oxygenase-2.,,,0,,,,,,,,,,,,,
P30519_HMOX2_wild_cl1,HMOX2_2q32A_OXN,P30519,,HMOX2,wild,cl1,2q32A,OXN,,2q32,3,1,,0,,,Comparison of Apo- and Heme-bound Crystal Structures of a Truncated Human Heme Oxygenase-2.,,,0,,,,,,,,,,,,,
P30711_GSTT1_wild_cl1,GSTT1_2c3qA_GTX,P30711,,GSTT1,wild,cl1,2c3qA,GTX,,2c3q,3,1,,0,,,Structural Basis of the Suppressed Catalytic Activity of Wild-Type Human Glutathione Transferase T1-1 Compared to its W234R Mutant.,,,0,,,,,,,,,,,,,
P30711_GSTT1_wild_cl1,GSTT1_2c3qC_GTX,P30711,,GSTT1,wild,cl1,2c3qC,GTX,,2c3q,3,1,,0,,,Structural Basis of the Suppressed Catalytic Activity of Wild-Type Human Glutathione Transferase T1-1 Compared to its W234R Mutant.,,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl2,ATIC_1p4rA_AMZ,P31939,,ATIC,wild,cl2,1p4rA,AMZ,,1p4r,3,3,,0,,,Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates,,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl2,ATIC_1p4rA_354,P31939,,ATIC,wild,cl2,1p4rA,354,,1p4r,3,3,,0,,,Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates,,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl3,ATIC_1p4rA_XMP,P31939,,ATIC,wild,cl3,1p4rA,XMP,,1p4r,3,3,,0,,,Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates,,,0,,,,,,,,,,,,,
P31939_ATIC_wild_cl1,ATIC_1pl0A_AMZ,P31939,,ATIC,wild,cl1,1pl0A,AMZ,,1pl0,3,3,,0,,,Crystal Structures of Human Bifunctional Enzyme Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase in Complex with Potent Sulfonyl-containing Antifolates.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl1,SFN_3smmA_FJA,P31947,,SFN,wild,cl1,3smmA,FJA,,3smm,2,5,,0,,,A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl1,SFN_7ba6A_T5Q,P31947,,SFN,wild,cl1,7ba6A,T5Q,,7ba6,2,5,,0,,,Exploration of a 14-3-3 PPI Pocket by Covalent Fragments as Stabilizers.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl2,SFN_6s40A_KTW,P31947,,SFN,wild,cl2,6s40A,KTW,,6s40,2,5,,0,,,Fragment-based Differential Targeting of PPI Stabilizer Interfaces.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl2,SFN_6sioA_LFQ,P31947,,SFN,wild,cl2,6sioA,LFQ,,6sio,2,5,,0,,,Fragment-based Differential Targeting of PPI Stabilizer Interfaces.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl3,SFN_6rwhA_KLB,P31947,,SFN,wild,cl3,6rwhA,KLB,,6rwh,2,5,,0,,,Fragment-based Differential Targeting of PPI Stabilizer Interfaces.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl3,SFN_6rjqA_JT2,P31947,,SFN,wild,cl3,6rjqA,JT2,,6rjq,2,5,,0,,,Fragment-based Differential Targeting of PPI Stabilizer Interfaces.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl5,SFN_5n5rA_NV1,P31947,,SFN,wild,cl5,5n5rA,NV1,,5n5r,2,5,,0,,,Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl4,SFN_5oehA_9SZ,P31947,,SFN,wild,cl4,5oehA,9SZ,,5oeh,2,5,,0,,,Molecular tweezers modulate 14-3-3 protein-protein interactions.,,,0,,,,,,,,,,,,,
P31947_SFN_wild_cl4,SFN_4hqwA_19O,P31947,,SFN,wild,cl4,4hqwA,19O,,4hqw,2,5,5OEH,0,,,Molecular tweezers modulate 14-3-3 protein-protein interactions.,,,0,,,,,,,,,,,,,
P32929_CTH_wild_cl2,CTH_5tsuB_MET,P32929,,CTH,wild,cl2,5tsuB,MET,,5tsu,3,2,,0,,,Structural Snapshots of an Engineered Cystathionine-gamma-lyase Reveal the Critical Role of Electrostatic Interactions in the Active Site.,,,0,,,,,,,,,,,,,
P32929_CTH_wild_cl2,CTH_5eigF_CYS,P32929,,CTH,wild,cl2,5eigF,CYS,,5eig,3,2,,0,,,Systemic Depletion of Serum L-Cyst(e)ine with an Engineered Human Enzyme Mediates Potent Induction of ROS and Cancer Ablation,,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl3,DUT_2hquA_DUP,P33316,,DUT,wild,cl3,2hquA,DUP,,2hqu,2,3,,0,,,Active site closure facilitates juxtaposition of reactant atoms for initiation of catalysis by human dUTPase.,,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl2,DUT_1q5hB_DUD,P33316,,DUT,wild,cl2,1q5hB,DUD,,1q5h,2,3,,0,,,Human dUTP pyrophosphatase: uracil recognition by a Beta hairpin and active sites formed by three separate subunits,,,0,,,,,,,,,,,,,
P33316_DUT_wild_cl3,DUT_1q5hB_DUD,P33316,,DUT,wild,cl3,1q5hB,DUD,,1q5h,2,3,,0,,,Human dUTP pyrophosphatase: uracil recognition by a Beta hairpin and active sites formed by three separate subunits,,,0,,,,,,,,,,,,,
P33991_MCM4_wild_cl1,MCM4_6xtx4_AGS,P33991,,MCM4,wild,cl1,6xtx4,AGS,,6xtx,3,1,,0,,,CryoEM structures of human CMG-ATP gamma S-DNA and CMG-AND-1 complexes.,,,0,,,,,,,,,,,,,
P33992_MCM5_wild_cl1,MCM5_6xtx5_ADP,P33992,,MCM5,wild,cl1,6xtx5,ADP,,6xtx,3,1,,0,,,CryoEM structures of human CMG-ATP gamma S-DNA and CMG-AND-1 complexes.,,,0,,,,,,,,,,,,,
P33993_MCM7_wild_cl1,MCM7_6xtx7_AGS,P33993,,MCM7,wild,cl1,6xtx7,AGS,,6xtx,3,1,,0,,,CryoEM structures of human CMG-ATP gamma S-DNA and CMG-AND-1 complexes.,,,0,,,,,,,,,,,,,
P34059_GALNS_wild_cl1,GALNS_4fdjA_NGA,P34059,,GALNS,wild,cl1,4fdjA,NGA,,4fdj,3,1,,0,,,The Structure of Human GALNS Reveals the Molecular Basis for Mucopolysaccharidosis IV A.,,,0,,,,,,,,,,,,,
P34896_SHMT1_wild_cl1,SHMT1_6fl5G_PLP,P34896,,SHMT1,wild,cl1,6fl5G,PLP,,6fl5,3,1,,0,,,The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells.,,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl2,NOS2_2nsiB_H4B,P35228,,NOS2,wild,cl2,2nsiB,H4B,,2nsi,3,3,,0,,,Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.,,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl3,NOS2_3hr4A_FMN,P35228,,NOS2,wild,cl3,3hr4A,FMN,,3hr4,3,3,,0,,,Regulation of Interdomain Interactions by CaM in Inducible Nitric Oxide Synthase,,,0,,,,,,,,,,,,,
P35228_NOS2_wild_cl3,NOS2_3hr4C_FMN,P35228,,NOS2,wild,cl3,3hr4C,FMN,,3hr4,3,3,,0,,,Regulation of Interdomain Interactions by CaM in Inducible Nitric Oxide Synthase,,,0,,,,,,,,,,,,,
P35247_SFTPD_wild_cl1,SFTPD_2ricA_GMH,P35247,,SFTPD,wild,cl1,2ricA,GMH,,2ric,3,1,,0,,,Recognition of heptoses and the inner core of bacterial lipopolysaccharides by surfactant protein d.,,,0,,,,,,,,,,,,,
P35247_SFTPD_wild_cl1,SFTPD_3g84C_MAN,P35247,,SFTPD,wild,cl1,3g84C,MAN,,3g84,3,1,,0,,,Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.,,,0,,,,,,,,,,,,,
P38117_ETFB_wild_cl1,ETFB_1efvB_FAD,P38117,,ETFB,wild,cl1,1efvB,FAD,,1efv,3,2,,0,,,Three-dimensional structure of human electron transfer flavoprotein to 2.1-A resolution.,,,0,,,,,,,,,,,,,
P38117_ETFB_wild_cl2,ETFB_1efvB_AMP,P38117,,ETFB,wild,cl2,1efvB,AMP,,1efv,3,2,,0,,,Three-dimensional structure of human electron transfer flavoprotein to 2.1-A resolution.,,,0,,,,,,,,,,,,,
P38646_HSPA9_wild_cl1,HSPA9_6nhkA_ADP,P38646,,HSPA9,wild,cl1,6nhkA,ADP,,6nhk,2,1,,0,,,Biophysical Consequences of EVEN-PLUS Syndrome Mutations for the Function of Mortalin.,,,0,,,,,,,,,,,,,
P38646_HSPA9_wild_cl1,HSPA9_6pmtA_AMP,P38646,,HSPA9,wild,cl1,6pmtA,AMP,,6pmt,2,1,,0,,,Structure of the mortalin nucleotide binding domain in complex with adenosine monophosphate,,,0,,,,,,,,,,,,,
P38919_EIF4A3_wild_cl1,EIF4A3_2hyiC_ANP,P38919,,EIF4A3,wild,cl1,2hyiC,ANP,,2hyi,2,1,,0,,,Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA.,,,0,,,,,,,,,,,,,
P40763_STAT3_wild_cl1,STAT3_6njsA_KQV,P40763,,STAT3,wild,cl1,6njsA,KQV,,6njs,3,1,,0,,,A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.,,,0,,,,,,,,,,,,,
P40926_MDH2_wild_cl1,MDH2_2dfdA_NAD,P40926,,MDH2,wild,cl1,2dfdA,NAD,,2dfd,1,2,,0,,,Crystal Structure of Human Malate Dehydrogenase Type 2,,,0,,,,,,,,,,,,,
P40926_MDH2_wild_cl2,MDH2_2dfdA_HIS,P40926,,MDH2,wild,cl2,2dfdA,HIS,,2dfd,1,2,,0,,,Crystal Structure of Human Malate Dehydrogenase Type 2,,,0,,,,,,,,,,,,,
P40926_MDH2_wild_cl1,MDH2_4wloA_NAI,P40926,,MDH2,wild,cl1,4wloA,NAI,,4wlo,1,2,,0,,,Crystal structure of oxaloacetate and NADH bound MDH2,,,0,,,,,,,,,,,,,
P40937_RFC5_wild_cl1,RFC5_6vvoC_AGS,P40937,,RFC5,wild,cl1,6vvoC,AGS,,6vvo,3,1,,0,,,Structure of the human clamp loader bound to the sliding clamp: a further twist on AAA+ mechanism,,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl2,BCL6_7lzrD_YJJ,P41182,,BCL6,wild,cl2,7lzrD,YJJ,,7lzr,2,6,,0,,,Crystal structure of the BCL6 BTB domain in complex with OICR-10256,,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl1,BCL6_6ew6A_C0H,P41182,,BCL6,wild,cl1,6ew6A,C0H,,6ew6,2,6,,0,,,Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.,,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl2,BCL6_6xmxA_U52,P41182,,BCL6,wild,cl2,6xmxA,U52,,6xmx,2,6,,0,,,Small-molecule-induced polymerization triggers degradation of BCL6.,,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl3,BCL6_6xmxD_U52,P41182,,BCL6,wild,cl3,6xmxD,U52,,6xmx,2,6,,0,,,Small-molecule-induced polymerization triggers degradation of BCL6.,,,0,,,,,,,,,,,,,
P41182_BCL6_wild_cl3,BCL6_6xmxA_U52,P41182,,BCL6,wild,cl3,6xmxA,U52,,6xmx,2,6,,0,,,Small-molecule-induced polymerization triggers degradation of BCL6.,,,0,,,,,,,,,,,,,
P41222_PTGDS_wild_cl1,PTGDS_4imoA_PWZ,P41222,,PTGDS,wild,cl1,4imoA,PWZ,,4imo,3,1,,0,,,Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.,,,0,,,,,,,,,,,,,
P46063_RECQL_wild_cl1,RECQL_2v1xA_ADP,P46063,,RECQL,wild,cl1,2v1xA,ADP,,2v1x,3,1,,0,,,Structure of the Human Recq1 Helicase Reveals a Putative Strand-Separation Pin.,,,0,,,,,,,,,,,,,
P46934_NEDD4_wild_cl1,NEDD4_5c91A_4YU,P46934,,NEDD4,wild,cl1,5c91A,4YU,,5c91,3,1,,0,,,A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism.,,,0,,,,,,,,,,,,,
P48061_CXCL12_wild_cl2,CXCL12_4uaiA_3GG,P48061,,CXCL12,wild,cl2,4uaiA,3GG,,4uai,3,2,,0,,,Structural Analysis of a Novel Small Molecule Ligand Bound to the CXCL12 Chemokine.,,,0,,,,,,,,,,,,,
P48061_CXCL12_wild_cl1,CXCL12_2nwgA_H1S,P48061,,CXCL12,wild,cl1,2nwgA,H1S,,2nwg,3,2,,0,,,Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1{alpha}) Binding to Heparin,,,0,,,,,,,,,,,,,
P48643_CCT5_wild_cl1,CCT5_7nvmE_ADP,P48643,,CCT5,wild,cl1,7nvmE,ADP,,7nvm,3,1,,0,,,Snapshots of actin and tubulin folding inside the TRiC chaperonin.,,,0,,,,,,,,,,,,,
P48643_CCT5_wild_cl1,CCT5_5uyxD_ADP,P48643,,CCT5,wild,cl1,5uyxD,ADP,,5uyx,3,1,,0,,,Structure of the human TRiC/CCT Subunit 5 associated with hereditary sensory neuropathy.,,,0,,,,,,,,,,,,,
P49023_PXN_wild_cl1,PXN_3py7A_MLR,P49023,,PXN,wild,cl1,3py7A,MLR,,3py7,3,1,,0,,,Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.,,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl6,FASN_2cg5B_COA,P49327,,FASN,wild,cl6,2cg5B,COA,,2cg5,2,7,,0,,,Mechanism and Substrate Recognition of Human Holo Acp Synthase.,,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl3,FASN_2jfkB_COA,P49327,,FASN,wild,cl3,2jfkB,COA,,2jfk,2,7,,0,,,Structure of the MAT Domain of Human Fas with Malonyl-Coa,,,0,,,,,,,,,,,,,
P49327_FASN_wild_cl3,FASN_2jfkD_COA,P49327,,FASN,wild,cl3,2jfkD,COA,,2jfk,2,7,,0,,,Structure of the MAT Domain of Human Fas with Malonyl-Coa,,,0,,,,,,,,,,,,,
P49638_TTPA_wild_cl1,TTPA_5mugA_VIV,P49638,,TTPA,wild,cl1,5mugA,VIV,,5mug,3,2,,0,,,Self-assembled alpha-Tocopherol Transfer Protein Nanoparticles Promote Vitamin E Delivery Across an Endothelial Barrier.,,,0,,,,,,,,,,,,,
P49638_TTPA_wild_cl1,TTPA_5mueA_VIV,P49638,,TTPA,wild,cl1,5mueA,VIV,,5mue,3,2,,0,,,Self-assembled alpha-Tocopherol Transfer Protein Nanoparticles Promote Vitamin E Delivery Across an Endothelial Barrier.,,,0,,,,,,,,,,,,,
P49638_TTPA_wild_cl2,TTPA_1oizA_TRT,P49638,,TTPA,wild,cl2,1oizA,TRT,,1oiz,3,2,,0,,,The Molecular Basis of Vitamin E Retention: Structure of Human Alpha-Tocopherol Transfer Protein,,,0,,,,,,,,,,,,,
P49773_HINT1_wild_cl1,HINT1_5km2A_C5P,P49773,,HINT1,wild,cl1,5km2A,C5P,,5km2,3,2,,0,,,A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides.,,,0,,,,,,,,,,,,,
P49773_HINT1_wild_cl1,HINT1_5km4A_IU,P49773,,HINT1,wild,cl1,5km4A,IU,,5km4,3,2,,0,,,A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides.,,,0,,,,,,,,,,,,,
P49773_HINT1_wild_cl2,HINT1_5klyB_6UR,P49773,,HINT1,wild,cl2,5klyB,6UR,,5kly,3,2,,0,,,A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides.,,,0,,,,,,,,,,,,,
P49789_FHIT_wild_cl1,FHIT_1fhiA_IB2,P49789,,FHIT,wild,cl1,1fhiA,IB2,,1fhi,3,2,,0,,,Genetic_ biochemical_ and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.,,,0,,,,,,,,,,,,,
P49789_FHIT_wild_cl1,FHIT_3fitA_A,P49789,,FHIT,wild,cl1,3fitA,A,,3fit,3,2,,0,,,MAD analysis of FHIT_ a putative human tumor suppressor from the HIT protein family.,,,0,,,,,,,,,,,,,
P49789_FHIT_wild_cl2,FHIT_1fitA_FRU,P49789,,FHIT,wild,cl2,1fitA,FRU,,1fit,3,2,,0,,,MAD analysis of FHIT_ a putative human tumor suppressor from the HIT protein family.,,,0,,,,,,,,,,,,,
P49915_GMPS_wild_cl1,GMPS_2vxoA_XMP,P49915,,GMPS,wild,cl1,2vxoA,XMP,,2vxo,3,1,,0,,,Substrate Specificity and Oligomerization of Human Gmp Synthetase,,,0,,,,,,,,,,,,,
P49916_LIG3_wild_cl1,LIG3_3l2pA_AMP,P49916,,LIG3,wild,cl1,3l2pA,AMP,,3l2p,3,1,,0,,,Human DNA Ligase III Recognizes DNA Ends by Dynamic Switching between Two DNA-Bound States.,,,0,,,,,,,,,,,,,
P49917_LIG4_wild_cl1,LIG4_3w1gA_ATP,P49917,,LIG4,wild,cl1,3w1gA,ATP,,3w1g,3,1,,0,,,Structure of the catalytic region of DNA ligase IV in complex with an artemis fragment sheds light on double-strand break repair,,,0,,,,,,,,,,,,,
P49917_LIG4_wild_cl1,LIG4_6bkfA_AMP,P49917,,LIG4,wild,cl1,6bkfA,AMP,,6bkf,3,1,,0,,,Structures of DNA-bound human ligase IV catalytic core reveal insights into substrate binding and catalysis.,,,0,,,,,,,,,,,,,
P50990_CCT8_wild_cl1,CCT8_7nvnQ_ADP,P50990,,CCT8,wild,cl1,7nvnQ,ADP,,7nvn,3,1,,0,,,Snapshots of actin and tubulin folding inside the TRiC chaperonin.,,,0,,,,,,,,,,,,,
P50990_CCT8_wild_cl1,CCT8_7nvoQ_ADP,P50990,,CCT8,wild,cl1,7nvoQ,ADP,,7nvo,3,1,,0,,,Snapshots of actin and tubulin folding inside the TRiC chaperonin.,,,0,,,,,,,,,,,,,
P51161_FABP6_wild_cl1,FABP6_5l8nC_6RQ,P51161,,FABP6,wild,cl1,5l8nC,6RQ,,5l8n,2,1,,0,,,Identification and Investigation of Novel Binding Fragments in the Fatty Acid Binding Protein 6 (FABP6).,,,0,,,,,,,,,,,,,
P51161_FABP6_wild_cl1,FABP6_1o1vA_TCH,P51161,,FABP6,wild,cl1,1o1vA,TCH,,1o1v,2,1,,0,,,Insights into the bile acid transportation system: the human ileal lipid-binding protein-cholyltaurine complex and                its comparison with homologous structures.,,,0,,,,,,,,,,,,,
P52565_ARHGDIA_wild_cl1,ARHGDIA_1hh4E_GER,P52565,,ARHGDIA,wild,cl1,1hh4E,GER,,1hh4,3,1,,0,,,Crystal Structure of the Rac1-Rhogdi Complex Involved in Nadph Oxidase Activation,,,0,,,,,,,,,,,,,
P53816_PLAAT3_wild_cl1,PLAAT3_4q95A_SHV,P53816,,PLAAT3,wild,cl1,4q95A,SHV,,4q95,3,2,,0,,,LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3.,,,0,,,,,,,,,,,,,
P53816_PLAAT3_wild_cl2,PLAAT3_4q95A_SHV,P53816,,PLAAT3,wild,cl2,4q95A,SHV,,4q95,3,2,,0,,,LRAT-specific domain facilitates vitamin A metabolism by domain swapping in HRASLS3.,,,0,,,,,,,,,,,,,
P54132_BLM_wild_cl1,BLM_4cdgA_ADP,P54132,,BLM,wild,cl1,4cdgA,ADP,,4cdg,2,2,,0,,,Crystal Structure of the Bloom'S Syndrome Helicase Indicates a Role for the Hrdc Domain in Conformational Changes.,,,0,,,,,,,,,,,,,
P54652_HSPA2_wild_cl1,HSPA2_5fpnA_KYD,P54652,,HSPA2,wild,cl1,5fpnA,KYD,,5fpn,2,3,,0,,,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,,,0,,,,,,,,,,,,,
P54652_HSPA2_wild_cl1,HSPA2_5fpeB_3TR,P54652,,HSPA2,wild,cl1,5fpeB,3TR,,5fpe,2,3,,0,,,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,,,0,,,,,,,,,,,,,
P54652_HSPA2_wild_cl2,HSPA2_5fpdA_PZA,P54652,,HSPA2,wild,cl2,5fpdA,PZA,,5fpd,2,3,,0,,,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,,,0,,,,,,,,,,,,,
P54652_HSPA2_wild_cl3,HSPA2_5fpmA_IWT,P54652,,HSPA2,wild,cl3,5fpmA,IWT,,5fpm,2,3,,0,,,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,,,0,,,,,,,,,,,,,
P55064_AQP5_wild_cl1,AQP5_5c5xD_PS6,P55064,,AQP5,wild,cl1,5c5xD,PS6,,5c5x,3,1,,0,,,Plasma Membrane Abundance of Human Aquaporin 5 Is Dynamically Regulated by Multiple Pathways.,,,0,,,,,,,,,,,,,
P55064_AQP5_wild_cl1,AQP5_5dyeA_PS6,P55064,,AQP5,wild,cl1,5dyeA,PS6,,5dye,3,1,,0,,,Plasma Membrane Abundance of Human Aquaporin 5 Is Dynamically Regulated by Multiple Pathways.,,,0,,,,,,,,,,,,,
P55789_GFER_wild_cl1,GFER_3u2lA_FAD,P55789,,GFER,wild,cl1,3u2lA,FAD,,3u2l,3,1,,0,,,An electron-transfer path through an extended disulfide relay system: the case of the redox protein ALR.,,,0,,,,,,,,,,,,,
P55789_GFER_wild_cl1,GFER_3mbgA_FAD,P55789,,GFER,wild,cl1,3mbgA,FAD,,3mbg,3,1,,0,,,Structure of the human sulfhydryl oxidase augmenter of liver regeneration and characterization of a human mutation causing an autosomal recessive myopathy .,,,0,,,,,,,,,,,,,
P55899_FCGRT_wild_cl1,FCGRT_6c99C_EQY,P55899,,FCGRT,wild,cl1,6c99C,EQY,,6c99,3,1,,0,,,Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.,,,0,,,,,,,,,,,,,
P55899_FCGRT_wild_cl1,FCGRT_6c98A_ER7,P55899,,FCGRT,wild,cl1,6c98A,ER7,,6c98,3,1,,0,,,Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.,,,0,,,,,,,,,,,,,
P56470_LGALS4_wild_cl1,LGALS4_5duvA_LAT,P56470,,LGALS4,wild,cl1,5duvA,LAT,,5duv,1,1,,0,,,Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol_ lactose_ 3'-sulfo-lactose_ and 2'-fucosyllactose.,,,0,,,,,,,,,,,,,
P56470_LGALS4_wild_cl1,LGALS4_4ylzA_NAG,P56470,,LGALS4,wild,cl1,4ylzA,NAG,,4ylz,1,1,,0,,,Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids_ sulfated saccharides and blood group antigens.,,,0,,,,,,,,,,,,,
P60174_TPI1_wild_cl1,TPI1_1htiB_PGA,P60174,,TPI1,wild,cl1,1htiB,PGA,,1hti,3,1,,0,,,Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme.,,,0,,,,,,,,,,,,,
P60174_TPI1_wild_cl1,TPI1_6upfA_PGA,P60174,,TPI1,wild,cl1,6upfA,PGA,,6upf,3,1,,0,,,Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure.,,,0,,,,,,,,,,,,,
P60568_IL2_wild_cl1,IL2_1qvnC_FRI,P60568,,IL2,wild,cl1,1qvnC,FRI,,1qvn,1,1,,0,,,Hot-spot mimicry of a cytokine receptor by a small molecule.,,,0,,,,,,,,,,,,,
P60568_IL2_wild_cl2,IL2_1qvnC_FRI,P60568,,IL2,wild,cl2,1qvnC,FRI,,1qvn,1,1,,0,,,Hot-spot mimicry of a cytokine receptor by a small molecule.,,,0,,,,,,,,,,,,,
P60568_IL2_wild_cl1,IL2_1py2A_FRH,P60568,,IL2,wild,cl1,1py2A,FRH,,1py2,1,1,,0,,,Potent small-molecule binding to a dynamic hot spot on IL-2.,,,0,,,,,,,,,,,,,
P60709_ACTB_wild_cl1,ACTB_7p1hB_ATP,P60709,,ACTB,wild,cl1,7p1hB,ATP,,7p1h,3,1,,0,,,Mechanism of actin-dependent activation of nucleotidyl cyclase toxins from bacterial human pathogens.,,,0,,,,,,,,,,,,,
P61011_SRP54_wild_cl1,SRP54_5l3qA_AMP,P61011,,SRP54,wild,cl1,5l3qA,AMP,,5l3q,3,2,,0,,,Structural Basis for Conserved Regulation and Adaptation of the Signal Recognition Particle Targeting Complex.,,,0,,,,,,,,,,,,,
P61011_SRP54_wild_cl2,SRP54_5l3qA_GNP,P61011,,SRP54,wild,cl2,5l3qA,GNP,,5l3q,3,2,,0,,,Structural Basis for Conserved Regulation and Adaptation of the Signal Recognition Particle Targeting Complex.,,,0,,,,,,,,,,,,,
P61158_ACTR3_wild_cl1,ACTR3_6yw7A_ATP,P61158,,ACTR3,wild,cl1,6yw7A,ATP,,6yw7,3,1,,0,,,Cryo-EM of human Arp2/3 complexes provides structural insights into actin nucleation modulation by ARPC5 isoforms.,,,0,,,,,,,,,,,,,
P61158_ACTR3_wild_cl1,ACTR3_6uhcA_ATP,P61158,,ACTR3,wild,cl1,6uhcA,ATP,,6uhc,3,1,,0,,,Cryo-EM structure of NPF-bound human Arp2/3 complex and activation mechanism.,,,0,,,,,,,,,,,,,
P61160_ACTR2_wild_cl1,ACTR2_6yw7B_ATP,P61160,,ACTR2,wild,cl1,6yw7B,ATP,,6yw7,3,1,,0,,,Cryo-EM of human Arp2/3 complexes provides structural insights into actin nucleation modulation by ARPC5 isoforms.,,,0,,,,,,,,,,,,,
P61160_ACTR2_wild_cl1,ACTR2_6uhcB_ATP,P61160,,ACTR2,wild,cl1,6uhcB,ATP,,6uhc,3,1,,0,,,Cryo-EM structure of NPF-bound human Arp2/3 complex and activation mechanism.,,,0,,,,,,,,,,,,,
P62166_NCS1_wild_cl1,NCS1_6qi4B_FKW,P62166,,NCS1,wild,cl1,6qi4B,FKW,,6qi4,3,1,,0,,,Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library.,,,0,,,,,,,,,,,,,
P62166_NCS1_wild_cl1,NCS1_4gukC_P2G,P62166,,NCS1,wild,cl1,4gukC,P2G,,4guk,3,1,,0,,,new crystal form structure of human NCS1,,,0,,,,,,,,,,,,,
P62942_FKBP1A_wild_cl2,FKBP1A_1qplC_587,P62942,,FKBP1A,wild,cl2,1qplC,587,,1qpl,1,2,,0,,,32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein.,,,0,,,,,,,,,,,,,
P62942_FKBP1A_wild_cl1,FKBP1A_1fkfA_FK5,P62942,,FKBP1A,wild,cl1,1fkfA,FK5,,1fkf,1,2,,0,,,Atomic structure of FKBP-FK506_ an immunophilin-immunosuppressant complex.,,,0,,,,,,,,,,,,,
P62942_FKBP1A_wild_cl1,FKBP1A_1bl4A_AP1,P62942,,FKBP1A,wild,cl1,1bl4A,AP1,,1bl4,1,2,,0,,,Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity.,,,0,,,,,,,,,,,,,
P62993_GRB2_wild_cl1,GRB2_2aobC_S1S,P62993,,GRB2,wild,cl1,2aobC,S1S,,2aob,1,2,,0,,,Crystal Structures of a High-affinity Macrocyclic Peptide Mimetic in Complex with the Grb2 SH2 Domain.,,,0,,,,,,,,,,,,,
P62993_GRB2_wild_cl2,GRB2_2aobB_S1S,P62993,,GRB2,wild,cl2,2aobB,S1S,,2aob,1,2,,0,,,Crystal Structures of a High-affinity Macrocyclic Peptide Mimetic in Complex with the Grb2 SH2 Domain.,,,0,,,,,,,,,,,,,
P68106_FKBP1B_wild_cl1,FKBP1B_1c9hA_RAP,P68106,,FKBP1B,wild,cl1,1c9hA,RAP,,1c9h,3,1,,0,,,Structure of FKBP12.6 in complex with rapamycin.,,,0,,,,,,,,,,,,,
P68363_TUBA1B_wild_cl1,TUBA1B_7lxbA_GTP,P68363,,TUBA1B,wild,cl1,7lxbA,GTP,,7lxb,3,2,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
P68363_TUBA1B_wild_cl2,TUBA1B_7m18A_YNP,P68363,,TUBA1B,wild,cl2,7m18A,YNP,,7m18,3,2,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
P68363_TUBA1B_wild_cl2,TUBA1B_7m20O_YNP,P68363,,TUBA1B,wild,cl2,7m20O,YNP,,7m20,3,2,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
P68363_TUBA1B_wild_cl1,TUBA1B_6qusA_GTP,P68363,,TUBA1B,wild,cl1,6qusA,GTP,,6qus,3,2,,0,,,Structural determinants of microtubule minus end preference in CAMSAP CKK domains.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl3,HBB_1sdkB_TMM,P68871,,HBB,wild,cl3,1sdkB,TMM,,1sdk,3,6,,0,,,Allosteric transition intermediates modelled by crosslinked haemoglobins.,,allosteric,0,,,,,,,,,,,,,
P68871_HBB_wild_cl6,HBB_5hy8B_FRU,P68871,,HBB,wild,cl6,5hy8B,FRU,,5hy8,3,6,,0,,,Glycation restrains Allosteric transition in hemoglobin: The molecular basis of oxidative stress under hyperglycemic conditions in diabetes,,allosteric,0,,,,,,,,,,,,,
P68871_HBB_wild_cl1,HBB_1j3yF_HNI,P68871,,HBB,wild,cl1,1j3yF,HNI,,1j3y,3,6,,0,,,Direct observation of photolysis-induced tertiary structural changes in hemoglobin,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl4,HBB_7jy0B_O4B,P68871,,HBB,wild,cl4,7jy0B,O4B,,7jy0,3,6,,0,,,PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl4,HBB_7jy1B_O4B,P68871,,HBB,wild,cl4,7jy1B,O4B,,7jy1,3,6,,0,,,PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl3,HBB_1thbD_IHP,P68871,,HBB,wild,cl3,1thbD,IHP,,1thb,3,6,,0,,,Refinement of a partially oxygenated T state human haemoglobin at 1.5 A resolution.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl1,HBB_5ee4F_HEM,P68871,,HBB,wild,cl1,5ee4F,HEM,,5ee4,3,6,,0,,,Structural analysis of haemoglobin binding by HpuA from the Neisseriaceae family.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl5,HBB_5ksiB_S1P,P68871,,HBB,wild,cl5,5ksiB,S1P,,5ksi,3,6,,0,,,Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl5,HBB_5ksiD_S1P,P68871,,HBB,wild,cl5,5ksiD,S1P,,5ksi,3,6,,0,,,Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl2,HBB_3ic0D_B77,P68871,,HBB,wild,cl2,3ic0D,B77,,3ic0,3,6,,0,,,Structural and in Vitro Chracterization of Pridyl Derivatives of Benzaldehydes: Highly Potent Antisickling Agents,,,0,,,,,,,,,,,,,
P68871_HBB_wild_cl2,HBB_3b75F_FRU,P68871,,HBB,wild,cl2,3b75F,FRU,,3b75,3,6,,0,,,The effect of hemoglobin glycosylation on diabete linked oxidative stress,,,0,,,,,,,,,,,,,
P78325_ADAM8_wild_cl1,ADAM8_4dd8A_BAT,P78325,,ADAM8,wild,cl1,4dd8A,BAT,,4dd8,3,1,,0,,,Structure of human ADAM-8 catalytic domain complexed with batimastat.,,,0,,,,,,,,,,,,,
P78352_DLG4_wild_cl1,DLG4_6spzA_GSH,P78352,,DLG4,wild,cl1,6spzA,GSH,,6spz,3,1,,0,,,The Dual PDZ Domain from Postsynaptic Density Protein 95 Forms a Scaffold with Peptide Ligand.,,,0,,,,,,,,,,,,,
P78380_OLR1_wild_cl2,OLR1_1ypqB_DIO,P78380,,OLR1,wild,cl2,1ypqB,DIO,,1ypq,3,2,,0,,,The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1.,,,0,,,,,,,,,,,,,
P78417_GSTO1_wild_cl1,GSTO1_4is0A_GDS,P78417,,GSTO1,wild,cl1,4is0A,GDS,,4is0,3,1,,0,,,Structural insights into omega-class glutathione transferases: a snapshot of enzyme reduction and identification of a non-catalytic ligandin site.,,,0,,,,,,,,,,,,,
P78504_JAG1_wild_cl1,JAG1_4cc1A_FUC,P78504,,JAG1,wild,cl1,4cc1A,FUC,,4cc1,3,1,,0,,,Structural Analysis Uncovers Lipid-Binding Properties of Notch Ligands,,,0,,,,,,,,,,,,,
P78549_NTHL1_wild_cl1,NTHL1_7rdtA_SF4,P78549,,NTHL1,wild,cl1,7rdtA,SF4,,7rdt,3,1,,0,,,Caught in motion: human NTHL1 undergoes interdomain rearrangement necessary for catalysis.,,,0,,,,,,,,,,,,,
P99999_CYCS_wild_cl2,CYCS_6xnkA_HEC,P99999,,CYCS,wild,cl2,6xnkA,HEC,,6xnk,3,2,,0,,,Alkaline State of the Domain-Swapped Dimer of Human Cytochrome c : A Conformational Switch for Apoptotic Peroxidase Activity.,,,0,,,,,,,,,,,,,
P99999_CYCS_wild_cl1,CYCS_2n9jA_HEC,P99999,,CYCS,wild,cl1,2n9jA,HEC,,2n9j,3,2,,0,,,Investigation of the redox-dependent modulation of structure and dynamics in human cytochrome c.,,,0,,,,,,,,,,,,,
P99999_CYCS_wild_cl1,CYCS_3zcfB_HEC,P99999,,CYCS,wild,cl1,3zcfB,HEC,,3zcf,3,2,,0,,,The Hydrogen Peroxide Induced Radical Behaviour in Human Cytochrome C Phospholipid Complexes: Implications for the Enhanced Pro-Apoptotic Activity of the G41S Mutant,,,0,,,,,,,,,,,,,
Q00688_FKBP3_wild_cl1,FKBP3_1pbkA_RAP,Q00688,,FKBP3,wild,cl1,1pbkA,RAP,,1pbk,3,1,,0,,,Structure of the human 25 kDa FK506 binding protein complexed with rapamycin.,,,0,,,,,,,,,,,,,
Q01105_SET_wild_cl1,SET_2e50A_TRE,Q01105,,SET,wild,cl1,2e50A,TRE,,2.00E+50,3,2,,0,,,Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity,,,0,,,,,,,,,,,,,
Q01105_SET_wild_cl1,SET_2e50P_TRE,Q01105,,SET,wild,cl1,2e50P,TRE,,2.00E+50,3,2,,0,,,Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity,,,0,,,,,,,,,,,,,
Q01105_SET_wild_cl2,SET_2e50A_TRE,Q01105,,SET,wild,cl2,2e50A,TRE,,2.00E+50,3,2,,0,,,Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity,,,0,,,,,,,,,,,,,
Q01469_FABP5_wild_cl2,FABP5_4azmA_T4B,Q01469,,FABP5,wild,cl2,4azmA,T4B,,4azm,2,2,,0,,,Crystallographic Study of Fabp5 as an Intracellular Endocannabinoid Transporter.,,,0,,,,,,,,,,,,,
Q01469_FABP5_wild_cl2,FABP5_4azrB_A9M,Q01469,,FABP5,wild,cl2,4azrB,A9M,,4azr,2,2,,0,,,Crystallographic Study of Fabp5 as an Intracellular Endocannabinoid Transporter.,,,0,,,,,,,,,,,,,
Q01469_FABP5_wild_cl1,FABP5_5ur9D_8KS,Q01469,,FABP5,wild,cl1,5ur9D,8KS,,5ur9,2,2,,0,,,The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.,,,0,,,,,,,,,,,,,
Q01469_FABP5_wild_cl1,FABP5_5ur9E_8KS,Q01469,,FABP5,wild,cl1,5ur9E,8KS,,5ur9,2,2,,0,,,The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl1,NAAA_6dxxC_TON,Q02083,,NAAA,wild,cl1,6dxxC,TON,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl1,NAAA_6dxxE_TON,Q02083,,NAAA,wild,cl1,6dxxE,TON,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl2,NAAA_6dxxB_TON,Q02083,,NAAA,wild,cl2,6dxxB,TON,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl2,NAAA_6dxxD_TON,Q02083,,NAAA,wild,cl2,6dxxD,TON,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl3,NAAA_6dxxA_WTF,Q02083,,NAAA,wild,cl3,6dxxA,WTF,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02083_NAAA_wild_cl4,NAAA_6dxxB_WTF,Q02083,,NAAA,wild,cl4,6dxxB,WTF,,6dxx,3,4,,0,,,Molecular mechanism of activation of the immunoregulatory amidase NAAA.,,,0,,,,,,,,,,,,,
Q02790_FKBP4_wild_cl1,FKBP4_4drjA_RAP,Q02790,,FKBP4,wild,cl1,4drjA,RAP,,4drj,3,1,,0,,,Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin.,,,0,,,,,,,,,,,,,
Q03111_MLLT1_wild_cl1,MLLT1_6t1iA_M7W,Q03111,,MLLT1,wild,cl1,6t1iA,M7W,,6t1i,2,1,,0,,,Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.,,,0,,,,,,,,,,,,,
Q04721_NOTCH2_wild_cl1,NOTCH2_5mwbA_FUC,Q04721,,NOTCH2,wild,cl1,5mwbA,FUC,,5mwb,3,2,,0,,,Structural and functional dissection of the interplay between lipid and Notch binding by human Notch ligands.,,,0,,,,,,,,,,,,,
Q04721_NOTCH2_wild_cl2,NOTCH2_5mwbA_BGC,Q04721,,NOTCH2,wild,cl2,5mwbA,BGC,,5mwb,3,2,,0,,,Structural and functional dissection of the interplay between lipid and Notch binding by human Notch ligands.,,,0,,,,,,,,,,,,,
Q04760_GLO1_wild_cl1,GLO1_1qipA_GNB,Q04760,,GLO1,wild,cl1,1qipA,GNB,,1qip,3,2,,0,,,Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue.,,,0,,,,,,,,,,,,,
Q05329_GAD2_wild_cl1,GAD2_2okkA_ABU,Q05329,,GAD2,wild,cl1,2okkA,ABU,,2okk,3,1,,0,,,GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop.,,,0,,,,,,,,,,,,,
Q06210_GFPT1_wild_cl1,GFPT1_2zj3A_G6P,Q06210,,GFPT1,wild,cl1,2zj3A,G6P,,2zj3,3,1,,0,,,Structural analysis of human glutamine:fructose-6-phosphate amidotransferase_ a key regulator in type 2 diabetes,,,0,,,,,,,,,,,,,
Q06609_RAD51_wild_cl1,RAD51_7c9aC_ANP,Q06609,,RAD51,wild,cl1,7c9aC,ANP,,7c9a,3,2,,0,,,Identification of fidelity-governing factors in human recombinases DMC1 and RAD51 from cryo-EM structures.,,,0,,,,,,,,,,,,,
Q06609_RAD51_wild_cl1,RAD51_5nwlA_ATP,Q06609,,RAD51,wild,cl1,5nwlA,ATP,,5nwl,3,2,,0,,,Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA.,,,0,,,,,,,,,,,,,
Q06609_RAD51_wild_cl2,RAD51_5nwlD_ATP,Q06609,,RAD51,wild,cl2,5nwlD,ATP,,5nwl,3,2,,0,,,Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA.,,,0,,,,,,,,,,,,,
Q06609_RAD51_wild_cl2,RAD51_5nwlJ_ATP,Q06609,,RAD51,wild,cl2,5nwlJ,ATP,,5nwl,3,2,,0,,,Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA.,,,0,,,,,,,,,,,,,
Q06830_PRDX1_wild_cl1,PRDX1_7lj1G_ATP,Q06830,,PRDX1,wild,cl1,7lj1G,ATP,,7lj1,3,1,,0,,,Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric State.,,,0,,,,,,,,,,,,,
Q07889_SOS1_wild_cl1,SOS1_6d56B_FVM,Q07889,,SOS1,wild,cl1,6d56B,FVM,,6d56,1,3,,0,,,Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS.,,,0,,,,,,,,,,,,,
Q12888_TP53BP1_wild_cl1,TP53BP1_4rg2A_3OO,Q12888,,TP53BP1,wild,cl1,4rg2A,3OO,,4rg2,3,1,,0,,,Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein_ 53BP1.,,,0,,,,,,,,,,,,,
Q12888_TP53BP1_wild_cl1,TP53BP1_6mxxJ_K6P,Q12888,,TP53BP1,wild,cl1,6mxxJ,K6P,,6mxx,3,1,,0,,,Structure of 53BP1 tandem Tudor domains in complex with small molecule UNC2991,,,0,,,,,,,,,,,,,
Q12931_TRAP1_wild_cl1,TRAP1_7kckA_ANP,Q12931,,TRAP1,wild,cl1,7kckA,ANP,,7kck,1,1,,0,,,Cryo-EM reveals the dynamic interplay between mitochondrial Hsp90 and SdhB folding intermediates,,,0,,,,,,,,,,,,,
Q13009_TIAM1_wild_cl1,TIAM1_4nxrA_ANS,Q13009,,TIAM1,wild,cl1,4nxrA,ANS,,4nxr,3,1,,0,,,Distinct Roles for Conformational Dynamics in Protein-Ligand Interactions.,,,0,,,,,,,,,,,,,
Q13162_PRDX4_wild_cl1,PRDX4_4rqxA_COM,Q13162,,PRDX4,wild,cl1,4rqxA,COM,,4rqx,3,1,,0,,,Cysteine Specific Targeting of the Functionally Distinct Peroxiredoxin and Glutaredoxin Proteins by the Investigational Disulfide BNP7787.,,,0,,,,,,,,,,,,,
Q13162_PRDX4_wild_cl1,PRDX4_4rqxD_COM,Q13162,,PRDX4,wild,cl1,4rqxD,COM,,4rqx,3,1,,0,,,Cysteine Specific Targeting of the Functionally Distinct Peroxiredoxin and Glutaredoxin Proteins by the Investigational Disulfide BNP7787.,,,0,,,,,,,,,,,,,
Q13451_FKBP5_wild_cl1,FKBP5_6txxA_37K,Q13451,,FKBP5,wild,cl1,6txxA,37K,,6txx,1,2,,0,,,Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.,,,0,,,,,,,,,,,,,
Q13451_FKBP5_wild_cl1,FKBP5_4driA_RAP,Q13451,,FKBP5,wild,cl1,4driA,RAP,,4dri,1,2,,0,,,Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin.,,,0,,,,,,,,,,,,,
Q13490_BIRC2_wild_cl1,BIRC2_6w7oD_TL7,Q13490,,BIRC2,wild,cl1,6w7oD,TL7,,6w7o,3,1,,0,,,Structural Characterization of BTK:PROTAC:cIAP Ternary Complexes: From Snapshots to Ensembles,,,0,,,,,,,,,,,,,
Q13501_SQSTM1_wild_cl1,SQSTM1_6mj7A_ARG,Q13501,,SQSTM1,wild,cl1,6mj7A,ARG,,6mj7,3,1,,0,,,ZZ-dependent regulation of p62/SQSTM1 in autophagy.,,,0,,,,,,,,,,,,,
Q13509_TUBB3_wild_cl1,TUBB3_7lxbB_GDP,Q13509,,TUBB3,wild,cl1,7lxbB,GDP,,7lxb,2,3,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
Q13509_TUBB3_wild_cl2,TUBB3_7lxbB_YGY,Q13509,,TUBB3,wild,cl2,7lxbB,YGY,,7lxb,2,3,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
Q13509_TUBB3_wild_cl2,TUBB3_7m18B_YNP,Q13509,,TUBB3,wild,cl2,7m18B,YNP,,7m18,2,3,,0,,,Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action.,,,0,,,,,,,,,,,,,
Q13509_TUBB3_wild_cl1,TUBB3_5jcoK_G2P,Q13509,,TUBB3,wild,cl1,5jcoK,G2P,,5jco,2,3,,0,,,Structure and Dynamics of Single-isoform Recombinant Neuronal Human Tubulin.,,,0,,,,,,,,,,,,,
Q13509_TUBB3_wild_cl3,TUBB3_6s8lB_PN6,Q13509,,TUBB3,wild,cl3,6s8lB,PN6,,6s8l,2,3,,0,,,Structure_ Thermodynamics_ and Kinetics of Plinabulin Binding to Two Tubulin Isotypes,,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl2,PIN1_3wh0A_O4B,Q13526,,PIN1,wild,cl2,3wh0A,O4B,,3wh0,1,4,,0,,,Crowning proteins: modulating the protein surface properties using crown ethers.,,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl2,PIN1_3oobA_KDH,Q13526,,PIN1,wild,cl2,3oobA,KDH,,3oob,1,4,,0,,,Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.,,,0,,,,,,,,,,,,,
Q13526_PIN1_wild_cl4,PIN1_4gwtA_LMR,Q13526,,PIN1,wild,cl4,4gwtA,LMR,,4gwt,1,4,,0,,,Evidence for small-molecule-mediated loop stabilization in the structure of the isolated Pin1 WW domain.,,,0,,,,,,,,,,,,,
Q13563_PKD2_wild_cl1,PKD2_6t9nD_CLR,Q13563,,PKD2,wild,cl1,6t9nD,CLR,,6t9n,3,1,,0,,,Lipid Interactions of a Ciliary Membrane TRP Channel: Simulation and Structural Studies of Polycystin-2.,,,0,,,,,,,,,,,,,
Q13563_PKD2_wild_cl1,PKD2_5mkfD_PX6,Q13563,,PKD2,wild,cl1,5mkfD,PX6,,5mkf,3,1,,0,,,Molecular insights into lipid-assisted Ca(2+) regulation of the TRP channel Polycystin-2.,,,0,,,,,,,,,,,,,
Q13572_ITPK1_wild_cl1,ITPK1_2qb5A_ADP,Q13572,,ITPK1,wild,cl1,2qb5A,ADP,,2qb5,3,1,,0,,,Integration of inositol phosphate signaling pathways via human ITPK1.,,,0,,,,,,,,,,,,,
Q13907_IDI1_wild_cl1,IDI1_2i6kA_EA2,Q13907,,IDI1,wild,cl1,2i6kA,EA2,,2i6k,3,1,,0,,,Crystal structures of human IPP isomerase: new insights into the catalytic mechanism,,,0,,,,,,,,,,,,,
Q13907_IDI1_wild_cl1,IDI1_2i6kB_EA2,Q13907,,IDI1,wild,cl1,2i6kB,EA2,,2i6k,3,1,,0,,,Crystal structures of human IPP isomerase: new insights into the catalytic mechanism,,,0,,,,,,,,,,,,,
Q14376_GALE_wild_cl2,GALE_1ek5A_NAD,Q14376,,GALE,wild,cl2,1ek5A,NAD,,1ek5,3,2,,0,,,Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase.,,,0,,,,,,,,,,,,,
Q14376_GALE_wild_cl1,GALE_1i3kA_UPG,Q14376,,GALE,wild,cl1,1i3kA,UPG,,1i3k,3,2,,0,,,Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase.,,,0,,,,,,,,,,,,,
Q14376_GALE_wild_cl1,GALE_1i3mA_UD1,Q14376,,GALE,wild,cl1,1i3mA,UD1,,1i3m,3,2,,0,,,Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase.,,,0,,,,,,,,,,,,,
Q14397_GCKR_wild_cl2,GCKR_4ly9A_S6P,Q14397,,GCKR,wild,cl2,4ly9A,S6P,,4ly9,1,2,,0,,,Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.,,,0,,,,,,,,,,,,,
Q14397_GCKR_wild_cl2,GCKR_4bb9A_F1P,Q14397,,GCKR,wild,cl2,4bb9A,F1P,,4bb9,1,2,,0,,,Crystal Structure of Glucokinase Regulatory Protein.,,,0,,,,,,,,,,,,,
Q14397_GCKR_wild_cl1,GCKR_4mquA_MG9,Q14397,,GCKR,wild,cl1,4mquA,MG9,,4mqu,1,2,,0,,,Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles.,,,0,,,,,,,,,,,,,
Q14397_GCKR_wild_cl1,GCKR_4mquB_MG9,Q14397,,GCKR,wild,cl1,4mquB,MG9,,4mqu,1,2,,0,,,Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles.,,,0,,,,,,,,,,,,,
Q14498_RBM39_wild_cl1,RBM39_6q0rD_O6M,Q14498,,RBM39,wild,cl1,6q0rD,O6M,,6q0r,3,1,,0,,,Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.,,,0,,,,,,,,,,,,,
Q14498_RBM39_wild_cl1,RBM39_6q0wD_EF6,Q14498,,RBM39,wild,cl1,6q0wD,EF6,,6q0w,3,1,,0,,,Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.,,,0,,,,,,,,,,,,,
Q15125_EBP_wild_cl1,EBP_6ohuC_CTX,Q15125,,EBP,wild,cl1,6ohuC,CTX,,6ohu,2,1,,0,,,Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition.,,,0,,,,,,,,,,,,,
Q15125_EBP_wild_cl1,EBP_6ohtC_MKM,Q15125,,EBP,wild,cl1,6ohtC,MKM,,6oht,2,1,,0,,,Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition.,,,0,,,,,,,,,,,,,
Q15257_PTPA_wild_cl1,PTPA_2hv7B_ADP,Q15257,,PTPA,wild,cl1,2hv7B,ADP,,2hv7,3,1,,0,,,Structure and mechanism of the phosphotyrosyl phosphatase activator.,,,0,,,,,,,,,,,,,
Q15257_PTPA_wild_cl1,PTPA_2hv7G_ADP,Q15257,,PTPA,wild,cl1,2hv7G,ADP,,2hv7,3,1,,0,,,Structure and mechanism of the phosphotyrosyl phosphatase activator.,,,0,,,,,,,,,,,,,
Q15465_SHH_wild_cl1,SHH_6dmyB_SER,Q15465,,SHH,wild,cl1,6dmyB,SER,,6dmy,3,1,,0,,,Structural basis for the recognition of Sonic Hedgehog by human Patched1.,,,0,,,,,,,,,,,,,
Q15475_SIX1_wild_cl1,SIX1_4egcA_MAL,Q15475,,SIX1,wild,cl1,4egcA,MAL,,4egc,3,1,,0,,,Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.,,,0,,,,,,,,,,,,,
Q15544_TAF11_wild_cl1,TAF11_1bh9B_PMB,Q15544,,TAF11,wild,cl1,1bh9B,PMB,,1bh9,3,1,,0,,,Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family.,,,0,,,,,,,,,,,,,
Q15562_TEAD2_wild_cl1,TEAD2_5dqeA_5E4,Q15562,,TEAD2,wild,cl1,5dqeA,50000,,5dqe,3,2,,0,,,Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.,,,0,,,,,,,,,,,,,
Q15811_ITSN1_wild_cl1,ITSN1_5hziA_FMN,Q15811,,ITSN1,wild,cl1,5hziA,FMN,,5hzi,3,1,,0,,,Engineering extrinsic disorder to control protein activity in living cells.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl1,BAK1_6uxrA_K6G,Q16611,,BAK1,wild,cl1,6uxrA,K6G,,6uxr,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl1,BAK1_6uxqB_LBN,Q16611,,BAK1,wild,cl1,6uxqB,LBN,,6uxq,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl2,BAK1_6uxnD_8SP,Q16611,,BAK1,wild,cl2,6uxnD,8SP,,6uxn,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl2,BAK1_6uxnF_8SP,Q16611,,BAK1,wild,cl2,6uxnF,8SP,,6uxn,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl3,BAK1_6uxnA_8SP,Q16611,,BAK1,wild,cl3,6uxnA,8SP,,6uxn,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16611_BAK1_wild_cl3,BAK1_6uxnH_8SP,Q16611,,BAK1,wild,cl3,6uxnH,8SP,,6uxn,3,3,,0,,,BAK core dimers bind lipids and can be bridged by them.,,,0,,,,,,,,,,,,,
Q16647_PTGIS_wild_cl1,PTGIS_2iagA_HEM,Q16647,,PTGIS,wild,cl1,2iagA,HEM,,2iag,3,1,,0,,,Crystal Structure of the Human Prostacyclin Synthase,,,0,,,,,,,,,,,,,
Q16658_FSCN1_wild_cl2,FSCN1_3p53A_GOL,Q16658,,FSCN1,wild,cl2,3p53A,GOL,,3p53,1,2,,0,,,Mechanism of actin filament bundling by fascin.,,,0,,,,,,,,,,,,,
Q16658_FSCN1_wild_cl2,FSCN1_3p53B_GOL,Q16658,,FSCN1,wild,cl2,3p53B,GOL,,3p53,1,2,,0,,,Mechanism of actin filament bundling by fascin.,,,0,,,,,,,,,,,,,
Q16772_GSTA3_wild_cl1,GSTA3_1tdiB_GSH,Q16772,,GSTA3,wild,cl1,1tdiB,GSH,,1tdi,3,2,,0,,,Crystal structure of human glutathione S-transferase A3-3 and mechanistic implications for its high steroid isomerase activity.,,,0,,,,,,,,,,,,,
Q16772_GSTA3_wild_cl2,GSTA3_1tdiA_GSH,Q16772,,GSTA3,wild,cl2,1tdiA,GSH,,1tdi,3,2,,0,,,Crystal structure of human glutathione S-transferase A3-3 and mechanistic implications for its high steroid isomerase activity.,,,0,,,,,,,,,,,,,
Q16772_GSTA3_wild_cl1,GSTA3_2vcvH_ASD,Q16772,,GSTA3,wild,cl1,2vcvH,ASD,,2vcv,3,2,,0,,,Structural Basis for Featuring of Steroid Isomerase Activity in Alpha Class Glutathione Transferases.,,,0,,,,,,,,,,,,,
Q16775_HAGH_wild_cl1,HAGH_1qh5A_GSH,Q16775,,HAGH,wild,cl1,1qh5A,GSH,,1qh5,3,1,,0,,,Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue.,,,0,,,,,,,,,,,,,
Q16820_MEP1B_wild_cl1,MEP1B_4gwmA_FUC,Q16820,,MEP1B,wild,cl1,4gwmA,FUC,,4gwm,3,2,,0,,,Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane,,,0,,,,,,,,,,,,,
Q16820_MEP1B_wild_cl1,MEP1B_4gwnA_FUC,Q16820,,MEP1B,wild,cl1,4gwnA,FUC,,4gwn,3,2,,0,,,Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane,,,0,,,,,,,,,,,,,
Q16820_MEP1B_wild_cl2,MEP1B_4gwmB_MAN,Q16820,,MEP1B,wild,cl2,4gwmB,MAN,,4gwm,3,2,,0,,,Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane,,,0,,,,,,,,,,,,,
Q16854_DGUOK_wild_cl1,DGUOK_2ocpA_DTP,Q16854,,DGUOK,wild,cl1,2ocpA,DTP,,2ocp,3,1,,0,,,Structural Basis for Substrate Specificities of Cellular Deoxyribonucleoside Kinases.,,,0,,,,,,,,,,,,,
Q16873_LTC4S_wild_cl2,LTC4S_2pnoA_GSH,Q16873,,LTC4S,wild,cl2,2pnoA,GSH,,2pno,3,2,,0,,,Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis,,,0,,,,,,,,,,,,,
Q16875_PFKFB3_wild_cl1,PFKFB3_2i1vB_ADP,Q16875,,PFKFB3,wild,cl1,2i1vB,ADP,,2i1v,1,3,,0,,,A Direct Substrate-Substrate Interaction Found in the Kinase Domain of the Bifunctional Enzyme_ 6-Phosphofructo-2-kinase/Fructose-2_6-bisphosphatase,,,0,,,,,,,,,,,,,
Q16875_PFKFB3_wild_cl2,PFKFB3_2i1vB_F6P,Q16875,,PFKFB3,wild,cl2,2i1vB,F6P,,2i1v,1,3,,0,,,A Direct Substrate-Substrate Interaction Found in the Kinase Domain of the Bifunctional Enzyme_ 6-Phosphofructo-2-kinase/Fructose-2_6-bisphosphatase,,,0,,,,,,,,,,,,,
Q16875_PFKFB3_wild_cl2,PFKFB3_2axnA_F6P,Q16875,,PFKFB3,wild,cl2,2axnA,F6P,,2axn,1,3,,0,,,Crystal structure of the hypoxia-inducible form of 6-phosphofructo-2-kinase/fructose-2_6-bisphosphatase (PFKFB3): a possible new target for cancer therapy.,,,0,,,,,,,,,,,,,
Q16875_PFKFB3_wild_cl1,PFKFB3_4ma4A_ADP,Q16875,,PFKFB3,wild,cl1,4ma4A,ADP,,4ma4,1,3,,0,,,PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer.,,,0,,,,,,,,,,,,,
Q16875_PFKFB3_wild_cl3,PFKFB3_4ma4A_GSH,Q16875,,PFKFB3,wild,cl3,4ma4A,GSH,,4ma4,1,3,,0,,,PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer.,,,0,,,,,,,,,,,,,
Q5JWF2_GNAS_wild_cl2,GNAS_5g53C_GDP,Q5JWF2,,GNAS,wild,cl2,5g53C,GDP,,5g53,3,1,,0,,,Structure of the Adenosine A2A Receptor Bound to an Engineered G Protein,,,0,,,,,,,,,,,,,
Q6EIG7_CLEC6A_wild_cl1,CLEC6A_5vybA_MAN,Q6EIG7,,CLEC6A,wild,cl1,5vybA,MAN,,5vyb,3,1,,0,,,Mechanism of pathogen recognition by human dectin-2.,,,0,,,,,,,,,,,,,
Q6IQ20_NAPEPLD_wild_cl1,NAPEPLD_4qn9A_DXC,Q6IQ20,,NAPEPLD,wild,cl1,4qn9A,DXC,,4qn9,3,1,,0,,,Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids.,,,0,,,,,,,,,,,,,
Q6IQ20_NAPEPLD_wild_cl1,NAPEPLD_4qn9B_DXC,Q6IQ20,,NAPEPLD,wild,cl1,4qn9B,DXC,,4qn9,3,1,,0,,,Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids.,,,0,,,,,,,,,,,,,
Q6NVY1_HIBCH_wild_cl1,HIBCH_3bptA_QUE,Q6NVY1,,HIBCH,wild,cl1,3bptA,QUE,,3bpt,3,1,,0,,,Crystal structure of human beta-hydroxyisobutyryl-CoA hydrolase in complex with quercetin.,,,0,,,,,,,,,,,,,
Q6P587_FAHD1_wild_cl1,FAHD1_6fogB_OXL,Q6P587,,FAHD1,wild,cl1,6fogB,OXL,,6fog,3,1,,0,,,Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.,,,0,,,,,,,,,,,,,
Q6P587_FAHD1_wild_cl1,FAHD1_6fogD_OXL,Q6P587,,FAHD1,wild,cl1,6fogD,OXL,,6fog,3,1,,0,,,Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.,,,0,,,,,,,,,,,,,
Q6PJP8_DCLRE1A_wild_cl2,DCLRE1A_5nzwA_9F2,Q6PJP8,,DCLRE1A,wild,cl2,5nzwA,9F2,,5nzw,3,3,,0,,,Crystal structure of DNA cross-link repair protein 1A in complex with ceftriaxone,,,0,,,,,,,,,,,,,
Q6PJP8_DCLRE1A_wild_cl3,DCLRE1A_5nzxA_9F2,Q6PJP8,,DCLRE1A,wild,cl3,5nzxA,9F2,,5nzx,3,3,,0,,,Crystal structure of DNA cross-link repair protein 1A in complex with Ceftriaxone (alternative site),,,0,,,,,,,,,,,,,
Q6PJP8_DCLRE1A_wild_cl1,DCLRE1A_5nzyA_CE3,Q6PJP8,,DCLRE1A,wild,cl1,5nzyA,CE3,,5nzy,3,3,,0,,,To Be published,,,0,,,,,,,,,,,,,
Q71U36_TUBA1A_wild_cl1,TUBA1A_5jcoH_GTP,Q71U36,,TUBA1A,wild,cl1,5jcoH,GTP,,5jco,3,1,,0,,,Structure and Dynamics of Single-isoform Recombinant Neuronal Human Tubulin.,,,0,,,,,,,,,,,,,
Q76LX8_ADAMTS13_wild_cl1,ADAMTS13_3ghmA_BGC,Q76LX8,,ADAMTS13,wild,cl1,3ghmA,BGC,,3ghm,3,2,,0,,,Crystal structures of the non-catalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor,,,0,,,,,,,,,,,,,
Q76LX8_ADAMTS13_wild_cl1,ADAMTS13_3ghmA_FUC,Q76LX8,,ADAMTS13,wild,cl1,3ghmA,FUC,,3ghm,3,2,,0,,,Crystal structures of the non-catalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor,,,0,,,,,,,,,,,,,
Q76LX8_ADAMTS13_wild_cl2,ADAMTS13_3vn4A_BMA,Q76LX8,,ADAMTS13,wild,cl2,3vn4A,BMA,,3vn4,3,2,,0,,,Structural analysis and biochemical studies of ADAMTS13 P475S mutant,,,0,,,,,,,,,,,,,
Q7Z2E3_APTX_wild_cl1,APTX_4ndgA_V5A,Q7Z2E3,,APTX,wild,cl1,4ndgA,V5A,,4ndg,3,1,,0,,,Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity.,,,0,,,,,,,,,,,,,
Q7Z434_MAVS_wild_cl1,MAVS_2vgqA_MTT,Q7Z434,,MAVS,wild,cl1,2vgqA,MTT,,2vgq,3,1,,0,,,Crystal Structure of Human Ips-1 Caspase Activation Recruitment Domain,,,0,,,,,,,,,,,,,
Q7Z6Z7_HUWE1_wild_cl1,HUWE1_6pflB_APR,Q7Z6Z7,,HUWE1,wild,cl1,6pflB,APR,,6pfl,3,1,,0,,,Crystal structure of Human HUWE1 WWE domain in complex with ADPR,,,0,,,,,,,,,,,,,
Q86V24_ADIPOR2_wild_cl1,ADIPOR2_6ks1A_LPX,Q86V24,,ADIPOR2,wild,cl1,6ks1A,LPX,,6ks1,3,1,,0,,,Human adiponectin receptor AdipoR1 assumes closed and open structures.,,,0,,,,,,,,,,,,,
Q86W47_KCNMB4_wild_cl1,KCNMB4_6v35E_PGW,Q86W47,,KCNMB4,wild,cl1,6v35E,PGW,,6v35,3,1,,0,,,Molecular structures of the human Slo1 K + channel in complex with beta 4.,,,0,,,,,,,,,,,,,
Q86WV6_STING1_wild_cl2,STING1_7siiA_9IM,Q86WV6,,STING1,wild,cl2,7siiA,9IM,,7sii,3,2,,0,,,Activation of STING by targeting a pocket in the transmembrane domain.,,,0,,,,,,,,,,,,,
Q86WV6_STING1_wild_cl2,STING1_7siiB_9IM,Q86WV6,,STING1,wild,cl2,7siiB,9IM,,7sii,3,2,,0,,,Activation of STING by targeting a pocket in the transmembrane domain.,,,0,,,,,,,,,,,,,
Q86WV6_STING1_wild_cl1,STING1_4qxqA_1YE,Q86WV6,,STING1,wild,cl1,4qxqA,1YE,,4qxq,3,2,,0,,,Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA.,,,0,,,,,,,,,,,,,
Q8IYB8_SUPV3L1_wild_cl1,SUPV3L1_3rc3A_ANP,Q8IYB8,,SUPV3L1,wild,cl1,3rc3A,ANP,,3rc3,3,1,,0,,,Human Suv3 protein reveals unique features among SF2 helicases.,,,0,,,,,,,,,,,,,
Q8N371_KDM8_wild_cl1,KDM8_7dywA_HRL,Q8N371,,KDM8,wild,cl1,7dywA,HRL,,7dyw,3,1,,0,,,Human JMJD5 in complex with MN and 5-((2-methoxybenzyl)amino)pyridine-2_4-dicarboxylic acid.,,,0,,,,,,,,,,,,,
Q8N371_KDM8_wild_cl1,KDM8_5fbjA_AKG,Q8N371,,KDM8,wild,cl1,5fbjA,AKG,,5fbj,3,1,,0,,,to be published,,,0,,,,,,,,,,,,,
Q8N539_FIBCD1_wild_cl1,FIBCD1_6zqrA_NAG,Q8N539,,FIBCD1,wild,cl1,6zqrA,NAG,,6zqr,3,1,,0,,,Crystal structures of human immune protein FIBCD1 reveal an extended ligand binding site compatible with recognition of chitin oligomers,,,0,,,,,,,,,,,,,
Q8N539_FIBCD1_wild_cl1,FIBCD1_6zqyA_SLB,Q8N539,,FIBCD1,wild,cl1,6zqyA,SLB,,6zqy,3,1,,0,,,Crystal structures of human immune protein FIBCD1 reveal an extended ligand binding site compatible with recognition of chitin oligomers,,,0,,,,,,,,,,,,,
Q8N543_OGFOD1_wild_cl1,OGFOD1_4nhxA_OGA,Q8N543,,OGFOD1,wild,cl1,4nhxA,OGA,,4nhx,3,1,,0,,,Structure of the Ribosomal Oxygenase OGFOD1 Provides Insights into the Regio- and Stereoselectivity of Prolyl Hydroxylases.,,,0,,,,,,,,,,,,,
Q8WTT0_CLEC4C_wild_cl1,CLEC4C_4zetA_GAL,Q8WTT0,,CLEC4C,wild,cl1,4zetA,GAL,,4zet,3,1,,0,,,A Novel Mechanism for Binding of Galactose-terminated Glycans by the C-type Carbohydrate Recognition Domain in Blood Dendritic Cell Antigen 2.,,,0,,,,,,,,,,,,,
Q8WTT0_CLEC4C_wild_cl1,CLEC4C_4zesB_MMA,Q8WTT0,,CLEC4C,wild,cl1,4zesB,MMA,,4zes,3,1,,0,,,A Novel Mechanism for Binding of Galactose-terminated Glycans by the C-type Carbohydrate Recognition Domain in Blood Dendritic Cell Antigen 2.,,,0,,,,,,,,,,,,,
Q92600_CNOT9_wild_cl1,CNOT9_4ct7B_TRP,Q92600,,CNOT9,wild,cl1,4ct7B,TRP,,4ct7,3,1,,0,,,Structural and Biochemical Insights to the Role of the Ccr4-not Complex and Ddx6 ATPase in Microrna Repression.,,,0,,,,,,,,,,,,,
Q92794_KAT6A_wild_cl1,KAT6A_2rc4A_ACO,Q92794,,KAT6A,wild,cl1,2rc4A,ACO,,2rc4,3,1,,0,,,The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting.,,,0,,,,,,,,,,,,,
Q92841_DDX17_wild_cl1,DDX17_6uv1B_ADP,Q92841,,DDX17,wild,cl1,6uv1B,ADP,,6uv1,3,1,,0,,,RNA Specificity and Autoregulation of DDX17_ a Modulator of MicroRNA Biogenesis.,,,0,,,,,,,,,,,,,
Q92841_DDX17_wild_cl1,DDX17_6uv2A_ADP,Q92841,,DDX17,wild,cl1,6uv2A,ADP,,6uv2,3,1,,0,,,RNA Specificity and Autoregulation of DDX17_ a Modulator of MicroRNA Biogenesis.,,,0,,,,,,,,,,,,,
Q93088_BHMT_wild_cl1,BHMT_1lt8A_CBH,Q93088,,BHMT,wild,cl1,1lt8A,CBH,,1lt8,3,1,,0,,,Betaine-homocysteine methyltransferase: zinc in a distorted barrel.,,,0,,,,,,,,,,,,,
Q96C86_DCPS_wild_cl2,DCPS_1xmmC_M7G,Q96C86,,DCPS,wild,cl2,1xmmC,M7G,,1xmm,3,2,,0,,,Crystal structures of human DcpS in ligand-free and m7GDP-bound forms suggest a dynamic mechanism for scavenger mRNA decapping.,,,0,,,,,,,,,,,,,
Q96C86_DCPS_wild_cl1,DCPS_4qdvA_30U,Q96C86,,DCPS,wild,cl1,4qdvA,30U,,4qdv,3,2,,0,,,Dcps in complex with covalent ligands targeting Tyrosines,,,0,,,,,,,,,,,,,
Q96C86_DCPS_wild_cl2,DCPS_1st0B_GTG,Q96C86,,DCPS,wild,cl2,1st0B,GTG,,1st0,3,2,,0,,,Insights into the structure_ mechanism_ and regulation of scavenger mRNA decapping activity,,,0,,,,,,,,,,,,,
Q96HE7_ERO1A_wild_cl1,ERO1A_3ahqA_FAD,Q96HE7,,ERO1A,wild,cl1,3ahqA,FAD,,3ahq,3,1,,0,,,Crystal structures of human Ero1-alpha reveal the mechanisms of regulated and targeted oxidation of PDI,,,0,,,,,,,,,,,,,
Q96I25_RBM17_wild_cl1,RBM17_6hipB_TRP,Q96I25,,RBM17,wild,cl1,6hipB,TRP,,6hip,3,1,,0,,,Modulation of HIV-1 gene expression by binding of a ULM motif in the Rev protein to UHM-containing splicing factors.,,,0,,,,,,,,,,,,,
Q96LI5_CNOT6L_wild_cl1,CNOT6L_3ngqA_1PS,Q96LI5,,CNOT6L,wild,cl1,3ngqA,1PS,,3ngq,3,1,,0,,,Crystal structure of the human CNOT6L nuclease domain reveals strict poly(A) substrate specificity.,,,0,,,,,,,,,,,,,
Q96Q83_ALKBH3_wild_cl1,ALKBH3_2iuwA_AKG,Q96Q83,,ALKBH3,wild,cl1,2iuwA,AKG,,2iuw,3,1,,0,,,Human Abh3 Structure and Key Residues for Oxidative Demethylation to Reverse DNA/RNA Damage.,,,0,,,,,,,,,,,,,
Q96SW2_CRBN_wild_cl1,CRBN_5hxbZ_85C,Q96SW2,,CRBN,wild,cl1,5hxbZ,85C,,5hxb,3,1,,0,,,A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.,,,0,,,,,,,,,,,,,
Q96SW2_CRBN_wild_cl1,CRBN_5fqdB_LVY,Q96SW2,,CRBN,wild,cl1,5fqdB,LVY,,5fqd,3,1,,0,,,Structural Basis of Lenalidomide-Induced Ck1Alpha Degradation by the Crl4(Crbn) Ubiquitin Ligase.,,,0,,,,,,,,,,,,,
Q99259_GAD1_wild_cl1,GAD1_2okjA_ABU,Q99259,,GAD1,wild,cl1,2okjA,ABU,,2okj,3,2,,0,,,GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop.,,,0,,,,,,,,,,,,,
Q99259_GAD1_wild_cl1,GAD1_3vp6A_HLD,Q99259,,GAD1,wild,cl1,3vp6A,HLD,,3vp6,3,2,,0,,,Structural characterization of the mechanism through which human glutamic acid decarboxylase auto-activates,,,0,,,,,,,,,,,,,
Q99259_GAD1_wild_cl2,GAD1_3vp6A_HLD,Q99259,,GAD1,wild,cl2,3vp6A,HLD,,3vp6,3,2,,0,,,Structural characterization of the mechanism through which human glutamic acid decarboxylase auto-activates,,,0,,,,,,,,,,,,,
Q99720_SIGMAR1_wild_cl1,SIGMAR1_6dk0A_GKY,Q99720,,SIGMAR1,wild,cl1,6dk0A,GKY,,6dk0,1,1,,0,,,Structural basis for sigma1receptor ligand recognition.,,,0,,,,,,,,,,,,,
Q99720_SIGMAR1_wild_cl1,SIGMAR1_6dk1B_GM4,Q99720,,SIGMAR1,wild,cl1,6dk1B,GM4,,6dk1,1,1,,0,,,Structural basis for sigma1receptor ligand recognition.,,,0,,,,,,,,,,,,,
Q99735_MGST2_wild_cl1,MGST2_6sssB_M88,Q99735,,MGST2,wild,cl1,6sssB,M88,,6sss,3,2,,0,,,Crystal structures of human MGST2 reveal synchronized conformational changes regulating catalysis.,,,0,,,,,,,,,,,,,
Q99735_MGST2_wild_cl2,MGST2_6sssF_M88,Q99735,,MGST2,wild,cl2,6sssF,M88,,6sss,3,2,,0,,,Crystal structures of human MGST2 reveal synchronized conformational changes regulating catalysis.,,,0,,,,,,,,,,,,,
Q99828_CIB1_wild_cl1,CIB1_1y1aB_GSH,Q99828,,CIB1,wild,cl1,1y1aB,GSH,,1y1a,3,1,,0,,,The crystal structure of calcium- and integrin-binding protein 1: Insights into redox regulated functions,,,0,,,,,,,,,,,,,
Q99972_MYOC_wild_cl1,MYOC_4wxuA_GOL,Q99972,,MYOC,wild,cl1,4wxuA,GOL,,4wxu,3,1,,0,,,Structural basis for misfolding in myocilin-associated glaucoma.,,,0,,,,,,,,,,,,,
Q9BY32_ITPA_wild_cl1,ITPA_2j4eA_ITT,Q9BY32,,ITPA,wild,cl1,2j4eA,ITT,,2j4e,3,1,,0,,,Crystal Structure of Human Inosine Triphosphatase: Substrate Binding and Implication of the Inosine Triphosphatase Deficiency Mutation P32T.,,,0,,,,,,,,,,,,,
Q9BY32_ITPA_wild_cl1,ITPA_2j4eB_ITT,Q9BY32,,ITPA,wild,cl1,2j4eB,ITT,,2j4e,3,1,,0,,,Crystal Structure of Human Inosine Triphosphatase: Substrate Binding and Implication of the Inosine Triphosphatase Deficiency Mutation P32T.,,,0,,,,,,,,,,,,,
Q9BYX4_IFIH1_wild_cl1,IFIH1_4gl2A_ANP,Q9BYX4,,IFIH1,wild,cl1,4gl2A,ANP,,4gl2,3,1,,0,,,Structural Basis for dsRNA Recognition_ Filament Formation_ and Antiviral Signal Activation by MDA5.,,,0,,,,,,,,,,,,,
Q9BZ11_ADAM33_wild_cl1,ADAM33_1r55A_097,Q9BZ11,,ADAM33,wild,cl1,1r55A,97,,1r55,3,1,,0,,,Crystal structre of the catalytic domain of human ADAM33,,,0,,,,,,,,,,,,,
Q9C000_NLRP1_wild_cl1,NLRP1_4ifpA_MAL,Q9C000,,NLRP1,wild,cl1,4ifpA,MAL,,4ifp,3,1,,0,,,Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1.,,,0,,,,,,,,,,,,,
Q9GZV9_FGF23_wild_cl1,FGF23_2p39A_SCR,Q9GZV9,,FGF23,wild,cl1,2p39A,SCR,,2p39,3,1,,0,,,Molecular insights into the klotho-dependent_ endocrine mode of action of fibroblast growth factor 19 subfamily members.,,,0,,,,,,,,,,,,,
Q9GZX7_AICDA_wild_cl2,AICDA_5w1cB_CTN,Q9GZX7,,AICDA,wild,cl2,5w1cB,CTN,,5w1c,3,2,,0,,,AID Recognizes Structured DNA for Class Switch Recombination.,,,0,,,,,,,,,,,,,
Q9GZX7_AICDA_wild_cl1,AICDA_5jj4B_MTT,Q9GZX7,,AICDA,wild,cl1,5jj4B,MTT,,5jj4,3,2,,0,,,Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification.,,,0,,,,,,,,,,,,,
Q9GZX7_AICDA_wild_cl1,AICDA_5jj4C_MTT,Q9GZX7,,AICDA,wild,cl1,5jj4C,MTT,,5jj4,3,2,,0,,,Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification.,,,0,,,,,,,,,,,,,
Q9H0H5_RACGAP1_wild_cl1,RACGAP1_5c2kA_GDP,Q9H0H5,,RACGAP1,wild,cl1,5c2kA,GDP,,5c2k,3,1,,0,,,Structural basis of G-protein target alternation of MgcRacGAP by phospholylation,,,0,,,,,,,,,,,,,
Q9H2X3_CLEC4M_wild_cl2,CLEC4M_1sl6A_FUC,Q9H2X3,,CLEC4M,wild,cl2,1sl6A,FUC,,1sl6,3,2,,0,,,Structural basis for distinct ligand-binding and targeting properties of the receptors  DC-SIGN and DC-SIGNR,,,0,,,,,,,,,,,,,
Q9H2X3_CLEC4M_wild_cl1,CLEC4M_1k9jA_MAN,Q9H2X3,,CLEC4M,wild,cl1,1k9jA,MAN,,1k9j,3,2,,0,,,Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.,,,0,,,,,,,,,,,,,
Q9H492_MAP1LC3A_wild_cl1,MAP1LC3A_7r9wA_JO4,Q9H492,,MAP1LC3A,wild,cl1,7r9wA,JO4,,7r9w,2,1,,0,,,A Multifaceted Hit-Finding Approach Reveals Novel LC3 Family Ligands.,,,0,,,,,,,,,,,,,
Q9H492_MAP1LC3A_wild_cl1,MAP1LC3A_6tbeA_NOV,Q9H492,,MAP1LC3A,wild,cl1,6tbeA,NOV,,6tbe,2,1,,0,,,Demonstrating Ligandability of the LC3A and LC3B Adapter Interface.,,,0,,,,,,,,,,,,,
Q9H4Y5_GSTO2_wild_cl1,GSTO2_3q19A_GSH,Q9H4Y5,,GSTO2,wild,cl1,3q19A,GSH,,3q19,3,1,,0,,,Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases.,,,0,,,,,,,,,,,,,
Q9H816_DCLRE1B_wild_cl1,DCLRE1B_7a1fA_D5M,Q9H816,,DCLRE1B,wild,cl1,7a1fA,D5M,,7a1f,3,1,,0,,,A phosphate binding pocket is a key determinant of exo- versus endo-nucleolytic activity in the SNM1 nuclease family.,,,0,,,,,,,,,,,,,
Q9HB21_PLEKHA1_wild_cl1,PLEKHA1_1eazA_CIT,Q9HB21,,PLEKHA1,wild,cl1,1eazA,CIT,,1eaz,3,1,,0,,,Crystal Structure of the Phosphatidylinositol 3_4-Bisphosphate-Binding Pleckstrin Homology (Ph) Domain of Tandem Ph-Domain-Containing Protein 1 (Tapp1): Molecular Basis of Lipid Specificity,,,0,,,,,,,,,,,,,
Q9HBH1_PDF_wild_cl1,PDF_3g5kA_BB2,Q9HBH1,,PDF,wild,cl1,3g5kA,BB2,,3g5k,3,1,,0,,,Structure and activity of human mitochondrial peptide deformylase_ a novel cancer target,,,0,,,,,,,,,,,,,
Q9NNX6_CD209_wild_cl1,CD209_2it6A_MAN,Q9NNX6,,CD209,wild,cl1,2it6A,MAN,,2it6,2,1,,0,,,Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins.,,,0,,,,,,,,,,,,,
Q9NNX6_CD209_wild_cl1,CD209_1sl5A_GAL,Q9NNX6,,CD209,wild,cl1,1sl5A,GAL,,1sl5,2,1,,0,,,Structural basis for distinct ligand-binding and targeting properties of the receptors  DC-SIGN and DC-SIGNR,,,0,,,,,,,,,,,,,
Q9NP87_POLM_wild_cl1,POLM_6aehA_UTP,Q9NP87,,POLM,wild,cl1,6aehA,UTP,,6aeh,1,1,,0,,,Human DNA Polymerase mu Can Use a Noncanonical Mechanism for Multiple Mn2+-Mediated Functions.,,,0,,,,,,,,,,,,,
Q9NP87_POLM_wild_cl1,POLM_7co9A_XG4,Q9NP87,,POLM,wild,cl1,7co9A,XG4,,7co9,1,1,,0,,,Mechanism of genome instability mediated by human DNA polymerase mu misincorporation.,,,0,,,,,,,,,,,,,
Q9NP99_TREM1_wild_cl1,TREM1_1q8mA_GSH,Q9NP99,,TREM1,wild,cl1,1q8mA,GSH,,1q8m,3,1,,0,,,Crystal structure of the human myeloid cell activating receptor TREM-1,,,0,,,,,,,,,,,,,
Q9NR30_DDX21_wild_cl1,DDX21_6l5mB_AMP,Q9NR30,,DDX21,wild,cl1,6l5mB,AMP,,6l5m,3,2,,0,,,Structural Basis of Human Helicase DDX21 in RNA Binding_ Unwinding_ and Antiviral Signal Activation.,,,0,,,,,,,,,,,,,
Q9NR30_DDX21_wild_cl1,DDX21_6l5oA_ADP,Q9NR30,,DDX21,wild,cl1,6l5oA,ADP,,6l5o,3,2,,0,,,Structural Basis of Human Helicase DDX21 in RNA Binding_ Unwinding_ and Antiviral Signal Activation.,,,0,,,,,,,,,,,,,
Q9NR30_DDX21_wild_cl2,DDX21_6l5nA_ANP,Q9NR30,,DDX21,wild,cl2,6l5nA,ANP,,6l5n,3,2,,0,,,Structural Basis of Human Helicase DDX21 in RNA Binding_ Unwinding_ and Antiviral Signal Activation.,,,0,,,,,,,,,,,,,
Q9NR30_DDX21_wild_cl2,DDX21_6l5nB_ANP,Q9NR30,,DDX21,wild,cl2,6l5nB,ANP,,6l5n,3,2,,0,,,Structural Basis of Human Helicase DDX21 in RNA Binding_ Unwinding_ and Antiviral Signal Activation.,,,0,,,,,,,,,,,,,
Q9NX74_DUS2_wild_cl1,DUS2_4wfsA_FMN,Q9NX74,,DUS2,wild,cl1,4wfsA,FMN,,4wfs,3,1,,0,,,An extended dsRBD is required for post-transcriptional modification in human tRNAs.,,,0,,,,,,,,,,,,,
Q9NX74_DUS2_wild_cl1,DUS2_4xp7A_FNR,Q9NX74,,DUS2,wild,cl1,4xp7A,FNR,,4xp7,3,1,,0,,,From bacterial to human dihydrouridine synthase: automated structure determination.,,,0,,,,,,,,,,,,,
Q9NZ45_CISD1_wild_cl1,CISD1_6de9A_FUN,Q9NZ45,,CISD1,wild,cl1,6de9A,FUN,,6de9,3,1,,0,,,Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand.,,,0,,,,,,,,,,,,,
Q9P2T1_GMPR2_wild_cl1,GMPR2_2c6qB_NDP,Q9P2T1,,GMPR2,wild,cl1,2c6qB,NDP,,2c6q,3,3,,0,,,Cofactor Mobility Determines Reaction Outcome in the Impdh and Gmpr (Beta-Alpha)(8) Barrel Enzymes.,,,0,,,,,,,,,,,,,
Q9P2T1_GMPR2_wild_cl1,GMPR2_2c6qA_NDP,Q9P2T1,,GMPR2,wild,cl1,2c6qA,NDP,,2c6q,3,3,,0,,,Cofactor Mobility Determines Reaction Outcome in the Impdh and Gmpr (Beta-Alpha)(8) Barrel Enzymes.,,,0,,,,,,,,,,,,,
Q9P2T1_GMPR2_wild_cl2,GMPR2_2bznA_IMP,Q9P2T1,,GMPR2,wild,cl2,2bznA,IMP,,2bzn,3,3,,0,,,Cofactor Mobility Determines Reaction Outcome in the Impdh and Gmpr (Beta-Alpha)(8) Barrel Enzymes.,,,0,,,,,,,,,,,,,
Q9P2T1_GMPR2_wild_cl3,GMPR2_2c6qA_NDP,Q9P2T1,,GMPR2,wild,cl3,2c6qA,NDP,,2c6q,3,3,,0,,,Cofactor Mobility Determines Reaction Outcome in the Impdh and Gmpr (Beta-Alpha)(8) Barrel Enzymes.,,,0,,,,,,,,,,,,,
Q9P2T1_GMPR2_wild_cl2,GMPR2_2a7rA_5GP,Q9P2T1,,GMPR2,wild,cl2,2a7rA,5GP,,2a7r,3,3,,0,,,Crystal Structure of Human Guanosine Monophosphate Reductase 2 (GMPR2) in Complex with GMP,,,0,,,,,,,,,,,,,
Q9UBT6_POLK_wild_cl1,POLK_6cstA_DZ4,Q9UBT6,,POLK,wild,cl1,6cstA,DZ4,,6cst,1,1,,0,,,2.0 angstrom resolution crystal structure of human pol kappa reveals a new catalytic function of N-clasp in DNA replication.,,,0,,,,,,,,,,,,,
Q9UBT6_POLK_wild_cl1,POLK_4u7cA_0KX,Q9UBT6,,POLK,wild,cl1,4u7cA,0KX,,4u7c,1,1,,0,,,Structure and mechanism of error-free replication past the major benzo[a]pyrene adduct by human DNA polymerase kappa.,,,0,,,,,,,,,,,,,
Q9UBZ9_REV1_wild_cl1,REV1_3gqcA_DCP,Q9UBZ9,,REV1,wild,cl1,3gqcA,DCP,,3gqc,3,1,,0,,,Structure of the human Rev1-DNA-dNTP ternary complex.,,,0,,,,,,,,,,,,,
Q9UGP5_POLL_wild_cl1,POLL_4xusA_TTP,Q9UGP5,,POLL,wild,cl1,4xusA,TTP,,4xus,1,1,,0,,,Nucleotide binding interactions modulate dNTP selectivity and facilitate 8-oxo-dGTP incorporation by DNA polymerase lambda.,,,0,,,,,,,,,,,,,
Q9UGP5_POLL_wild_cl1,POLL_5ddyG_DCP,Q9UGP5,,POLL,wild,cl1,5ddyG,DCP,,5ddy,1,1,,0,,,Structural Mechanism for the Fidelity Modulation of DNA Polymerase lambda,,,0,,,,,,,,,,,,,
Q9UH17_APOBEC3B_wild_cl2,APOBEC3B_5cqhA_DC,Q9UH17,,APOBEC3B,wild,cl2,5cqhA,DC,,5cqh,3,2,,0,,,Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.,,,0,,,,,,,,,,,,,
Q9UJ71_CD207_wild_cl1,CD207_4n32D_2F8,Q9UJ71,,CD207,wild,cl1,4n32D,2F8,,4n32,3,3,,0,,,Common polymorphisms in human langerin change specificity for glycan ligands.,,,0,,,,,,,,,,,,,
Q9UJ71_CD207_wild_cl1,CD207_4n35C_NAG,Q9UJ71,,CD207,wild,cl1,4n35C,NAG,,4n35,3,3,,0,,,Common polymorphisms in human langerin change specificity for glycan ligands.,,,0,,,,,,,,,,,,,
Q9UJ71_CD207_wild_cl2,CD207_5g6uB_TRP,Q9UJ71,,CD207,wild,cl2,5g6uB,TRP,,5g6u,3,3,,0,,,Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.,,,0,,,,,,,,,,,,,
Q9UJ71_CD207_wild_cl2,CD207_5g6uC_TRP,Q9UJ71,,CD207,wild,cl2,5g6uC,TRP,,5g6u,3,3,,0,,,Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.,,,0,,,,,,,,,,,,,
Q9UJ71_CD207_wild_cl3,CD207_5g6uA_TRP,Q9UJ71,,CD207,wild,cl3,5g6uA,TRP,,5g6u,3,3,,0,,,Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.,,,0,,,,,,,,,,,,,
Q9UKL6_PCTP_wild_cl1,PCTP_1ln3B_CPL,Q9UKL6,,PCTP,wild,cl1,1ln3B,CPL,,1ln3,3,1,,0,,,Structure of human phosphatidylcholine transfer protein in complex with its ligand.,,,0,,,,,,,,,,,,,
Q9UKL6_PCTP_wild_cl1,PCTP_1ln2B_DLP,Q9UKL6,,PCTP,wild,cl1,1ln2B,DLP,,1ln2,3,1,,0,,,Structure of human phosphatidylcholine transfer protein in complex with its ligand.,,,0,,,,,,,,,,,,,
Q9UKV8_AGO2_wild_cl1,AGO2_3ludA_AMP,Q9UKV8,,AGO2,wild,cl1,3ludA,AMP,,3lud,3,1,,0,,,Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2.,,,0,,,,,,,,,,,,,
Q9UKV8_AGO2_wild_cl1,AGO2_3ludB_AMP,Q9UKV8,,AGO2,wild,cl1,3ludB,AMP,,3lud,3,1,,0,,,Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2.,,,0,,,,,,,,,,,,,
Q9ULY5_CLEC4E_wild_cl1,CLEC4E_3wh2A_FLC,Q9ULY5,,CLEC4E,wild,cl1,3wh2A,FLC,,3wh2,3,1,,0,,,Structural analysis for glycolipid recognition by the C-type lectins Mincle and MCL,,,0,,,,,,,,,,,,,
Q9UM07_PADI4_wild_cl1,PADI4_1wdaA_BAG,Q9UM07,,PADI4,wild,cl1,1wdaA,BAG,,1wda,2,1,,0,,,Structural basis for Ca(2+)-induced activation of human PAD4,,,0,,,,,,,,,,,,,
Q9UNA0_ADAMTS5_wild_cl1,ADAMTS5_3b8zA_294,Q9UNA0,,ADAMTS5,wild,cl1,3b8zA,294,,3b8z,2,1,,0,,,High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2).,,,0,,,,,,,,,,,,,
Q9UNA0_ADAMTS5_wild_cl1,ADAMTS5_3ljtA_LA3,Q9UNA0,,ADAMTS5,wild,cl1,3ljtA,LA3,,3ljt,2,1,,0,,,Structure analysis reveals the flexibility of the ADAMTS-5 active site.,,,0,,,,,,,,,,,,,
Q9UNA4_POLI_wild_cl1,POLI_3ngdA_DCP,Q9UNA4,,POLI,wild,cl1,3ngdA,DCP,,3ngd,3,1,,0,,,Structural Basis for Proficient Incorporation of dTTP Opposite O6-Methylguanine by Human DNA Polymerase {iota}.,,,0,,,,,,,,,,,,,
Q9UNA4_POLI_wild_cl1,POLI_3q8pB_DCP,Q9UNA4,,POLI,wild,cl1,3q8pB,DCP,,3q8p,3,1,,0,,,Unique active site promotes error-free replication opposite an 8-oxo-guanine lesion by human DNA polymerase iota.,,,0,,,,,,,,,,,,,
Q9Y230_RUVBL2_wild_cl2,RUVBL2_5oafB_ADP,Q9Y230,,RUVBL2,wild,cl2,5oafB,ADP,,5oaf,3,2,,0,,,Cryo-EM structures of the human INO80 chromatin-remodeling complex.,,,0,,,,,,,,,,,,,
Q9Y230_RUVBL2_wild_cl2,RUVBL2_5oafD_ADP,Q9Y230,,RUVBL2,wild,cl2,5oafD,ADP,,5oaf,3,2,,0,,,Cryo-EM structures of the human INO80 chromatin-remodeling complex.,,,0,,,,,,,,,,,,,
Q9Y230_RUVBL2_wild_cl1,RUVBL2_3uk6A_ADP,Q9Y230,,RUVBL2,wild,cl1,3uk6A,ADP,,3uk6,3,2,,0,,,Large-Scale Conformational Flexibility Determines the Properties of AAA+ TIP49 ATPases.,,,0,,,,,,,,,,,,,
Q9Y230_RUVBL2_wild_cl1,RUVBL2_3uk6E_ADP,Q9Y230,,RUVBL2,wild,cl1,3uk6E,ADP,,3uk6,3,2,,0,,,Large-Scale Conformational Flexibility Determines the Properties of AAA+ TIP49 ATPases.,,,0,,,,,,,,,,,,,
Q9Y253_POLH_wild_cl1,POLH_4j9kA_XG4,Q9Y253,,POLH,wild,cl1,4j9kA,XG4,,4j9k,1,1,,0,,,Mechanism of somatic hypermutation at the WA motif by human DNA polymerase eta.,,,0,,,,,,,,,,,,,
Q9Y253_POLH_wild_cl1,POLH_4yp3A_DCP,Q9Y253,,POLH,wild,cl1,4yp3A,DCP,,4yp3,1,1,,0,,,Roles of Residues Arg-61 and Gln-38 of Human DNA Polymerase eta in Bypass of Deoxyguanosine and 7_8-Dihydro-8-oxo-2'-deoxyguanosine.,,,0,,,,,,,,,,,,,
Q9Y265_RUVBL1_wild_cl1,RUVBL1_7p6xC_ADP,Q9Y265,,RUVBL1,wild,cl1,7p6xC,ADP,,7p6x,3,1,,0,,,Cryo-Em structure of the hexameric RUVBL1-RUVBL2 in complex with ZNHIT2,,,0,,,,,,,,,,,,,
Q9Y265_RUVBL1_wild_cl1,RUVBL1_6qi9B_ADP,Q9Y265,,RUVBL1,wild,cl1,6qi9B,ADP,,6qi9,3,1,,0,,,Structural mechanism for regulation of the AAA-ATPases RUVBL1-RUVBL2 in the R2TP co-chaperone revealed by cryo-EM.,,,0,,,,,,,,,,,,,
Q9Y286_SIGLEC7_wild_cl2,SIGLEC7_1o7sA_CYS,Q9Y286,,SIGLEC7,wild,cl2,1o7sA,CYS,,1o7s,3,3,,0,,,High Resolution Structures of Siglec-7 - Insights Into Ligand Specificity in the Siglec Family,,,0,,,,,,,,,,,,,
Q9Y286_SIGLEC7_wild_cl1,SIGLEC7_2hrlA_CEQ,Q9Y286,,SIGLEC7,wild,cl1,2hrlA,CEQ,,2hrl,3,3,,0,,,Siglec-7 Undergoes a Major Conformational Change When Complexed with the {alpha}(2_8)-Disialylganglioside GT1b,,,0,,,,,,,,,,,,,
Q9Y2Q3_GSTK1_wild_cl1,GSTK1_1yzxA_GSF,Q9Y2Q3,,GSTK1,wild,cl1,1yzxA,GSF,,1yzx,3,1,,0,,,Thioredoxin-like domain of human kappa class glutathione transferase reveals sequence homology and structure similarity to the theta class enzyme,,,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl1,SAMHD1_4bzbA_DGT,Q9Y3Z3,,SAMHD1,wild,cl1,4bzbA,DGT,,4bzb,3,5,,0,,,Mechanism of Allosteric Activation of Samhd1 by Dgtp,,allosteric,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl3,SAMHD1_4bzbA_DGT,Q9Y3Z3,,SAMHD1,wild,cl3,4bzbA,DGT,,4bzb,3,5,,0,,,Mechanism of Allosteric Activation of Samhd1 by Dgtp,,allosteric,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl4,SAMHD1_4bzbA_DGT,Q9Y3Z3,,SAMHD1,wild,cl4,4bzbA,DGT,,4bzb,3,5,,0,,,Mechanism of Allosteric Activation of Samhd1 by Dgtp,,allosteric,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl5,SAMHD1_6dwdA_TCE,Q9Y3Z3,,SAMHD1,wild,cl5,6dwdA,TCE,,6dwd,3,5,,0,,,The structural basis for cancer drug interactions with the catalytic and Allosteric sites of SAMHD1.,,allosteric,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl1,SAMHD1_4zwgA_DTP,Q9Y3Z3,,SAMHD1,wild,cl1,4zwgA,DTP,,4zwg,3,5,,0,,,Impaired dNTPase Activity of SAMHD1 by Phosphomimetic Mutation of Thr-592.,,,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl2,SAMHD1_5ao4C_GTP,Q9Y3Z3,,SAMHD1,wild,cl2,5ao4C,GTP,,5ao4,3,5,,0,,,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,,,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl2,SAMHD1_5ao2C_DGT,Q9Y3Z3,,SAMHD1,wild,cl2,5ao2C,DGT,,5ao2,3,5,,0,,,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,,,0,,,,,,,,,,,,,
Q9Y3Z3_SAMHD1_wild_cl3,SAMHD1_5ao0B_DG3,Q9Y3Z3,,SAMHD1,wild,cl3,5ao0B,DG3,,5ao0,3,5,,0,,,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,,,0,,,,,,,,,,,,,
Q9Y530_OARD1_wild_cl1,OARD1_4j5sA_ZZC,Q9Y530,,OARD1,wild,cl1,4j5sA,ZZC,,4j5s,3,1,,0,,,Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.,,,0,,,,,,,,,,,,,
Q9Y530_OARD1_wild_cl1,OARD1_4j5sB_ZZC,Q9Y530,,OARD1,wild,cl1,4j5sB,ZZC,,4j5s,3,1,,0,,,Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.,,,0,,,,,,,,,,,,,
Q9Y5P4_CERT1_wild_cl1,CERT1_2e3pB_16C,Q9Y5P4,,CERT1,wild,cl1,2e3pB,16C,,2e3p,1,1,,0,,,Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide.,,,0,,,,,,,,,,,,,
Q9Y657_SPIN1_wild_cl1,SPIN1_6i8yA_2OD,Q9Y657,,SPIN1,wild,cl1,6i8yA,2OD,,6i8y,2,1,,0,,,A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.,,,0,,,,,,,,,,,,,
Q9Y6N5_SQOR_wild_cl1,SQOR_6mp5C_FAD,Q9Y6N5,,SQOR,wild,cl1,6mp5C,FAD,,6mp5,3,1,,0,,,X-Ray Structure of Human Sulfide:Quinone Oxidoreductase: Insights into the Mechanism of Mitochondrial Hydrogen Sulfide Oxidation.,,,0,,,,,,,,,,,,,
Q9Y6N5_SQOR_wild_cl1,SQOR_6mo6B_FAD,Q9Y6N5,,SQOR,wild,cl1,6mo6B,FAD,,6mo6,3,1,,0,,,X-Ray Structure of Human Sulfide:Quinone Oxidoreductase: Insights into the Mechanism of Mitochondrial Hydrogen Sulfide Oxidation.,,,0,,,,,,,,,,,,,
Q9Y6Y9_LY96_wild_cl1,LY96_4g8aC_LP4,Q9Y6Y9,,LY96,wild,cl1,4g8aC,LP4,,4g8a,3,2,,0,,,Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I,,,0,,,,,,,,,,,,,
Q9Y6Y9_LY96_wild_cl2,LY96_2e56A_NAG,Q9Y6Y9,,LY96,wild,cl2,2e56A,NAG,,2.00E+56,3,2,,0,,,Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.,,,0,,,,,,,,,,,,,
Q9GZZ1_NAA50_wild_cl1,NAA50_6wfoA_ACO,Q9GZZ1,,NAA50,wild,cl1,6wfoA,ACO,,6wfo,1,2,,Acetylase,,,Characterization of SpecificN-alpha-Acetyltransferase 50 (Naa50) inhibitors Identified Using a DNA Encoded Library.,inhibitor,,0,,,,,,,,,,,,,
Q9GZZ1_NAA50_wild_cl2,NAA50_6wfgA_U3V,Q9GZZ1,,NAA50,wild,cl2,6wfgA,U3V,,6wfg,1,2,,Acetylase,,,Characterization of SpecificN-alpha-Acetyltransferase 50 (Naa50) inhibitors Identified Using a DNA Encoded Library.,inhibitor,,0,,,,,,,,,,,,,
Q9GZZ1_NAA50_wild_cl2,NAA50_6wfoC_U3Y,Q9GZZ1,,NAA50,wild,cl2,6wfoC,U3Y,,6wfo,1,2,,Acetylase,,,Characterization of SpecificN-alpha-Acetyltransferase 50 (Naa50) inhibitors Identified Using a DNA Encoded Library.,inhibitor,,0,,,,,,,,,,,,,
P11245_NAT2_wild_cl1,NAT2_2pfrA_COA,P11245,,NAT2,wild,cl1,2pfrA,COA,,2pfr,3,1,,Acetylase,,,The Crystal Structure of Human N-acetyltransferase 2 in complex with CoA,,,0,,,,,,,,,,,,,
P21673_SAT1_wild_cl1,SAT1_2jevA_NHQ,P21673,,SAT1,wild,cl1,2jevA,NHQ,,2jev,3,3,,Acetylase,,,Mechanistic and Structural Analysis of Human Spermidine/Spermine N(1)-Acetyltransferase.,,,0,,,,,,,,,,,,,
P21673_SAT1_wild_cl2,SAT1_2jevA_NHQ,P21673,,SAT1,wild,cl2,2jevA,NHQ,,2jev,3,3,,Acetylase,,,Mechanistic and Structural Analysis of Human Spermidine/Spermine N(1)-Acetyltransferase.,,,0,,,,,,,,,,,,,
P21673_SAT1_wild_cl1,SAT1_2b4bB_COA,P21673,,SAT1,wild,cl1,2b4bB,COA,,2b4b,3,3,,Acetylase,,,Structures of wild-type and mutant human spermidine/spermine N1-acetyltransferase_ a potential therapeutic drug target,,,0,,,,,,,,,,,,,
P21673_SAT1_wild_cl3,SAT1_2b4bB_B33,P21673,,SAT1,wild,cl3,2b4bB,B33,,2b4b,3,3,,Acetylase,,,Structures of wild-type and mutant human spermidine/spermine N1-acetyltransferase_ a potential therapeutic drug target,,,0,,,,,,,,,,,,,
P21673_SAT1_wild_cl4,SAT1_2b4bA_B33,P21673,,SAT1,wild,cl4,2b4bA,B33,,2b4b,3,3,,Acetylase,,,Structures of wild-type and mutant human spermidine/spermine N1-acetyltransferase_ a potential therapeutic drug target,,,0,,,,,,,,,,,,,
P28329_CHAT_wild_cl1,CHAT_2fy4A_COA,P28329,,CHAT,wild,cl1,2fy4A,COA,,2fy4,3,2,,Acetylase,,,Substrate binding and catalytic mechanism of human choline acetyltransferase.,,,0,,,,,,,,,,,,,
P28329_CHAT_wild_cl1,CHAT_2fy5A_SOP,P28329,,CHAT,wild,cl1,2fy5A,SOP,,2fy5,3,2,,Acetylase,,,Substrate binding and catalytic mechanism of human choline acetyltransferase.,,,0,,,,,,,,,,,,,
P28329_CHAT_wild_cl2,CHAT_2fy3A_CHT,P28329,,CHAT,wild,cl2,2fy3A,CHT,,2fy3,3,2,,Acetylase,,,Substrate binding and catalytic mechanism of human choline acetyltransferase.,,,0,,,,,,,,,,,,,
P41227_NAA10_wild_cl1,NAA10_6pw9C_IHP,P41227,,NAA10,wild,cl1,6pw9C,IHP,,6pw9,3,2,,Acetylase,,,Molecular basis for N-terminal acetylation by human NatE and its modulation by HYPK.,,,0,,,,,,,,,,,,,
P41227_NAA10_wild_cl2,NAA10_6pw9C_ACO,P41227,,NAA10,wild,cl2,6pw9C,ACO,,6pw9,3,2,,Acetylase,,,Molecular basis for N-terminal acetylation by human NatE and its modulation by HYPK.,,,0,,,,,,,,,,,,,
P41227_NAA10_wild_cl1,NAA10_6c9mD_IHP,P41227,,NAA10,wild,cl1,6c9mD,IHP,,6c9m,3,2,,Acetylase,,,Structure of Human NatA and Its Regulation by the Huntingtin Interacting Protein HYPK.,,,0,,,,,,,,,,,,,
P43155_CRAT_wild_cl1,CRAT_1s5oA_152,P43155,,CRAT,wild,cl1,1s5oA,152,,1s5o,3,1,,Acetylase,,,Structural and mutational characterization of l-carnitine binding to human carnitine acetyltransferase.,,,0,,,,,,,,,,,,,
Q86UY6_NAA40_wild_cl1,NAA40_4u9wD_COA,Q86UY6,,NAA40,wild,cl1,4u9wD,COA,,4u9w,3,1,,Acetylase,,,The Molecular Basis for Histone H4- and H2A-Specific Amino-Terminal Acetylation by NatD.,,,0,,,,,,,,,,,,,
Q86UY6_NAA40_wild_cl1,NAA40_4u9wA_COA,Q86UY6,,NAA40,wild,cl1,4u9wA,COA,,4u9w,3,1,,Acetylase,,,The Molecular Basis for Histone H4- and H2A-Specific Amino-Terminal Acetylation by NatD.,,,0,,,,,,,,,,,,,
Q96F10_SAT2_wild_cl1,SAT2_2q4vA_ACO,Q96F10,,SAT2,wild,cl1,2q4vA,ACO,,2q4v,3,1,,Acetylase,,,Ensemble refinement of protein crystal structures: validation and application.,,,0,,,,,,,,,,,,,
Q9GZZ1_NAA50_wild_cl1,NAA50_4x5kA_COA,Q9GZZ1,,NAA50,wild,cl1,4x5kA,COA,,4x5k,1,2,,Acetylase,,,Human NAA50 with coenzymeA and a peptide,,,0,,,,,,,,,,,,,
Q9H7X0_NAA60_wild_cl1,NAA60_5icwA_COA,Q9H7X0,,NAA60,wild,cl1,5icwA,COA,,5icw,3,1,,Acetylase,,,Crystal Structure of the Golgi-Associated Human N alpha-Acetyltransferase 60 Reveals the Molecular Determinants for Substrate-Specific Acetylation.,,,0,,,,,,,,,,,,,
P23526_AHCY_wild_cl2,AHCY_4yvfA_NAI,P23526,,AHCY,wild,cl2,4yvfA,NAI,,4yvf,1,3,,Adenosylhomocysteinase ,,,Discovery and structural analyses of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.,inhibitor,,0,,,,,,,,,,,,,
P23526_AHCY_wild_cl1,AHCY_5w4bA_9W4,P23526,,AHCY,wild,cl1,5w4bA,9W4,,5w4b,1,3,,Adenosylhomocysteinase ,,,Identification of AHCY inhibitors using novel high-throughput mass spectrometry.,inhibitor,,0,,,,,,,,,,,,,
P23526_AHCY_wild_cl1,AHCY_5w4bB_9W4,P23526,,AHCY,wild,cl1,5w4bB,9W4,,5w4b,1,3,,Adenosylhomocysteinase ,,,Identification of AHCY inhibitors using novel high-throughput mass spectrometry.,inhibitor,,0,,,,,,,,,,,,,
P23526_AHCY_wild_cl2,AHCY_5w49A_NAD,P23526,,AHCY,wild,cl2,5w49A,NAD,,5w49,1,3,,Adenosylhomocysteinase ,,,Identification of AHCY inhibitors using novel high-throughput mass spectrometry.,inhibitor,,0,,,,,,,,,,,,,
O43865_AHCYL1_wild_cl1,AHCYL1_3mtgA_NAD,O43865,,AHCYL1,wild,cl1,3mtgA,NAD,,3mtg,3,1,,Adenosylhomocysteinase ,,,Crystal structure of human S-adenosyl homocysteine hydrolase-like 1 protein,,,0,,,,,,,,,,,,,
O43865_AHCYL1_wild_cl1,AHCYL1_3mtgB_NAD,O43865,,AHCYL1,wild,cl1,3mtgB,NAD,,3mtg,3,1,,Adenosylhomocysteinase ,,,Crystal structure of human S-adenosyl homocysteine hydrolase-like 1 protein,,,0,,,,,,,,,,,,,
P23526_AHCY_wild_cl3,AHCY_1a7aA_NAD,P23526,,AHCY,wild,cl3,1a7aA,NAD,,1a7a,1,3,,Adenosylhomocysteinase ,,,Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength.,,,0,,,,,,,,,,,,,
O43570_CA12_wild_cl2,CA12_4ht2D_PEG,O43570,,CA12,wild,cl2,4ht2D,PEG,,4ht2,1,4,,anhydrase,,,4-Substituted-2_3_5_6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I_ II_ VII_ XII_ and XIII.,inhibitor,,0,,,,,,,,,,,,,
O43570_CA12_wild_cl3,CA12_5msbB_PEG,O43570,,CA12,wild,cl3,5msbB,PEG,,5msb,1,4,,anhydrase,,,Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding.,inhibitor,,0,,,,,,,,,,,,,
O43570_CA12_wild_cl1,CA12_6g7aA_EOQ,O43570,,CA12,wild,cl1,6g7aA,EOQ,,6g7a,1,4,,anhydrase,,,Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.,inhibitor,,0,,,,,,,,,,,,,
O43570_CA12_wild_cl4,CA12_6g5lD_PEG,O43570,,CA12,wild,cl4,6g5lD,PEG,,6g5l,1,4,,anhydrase,,,Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.,inhibitor,,0,,,,,,,,,,,,,
O43570_CA12_wild_cl1,CA12_4q0lB_V14,O43570,,CA12,wild,cl1,4q0lB,V14,,4q0l,1,4,,anhydrase,,,Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.,inhibitor,,0,,,,,,,,,,,,,
P22748_CA4_wild_cl1,CA4_3f7uD_AG4,P22748,,CA4,wild,cl1,3f7uD,AG4,,3f7u,3,2,,anhydrase,,,Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design_ synthesis_ and biological evaluation.,inhibitor,,0,,,,,,,,,,,,,
P22748_CA4_wild_cl1,CA4_3fw3A_ETS,P22748,,CA4,wild,cl1,3fw3A,ETS,,3fw3,3,2,,anhydrase,,,Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design_ synthesis_ and biological evaluation.,inhibitor,,0,,,,,,,,,,,,,
P22748_CA4_wild_cl2,CA4_3fw3A_GLC,P22748,,CA4,wild,cl2,3fw3A,GLC,,3fw3,3,2,,anhydrase,,,Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design_ synthesis_ and biological evaluation.,inhibitor,,0,,,,,,,,,,,,,
P43166_CA7_wild_cl1,CA7_6h38A_FKK,P43166,,CA7,wild,cl1,6h38A,FKK,,6h38,3,1,,anhydrase,,,Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety.,inhibitor,,0,,,,,,,,,,,,,
Q8N1Q1_CA13_wild_cl3,CA13_4hu1A_PEG,Q8N1Q1,,CA13,wild,cl3,4hu1A,PEG,,4hu1,1,4,,anhydrase,,,4-Substituted-2_3_5_6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I_ II_ VII_ XII_ and XIII.,inhibitor,,0,,,,,,,,,,,,,
Q8N1Q1_CA13_wild_cl1,CA13_5llaA_6YQ,Q8N1Q1,,CA13,wild,cl1,5llaA,6YQ,,5lla,1,4,,anhydrase,,,Combinatorial Design of Isoform-Selective N-Alkylated Benzimidazole-Based inhibitors of Carbonic Anhydrases,inhibitor,,0,,,,,,,,,,,,,
Q8N1Q1_CA13_wild_cl1,CA13_4qjpB_V1F,Q8N1Q1,,CA13,wild,cl1,4qjpB,V1F,,4qjp,1,4,,anhydrase,,,Functionalization of Fluorinated Benzenesulfonamides and Their inhibitory Properties toward Carbonic Anhydrases,inhibitor,,0,,,,,,,,,,,,,
Q9ULX7_CA14_wild_cl1,CA14_5cjfA_520,Q9ULX7,,CA14,wild,cl1,5cjfA,520,,5cjf,3,1,,anhydrase,,,Discovery of 1_1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P43166_CA7_wild_cl1,CA7_3mdzA_EZL,P43166,,CA7,wild,cl1,3mdzA,EZL,,3mdz,3,1,,anhydrase,,,Crystal Structure of Human Carbonic Anhydrase VII [isoform 1]_ CA7,,,0,,,,,,,,,,,,,
Q8N1Q1_CA13_wild_cl4,CA13_5ohhB_PEG,Q8N1Q1,,CA13,wild,cl4,5ohhB,PEG,,5ohh,1,4,,anhydrase,,,Crystal structure of human carbonic anhydrase isozyme XIII with 2-[(1S)-2_3-Dihydro-1H-inden-1-ylamino]-3_5_6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide,,,0,,,,,,,,,,,,,
Q8N1Q1_CA13_wild_cl2,CA13_5e2nA_PEG,Q8N1Q1,,CA13,wild,cl2,5e2nA,PEG,,5e2n,1,4,,anhydrase,,,Intrinsic Thermodynamics and Structures of 2_4- and 3_4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases.,,,0,,,,,,,,,,,,,
Q12756_KIF1A_wild_cl1,KIF1A_4uxpC_ANP,Q12756,,KIF1A,wild,cl1,4uxpC,ANP,,4uxp,3,1,,ATPase,,,Conserved Mechanisms of Microtubule-stimulated Adp Release_ ATP Binding_ and Force Generation in Transport Kinesins.,agonist,,0,,,,,,,,,,,,,
Q12840_KIF5A_wild_cl1,KIF5A_4uy0C_ADP,Q12840,,KIF5A,wild,cl1,4uy0C,ADP,,4uy0,3,1,,ATPase,,,Conserved Mechanisms of Microtubule-stimulated Adp Release_ ATP Binding_ and Force Generation in Transport Kinesins.,agonist,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl1,KIF11_6g6zA_EOK,P52732,,KIF11,wild,cl1,6g6zA,EOK,,6g6z,1,3,,ATPase,,,Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl1,KIF11_1yrsA_L47,P52732,,KIF11,wild,cl1,1yrsA,L47,,1yrs,1,3,,ATPase,,,Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3_5-diaryl-4_5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP,inhibitor,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl2,KIF11_2q2yB_ADP,P52732,,KIF11,wild,cl2,2q2yB,ADP,,2q2y,1,3,,ATPase,,,Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1_4-diaryl-4_5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.,inhibitor,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl3,KIF11_3zcwA_4A2,P52732,,KIF11,wild,cl3,3zcwA,4A2,,3zcw,1,3,,ATPase,,,Structural Insights Into a Unique inhibitor Binding Pocket in Kinesin Spindle Protein.,inhibitor,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl3,KIF11_6ta3K_MZK,P52732,,KIF11,wild,cl3,6ta3K,MZK,,6ta3,1,3,,ATPase,,,Structure of Microtubule-Trapped Human Kinesin-5 and Its Mechanism of inhibition Revealed Using Cryoelectron Microscopy.,inhibitor,,0,,,,,,,,,,,,,
P52732_KIF11_wild_cl2,KIF11_4a51A_ADP,P52732,,KIF11,wild,cl2,4a51A,ADP,,4a51,1,3,,ATPase,,,Triphenylbutanamines: Kinesin Spindle Protein inhibitors with in Vivo Antitumor Activity.,inhibitor,,0,,,,,,,,,,,,,
Q9BVG8_KIFC3_wild_cl1,KIFC3_2h58A_ADP,Q9BVG8,,KIFC3,wild,cl1,2h58A,ADP,,2h58,3,1,5WDE,ATPase,,,Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein,inhibitor,,0,,,,,,,,,,,,,
Q9BW19_KIFC1_wild_cl1,KIFC1_2repA_ADP,Q9BW19,,KIFC1,wild,cl1,2repA,ADP,,2rep,3,1,5WDH,ATPase,,,Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein.,inhibitor,,0,,,,,,,,,,,,,
Q9NS87_KIF15_wild_cl1,KIF15_6zphB_ADP,Q9NS87,,KIF15,wild,cl1,6zphB,ADP,,6zph,3,1,,ATPase,,,The mechanism of kinesin inhibition by kinesin-binding protein.,inhibitor,,0,,,,,,,,,,,,,
O14782_KIF3C_wild_cl1,KIF3C_3b6vA_ADP,O14782,,KIF3C,wild,cl1,3b6vA,ADP,,3b6v,3,1,,ATPase,,,Motor domain of human kinesin family member 3C in complex with ADP.,,,0,,,,,,,,,,,,,
O15066_KIF3B_wild_cl1,KIF3B_3b6uB_ADP,O15066,,KIF3B,wild,cl1,3b6uB,ADP,,3b6u,3,1,,ATPase,,,Motor domain of human kinesin family member 3B in complex with ADP.,,,0,,,,,,,,,,,,,
O75449_KATNA1_wild_cl1,KATNA1_5zqmA_AGS,O75449,,KATNA1,wild,cl1,5zqmA,AGS,,5zqm,3,1,,ATPase,,,Structural and Molecular Basis for Katanin-Mediated Severing of Glutamylated Microtubules.,,,0,,,,,,,,,,,,,
P21281_ATP6V1B2_wild_cl1,ATP6V1B2_6wlzF_ADP,P21281,,ATP6V1B2,wild,cl1,6wlzF,ADP,,6wlz,3,1,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
P38606_ATP6V1A_wild_cl1,ATP6V1A_6wlzC_ADP,P38606,,ATP6V1A,wild,cl1,6wlzC,ADP,,6wlz,3,1,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
P38606_ATP6V1A_wild_cl1,ATP6V1A_6wm4A_ADP,P38606,,ATP6V1A,wild,cl1,6wm4A,ADP,,6wm4,3,1,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
P43686_PSMC4_wild_cl1,PSMC4_5m32e_ADP,P43686,,PSMC4,wild,cl1,5m32e,ADP,,5m32,3,1,,ATPase,,,Long-range Allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs.,,allosteric,0,,,,,,,,,,,,,
P43686_PSMC4_wild_cl1,PSMC4_5t0gD_ATP,P43686,,PSMC4,wild,cl1,5t0gD,ATP,,5t0g,3,1,,ATPase,,,Structural basis for dynamic regulation of the human 26S proteasome.,,,0,,,,,,,,,,,,,
Q02224_CENPE_wild_cl1,CENPE_1t5cA_PIN,Q02224,,CENPE,wild,cl1,1t5cA,PIN,,1t5c,3,1,,ATPase,,,Crystal structure of the motor domain of the human kinetochore protein CENP-E.,,,0,,,,,,,,,,,,,
Q14807_KIF22_wild_cl1,KIF22_6njeA_ADP,Q14807,,KIF22,wild,cl1,6njeA,ADP,,6nje,3,1,,ATPase,,,Crystal structure of the motor domain of human kinesin family member 22,,,0,,,,,,,,,,,,,
Q15904_ATP6AP1_wild_cl1,ATP6AP1_6wlwU_WSS,Q15904,,ATP6AP1,wild,cl1,6wlwU,WSS,,6wlw,3,3,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
Q15904_ATP6AP1_wild_cl1,ATP6AP1_6wm2U_WSS,Q15904,,ATP6AP1,wild,cl1,6wm2U,WSS,,6wm2,3,3,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
Q15904_ATP6AP1_wild_cl2,ATP6AP1_6wlwU_WSS,Q15904,,ATP6AP1,wild,cl2,6wlwU,WSS,,6wlw,3,3,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
Q15904_ATP6AP1_wild_cl3,ATP6AP1_6wlwU_WSS,Q15904,,ATP6AP1,wild,cl3,6wlwU,WSS,,6wlw,3,3,,ATPase,,,Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.,,,0,,,,,,,,,,,,,
Q2M1P5_KIF7_wild_cl1,KIF7_6mlqC_ADP,Q2M1P5,,KIF7,wild,cl1,6mlqC,ADP,,6mlq,3,1,,ATPase,,,Interplay between the Kinesin and Tubulin Mechanochemical Cycles Underlies Microtubule Tip Tracking by the Non-motile Ciliary Kinesin Kif7.,,,0,,,,,,,,,,,,,
Q2M1P5_KIF7_wild_cl1,KIF7_6mlrC_ANP,Q2M1P5,,KIF7,wild,cl1,6mlrC,ANP,,6mlr,3,1,,ATPase,,,Interplay between the Kinesin and Tubulin Mechanochemical Cycles Underlies Microtubule Tip Tracking by the Non-motile Ciliary Kinesin Kif7.,,,0,,,,,,,,,,,,,
Q8NI77_KIF18A_wild_cl1,KIF18A_3lreB_ADP,Q8NI77,,KIF18A,wild,cl1,3lreB,ADP,,3lre,3,1,,ATPase,,,Insight into the molecular mechanism of the multitasking kinesin-8 motor.,,,0,,,,,,,,,,,,,
Q8NI77_KIF18A_wild_cl1,KIF18A_7rsiC_ADP,Q8NI77,,KIF18A,wild,cl1,7rsiC,ADP,,7rsi,3,1,,ATPase,,,Kinesin-binding protein remodels the kinesin motor to prevent microtubule binding.,,,0,,,,,,,,,,,,,
Q99661_KIF2C_wild_cl1,KIF2C_5mioC_ANP,Q99661,,KIF2C,wild,cl1,5mioC,ANP,,5mio,3,1,,ATPase,,,Insight into microtubule disassembly by kinesin-13s from the structure of Kif2C bound to tubulin.,,,0,,,,,,,,,,,,,
Q99661_KIF2C_wild_cl1,KIF2C_4y05A_ADP,Q99661,,KIF2C,wild,cl1,4y05A,ADP,,4y05,3,1,,ATPase,,,New Insights into the Coupling between Microtubule Depolymerization and ATP Hydrolysis by Kinesin-13 Protein Kif2C.,,,0,,,,,,,,,,,,,
Q9HAQ2_KIF9_wild_cl1,KIF9_3nwnA_ADP,Q9HAQ2,,KIF9,wild,cl1,3nwnA,ADP,,3nwn,3,1,,ATPase,,,Crystal structure of the human KIF9 motor domain in complex with ADP,,,0,,,,,,,,,,,,,
Q9NS87_KIF15_wild_cl1,KIF15_4bn2A_ADP,Q9NS87,,KIF15,wild,cl1,4bn2A,ADP,,4bn2,3,1,,ATPase,,,The Crystal Structure and Biochemical Characterization of Kif15: A Bifunctional Molecular Motor Involved in Bipolar Spindle Formation and Neuronal Development,,,0,,,,,,,,,,,,,
Q9Y4W6_AFG3L2_wild_cl1,AFG3L2_6nyyB_ANP,Q9Y4W6,,AFG3L2,wild,cl1,6nyyB,ANP,,6nyy,3,2,,ATPase,,,Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.,,,0,,,,,,,,,,,,,
Q9Y4W6_AFG3L2_wild_cl1,AFG3L2_6nyyE_ADP,Q9Y4W6,,AFG3L2,wild,cl1,6nyyE,ADP,,6nyy,3,2,,ATPase,,,Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.,,,0,,,,,,,,,,,,,
Q9Y4W6_AFG3L2_wild_cl2,AFG3L2_6nyyC_ANP,Q9Y4W6,,AFG3L2,wild,cl2,6nyyC,ANP,,6nyy,3,2,,ATPase,,,Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.,,,0,,,,,,,,,,,,,
P32297_CHRNA3_wild_cl1,CHRNA3_6pv8A_P1M,P32297,,CHRNA3,wild,cl1,6pv8A,P1M,,6pv8,3,2,,Channel,,,Agonist Selectivity and Ion Permeation in the alpha 3 beta 4 Ganglionic Nicotinic Receptor.,agonist,,0,,,,,,,,,,,,,
P32297_CHRNA3_wild_cl1,CHRNA3_6pv7A_NCT,P32297,,CHRNA3,wild,cl1,6pv7A,NCT,,6pv7,3,2,,Channel,,,Agonist Selectivity and Ion Permeation in the alpha 3 beta 4 Ganglionic Nicotinic Receptor.,agonist,,0,,,,,,,,,,,,,
P32297_CHRNA3_wild_cl2,CHRNA3_6pv8A_Y01,P32297,,CHRNA3,wild,cl2,6pv8A,Y01,,6pv8,3,2,,Channel,,,Agonist Selectivity and Ion Permeation in the alpha 3 beta 4 Ganglionic Nicotinic Receptor.,agonist,,0,,,,,,,,,,,,,
P32297_CHRNA3_wild_cl2,CHRNA3_6pv8D_Y01,P32297,,CHRNA3,wild,cl2,6pv8D,Y01,,6pv8,3,2,,Channel,,,Agonist Selectivity and Ion Permeation in the alpha 3 beta 4 Ganglionic Nicotinic Receptor.,agonist,,0,,,,,,,,,,,,,
P42262_GRIA2_wild_cl2,GRIA2_5zg2A_GOL,P42262,,GRIA2,wild,cl2,5zg2A,GOL,,5zg2,2,3,,Channel,,,TAK-137_ an AMPA-R potentiator with little Agonistic effect_ has a wide therapeutic window.,agonist,,0,,,,,,,,,,,,,
P42262_GRIA2_wild_cl3,GRIA2_5zg1A_GOL,P42262,,GRIA2,wild,cl3,5zg1A,GOL,,5zg1,2,3,,Channel,,,TAK-137_ an AMPA-R potentiator with little Agonistic effect_ has a wide therapeutic window.,agonist,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl1,KCNK3_6rv2D_Y01,O14649,,KCNK3,wild,cl1,6rv2D,Y01,,6rv2,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl1,KCNK3_6rv4A_Y01,O14649,,KCNK3,wild,cl1,6rv4A,Y01,,6rv4,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl2,KCNK3_6rv3A_DMU,O14649,,KCNK3,wild,cl2,6rv3A,DMU,,6rv3,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl2,KCNK3_6rv2B_DMU,O14649,,KCNK3,wild,cl2,6rv2B,DMU,,6rv2,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl3,KCNK3_6rv3B_KKQ,O14649,,KCNK3,wild,cl3,6rv3B,KKQ,,6rv3,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl3,KCNK3_6rv4A_KKZ,O14649,,KCNK3,wild,cl3,6rv4A,KKZ,,6rv4,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl4,KCNK3_6rv2C_Y01,O14649,,KCNK3,wild,cl4,6rv2C,Y01,,6rv2,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl4,KCNK3_6rv4C_Y01,O14649,,KCNK3,wild,cl4,6rv4C,Y01,,6rv4,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl5,KCNK3_6rv2C_Y01,O14649,,KCNK3,wild,cl5,6rv2C,Y01,,6rv2,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O14649_KCNK3_wild_cl5,KCNK3_6rv4C_Y01,O14649,,KCNK3,wild,cl5,6rv4C,Y01,,6rv4,3,5,,Channel,,,A lower X-gate in TASK channels traps inhibitors within the vestibule.,inhibitor,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl2,GLRA3_5cfbD_SY9,O75311,,GLRA3,wild,cl2,5cfbD,SY9,,5cfb,3,4,,Channel,,,Crystal structure of human glycine receptor-alpha 3 bound to antagonist strychnine.,inhibitor,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl2,GLRA3_5cfbA_SY9,O75311,,GLRA3,wild,cl2,5cfbA,SY9,,5cfb,3,4,,Channel,,,Crystal structure of human glycine receptor-alpha 3 bound to antagonist strychnine.,inhibitor,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl3,GLRA3_5cfbC_SY9,O75311,,GLRA3,wild,cl3,5cfbC,SY9,,5cfb,3,4,,Channel,,,Crystal structure of human glycine receptor-alpha 3 bound to antagonist strychnine.,inhibitor,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl3,GLRA3_5cfbB_SY9,O75311,,GLRA3,wild,cl3,5cfbB,SY9,,5cfb,3,4,,Channel,,,Crystal structure of human glycine receptor-alpha 3 bound to antagonist strychnine.,inhibitor,,0,,,,,,,,,,,,,
P39086_GRIK1_wild_cl1,GRIK1_4mf3A_SXI,P39086,,GRIK1,wild,cl1,4mf3A,SXI,,4mf3,2,1,,Channel,,,GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.,inhibitor,,0,,,,,,,,,,,,,
P42262_GRIA2_wild_cl2,GRIA2_3r7xA_QSN,P42262,,GRIA2,wild,cl2,3r7xA,QSN,,3r7x,2,3,,Channel,,,Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity.,inhibitor,,0,,,,,,,,,,,,,
P78348_ASIC1_wild_cl1,ASIC1_7cfsB_Y01,P78348,,ASIC1,wild,cl1,7cfsB,Y01,,7cfs,3,1,,Channel,,,Structural insights into human acid-sensing ion channel 1a inhibition by snake toxin mambalgin1.,inhibitor,,0,,,,,,,,,,,,,
Q9UGM1_CHRNA9_wild_cl1,CHRNA9_4uxuB_MLK,Q9UGM1,,CHRNA9,wild,cl1,4uxuB,MLK,,4uxu,3,1,,Channel,,,Crystal Structures of Free and antagonist-Bound States of Human Alpha9 Nicotinic Receptor Extracellular Domain,inhibitor,,0,,,,,,,,,,,,,
O43526_KCNQ2_wild_cl1,KCNQ2_7cr7A_FBX,O43526,,KCNQ2,wild,cl1,7cr7A,FBX,,7cr7,3,3,,Channel,,,Molecular basis for ligand activation of the human KCNQ2 channel.,,,0,,,,,,,,,,,,,
O43526_KCNQ2_wild_cl1,KCNQ2_7cr2A_FBX,O43526,,KCNQ2,wild,cl1,7cr2A,FBX,,7cr2,3,3,,Channel,,,Molecular basis for ligand activation of the human KCNQ2 channel.,,,0,,,,,,,,,,,,,
O43526_KCNQ2_wild_cl2,KCNQ2_7cr1A_GB9,O43526,,KCNQ2,wild,cl2,7cr1A,GB9,,7cr1,3,3,,Channel,,,Molecular basis for ligand activation of the human KCNQ2 channel.,,,0,,,,,,,,,,,,,
O43526_KCNQ2_wild_cl2,KCNQ2_7cr4A_GB9,O43526,,KCNQ2,wild,cl2,7cr4A,GB9,,7cr4,3,3,,Channel,,,Molecular basis for ligand activation of the human KCNQ2 channel.,,,0,,,,,,,,,,,,,
O43526_KCNQ2_wild_cl3,KCNQ2_7cr2A_FBX,O43526,,KCNQ2,wild,cl3,7cr2A,FBX,,7cr2,3,3,,Channel,,,Molecular basis for ligand activation of the human KCNQ2 channel.,,,0,,,,,,,,,,,,,
O60741_HCN1_wild_cl1,HCN1_5u6pA_CMP,O60741,,HCN1,wild,cl1,5u6pA,CMP,,5u6p,3,1,,Channel,,,Structures of the Human HCN1 Hyperpolarization-Activated Channel.,,,0,,,,,,,,,,,,,
O60741_HCN1_wild_cl1,HCN1_6uqgA_CMP,O60741,,HCN1,wild,cl1,6uqgA,CMP,,6uqg,3,1,,Channel,,,Voltage Sensor Movements during Hyperpolarization in the HCN Channel.,,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl1,GLRA3_5tinA_7C6,O75311,,GLRA3,wild,cl1,5tinA,7C6,,5tin,3,4,,Channel,,,Crystal Structures of Human GlyRa3 Bound to a Novel Class of Potentiators with Efficacy in a Mouse Model of Neuropathic Pain,,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl1,GLRA3_5tioC_7C6,O75311,,GLRA3,wild,cl1,5tioC,7C6,,5tio,3,4,,Channel,,,Crystal Structures of Human GlyRa3 Bound to a Novel Class of Potentiators with Efficacy in a Mouse Model of Neuropathic Pain,,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl4,GLRA3_5tinA_7C6,O75311,,GLRA3,wild,cl4,5tinA,7C6,,5tin,3,4,,Channel,,,Crystal Structures of Human GlyRa3 Bound to a Novel Class of Potentiators with Efficacy in a Mouse Model of Neuropathic Pain,,,0,,,,,,,,,,,,,
O75311_GLRA3_wild_cl4,GLRA3_5tioA_7C6,O75311,,GLRA3,wild,cl4,5tioA,7C6,,5tio,3,4,,Channel,,,Crystal Structures of Human GlyRa3 Bound to a Novel Class of Potentiators with Efficacy in a Mouse Model of Neuropathic Pain,,,0,,,,,,,,,,,,,
O95069_KCNK2_wild_cl1,KCNK2_4twkB_37X,O95069,,KCNK2,wild,cl1,4twkB,37X,,4twk,3,2,,Channel,,,Crystal structure of human two pore domain potassium ion channel TREK1 (K2P2.1),,,0,,,,,,,,,,,,,
O95069_KCNK2_wild_cl2,KCNK2_4twkA_37X,O95069,,KCNK2,wild,cl2,4twkA,37X,,4twk,3,2,,Channel,,,Crystal structure of human two pore domain potassium ion channel TREK1 (K2P2.1),,,0,,,,,,,,,,,,,
P14867_GBRA1_wild_cl1,GBRA1_6hupD_DZP,P14867,,GBRA1,wild,cl1,6hupD,DZP,,6hup,2,1,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P14867_GBRA1_wild_cl1,GBRA1_6d6uD_FYP,P14867,,GBRA1,wild,cl1,6d6uD,FYP,,6d6u,2,1,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P17787_CHRNB2_wild_cl1,CHRNB2_6ur8E_QMR,P17787,,CHRNB2,wild,cl1,6ur8E,QMR,,6ur8,3,1,,Channel,,,Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins.,,,0,,,,,,,,,,,,,
P17787_CHRNB2_wild_cl1,CHRNB2_5kxiB_NCT,P17787,,CHRNB2,wild,cl1,5kxiB,NCT,,5kxi,3,1,,Channel,,,X-ray structure of the human alpha 4 beta 2 nicotinic receptor.,,,0,,,,,,,,,,,,,
P18507_GABRG2_wild_cl3,GABRG2_6hugC_RI5,P18507,,GABRG2,wild,cl3,6hugC,RI5,,6hug,3,3,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P18507_GABRG2_wild_cl1,GABRG2_6d6uE_Y01,P18507,,GABRG2,wild,cl1,6d6uE,Y01,,6d6u,3,3,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P18507_GABRG2_wild_cl2,GABRG2_6d6uE_FYP,P18507,,GABRG2,wild,cl2,6d6uE,FYP,,6d6u,3,3,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P23416_GLRA2_wild_cl1,GLRA2_7l31D_SY9,P23416,,GLRA2,wild,cl1,7l31D,SY9,,7l31,3,2,,Channel,,,Characterization of the subunit composition and structure of adult human glycine receptors,,,0,,,,,,,,,,,,,
P23416_GLRA2_wild_cl1,GLRA2_7kuyA_SY9,P23416,,GLRA2,wild,cl1,7kuyA,SY9,,7kuy,3,2,,Channel,,,Characterization of the subunit composition and structure of adult human glycine receptors,,,0,,,,,,,,,,,,,
P23416_GLRA2_wild_cl2,GLRA2_7kuyB_SY9,P23416,,GLRA2,wild,cl2,7kuyB,SY9,,7kuy,3,2,,Channel,,,Characterization of the subunit composition and structure of adult human glycine receptors,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl1,GABRB3_6hujE_ABU,P28472,,GABRB3,wild,cl1,6hujE,ABU,,6huj,3,4,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl2,GABRB3_6hugB_RI5,P28472,,GABRB3,wild,cl2,6hugB,RI5,,6hug,3,4,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl2,GABRB3_6hugE_RI5,P28472,,GABRB3,wild,cl2,6hugE,RI5,,6hug,3,4,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl3,GABRB3_6hupB_DZP,P28472,,GABRB3,wild,cl3,6hupB,DZP,,6hup,3,4,,Channel,,,GABAAreceptor signalling mechanisms revealed by structural pharmacology.,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl1,GABRB3_6qfaE_HSM,P28472,,GABRB3,wild,cl1,6qfaE,HSM,,6qfa,3,4,,Channel,,,Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM.,,,0,,,,,,,,,,,,,
P28472_GABRB3_wild_cl4,GABRB3_6qfaB_HSM,P28472,,GABRB3,wild,cl4,6qfaB,HSM,,6qfa,3,4,,Channel,,,Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM.,,,0,,,,,,,,,,,,,
P29973_CNGA1_wild_cl1,CNGA1_7rhgA_CMP,P29973,,CNGA1,wild,cl1,7rhgA,CMP,,7rhg,3,2,,Channel,,,Structural mechanisms of assembly_ permeation_ gating_ and pharmacology of native human rod CNG channel.,,,0,,,,,,,,,,,,,
P29973_CNGA1_wild_cl1,CNGA1_7rhhD_PCG,P29973,,CNGA1,wild,cl1,7rhhD,PCG,,7rhh,3,2,,Channel,,,Structural mechanisms of assembly_ permeation_ gating_ and pharmacology of native human rod CNG channel.,,,0,,,,,,,,,,,,,
P29973_CNGA1_wild_cl2,CNGA1_7rhjD_5H0,P29973,,CNGA1,wild,cl2,7rhjD,5H0,,7rhj,3,2,,Channel,,,Structural mechanisms of assembly_ permeation_ gating_ and pharmacology of native human rod CNG channel.,,,0,,,,,,,,,,,,,
P29973_CNGA1_wild_cl2,CNGA1_7rhjA_5H0,P29973,,CNGA1,wild,cl2,7rhjA,5H0,,7rhj,3,2,,Channel,,,Structural mechanisms of assembly_ permeation_ gating_ and pharmacology of native human rod CNG channel.,,,0,,,,,,,,,,,,,
P31644_GABRA5_wild_cl1,GABRA5_5o8fA_P9N,P31644,,GABRA5,wild,cl1,5o8fA,P9N,,5o8f,3,1,,Channel,,,Structural basis for GABAA receptor potentiation by neurosteroids.,,,0,,,,,,,,,,,,,
P39086_GRIK1_wild_cl1,GRIK1_2zntA_DYH,P39086,,GRIK1,wild,cl1,2zntA,DYH,,2znt,2,1,,Channel,,,Binding and Selectivity of the Marine Toxin Neodysiherbaine A and Its Synthetic Analogues to GluK1 and GluK2 Kainate Receptors.,,,0,,,,,,,,,,,,,
P42262_GRIA2_wild_cl1,GRIA2_3rn8A_RN8,P42262,,GRIA2,wild,cl1,3rn8A,RN8,,3rn8,2,3,,Channel,,,Structural and functional analysis of two new positive Allosteric modulators of GluA2 desensitization and deactivation.,,allosteric,0,,,,,,,,,,,,,
P42262_GRIA2_wild_cl1,GRIA2_3rn8B_RN8,P42262,,GRIA2,wild,cl1,3rn8B,RN8,,3rn8,2,3,,Channel,,,Structural and functional analysis of two new positive Allosteric modulators of GluA2 desensitization and deactivation.,,allosteric,0,,,,,,,,,,,,,
P43681_ACHA4_wild_cl1,ACHA4_6cnkA_NCT,P43681,,ACHA4,wild,cl1,6cnkA,NCT,,6cnk,3,1,,Channel,,,Structural principles of distinct assemblies of the human alpha 4 beta 2 nicotinic receptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl1,GABRB2_6d6tA_ABU,P47870,,GABRB2,wild,cl1,6d6tA,ABU,,6d6t,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl1,GABRB2_6d6tC_ABU,P47870,,GABRB2,wild,cl1,6d6tC,ABU,,6d6t,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl2,GABRB2_6d6tC_Y01,P47870,,GABRB2,wild,cl2,6d6tC,Y01,,6d6t,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl2,GABRB2_6d6uC_Y01,P47870,,GABRB2,wild,cl2,6d6uC,Y01,,6d6u,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl3,GABRB2_6d6uC_Y01,P47870,,GABRB2,wild,cl3,6d6uC,Y01,,6d6u,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P47870_GABRB2_wild_cl4,GABRB2_6d6tA_Y01,P47870,,GABRB2,wild,cl4,6d6tA,Y01,,6d6t,3,4,,Channel,,,Structure of a human synaptic GABAAreceptor.,,,0,,,,,,,,,,,,,
P48167_GLRB_wild_cl1,GLRB_7l31E_SY9,P48167,,GLRB,wild,cl1,7l31E,SY9,,7l31,3,2,,Channel,,,Characterization of the subunit composition and structure of adult human glycine receptors,,,0,,,,,,,,,,,,,
P48167_GLRB_wild_cl2,GLRB_7kuyE_SY9,P48167,,GLRB,wild,cl2,7kuyE,SY9,,7kuy,3,2,,Channel,,,Characterization of the subunit composition and structure of adult human glycine receptors,,,0,,,,,,,,,,,,,
P51787_KCNQ1_wild_cl1,KCNQ1_6v01A_PT5,P51787,,KCNQ1,wild,cl1,6v01A,PT5,,6v01,3,1,,Channel,,,Structural Basis of Human KCNQ1 Modulation and Gating.,,,0,,,,,,,,,,,,,
P56696_KCNQ4_wild_cl1,KCNQ4_7bynA_PT5,P56696,,KCNQ4,wild,cl1,7bynA,PT5,,7byn,3,4,,Channel,,,Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.,,,0,,,,,,,,,,,,,
P56696_KCNQ4_wild_cl1,KCNQ4_7bynC_PT5,P56696,,KCNQ4,wild,cl1,7bynC,PT5,,7byn,3,4,,Channel,,,Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.,,,0,,,,,,,,,,,,,
P56696_KCNQ4_wild_cl2,KCNQ4_7bymA_FBX,P56696,,KCNQ4,wild,cl2,7bymA,FBX,,7bym,3,4,,Channel,,,Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.,,,0,,,,,,,,,,,,,
P56696_KCNQ4_wild_cl3,KCNQ4_7bynE_FCC,P56696,,KCNQ4,wild,cl3,7bynE,FCC,,7byn,3,4,,Channel,,,Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.,,,0,,,,,,,,,,,,,
P56696_KCNQ4_wild_cl4,KCNQ4_7bymG_FBX,P56696,,KCNQ4,wild,cl4,7bymG,FBX,,7bym,3,4,,Channel,,,Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.,,,0,,,,,,,,,,,,,
P57789_KCNK10_wild_cl1,KCNK10_4xdlC_40D,P57789,,KCNK10,wild,cl1,4xdlC,40D,,4xdl,3,2,,Channel,,,K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.,,,0,,,,,,,,,,,,,
P57789_KCNK10_wild_cl1,KCNK10_4xdkC_408,P57789,,KCNK10,wild,cl1,4xdkC,408,,4xdk,3,2,,Channel,,,K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.,,,0,,,,,,,,,,,,,
P57789_KCNK10_wild_cl2,KCNK10_4xdkA_405,P57789,,KCNK10,wild,cl2,4xdkA,405,,4xdk,3,2,,Channel,,,K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.,,,0,,,,,,,,,,,,,
P57789_KCNK10_wild_cl2,KCNK10_4xdkD_408,P57789,,KCNK10,wild,cl2,4xdkD,408,,4xdk,3,2,,Channel,,,K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.,,,0,,,,,,,,,,,,,
Q05586_GRIN1_wild_cl1,GRIN1_5tpaB_7H2,Q05586,,GRIN1,wild,cl1,5tpaB,7H2,,5tpa,3,1,,Channel,,,GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile.,,allosteric,0,,,,,,,,,,,,,
Q05586_GRIN1_wild_cl1,GRIN1_5i2jB_67G,Q05586,,GRIN1,wild,cl1,5i2jB,67G,,5i2j,3,1,5KDT_ Diff Lig,Channel,,,Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design,,allosteric,0,,,,,,,,,,,,,
Q12879_GRIN2A_wild_cl1,GRIN2A_5tpaA_7H2,Q12879,,GRIN2A,wild,cl1,5tpaA,7H2,,5tpa,3,2,,Channel,,,GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile.,,allosteric,0,,,,,,,,,,,,,
Q12879_GRIN2A_wild_cl2,GRIN2A_5h8nA_GLU,Q12879,,GRIN2A,wild,cl2,5h8nA,GLU,,5h8n,3,2,,Channel,,,Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.,,allosteric,0,,,,,,,,,,,,,
Q12879_GRIN2A_wild_cl1,GRIN2A_5i2jA_67G,Q12879,,GRIN2A,wild,cl1,5i2jA,67G,,5i2j,3,2,5KDT_ Diff Lig,Channel,,,Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.,,allosteric,0,,,,,,,,,,,,,
Q13002_GRIK2_wild_cl1,GRIK2_3qxmA_NDZ,Q13002,,GRIK2,wild,cl1,3qxmA,NDZ,,3qxm,3,1,,Channel,,,Binding and Selectivity of the Marine Toxin Neodysiherbaine A and Its Synthetic Analogues to GluK1 and GluK2 Kainate Receptors.,,,0,,,,,,,,,,,,,
Q13224_GRIN2B_wild_cl1,GRIN2B_7eu8B_JC9,Q13224,,GRIN2B,wild,cl1,7eu8B,JC9,,7eu8,3,1,,Channel,,,Structural basis of ketamine action on human NMDA receptors.,,,0,,,,,,,,,,,,,
Q14654_KCNJ11_wild_cl1,KCNJ11_6c3oC_ATP,Q14654,,KCNJ11,wild,cl1,6c3oC,ATP,,6c3o,2,1,,Channel,,,Molecular structure of human KATP in complex with ATP and ADP,,,0,,,,,,,,,,,,,
Q14654_KCNJ11_wild_cl1,KCNJ11_6c3oA_ATP,Q14654,,KCNJ11,wild,cl1,6c3oA,ATP,,6c3o,2,1,,Channel,,,Molecular structure of human KATP in complex with ATP and ADP,,,0,,,,,,,,,,,,,
Q15822_CHRNA2_wild_cl1,CHRNA2_5fjvD_EPJ,Q15822,,CHRNA2,wild,cl1,5fjvD,EPJ,,5fjv,3,2,,Channel,,,Crystal Structure of a Human Neuronal Nachr Extracellular Domain in Pentameric Assembly: Ligand-Bound Alpah2 Homopentamer.,,,0,,,,,,,,,,,,,
Q15822_CHRNA2_wild_cl1,CHRNA2_5fjvB_EPJ,Q15822,,CHRNA2,wild,cl1,5fjvB,EPJ,,5fjv,3,2,,Channel,,,Crystal Structure of a Human Neuronal Nachr Extracellular Domain in Pentameric Assembly: Ligand-Bound Alpah2 Homopentamer.,,,0,,,,,,,,,,,,,
Q15822_CHRNA2_wild_cl2,CHRNA2_5fjvC_EPJ,Q15822,,CHRNA2,wild,cl2,5fjvC,EPJ,,5fjv,3,2,,Channel,,,Crystal Structure of a Human Neuronal Nachr Extracellular Domain in Pentameric Assembly: Ligand-Bound Alpah2 Homopentamer.,,,0,,,,,,,,,,,,,
Q15822_CHRNA2_wild_cl2,CHRNA2_5fjvD_EPJ,Q15822,,CHRNA2,wild,cl2,5fjvD,EPJ,,5fjv,3,2,,Channel,,,Crystal Structure of a Human Neuronal Nachr Extracellular Domain in Pentameric Assembly: Ligand-Bound Alpah2 Homopentamer.,,,0,,,,,,,,,,,,,
Q9H2S1_KCNN2_wild_cl1,KCNN2_6aleB_1KP,Q9H2S1,,KCNN2,wild,cl1,6aleB,1KP,,6ale,3,1,,Channel,,,A V-to-F substitution in SK2 channels causes Ca2+hypersensitivity and improves locomotion in a C. elegans ALS model.,,,0,,,,,,,,,,,,,
Q9H2S1_KCNN2_wild_cl1,KCNN2_5wbxB_AJY,Q9H2S1,,KCNN2,wild,cl1,5wbxB,AJY,,5wbx,3,1,,Channel,,,Structural insights into the potency of SK channel positive modulators.,,,0,,,,,,,,,,,,,
Q9Y3Q4_HCN4_wild_cl1,HCN4_4kl1D_PCG,Q9Y3Q4,,HCN4,wild,cl1,4kl1D,PCG,,4kl1,1,2,,Channel,,,Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness.,,,0,,,,,,,,,,,,,
Q9Y3Q4_HCN4_wild_cl2,HCN4_6gyoA_PIE,Q9Y3Q4,,HCN4,wild,cl2,6gyoA,PIE,,6gyo,1,2,,Channel,,,Structure of human HCN4 hyperpolarization-activated cyclic nucleotide-gated ion channel,,,0,,,,,,,,,,,,,
Q9Y3Q4_HCN4_wild_cl1,HCN4_3u11A_CMP,Q9Y3Q4,,HCN4,wild,cl1,3u11A,CMP,,3u11,1,2,,Channel,,,Tetramerization dynamics of C-terminal domain underlies isoform-specific cAMP gating in hyperpolarization-activated cyclic nucleotide-gated channels.,,,0,,,,,,,,,,,,,
Q96PN6_ADCY10_wild_cl1,ADCY10_4clwA_APC,Q96PN6,,ADCY10,wild,cl1,4clwA,APC,,4clw,1,2,,cyclase,,,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,,,0,,,,,,,,,,,,,
Q96PN6_ADCY10_wild_cl2,ADCY10_4clzA_4DS,Q96PN6,,ADCY10,wild,cl2,4clzA,4DS,,4clz,1,2,,cyclase,,,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,,,0,,,,,,,,,,,,,
Q96PN6_ADCY10_wild_cl1,ADCY10_4uswA_ATP,Q96PN6,,ADCY10,wild,cl1,4uswA,ATP,,4usw,1,2,,cyclase,,,Structural Analysis of Human Soluble Adenylyl Cyclase and Crystal Structures of its Nucleotide Complexes -Implications for Cyclase Catalysis and Evolution.,,,0,,,,,,,,,,,,,
Q6NYC1_JMJD6_wild_cl1,JMJD6_6gdyA_AKG,Q6NYC1,,JMJD6,wild,cl1,6gdyA,AKG,,6gdy,1,1,,Demethylase,,,Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.,,,0,,,,,,,,,,,,,
Q6NYC1_JMJD6_wild_cl1,JMJD6_6mevG_AKG,Q6NYC1,,JMJD6,wild,cl1,6mevG,AKG,,6mev,1,1,,Demethylase,,,JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl4,BCHE_7awgA_SIA,P06276,,BCHE,wild,cl4,7awgA,SIA,,7awg,1,6,,esterase,,,Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT 6 R antagonists with beta-amyloid anti-aggregation properties.,inhibitor,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl6,BCHE_7bo3A_SIA,P06276,,BCHE,wild,cl6,7bo3A,SIA,,7bo3,1,6,,esterase,,,From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series.,inhibitor,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl3,BCHE_6f7qB_CWQ,P06276,,BCHE,wild,cl3,6f7qB,CWQ,,6f7q,1,6,,esterase,,,Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.,inhibitor,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl5,BCHE_1xlwA_FUC,P06276,,BCHE,wild,cl5,1xlwA,FUC,,1xlw,1,6,,esterase,,,Role of Water in Aging of Human Butyrylcholinesterase inhibited by Echothiophate: The Crystal Structure Suggests Two Alternative Mechanisms of Aging,inhibitor,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl2,BCHE_2wilB_FUC,P06276,,BCHE,wild,cl2,2wilB,FUC,,2wil,1,6,,esterase,,,Structure-Activity Analysis of Aging and Reactivation of Human Butyrylcholinesterase inhibited by Analogues of Tabun,inhibitor,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl2,BCHE_2wigA_FUL,P06276,,BCHE,wild,cl2,2wigA,FUL,,2wig,1,6,,esterase,,,Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.,inhibitor,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl1,CES1_1ya4B_CTX,P23141,,CES1,wild,cl1,1ya4B,CTX,,1ya4,1,5,,esterase,,,Structural insights into drug processing by human carboxylesterase 1: tamoxifen_ mevastatin_ and inhibition by benzil.,inhibitor,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl3,CES1_1yajE_SIA,P23141,,CES1,wild,cl3,1yajE,SIA,,1yaj,1,5,,esterase,,,Structural insights into drug processing by human carboxylesterase 1: tamoxifen_ mevastatin_ and inhibition by benzil.,inhibitor,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl4,CES1_1ya8A_MVB,P23141,,CES1,wild,cl4,1ya8A,MVB,,1ya8,1,5,,esterase,,,Structural insights into drug processing by human carboxylesterase 1: tamoxifen_ mevastatin_ and inhibition by benzil.,inhibitor,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl1,NOTUM_7bltA_U2T,Q6P988,,NOTUM,wild,cl1,7bltA,U2T,,7blt,1,4,,esterase,,,Notum inhibitor,inhibitor,,0,,,,,,,,,,,,,
Q9NUW8_TDP1_wild_cl1,TDP1_1mu9B_GOL,Q9NUW8,,TDP1,wild,cl1,1mu9B,GOL,,1mu9,1,1,,esterase,,,Insights Into Substrate Binding and Catalytic Mechanism of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) from Vanadate- and Tungstate-inhibited Structures,inhibitor,,0,,,,,,,,,,,,,
O43924_PDE6D_wild_cl1,PDE6D_5f2uB_FAR,O43924,,PDE6D,wild,cl1,5f2uB,FAR,,5f2u,3,1,,esterase,,,PDE6delta-mediated sorting of INPP5E into the cilium is determined by cargo-carrier affinity.,,,0,,,,,,,,,,,,,
O43924_PDE6D_wild_cl1,PDE6D_5f2uA_FAR,O43924,,PDE6D,wild,cl1,5f2uA,FAR,,5f2u,3,1,,esterase,,,PDE6delta-mediated sorting of INPP5E into the cilium is determined by cargo-carrier affinity.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl1,BCHE_4bdsA_FPK,P06276,,BCHE,wild,cl1,4bdsA,FPK,,4bds,1,6,,esterase,,,Crystal Structures of Human Cholinesterases in Complex with Huprine W and Tacrine: Elements of Specificity for Anti-Alzheimer'S Drugs Targeting Acetyl- and Butyrylcholinesterase.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl4,BCHE_6zwiA_SIA,P06276,,BCHE,wild,cl4,6zwiA,SIA,,6zwi,1,6,,esterase,,,Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl1,BCHE_4xiiB_40V,P06276,,BCHE,wild,cl1,4xiiB,40V,,4xii,1,6,,esterase,,,Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl3,BCHE_4xiiA_FUL,P06276,,BCHE,wild,cl3,4xiiA,FUL,,4xii,1,6,,esterase,,,Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.,,,0,,,,,,,,,,,,,
P06276_BCHE_wild_cl5,BCHE_2xmdA_FUL,P06276,,BCHE,wild,cl5,2xmdA,FUL,,2xmd,1,6,,esterase,,,X-Ray Crystallographic Snapshots of Reaction Intermediates in the G117H Mutant of Human Butyrylcholinesterase_ a Nerve Agent Target Engineered Into a Catalytic Bioscavenge,,,0,,,,,,,,,,,,,
P22303_ACES_wild_cl1,ACES_6o52B_EBW,P22303,,ACES,wild,cl1,6o52B,EBW,,6o52,1,1,,esterase,,,A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies.,,,0,CEREP,,,,,,,,,,,,
P22303_ACES_wild_cl1,ACES_4m0fB_1YK,P22303,,ACES,wild,cl1,4m0fB,1YK,,4m0f,1,1,,esterase,,,Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.,,,0,CEREP,,,,,,,,,,,,
P23141_CES1_wild_cl2,CES1_2hrrA_SIA,P23141,,CES1,wild,cl2,2hrrA,SIA,,2hrr,1,5,,esterase,,,Crystal Structures of Human Carboxylesterase 1 in Covalent Complexes with the Chemical Warfare Agents Soman and Tabun.,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl2,CES1_2hrqB_SIA,P23141,,CES1,wild,cl2,2hrqB,SIA,,2hrq,1,5,,esterase,,,Crystal Structures of Human Carboxylesterase 1 in Covalent Complexes with the Chemical Warfare Agents Soman and Tabun.,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl4,CES1_2dqzC_HTQ,P23141,,CES1,wild,cl4,2dqzC,HTQ,,2dqz,1,5,,esterase,,,Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl5,CES1_2h7cD_COA,P23141,,CES1,wild,cl5,2h7cD,COA,,2h7c,1,5,,esterase,,,Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl5,CES1_2h7cB_COA,P23141,,CES1,wild,cl5,2h7cB,COA,,2h7c,1,5,,esterase,,,Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl1,CES1_1mx5D_HTQ,P23141,,CES1,wild,cl1,1mx5D,HTQ,,1mx5,1,5,,esterase,,,Structural Basis of Heroin and Cocaine Metabolism by a Promiscuous Human Drug-Processing Enzyme,,,0,,,,,,,,,,,,,
P23141_CES1_wild_cl3,CES1_1mx5B_SIA,P23141,,CES1,wild,cl3,1mx5B,SIA,,1mx5,1,5,,esterase,,,Structural Basis of Heroin and Cocaine Metabolism by a Promiscuous Human Drug-Processing Enzyme,,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl2,NOTUM_4uz6B_SCR,Q6P988,,NOTUM,wild,cl2,4uz6B,SCR,,4uz6,1,4,,esterase,,,Notum Deacylates Wnt Proteins to Suppress Signalling Activity.,,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl2,NOTUM_4uz6A_SCR,Q6P988,,NOTUM,wild,cl2,4uz6A,SCR,,4uz6,1,4,,esterase,,,Notum Deacylates Wnt Proteins to Suppress Signalling Activity.,,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl3,NOTUM_4uywA_H1S,Q6P988,,NOTUM,wild,cl3,4uywA,H1S,,4uyw,1,4,,esterase,,,Notum Deacylates Wnt Proteins to Suppress Signalling Activity.,,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl4,NOTUM_7bo1A_U5Z,Q6P988,,NOTUM,wild,cl4,7bo1A,U5Z,,7bo1,1,4,,esterase,,,Notum Fragment Screen,,,0,,,,,,,,,,,,,
Q6P988_NOTUM_wild_cl1,NOTUM_7b9uA_O3D,Q6P988,,NOTUM,wild,cl1,7b9uA,O3D,,7b9u,1,4,,esterase,,,Structural Analysis and Development of Notum Fragment Screening Hits.,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl1,ACOT13_3f5oA_UOC,Q9NPJ3,,ACOT13,wild,cl1,3f5oA,UOC,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl1,ACOT13_3f5oF_UOC,Q9NPJ3,,ACOT13,wild,cl1,3f5oF,UOC,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl2,ACOT13_3f5oA_UOC,Q9NPJ3,,ACOT13,wild,cl2,3f5oA,UOC,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl2,ACOT13_3f5oH_UOC,Q9NPJ3,,ACOT13,wild,cl2,3f5oH,UOC,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl3,ACOT13_3f5oD_COA,Q9NPJ3,,ACOT13,wild,cl3,3f5oD,COA,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl3,ACOT13_3f5oA_COA,Q9NPJ3,,ACOT13,wild,cl3,3f5oA,COA,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl4,ACOT13_3f5oA_COA,Q9NPJ3,,ACOT13,wild,cl4,3f5oA,COA,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl4,ACOT13_3f5oB_COA,Q9NPJ3,,ACOT13,wild,cl4,3f5oB,COA,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NPJ3_ACOT13_wild_cl5,ACOT13_3f5oA_COA,Q9NPJ3,,ACOT13,wild,cl5,3f5oA,COA,,3f5o,3,5,,esterase,,,The mechanisms of human hotdog-fold thioesterase 2 (hTHEM2) substrate recognition and catalysis illuminated by a structure and function based analysis,,,0,,,,,,,,,,,,,
Q9NUW8_TDP1_wild_cl1,TDP1_6mz0B_K7A,Q9NUW8,,TDP1,wild,cl1,6mz0B,K7A,,6mz0,1,1,,esterase,,,Structure of Tdp1 catalytic domain in complex with compound XZ530,,,0,,,,,,,,,,,,,
O00222_GRM8_wild_cl1,GRM8_6e5vA_HVG,O00222,,GRM8,wild,cl1,6e5vA,HVG,,6e5v,3,1,,GPCR,,,Structural Basis for ( S)-3_4-Dicarboxyphenylglycine (DCPG) As a Potent and Subtype Selective Agonist of the mGlu8Receptor.,agonist,,0,,,,,,,,,,,,,
Q9Y271_CYSLTR1_wild_cl1,CYSLTR1_6rz4A_KNT,Q9Y271,,CYSLTR1,wild,cl1,6rz4A,KNT,,6rz4,3,1,,GPCR,,,Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs.,inhibitor,,0,,,,,,,,,,,,,
Q9Y271_CYSLTR1_wild_cl1,CYSLTR1_6rz5B_ZLK,Q9Y271,,CYSLTR1,wild,cl1,6rz5B,ZLK,,6rz5,3,1,,GPCR,,,Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs.,inhibitor,,0,,,,,,,,,,,,,
O00222_GRM8_wild_cl1,GRM8_6bszA_GGL,O00222,,GRM8,wild,cl1,6bszA,GGL,,6bsz,3,1,,GPCR,,,Determination of L-AP4-bound human mGlu8 receptor amino terminal domain structure and the molecular basis for L-AP4's group III mGlu receptor functional potency and selectivity.,,,0,,,,,,,,,,,,,
P50052_AGTR2_wild_cl1,AGTR2_5unhB_8EM,P50052,,AGTR2,wild,cl1,5unhB,8EM,,5unh,2,1,,GPCR,,,Structural basis for selectivity and diversity in angiotensin II receptors.,,,0,,,,,,,,,,,,,
P50052_AGTR2_wild_cl1,AGTR2_5unfB_8ES,P50052,,AGTR2,wild,cl1,5unfB,8ES,,5unf,2,1,,GPCR,,,Structural basis for selectivity and diversity in angiotensin II receptors.,,,0,,,,,,,,,,,,,
Q13467_FZD5_wild_cl1,FZD5_5uryA_FUC,Q13467,,FZD5,wild,cl1,5uryA,FUC,,5ury,3,1,,GPCR,,,Unsaturated fatty acyl recognition by Frizzled receptors mediates dimerization upon Wnt ligand binding.,,,0,,,,,,,,,,,,,
Q14831_GRM7_wild_cl1,GRM7_3mq4A_Z99,Q14831,,GRM7,wild,cl1,3mq4A,Z99,,3mq4,3,1,,GPCR,,,mGluR7 complexed with LY341495,,,0,,,,,,,,,,,,,
Q5T848_GPR158_wild_cl1,GPR158_7sheA_PEE,Q5T848,,GPR158,wild,cl1,7sheA,PEE,,7she,3,1,,GPCR,,,Cryo-EM structure of human GPR158 receptor coupled to the RGS7-G beta 5 signaling complex.,,,0,,,,,,,,,,,,,
Q5T848_GPR158_wild_cl1,GPR158_7sheB_PEE,Q5T848,,GPR158,wild,cl1,7sheB,PEE,,7she,3,1,,GPCR,,,Cryo-EM structure of human GPR158 receptor coupled to the RGS7-G beta 5 signaling complex.,,,0,,,,,,,,,,,,,
Q9H228_S1PR5_wild_cl1,S1PR5_7ew1A_J8C,Q9H228,,S1PR5,wild,cl1,7ew1A,J8C,,7ew1,3,1,,GPCR,,,Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.,,,0,,,,,,,,,,,,,
Q9ULV1_FZD4_wild_cl1,FZD4_5bqcB_SCR,Q9ULV1,,FZD4,wild,cl1,5bqcB,SCR,,5bqc,3,1,,GPCR,,,Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4_ Lrp5/6_ and proteoglycan.,,,0,,,,,,,,,,,,,
P62330_ARF6_wild_cl1,ARF6_4fmeC_GTP,P62330,,ARF6,wild,cl1,4fmeC,GTP,,4fme,3,2,,GTPase,,,Structurally Distinct Bacterial TBC-like GAPs Link Arf GTPase to Rab1 inactivation to Counteract Host Defenses.,?,,0,,,,,,,,,,,,,
P01112_RASH_12_cl1,RASH_1rvdA_DBG,P01112,,RASH,12,cl1,1rvdA,DBG,,1rvd,1,5,,GTPase,,,Guanosine triphosphatase stimulation of oncogenic Ras mutants.,agonist,,0,,,,,,,,,,,,,
Q05193_DNM1_wild_cl1,DNM1_2x2eA_GDP,Q05193,,DNM1,wild,cl1,2x2eA,GDP,,2x2e,3,1,,GTPase,,,G Domain Dimerization Controls Dynamin'S Assembly-stimulated Gtpase Activity.,agonist,,0,,,,,,,,,,,,,
P01112_RASH_12_cl1,RASH_4l9wA_GNP,P01112,,RASH,12,cl1,4l9wA,GNP,,4l9w,1,5,,GTPase,,,K-Ras(G12C) inhibitors Allosterically control GTP affinity and effector interactions.,inhibitor,allosteric,0,,,,,,,,,,,,,
P01112_RASH_wild_cl1,RASH_4urzR_VJP,P01112,,RASH,wild,cl1,4urzR,VJP,,4urz,1,5,,GTPase,,,Small Molecule Binding Sites on the Ras:SOS Complex Can be Exploited for inhibition of Ras Activation.,inhibitor,,0,,,,,,,,,,,,,
P62826_RAN_wild_cl1,RAN_6a3bA_GTP,P62826,,RAN,wild,cl1,6a3bA,GTP,,6a3b,3,1,,GTPase,,,Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P84077_ARF1_wild_cl1,ARF1_7dn8D_GDP,P84077,,ARF1,wild,cl1,7dn8D,GDP,,7dn8,3,3,,GTPase,,,ARF GTPases activate Salmonella effector SopF to ADP-ribosylate host V-ATPase and inhibit endomembrane damage-induced autophagy.,inhibitor,,0,,,,,,,,,,,,,
Q15382_RHEB_wild_cl2,RHEB_6bsxC_E7S,Q15382,,RHEB,wild,cl2,6bsxC,E7S,,6bsx,3,3,,GTPase,,,A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.,inhibitor,,0,,,,,,,,,,,,,
Q15382_RHEB_wild_cl2,RHEB_6bsxB_E7S,Q15382,,RHEB,wild,cl2,6bsxB,E7S,,6bsx,3,3,,GTPase,,,A small molecule inhibitor of Rheb selectively targets mTORC1 signaling.,inhibitor,,0,,,,,,,,,,,,,
O00429_DNM1L_wild_cl1,DNM1L_3w6nA_GNH,O00429,,DNM1L,wild,cl1,3w6nA,GNH,,3w6n,3,1,,GTPase,,,Crystal structure of GTPase domain fused with minimal stalks from human dynamin-1-like protein (Dlp1) in complex with several nucleotide analogues,,,0,,,,,,,,,,,,,
O14966_RAB29_wild_cl1,RAB29_6hh2A_GDP,O14966,,RAB29,wild,cl1,6hh2A,GDP,,6hh2,3,1,,GTPase,,,LRRK2 binds to the Rab32 subfamily in a GTP-dependent mannerviaits armadillo domain.,,,0,,,,,,,,,,,,,
O95057_DIRAS1_wild_cl1,DIRAS1_2gf0C_GDP,O95057,,DIRAS1,wild,cl1,2gf0C,GDP,,2gf0,3,1,,GTPase,,,The crystal structure of the human DiRas1 GTPase in the inactive GDP bound state,,,0,,,,,,,,,,,,,
O95140_MFN2_wild_cl1,MFN2_6jfkA_GDP,O95140,,MFN2,wild,cl1,6jfkA,GDP,,6jfk,3,1,,GTPase,,,Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset.,,,0,,,,,,,,,,,,,
P01112_RASH_wild_cl3,RASH_4dlvA_DTT,P01112,,RASH,wild,cl3,4dlvA,DTT,,4dlv,1,5,,GTPase,,,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,,allosteric,0,,,,,,,,,,,,,
P01112_RASH_wild_cl3,RASH_4dlrA_DTU,P01112,,RASH,wild,cl3,4dlrA,DTU,,4dlr,1,5,,GTPase,,,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,,allosteric,0,,,,,,,,,,,,,
P01112_RASH_64_cl1,RASH_6cuoA_GNP,P01112,,RASH,64,cl1,6cuoA,GNP,,6cuo,1,5,,GTPase,,,Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS.,,,0,,,,,,,,,,,,,
P01112_RASH_wild_cl1,RASH_6zl3A_EZZ,P01112,,RASH,wild,cl1,6zl3A,EZZ,,6zl3,1,5,,GTPase,,,Drugging all RAS isoforms with one pocket.,,,0,,,,,,,,,,,,,
P01112_RASH_wild_cl2,RASH_1p2uA_GNP,P01112,,RASH,wild,cl2,1p2uA,GNP,,1p2u,1,5,,GTPase,,,Organic solvents order the dynamic switch II in Ras crystals,,,0,,,,,,,,,,,,,
P01112_RASH_wild_cl2,RASH_1gnrA_CAG,P01112,,RASH,wild,cl2,1gnrA,CAG,,1gnr,1,5,,GTPase,,,X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp.,,,0,,,,,,,,,,,,,
P11233_RALA_wild_cl1,RALA_1zc3C_GNP,P11233,,RALA,wild,cl1,1zc3C,GNP,,1zc3,3,1,,GTPase,,,Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.,,,0,,,,,,,,,,,,,
P11233_RALA_wild_cl1,RALA_1uadA_GNP,P11233,,RALA,wild,cl1,1uadA,GNP,,1uad,3,1,,GTPase,,,Structural basis of the interaction between RalA and Sec5_ a subunit of the Sec6/8 complex,,,0,,,,,,,,,,,,,
P11234_RALB_wild_cl1,RALB_6zqtA_GNP,P11234,,RALB,wild,cl1,6zqtA,GNP,,6zqt,3,1,,GTPase,,,Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases.,,,0,,,,,,,,,,,,,
P11234_RALB_wild_cl1,RALB_2ke5A_GNP,P11234,,RALB,wild,cl1,2ke5A,GNP,,2ke5,3,1,,GTPase,,,Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding,,,0,,,,,,,,,,,,,
P15170_GSPT1_wild_cl1,GSPT1_5hxbX_85C,P15170,,GSPT1,wild,cl1,5hxbX,85C,,5hxb,3,1,,GTPase,,,A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.,,,0,,,,,,,,,,,,,
P15170_GSPT1_wild_cl1,GSPT1_6xk9A_V4M,P15170,,GSPT1,wild,cl1,6xk9A,V4M,,6xk9,3,1,,GTPase,,,CC-90009_ a novel cereblon E3 ligase modulator_ targets acute myeloid leukemia blasts and leukemia stem cells.,,,0,,,,,,,,,,,,,
P17081_RHOQ_wild_cl1,RHOQ_2atxA_GNP,P17081,,RHOQ,wild,cl1,2atxA,GNP,,2atx,3,1,,GTPase,,,An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins,,,0,,,,,,,,,,,,,
P20340_RAB6A_wild_cl1,RAB6A_5lefA_GTP,P20340,,RAB6A,wild,cl1,5lefA,GTP,,5lef,3,1,,GTPase,,,Coupling fission and exit of RAB6 vesicles at Golgi hotspots through kinesin-myosin interactions.,,,0,,,,,,,,,,,,,
P20340_RAB6A_wild_cl1,RAB6A_1yzqA_GNP,P20340,,RAB6A,wild,cl1,1yzqA,GNP,,1yzq,3,1,,GTPase,,,Structural basis of family-wide Rab GTPase recognition by rabenosyn-5.,,,0,,,,,,,,,,,,,
P51149_RAB7A_wild_cl1,RAB7A_3lawD_GNP,P51149,,RAB7A,wild,cl1,3lawD,GNP,,3law,3,1,,GTPase,,,Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation.,,,0,,,,,,,,,,,,,
P51149_RAB7A_wild_cl1,RAB7A_1t91A_GTP,P51149,,RAB7A,wild,cl1,1t91A,GTP,,1t91,3,1,,GTPase,,,Structural basis for recruitment of RILP by small GTPase Rab7.,,,0,,,,,,,,,,,,,
P51159_RAB27A_wild_cl1,RAB27A_6hufA_GNP,P51159,,RAB27A,wild,cl1,6hufA,GNP,,6huf,3,1,,GTPase,,,Coping with strong translational noncrystallographic symmetry and extreme anisotropy in molecular replacement with Phaser: human Rab27a.,,,0,,,,,,,,,,,,,
P51159_RAB27A_wild_cl1,RAB27A_6hufI_GNP,P51159,,RAB27A,wild,cl1,6hufI,GNP,,6huf,3,1,,GTPase,,,Coping with strong translational noncrystallographic symmetry and extreme anisotropy in molecular replacement with Phaser: human Rab27a.,,,0,,,,,,,,,,,,,
P55040_GEM_wild_cl1,GEM_2cjwA_GDP,P55040,,GEM,wild,cl1,2cjwA,GDP,,2cjw,3,1,,GTPase,,,Biochemical and Structural Characterization of the Gem Gtpase.,,,0,,,,,,,,,,,,,
P61019_RAB2A_wild_cl1,RAB2A_1z0aA_GDP,P61019,,RAB2A,wild,cl1,1z0aA,GDP,,1z0a,3,1,,GTPase,,,Structural basis of family-wide Rab GTPase recognition by rabenosyn-5.,,,0,,,,,,,,,,,,,
P61019_RAB2A_wild_cl1,RAB2A_1z0aC_GDP,P61019,,RAB2A,wild,cl1,1z0aC,GDP,,1z0a,3,1,,GTPase,,,Structural basis of family-wide Rab GTPase recognition by rabenosyn-5.,,,0,,,,,,,,,,,,,
P61026_RAB10_wild_cl1,RAB10_5lpnA_GNP,P61026,,RAB10,wild,cl1,5lpnA,GNP,,5lpn,3,1,,GTPase,,,bMERB domains are bivalent Rab8 family effectors evolved by gene duplication.,,,0,,,,,,,,,,,,,
P62330_ARF6_wild_cl2,ARF6_6bbpA_4IP,P62330,,ARF6,wild,cl2,6bbpA,4IP,,6bbp,3,2,,GTPase,,,Structural Dynamics Control Allosteric Activation of Cytohesin Family Arf GTPase Exchange Factors.,,allosteric,0,,,,,,,,,,,,,
P62330_ARF6_wild_cl1,ARF6_2a5gA_GTP,P62330,,ARF6,wild,cl1,2a5gA,GTP,,2a5g,3,2,,GTPase,,,Structural basis for the activation of cholera toxin by human ARF6-GTP.,,,0,,,,,,,,,,,,,
P62745_RHOB_wild_cl1,RHOB_6hxuA_GTP,P62745,,RHOB,wild,cl1,6hxuA,GTP,,6hxu,3,1,,GTPase,,,A Targeted Protein Degradation Cell-Based Screening for Nanobodies Selective toward the Cellular RHOB GTP-Bound Conformation.,,,0,,,,,,,,,,,,,
P62745_RHOB_wild_cl1,RHOB_2fv8A_GDP,P62745,,RHOB,wild,cl1,2fv8A,GDP,,2fv8,3,1,,GTPase,,,The crystal structure of RhoB in the GDP-bound state,,,0,,,,,,,,,,,,,
P62820_RAB1A_wild_cl1,RAB1A_4iruF_GDP,P62820,,RAB1A,wild,cl1,4iruF,GDP,,4iru,3,1,,GTPase,,,The Legionella pneumophila GTPase Activating Protein LepB Accelerates Rab1 Deactivation by a Non-canonical Hydrolytic Mechanism.,,,0,,,,,,,,,,,,,
P62820_RAB1A_wild_cl1,RAB1A_4iruB_GDP,P62820,,RAB1A,wild,cl1,4iruB,GDP,,4iru,3,1,,GTPase,,,The Legionella pneumophila GTPase Activating Protein LepB Accelerates Rab1 Deactivation by a Non-canonical Hydrolytic Mechanism.,,,0,,,,,,,,,,,,,
P62826_RAN_wild_cl1,RAN_5cllA_GDP,P62826,,RAN,wild,cl1,5cllA,GDP,,5cll,3,1,,GTPase,,,Catalysis of GTP Hydrolysis by Small GTPases at Atomic Detail by Integration of X-ray Crystallography_ Experimental_ and Theoretical IR Spectroscopy.,,,0,,,,,,,,,,,,,
P62834_RAP1A_wild_cl1,RAP1A_1guaA_GNP,P62834,,RAP1A,wild,cl1,1guaA,GNP,,1gua,3,1,,GTPase,,,Ras/Rap effector specificity determined by charge reversal.,,,0,,,,,,,,,,,,,
P62834_RAP1A_wild_cl1,RAP1A_3kucA_GDP,P62834,,RAP1A,wild,cl1,3kucA,GDP,,3kuc,3,1,,GTPase,,,What makes Ras an efficient molecular switch: a computational_ biophysical_ and structural study of Ras-GDP interactions with mutants of Raf.,,,0,,,,,,,,,,,,,
P84077_ARF1_wild_cl3,ARF1_1re0A_AFB,P84077,,ARF1,wild,cl3,1re0A,AFB,,1re0,3,3,,GTPase,,,Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism.,,,0,,,,,,,,,,,,,
P84077_ARF1_wild_cl1,ARF1_6d83H_GTP,P84077,,ARF1,wild,cl1,6d83H,GTP,,6d83,3,3,,GTPase,,,HIV-1 Nefs Are Cargo-Sensitive AP-1 Trimerization Switches in Tetherin Downregulation.,,,0,,,,,,,,,,,,,
P84077_ARF1_wild_cl2,ARF1_1hurB_GDP,P84077,,ARF1,wild,cl2,1hurB,GDP,,1hur,3,3,,GTPase,,,Structure of the human ADP-ribosylation factor 1 complexed with GDP.,,,0,,,,,,,,,,,,,
P84085_ARF5_wild_cl1,ARF5_2b6hA_GDP,P84085,,ARF5,wild,cl1,2b6hA,GDP,,2b6h,3,1,,GTPase,,,Structure of human ADP-ribosylation factor 5,,,0,,,,,,,,,,,,,
Q15382_RHEB_wild_cl3,RHEB_3t5gA_FAR,Q15382,,RHEB,wild,cl3,3t5gA,FAR,,3t5g,3,3,,GTPase,,,Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo.,,,0,,,,,,,,,,,,,
Q15382_RHEB_wild_cl1,RHEB_1xtrA_GNP,Q15382,,RHEB,wild,cl1,1xtrA,GNP,,1xtr,3,3,,GTPase,,,Structural Basis for the Unique Biological Function of Small GTPase RHEB,,,0,,,,,,,,,,,,,
Q15382_RHEB_wild_cl1,RHEB_1xtqA_GDP,Q15382,,RHEB,wild,cl1,1xtqA,GDP,,1xtq,3,3,,GTPase,,,Structural Basis for the Unique Biological Function of Small GTPase RHEB,,,0,,,,,,,,,,,,,
Q9NR31_SAR1A_wild_cl1,SAR1A_2gaoA_GDP,Q9NR31,,SAR1A,wild,cl1,2gaoA,GDP,,2gao,3,1,,GTPase,,,Crystal Structure of Human SAR1a in Complex With GDP,,,0,,,,,,,,,,,,,
Q9NTK5_OLA1_wild_cl1,OLA1_2ohfA_ACP,Q9NTK5,,OLA1,wild,cl1,2ohfA,ACP,,2ohf,3,1,,GTPase,,,Human OLA1 defines an ATPase subfamily in the Obg family of GTP-binding proteins,,,0,,,,,,,,,,,,,
Q9NVJ2_ARL8B_wild_cl1,ARL8B_2al7A_GDP,Q9NVJ2,,ARL8B,wild,cl1,2al7A,GDP,,2al7,3,1,,GTPase,,,GTP-like conformation of GDP-bound ARL10C GTPase,,,0,,,,,,,,,,,,,
Q9UHD8_SEPTIN9_wild_cl1,SEPTIN9_5cypA_GSP,Q9UHD8,,SEPTIN9,wild,cl1,5cypA,GSP,,5cyp,3,1,,GTPase,,,A complete compendium of crystal structures for the human SEPT3 subgroup reveals functional plasticity at a specific septin interface,,,0,,,,,,,,,,,,,
Q9UHD8_SEPTIN9_wild_cl1,SEPTIN9_4yqfB_GDP,Q9UHD8,,SEPTIN9,wild,cl1,4yqfB,GDP,,4yqf,3,1,,GTPase,,,GTPase domain of Human Septin 9,,,0,,,,,,,,,,,,,
O43598_DNPH1_wild_cl1,DNPH1_4p5eB_N6P,O43598,,DNPH1,wild,cl1,4p5eB,N6P,,4p5e,3,1,,hydrolase,,,6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: Synthesis_ structural studies and cytotoxic activities.,inhibitor,,0,,,,,,,,,,,,,
O60502_OGA_wild_cl1,OGA_6pm9C_OQ1,O60502,,OGA,wild,cl1,6pm9C,OQ1,,6pm9,1,2,,hydrolase,,,Discovery of MK-8719_ a Potent O-GlcNAcase inhibitor as a Potential Treatment for Tauopathies.,inhibitor,,0,,,,,,,,,,,,,
O60502_OGA_wild_cl1,OGA_6pm9D_OQ1,O60502,,OGA,wild,cl1,6pm9D,OQ1,,6pm9,1,2,,hydrolase,,,Discovery of MK-8719_ a Potent O-GlcNAcase inhibitor as a Potential Treatment for Tauopathies.,inhibitor,,0,,,,,,,,,,,,,
O95372_LYPLA2_wild_cl1,LYPLA2_5synA_71T,O95372,,LYPLA2,wild,cl1,5synA,71T,,5syn,3,1,,hydrolase,,,Molecular Mechanism for Isoform-Selective inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2).,inhibitor,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl2,GBA_6q6lA_RJR,P04062,,GBA,wild,cl2,6q6lA,RJR,,6q6l,1,3,,hydrolase,,,Functionalized Cyclophellitols Are Selective Glucocerebrosidase inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish.,inhibitor,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl2,GBA_6q6kB_HKW,P04062,,GBA,wild,cl2,6q6kB,HKW,,6q6k,1,3,,hydrolase,,,Functionalized Cyclophellitols Are Selective Glucocerebrosidase inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish.,inhibitor,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl2,AMY2A_3ij9A_B0D,P04746,,AMY2A,wild,cl2,3ij9A,B0D,,3ij9,1,7,,hydrolase,,,"Directed ""in situ"" inhibitor elongation as a strategy to structurally characterize the covalent glycosyl-enzyme intermediate of human pancreatic alpha-amylase",inhibitor,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl4,AMY2A_3ij7A_GLF,P04746,,AMY2A,wild,cl4,3ij7A,GLF,,3ij7,1,7,,hydrolase,,,"Directed ""in situ"" inhibitor elongation as a strategy to structurally characterize the covalent glycosyl-enzyme intermediate of human pancreatic alpha-amylase",inhibitor,,0,,,,,,,,,,,,,
P11586_MTHFD1_wild_cl2,MTHFD1_1dibA_L34,P11586,,MTHFD1,wild,cl2,1dibA,L34,,1dib,1,2,,hydrolase,,,Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase.,inhibitor,,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl1,MTHFD2_6kg2A_NAD,P13995,,MTHFD2,wild,cl1,6kg2A,NAD,,6kg2,1,3,,hydrolase,,,Discovery of a Potent_ Selective_ and Orally Available MTHFD2 inhibitor (DS18561882) with in Vivo Antitumor Activity.,inhibitor,,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl2,MTHFD2_6kg2A_D8C,P13995,,MTHFD2,wild,cl2,6kg2A,D8C,,6kg2,1,3,,hydrolase,,,Discovery of a Potent_ Selective_ and Orally Available MTHFD2 inhibitor (DS18561882) with in Vivo Antitumor Activity.,inhibitor,,0,,,,,,,,,,,,,
P16233_PNLIP_wild_cl1,PNLIP_1lpbB_MUP,P16233,,PNLIP,wild,cl1,1lpbB,MUP,,1lpb,3,1,,hydrolase,,,The 2.46 A resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate.,inhibitor,,0,,,,,,,,,,,,,
P34913_EPHX2_wild_cl2,EPHX2_5mwaA_8S9,P34913,,EPHX2,wild,cl2,5mwaA,8S9,,5mwa,1,2,,hydrolase,,,Discovery of first in vivo active inhibitors of soluble epoxide hydrolase (sEH) phosphatase domain.,inhibitor,,0,,,,,,,,,,,,,
P34913_EPHX2_wild_cl1,EPHX2_4od0A_2RV,P34913,,EPHX2,wild,cl1,4od0A,2RV,,4od0,1,2,,hydrolase,,,Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.,inhibitor,,0,,,,,,,,,,,,,
Q13093_PLA2G7_wild_cl1,PLA2G7_5lyyA_7BJ,Q13093,,PLA2G7,wild,cl1,5lyyA,7BJ,,5lyy,1,1,,hydrolase,,,Fragment-Based Approach to the Development of an Orally Bioavailable Lactam inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2).,inhibitor,,0,,,,,,,,,,,,,
Q13093_PLA2G7_wild_cl1,PLA2G7_5i9iA_5HV,Q13093,,PLA2G7,wild,cl1,5i9iA,5HV,,5i9i,1,1,,hydrolase,,,Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q5VWZ2_LYPLAL1_wild_cl1,LYPLAL1_5kreA_6WG,Q5VWZ2,,LYPLAL1,wild,cl1,5kreA,6WG,,5kre,3,1,,hydrolase,,,Discovery of a Selective Covalent inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism.,inhibitor,,0,,,,,,,,,,,,,
Q99685_MGLL_wild_cl1,MGLL_6ax1A_C0S,Q99685,,MGLL,wild,cl1,6ax1A,C0S,,6ax1,1,1,,hydrolase,,,Azetidine and Piperidine Carbamates as Efficient_ Covalent inhibitors of Monoacylglycerol Lipase.,inhibitor,,0,,,,,,,,,,,,,
Q9BZP6_CHIA_wild_cl1,CHIA_2ybtA_DW0,Q9BZP6,,CHIA,wild,cl1,2ybtA,DW0,,2ybt,1,1,,hydrolase,,,Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor.,inhibitor,,0,,,,,,,,,,,,,
Q9BZP6_CHIA_wild_cl1,CHIA_3rm4A_3RM,Q9BZP6,,CHIA,wild,cl1,3rm4A,3RM,,3rm4,1,1,,hydrolase,,,Identification and Characterization of Acidic Mammalian Chitinase inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q9H227_GBA3_wild_cl1,GBA3_3vkkA_MAN,Q9H227,,GBA3,wild,cl1,3vkkA,MAN,,3vkk,3,2,,hydrolase,,,Structural basis for inhibition mechanism of human cytosolic beta-glucosidase by monnoside,inhibitor,,0,,,,,,,,,,,,,
Q9Y3R4_NEU2_wild_cl1,NEU2_2f0zA_ZMR,Q9Y3R4,,NEU2,wild,cl1,2f0zA,ZMR,,2f0z,3,1,,hydrolase,,,Crystal Structure of the Human Sialidase Neu2 in Complex with  Zanamivir inhibitor,inhibitor,,0,,,,,,,,,,,,,
Q9Y3R4_NEU2_wild_cl1,NEU2_2f29A_DAN,Q9Y3R4,,NEU2,wild,cl1,2f29A,DAN,,2f29,3,1,,hydrolase,,,Crystal Structure of the Human Sialidase Neu2 Q116E Mutant in Complex with DANA inhibitor,inhibitor,,0,,,,,,,,,,,,,
A1Z1Q3_MACROD2_wild_cl1,MACROD2_4iqyA_AR6,A1Z1Q3,,MACROD2,wild,cl1,4iqyA,AR6,,4iqy,3,1,,hydrolase,,,A family of macrodomain proteins reverses cellular mono-ADP-ribosylation.,,,0,,,,,,,,,,,,,
O60502_OGA_wild_cl2,OGA_5m7uA_XHA,O60502,,OGA,wild,cl2,5m7uA,XHA,,5m7u,1,2,,hydrolase,,,Structural and functional insight into human O-GlcNAcase.,,,0,,,,,,,,,,,,,
O75608_LYPLA1_wild_cl1,LYPLA1_6qgsD_PLM,O75608,,LYPLA1,wild,cl1,6qgsD,PLM,,6qgs,3,1,,hydrolase,,,Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains.,,,0,,,,,,,,,,,,,
O75608_LYPLA1_wild_cl1,LYPLA1_6qgsA_PLM,O75608,,LYPLA1,wild,cl1,6qgsA,PLM,,6qgs,3,1,,hydrolase,,,Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains.,,,0,,,,,,,,,,,,,
O95989_NUDT3_wild_cl1,NUDT3_2q9pA_IHP,O95989,,NUDT3,wild,cl1,2q9pA,IHP,,2q9p,3,1,,hydrolase,,,Crystal structure of human diphosphoinositol phosphatase 1.,,,0,,,,,,,,,,,,,
O95989_NUDT3_wild_cl1,NUDT3_6pckA_O81,O95989,,NUDT3,wild,cl1,6pckA,O81,,6pck,3,1,,hydrolase,,,Vip1 is a kinase and pyrophosphatase switch that regulates inositol diphosphate signaling.,,,0,,,,,,,,,,,,,
P00813_ADA_wild_cl1,ADA_3iarA_3D1,P00813,,ADA,wild,cl1,3iarA,3D1,,3iar,3,1,,hydrolase,,,The crystal structure of human adenosine deaminase,,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl3,GBA_2wcgA_NAG,P04062,,GBA,wild,cl3,2wcgA,NAG,,2wcg,1,3,,hydrolase,,,6-Amino-6-Deoxy-5_6-Di-N-(N'-Octyliminomethylidene)Nojirimycin: Synthesis_ Biological Evaluation_ and Crystal Structure in Complex with Acid Beta-Glucosidase.,,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl1,GBA_2v3dB_NBV,P04062,,GBA,wild,cl1,2v3dB,NBV,,2v3d,1,3,,hydrolase,,,Crystal Structures of Complexes of N-Butyl- and N-Nonyl-Deoxynojirimycin Bound to Acid Beta-Glucosidase: Insights Into the Mechanism of Chemical Chaperone Action in Gaucher Disease.,,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl3,GBA_3gxdA_NAG,P04062,,GBA,wild,cl3,3gxdA,NAG,,3gxd,1,3,,hydrolase,,,Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.,,,0,,,,,,,,,,,,,
P04062_GBA_wild_cl1,GBA_1y7vA_INS,P04062,,GBA,wild,cl1,1y7vA,INS,,1y7v,1,3,,hydrolase,,,X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.,,,0,,,,,,,,,,,,,
P04180_LCAT_wild_cl1,LCAT_6mvdA_H94,P04180,,LCAT,wild,cl1,6mvdA,H94,,6mvd,3,2,,hydrolase,,,Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.,,,0,,,,,,,,,,,,,
P04180_LCAT_wild_cl2,LCAT_6mvdA_H9A,P04180,,LCAT,wild,cl2,6mvdA,H9A,,6mvd,3,2,,hydrolase,,,Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.,,,0,,,,,,,,,,,,,
P04180_LCAT_wild_cl1,LCAT_6dtjA_H94,P04180,,LCAT,wild,cl1,6dtjA,H94,,6dtj,3,2,6MVD,hydrolase,,,Crystal structure of Lecithin:cholesterol acyltransferase (LCAT) in complex with isopropyl dodec-11-enylfluorophosphonate (IDFP) and a small molecule activator,,,0,,,,,,,,,,,,,
P04180_LCAT_wild_cl2,LCAT_6dtjB_H9A,P04180,,LCAT,wild,cl2,6dtjB,H9A,,6dtj,3,2,6MVD,hydrolase,,,Crystal structure of Lecithin:cholesterol acyltransferase (LCAT) in complex with isopropyl dodec-11-enylfluorophosphonate (IDFP) and a small molecule activator,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl1,AMY2A_1xd1A_6SA,P04746,,AMY2A,wild,cl1,1xd1A,6SA,,1xd1,1,7,,hydrolase,,,Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl3,AMY2A_6z8lA_GLC,P04746,,AMY2A,wild,cl3,6z8lA,GLC,,6z8l,1,7,,hydrolase,,,Enhancing glycan stability via site-selective fluorination: modulating substrate orientation by molecular design.,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl6,AMY2A_5td4A_MTT,P04746,,AMY2A,wild,cl6,5td4A,MTT,,5td4,1,7,,hydrolase,,,Evaluation of the Significance of Starch Surface Binding Sites on Human Pancreatic alpha-Amylase.,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl7,AMY2A_4gqqA_0XR,P04746,,AMY2A,wild,cl7,4gqqA,0XR,,4gqq,1,7,,hydrolase,,,Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase_ an antidiabetic target.,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl1,AMY2A_3oldA_GLC,P04746,,AMY2A,wild,cl1,3oldA,GLC,,3old,1,7,,hydrolase,,,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl2,AMY2A_3olgA_BGC,P04746,,AMY2A,wild,cl2,3olgA,BGC,,3olg,1,7,,hydrolase,,,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes.,,,0,,,,,,,,,,,,,
P04746_AMY2A_wild_cl5,AMY2A_3oleA_GLC,P04746,,AMY2A,wild,cl5,3oleA,GLC,,3ole,1,7,,hydrolase,,,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl3,GLA_3hg2B_GAL,P06280,,GLA,wild,cl3,3hg2B,GAL,,3hg2,1,4,,hydrolase,,,Catalytic mechanism of human alpha-galactosidase.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl1,GLA_3gxtA_NAG,P06280,,GLA,wild,cl1,3gxtA,NAG,,3gxt,1,4,,hydrolase,,,Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl2,GLA_3gxtA_NOJ,P06280,,GLA,wild,cl2,3gxtA,NOJ,,3gxt,1,4,,hydrolase,,,Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl4,GLA_3gxnA_NAG,P06280,,GLA,wild,cl4,3gxnA,NAG,,3gxn,1,4,,hydrolase,,,Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl2,GLA_3lxaA_GLA,P06280,,GLA,wild,cl2,3lxaA,GLA,,3lxa,1,4,,hydrolase,,,Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases.,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl1,GLA_3s5yA_FUC,P06280,,GLA,wild,cl1,3s5yA,FUC,,3s5y,1,4,,hydrolase,,,The molecular basis of pharmacological chaperoning in human alpha-galactosidase,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl3,GLA_3s5zA_GAL,P06280,,GLA,wild,cl3,3s5zA,GAL,,3s5z,1,4,,hydrolase,,,The molecular basis of pharmacological chaperoning in human alpha-galactosidase,,,0,,,,,,,,,,,,,
P06280_GLA_wild_cl4,GLA_3s5yA_XYP,P06280,,GLA,wild,cl4,3s5yA,XYP,,3s5y,1,4,,hydrolase,,,The molecular basis of pharmacological chaperoning in human alpha-galactosidase,,,0,,,,,,,,,,,,,
P06858_LPL_wild_cl1,LPL_6e7kA_FUC,P06858,,LPL,wild,cl1,6e7kA,FUC,,6e7k,3,1,,hydrolase,,,Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.,,,0,,,,,,,,,,,,,
P06865_HEXA_wild_cl1,HEXA_2gjxD_NAG,P06865,,HEXA,wild,cl1,2gjxD,NAG,,2gjx,3,1,,hydrolase,,,Crystallographic structure of human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss    of GM2 Ganglioside Hydrolysis,,,0,,,,,,,,,,,,,
P06865_HEXA_wild_cl1,HEXA_2gk1C_NAG,P06865,,HEXA,wild,cl1,2gk1C,NAG,,2gk1,3,1,,hydrolase,,,Crystallographic Structure of Human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of G(M2) Ganglioside Hydrolysis.,,,0,,,,,,,,,,,,,
P06865_HEXA_wild_cl2,HEXA_2gk1A_NGT,P06865,,HEXA,wild,cl2,2gk1A,NGT,,2gk1,3,1,,hydrolase,,,Crystallographic Structure of Human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of G(M2) Ganglioside Hydrolysis.,,,0,,,,,,,,,,,,,
P06865_HEXA_wild_cl2,HEXA_2gk1C_NGT,P06865,,HEXA,wild,cl2,2gk1C,NGT,,2gk1,3,1,,hydrolase,,,Crystallographic Structure of Human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of G(M2) Ganglioside Hydrolysis.,,,0,,,,,,,,,,,,,
P07686_HEXB_wild_cl1,HEXB_1nowA_IFG,P07686,,HEXB,wild,cl1,1nowA,IFG,,1now,2,2,,hydrolase,,,Crystal structure of Human beta-hexosaminidase B: Understanding the molecular basis of Sandhoff and Tay-Sachs disease,,,0,,,,,,,,,,,,,
P07686_HEXB_wild_cl2,HEXB_2gjxB_NDG,P07686,,HEXB,wild,cl2,2gjxB,NDG,,2gjx,2,2,,hydrolase,,,Crystallographic structure of human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss    of GM2 Ganglioside Hydrolysis,,,0,,,,,,,,,,,,,
P07686_HEXB_wild_cl2,HEXB_2gk1F_NAG,P07686,,HEXB,wild,cl2,2gk1F,NAG,,2gk1,2,2,,hydrolase,,,Crystallographic Structure of Human beta-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of G(M2) Ganglioside Hydrolysis.,,,0,,,,,,,,,,,,,
P07686_HEXB_wild_cl1,HEXB_3lmyA_CP6,P07686,,HEXB,wild,cl1,3lmyA,CP6,,3lmy,2,2,,hydrolase,,,The Crystal Structure of beta-hexosaminidase B in complex with Pyrimethamine,,,0,,,,,,,,,,,,,
P08236_GUSB_wild_cl1,GUSB_3hn3D_MAN,P08236,,GUSB,wild,cl1,3hn3D,MAN,,3hn3,3,2,,hydrolase,,,Human beta-glucuronidasel at 1.7 A resolution,,,0,,,,,,,,,,,,,
P08236_GUSB_wild_cl2,GUSB_3hn3A_MAN,P08236,,GUSB,wild,cl2,3hn3A,MAN,,3hn3,3,2,,hydrolase,,,Human beta-glucuronidasel at 1.7 A resolution,,,0,,,,,,,,,,,,,
P11586_MTHFD1_wild_cl1,MTHFD1_6ecqA_NAP,P11586,,MTHFD1,wild,cl1,6ecqA,NAP,,6ecq,1,2,,hydrolase,,,An assessment of three human methylenetetrahydrofolate dehydrogenase/cyclohydrolase-ligand complexes following further refinement.,,,0,,,,,,,,,,,,,
P11586_MTHFD1_wild_cl2,MTHFD1_6ecqA_LUD,P11586,,MTHFD1,wild,cl2,6ecqA,LUD,,6ecq,1,2,,hydrolase,,,An assessment of three human methylenetetrahydrofolate dehydrogenase/cyclohydrolase-ligand complexes following further refinement.,,,0,,,,,,,,,,,,,
P11586_MTHFD1_wild_cl1,MTHFD1_1a4iA_NDP,P11586,,MTHFD1,wild,cl1,1a4iA,NDP,,1a4i,1,2,,hydrolase,,,The 3-D structure of a folate-dependent dehydrogenase/cyclohydrolase bifunctional enzyme at 1.5 A resolution.,,,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl3,MTHFD2_7ehnA_J4F,P13995,,MTHFD2,wild,cl3,7ehnA,J4F,,7ehn,1,3,,hydrolase,,,Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).,,allosteric,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl3,MTHFD2_7ehvB_J4L,P13995,,MTHFD2,wild,cl3,7ehvB,J4L,,7ehv,1,3,,hydrolase,,,Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).,,allosteric,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl1,MTHFD2_6s4fA_ADP,P13995,,MTHFD2,wild,cl1,6s4fA,ADP,,6s4f,1,3,,hydrolase,,,Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.,,,0,,,,,,,,,,,,,
P13995_MTHFD2_wild_cl2,MTHFD2_6s4fA_KUN,P13995,,MTHFD2,wild,cl2,6s4fA,KUN,,6s4f,1,3,,hydrolase,,,Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.,,,0,,,,,,,,,,,,,
P16278_GLB1_wild_cl3,GLB1_3thcD_NAG,P16278,,GLB1,wild,cl3,3thcD,NAG,,3thc,2,3,,hydrolase,,,Crystal structure of human beta-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases,,,0,,,,,,,,,,,,,
P16278_GLB1_wild_cl1,GLB1_3wf3A_GAL,P16278,,GLB1,wild,cl1,3wf3A,GAL,,3wf3,2,3,,hydrolase,,,Structural basis of pharmacological chaperoning for human beta-galactosidase,,,0,,,,,,,,,,,,,
P16278_GLB1_wild_cl1,GLB1_3wezA_N8V,P16278,,GLB1,wild,cl1,3wezA,N8V,,3wez,2,3,,hydrolase,,,Structural basis of pharmacological chaperoning for human beta-galactosidase,,,0,,,,,,,,,,,,,
P16278_GLB1_wild_cl2,GLB1_3wf3A_NAG,P16278,,GLB1,wild,cl2,3wf3A,NAG,,3wf3,2,3,,hydrolase,,,Structural basis of pharmacological chaperoning for human beta-galactosidase,,,0,,,,,,,,,,,,,
P16278_GLB1_wild_cl2,GLB1_3wf3B_NAG,P16278,,GLB1,wild,cl2,3wf3B,NAG,,3wf3,2,3,,hydrolase,,,Structural basis of pharmacological chaperoning for human beta-galactosidase,,,0,,,,,,,,,,,,,
P16444_DPEP1_wild_cl1,DPEP1_1ituA_CIL,P16444,,DPEP1,wild,cl1,1ituA,CIL,,1itu,3,1,,hydrolase,,,Crystal Structure of Human Renal Dipeptidase Involved in beta-Lactam Hydrolysis,,,0,,,,,,,,,,,,,
P17050_NAGA_wild_cl1,NAGA_4do5A_DGJ,P17050,,NAGA,wild,cl1,4do5A,DGJ,,4do5,3,4,,hydrolase,,,Pharmacological chaperones for human alpha-N-acetylgalactosaminidase,,,0,,,,,,,,,,,,,
P17050_NAGA_wild_cl2,NAGA_4do6A_BGC,P17050,,NAGA,wild,cl2,4do6A,BGC,,4do6,3,4,,hydrolase,,,Pharmacological chaperones for human alpha-N-acetylgalactosaminidase,,,0,,,,,,,,,,,,,
P17050_NAGA_wild_cl3,NAGA_4do6A_GLC,P17050,,NAGA,wild,cl3,4do6A,GLC,,4do6,3,4,,hydrolase,,,Pharmacological chaperones for human alpha-N-acetylgalactosaminidase,,,0,,,,,,,,,,,,,
P17050_NAGA_wild_cl1,NAGA_3h54A_A2G,P17050,,NAGA,wild,cl1,3h54A,A2G,,3h54,3,4,,hydrolase,,,The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases,,,0,,,,,,,,,,,,,
P17050_NAGA_wild_cl4,NAGA_3h55A_NAG,P17050,,NAGA,wild,cl4,3h55A,NAG,,3h55,3,4,,hydrolase,,,The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases,,,0,,,,,,,,,,,,,
P27708_CAD_wild_cl1,CAD_5g1pD_CP,P27708,,CAD,wild,cl1,5g1pD,CP,,5g1p,3,3,,hydrolase,,,Structure and Functional Characterization of Human Aspartate Transcarbamoylase_ the Target of the Anti-Tumoral Drug Pala.,,,0,,,,,,,,,,,,,
P27708_CAD_wild_cl1,CAD_5g1pA_CP,P27708,,CAD,wild,cl1,5g1pA,CP,,5g1p,3,3,,hydrolase,,,Structure and Functional Characterization of Human Aspartate Transcarbamoylase_ the Target of the Anti-Tumoral Drug Pala.,,,0,,,,,,,,,,,,,
P27708_CAD_wild_cl3,CAD_5g1nA_PAL,P27708,,CAD,wild,cl3,5g1nA,PAL,,5g1n,3,3,,hydrolase,,,Structure and Functional Characterization of Human Aspartate Transcarbamoylase_ the Target of the Anti-Tumoral Drug Pala.,,,0,,,,,,,,,,,,,
P27708_CAD_wild_cl2,CAD_4c6iA_DOR,P27708,,CAD,wild,cl2,4c6iA,DOR,,4c6i,3,3,,hydrolase,,,Structure_ Functional Characterization and Evolution of the Dihydroorotase Domain of Human Cad.,,,0,,,,,,,,,,,,,
P27708_CAD_wild_cl2,CAD_4c6mA_FOT,P27708,,CAD,wild,cl2,4c6mA,FOT,,4c6m,3,3,,hydrolase,,,Structure_ Functional Characterization and Evolution of the Dihydroorotase Domain of Human Cad.,,,0,,,,,,,,,,,,,
P34913_EPHX2_wild_cl1,EPHX2_5akiA_6NF,P34913,,EPHX2,wild,cl1,5akiA,6NF,,5aki,1,2,,hydrolase,,,Successful Generation of Structural Information for Fragment-Based Drug Discovery.,,,0,,,,,,,,,,,,,
P50583_NUDT2_wild_cl1,NUDT2_4ijxA_DPO,P50583,,NUDT2,wild,cl1,4ijxA,DPO,,4ijx,3,1,,hydrolase,,,Crystal structure of wild-type and mutant human Ap4A hydrolase.,,,0,,,,,,,,,,,,,
P54317_PNLIPRP2_wild_cl1,PNLIPRP2_2oxeB_MAN,P54317,,PNLIPRP2,wild,cl1,2oxeB,MAN,,2oxe,3,1,,hydrolase,,,Structure of human pancreatic lipase-related protein 2 with the lid in an open conformation.,,,0,,,,,,,,,,,,,
Q13231_CHIT1_wild_cl1,CHIT1_4wkhA_CBS,Q13231,,CHIT1,wild,cl1,4wkhA,CBS,,4wkh,1,1,,hydrolase,,,New insights into the enzymatic mechanism of human chitotriosidase (CHIT1) catalytic domain by atomic resolution X-ray diffraction and hybrid QM/MM.,,,0,,,,,,,,,,,,,
Q13231_CHIT1_wild_cl1,CHIT1_5nr8A_95N,Q13231,,CHIT1,wild,cl1,5nr8A,95N,,5nr8,1,1,,hydrolase,,,Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.,,,0,,,,,,,,,,,,,
Q86WA6_BPHL_wild_cl1,BPHL_2ociA_TYC,Q86WA6,,BPHL,wild,cl1,2ociA,TYC,,2oci,3,1,,hydrolase,,,Molecular basis of prodrug activation by human valacyclovirase_ an alpha-amino acid ester hydrolase.,,,0,,,,,,,,,,,,,
Q8NCC3_PLA2G15_wild_cl1,PLA2G15_4x97C_MAY,Q8NCC3,,PLA2G15,wild,cl1,4x97C,MAY,,4x97,3,1,,hydrolase,,,Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.,,,0,,,,,,,,,,,,,
Q8NCC3_PLA2G15_wild_cl1,PLA2G15_4x97B_MAY,Q8NCC3,,PLA2G15,wild,cl1,4x97B,MAY,,4x97,3,1,,hydrolase,,,Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.,,,0,,,,,,,,,,,,,
Q8TDX5_ACMSD_wild_cl1,ACMSD_4ih3D_PDC,Q8TDX5,,ACMSD,wild,cl1,4ih3D,PDC,,4ih3,3,1,,hydrolase,,,Human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD): A structural and mechanistic unveiling.,,,0,,,,,,,,,,,,,
Q8TDX5_ACMSD_wild_cl1,ACMSD_4ih3B_PDC,Q8TDX5,,ACMSD,wild,cl1,4ih3B,PDC,,4ih3,3,1,,hydrolase,,,Human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD): A structural and mechanistic unveiling.,,,0,,,,,,,,,,,,,
Q99685_MGLL_wild_cl1,MGLL_4uuqA_64D,Q99685,,MGLL,wild,cl1,4uuqA,64D,,4uuq,1,1,,hydrolase,,,Selective Blockade of the Hydrolysis of the Endocannabinoid 2-Arachidonoylglycerol Impairs Learning and Memory Performance While Producing Antinociceptive Activity in Rodents.,,,0,,,,,,,,,,,,,
Q9BV23_ABHD6_wild_cl1,ABHD6_7otsB_OLA,Q9BV23,,ABHD6,wild,cl1,7otsB,OLA,,7ots,3,2,,hydrolase,,,Crystal structure of human Monoacylglycerol Lipase ABHD6 in complex with oleic acid and octyl glucoside,,,0,,,,,,,,,,,,,
Q9BV23_ABHD6_wild_cl2,ABHD6_7otsA_BOG,Q9BV23,,ABHD6,wild,cl2,7otsA,BOG,,7ots,3,2,,hydrolase,,,Crystal structure of human Monoacylglycerol Lipase ABHD6 in complex with oleic acid and octyl glucoside,,,0,,,,,,,,,,,,,
Q9BW91_NUDT9_wild_cl1,NUDT9_1q33A_BGC,Q9BW91,,NUDT9,wild,cl1,1q33A,BGC,,1q33,3,1,,hydrolase,,,The Crystal Structure and Mutational Analysis of Human NUDT9,,,0,,,,,,,,,,,,,
Q9H227_GBA3_wild_cl2,GBA3_2zoxA_PNG,Q9H227,,GBA3,wild,cl2,2zoxA,PNG,,2zox,3,2,,hydrolase,,,Crystal structure of the covalent intermediate of human cytosolic beta-glucosidase,,,0,,,,,,,,,,,,,
Q9H227_GBA3_wild_cl1,GBA3_2e9mA_GAL,Q9H227,,GBA3,wild,cl1,2e9mA,GAL,,2e9m,3,2,,hydrolase,,,Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase.,,,0,,,,,,,,,,,,,
Q9NV35_NUDT15_wild_cl1,NUDT15_6t5jA_MKB,Q9NV35,,NUDT15,wild,cl1,6t5jA,MKB,,6t5j,3,1,,hydrolase,,,Development of a chemical probe against NUDT15.,,,0,,,,,,,,,,,,,
Q9NV35_NUDT15_wild_cl1,NUDT15_5lpgA_71V,Q9NV35,,NUDT15,wild,cl1,5lpgA,71V,,5lpg,3,1,,hydrolase,,,NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine.,,,0,,,,,,,,,,,,,
Q9NX46_ADPRS_wild_cl1,ADPRS_6d3aC_AR6,Q9NX46,,ADPRS,wild,cl1,6d3aC,AR6,,6d3a,3,1,,hydrolase,,,Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition.,,,0,,,,,,,,,,,,,
Q9NX46_ADPRS_wild_cl1,ADPRS_6d36D_AR6,Q9NX46,,ADPRS,wild,cl1,6d36D,AR6,,6d36,3,1,,hydrolase,,,Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition.,,,0,,,,,,,,,,,,,
Q9NZJ9_NUDT4_wild_cl1,NUDT4_7nnjB_UJN,Q9NZJ9,,NUDT4,wild,cl1,7nnjB,UJN,,7nnj,3,1,,hydrolase,,,Crystal Structure of NUDT4 (Diphosphoinositol polyphosphate phosphohydrolase 2) in complex with 4-O-Bn-1-PCP-InsP4 (AMR2105),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl1,NUDT5_5qjjD_6SU,Q9UKK9,,NUDT5,wild,cl1,5qjjD,6SU,,5qjj,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl1,NUDT5_5qjeA_K0P,Q9UKK9,,NUDT5,wild,cl1,5qjeA,K0P,,5qje,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl2,NUDT5_5qjlD_JJM,Q9UKK9,,NUDT5,wild,cl2,5qjlD,JJM,,5qjl,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl2,NUDT5_5qjeB_K0P,Q9UKK9,,NUDT5,wild,cl2,5qjeB,K0P,,5qje,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl3,NUDT5_5qj6B_GQJ,Q9UKK9,,NUDT5,wild,cl3,5qj6B,GQJ,,5qj6,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl3,NUDT5_5qj6D_GQJ,Q9UKK9,,NUDT5,wild,cl3,5qj6D,GQJ,,5qj6,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl4,NUDT5_5qjxA_K2P,Q9UKK9,,NUDT5,wild,cl4,5qjxA,K2P,,5qjx,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKK9_NUDT5_wild_cl5,NUDT5_5qjxB_K2P,Q9UKK9,,NUDT5,wild,cl5,5qjxB,K2P,,5qjx,3,5,,hydrolase,,,PanDDA analysis group deposition of models with modelled events (e.g. bound ligands),,,0,,,,,,,,,,,,,
Q9UKM7_MAN1B1_wild_cl1,MAN1B1_5kijA_MAN,Q9UKM7,,MAN1B1,wild,cl1,5kijA,MAN,,5kij,2,2,,hydrolase,,,Substrate recognition and catalysis by GH47 alpha-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway.,,,0,,,,,,,,,,,,,
Q9UKM7_MAN1B1_wild_cl1,MAN1B1_5kk7A_SMD,Q9UKM7,,MAN1B1,wild,cl1,5kk7A,SMD,,5kk7,2,2,,hydrolase,,,Substrate recognition and catalysis by GH47 alpha-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway.,,,0,,,,,,,,,,,,,
Q9UKM7_MAN1B1_wild_cl2,MAN1B1_5kijA_1PS,Q9UKM7,,MAN1B1,wild,cl2,5kijA,1PS,,5kij,2,2,,hydrolase,,,Substrate recognition and catalysis by GH47 alpha-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway.,,,0,,,,,,,,,,,,,
Q9UKM7_MAN1B1_wild_cl2,MAN1B1_5kk7A_1PS,Q9UKM7,,MAN1B1,wild,cl2,5kk7A,1PS,,5kk7,2,2,,hydrolase,,,Substrate recognition and catalysis by GH47 alpha-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway.,,,0,,,,,,,,,,,,,
Q9Y251_HPSE_wild_cl1,HPSE_5l9zA_GUX,Q9Y251,,HPSE,wild,cl1,5l9zA,GUX,,5l9z,2,2,,hydrolase,,,Activity-based probes for functional interrogation of retaining beta-glucuronidases.,,,0,,,,,,,,,,,,,
Q9Y251_HPSE_wild_cl2,HPSE_5la7A_FUC,Q9Y251,,HPSE,wild,cl2,5la7A,FUC,,5la7,2,2,,hydrolase,,,Activity-based probes for functional interrogation of retaining beta-glucuronidases.,,,0,,,,,,,,,,,,,
Q9Y251_HPSE_wild_cl2,HPSE_5e8mA_FUC,Q9Y251,,HPSE,wild,cl2,5e8mA,FUC,,5e8m,2,2,,hydrolase,,,Structural characterization of human heparanase reveals insights into substrate recognition.,,,0,,,,,,,,,,,,,
Q9Y251_HPSE_wild_cl1,HPSE_5e97A_BDP,Q9Y251,,HPSE,wild,cl1,5e97A,BDP,,5.00E+97,2,2,,hydrolase,,,Structural characterization of human heparanase reveals insights into substrate recognition.,,,0,,,,,,,,,,,,,
Q9Y2T3_GDA_wild_cl1,GDA_4aqlA_TXC,Q9Y2T3,,GDA,wild,cl1,4aqlA,TXC,,4aql,3,1,,hydrolase,,,Pan-Pathway Based Interaction Profiling of Fda-Approved Nucleoside and Nucleobase Analogs with Enzymes of the Human Nucleotide Metabolism.,,,0,,,,,,,,,,,,,
O00764_PDXK_wild_cl1,PDXK_3keuB_ATP,O00764,,PDXK,wild,cl1,3keuB,ATP,,3keu,3,1,,Kinase,,,Crystal structure of PL kinase in complex with MgATP and PLP: Structural basis of severe induced MgATP substrate inhibition of the enzyme,inhibitor,,0,,,,,,,,,,,,,
P05771_PRKCB_wild_cl1,PRKCB_2i0eB_PDS,P05771,,PRKCB,wild,cl1,2i0eB,PDS,,2i0e,3,1,,Kinase,,,Structure of the Catalytic Domain of Human Protein Kinase C beta II Complexed with a Bisindolylmaleimide inhibitor,inhibitor,,0,,,,,,,,,,,,,
P35558_PCK1_wild_cl2,PCK1_2gmvA_PEP,P35558,,PCK1,wild,cl2,2gmvA,PEP,,2gmv,2,2,,Kinase,,,C-8 Modifications of 3-alkyl-1_8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase.,inhibitor,,0,,,,,,,,,,,,,
P35558_PCK1_wild_cl1,PCK1_1nhxA_FTB,P35558,,PCK1,wild,cl1,1nhxA,FTB,,1nhx,2,2,,Kinase,,,X-RAY STRUCTURES OF TWO XANTHINE inhibitorS BOUND TO PEPCK and N-3 modifications of substituted 1_8-Dibenzylxanthines,inhibitor,,0,,,,,,,,,,,,,
P35558_PCK1_wild_cl1,PCK1_1m51A_TSX,P35558,,PCK1,wild,cl1,1m51A,TSX,,1m51,2,2,,Kinase,,,X-ray Structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1_8-Dibenzylxanthines,inhibitor,,0,,,,,,,,,,,,,
P35558_PCK1_wild_cl2,PCK1_1nhxA_PEP,P35558,,PCK1,wild,cl2,1nhxA,PEP,,1nhx,2,2,,Kinase,,,X-RAY STRUCTURES OF TWO XANTHINE inhibitorS BOUND TO PEPCK and N-3 modifications of substituted 1_8-Dibenzylxanthines,inhibitor,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl2,CHKA_5w6oA_9X1,P35790,,CHKA,wild,cl2,5w6oA,9X1,,5w6o,1,4,,Kinase,,,Identification of a Unique inhibitor-Binding Site on Choline Kinase alpha.,inhibitor,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl2,CHKA_5w6oB_9X1,P35790,,CHKA,wild,cl2,5w6oB,9X1,,5w6o,1,4,,Kinase,,,Identification of a Unique inhibitor-Binding Site on Choline Kinase alpha.,inhibitor,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl4,CHKA_5w6oA_9X1,P35790,,CHKA,wild,cl4,5w6oA,9X1,,5w6o,1,4,,Kinase,,,Identification of a Unique inhibitor-Binding Site on Choline Kinase alpha.,inhibitor,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl1,CHKA_5eqyA_5RA,P35790,,CHKA,wild,cl1,5eqyA,5RA,,5eqy,1,4,,Kinase,,,Novel Small Molecule inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.,inhibitor,,0,,,,,,,,,,,,,
P50053_KHK_wild_cl2,KHK_3nbvA_FRU,P50053,,KHK,wild,cl2,3nbvA,FRU,,3nbv,1,2,,Kinase,,,Electron density guided fragment-based lead discovery of ketohexokinase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P50053_KHK_wild_cl1,KHK_3q92A_XNB,P50053,,KHK,wild,cl1,3q92A,XNB,,3q92,1,2,,Kinase,,,inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site.,inhibitor,,0,,,,,,,,,,,,,
P50053_KHK_wild_cl1,KHK_3qaiA_XNN,P50053,,KHK,wild,cl1,3qaiA,XNN,,3qai,1,2,,Kinase,,,inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site.,inhibitor,,0,,,,,,,,,,,,,
P55263_ADK_wild_cl1,ADK_2i6aA_5I5,P55263,,ADK,wild,cl1,2i6aA,5I5,,2i6a,2,2,,Kinase,,,Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.,inhibitor,,0,,,,,,,,,,,,,
P55263_ADK_wild_cl1,ADK_2i6bB_89I,P55263,,ADK,wild,cl1,2i6bB,89I,,2i6b,2,2,,Kinase,,,Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.,inhibitor,,0,,,,,,,,,,,,,
Q12852_M3K12_wild_cl1,M3K12_5cepA_50E,Q12852,,M3K12,wild,cl1,5cepA,50E,,5cep,2,1,,Kinase,,,Scaffold-Hopping and Structure-Based Discovery of Potent_ Selective_ And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine inhibitors of Dual Leucine Zipper Kinase (DLK_ MAP3K12).,inhibitor,,0,,,,,,,,,,,,,
Q12852_M3K12_wild_cl1,M3K12_5vo2A_9FV,Q12852,,M3K12,wild,cl1,5vo2A,9FV,,5vo2,2,1,,Kinase,,,Selective inhibitors of Dual Leucine Zipper Kinase (DLK_ MAP3K12) with Activity in a Model of Alzheimer's Disease.,inhibitor,,0,,,,,,,,,,,,,
Q13153_PAK1_wild_cl1,PAK1_4zjjA_4OR,Q13153,,PAK1,wild,cl1,4zjjA,4OR,,4zjj,1,1,,Kinase,,,Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 inhibitor.,inhibitor,allosteric,0,,,,,,,,,,,,,
Q13153_PAK1_wild_cl1,PAK1_5imeA_6BZ,Q13153,,PAK1,wild,cl1,5imeA,6BZ,,5ime,1,1,,Kinase,,,Chemically Diverse Group I p21-Activated Kinase (PAK) inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window.,inhibitor,,0,,,,,,,,,,,,,
Q8NFU5_IPMK_wild_cl1,IPMK_6m88A_MYC,Q8NFU5,,IPMK,wild,cl1,6m88A,MYC,,6m88,2,2,,Kinase,,,inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.,inhibitor,,0,,,,,,,,,,,,,
Q8NFU5_IPMK_wild_cl1,IPMK_6m8aA_LU2,Q8NFU5,,IPMK,wild,cl1,6m8aA,LU2,,6m8a,2,2,,Kinase,,,inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.,inhibitor,,0,,,,,,,,,,,,,
Q9Y259_CHKB_wild_cl1,CHKB_3fegA_ADP,Q9Y259,,CHKB,wild,cl1,3fegA,ADP,,3feg,3,2,,Kinase,,,Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.,inhibitor,,0,,,,,,,,,,,,,
Q9Y259_CHKB_wild_cl1,CHKB_3fegA_AMP,Q9Y259,,CHKB,wild,cl1,3fegA,AMP,,3feg,3,2,,Kinase,,,Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.,inhibitor,,0,,,,,,,,,,,,,
Q9Y259_CHKB_wild_cl2,CHKB_3fegA_HC7,Q9Y259,,CHKB,wild,cl2,3fegA,HC7,,3feg,3,2,,Kinase,,,Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.,inhibitor,,0,,,,,,,,,,,,,
Q9Y5S2_MRCKB_wild_cl1,MRCKB_4ualA_3FV,Q9Y5S2,,MRCKB,wild,cl1,4ualA,3FV,,4ual,2,1,,Kinase,,,A novel small-molecule MRCK inhibitor blocks cancer cell invasion.,inhibitor,,0,,,,,,,,,,,,,
Q9Y5S2_MRCKB_wild_cl1,MRCKB_5otfA_AQ5,Q9Y5S2,,MRCKB,wild,cl1,5otfA,AQ5,,5otf,2,1,,Kinase,,,Discovery of Potent and Selective MRCK inhibitors with Therapeutic Effect on Skin Cancer.,inhibitor,,0,,,,,,,,,,,,,
O00764_PDXK_wild_cl1,PDXK_2ajpA_ANP,O00764,,PDXK,wild,cl1,2ajpA,ANP,,2ajp,3,1,,Kinase,,,Crystal structure of a human pyridoxal kinase,,,0,,,,,,,,,,,,,
O43741_PRKAB2_wild_cl1,PRKAB2_6b2eB_CG7,O43741,,PRKAB2,wild,cl1,6b2eB,CG7,,6b2e,3,1,,Kinase,,,Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK alpha 2 beta 2 gamma 1 by the Glucose Importagog SC4.,,,0,,,,,,,,,,,,,
O95340_PAPSS2_wild_cl1,PAPSS2_2ax4A_ADP,O95340,,PAPSS2,wild,cl1,2ax4A,ADP,,2ax4,3,2,,Kinase,,,Crystal structure of the kinase domain of PAPSS 2,,,0,,,,,,,,,,,,,
O95340_PAPSS2_wild_cl1,PAPSS2_7fhaA_ADX,O95340,,PAPSS2,wild,cl1,7fhaA,ADX,,7fha,3,2,,Kinase,,,Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2.,,,0,,,,,,,,,,,,,
O95340_PAPSS2_wild_cl2,PAPSS2_7fh3A_BGC,O95340,,PAPSS2,wild,cl2,7fh3A,BGC,,7fh3,3,2,,Kinase,,,Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2.,,,0,,,,,,,,,,,,,
P00558_PGK1_wild_cl1,PGK1_5m3uA_ADP,P00558,,PGK1,wild,cl1,5m3uA,ADP,,5m3u,3,1,,Kinase,,,The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme.,,,0,,,,,,,,,,,,,
P00558_PGK1_wild_cl1,PGK1_2x14A_ACP,P00558,,PGK1,wild,cl1,2x14A,ACP,,2x14,3,1,,Kinase,,,The Structure of Human Phosphoglycerate Kinase in its Fully Active Conformation in Complex with Ground State Analogues,,,0,,,,,,,,,,,,,
P00568_AK1_wild_cl1,AK1_1z83C_AP5,P00568,,AK1,wild,cl1,1z83C,AP5,,1z83,3,1,,Kinase,,,Crystal structure of human AK1A in complex with  AP5A,,,0,,,,,,,,,,,,,
P04183_TK1_wild_cl1,TK1_1w4rA_TTP,P04183,,TK1,wild,cl1,1w4rA,TTP,,1w4r,2,1,,Kinase,,,Structure of a Type II Thymidine Kinase with Bound Dttp,,,0,,,,,,,,,,,,,
P04183_TK1_wild_cl1,TK1_1w4rD_TTP,P04183,,TK1,wild,cl1,1w4rD,TTP,,1w4r,2,1,,Kinase,,,Structure of a Type II Thymidine Kinase with Bound Dttp,,,0,,,,,,,,,,,,,
P05129_KPCG_wild_cl1,KPCG_2uzpA_PLP,P05129,,KPCG,wild,cl1,2uzpA,PLP,,2uzp,3,1,,Kinase,,,Crystal Structure of C2 Domain of Protein Kinase C Gamma,,,0,,,,,,,,,,,,,
P10644_PRKAR1A_wild_cl1,PRKAR1A_5kjyA_CMP,P10644,,PRKAR1A,wild,cl1,5kjyA,CMP,,5kjy,3,1,,Kinase,,,Mutations of PKA cyclic nucleotide-binding domains reveal novel aspects of cyclic nucleotide selectivity.,,,0,,,,,,,,,,,,,
P10644_PRKAR1A_wild_cl1,PRKAR1A_5kjzA_PCG,P10644,,PRKAR1A,wild,cl1,5kjzA,PCG,,5kjz,3,1,,Kinase,,,Mutations of PKA cyclic nucleotide-binding domains reveal novel aspects of cyclic nucleotide selectivity.,,,0,,,,,,,,,,,,,
P13861_PRKAR2A_wild_cl1,PRKAR2A_2izxA_DTD,P13861,,PRKAR2A,wild,cl1,2izxA,DTD,,2izx,3,1,,Kinase,,,Molecular Basis of Akap Specificity for Pka Regulatory Subunits.,,,0,,,,,,,,,,,,,
P23677_ITPKA_wild_cl1,ITPKA_1w2cA_I3P,P23677,,ITPKA,wild,cl1,1w2cA,I3P,,1w2c,3,2,,Kinase,,,Structure of a Human Inositol 1_4_5-Trisphosphate 3-Kinase; Substrate Binding Reveals Why It is not a Phosphoinositide 3-Kinase,,,0,,,,,,,,,,,,,
P23677_ITPKA_wild_cl1,ITPKA_1w2cB_I3P,P23677,,ITPKA,wild,cl1,1w2cB,I3P,,1w2c,3,2,,Kinase,,,Structure of a Human Inositol 1_4_5-Trisphosphate 3-Kinase; Substrate Binding Reveals Why It is not a Phosphoinositide 3-Kinase,,,0,,,,,,,,,,,,,
P23677_ITPKA_wild_cl2,ITPKA_1w2cA_ANP,P23677,,ITPKA,wild,cl2,1w2cA,ANP,,1w2c,3,2,,Kinase,,,Structure of a Human Inositol 1_4_5-Trisphosphate 3-Kinase; Substrate Binding Reveals Why It is not a Phosphoinositide 3-Kinase,,,0,,,,,,,,,,,,,
P23919_KTHY_wild_cl2,KTHY_1e2qA_ATP,P23919,,KTHY,wild,cl2,1e2qA,ATP,,1e2q,1,2,,Kinase,,,Insights Into the Phosphoryltransfer Mechanism of Human Thymidylate Kinase Gained from Crystal Structures of Enzyme Complexes Along the Reaction Coordinate,,,0,,,,,,,,,,,,,
P23919_KTHY_wild_cl1,KTHY_1nmxA_FDM,P23919,,KTHY,wild,cl1,1nmxA,FDM,,1nmx,1,2,,Kinase,,,Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds,,,0,,,,,,,,,,,,,
P23919_KTHY_wild_cl1,KTHY_1nmzA_NYM,P23919,,KTHY,wild,cl1,1nmzA,NYM,,1nmz,1,2,,Kinase,,,Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds,,,0,,,,,,,,,,,,,
P23919_KTHY_wild_cl2,KTHY_1nn5A_ANP,P23919,,KTHY,wild,cl2,1nn5A,ANP,,1nn5,1,2,,Kinase,,,Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds,,,0,,,,,,,,,,,,,
P27144_AK4_wild_cl1,AK4_2bbwB_GP5,P27144,,AK4,wild,cl1,2bbwB,GP5,,2bbw,3,1,,Kinase,,,Crystal structure of human adenylate kinase 4 (AK4) in complex with diguanosine pentaphosphate,,,0,,,,,,,,,,,,,
P31321_PRKAR1B_wild_cl1,PRKAR1B_4dinB_ATP,P31321,,PRKAR1B,wild,cl1,4dinB,ATP,,4din,3,1,,Kinase,,,Localization and quaternary structure of the PKA RI Beta holoenzyme,,,0,,,,,,,,,,,,,
P35557_GCK_wild_cl3,GCK_3fguA_ANP,P35557,,GCK,wild,cl3,3fguA,ANP,,3fgu,1,3,,Kinase,,,The active conformation of human glucokinase is not altered by Allosteric activators,,allosteric,0,,,,,,,,,,,,,
P35557_GCK_wild_cl2,GCK_4rchA_GLC,P35557,,GCK,wild,cl2,4rchA,GLC,,4rch,1,3,,Kinase,,,Discovery of 2-pyridylureas as glucokinase activators.,,,0,,,,,,,,,,,,,
P35557_GCK_wild_cl1,GCK_7t79A_G1S,P35557,,GCK,wild,cl1,7t79A,G1S,,7t79,1,3,,Kinase,,,Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1 H -pyrazol-1-yl)methyl)phosphonate (BMS-820132).,,,0,,,,,,,,,,,,,
P35557_GCK_wild_cl3,GCK_3veyA_AGS,P35557,,GCK,wild,cl3,3veyA,AGS,,3vey,1,3,,Kinase,,,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,,,0,,,,,,,,,,,,,
P35557_GCK_wild_cl1,GCK_4ixcA_1JD,P35557,,GCK,wild,cl1,4ixcA,1JD,,4ixc,1,3,,Kinase,,,Matched triplicate design sets in the optimisation of glucokinase activators    maximising medicinal chemistry information content,,,0,,,,,,,,,,,,,
P35557_GCK_wild_cl2,GCK_4l3qA_GLC,P35557,,GCK,wild,cl2,4l3qA,GLC,,4l3q,1,3,,Kinase,,,Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif.,,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl1,CHKA_4br3A_U85,P35790,,CHKA,wild,cl1,4br3A,U85,,4br3,1,4,,Kinase,,,Determination of Potential Scaffolds for Human Choline Kinase Alpha 1 by Chemical Deconvolution Studies,,,0,,,,,,,,,,,,,
P35790_CHKA_wild_cl3,CHKA_4cg8A_G8V,P35790,,CHKA,wild,cl3,4cg8A,G8V,,4cg8,1,4,,Kinase,,,Discovery of a New Binding Site on Human Choline Kinase A1: Design_ Synthesis_ Crystallographic Studies and Biological Evaluation of Asymmetrical Bispyridinium Derivatives,,,0,,,,,,,,,,,,,
P50053_KHK_wild_cl2,KHK_2hw1A_FRU,P50053,,KHK,wild,cl2,2hw1A,FRU,,2hw1,1,2,,Kinase,,,Structures of alternatively spliced isoforms of human ketohexokinase.,,,0,,,,,,,,,,,,,
P52790_HK3_wild_cl1,HK3_3hm8A_BG6,P52790,,HK3,wild,cl1,3hm8A,BG6,,3hm8,3,1,,Kinase,,,Crystal structure of the C-terminal Hexokinase domain of human HK3,,,0,,,,,,,,,,,,,
P54619_PRKAG1_wild_cl1,PRKAG1_4rerG_AMP,P54619,,PRKAG1,wild,cl1,4rerG,AMP,,4rer,3,1,,Kinase,,,Structural basis of AMPK regulation by adenine nucleotides and glycogen.,,,0,,,,,,,,,,,,,
P54619_PRKAG1_wild_cl1,PRKAG1_6b2eC_AMP,P54619,,PRKAG1,wild,cl1,6b2eC,AMP,,6b2e,3,1,,Kinase,,,Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK alpha 2 beta 2 gamma 1 by the Glucose Importagog SC4.,,,0,,,,,,,,,,,,,
P54819_AK2_wild_cl1,AK2_2c9yA_B4P,P54819,,AK2,wild,cl1,2c9yA,B4P,,2c9y,3,1,,Kinase,,,Structure of Human Adenylate Kinase 2,,,0,,,,,,,,,,,,,
P55263_ADK_wild_cl2,ADK_1bx4A_ADN,P55263,,ADK,wild,cl2,1bx4A,ADN,,1bx4,2,2,,Kinase,,,Structure of human adenosine kinase at 1.5 A resolution.,,,0,,,,,,,,,,,,,
P60891_PRPS1_wild_cl1,PRPS1_2hcrB_AMP,P60891,,PRPS1,wild,cl1,2hcrB,AMP,,2hcr,3,1,,Kinase,,,Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel Allosteric site,,allosteric,0,,,,,,,,,,,,,
Q05823_RNASEL_wild_cl1,RNASEL_4g8lA_25A,Q05823,,RNASEL,wild,cl1,4g8lA,25A,,4g8l,3,1,,Kinase,,,Innate Immune Messenger 2-5A Tethers Human RNase L into Active High-Order Complexes.,,,0,,,,,,,,,,,,,
Q13131_AAPK1_wild_cl1,AAPK1_6c9gA_R93,Q13131,,AAPK1,wild,cl1,6c9gA,R93,,6c9g,2,1,,Kinase,,,Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated_ non-phosphorylated_ and nucleotide-free states.,,,0,,,,,,,,,,,,,
Q13131_AAPK1_wild_cl1,AAPK1_6c9jA_R34,Q13131,,AAPK1,wild,cl1,6c9jA,R34,,6c9j,2,1,,Kinase,,,Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated_ non-phosphorylated_ and nucleotide-free states.,,,0,,,,,,,,,,,,,
Q13418_ILK_wild_cl1,ILK_3kmwA_ATP,Q13418,,ILK,wild,cl1,3kmwA,ATP,,3kmw,3,1,,Kinase,,,The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.,,,0,,,,,,,,,,,,,
Q7RTN6_STRADA_wild_cl1,STRADA_3gniB_ATP,Q7RTN6,,STRADA,wild,cl1,3gniB,ATP,,3gni,3,1,,Kinase,,,ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor,,,0,,,,,,,,,,,,,
Q8NFU5_IPMK_wild_cl2,IPMK_5w2hA_I3P,Q8NFU5,,IPMK,wild,cl2,5w2hA,I3P,,5w2h,2,2,,Kinase,,,Structural features of human inositol phosphate multikinase rationalize its inositol phosphate kinase and phosphoinositide 3-kinase activities.,,,0,,,,,,,,,,,,,
Q8TE04_PANK1_wild_cl1,PANK1_2i7nB_ACO,Q8TE04,,PANK1,wild,cl1,2i7nB,ACO,,2i7n,3,2,,Kinase,,,Crystal structures of human pantothenate kinases. Insights into Allosteric regulation and mutations linked to a neurodegeneration disorder.,,allosteric,0,,,,,,,,,,,,,
Q8TE04_PANK1_wild_cl1,PANK1_3smpB_ACO,Q8TE04,,PANK1,wild,cl1,3smpB,ACO,,3smp,3,2,,Kinase,,,Monoclinic crystal structure of human pantothenate kinase 1 alpha,,,0,,,,,,,,,,,,,
Q8TE04_PANK1_wild_cl2,PANK1_3smpA_ACO,Q8TE04,,PANK1,wild,cl2,3smpA,ACO,,3smp,3,2,,Kinase,,,Monoclinic crystal structure of human pantothenate kinase 1 alpha,,,0,,,,,,,,,,,,,
Q8TE04_PANK1_wild_cl2,PANK1_3smpB_ACO,Q8TE04,,PANK1,wild,cl2,3smpB,ACO,,3smp,3,2,,Kinase,,,Monoclinic crystal structure of human pantothenate kinase 1 alpha,,,0,,,,,,,,,,,,,
Q96DU7_ITPKC_wild_cl1,ITPKC_2a98A_I3P,Q96DU7,,ITPKC,wild,cl1,2a98A,I3P,,2a98,3,1,,Kinase,,,The crystal structure of the catalytic domain of human inositol 1_4_5-trisphosphate 3-kinase C,,,0,,,,,,,,,,,,,
Q9BZ23_PANK2_wild_cl1,PANK2_5e26A_ADP,Q9BZ23,,PANK2,wild,cl1,5e26A,ADP,,5.00E+26,3,3,,Kinase,,,Crystal structure of human PANK2: the catalytic core domain in complex with pantothenate and adenosine diphosphate,,,0,,,,,,,,,,,,,
Q9BZ23_PANK2_wild_cl2,PANK2_5e26C_PAU,Q9BZ23,,PANK2,wild,cl2,5e26C,PAU,,5.00E+26,3,3,,Kinase,,,Crystal structure of human PANK2: the catalytic core domain in complex with pantothenate and adenosine diphosphate,,,0,,,,,,,,,,,,,
Q9BZ23_PANK2_wild_cl3,PANK2_5e26A_PAU,Q9BZ23,,PANK2,wild,cl3,5e26A,PAU,,5.00E+26,3,3,,Kinase,,,Crystal structure of human PANK2: the catalytic core domain in complex with pantothenate and adenosine diphosphate,,,0,,,,,,,,,,,,,
Q9H3S4_TPK1_wild_cl1,TPK1_3s4yA_TPP,Q9H3S4,,TPK1,wild,cl1,3s4yA,TPP,,3s4y,3,2,,Kinase,,,Crystal structure of human thiamin pyrophosphokinase 1,,,0,,,,,,,,,,,,,
Q9H3S4_TPK1_wild_cl1,TPK1_3s4yB_TPP,Q9H3S4,,TPK1,wild,cl1,3s4yB,TPP,,3s4y,3,2,,Kinase,,,Crystal structure of human thiamin pyrophosphokinase 1,,,0,,,,,,,,,,,,,
Q9H3S4_TPK1_wild_cl2,TPK1_3s4yB_TPP,Q9H3S4,,TPK1,wild,cl2,3s4yB,TPP,,3s4y,3,2,,Kinase,,,Crystal structure of human thiamin pyrophosphokinase 1,,,0,,,,,,,,,,,,,
Q9H999_PANK3_wild_cl2,PANK3_2i7pD_ACO,Q9H999,,PANK3,wild,cl2,2i7pD,ACO,,2i7p,3,2,,Kinase,,,Crystal structures of human pantothenate kinases. Insights into Allosteric regulation and mutations linked to a neurodegeneration disorder.,,allosteric,0,,,,,,,,,,,,,
Q9H999_PANK3_wild_cl2,PANK3_2i7pB_ACO,Q9H999,,PANK3,wild,cl2,2i7pB,ACO,,2i7p,3,2,,Kinase,,,Crystal structures of human pantothenate kinases. Insights into Allosteric regulation and mutations linked to a neurodegeneration disorder.,,allosteric,0,,,,,,,,,,,,,
Q9H999_PANK3_wild_cl1,PANK3_6b3vA_7DQ,Q9H999,,PANK3,wild,cl1,6b3vA,7DQ,,6b3v,3,2,,Kinase,,,A therapeutic approach to pantothenate kinase associated neurodegeneration.,,,0,,,,,,,,,,,,,
Q9H999_PANK3_wild_cl1,PANK3_3smsA_ADP,Q9H999,,PANK3,wild,cl1,3smsA,ADP,,3sms,3,2,,Kinase,,,Human Pantothenate kinase 3 in complex with a pantothenate analog,,,0,,,,,,,,,,,,,
Q9UJ70_NAGK_wild_cl1,NAGK_2ch6A_GLC,Q9UJ70,,NAGK,wild,cl1,2ch6A,GLC,,2ch6,3,2,,Kinase,,,Structures of Human N-Acetylglucosamine Kinase in Two Complexes with N-Acetylglucosamine and with Adp/Glucose: Insights Into Substrate Specificity and Regulation.,,,0,,,,,,,,,,,,,
Q9UJ70_NAGK_wild_cl1,NAGK_2ch6B_GLC,Q9UJ70,,NAGK,wild,cl1,2ch6B,GLC,,2ch6,3,2,,Kinase,,,Structures of Human N-Acetylglucosamine Kinase in Two Complexes with N-Acetylglucosamine and with Adp/Glucose: Insights Into Substrate Specificity and Regulation.,,,0,,,,,,,,,,,,,
Q9UJ70_NAGK_wild_cl2,NAGK_2ch6A_ADP,Q9UJ70,,NAGK,wild,cl2,2ch6A,ADP,,2ch6,3,2,,Kinase,,,Structures of Human N-Acetylglucosamine Kinase in Two Complexes with N-Acetylglucosamine and with Adp/Glucose: Insights Into Substrate Specificity and Regulation.,,,0,,,,,,,,,,,,,
Q9UJ70_NAGK_wild_cl2,NAGK_2ch6D_ADP,Q9UJ70,,NAGK,wild,cl2,2ch6D,ADP,,2ch6,3,2,,Kinase,,,Structures of Human N-Acetylglucosamine Kinase in Two Complexes with N-Acetylglucosamine and with Adp/Glucose: Insights Into Substrate Specificity and Regulation.,,,0,,,,,,,,,,,,,
Q9Y478_PRKAB1_wild_cl1,PRKAB1_4cffD_C1V,Q9Y478,,PRKAB1,wild,cl1,4cffD,C1V,,4cff,3,1,,Kinase,,,Structural Basis of Ampk Regulation by Small Molecule Activators.,,,0,,,,,,,,,,,,,
Q9Y478_PRKAB1_wild_cl1,PRKAB1_5isoD_992,Q9Y478,,PRKAB1,wild,cl1,5isoD,992,,5iso,3,1,,Kinase,,,STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR_ A BENZIMIDAZOLE DERIVATIVE (991),,,0,,,,,,,,,,,,,
O15496_PLA2G10_wild_cl1,PLA2G10_6g5jA_EM8,O15496,,PLA2G10,wild,cl1,6g5jA,EM8,,6g5j,2,1,,lipase,,,Design of Selective sPLA2-X inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl]pyridine-2-yl}propanoic Acid.,inhibitor,,0,,,,,,,,,,,,,
O15496_PLA2G10_wild_cl1,PLA2G10_5owcA_AYZ,O15496,,PLA2G10,wild,cl1,5owcA,AYZ,,5owc,2,1,,lipase,,,Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2Type X (sPLA2-X) inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P14555_PLA2G2A_wild_cl2,PLA2G2A_1j1aA_BHP,P14555,,PLA2G2A,wild,cl2,1j1aA,BHP,,1j1a,1,2,,lipase,,,D-Tyrosine as a Chiral Precusor to Potent inhibitors of Human Nonpancreatic Secretory Phospholipase A2 (IIa) with Antiinflammatory Activity,inhibitor,,0,,,,,,,,,,,,,
P14555_PLA2G2A_wild_cl1,PLA2G2A_1kvoC_OAP,P14555,,PLA2G2A,wild,cl1,1kvoC,OAP,,1kvo,1,2,,lipase,,,High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).,inhibitor,,0,,,,,,,,,,,,,
P14555_PLA2G2A_wild_cl2,PLA2G2A_3u8hA_BHP,P14555,,PLA2G2A,wild,cl2,3u8hA,BHP,,3u8h,1,2,,lipase,,,Selective inhibition of Human Group IIA-secreted Phospholipase A2 (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid Synoviocytes.,inhibitor,,0,,,,,,,,,,,,,
O14939_PLD2_wild_cl1,PLD2_6ohpD_MJV,O14939,,PLD2,wild,cl1,6ohpD,MJV,,6ohp,1,1,,lipase,,,Human PLD structures enable drug design and characterization of isoenzyme selectivity.,,,0,,,,,,,,,,,,,
O14939_PLD2_wild_cl1,PLD2_6ohpB_MJV,O14939,,PLD2,wild,cl1,6ohpB,MJV,,6ohp,1,1,,lipase,,,Human PLD structures enable drug design and characterization of isoenzyme selectivity.,,,0,,,,,,,,,,,,,
P14555_PLA2G2A_wild_cl1,PLA2G2A_1aypF_INB,P14555,,PLA2G2A,wild,cl1,1aypF,INB,,1ayp,1,2,,lipase,,,A probe molecule composed of seventeen percent of total diffracting matter gives correct solutions in molecular replacement.,,,0,,,,,,,,,,,,,
Q13393_PLD1_wild_cl1,PLD1_6ohrA_MKG,Q13393,,PLD1,wild,cl1,6ohrA,MKG,,6ohr,2,1,,lipase,,,Human PLD structures enable drug design and characterization of isoenzyme selectivity.,,,0,,,,,,,,,,,,,
Q13393_PLD1_wild_cl1,PLD1_6ohrF_MKG,Q13393,,PLD1,wild,cl1,6ohrF,MKG,,6ohr,2,1,,lipase,,,Human PLD structures enable drug design and characterization of isoenzyme selectivity.,,,0,,,,,,,,,,,,,
Q9NZK7_PLA2G2E_wild_cl1,PLA2G2E_5y5eA_7W3,Q9NZK7,,PLA2G2E,wild,cl1,5y5eA,7W3,,5y5e,3,1,,lipase,,,Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A2group IIE,,,0,,,,,,,,,,,,,
P50135_HNMT_wild_cl1,HNMT_2aouA_CQA,P50135,,HNMT,wild,cl1,2aouA,CQA,,2aou,3,1,,methylase,,,Structural basis for inhibition of histamine N-methyltransferase by diverse drugs,inhibitor,,0,,,,,,,,,,,,,
Q9NR48_ASH1L_wild_cl1,ASH1L_6agoA_SAM,Q9NR48,,ASH1L,wild,cl1,6agoA,SAM,,6ago,3,1,,methylase,,,Structural Basis of MRG15-Mediated Activation of the ASH1L Histone Methyltransferase by Releasing an Autoinhibitory Loop.,inhibitor,,0,,,,,,,,,,,,,
O14717_TRDMT1_wild_cl1,TRDMT1_1g55A_SAH,O14717,,TRDMT1,wild,cl1,1g55A,SAH,,1g55,3,1,,methylase,,,Structure of human DNMT2_ an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA.,,,0,,,,,,,,,,,,,
O43148_RNMT_wild_cl1,RNMT_5e9jA_SAH,O43148,,RNMT,wild,cl1,5e9jA,SAH,,5e9j,3,1,,methylase,,,Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM.,,,0,,,,,,,,,,,,,
O43148_RNMT_wild_cl1,RNMT_3bgvC_SAH,O43148,,RNMT,wild,cl1,3bgvC,SAH,,3bgv,3,1,,methylase,,,The crystal structure of human RNA (guanine-7-) methyltransferase in complex with SAH.,,,0,,,,,,,,,,,,,
O75151_PHF2_wild_cl1,PHF2_3pu8B_OGA,O75151,,PHF2,wild,cl1,3pu8B,OGA,,3pu8,3,1,,methylase,,,Structural basis for human PHF2 Jumonji domain interaction with metal ions.,,,0,,,,,,,,,,,,,
O75151_PHF2_wild_cl1,PHF2_3puaA_OGA,O75151,,PHF2,wild,cl1,3puaA,OGA,,3pua,3,1,,methylase,,,Structural basis for human PHF2 Jumonji domain interaction with metal ions.,,,0,,,,,,,,,,,,,
O95050_INMT_wild_cl1,INMT_2a14A_SAH,O95050,,INMT,wild,cl1,2a14A,SAH,,2a14,3,1,,methylase,,,The Crystal Structure of Human Indolethylamine N-methyltransferase in complex with SAH.,,,0,,,,,,,,,,,,,
P22061_PCMT1_wild_cl1,PCMT1_1i1nA_SAH,P22061,,PCMT1,wild,cl1,1i1nA,SAH,,1i1n,3,1,,methylase,,,Crystal structure of human L-isoaspartyl-O-methyl-transferase with S-adenosyl homocysteine at 1.6-A resolution and modeling of an isoaspartyl-containing peptide at the active site.,,,0,,,,,,,,,,,,,
P50135_HNMT_wild_cl1,HNMT_1jqeA_SAH,P50135,,HNMT,wild,cl1,1jqeA,SAH,,1jqe,3,1,,methylase,,,Two polymorphic forms of human histamine methyltransferase: structural_ thermal_ and kinetic comparisons.,,,0,,,,,,,,,,,,,
P51580_TPMT_wild_cl1,TPMT_2bzgA_SAH,P51580,,TPMT,wild,cl1,2bzgA,SAH,,2bzg,3,1,,methylase,,,Structural Basis of Allele Variation of Human Thiopurine-S-Methyltransferase.,,,0,,,,,,,,,,,,,
Q13395_TARBP1_wild_cl1,TARBP1_2ha8A_SAH,Q13395,,TARBP1,wild,cl1,2ha8A,SAH,,2ha8,3,1,,methylase,,,The Crystal Structure of Methyltransferase Domain of Human TAR (HIV-1) RNA binding protein 1 in complex with S-adenosyl-L-homocystein.,,,0,,,,,,,,,,,,,
Q14353_GAMT_wild_cl1,GAMT_3orhA_SAH,Q14353,,GAMT,wild,cl1,3orhA,SAH,,3orh,3,1,,methylase,,,The crystal structure of human guanidinoacetate N-methyltransferase with SAH,,,0,,,,,,,,,,,,,
Q53H47_SETMAR_wild_cl1,SETMAR_3bo5A_SAH,Q53H47,,SETMAR,wild,cl1,3bo5A,SAH,,3bo5,3,1,,methylase,,,The Crystal Structure of Methyltransferase Domain of Human Histone-lysine N-methyltransferase SETMAR in Complex With AdoHcy.,,,0,,,,,,,,,,,,,
Q5VVY1_NTMT2_wild_cl1,NTMT2_5ubbA_SAM,Q5VVY1,,NTMT2,wild,cl1,5ubbA,SAM,,5ubb,3,1,,methylase,,,An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2.,,,0,,,,,,,,,,,,,
Q5VVY1_NTMT2_wild_cl1,NTMT2_6dubA_SAH,Q5VVY1,,NTMT2,wild,cl1,6dubA,SAH,,6dub,3,1,,methylase,,,An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2.,,,0,,,,,,,,,,,,,
Q7Z5W3_BCDIN3D_wild_cl1,BCDIN3D_6l8uB_SAH,Q7Z5W3,,BCDIN3D,wild,cl1,6l8uB,SAH,,6l8u,3,1,,methylase,,,Crystal structure of human cytoplasmic tRNAHis-specific 5'-monomethylphosphate capping enzyme.,,,0,,,,,,,,,,,,,
Q7Z5W3_BCDIN3D_wild_cl1,BCDIN3D_6l8uC_SAH,Q7Z5W3,,BCDIN3D,wild,cl1,6l8uC,SAH,,6l8u,3,1,,methylase,,,Crystal structure of human cytoplasmic tRNAHis-specific 5'-monomethylphosphate capping enzyme.,,,0,,,,,,,,,,,,,
Q86Y97_KMT5C_wild_cl1,KMT5C_3rq4A_SAM,Q86Y97,,KMT5C,wild,cl1,3rq4A,SAM,,3rq4,3,1,,methylase,,,Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2.,,,0,,,,,,,,,,,,,
Q8WXB1_METTL21A_wild_cl1,METTL21A_4lecB_SAH,Q8WXB1,,METTL21A,wild,cl1,4lecB,SAH,,4lec,3,1,,methylase,,,The Crystal Structure of Human Methyltransferase-Like Protein 21A in Complex with SAH,,,0,,,,,,,,,,,,,
Q96P11_NSUN5_wild_cl1,NSUN5_2b9eA_SAM,Q96P11,,NSUN5,wild,cl1,2b9eA,SAM,,2b9e,3,1,,methylase,,,The Crystal Structure of Human NSUN5 protein in complex with S-adenosyl-L-methionine,,,0,,,,,,,,,,,,,
Q9BV86_NTMT1_wild_cl1,NTMT1_5cvdA_SAH,Q9BV86,,NTMT1,wild,cl1,5cvdA,SAH,,5cvd,3,1,,methylase,,,Molecular basis for histone N-terminal methylation by NRMT1,,,0,,,,,,,,,,,,,
Q9BV86_NTMT1_wild_cl1,NTMT1_2ex4A_SAH,Q9BV86,,NTMT1,wild,cl1,2ex4A,SAH,,2ex4,3,1,,methylase,,,The Crystal Structure of Human AD-003 protein in complex with S-adenosyl-L-homocysteine,,,0,,,,,,,,,,,,,
Q9NR48_ASH1L_wild_cl1,ASH1L_3opeA_SAM,Q9NR48,,ASH1L,wild,cl1,3opeA,SAM,,3ope,3,1,,methylase,,,Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism,,,0,,,,,,,,,,,,,
Q9UMN6_KMT2B_wild_cl1,KMT2B_7breE_SAH,Q9UMN6,,KMT2B,wild,cl1,7breE,SAH,,7bre,3,1,,methylase,,,Crystal Structure of MLL2 Complex Guides the Identification of a Methylation Site on P53 Catalyzed by KMT2 Family Methyltransferases.,,,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl3,NT5C2_5cqzA_53O,P49902,,NT5C2,wild,cl3,5cqzA,53O,,5cqz,3,5,,nucleotidase,,,Identification of Noncompetitive inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.,inhibitor,,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl3,NT5C2_5cqzB_53O,P49902,,NT5C2,wild,cl3,5cqzB,53O,,5cqz,3,5,,nucleotidase,,,Identification of Noncompetitive inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.,inhibitor,,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl4,NT5C2_5cr7A_5WO,P49902,,NT5C2,wild,cl4,5cr7A,5WO,,5cr7,3,5,,nucleotidase,,,Identification of Noncompetitive inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.,inhibitor,,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl4,NT5C2_5cr7B_5WO,P49902,,NT5C2,wild,cl4,5cr7B,5WO,,5cr7,3,5,,nucleotidase,,,Identification of Noncompetitive inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.,inhibitor,,0,,,,,,,,,,,,,
Q8TCD5_NT5C_wild_cl1,NT5C_4yihA_2O2,Q8TCD5,,NT5C,wild,cl1,4yihA,2O2,,4yih,3,1,,nucleotidase,,,Structure-based design of a bisphosphonate 5'(3')-deoxyribonucleotidase inhibitor,inhibitor,,0,,,,,,,,,,,,,
Q8TCD5_NT5C_wild_cl1,NT5C_6g2nA_O84,Q8TCD5,,NT5C,wild,cl1,6g2nA,O84,,6g2n,3,1,,nucleotidase,,,Structure-based optimization of bisphosphonate nucleoside inhibitors of human 5'(3')-deoxyribonucleotidases,inhibitor,,0,,,,,,,,,,,,,
Q9NPB1_NT5M_wild_cl1,NT5M_1q91A_DPB,Q9NPB1,,NT5M,wild,cl1,1q91A,DPB,,1q91,1,1,,nucleotidase,,,Crystal structures of the mitochondrial deoxyribonucleotidase in complex with two specific inhibitors,inhibitor,,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl5,NT5C2_2jc9A_ADN,P49902,,NT5C2,wild,cl5,2jc9A,ADN,,2jc9,3,5,,nucleotidase,,,Crystal Structure of Human Cytosolic 5'-Nucleotidase II: Insights Into Allosteric Regulation and Substrate Recognition,,allosteric,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl1,NT5C2_2xjbA_DTP,P49902,,NT5C2,wild,cl1,2xjbA,DTP,,2xjb,3,5,,nucleotidase,,,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,,allosteric,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl2,NT5C2_2xcvA_IMP,P49902,,NT5C2,wild,cl2,2xcvA,IMP,,2xcv,3,5,,nucleotidase,,,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,,allosteric,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl2,NT5C2_2xcwA_IMP,P49902,,NT5C2,wild,cl2,2xcwA,IMP,,2xcw,3,5,,nucleotidase,,,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,,allosteric,0,,,,,,,,,,,,,
P49902_NT5C2_wild_cl1,NT5C2_6ddzA_ATP,P49902,,NT5C2,wild,cl1,6ddzA,ATP,,6ddz,3,5,,nucleotidase,,,Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia.,,,0,,,,,,,,,,,,,
Q9NPB1_NT5M_wild_cl1,NT5M_2jawA_BVP,Q9NPB1,,NT5M,wild,cl1,2jawA,BVP,,2jaw,1,1,,nucleotidase,,,Crystal Structures of Human and Murine Deoxyribonucleotidases: Insights Into Recognition of Substrates and Nucleotide Analogues.,,,0,,,,,,,,,,,,,
P05091_ALDH2_wild_cl1,ALDH2_3inlC_BXB,P05091,,ALDH2,wild,cl1,3inlC,BXB,,3inl,1,2,,oxidoreductases ,,,Alda-1 is an Agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant.,agonist,,0,,,,,,,,,,,,,
O43175_PHGDH_wild_cl3,PHGDH_7dkmA_ODN,O43175,,PHGDH,wild,cl3,7dkmA,ODN,,7dkm,1,3,,oxidoreductases ,,,Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O43175_PHGDH_wild_cl1,PHGDH_6rj3A_K58,O43175,,PHGDH,wild,cl1,6rj3A,K58,,6rj3,1,3,,oxidoreductases ,,,Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) inhibitorBI-4924Disrupts Serine Biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
O43175_PHGDH_wild_cl2,PHGDH_6cwaA_3PG,O43175,,PHGDH,wild,cl2,6cwaA,3PG,,6cwa,1,3,,oxidoreductases ,,,Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) inhibitorBI-4924Disrupts Serine Biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
O43175_PHGDH_wild_cl2,PHGDH_6cwaB_3PG,O43175,,PHGDH,wild,cl2,6cwaB,3PG,,6cwa,1,3,,oxidoreductases ,,,Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) inhibitorBI-4924Disrupts Serine Biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
O60218_AKR1B10_wild_cl1,AKR1B10_4wevX_SUZ,O60218,,AKR1B10,wild,cl1,4wevX,SUZ,,4wev,1,2,,oxidoreductases ,,,Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10.,inhibitor,,0,,,,,,,,,,,,,
O94788_ALDH1A2_wild_cl1,ALDH1A2_6b5iA_CU4,O94788,,ALDH1A2,wild,cl1,6b5iA,CU4,,6b5i,1,2,,oxidoreductases ,,,Structural Basis of ALDH1A2 inhibition by Irreversible and Reversible Small Molecule inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O94788_ALDH1A2_wild_cl1,ALDH1A2_6b5iB_CU4,O94788,,ALDH1A2,wild,cl1,6b5iB,CU4,,6b5i,1,2,,oxidoreductases ,,,Structural Basis of ALDH1A2 inhibition by Irreversible and Reversible Small Molecule inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O94788_ALDH1A2_wild_cl2,ALDH1A2_6b5gA_NAD,O94788,,ALDH1A2,wild,cl2,6b5gA,NAD,,6b5g,1,2,,oxidoreductases ,,,Structural Basis of ALDH1A2 inhibition by Irreversible and Reversible Small Molecule inhibitors.,inhibitor,,0,,,,,,,,,,,,,
O94788_ALDH1A2_wild_cl2,ALDH1A2_6b5hB_NAD,O94788,,ALDH1A2,wild,cl2,6b5hB,NAD,,6b5h,1,2,,oxidoreductases ,,,Structural Basis of ALDH1A2 inhibition by Irreversible and Reversible Small Molecule inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00325_ADH1B_wild_cl2,ADH1B_1u3uA_BNF,P00325,,ADH1B,wild,cl2,1u3uA,BNF,,1u3u,1,2,,oxidoreductases ,,,Structure of three class I human alcohol dehydrogenases complexed with isoenzyme specific formamide inhibitors,inhibitor,,0,,,,,,,,,,,,,
P00326_ADH1C_wild_cl2,ADH1C_1u3wA_FXY,P00326,,ADH1C,wild,cl2,1u3wA,FXY,,1u3w,3,3,,oxidoreductases ,,,Structure of three class I human alcohol dehydrogenases complexed with isoenzyme specific formamide inhibitors,inhibitor,,0,,,,,,,,,,,,,
P00326_ADH1C_wild_cl3,ADH1C_1u3wB_FXY,P00326,,ADH1C,wild,cl3,1u3wB,FXY,,1u3w,3,3,,oxidoreductases ,,,Structure of three class I human alcohol dehydrogenases complexed with isoenzyme specific formamide inhibitors,inhibitor,,0,,,,,,,,,,,,,
P00352_ALDH1A1_wild_cl1,ALDH1A1_4x4lA_3XG,P00352,,ALDH1A1,wild,cl1,4x4lA,3XG,,4x4l,2,2,,oxidoreductases ,,,Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00352_ALDH1A1_wild_cl2,ALDH1A1_5l2oA_6ZW,P00352,,ALDH1A1,wild,cl2,5l2oA,6ZW,,5l2o,2,2,,oxidoreductases ,,,inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.,inhibitor,,0,,,,,,,,,,,,,
P00352_ALDH1A1_wild_cl1,ALDH1A1_5ac2A_K9P,P00352,,ALDH1A1,wild,cl1,5ac2A,K9P,,5ac2,2,2,,oxidoreductases ,,,Structural_ Biochemical_ and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 inhibition by Cytotoxic Duocarmycin Analogues.,inhibitor,,0,,,,,,,,,,,,,
P00352_ALDH1A1_wild_cl2,ALDH1A1_5ac2A_TXE,P00352,,ALDH1A1,wild,cl2,5ac2A,TXE,,5ac2,2,2,,oxidoreductases ,,,Structural_ Biochemical_ and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 inhibition by Cytotoxic Duocarmycin Analogues.,inhibitor,,0,,,,,,,,,,,,,
P00374_DHFR_wild_cl1,DHFR_2w3bA_VG9,P00374,,DHFR,wild,cl1,2w3bA,VG9,,2w3b,1,2,,oxidoreductases ,,,Structural Basis for Selective inhibition of Mycobacterium Avium Dihydrofolate Reductase by a Lipophilic Antifolate,inhibitor,,0,,,,,,,,,,,,,
P00374_DHFR_wild_cl2,DHFR_6vcjC_NAP,P00374,,DHFR,wild,cl2,6vcjC,NAP,,6vcj,1,2,,oxidoreductases ,,,The Structural Basis for Nonsteroidal Anti-Inflammatory Drug inhibition of Human Dihydrofolate Reductase.,inhibitor,,0,,,,,,,,,,,,,
P00439_PAH_wild_cl1,PAH_4pahA_LNR,P00439,,PAH,wild,cl1,4pahA,LNR,,4pah,1,3,,oxidoreductases ,,,Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution.,inhibitor,,0,,,,,,,,,,,,,
P00451_F8_wild_cl1,F8_3hnbM_768,P00451,,F8,wild,cl1,3hnbM,768,,3hnb,3,1,,oxidoreductases ,,,Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.,inhibitor,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl1,HMGCR_1hw9A_SIM,P04035,,HMGCR,wild,cl1,1hw9A,SIM,,1hw9,3,4,,oxidoreductases ,,,Structural mechanism for statin inhibition of HMG-CoA reductase.,inhibitor,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl2,HMGCR_1hw8A_ADP,P04035,,HMGCR,wild,cl2,1hw8A,ADP,,1hw8,3,4,,oxidoreductases ,,,Structural mechanism for statin inhibition of HMG-CoA reductase.,inhibitor,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl2,HMGCR_1hw8A_114,P04035,,HMGCR,wild,cl2,1hw8A,114,,1hw8,3,4,,oxidoreductases ,,,Structural mechanism for statin inhibition of HMG-CoA reductase.,inhibitor,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl3,HMGCR_1hw8D_ADP,P04035,,HMGCR,wild,cl3,1hw8D,ADP,,1hw8,3,4,,oxidoreductases ,,,Structural mechanism for statin inhibition of HMG-CoA reductase.,inhibitor,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl1,HMGCR_3cdbD_9HI,P04035,,HMGCR,wild,cl1,3cdbD,9HI,,3cdb,3,4,,oxidoreductases ,,,Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl1,MPO_6wy7E_UFD,P05164,,MPO,wild,cl1,6wy7E,UFD,,6wy7,3,6,,oxidoreductases ,,,Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable_ selective_ and reversible inhibitors of myeloperoxidase.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl4,MPO_6wydI_HEC,P05164,,MPO,wild,cl4,6wydI,HEC,,6wyd,3,6,,oxidoreductases ,,,Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable_ selective_ and reversible inhibitors of myeloperoxidase.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl1,MPO_7ni1C_UEB,P05164,,MPO,wild,cl1,7ni1C,UEB,,7ni1,3,6,,oxidoreductases ,,,Discovery of AZD4831_ a Mechanism-Based Irreversible inhibitor of Myeloperoxidase_ As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl2,MPO_7ni1A_UEB,P05164,,MPO,wild,cl2,7ni1A,UEB,,7ni1,3,6,,oxidoreductases ,,,Discovery of AZD4831_ a Mechanism-Based Irreversible inhibitor of Myeloperoxidase_ As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl3,MPO_7ni1C_FUC,P05164,,MPO,wild,cl3,7ni1C,FUC,,7ni1,3,6,,oxidoreductases ,,,Discovery of AZD4831_ a Mechanism-Based Irreversible inhibitor of Myeloperoxidase_ As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.,inhibitor,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl2,MPO_3zs1A_PVW,P05164,,MPO,wild,cl2,3zs1A,PVW,,3zs1,3,6,,oxidoreductases ,,,2-Thioxanthines are Mechanism-Based inactivators of Myeloperoxidase that Block Oxidative Stress During Inflammation.,inhibitor,,0,,,,,,,,,,,,,
P07101_TH_wild_cl1,TH_6zn2A_LDP,P07101,,TH,wild,cl1,6zn2A,LDP,,6zn2,3,1,,oxidoreductases ,,,Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.,inhibitor,,0,,,,,,,,,,,,,
P07101_TH_wild_cl1,TH_6zvpD_LDP,P07101,,TH,wild,cl1,6zvpD,LDP,,6zvp,3,1,,oxidoreductases ,,,Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.,inhibitor,,0,,,,,,,,,,,,,
P07327_ADH1A_wild_cl1,ADH1A_1u3tA_CCB,P07327,,ADH1A,wild,cl1,1u3tA,CCB,,1u3t,2,1,,oxidoreductases ,,,Structure of three class I human alcohol dehydrogenases complexed with isoenzyme specific formamide inhibitors,inhibitor,,0,,,,,,,,,,,,,
P14061_HSD17B1_wild_cl1,HSD17B1_6cgeB_F0D,P14061,,HSD17B1,wild,cl1,6cgeB,F0D,,6cge,1,1,,oxidoreductases ,,,Combined Biophysical Chemistry Reveals a New Covalent inhibitor with a Low-Reactivity Alkyl Halide.,inhibitor,,0,,,,,,,,,,,,,
P15121_AKR1B1_wild_cl2,AKR1B1_1z3nA_NDP,P15121,,AKR1B1,wild,cl2,1z3nA,NDP,,1z3n,1,2,,oxidoreductases ,,,Discovery of 3-[(4_5_7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications,inhibitor,,0,,,,,,,,,,,,,
P15428_HPGD_wild_cl1,HPGD_2gdzA_NAD,P15428,,HPGD,wild,cl1,2gdzA,NAD,,2gdz,3,1,,oxidoreductases ,,,High-Affinity inhibitors of Human NAD-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of inhibition and Structure-Activity Relationships.,inhibitor,,0,,,,,,,,,,,,,
P15559_NQO1_wild_cl1,NQO1_1kboC_340,P15559,,NQO1,wild,cl1,1kboC,340,,1kbo,3,2,,oxidoreductases ,,,Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical_ X-ray crystallographic_ and mass spectrometric approaches.,inhibitor,,0,,,,,,,,,,,,,
P16083_NQO2_wild_cl1,NQO2_3tzbB_FAD,P16083,,NQO2,wild,cl1,3tzbB,FAD,,3tzb,1,3,,oxidoreductases ,,,In silico screening reveals structurally diverse_ nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-kappa B signaling.,inhibitor,,0,,,,,,,,,,,,,
P16083_NQO2_wild_cl1,NQO2_4u7fA_FAD,P16083,,NQO2,wild,cl1,4u7fA,FAD,,4u7f,1,3,,oxidoreductases ,,,Quinone Reductase 2 Is an Adventitious Target of Protein Kinase CK2 inhibitors TBBz (TBI) and DMAT.,inhibitor,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl1,MAOA_2z5yA_HRM,P21397,,MAOA,wild,cl1,2z5yA,HRM,,2z5y,2,3,,oxidoreductases ,,,Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors,inhibitor,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl2,MAOA_2z5yA_FAD,P21397,,MAOA,wild,cl2,2z5yA,FAD,,2z5y,2,3,,oxidoreductases ,,,Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors,inhibitor,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl3,MAOA_2z5xA_DCX,P21397,,MAOA,wild,cl3,2z5xA,DCX,,2z5x,2,3,,oxidoreductases ,,,Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors,inhibitor,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl3,MAOA_2z5yA_DCX,P21397,,MAOA,wild,cl3,2z5yA,DCX,,2z5y,2,3,,oxidoreductases ,,,Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors,inhibitor,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl2,MAOB_1ojdF_FAD,P27338,,MAOB,wild,cl2,1ojdF,FAD,,1ojd,1,3,,oxidoreductases ,,,Insights Into the Mode of inhibition of Human Mitochondrial Monoamine Oxidase B from High-Resolution Crystal Structures,inhibitor,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl1,MAOB_3po7A_ZON,P27338,,MAOB,wild,cl1,3po7A,ZON,,3po7,1,3,,oxidoreductases ,,,Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex,inhibitor,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl3,MAOB_2vz2B_C15,P27338,,MAOB,wild,cl3,2vz2B,C15,,2vz2,1,3,,oxidoreductases ,,,Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.,inhibitor,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl3,MAOB_2vz2A_C15,P27338,,MAOB,wild,cl3,2vz2A,C15,,2vz2,1,3,,oxidoreductases ,,,Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.,inhibitor,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl1,MAOB_6fvzA_E8Z,P27338,,MAOB,wild,cl1,6fvzA,E8Z,,6fvz,1,3,,oxidoreductases ,,,Tight-Binding inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic_ Crystallographic_ and Biological Analysis.,inhibitor,,0,,,,,,,,,,,,,
P28845_HSD11B1_wild_cl1,HSD11B1_5qiiA_HJG,P28845,,HSD11B1,wild,cl1,5qiiA,HJG,,5qii,3,2,,oxidoreductases ,,,Discovery of Clinical Candidate BMS-823778 as an inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1).,inhibitor,,0,,,,,,,,,,,,,
P28845_HSD11B1_wild_cl2,HSD11B1_4hx5D_19V,P28845,,HSD11B1,wild,cl2,4hx5D,19V,,4hx5,3,2,,oxidoreductases ,,,Discovery of SAR184841_ a potent and long-lasting inhibitor of 11beta-hydroxysteroid dehydrogenase type 1_ active in a physiopathological animal model of T2D,inhibitor,,0,,,,,,,,,,,,,
P28845_HSD11B1_wild_cl1,HSD11B1_3h6kD_33T,P28845,,HSD11B1,wild,cl1,3h6kD,33T,,3h6k,3,2,,oxidoreductases ,,,Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.,inhibitor,,0,,,,,,,,,,,,,
P28845_HSD11B1_wild_cl2,HSD11B1_3h6kC_33T,P28845,,HSD11B1,wild,cl2,3h6kC,33T,,3h6k,3,2,,oxidoreductases ,,,Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.,inhibitor,,0,,,,,,,,,,,,,
P30838_ALDH3A1_wild_cl2,ALDH3A1_4l2oA_NAD,P30838,,ALDH3A1,wild,cl2,4l2oA,NAD,,4l2o,2,2,,oxidoreductases ,,,Crystal structure of human ALDH3A1 with its selective inhibitor 1-(4-fluorophenyl)sulfonyl-2-methylbenzimidazole,inhibitor,,0,,,,,,,,,,,,,
P30838_ALDH3A1_wild_cl1,ALDH3A1_3szbA_I1E,P30838,,ALDH3A1,wild,cl1,3szbA,I1E,,3szb,2,2,,oxidoreductases ,,,Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.,inhibitor,,0,,,,,,,,,,,,,
P30838_ALDH3A1_wild_cl1,ALDH3A1_4h80A_04T,P30838,,ALDH3A1,wild,cl1,4h80A,04T,,4h80,2,2,,oxidoreductases ,,,Kinetic and Structural Characterization of a Selective inhibitor for Human ALDH3A1,inhibitor,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl2,PYCR1_6xp2E_PRS,P32322,,PYCR1,wild,cl2,6xp2E,PRS,,6xp2,3,4,,oxidoreductases ,,,In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1.,inhibitor,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl1,SPR_6i6vB_H6E,P35270,,SPR,wild,cl1,6i6vB,H6E,,6i6v,1,3,,oxidoreductases ,,,Fragment-Based Discovery of Novel Potent Sepiapterin Reductase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl2,SPR_6i6fB_NAP,P35270,,SPR,wild,cl2,6i6fB,NAP,,6i6f,1,3,,oxidoreductases ,,,Fragment-Based Discovery of Novel Potent Sepiapterin Reductase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl3,SPR_6i6tA_H5B,P35270,,SPR,wild,cl3,6i6tA,H5B,,6i6t,1,3,,oxidoreductases ,,,Fragment-Based Discovery of Novel Potent Sepiapterin Reductase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl3,SPR_6i6tB_H5B,P35270,,SPR,wild,cl3,6i6tB,H5B,,6i6t,1,3,,oxidoreductases ,,,Fragment-Based Discovery of Novel Potent Sepiapterin Reductase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P36969_GPX4_wild_cl1,GPX4_6hkqA_G9N,P36969,,GPX4,wild,cl1,6hkqA,G9N,,6hkq,3,1,,oxidoreductases ,,,Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162.,inhibitor,,0,,,,,,,,,,,,,
P42330_AKR1C3_wild_cl1,AKR1C3_4hmnA_NAP,P42330,,AKR1C3,wild,cl1,4hmnA,NAP,,4hmn,2,2,,oxidoreductases ,,,Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-beta-hydroxysteroid dehydrogenase (AKR1C3).,inhibitor,,0,,,,,,,,,,,,,
P42330_AKR1C3_wild_cl1,AKR1C3_4xvdA_WDV,P42330,,AKR1C3,wild,cl1,4xvdA,WDV,,4xvd,2,2,,oxidoreductases ,,,Structures of complexes of type 5 17 beta-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding.,inhibitor,,0,,,,,,,,,,,,,
P47895_ALDH1A3_wild_cl1,ALDH1A3_6s6wA_NAD,P47895,,ALDH1A3,wild,cl1,6s6wA,NAD,,6s6w,1,2,,oxidoreductases ,,,Imidazo[1_2-a]pyridine Derivatives as Aldehyde Dehydrogenase inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.,inhibitor,,0,,,,,,,,,,,,,
P47895_ALDH1A3_wild_cl2,ALDH1A3_6s6wA_KXT,P47895,,ALDH1A3,wild,cl2,6s6wA,KXT,,6s6w,1,2,,oxidoreductases ,,,Imidazo[1_2-a]pyridine Derivatives as Aldehyde Dehydrogenase inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.,inhibitor,,0,,,,,,,,,,,,,
P50213_IDH3A_wild_cl1,IDH3A_5yvtA_NAI,P50213,,IDH3A,wild,cl1,5yvtA,NAI,,5yvt,3,2,,oxidoreductases ,,,Insights into the inhibitory mechanisms of NADH on the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,inhibitor,,0,,,,,,,,,,,,,
P50213_IDH3A_wild_cl2,IDH3A_5yvtA_NAI,P50213,,IDH3A,wild,cl2,5yvtA,NAI,,5yvt,3,2,,oxidoreductases ,,,Insights into the inhibitory mechanisms of NADH on the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,inhibitor,,0,,,,,,,,,,,,,
P56545_CTBP2_wild_cl1,CTBP2_4lcjH_NAD,P56545,,CTBP2,wild,cl1,4lcjH,NAD,,4lcj,1,2,,oxidoreductases ,,,Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P56545_CTBP2_wild_cl2,CTBP2_4lcjA_KMT,P56545,,CTBP2,wild,cl2,4lcjA,KMT,,4lcj,1,2,,oxidoreductases ,,,Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P56545_CTBP2_wild_cl2,CTBP2_4lcjE_KMT,P56545,,CTBP2,wild,cl2,4lcjE,KMT,,4lcj,1,2,,oxidoreductases ,,,Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
Q02127_DHODH_wild_cl1,DHODH_6j3cA_B5X,Q02127,,DHODH,wild,cl1,6j3cA,B5X,,6j3c,1,3,,oxidoreductases ,,,A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode.,inhibitor,,0,,,,,,,,,,,,,
Q02127_DHODH_wild_cl1,DHODH_5mutA_HYT,Q02127,,DHODH,wild,cl1,5mutA,HYT,,5mut,1,3,,oxidoreductases ,,,Design_ synthesis_ biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.,inhibitor,,0,,,,,,,,,,,,,
Q04828_AKR1C1_wild_cl2,AKR1C1_4yvpA_NAP,Q04828,,AKR1C1,wild,cl2,4yvpA,NAP,,4yvp,2,2,,oxidoreductases ,,,In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis,inhibitor,,0,,,,,,,,,,,,,
Q04828_AKR1C1_wild_cl1,AKR1C1_3ntyA_5P3,Q04828,,AKR1C1,wild,cl1,3ntyA,5P3,,3nty,2,2,,oxidoreductases ,,,Probing the inhibitor selectivity pocket of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis,inhibitor,,0,,,,,,,,,,,,,
Q04828_AKR1C1_wild_cl2,AKR1C1_6ijxA_NAP,Q04828,,AKR1C1,wild,cl2,6ijxA,NAP,,6ijx,2,2,,oxidoreductases ,,,Screening_ synthesis_ crystal structure_ and molecular basis of 6-amino-4-phenyl-1_4-dihydropyrano[2_3-c]pyrazole-5-carbonitriles as novel AKR1C3 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q04828_AKR1C1_wild_cl1,AKR1C1_3c3uA_C2U,Q04828,,AKR1C1,wild,cl1,3c3uA,C2U,,3c3u,2,2,,oxidoreductases ,,,Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3_5-dichlorosalicylic acid,inhibitor,,0,,,,,,,,,,,,,
Q13363_CTBP1_wild_cl2,CTBP1_4lceA_KMT,Q13363,,CTBP1,wild,cl2,4lceA,KMT,,4lce,3,2,,oxidoreductases ,,,Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl1,TXNRD1_2zzcD_NAP,Q16881,,TXNRD1,wild,cl1,2zzcD,NAP,,2zzc,1,5,,oxidoreductases ,,,Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.,inhibitor,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl3,TXNRD1_2zzbB_TPT,Q16881,,TXNRD1,wild,cl3,2zzbB,TPT,,2zzb,1,5,,oxidoreductases ,,,Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.,inhibitor,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl5,TXNRD1_2zzbC_TPT,Q16881,,TXNRD1,wild,cl5,2zzbC,TPT,,2zzb,1,5,,oxidoreductases ,,,Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.,inhibitor,,0,,,,,,,,,,,,,
Q7Z4W1_DCXR_wild_cl1,DCXR_1wntC_NAP,Q7Z4W1,,DCXR,wild,cl1,1wntC,NAP,,1wnt,3,1,,oxidoreductases ,,,Structure of the tetrameric form of human L-Xylulose reductase: Probing the inhibitor-binding site with molecular modeling and site-directed mutagenesis,inhibitor,,0,,,,,,,,,,,,,
Q9BPX1_HSD17B14_wild_cl2,HSD17B14_5l7wA_BGC,Q9BPX1,,HSD17B14,wild,cl2,5l7wA,BGC,,5l7w,2,2,,oxidoreductases ,,,First Structure-Activity Relationship of 17 beta-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal inhibitors and Crystal Structures in Complex with the Enzyme.,inhibitor,,0,,,,,,,,,,,,,
Q9BPX1_HSD17B14_wild_cl2,HSD17B14_5icmA_GLC,Q9BPX1,,HSD17B14,wild,cl2,5icmA,GLC,,5icm,2,2,,oxidoreductases ,,,New Insights into Human 17 beta-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal inhibitor.,inhibitor,,0,,,,,,,,,,,,,
Q9BPX1_HSD17B14_wild_cl1,HSD17B14_5o72A_9MH,Q9BPX1,,HSD17B14,wild,cl1,5o72A,9MH,,5o72,2,2,,oxidoreductases ,,,Structure-based design and profiling of novel 17 beta-HSD14 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q9UJM8_HAO1_wild_cl1,HAO1_7m2oA_YOJ,Q9UJM8,,HAO1,wild,cl1,7m2oA,YOJ,,7m2o,1,1,,oxidoreductases ,,,Dual Glycolate Oxidase/Lactate Dehydrogenase A inhibitors for Primary Hyperoxaluria,inhibitor,,0,,,,,,,,,,,,,
Q9UJM8_HAO1_wild_cl1,HAO1_2w0uA_C7C,Q9UJM8,,HAO1,wild,cl1,2w0uA,C7C,,2w0u,1,1,,oxidoreductases ,,,Structure of Human Glycolate Oxidase in Complex with the inhibitor 4-Carboxy-5-[(4-Chlorophenyl)Sulfanyl]-1_2_3-Thiadiazole.,inhibitor,,0,,,,,,,,,,,,,
O00391_QSOX1_wild_cl1,QSOX1_3lliA_FAD,O00391,,QSOX1,wild,cl1,3lliA,FAD,,3lli,3,1,,oxidoreductases ,,,QSOX contains a pseudo-dimer of functional and degenerate sulfhydryl oxidase domains.,,,0,,,,,,,,,,,,,
O43175_PHGDH_wild_cl1,PHGDH_5ofwA_9TW,O43175,,PHGDH,wild,cl1,5ofwA,9TW,,5ofw,1,3,,oxidoreductases ,,,Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer.,,,0,,,,,,,,,,,,,
O60218_AKR1B10_wild_cl2,AKR1B10_1zuaX_NAP,O60218,,AKR1B10,wild,cl2,1zuaX,NAP,,1zua,1,2,,oxidoreductases ,,,Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.,,,0,,,,,,,,,,,,,
O60218_AKR1B10_wild_cl1,AKR1B10_4xzlX_F49,O60218,,AKR1B10,wild,cl1,4xzlX,F49,,4xzl,1,2,,oxidoreductases ,,,Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.,,,0,,,,,,,,,,,,,
O60218_AKR1B10_wild_cl2,AKR1B10_4ga8A_NAP,O60218,,AKR1B10,wild,cl2,4ga8A,NAP,,4ga8,1,2,,oxidoreductases ,,,Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil,,,0,,,,,,,,,,,,,
O75828_CBR3_wild_cl1,CBR3_2hrbA_NAP,O75828,,CBR3,wild,cl1,2hrbA,NAP,,2hrb,3,1,,oxidoreductases ,,,Crystal Structure of human Carbonyl Reductase 3_ complexed with NADP+,,,0,,,,,,,,,,,,,
O95154_AKR7A3_wild_cl1,AKR7A3_2clpI_NDP,O95154,,AKR7A3,wild,cl1,2clpI,NDP,,2clp,3,1,,oxidoreductases ,,,Crystal Structure of Human Aflatoxin B1 Aldehyde Reductase Member 3,,,0,,,,,,,,,,,,,
O95154_AKR7A3_wild_cl1,AKR7A3_2clpB_NDP,O95154,,AKR7A3,wild,cl1,2clpB,NDP,,2clp,3,1,,oxidoreductases ,,,Crystal Structure of Human Aflatoxin B1 Aldehyde Reductase Member 3,,,0,,,,,,,,,,,,,
O95831_AIFM1_wild_cl1,AIFM1_4burC_FAD,O95831,,AIFM1,wild,cl1,4burC,FAD,,4bur,3,2,,oxidoreductases ,,,Structural Insights Into the Coenzyme Mediated Monomer-Dimer Transition of the Pro-Apoptotic Apoptosis Inducing Factor.,,,0,,,,,,,,,,,,,
O95831_AIFM1_wild_cl2,AIFM1_4burB_NAD,O95831,,AIFM1,wild,cl2,4burB,NAD,,4bur,3,2,,oxidoreductases ,,,Structural Insights Into the Coenzyme Mediated Monomer-Dimer Transition of the Pro-Apoptotic Apoptosis Inducing Factor.,,,0,,,,,,,,,,,,,
O95831_AIFM1_wild_cl2,AIFM1_4burA_NAD,O95831,,AIFM1,wild,cl2,4burA,NAD,,4bur,3,2,,oxidoreductases ,,,Structural Insights Into the Coenzyme Mediated Monomer-Dimer Transition of the Pro-Apoptotic Apoptosis Inducing Factor.,,,0,,,,,,,,,,,,,
O95831_AIFM1_wild_cl1,AIFM1_5fs6A_FAD,O95831,,AIFM1,wild,cl1,5fs6A,FAD,,5fs6,3,2,,oxidoreductases ,,,Structure/Function Relations in Aifm1 Variants Associated with Neurodegenerative Disorders,,,0,,,,,,,,,,,,,
P00325_ADH1B_wild_cl1,ADH1B_1hdxB_NAD,P00325,,ADH1B,wild,cl1,1hdxB,NAD,,1hdx,1,2,,oxidoreductases ,,,Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences.,,,0,,,,,,,,,,,,,
P00325_ADH1B_wild_cl2,ADH1B_1hdxA_CXL,P00325,,ADH1B,wild,cl2,1hdxA,CXL,,1hdx,1,2,,oxidoreductases ,,,Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences.,,,0,,,,,,,,,,,,,
P00325_ADH1B_wild_cl1,ADH1B_1dehA_NAD,P00325,,ADH1B,wild,cl1,1dehA,NAD,,1deh,1,2,,oxidoreductases ,,,X-ray structure of human beta3beta3 alcohol dehydrogenase. The contribution of ionic interactions to coenzyme binding.,,,0,,,,,,,,,,,,,
P00326_ADH1C_wild_cl1,ADH1C_1ht0A_NAD,P00326,,ADH1C,wild,cl1,1ht0A,NAD,,1ht0,3,3,,oxidoreductases ,,,Three-dimensional structures of the three human class I alcohol dehydrogenases.,,,0,,,,,,,,,,,,,
P00374_DHFR_wild_cl2,DHFR_4m6jA_NDP,P00374,,DHFR,wild,cl2,4m6jA,NDP,,4m6j,1,2,,oxidoreductases ,,,Divergent evolution of protein conformational dynamics in dihydrofolate reductase.,,,0,,,,,,,,,,,,,
P00374_DHFR_wild_cl1,DHFR_5hpbA_63W,P00374,,DHFR,wild,cl1,5hpbA,63W,,5hpb,1,2,,oxidoreductases ,,,Human dihydrofolate reductase ternary complex with a series offluorine substituted 5-methyl-6-phenythio)thieno[2_3-d]pyrimidine-2_4-diamines,,,0,,,,,,,,,,,,,
P00387_CYB5R3_wild_cl1,CYB5R3_1umkA_FAD,P00387,,CYB5R3,wild,cl1,1umkA,FAD,,1umk,3,1,,oxidoreductases ,,,Structure of human erythrocyte NADH-cytochrome b5 reductase.,,,0,,,,,,,,,,,,,
P00395_MT-CO1_wild_cl1,MT-CO1_5z62A_HEA,P00395,,MT-CO1,wild,cl1,5z62A,HEA,,5z62,3,1,,oxidoreductases ,,,Structure of the intact 14-subunit human cytochrome c oxidase.,,,0,,,,,,,,,,,,,
P00403_MT-CO2_wild_cl1,MT-CO2_5z62B_HEA,P00403,,MT-CO2,wild,cl1,5z62B,HEA,,5z62,3,1,,oxidoreductases ,,,Structure of the intact 14-subunit human cytochrome c oxidase.,,,0,,,,,,,,,,,,,
P00439_PAH_wild_cl1,PAH_1tg2A_H2B,P00439,,PAH,wild,cl1,1tg2A,H2B,,1tg2,1,3,,oxidoreductases ,,,Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.,,,0,,,,,,,,,,,,,
P00439_PAH_wild_cl2,PAH_5fiiA_PHE,P00439,,PAH,wild,cl2,5fiiA,PHE,,5fii,1,3,,oxidoreductases ,,,Structural Basis for Ligand-Dependent Dimerization of Phenylalanine Hydroxylase Regulatory Domain.,,,0,,,,,,,,,,,,,
P00439_PAH_wild_cl2,PAH_5fiiC_PHE,P00439,,PAH,wild,cl2,5fiiC,PHE,,5fii,1,3,,oxidoreductases ,,,Structural Basis for Ligand-Dependent Dimerization of Phenylalanine Hydroxylase Regulatory Domain.,,,0,,,,,,,,,,,,,
P00439_PAH_wild_cl3,PAH_5fiiA_PHE,P00439,,PAH,wild,cl3,5fiiA,PHE,,5fii,1,3,,oxidoreductases ,,,Structural Basis for Ligand-Dependent Dimerization of Phenylalanine Hydroxylase Regulatory Domain.,,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl3,HMGCR_1dqaA_NAP,P04035,,HMGCR,wild,cl3,1dqaA,NAP,,1dqa,3,4,,oxidoreductases ,,,Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.,,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl4,HMGCR_1dqaA_NAP,P04035,,HMGCR,wild,cl4,1dqaA,NAP,,1dqa,3,4,,oxidoreductases ,,,Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.,,,0,,,,,,,,,,,,,
P04035_HMGCR_wild_cl4,HMGCR_1dqaB_NAP,P04035,,HMGCR,wild,cl4,1dqaB,NAP,,1dqa,3,4,,oxidoreductases ,,,Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.,,,0,,,,,,,,,,,,,
P04406_GAPDH_wild_cl1,GAPDH_1u8fP_NAD,P04406,,GAPDH,wild,cl1,1u8fP,NAD,,1u8f,1,1,,oxidoreductases ,,,High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase.,,,0,,,,,,,,,,,,,
P04406_GAPDH_wild_cl1,GAPDH_6iq6E_AW9,P04406,,GAPDH,wild,cl1,6iq6E,AW9,,6iq6,1,1,,oxidoreductases ,,,Structural Study of Monomethyl Fumarate-Bound Human GAPDH.,,,0,,,,,,,,,,,,,
P05091_ALDH2_wild_cl2,ALDH2_3n82H_NAD,P05091,,ALDH2,wild,cl2,3n82H,NAD,,3n82,1,2,,oxidoreductases ,,,Conformational Selection During Catalysis: The role of Threonine 244 in ALDH2,,,0,,,,,,,,,,,,,
P05091_ALDH2_wild_cl2,ALDH2_1cw3E_NAD,P05091,,ALDH2,wild,cl2,1cw3E,NAD,,1cw3,1,2,,oxidoreductases ,,,Human liver mitochondrial aldehyde dehydrogenase: three-dimensional structure and the restoration of solubility and activity of chimeric forms.,,,0,,,,,,,,,,,,,
P05091_ALDH2_wild_cl1,ALDH2_2vleG_DZN,P05091,,ALDH2,wild,cl1,2vleG,DZN,,2vle,1,2,,oxidoreductases ,,,Structure of Daidzin_ a Naturally Occurring Anti-Alcohol-Addiction Agent_ in Complex with Human Mitochondrial Aldehyde Dehydrogenase.,,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl3,MPO_4dl1L_BMA,P05164,,MPO,wild,cl3,4dl1L,BMA,,4dl1,3,6,,oxidoreductases ,,,Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS(4)).,,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl6,MPO_4dl1P_MAN,P05164,,MPO,wild,cl6,4dl1P,MAN,,4dl1,3,6,,oxidoreductases ,,,Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS(4)).,,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl5,MPO_1mhlC_MAN,P05164,,MPO,wild,cl5,1mhlC,MAN,,1mhl,3,6,,oxidoreductases ,,,Structure of the green heme in myeloperoxidase.,,,0,,,,,,,,,,,,,
P05164_MPO_wild_cl4,MPO_1mypD_HEM,P05164,,MPO,wild,cl4,1mypD,HEM,,1myp,3,6,,oxidoreductases ,,,X-ray crystal structure of canine myeloperoxidase at 3 A resolution.,,,0,,,,,,,,,,,,,
P07327_ADH1A_wild_cl1,ADH1A_1hsoA_PYZ,P07327,,ADH1A,wild,cl1,1hsoA,PYZ,,1hso,2,1,,oxidoreductases ,,,Three-dimensional structures of the three human class I alcohol dehydrogenases.,,,0,,,,,,,,,,,,,
P08319_ADH4_wild_cl1,ADH4_3cosA_NAD,P08319,,ADH4,wild,cl1,3cosA,NAD,,3cos,3,1,,oxidoreductases ,,,Crystal structure of human class II alcohol dehydrogenase (ADH4) in complex with NAD and Zn.,,,0,,,,,,,,,,,,,
P09417_QDPR_wild_cl1,QDPR_1hdrA_NAD,P09417,,QDPR,wild,cl1,1hdrA,NAD,,1hdr,3,1,,oxidoreductases ,,,The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue.,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl1,ACADM_1egcD_FAD,P11310,,ACADM,wild,cl1,1egcD,FAD,,1egc,3,4,,oxidoreductases ,,,Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity.,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl3,ACADM_1egcA_CO8,P11310,,ACADM,wild,cl3,1egcA,CO8,,1egc,3,4,,oxidoreductases ,,,Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity.,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl3,ACADM_1egcC_CO8,P11310,,ACADM,wild,cl3,1egcC,CO8,,1egc,3,4,,oxidoreductases ,,,Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity.,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl1,ACADM_1t9gB_FAD,P11310,,ACADM,wild,cl1,1t9gB,FAD,,1t9g,3,4,,oxidoreductases ,,,Extensive domain motion and electron transfer in the human electron transferring flavoprotein-medium chain Acyl-CoA dehydrogenase complex,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl2,ACADM_1t9gA_FAD,P11310,,ACADM,wild,cl2,1t9gA,FAD,,1t9g,3,4,,oxidoreductases ,,,Extensive domain motion and electron transfer in the human electron transferring flavoprotein-medium chain Acyl-CoA dehydrogenase complex,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl2,ACADM_4p13B_FAD,P11310,,ACADM,wild,cl2,4p13B,FAD,,4p13,3,4,,oxidoreductases ,,,Medium chain acyl-CoA dehydrogenase_ K304E mutant,,,0,,,,,,,,,,,,,
P11310_ACADM_wild_cl4,ACADM_2a1tC_FAD,P11310,,ACADM,wild,cl4,2a1tC,FAD,,2a1t,3,4,,oxidoreductases ,,,Stabilization of Non-productive Conformations Underpins Rapid Electron Transfer to Electron-transferring Flavoprotein,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl1,G6PD_1qkiC_NAP,P11413,,G6PD,wild,cl1,1qkiC,NAP,,1qki,1,3,,oxidoreductases ,,,Human Glucose-6-Phosphate Dehydrogenase: The Crystal Structure Reveals a Structural Nadp+ Molecule and Provides Insights Into Enzyme Deficiency,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl2,G6PD_6va0A_NAP,P11413,,G6PD,wild,cl2,6va0A,NAP,,6va0,1,3,,oxidoreductases ,,,Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl2,G6PD_6va8A_NAP,P11413,,G6PD,wild,cl2,6va8A,NAP,,6va8,1,3,,oxidoreductases ,,,Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl3,G6PD_5ukwA_BG6,P11413,,G6PD,wild,cl3,5ukwA,BG6,,5ukw,1,3,,oxidoreductases ,,,Mutations in the tetramer interface of human glucose-6-phosphate dehydrogenase reveals kinetic differences between oligomeric states.,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl1,G6PD_2bh9A_NAP,P11413,,G6PD,wild,cl1,2bh9A,NAP,,2bh9,1,3,,oxidoreductases ,,,Structural Studies of Glucose-6-Phosphate and Nadp+ Binding to Human Glucose-6-Phosphate Dehydrogenase,,,0,,,,,,,,,,,,,
P11413_G6PD_wild_cl3,G6PD_2bhlA_BG6,P11413,,G6PD,wild,cl3,2bhlA,BG6,,2bhl,1,3,,oxidoreductases ,,,Structural Studies of Glucose-6-Phosphate and Nadp+ Binding to Human Glucose-6-Phosphate Dehydrogenase,,,0,,,,,,,,,,,,,
P12259_F5_wild_cl1,F5_1czsA_PHG,P12259,,F5,wild,cl1,1czsA,PHG,,1czs,3,1,,oxidoreductases ,,,Crystal structures of the membrane-binding C2 domain of human coagulation factor V.,,,0,,,,,,,,,,,,,
P14061_HSD17B1_wild_cl1,HSD17B1_3klpX_B81,P14061,,HSD17B1,wild,cl1,3klpX,B81,,3klp,1,1,,oxidoreductases ,,,Molecular basis of sex-steroids: their translational activity,,,0,,,,,,,,,,,,,
P15121_AKR1B1_wild_cl1,AKR1B1_4q7bA_2YZ,P15121,,AKR1B1,wild,cl1,4q7bA,2YZ,,4q7b,1,2,,oxidoreductases ,,,Aldose Reductase: How expensive is the opening of the specificity pocket? IDD ligands under investigation,,,0,,,,,,,,,,,,,
P15121_AKR1B1_wild_cl1,AKR1B1_6txpA_4G7,P15121,,AKR1B1,wild,cl1,6txpA,4G7,,6txp,1,2,,oxidoreductases ,,,Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid),,,0,,,,,,,,,,,,,
P15121_AKR1B1_wild_cl2,AKR1B1_6t5gA_NAP,P15121,,AKR1B1,wild,cl2,6t5gA,NAP,,6t5g,1,2,,oxidoreductases ,,,Structure of Human Aldose Reductase Mutant L300A with a Citrate Molecule Bound in the Anion Binding Pocket,,,0,,,,,,,,,,,,,
P15559_NQO1_wild_cl2,NQO1_4cetA_DTC,P15559,,NQO1,wild,cl2,4cetA,DTC,,4cet,3,2,,oxidoreductases ,,,Collapse of the Native Structure by a Single Amino Acid Exchange in Human Nad(P)H:Quinone Oxidoreductase (Nqo1).,,,0,,,,,,,,,,,,,
P15559_NQO1_wild_cl1,NQO1_1h66A_FAD,P15559,,NQO1,wild,cl1,1h66A,FAD,,1h66,3,2,,oxidoreductases ,,,Structure-Based Development of Anticancer Drugs: Complexes of Nad(P)H:Quinone Oxidoreductase 1 with Chemotherapeutic Quinones,,,0,,,,,,,,,,,,,
P15559_NQO1_wild_cl2,NQO1_1h66D_RH1,P15559,,NQO1,wild,cl2,1h66D,RH1,,1h66,3,2,,oxidoreductases ,,,Structure-Based Development of Anticancer Drugs: Complexes of Nad(P)H:Quinone Oxidoreductase 1 with Chemotherapeutic Quinones,,,0,,,,,,,,,,,,,
P16083_NQO2_wild_cl2,NQO2_1xi2A_CB1,P16083,,NQO2,wild,cl2,1xi2A,CB1,,1xi2,1,3,,oxidoreductases ,,,Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954,,,0,,,,,,,,,,,,,
P16083_NQO2_wild_cl2,NQO2_1sg0B_STL,P16083,,NQO2,wild,cl2,1sg0B,STL,,1sg0,1,3,,oxidoreductases ,,,Crystal structure of quinone reductase 2 in complex with resveratrol,,,0,,,,,,,,,,,,,
P16083_NQO2_wild_cl3,NQO2_4fglD_CLQ,P16083,,NQO2,wild,cl3,4fglD,CLQ,,4fgl,1,3,,oxidoreductases ,,,Crystal structures of quinone reductase 2 bound to antimalarial drugs reveal conformational change upon reduction,,,0,,,,,,,,,,,,,
P16152_CBR1_wild_cl2,CBR1_2pfgA_NAP,P16152,,CBR1,wild,cl2,2pfgA,NAP,,2pfg,2,2,,oxidoreductases ,,,Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct.,,,0,,,,,,,,,,,,,
P16152_CBR1_wild_cl1,CBR1_3bhmA_AB3,P16152,,CBR1,wild,cl1,3bhmA,AB3,,3bhm,2,2,,oxidoreductases ,,,Human carbonyl reductase 1 is an s-nitrosoglutathione reductase,,,0,,,,,,,,,,,,,
P16152_CBR1_wild_cl1,CBR1_3bhmA_AHE,P16152,,CBR1,wild,cl1,3bhmA,AHE,,3bhm,2,2,,oxidoreductases ,,,Human carbonyl reductase 1 is an s-nitrosoglutathione reductase,,,0,,,,,,,,,,,,,
P16152_CBR1_wild_cl2,CBR1_4z3dA_NDP,P16152,,CBR1,wild,cl2,4z3dA,NDP,,4z3d,2,2,,oxidoreductases ,,,Structural insights on the catalytic site protection of human carbonyl reductase 1 by glutathione.,,,0,,,,,,,,,,,,,
P16435_POR_wild_cl1,POR_5emnA_FAD,P16435,,POR,wild,cl1,5emnA,FAD,,5emn,2,3,,oxidoreductases ,,,Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.,,,0,,,,,,,,,,,,,
P16435_POR_wild_cl2,POR_5fa6B_NAP,P16435,,POR,wild,cl2,5fa6B,NAP,,5fa6,2,3,,oxidoreductases ,,,Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.,,,0,,,,,,,,,,,,,
P16435_POR_wild_cl3,POR_5emnA_FMN,P16435,,POR,wild,cl3,5emnA,FMN,,5emn,2,3,,oxidoreductases ,,,Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.,,,0,,,,,,,,,,,,,
P16435_POR_wild_cl1,POR_3qftA_FAD,P16435,,POR,wild,cl1,3qftA,FAD,,3qft,2,3,,oxidoreductases ,,,Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.,,,0,,,,,,,,,,,,,
P16435_POR_wild_cl2,POR_3qe2A_NAP,P16435,,POR,wild,cl2,3qe2A,NAP,,3qe2,2,3,,oxidoreductases ,,,Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.,,,0,,,,,,,,,,,,,
P17516_AKR1C4_wild_cl1,AKR1C4_2fvlA_NAP,P17516,,AKR1C4,wild,cl1,2fvlA,NAP,,2fvl,3,1,,oxidoreductases ,,,Crystal structure of human 3-alpha hydroxysteroid/dihydrodiol dehydrogenase (AKR1C4) complexed with NADP+,,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl1,MAOA_2bxsA_MLG,P21397,,MAOA,wild,cl1,2bxsA,MLG,,2bxs,2,3,,oxidoreductases ,,,Three-Dimensional Structure of Human Monoamine Oxidase a (Mao A): Relation to the Structures of Rat Mao a and Human Mao B,,,0,,,,,,,,,,,,,
P21397_MAOA_wild_cl2,MAOA_2bxrA_FAD,P21397,,MAOA,wild,cl2,2bxrA,FAD,,2bxr,2,3,,oxidoreductases ,,,Three-Dimensional Structure of Human Monoamine Oxidase a (Mao A): Relation to the Structures of Rat Mao a and Human Mao B,,,0,,,,,,,,,,,,,
P21912_SDHB_wild_cl1,SDHB_7kluC_ANP,P21912,,SDHB,wild,cl1,7kluC,ANP,,7klu,3,1,,oxidoreductases ,,,Cryo-EM analysis of human mitochondrial Hsp90 in multiple tetrameric states,,,0,,,,,,,,,,,,,
P27338_MAOB_wild_cl2,MAOB_2bybA_FAD,P27338,,MAOB,wild,cl2,2bybA,FAD,,2byb,1,3,,oxidoreductases ,,,Three-Dimensional Structure of Human Monoamine Oxidase a (Mao A): Relation to the Structures of Rat Mao a and Human Mao B,,,0,,,,,,,,,,,,,
P31213_SRD5A2_wild_cl1,SRD5A2_7bw1A_NDX,P31213,,SRD5A2,wild,cl1,7bw1A,NDX,,7bw1,3,1,,oxidoreductases ,,,Structure of human steroid 5 alpha-reductase 2 with anti-androgen drug finasteride.,,,0,,,,,,,,,,,,,
P31937_HIBADH_wild_cl1,HIBADH_2i9pA_NAD,P31937,,HIBADH,wild,cl1,2i9pA,NAD,,2i9p,3,1,,oxidoreductases ,,,Crystal structure of human hydroxyisobutyrate dehydrogenase complexed with NAD+,,,0,,,,,,,,,,,,,
P31937_HIBADH_wild_cl1,HIBADH_2i9pB_NAD,P31937,,HIBADH,wild,cl1,2i9pB,NAD,,2i9p,3,1,,oxidoreductases ,,,Crystal structure of human hydroxyisobutyrate dehydrogenase complexed with NAD+,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl3,PYCR1_2graC_NAP,P32322,,PYCR1,wild,cl3,2graC,NAP,,2gra,3,4,,oxidoreductases ,,,Crystal structure of human pyrroline-5-carboxylate reductase,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl3,PYCR1_2graB_NAP,P32322,,PYCR1,wild,cl3,2graB,NAP,,2gra,3,4,,oxidoreductases ,,,Crystal structure of human pyrroline-5-carboxylate reductase,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl1,PYCR1_5uauA_PRO,P32322,,PYCR1,wild,cl1,5uauA,PRO,,5uau,3,4,,oxidoreductases ,,,Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl1,PYCR1_5uatC_NDP,P32322,,PYCR1,wild,cl1,5uatC,NDP,,5uat,3,4,,oxidoreductases ,,,Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl2,PYCR1_5uavB_TFB,P32322,,PYCR1,wild,cl2,5uavB,TFB,,5uav,3,4,,oxidoreductases ,,,Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl4,PYCR1_5uauA_PRO,P32322,,PYCR1,wild,cl4,5uauA,PRO,,5uau,3,4,,oxidoreductases ,,,Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.,,,0,,,,,,,,,,,,,
P32322_PYCR1_wild_cl4,PYCR1_5uauB_PRO,P32322,,PYCR1,wild,cl4,5uauB,PRO,,5uau,3,4,,oxidoreductases ,,,Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.,,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl1,SPR_4j7uD_YTZ,P35270,,SPR,wild,cl1,4j7uD,YTZ,,4j7u,1,3,,oxidoreductases ,,,Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs.,,,0,,,,,,,,,,,,,
P35270_SPR_wild_cl2,SPR_7dsfA_NAP,P35270,,SPR,wild,cl2,7dsfA,NAP,,7dsf,1,3,,oxidoreductases ,,,The Crystal Structure of human SPR from Biortus.,,,0,,,,,,,,,,,,,
P36551_CPOX_wild_cl1,CPOX_2aexA_CIT,P36551,,CPOX,wild,cl1,2aexA,CIT,,2aex,3,1,,oxidoreductases ,,,Structural basis of hereditary coproporphyria.,,,0,,,,,,,,,,,,,
P40394_ADH7_wild_cl1,ADH7_1d1tD_NAD,P40394,,ADH7,wild,cl1,1d1tD,NAD,,1d1t,3,1,,oxidoreductases ,,,Methionine-141 directly influences the binding of 4-methylpyrazole in human sigma sigma alcohol dehydrogenase.,,,0,,,,,,,,,,,,,
P40394_ADH7_wild_cl1,ADH7_1agnB_NAD,P40394,,ADH7,wild,cl1,1agnB,NAD,,1agn,3,1,,oxidoreductases ,,,X-ray structure of human class IV sigmasigma alcohol dehydrogenase. Structural basis for substrate specificity.,,,0,,,,,,,,,,,,,
P42330_AKR1C3_wild_cl2,AKR1C3_5jm5A_6NY,P42330,,AKR1C3,wild,cl2,5jm5A,6NY,,5jm5,2,2,removed ,oxidoreductases ,,, ,,,0,,,,,,,,,,,,,
P47895_ALDH1A3_wild_cl1,ALDH1A3_5fhzE_NAD,P47895,,ALDH1A3,wild,cl1,5fhzE,NAD,,5fhz,1,2,,oxidoreductases ,,,Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid.,,,0,,,,,,,,,,,,,
P47895_ALDH1A3_wild_cl2,ALDH1A3_5fhzC_REA,P47895,,ALDH1A3,wild,cl2,5fhzC,REA,,5fhz,1,2,,oxidoreductases ,,,Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid.,,,0,,,,,,,,,,,,,
P49748_ACADVL_wild_cl1,ACADVL_2uxwA_FAD,P49748,,ACADVL,wild,cl1,2uxwA,FAD,,2uxw,3,2,,oxidoreductases ,,,Crystal Structure of Human Very Long Chain Acyl- Coa Dehydrogenase (Acadvl),,,0,,,,,,,,,,,,,
P49748_ACADVL_wild_cl2,ACADVL_2uxwA_TH3,P49748,,ACADVL,wild,cl2,2uxwA,TH3,,2uxw,3,2,,oxidoreductases ,,,Crystal Structure of Human Very Long Chain Acyl- Coa Dehydrogenase (Acadvl),,,0,,,,,,,,,,,,,
P50213_IDH3A_wild_cl1,IDH3A_6l59A_ATP,P50213,,IDH3A,wild,cl1,6l59A,ATP,,6l59,3,2,,oxidoreductases ,,,Molecular mechanism of the dual regulatory roles of ATP on the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,,,0,,,,,,,,,,,,,
P50336_PPOX_wild_cl1,PPOX_4ivmB_ACJ,P50336,,PPOX,wild,cl1,4ivmB,ACJ,,4ivm,3,2,,oxidoreductases ,,,Quantitative structural insight into human variegate porphyria disease.,,,0,,,,,,,,,,,,,
P50336_PPOX_wild_cl2,PPOX_4ivoB_FAD,P50336,,PPOX,wild,cl2,4ivoB,FAD,,4ivo,3,2,,oxidoreductases ,,,Quantitative structural insight into human variegate porphyria disease.,,,0,,,,,,,,,,,,,
P50336_PPOX_wild_cl1,PPOX_3nksA_ACJ,P50336,,PPOX,wild,cl1,3nksA,ACJ,,3nks,3,2,,oxidoreductases ,,,Structural insight into human variegate porphyria disease,,,0,,,,,,,,,,,,,
P51649_ALDH5A1_wild_cl1,ALDH5A1_2w8qA_SIN,P51649,,ALDH5A1,wild,cl1,2w8qA,SIN,,2w8q,3,1,,oxidoreductases ,,,Redox-Switch Modulation of Human Ssadh by Dynamic Catalytic Loop.,,,0,,,,,,,,,,,,,
P51659_HSD17B4_wild_cl1,HSD17B4_1iktA_OXN,P51659,,HSD17B4,wild,cl1,1iktA,OXN,,1ikt,3,1,,oxidoreductases ,,,Crystal structure of the liganded SCP-2-like domain of human peroxisomal multifunctional enzyme type 2 at 1.75 A resolution.,,,0,,,,,,,,,,,,,
P52209_PGD_wild_cl2,PGD_5uq9E_8HS,P52209,,PGD,wild,cl2,5uq9E,8HS,,5uq9,3,3,,oxidoreductases ,,,Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.,,,0,,,,,,,,,,,,,
P52209_PGD_wild_cl3,PGD_5uq9F_8HS,P52209,,PGD,wild,cl3,5uq9F,8HS,,5uq9,3,3,,oxidoreductases ,,,Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.,,,0,,,,,,,,,,,,,
P52209_PGD_wild_cl2,PGD_4gwkA_3PG,P52209,,PGD,wild,cl2,4gwkA,3PG,,4gwk,3,3,,oxidoreductases ,,,Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.,,,0,,,,,,,,,,,,,
P52209_PGD_wild_cl1,PGD_2jkvA_NAP,P52209,,PGD,wild,cl1,2jkvA,NAP,,2jkv,3,3,,oxidoreductases ,,,Structure of Human Phosphogluconate Dehydrogenase in Complex with Nadph at 2.53A,,,0,,,,,,,,,,,,,
P52209_PGD_wild_cl1,PGD_2jkvB_NAP,P52209,,PGD,wild,cl1,2jkvB,NAP,,2jkv,3,3,,oxidoreductases ,,,Structure of Human Phosphogluconate Dehydrogenase in Complex with Nadph at 2.53A,,,0,,,,,,,,,,,,,
P52895_AKR1C2_wild_cl2,AKR1C2_4xo7B_NAP,P52895,,AKR1C2,wild,cl2,4xo7B,NAP,,4xo7,1,2,,oxidoreductases ,,,Human 3 alpha-hydroxysteroid dehydrogenase type 3: structural clues of 5 alpha-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.,,,0,,,,,,,,,,,,,
P52895_AKR1C2_wild_cl2,AKR1C2_4xo6A_NAP,P52895,,AKR1C2,wild,cl2,4xo6A,NAP,,4xo6,1,2,,oxidoreductases ,,,Human 3 alpha-hydroxysteroid dehydrogenase type 3: structural clues of 5 alpha-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.,,,0,,,,,,,,,,,,,
P52895_AKR1C2_wild_cl1,AKR1C2_2ipjA_FFA,P52895,,AKR1C2,wild,cl1,2ipjA,FFA,,2ipj,1,2,,oxidoreductases ,,,Mouse 17alpha-Hydroxysteroid Dehydrogenase (AKR1C21) Binds Steroids Differently from other Aldo-keto Reductases: Identification and Characterization of Amino Acid Residues Critical for Substrate Binding.,,,0,,,,,,,,,,,,,
P52895_AKR1C2_wild_cl1,AKR1C2_1j96A_TES,P52895,,AKR1C2,wild,cl1,1j96A,TES,,1j96,1,2,,oxidoreductases ,,,Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution.,,,0,,,,,,,,,,,,,
P53004_BLVRA_wild_cl1,BLVRA_2h63A_NAP,P53004,,BLVRA,wild,cl1,2h63A,NAP,,2h63,3,1,,oxidoreductases ,,,Crystal Structure of Human Biliverdin Reductase A,,,0,,,,,,,,,,,,,
P56545_CTBP2_wild_cl1,CTBP2_6wkwC_NAD,P56545,,CTBP2,wild,cl1,6wkwC,NAD,,6wkw,1,2,,oxidoreductases ,,,Cryo-EM structure of CtBP2 confirms tetrameric architecture.,,,0,,,,,,,,,,,,,
Q00796_SORD_wild_cl1,SORD_1pl6A_572,Q00796,,SORD,wild,cl1,1pl6A,572,,1pl6,3,2,,oxidoreductases ,,,X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase.,,,0,,,,,,,,,,,,,
Q00796_SORD_wild_cl1,SORD_1pl6B_572,Q00796,,SORD,wild,cl1,1pl6B,572,,1pl6,3,2,,oxidoreductases ,,,X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase.,,,0,,,,,,,,,,,,,
Q00796_SORD_wild_cl2,SORD_1pl8B_NAD,Q00796,,SORD,wild,cl2,1pl8B,NAD,,1pl8,3,2,,oxidoreductases ,,,X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase.,,,0,,,,,,,,,,,,,
Q02127_DHODH_wild_cl2,DHODH_4ighA_ORO,Q02127,,DHODH,wild,cl2,4ighA,ORO,,4igh,1,3,,oxidoreductases ,,,SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity.,,,0,,,,,,,,,,,,,
Q02127_DHODH_wild_cl2,DHODH_4ighA_FMN,Q02127,,DHODH,wild,cl2,4ighA,FMN,,4igh,1,3,,oxidoreductases ,,,SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity.,,,0,,,,,,,,,,,,,
Q02127_DHODH_wild_cl3,DHODH_4ighA_ZWI,Q02127,,DHODH,wild,cl3,4ighA,ZWI,,4igh,1,3,,oxidoreductases ,,,SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity.,,,0,,,,,,,,,,,,,
Q08257_CRYZ_wild_cl1,CRYZ_1yb5A_NAP,Q08257,,CRYZ,wild,cl1,1yb5A,NAP,,1yb5,3,1,,oxidoreductases ,,,Crystal Structure of human Zeta-Crystallin at 1.85A,,,0,,,,,,,,,,,,,
Q12797_ASPH_wild_cl1,ASPH_5jzzC_OGA,Q12797,,ASPH,wild,cl1,5jzzC,OGA,,5jzz,2,1,6RK9,oxidoreductases ,,,Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese_ N-oxalylglycine and cyclic peptide substrate mimic of factor X,,,0,,,,,,,,,,,,,
Q12797_ASPH_wild_cl1,ASPH_5jzzA_OGA,Q12797,,ASPH,wild,cl1,5jzzA,OGA,,5jzz,2,1,6RK9,oxidoreductases ,,,Aspartyl/Asparaginyl beta-hydroxylase (AspH)oxygenase and TPR domains in complex with manganese_ N-oxalylglycine and cyclic peptide substrate mimic of factor X,,,0,,,,,,,,,,,,,
Q13363_CTBP1_wild_cl1,CTBP1_6cdfA_NAI,Q13363,,CTBP1,wild,cl1,6cdfA,NAI,,6cdf,3,2,,oxidoreductases ,,,Assembly of human C-terminal binding protein (CtBP) into tetramers.,,,0,,,,,,,,,,,,,
Q13363_CTBP1_wild_cl1,CTBP1_1mx3A_NAD,Q13363,,CTBP1,wild,cl1,1mx3A,NAD,,1mx3,3,2,,oxidoreductases ,,,Transcription Corepressor CtBP Is an NAD+-Regulated Dehydrogenase,,,0,,,,,,,,,,,,,
Q14914_PTGR1_wild_cl1,PTGR1_2y05A_RAL,Q14914,,PTGR1,wild,cl1,2y05A,RAL,,2y05,3,1,,oxidoreductases ,,,Crystal Structure of Human Leukotriene B4 12-Hydroxydehydrogenase in Complex with Nadp and Raloxifene,,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl2,TXNRD1_2cfyB_FAD,Q16881,,TXNRD1,wild,cl2,2cfyB,FAD,,2cfy,1,5,,oxidoreductases ,,,Crystal Structure of Human Thioredoxin Reductase 1,,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl1,TXNRD1_2j3nF_NAP,Q16881,,TXNRD1,wild,cl1,2j3nF,NAP,,2j3n,1,5,,oxidoreductases ,,,The Structure of Human Thioredoxin Reductase 1 Provides Insights Into C-Terminal Rearrangements During Catalysis.,,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl2,TXNRD1_2j3nA_FAD,Q16881,,TXNRD1,wild,cl2,2j3nA,FAD,,2j3n,1,5,,oxidoreductases ,,,The Structure of Human Thioredoxin Reductase 1 Provides Insights Into C-Terminal Rearrangements During Catalysis.,,,0,,,,,,,,,,,,,
Q16881_TXNRD1_wild_cl4,TXNRD1_2j3nC_FAD,Q16881,,TXNRD1,wild,cl4,2j3nC,FAD,,2j3n,1,5,,oxidoreductases ,,,The Structure of Human Thioredoxin Reductase 1 Provides Insights Into C-Terminal Rearrangements During Catalysis.,,,0,,,,,,,,,,,,,
Q709F0_ACAD11_wild_cl1,ACAD11_2wbiA_FAD,Q709F0,,ACAD11,wild,cl1,2wbiA,FAD,,2wbi,3,2,,oxidoreductases ,,,Crystal Structure of Human Acyl-Coa Dehydrogenase 11,,,0,,,,,,,,,,,,,
Q709F0_ACAD11_wild_cl2,ACAD11_2wbiA_FAD,Q709F0,,ACAD11,wild,cl2,2wbiA,FAD,,2wbi,3,2,,oxidoreductases ,,,Crystal Structure of Human Acyl-Coa Dehydrogenase 11,,,0,,,,,,,,,,,,,
Q7Z4W1_DCXR_wild_cl1,DCXR_1pr9A_NAP,Q7Z4W1,,DCXR,wild,cl1,1pr9A,NAP,,1pr9,3,1,,oxidoreductases ,,,Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis,,,0,,,,,,,,,,,,,
Q92947_GCDH_wild_cl1,GCDH_1siqA_FAD,Q92947,,GCDH,wild,cl1,1siqA,FAD,,1siq,3,2,,oxidoreductases ,,,Crystal Structures of Human Glutaryl-CoA Dehydrogenase with and without an Alternate Substrate: Structural Bases of Dehydrogenation and Decarboxylation Reactions,,,0,,,,,,,,,,,,,
Q92947_GCDH_wild_cl2,GCDH_1sirA_NBC,Q92947,,GCDH,wild,cl2,1sirA,NBC,,1sir,3,2,,oxidoreductases ,,,Crystal Structures of Human Glutaryl-CoA Dehydrogenase with and without an Alternate Substrate: Structural Bases of Dehydrogenation and Decarboxylation Reactions,,,0,,,,,,,,,,,,,
Q92947_GCDH_wild_cl1,GCDH_2r0mA_4NI,Q92947,,GCDH,wild,cl1,2r0mA,4NI,,2r0m,3,2,,oxidoreductases ,,,The effect of a Glu370Asp mutation in glutaryl-CoA dehydrogenase on proton transfer to the dienolate intermediate.,,,0,,,,,,,,,,,,,
Q99714_HSD17B10_wild_cl1,HSD17B10_7onuC_NAD,Q99714,,HSD17B10,wild,cl1,7onuC,NAD,,7onu,3,1,,oxidoreductases ,,,Structural basis of RNA processing by human mitochondrial RNase P.,,,0,,,,,,,,,,,,,
Q99714_HSD17B10_wild_cl1,HSD17B10_2o23A_NAD,Q99714,,HSD17B10,wild,cl1,2o23A,NAD,,2o23,3,1,,oxidoreductases ,,,The structure of wild-type human HADH2 (17beta-hydroxysteroid dehydrogenase type 10) bound to NAD+ at 1.2 A,,,0,,,,,,,,,,,,,
Q9BPX1_HSD17B14_wild_cl1,HSD17B14_6zdeA_NAD,Q9BPX1,,HSD17B14,wild,cl1,6zdeA,NAD,,6zde,2,2,,oxidoreductases ,,,17beta-hydroxysteroid dehydrogenase type 14 variant S205 in complex with pentafluorophenol,,,0,,,,,,,,,,,,,
Q9BV57_ADI1_wild_cl1,ADI1_4qgnA_MSE,Q9BV57,,ADI1,wild,cl1,4qgnA,MSE,,4qgn,3,1,,oxidoreductases ,,,Human acireductone dioxygenase with iron ion and L-methionine in active center,,,0,,,,,,,,,,,,,
Q9BY49_PECR_wild_cl1,PECR_1yxmB_ADE,Q9BY49,,PECR,wild,cl1,1yxmB,ADE,,1yxm,3,1,,oxidoreductases ,,,Crystal structure of perixomal trans 2-enoyl CoA reductase (PECRA),,,0,,,,,,,,,,,,,
Q9HBL8_NMRAL1_wild_cl2,NMRAL1_2wmdA_ZZ0,Q9HBL8,,NMRAL1,wild,cl2,2wmdA,ZZ0,,2wmd,3,3,,oxidoreductases ,,,Crystal Structure of Nmra-Like Family Domain Containing Protein 1,,,0,,,,,,,,,,,,,
Q9HBL8_NMRAL1_wild_cl1,NMRAL1_2wm3A_NAP,Q9HBL8,,NMRAL1,wild,cl1,2wm3A,NAP,,2wm3,3,3,,oxidoreductases ,,,Crystal Structure of Nmra-Like Family Domain Containing Protein 1 in Complex with Niflumic Acid,,,0,,,,,,,,,,,,,
Q9HBL8_NMRAL1_wild_cl1,NMRAL1_2exxA_NAP,Q9HBL8,,NMRAL1,wild,cl1,2exxA,NAP,,2exx,3,3,,oxidoreductases ,,,Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein.,,,0,,,,,,,,,,,,,
Q9HBL8_NMRAL1_wild_cl3,NMRAL1_2exxB_NAP,Q9HBL8,,NMRAL1,wild,cl3,2exxB,NAP,,2exx,3,3,,oxidoreductases ,,,Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein.,,,0,,,,,,,,,,,,,
Q9NVS9_PNPO_wild_cl1,PNPO_3hy8A_PLP,Q9NVS9,,PNPO,wild,cl1,3hy8A,PLP,,3hy8,3,1,,oxidoreductases ,,,Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder,,,0,,,,,,,,,,,,,
Q9NVS9_PNPO_wild_cl1,PNPO_3hy8A_FMN,Q9NVS9,,PNPO,wild,cl1,3hy8A,FMN,,3hy8,3,1,,oxidoreductases ,,,Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder,,,0,,,,,,,,,,,,,
Q9UBQ7_GRHPR_wild_cl1,GRHPR_2gcgA_NDP,Q9UBQ7,,GRHPR,wild,cl1,2gcgA,NDP,,2gcg,3,1,,oxidoreductases ,,,Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase,,,0,,,,,,,,,,,,,
Q9UBQ7_GRHPR_wild_cl1,GRHPR_2gcgB_NDP,Q9UBQ7,,GRHPR,wild,cl1,2gcgB,NDP,,2gcg,3,1,,oxidoreductases ,,,Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase,,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl3,HGF_1gmoG_SGN,P14210,,HGF,wild,cl3,1gmoG,SGN,,1gmo,1,5,,Peptidase,,,Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor,agonist,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl3,HGF_1gmoA_IDS,P14210,,HGF,wild,cl3,1gmoA,IDS,,1gmo,1,5,,Peptidase,,,Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor,agonist,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl4,HGF_1gmnA_IDS,P14210,,HGF,wild,cl4,1gmnA,IDS,,1gmn,1,5,,Peptidase,,,Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor,agonist,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl4,HGF_1gmoF_IDS,P14210,,HGF,wild,cl4,1gmoF,IDS,,1gmo,1,5,,Peptidase,,,Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor,agonist,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl5,HGF_1gmoB_IDS,P14210,,HGF,wild,cl5,1gmoB,IDS,,1gmo,1,5,,Peptidase,,,Crystal Structures of Nk1-Heparin Complexes Reveal the Basis for Nk1 Activity and Enable Engineering of Potent Agonists of the met Receptor,agonist,,0,,,,,,,,,,,,,
P00734_F2_wild_cl1,F2_1k21H_IGN,P00734,,F2,wild,cl1,1k21H,IGN,,1k21,2,5,,Peptidase,,,Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.,inhibitor,,0,,,,,,,,,,,,,
P00740_F9_wild_cl1,F9_4zaeA_4M1,P00740,,F9,wild,cl1,4zaeA,4M1,,4zae,1,3,,Peptidase,,,Development of a novel class of potent and selective FIXa inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00740_F9_wild_cl2,F9_6x5jA_CIT,P00740,,F9,wild,cl2,6x5jA,CIT,,6x5j,1,3,,Peptidase,,,Discovery of hydroxy pyrimidine Factor IXa inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00740_F9_wild_cl1,F9_4z0kA_4LN,P00740,,F9,wild,cl1,4z0kA,4LN,,4z0k,1,3,,Peptidase,,,Rapid development of two factor IXa inhibitors from hit to lead.,inhibitor,,0,,,,,,,,,,,,,
P00742_F10_wild_cl1,F10_2phbA_230,P00742,,F10,wild,cl1,2phbA,230,,2phb,1,1,,Peptidase,,,The discovery of (2R_4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1_2-dicarboxamide (PD 0348292)_ an orally efficacious factor Xa inhibitor,inhibitor,,0,,,,,,,,,,,,,
P00742_F10_wild_cl1,F10_2q1jA_FXI,P00742,,F10,wild,cl1,2q1jA,FXI,,2q1j,1,1,,Peptidase,,,The Discovery of Glycine and Related Amino Acid-Based Factor Xa inhibitors,inhibitor,,0,,,,,,,,,,,,,
P00746_CFD_wild_cl1,CFD_5tcaD_J55,P00746,,CFD,wild,cl1,5tcaD,J55,,5tca,1,1,,Peptidase,,,Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00746_CFD_wild_cl1,CFD_5tcaC_J55,P00746,,CFD,wild,cl1,5tcaC,J55,,5tca,1,1,,Peptidase,,,Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00747_PLG_wild_cl3,PLG_1ki0A_BCN,P00747,,PLG,wild,cl3,1ki0A,BCN,,1ki0,2,3,,Peptidase,,,The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.,inhibitor,,0,,,,,,,,,,,,,
P00747_PLG_wild_cl2,PLG_5ugdA_89S,P00747,,PLG,wild,cl2,5ugdA,89S,,5ugd,2,3,,Peptidase,,,X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00748_F12_wild_cl1,F12_6b77B_CWV,P00748,,F12,wild,cl1,6b77B,CWV,,6b77,3,2,,Peptidase,,,Structures of human plasma beta-factor XIIa cocrystallized with potent inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl1,PLAU_5zajU_32I,P00749,,PLAU,wild,cl1,5zajU,32I,,5zaj,1,5,,Peptidase,,,6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.,inhibitor,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl3,PLAU_2o8uA_BEN,P00749,,PLAU,wild,cl3,2o8uA,BEN,,2o8u,1,5,,Peptidase,,,Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with inhibitors,inhibitor,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl1,PLAU_5yc6U_PZH,P00749,,PLAU,wild,cl1,5yc6U,PZH,,5yc6,1,5,,Peptidase,,,Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases,inhibitor,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl2,PLAU_3ig6B_438,P00749,,PLAU,wild,cl2,3ig6B,438,,3ig6,1,5,,Peptidase,,,Identification of orally bioavailable_ non-amidine inhibitors of Urokinase Plasminogen Activator (uPA),inhibitor,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl5,PLAU_3ig6D_438,P00749,,PLAU,wild,cl5,3ig6D,438,,3ig6,1,5,,Peptidase,,,Identification of orally bioavailable_ non-amidine inhibitors of Urokinase Plasminogen Activator (uPA),inhibitor,,0,,,,,,,,,,,,,
P00750_PLAT_wild_cl1,PLAT_1a5hA_BBA,P00750,,PLAT,wild,cl1,1a5hA,BBA,,1a5h,2,1,,Peptidase,,,Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P03951_F11_wild_cl2,F11_1zhmA_GSH,P03951,,F11,wild,cl2,1zhmA,GSH,,1zhm,1,2,,Peptidase,,,Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: an essential step for the iterative structure-based design of factor XI inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P03951_F11_wild_cl2,F11_1zhpA_GSH,P03951,,F11,wild,cl2,1zhpA,GSH,,1zhp,1,2,,Peptidase,,,Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: an essential step for the iterative structure-based design of factor XI inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P03951_F11_wild_cl1,F11_5exnA_5SU,P03951,,F11,wild,cl1,5exnA,5SU,,5exn,1,2,,Peptidase,,,Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group,inhibitor,,0,,,,,,,,,,,,,
P03951_F11_wild_cl1,F11_5tksA_7DL,P03951,,F11,wild,cl1,5tksA,7DL,,5tks,1,2,,Peptidase,,,Structure-Based Design of Macrocyclic Factor XIa inhibitors: Discovery of the Macrocyclic Amide Linker.,inhibitor,,0,,,,,,,,,,,,,
P03952_KLKB1_wild_cl3,KLKB1_6t7pA_GSH,P03952,,KLKB1,wild,cl3,6t7pA,GSH,,6t7p,3,3,,Peptidase,,,Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.,inhibitor,,0,,,,,,,,,,,,,
P03952_KLKB1_wild_cl1,KLKB1_4zj4A_MRZ,P03952,,KLKB1,wild,cl1,4zj4A,MRZ,,4zj4,3,3,5F8Z,Peptidase,,,The crystal structure of human Plasma Kallikrein in complex with its peptide inhibitor pkalin-1,inhibitor,,0,,,,,,,,,,,,,
P03952_KLKB1_wild_cl1,KLKB1_5tz9E_7SD,P03952,,KLKB1,wild,cl1,5tz9E,7SD,,5tz9,3,3,5TZ9,Peptidase,,,Structure of human plasma kallikrein protease domain with inhibitor,inhibitor,,0,,,,,,,,,,,,,
P05981_HPN_wild_cl1,HPN_5ce1A_50K,P05981,,HPN,wild,cl1,5ce1A,50K,,5ce1,2,1,,Peptidase,,,Crystal Structure of Serine protease Hepsin in complex with inhibitor,inhibitor,,0,,,,,,,,,,,,,
P05981_HPN_wild_cl1,HPN_1o5eH_132,P05981,,HPN,wild,cl1,1o5eH,132,,1o5e,2,1,,Peptidase,,,Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).,inhibitor,,0,,,,,,,,,,,,,
P07339_CTSD_wild_cl1,CTSD_6qcbB_HWE,P07339,,CTSD,wild,cl1,6qcbB,HWE,,6qcb,3,3,,Peptidase,,,Biomimetic Macrocyclic inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis.,inhibitor,,0,,,,,,,,,,,,,
P07339_CTSD_wild_cl3,CTSD_6qbgB_HVT,P07339,,CTSD,wild,cl3,6qbgB,HVT,,6qbg,3,3,,Peptidase,,,Biomimetic Macrocyclic inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis.,inhibitor,,0,,,,,,,,,,,,,
P07339_CTSD_wild_cl1,CTSD_4od9B_2RZ,P07339,,CTSD,wild,cl1,4od9B,2RZ,,4od9,3,3,,Peptidase,,,Structure-based optimization of non-peptidic Cathepsin D inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P07339_CTSD_wild_cl2,CTSD_4od9C_2RZ,P07339,,CTSD,wild,cl2,4od9C,2RZ,,4od9,3,3,,Peptidase,,,Structure-based optimization of non-peptidic Cathepsin D inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P07339_CTSD_wild_cl2,CTSD_4oc6A_2S1,P07339,,CTSD,wild,cl2,4oc6A,2S1,,4oc6,3,3,,Peptidase,,,Structure-based optimization of non-peptidic Cathepsin D inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P07384_CAPN1_wild_cl1,CAPN1_1zcmA_C1N,P07384,,CAPN1,wild,cl1,1zcmA,C1N,,1zcm,3,1,,Peptidase,,,Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core,inhibitor,,0,,,,,,,,,,,,,
P07711_CTSL_wild_cl1,CTSL_4axmA_V65,P07711,,CTSL,wild,cl1,4axmA,V65,,4axm,1,1,,Peptidase,,,Optimization of Triazine Nitriles as Rhodesain inhibitors: Structure-Activity Relationships_ Bioisosteric Imidazopyridine Nitriles_ and X-Ray Crystal Structure Analysis with Human Cathepsin L,inhibitor,,0,,,,,,,,,,,,,
P07858_CTSB_wild_cl2,CTSB_1csbB_EP0,P07858,,CTSB,wild,cl2,1csbB,EP0,,1csb,3,2,,Peptidase,,,Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P07858_CTSB_wild_cl2,CTSB_1csbE_EP0,P07858,,CTSB,wild,cl2,1csbE,EP0,,1csb,3,2,,Peptidase,,,Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P07858_CTSB_wild_cl1,CTSB_1gmyC_DFA,P07858,,CTSB,wild,cl1,1gmyC,DFA,,1gmy,3,2,,Peptidase,,,Identification of Dipeptidyl Nitriles as Potent and Selective inhibitors of Cathepsin B Through Structure-Based Drug Design,inhibitor,,0,,,,,,,,,,,,,
P07858_CTSB_wild_cl1,CTSB_1gmyA_APD,P07858,,CTSB,wild,cl1,1gmyA,APD,,1gmy,3,2,,Peptidase,,,Identification of Dipeptidyl Nitriles as Potent and Selective inhibitors of Cathepsin B Through Structure-Based Drug Design,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl5,ELANE_6f5mA_CQH,P08246,,ELANE,wild,cl5,6f5mA,CQH,,6f5m,2,5,,Peptidase,,,Crystal structure of highly glycosylated human leukocyte elastase in complex with an S2' site binding inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl5,ELANE_6f5mB_CQH,P08246,,ELANE,wild,cl5,6f5mB,CQH,,6f5m,2,5,,Peptidase,,,Crystal structure of highly glycosylated human leukocyte elastase in complex with an S2' site binding inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl1,ELANE_1h1bA_151,P08246,,ELANE,wild,cl1,1h1bA,151,,1h1b,2,5,,Peptidase,,,Discovery of Further Pyrrolidine Trans-Lactams as inhibitors of Human Neutrophil Elastase (Hne) with Potential as Development Candidates and the Crystal Structure of Hne Complexed with an inhibitor (Gw475151),inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl1,ELANE_1h1bB_151,P08246,,ELANE,wild,cl1,1h1bB,151,,1h1b,2,5,,Peptidase,,,Discovery of Further Pyrrolidine Trans-Lactams as inhibitors of Human Neutrophil Elastase (Hne) with Potential as Development Candidates and the Crystal Structure of Hne Complexed with an inhibitor (Gw475151),inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl2,ELANE_5a8yA_FUC,P08246,,ELANE,wild,cl2,5a8yA,FUC,,5a8y,2,5,,Peptidase,,,Potent and Selective Human Neutrophil Elastase inhibitors with Novel Equatorial Ring Topology: In Vivo Efficacy of the Polar Pyrimidopyridazine Bay-8040 in a Pulmonary Arterial Hypertension Rat Model.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl4,ELANE_4nzlA_FUL,P08246,,ELANE,wild,cl4,4nzlA,FUL,,4nzl,2,5,,Peptidase,,,Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl4,ELANE_7cbkD_FUC,P08246,,ELANE,wild,cl4,7cbkD,FUC,,7cbk,2,5,,Peptidase,,,Structural Basis for the inhibition Mechanism of Ecotin against Neutrophil Elastase by Targeting the Active Site and Secondary Binding Site.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl2,ELANE_1ppgE_FUC,P08246,,ELANE,wild,cl2,1ppgE,FUC,,1ppg,2,5,,Peptidase,,,The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl3,ELANE_1ppgE_BMA,P08246,,ELANE,wild,cl3,1ppgE,BMA,,1ppg,2,5,,Peptidase,,,The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P08246_ELANE_wild_cl3,ELANE_1ppgE_MAN,P08246,,ELANE,wild,cl3,1ppgE,MAN,,1ppg,2,5,,Peptidase,,,The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P08311_CTSG_wild_cl1,CTSG_1kynA_KTP,P08311,,CTSG,wild,cl1,1kynA,KTP,,1kyn,2,1,,Peptidase,,,Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design.,inhibitor,,0,,,,,,,,,,,,,
P08709_F7_wild_cl1,F7_4ngaH_2KF,P08709,,F7,wild,cl1,4ngaH,2KF,,4nga,2,8,,Peptidase,,,Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P08709_F7_wild_cl1,F7_4x8vH_3Z9,P08709,,F7,wild,cl1,4x8vH,3Z9,,4x8v,2,8,,Peptidase,,,Discovery of Novel P1 Groups for Coagulation Factor VIIa inhibition Using Fragment-Based Screening.,inhibitor,,0,,,,,,,,,,,,,
P08709_F7_wild_cl4,F7_1dvaL_GAL,P08709,,F7,wild,cl4,1dvaL,GAL,,1dva,2,8,,Peptidase,,,Peptide exosite inhibitors of factor VIIa as anticoagulants.,inhibitor,,0,,,,,,,,,,,,,
P08709_F7_wild_cl6,F7_1dvaL_FUC,P08709,,F7,wild,cl6,1dvaL,FUC,,1dva,2,8,,Peptidase,,,Peptide exosite inhibitors of factor VIIa as anticoagulants.,inhibitor,,0,,,,,,,,,,,,,
P08709_F7_wild_cl2,F7_1fakL_GLC,P08709,,F7,wild,cl2,1fakL,GLC,,1fak,2,8,,Peptidase,,,Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.,inhibitor,,0,,,,,,,,,,,,,
P09960_LTA4H_wild_cl1,LTA4H_3fheA_28P,P09960,,LTA4H,wild,cl1,3fheA,28P,,3fhe,1,2,,Peptidase,,,Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
P09960_LTA4H_wild_cl1,LTA4H_3fh5A_24P,P09960,,LTA4H,wild,cl1,3fh5A,24P,,3fh5,1,2,,Peptidase,,,Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
P09960_LTA4H_wild_cl2,LTA4H_3fudA_692,P09960,,LTA4H,wild,cl2,3fudA,692,,3fud,1,2,,Peptidase,,,Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.,inhibitor,,0,,,,,,,,,,,,,
P10619_CTSA_wild_cl1,CTSA_4az0B_S61,P10619,,CTSA,wild,cl1,4az0B,S61,,4az0,3,1,,Peptidase,,,Novel Beta-Amino Acid Derivatives as inhibitors of Cathepsin A.,inhibitor,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl4,ACE_3l3nA_FUC,P12821,,ACE,wild,cl4,3l3nA,FUC,,3l3n,1,4,,Peptidase,,,Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.,inhibitor,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl1,ACE_7q29A_8JV,P12821,,ACE,wild,cl1,7q29A,8JV,,7q29,1,4,,Peptidase,,,Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin inhibition.,inhibitor,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl2,HGF_5csqA_MPO,P14210,,HGF,wild,cl2,5csqA,MPO,,5csq,1,5,,Peptidase,,,Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding.,inhibitor,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl2,HGF_5coeB_EPE,P14210,,HGF,wild,cl2,5coeB,EPE,,5coe,1,5,,Peptidase,,,Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding.,inhibitor,,0,,,,,,,,,,,,,
P15085_CPA1_wild_cl1,CPA1_5om9A_O2S,P15085,,CPA1,wild,cl1,5om9A,O2S,,5om9,3,1,,Peptidase,,,Discovery of Mechanism-Based inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.,inhibitor,,0,,,,,,,,,,,,,
P15085_CPA1_wild_cl1,CPA1_5om9B_O2S,P15085,,CPA1,wild,cl1,5om9B,O2S,,5om9,3,1,,Peptidase,,,Discovery of Mechanism-Based inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.,inhibitor,,0,,,,,,,,,,,,,
P20618_PSMB1_wild_cl1,PSMB1_5leyZ_6V9,P20618,,PSMB1,wild,cl1,5leyZ,6V9,,5ley,3,1,,Peptidase,,,The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P23946_CMA1_wild_cl1,CMA1_3s0nA_0BB,P23946,,CMA1,wild,cl1,3s0nA,0BB,,3s0n,1,1,,Peptidase,,,Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P(1)) region.,inhibitor,,0,,,,,,,,,,,,,
P23946_CMA1_wild_cl1,CMA1_4k2yA_ES2,P23946,,CMA1,wild,cl1,4k2yA,ES2,,4k2y,1,1,,Peptidase,,,Discovery of Potent_ Selective Chymase inhibitors via Fragment Linking Strategies.,inhibitor,,0,,,,,,,,,,,,,
P25774_CTSS_wild_cl2,CTSS_3n3gA_93N,P25774,,CTSS,wild,cl2,3n3gA,93N,,3n3g,1,2,,Peptidase,,,4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3_ not N1 is critically important.,inhibitor,,0,,,,,,,,,,,,,
P28062_PSMB8_wild_cl1,PSMB8_7aweL_S5K,P28062,,PSMB8,wild,cl1,7aweL,S5K,,7awe,3,1,,Peptidase,,,M3258 Is a Selective inhibitor of the Immunoproteasome Subunit LMP7 ( beta 5i) Delivering Efficacy in Multiple Myeloma Models.,inhibitor,,0,,,,,,,,,,,,,
P28065_PSMB9_wild_cl1,PSMB9_7aweV_S5K,P28065,,PSMB9,wild,cl1,7aweV,S5K,,7awe,3,1,,Peptidase,,,M3258 Is a Selective inhibitor of the Immunoproteasome Subunit LMP7 ( beta 5i) Delivering Efficacy in Multiple Myeloma Models.,inhibitor,,0,,,,,,,,,,,,,
P28072_PSMB6_wild_cl1,PSMB6_5lezN_6VA,P28072,,PSMB6,wild,cl1,5lezN,6VA,,5lez,3,1,,Peptidase,,,The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P28074_PSMB5_wild_cl1,PSMB5_5leyY_6VA,P28074,,PSMB5,wild,cl1,5leyY,6VA,,5ley,3,1,,Peptidase,,,The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P28074_PSMB5_wild_cl1,PSMB5_5lf4K_6V7,P28074,,PSMB5,wild,cl1,5lf4K,6V7,,5lf4,3,1,,Peptidase,,,The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl1,CASP1_1bmqB_MNO,P29466,,CASP1,wild,cl1,1bmqB,MNO,,1bmq,3,4,,Peptidase,,,Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis_ structure activity relationships and crystallographic study of the ICE-inhibitor complex.,inhibitor,,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl2,CASP1_1bmqA_MNO,P29466,,CASP1,wild,cl2,1bmqA,MNO,,1bmq,3,4,,Peptidase,,,Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis_ structure activity relationships and crystallographic study of the ICE-inhibitor complex.,inhibitor,,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl1,CASP1_1rwpB_HQC,P29466,,CASP1,wild,cl1,1rwpB,HQC,,1rwp,3,4,,Peptidase,,,Structural analysis of caspase-1 inhibitors derived from Tethering.,inhibitor,,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl2,CASP1_3ns7A_3NS,P29466,,CASP1,wild,cl2,3ns7A,3NS,,3ns7,3,4,,Peptidase,,,Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).,inhibitor,,0,,,,,,,,,,,,,
P35030_PRSS3_wild_cl1,PRSS3_5tp0A_BRN,P35030,,PRSS3,wild,cl1,5tp0A,BRN,,5tp0,3,1,,Peptidase,,,Small molecule inhibitors of mesotrypsin from a structure-based docking screen.,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl7,CTSK_6ashA_1XF,P43235,,CTSK,wild,cl7,6ashA,1XF,,6ash,1,7,,Peptidase,,,Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution.,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl1,CTSK_3kwbY_ORH,P43235,,CTSK,wild,cl1,3kwbY,ORH,,3kwb,1,7,,Peptidase,,,Dioxo-triazines as a novel series of cathepsin K inhibitors,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl6,CTSK_1tu6B_FSP,P43235,,CTSK,wild,cl6,1tu6B,FSP,,1tu6,1,7,,Peptidase,,,Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with improved pharmacokinetic properties via favorable P1'_ P1_ and/or P3 substitutions,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl5,CTSK_6pxfA_J0V,P43235,,CTSK,wild,cl5,6pxfA,J0V,,6pxf,1,7,,Peptidase,,,Structure of human Cathepsin K with an ectosteric inhibitor at 1.85 Angstrom resolution,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl1,CTSK_6qlmA_HFH,P43235,,CTSK,wild,cl1,6qlmA,HFH,,6qlm,1,7,,Peptidase,,,Successful development of 3-oxohexahydrofuropyrrole amino acid amides as inhibitors of Cathepsin-K.,inhibitor,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl4,CTSK_6qlmB_MHA,P43235,,CTSK,wild,cl4,6qlmB,MHA,,6qlm,1,7,,Peptidase,,,Successful development of 3-oxohexahydrofuropyrrole amino acid amides as inhibitors of Cathepsin-K.,inhibitor,,0,,,,,,,,,,,,,
P48052_CPA2_wild_cl1,CPA2_1dtdA_GLU,P48052,,CPA2,wild,cl1,1dtdA,GLU,,1dtd,3,1,,Peptidase,,,Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.,inhibitor,,0,,,,,,,,,,,,,
P49720_PSMB3_wild_cl1,PSMB3_5lf1W_6VC,P49720,,PSMB3,wild,cl1,5lf1W,6VC,,5lf1,3,1,,Peptidase,,,The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
P49768_PSEN1_wild_cl1,PSEN1_6lqgB_EN9,P49768,,PSEN1,wild,cl1,6lqgB,EN9,,6lqg,2,2,,Peptidase,,,Structural basis of gamma-secretase inhibition and modulation by small molecule drugs.,inhibitor,,0,,,,,,,,,,,,,
P49768_PSEN1_wild_cl1,PSEN1_7c9iB_FTO,P49768,,PSEN1,wild,cl1,7c9iB,FTO,,7c9i,2,2,,Peptidase,,,Structural basis of gamma-secretase inhibition and modulation by small molecule drugs.,inhibitor,,0,,,,,,,,,,,,,
P49768_PSEN1_wild_cl2,PSEN1_7d8xB_GZR,P49768,,PSEN1,wild,cl2,7d8xB,GZR,,7d8x,2,2,,Peptidase,,,Structural basis of gamma-secretase inhibition and modulation by small molecule drugs.,inhibitor,,0,,,,,,,,,,,,,
P49862_KLK7_wild_cl1,KLK7_5fahA_5VT,P49862,,KLK7,wild,cl1,5fahA,5VT,,5fah,2,1,,Peptidase,,,Small-molecule factor D inhibitors targeting the alternative complement pathway.,inhibitor,,0,,,,,,,,,,,,,
P49862_KLK7_wild_cl1,KLK7_6shiC_SH8,P49862,,KLK7,wild,cl1,6shiC,SH8,,6shi,2,1,,Peptidase,,,Structural Studies on the inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.,inhibitor,,0,,,,,,,,,,,,,
P50579_METAP2_wild_cl1,METAP2_1yw9A_A84,P50579,,METAP2,wild,cl1,1yw9A,A84,,1yw9,1,1,,Peptidase,,,Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.,inhibitor,,0,,,,,,,,,,,,,
P50579_METAP2_wild_cl1,METAP2_6qedA_HZK,P50579,,METAP2,wild,cl1,6qedA,HZK,,6qed,1,1,,Peptidase,,,Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P53634_CTSC_wild_cl1,CTSC_4cddA_GDI,P53634,,CTSC,wild,cl1,4cddA,GDI,,4cdd,3,2,,Peptidase,,,Cathepsin C inhibitors: Property Optimization and Identification of a Clinical Candidate.,inhibitor,,0,,,,,,,,,,,,,
P53634_CTSC_wild_cl1,CTSC_4cdeE_U6B,P53634,,CTSC,wild,cl1,4cdeE,U6B,,4cde,3,2,,Peptidase,,,Cathepsin C inhibitors: Property Optimization and Identification of a Clinical Candidate.,inhibitor,,0,,,,,,,,,,,,,
P53634_CTSC_wild_cl2,CTSC_4cddF_GDI,P53634,,CTSC,wild,cl2,4cddF,GDI,,4cdd,3,2,,Peptidase,,,Cathepsin C inhibitors: Property Optimization and Identification of a Clinical Candidate.,inhibitor,,0,,,,,,,,,,,,,
P53634_CTSC_wild_cl2,CTSC_6ic5C_HB5,P53634,,CTSC,wild,cl2,6ic5C,HB5,,6ic5,3,2,,Peptidase,,,Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C.,inhibitor,,0,,,,,,,,,,,,,
P98073_TMPRSS15_wild_cl1,TMPRSS15_6zovA_GBS,P98073,,TMPRSS15,wild,cl1,6zovA,GBS,,6zov,3,1,,Peptidase,,,Targeting Enteropeptidase with Reversible Covalent inhibitors To Achieve Metabolic Benefits.,inhibitor,,0,,,,,,,,,,,,,
Q15661_TPSAB1_wild_cl1,TPSAB1_4a6lD_P43,Q15661,,TPSAB1,wild,cl1,4a6lD,P43,,4a6l,2,2,,Peptidase,,,Structure-Based Library Design and the Discovery of a Potent and Selective Mast Cell Beta-Tryptase inhibitor as an Oral Therapeutic Agent.,inhibitor,,0,,,,,,,,,,,,,
Q15661_TPSAB1_wild_cl1,TPSAB1_4a6lA_P43,Q15661,,TPSAB1,wild,cl1,4a6lA,P43,,4a6l,2,2,,Peptidase,,,Structure-Based Library Design and the Discovery of a Potent and Selective Mast Cell Beta-Tryptase inhibitor as an Oral Therapeutic Agent.,inhibitor,,0,,,,,,,,,,,,,
Q16651_PRSS8_wild_cl1,PRSS8_3e0pB_B3C,Q16651,,PRSS8,wild,cl1,3e0pB,B3C,,3e0p,2,1,,Peptidase,,,Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.,inhibitor,,0,,,,,,,,,,,,,
Q16651_PRSS8_wild_cl1,PRSS8_3e16B_B4C,Q16651,,PRSS8,wild,cl1,3e16B,B4C,,3.00E+16,2,1,,Peptidase,,,Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.,inhibitor,,0,,,,,,,,,,,,,
Q92876_KLK6_wild_cl1,KLK6_6skdA_LH2,Q92876,,KLK6,wild,cl1,6skdA,LH2,,6skd,3,1,,Peptidase,,,Design and development of a series of borocycles as selective_ covalent kallikrein 5 inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q92905_COPS5_wild_cl1,COPS5_5jogA_6LT,Q92905,,COPS5,wild,cl1,5jogA,6LT,,5jog,3,1,,Peptidase,,,Targeted inhibition of the COP9 signalosome for treatment of cancer.,inhibitor,,0,,,,,,,,,,,,,
Q92905_COPS5_wild_cl1,COPS5_5johA_6M3,Q92905,,COPS5,wild,cl1,5johA,6M3,,5joh,3,1,,Peptidase,,,Targeted inhibition of the COP9 signalosome for treatment of cancer.,inhibitor,,0,,,,,,,,,,,,,
Q96IY4_CPB2_wild_cl1,CPB2_3d67B_GEM,Q96IY4,,CPB2,wild,cl1,3d67B,GEM,,3d67,2,1,,Peptidase,,,Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation,inhibitor,,0,,,,,,,,,,,,,
Q96IY4_CPB2_wild_cl1,CPB2_4p10A_2B8,Q96IY4,,CPB2,wild,cl1,4p10A,2B8,,4p10,2,1,,Peptidase,,,Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).,inhibitor,,0,,,,,,,,,,,,,
Q99436_PSMB7_wild_cl1,PSMB7_6hubH_GRW,Q99436,,PSMB7,wild,cl1,6hubH,GRW,,6hub,3,2,,Peptidase,,,Structure-Based Design of inhibitors Selective for Human Proteasome beta 2c or beta 2i Subunits.,inhibitor,,0,,,,,,,,,,,,,
Q99436_PSMB7_wild_cl1,PSMB7_6htdH_GQH,Q99436,,PSMB7,wild,cl1,6htdH,GQH,,6htd,3,2,,Peptidase,,,Structure-Based Design of inhibitors Selective for Human Proteasome beta 2c or beta 2i Subunits.,inhibitor,,0,,,,,,,,,,,,,
Q99538_LGMN_wild_cl1,LGMN_5lu8A_5KN,Q99538,,LGMN,wild,cl1,5lu8A,5KN,,5lu8,3,2,,Peptidase,,,inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,inhibitor,,0,,,,,,,,,,,,,
Q99538_LGMN_wild_cl1,LGMN_5lu9A_3Y7,Q99538,,LGMN,wild,cl1,5lu9A,3Y7,,5lu9,3,2,,Peptidase,,,inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,inhibitor,,0,,,,,,,,,,,,,
Q99538_LGMN_wild_cl2,LGMN_5luaB_5KN,Q99538,,LGMN,wild,cl2,5luaB,5KN,,5lua,3,2,,Peptidase,,,inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,inhibitor,,0,,,,,,,,,,,,,
Q9Y5Y6_ST14_wild_cl1,ST14_4jytA_N4A,Q9Y5Y6,,ST14,wild,cl1,4jytA,N4A,,4jyt,1,1,,Peptidase,,,Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase inhibitors,inhibitor,,0,,,,,,,,,,,,,
Q9Y5Z0_BACE2_wild_cl1,BACE2_3zlqB_6T9,Q9Y5Z0,,BACE2,wild,cl1,3zlqB,6T9,,3zlq,1,2,,Peptidase,,,Beta-Secretase (Bace1) inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer'S Disease.,inhibitor,,0,,,,,,,,,,,,,
Q9Y5Z0_BACE2_wild_cl2,BACE2_2ewyA_DBO,Q9Y5Z0,,BACE2,wild,cl2,2ewyA,DBO,,2ewy,1,2,,Peptidase,,,Crystal structure of human BACE2 in complex with a hydroxyethylamine transition state inhibitor,inhibitor,,0,,,,,,,,,,,,,
Q9Y5Z0_BACE2_wild_cl1,BACE2_7f1gA_0QQ,Q9Y5Z0,,BACE2,wild,cl1,7f1gA,0QQ,,7f1g,1,2,,Peptidase,,,Discovery of Extremely Selective Fused Pyridine-Derived beta-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) inhibitors with High In Vivo Efficacy through 10s Loop Interactions.,inhibitor,,0,,,,,,,,,,,,,
O60259_KLK8_wild_cl1,KLK8_5ms4A_SVC,O60259,,KLK8,wild,cl1,5ms4A,SVC,,5ms4,3,1,,Peptidase,,,Structural determinants of specificity and regulation of activity in the Allosteric loop network of human KLK8/neuropsin.,,allosteric,0,,,,,,,,,,,,,
O60259_KLK8_wild_cl1,KLK8_5ms4B_SVC,O60259,,KLK8,wild,cl1,5ms4B,SVC,,5ms4,3,1,,Peptidase,,,Structural determinants of specificity and regulation of activity in the Allosteric loop network of human KLK8/neuropsin.,,allosteric,0,,,,,,,,,,,,,
O60882_MMP20_wild_cl1,MMP20_2jsdA_NGH,O60882,,MMP20,wild,cl1,2jsdA,NGH,,2jsd,3,1,,Peptidase,,,Catalytic domain of MMP20 (Enamelysin) - the NMR structure of a new matrix metalloproteinase.,,,0,,,,,,,,,,,,,
O60911_CTSV_wild_cl1,CTSV_1fh0A_0IW,O60911,,CTSV,wild,cl1,1fh0A,0IW,,1fh0,3,1,,Peptidase,,,Crystal structure of human cathepsin V.,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl2,F2_2b5tD_GU4,P00734,,F2,wild,cl2,2b5tD,GU4,,2b5t,2,5,,Peptidase,,,Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation.,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl2,F2_1xmnH_SGN,P00734,,F2,wild,cl2,1xmnH,SGN,,1xmn,2,5,,Peptidase,,,Crystal structure of thrombin bound to heparin,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl5,F2_4ud9H_TYS,P00734,,F2,wild,cl5,4ud9H,TYS,,4ud9,2,5,,Peptidase,,,Fragments Can Bind Either More Enthalpy or Entropy-Driven: Crystal Structures and Residual Hydration Pattern Suggest Why.,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl1,F2_3rmlH_M31,P00734,,F2,wild,cl1,3rmlH,M31,,3rml,2,5,,Peptidase,,,Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl4,F2_2h9tH_SVR,P00734,,F2,wild,cl4,2h9tH,SVR,,2h9t,2,5,,Peptidase,,,Structural and thermodynamic analysis of thrombin:suramin interaction in solution and crystal phases.,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl3,F2_3p70H_BGC,P00734,,F2,wild,cl3,3p70H,BGC,,3p70,2,5,,Peptidase,,,Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.,,,0,,,,,,,,,,,,,
P00734_F2_wild_cl3,F2_3p70F_BGC,P00734,,F2,wild,cl3,3p70F,BGC,,3p70,2,5,,Peptidase,,,Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.,,,0,,,,,,,,,,,,,
P00736_C1R_wild_cl1,C1R_1gpzA_FUC,P00736,,C1R,wild,cl1,1gpzA,FUC,,1gpz,3,2,,Peptidase,,,The Crystal Structure of the Zymogen Catalytic Domain of Complement Protease C1R Reveals that a Disruptive Mechanical Stress is Required to Trigger Activation of the C1 Complex.,,,0,,,,,,,,,,,,,
P00736_C1R_wild_cl2,C1R_1gpzB_FUC,P00736,,C1R,wild,cl2,1gpzB,FUC,,1gpz,3,2,,Peptidase,,,The Crystal Structure of the Zymogen Catalytic Domain of Complement Protease C1R Reveals that a Disruptive Mechanical Stress is Required to Trigger Activation of the C1 Complex.,,,0,,,,,,,,,,,,,
P00740_F9_wild_cl3,F9_5vygB_GXX,P00740,,F9,wild,cl3,5vygB,GXX,,5vyg,1,3,,Peptidase,,,O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking,,,0,,,,,,,,,,,,,
P00747_PLG_wild_cl1,PLG_1b2iA_AMH,P00747,,PLG,wild,cl1,1b2iA,AMH,,1b2i,2,3,,Peptidase,,,Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.,,,0,,,,,,,,,,,,,
P00747_PLG_wild_cl1,PLG_2pk4A_ACA,P00747,,PLG,wild,cl1,2pk4A,ACA,,2pk4,2,3,,Peptidase,,,The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4.,,,0,,,,,,,,,,,,,
P00747_PLG_wild_cl2,PLG_1buiA_0GJ,P00747,,PLG,wild,cl2,1buiA,0GJ,,1bui,2,3,,Peptidase,,,The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action.,,,0,,,,,,,,,,,,,
P00748_F12_wild_cl1,F12_6qf7B_0G6,P00748,,F12,wild,cl1,6qf7B,0G6,,6qf7,3,2,,Peptidase,,,Crystal structures of the recombinant beta-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics.,,,0,,,,,,,,,,,,,
P00748_F12_wild_cl2,F12_6gt6B_CYS,P00748,,F12,wild,cl2,6gt6B,CYS,,6gt6,3,2,,Peptidase,,,Crystal structures of the recombinant beta-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics.,,,0,,,,,,,,,,,,,
P00749_PLAU_wild_cl4,PLAU_1urkA_FUC,P00749,,PLAU,wild,cl4,1urkA,FUC,,1urk,1,5,,Peptidase,,,Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator.,,,0,,,,,,,,,,,,,
P00750_PLAT_wild_cl1,PLAT_1bdaA_2Z0,P00750,,PLAT,wild,cl1,1bdaA,2Z0,,1bda,2,1,,Peptidase,,,Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.,,,0,,,,,,,,,,,,,
P00751_CFB_wild_cl1,CFB_1rtkA_GBS,P00751,,CFB,wild,cl1,1rtkA,GBS,,1rtk,3,1,,Peptidase,,,Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.,,,0,,,,,,,,,,,,,
P03952_KLKB1_wild_cl2,KLKB1_6i44A_SER,P03952,,KLKB1,wild,cl2,6i44A,SER,,6i44,3,3,,Peptidase,,,Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.,,,0,,,,,,,,,,,,,
P04070_PROC_wild_cl1,PROC_1autC_0G6,P04070,,PROC,wild,cl1,1autC,0G6,,1aut,3,1,,Peptidase,,,The 2.8 A crystal structure of Gla-domainless activated protein C.,,,0,,,,,,,,,,,,,
P07477_PRSS1_wild_cl1,PRSS1_1trnA_ISP,P07477,,PRSS1,wild,cl1,1trnA,ISP,,1trn,3,1,,Peptidase,,,Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151.,,,0,,,,,,,,,,,,,
P07711_CTSL_wild_cl1,CTSL_5f02A_5T9,P07711,,CTSL,wild,cl1,5f02A,5T9,,5f02,1,1,,Peptidase,,,A Real-World Perspective on Molecular Design.,,,0,,,,,,,,,,,,,
P08311_CTSG_wild_cl1,CTSG_1au8A_0H8,P08311,,CTSG,wild,cl1,1au8A,0H8,,1au8,2,1,,Peptidase,,,HUMAN CATHEPSIN G,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl7,F7_5pafB_TFA,P08709,,F7,wild,cl7,5pafB,TFA,,5paf,2,8,,Peptidase,,,Crystal Structure of a Factor VIIa complex,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl5,F7_1j9cL_FUL,P08709,,F7,wild,cl5,1j9cL,FUL,,1j9c,2,8,,Peptidase,,,Ligand Induced Conformational Transitions of Tissue Factor. Crystal Structure of the Tissue Factor:Factor VIIa Complex.,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl8,F7_1qfkL_GLC,P08709,,F7,wild,cl8,1qfkL,GLC,,1qfk,2,8,,Peptidase,,,Structure of human factor VIIa and its implications for the triggering of blood coagulation.,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl2,F7_1danL_BGC,P08709,,F7,wild,cl2,1danL,BGC,,1dan,2,8,,Peptidase,,,The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl3,F7_1ff7A_FUC,P08709,,F7,wild,cl3,1ff7A,FUC,,1ff7,2,8,,Peptidase,,,The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.,,,0,,,,,,,,,,,,,
P08709_F7_wild_cl3,F7_1ffmA_FUC,P08709,,F7,wild,cl3,1ffmA,FUC,,1ffm,2,8,,Peptidase,,,The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.,,,0,,,,,,,,,,,,,
P09871_C1S_wild_cl1,C1S_1elvA_NES,P09871,,C1S,wild,cl1,1elvA,NES,,1elv,3,1,,Peptidase,,,Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle.,,,0,,,,,,,,,,,,,
P10619_CTSA_wild_cl1,CTSA_4cibA_7UZ,P10619,,CTSA,wild,cl1,4cibA,7UZ,,4cib,3,1,,Peptidase,,,Crystal structure of cathepsin A_ a novel target for the treatment of cardiovascular diseases.,,,0,,,,,,,,,,,,,
P12544_GZMA_wild_cl1,GZMA_1orfA_0G6,P12544,,GZMA,wild,cl1,1orfA,0G6,,1orf,3,1,,Peptidase,,,The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity.,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl4,ACE_4ca5A_FUC,P12821,,ACE,wild,cl4,4ca5A,FUC,,4ca5,1,4,,Peptidase,,,Crystal Structures of Highly Specific Phosphinic Tripeptide Enantiomers in Complex with the Angiotensin-I Converting Enzyme.,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl1,ACE_6f9vA_D0Z,P12821,,ACE,wild,cl1,6f9vA,D0Z,,6f9v,1,4,,Peptidase,,,Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity.,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl3,ACE_6f9vA_FUC,P12821,,ACE,wild,cl3,6f9vA,FUC,,6f9v,1,4,,Peptidase,,,Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity.,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl2,ACE_4ufbD_NAG,P12821,,ACE,wild,cl2,4ufbD,NAG,,4ufb,1,4,,Peptidase,,,Structural Basis of Ac-Sdkp Hydrolysis by Angiotensin-I Converting Enzyme,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl2,ACE_6en6A_FUC,P12821,,ACE,wild,cl2,6en6A,FUC,,6en6,1,4,,Peptidase,,,The Design and Development of a Potent and Selective Novel Diprolyl Derivative That Binds to the N-Domain of Angiotensin-I Converting Enzyme.,,,0,,,,,,,,,,,,,
P12821_ACE_wild_cl3,ACE_5am9A_FUL,P12821,,ACE,wild,cl3,5am9A,FUL,,5am9,1,4,,Peptidase,,,The Kinetic and Structural Characterisation of Amyloid-Beta Metabolism by Human Angiotensin-1- Converting Enzyme (Ace),,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl1,HGF_7moaD_IDS,P14210,,HGF,wild,cl1,7moaD,IDS,,7moa,1,5,,Peptidase,,,Structural basis of the activation of c-MET receptor.,,,0,,,,,,,,,,,,,
P14210_HGF_wild_cl1,HGF_7moaD_SGN,P14210,,HGF,wild,cl1,7moaD,SGN,,7moa,1,5,,Peptidase,,,Structural basis of the activation of c-MET receptor.,,,0,,,,,,,,,,,,,
P15169_CPN1_wild_cl1,CPN1_2nsmA_NAG,P15169,,CPN1,wild,cl1,2nsmA,NAG,,2nsm,3,1,,Peptidase,,,Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain,,,0,,,,,,,,,,,,,
P20151_KLK2_wild_cl1,KLK2_4nffA_0G6,P20151,,KLK2,wild,cl1,4nffA,0G6,,4nff,3,1,,Peptidase,,,Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity,,,0,,,,,,,,,,,,,
P20618_PSMB1_wild_cl1,PSMB1_4r67o_3BV,P20618,,PSMB1,wild,cl1,4r67o,3BV,,4r67,3,1,,Peptidase,,,Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib.,,,0,,,,,,,,,,,,,
P24158_PRTN3_wild_cl1,PRTN3_1fujB_FUC,P24158,,PRTN3,wild,cl1,1fujB,FUC,,1fuj,3,1,,Peptidase,,,The crystal structure of PR3_ a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.,,,0,,,,,,,,,,,,,
P24158_PRTN3_wild_cl1,PRTN3_1fujD_FUC,P24158,,PRTN3,wild,cl1,1fujD,FUC,,1fuj,3,1,,Peptidase,,,The crystal structure of PR3_ a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.,,,0,,,,,,,,,,,,,
P25774_CTSS_wild_cl1,CTSS_5qc3A_B9Y,P25774,,CTSS,wild,cl1,5qc3A,B9Y,,5qc3,1,2,,Peptidase,,,Crystal structure of human Cathepsin-S with bound ligand,,,0,,,,,,,,,,,,,
P25774_CTSS_wild_cl1,CTSS_5qcaA_BGJ,P25774,,CTSS,wild,cl1,5qcaA,BGJ,,5qca,1,2,,Peptidase,,,Crystal structure of human Cathepsin-S with bound ligand,,,0,,,,,,,,,,,,,
P28062_PSMB8_wild_cl1,PSMB8_7b12Z_SKN,P28062,,PSMB8,wild,cl1,7b12Z,SKN,,7b12,3,1,,Peptidase,,,HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]ethyl]boronic acid,,,0,,,,,,,,,,,,,
P28065_PSMB9_wild_cl1,PSMB9_7b12H_SKN,P28065,,PSMB9,wild,cl1,7b12H,SKN,,7b12,3,1,,Peptidase,,,HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]ethyl]boronic acid,,,0,,,,,,,,,,,,,
P28072_PSMB6_wild_cl1,PSMB6_4r67V_3BV,P28072,,PSMB6,wild,cl1,4r67V,3BV,,4r67,3,1,,Peptidase,,,Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib.,,,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl3,CASP1_2fqqB_F1G,P29466,,CASP1,wild,cl3,2fqqB,F1G,,2fqq,3,4,,Peptidase,,,A common Allosteric site and mechanism in caspases,,allosteric,0,,,,,,,,,,,,,
P29466_CASP1_wild_cl4,CASP1_2fqqA_F1G,P29466,,CASP1,wild,cl4,2fqqA,F1G,,2fqq,3,4,,Peptidase,,,A common Allosteric site and mechanism in caspases,,allosteric,0,,,,,,,,,,,,,
P40306_PSMB10_wild_cl1,PSMB10_7b12i_SKN,P40306,,PSMB10,wild,cl1,7b12i,SKN,,7b12,3,1,,Peptidase,,,HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]ethyl]boronic acid,,,0,,,,,,,,,,,,,
P40306_PSMB10_wild_cl1,PSMB10_7b12w_SKN,P40306,,PSMB10,wild,cl1,7b12w,SKN,,7b12,3,1,,Peptidase,,,HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]ethyl]boronic acid,,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl2,CTSK_5j94A_1XF,P43235,,CTSK,wild,cl2,5j94A,1XF,,5j94,1,7,,Peptidase,,,A novel Allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods.,,allosteric,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl2,CTSK_5ja7A_6HM,P43235,,CTSK,wild,cl2,5ja7A,6HM,,5ja7,1,7,,Peptidase,,,An Allosteric site enables fine-tuning of cathepsin K by diverse effectors.,,allosteric,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl3,CTSK_3h7dA_BDP,P43235,,CTSK,wild,cl3,3h7dA,BDP,,3h7d,1,7,,Peptidase,,,Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions.,,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl3,CTSK_3c9eA_ASG,P43235,,CTSK,wild,cl3,3c9eA,ASG,,3c9e,1,7,,Peptidase,,,The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.,,,0,,,,,,,,,,,,,
P43235_CTSK_wild_cl4,CTSK_3c9eA_BDP,P43235,,CTSK,wild,cl4,3c9eA,BDP,,3c9e,1,7,,Peptidase,,,The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.,,,0,,,,,,,,,,,,,
P49720_PSMB3_wild_cl1,PSMB3_4r67z_3BV,P49720,,PSMB3,wild,cl1,4r67z,3BV,,4r67,3,1,,Peptidase,,,Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib.,,,0,,,,,,,,,,,,,
P51512_MMP16_wild_cl1,MMP16_1rm8A_BAT,P51512,,MMP16,wild,cl1,1rm8A,BAT,,1rm8,3,1,,Peptidase,,,Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.,,,0,,,,,,,,,,,,,
P53582_METAP1_wild_cl1,METAP1_2nq6A_HM4,P53582,,METAP1,wild,cl1,2nq6A,HM4,,2nq6,1,1,,Peptidase,,,Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.,,,0,,,,,,,,,,,,,
P53582_METAP1_wild_cl1,METAP1_2nq7A_HM5,P53582,,METAP1,wild,cl1,2nq7A,HM5,,2nq7,1,1,,Peptidase,,,Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.,,,0,,,,,,,,,,,,,
Q15661_TPSAB1_wild_cl2,TPSAB1_2f9nA_BU3,Q15661,,TPSAB1,wild,cl2,2f9nA,BU3,,2f9n,2,2,,Peptidase,,,X-ray Structures of Free and Leupeptin-complexed Human alpha I-Tryptase Mutants: Indication for an alpha to beta-Tryptase Transition,,,0,,,,,,,,,,,,,
Q92876_KLK6_wild_cl1,KLK6_1lo6A_BEN,Q92876,,KLK6,wild,cl1,1lo6A,BEN,,1lo6,3,1,,Peptidase,,,Crystal structure and biochemical characterization of human kallikrein 6 reveals a trypsin-like kallikrein is expressed in the central nervous system,,,0,,,,,,,,,,,,,
Q99436_PSMB7_wild_cl2,PSMB7_4r67I_3BV,Q99436,,PSMB7,wild,cl2,4r67I,3BV,,4r67,3,2,,Peptidase,,,Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib.,,,0,,,,,,,,,,,,,
Q9UBX1_CTSF_wild_cl1,CTSF_1m6dA_MYP,Q9UBX1,,CTSF,wild,cl1,1m6dA,MYP,,1m6d,3,1,,Peptidase,,,The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators,,,0,,,,,,,,,,,,,
Q9UI42_CPA4_wild_cl1,CPA4_2pcuA_ASP,Q9UI42,,CPA4,wild,cl1,2pcuA,ASP,,2pcu,3,1,,Peptidase,,,Caught after the Act: a human A-type metallocarboxypeptidase in a product complex with a cleaved hexapeptide.,,,0,,,,,,,,,,,,,
Q9ULA0_DNPEP_wild_cl1,DNPEP_4dyoA_SD4,Q9ULA0,,DNPEP,wild,cl1,4dyoA,SD4,,4dyo,3,1,,Peptidase,,,Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism_ substrate specificity and M18 peptidase family.,,,0,,,,,,,,,,,,,
Q9Y5K2_KLK4_wild_cl1,KLK4_2bdiF_PBZ,Q9Y5K2,,KLK4,wild,cl1,2bdiF,PBZ,,2bdi,3,1,,Peptidase,,,Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.,,,0,,,,,,,,,,,,,
Q9Y5K2_KLK4_wild_cl1,KLK4_2bdgB_PBZ,Q9Y5K2,,KLK4,wild,cl1,2bdgB,PBZ,,2bdg,3,1,,Peptidase,,,Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.,,,0,,,,,,,,,,,,,
Q9Y5Y6_ST14_wild_cl1,ST14_1eaxA_BEN,Q9Y5Y6,,ST14,wild,cl1,1eaxA,BEN,,1eax,1,1,,Peptidase,,,Catalytic Domain Structures of Mt-Sp1/Matriptase_ a Matrix-Degrading Transmembrane Serine Proteinase.,,,0,,,,,,,,,,,,,
P15309_ACP3_wild_cl1,ACP3_1nd5A_2BF,P15309,,ACP3,wild,cl1,1nd5A,2BF,,1nd5,3,1,,phosphatase,,,Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update themechanistic picture and offer new insights into inhibitor design,inhibitor,,0,,,,,,,,,,,,,
P15309_ACP3_wild_cl1,ACP3_1nd5D_2BF,P15309,,ACP3,wild,cl1,1nd5D,2BF,,1nd5,3,1,,phosphatase,,,Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update themechanistic picture and offer new insights into inhibitor design,inhibitor,,0,,,,,,,,,,,,,
P43378_PTPN9_wild_cl1,PTPN9_4ge2A_75A,P43378,,PTPN9,wild,cl1,4ge2A,75A,,4ge2,3,1,,phosphatase,,,A Highly Selective and Potent PTP-MEG2 inhibitor with Therapeutic Potential for Type 2 Diabetes.,inhibitor,,0,,,,,,,,,,,,,
P43378_PTPN9_wild_cl1,PTPN9_4ge6A_B26,P43378,,PTPN9,wild,cl1,4ge6A,B26,,4ge6,3,1,,phosphatase,,,A Highly Selective and Potent PTP-MEG2 inhibitor with Therapeutic Potential for Type 2 Diabetes.,inhibitor,,0,,,,,,,,,,,,,
P51452_DUSP3_wild_cl1,DUSP3_3f81A_STT,P51452,,DUSP3,wild,cl1,3f81A,STT,,3f81,3,1,,phosphatase,,,Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.,inhibitor,,0,,,,,,,,,,,,,
P53041_PPP5C_wild_cl2,PPP5C_4zx2A_MPD,P53041,,PPP5C,wild,cl2,4zx2A,MPD,,4zx2,3,2,,phosphatase,,,Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.,inhibitor,,0,,,,,,,,,,,,,
P53041_PPP5C_wild_cl1,PPP5C_3h63A_NHC,P53041,,PPP5C,wild,cl1,3h63A,NHC,,3h63,3,2,,phosphatase,,,Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin,inhibitor,,0,,,,,,,,,,,,,
P53041_PPP5C_wild_cl1,PPP5C_3h61A_ENL,P53041,,PPP5C,wild,cl1,3h61A,ENL,,3h61,3,2,,phosphatase,,,Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin,inhibitor,,0,,,,,,,,,,,,,
P54829_PTPN5_wild_cl1,PTPN5_5ovrA_AXK,P54829,,PTPN5,wild,cl1,5ovrA,AXK,,5ovr,3,3,,phosphatase,,,X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P54829_PTPN5_wild_cl3,PTPN5_5ow1A_AY8,P54829,,PTPN5,wild,cl3,5ow1A,AY8,,5ow1,3,3,,phosphatase,,,X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q9Y2R2_PTPN22_wild_cl1,PTPN22_4j51A_N75,Q9Y2R2,,PTPN22,wild,cl1,4j51A,N75,,4j51,3,1,,phosphatase,,,A Potent and Selective Small-Molecule inhibitor for the Lymphoid-Specific Tyrosine Phosphatase (LYP)_ a Target Associated with Autoimmune Diseases.,inhibitor,,0,,,,,,,,,,,,,
Q9Y6W6_DUSP10_wild_cl1,DUSP10_6mc1E_CJA,Q9Y6W6,,DUSP10,wild,cl1,6mc1E,CJA,,6mc1,3,1,,phosphatase,,,An Allosteric site on MKP5 reveals a strategy for small-molecule inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
Q9Y6W6_DUSP10_wild_cl1,DUSP10_6mc1A_CJA,Q9Y6W6,,DUSP10,wild,cl1,6mc1A,CJA,,6mc1,3,1,,phosphatase,,,An Allosteric site on MKP5 reveals a strategy for small-molecule inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
O43314_PPIP5K2_wild_cl2,PPIP5K2_3t9bA_ANP,O43314,,PPIP5K2,wild,cl2,3t9bA,ANP,,3t9b,1,2,,phosphatase,,,Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding.,,,0,,,,,,,,,,,,,
O43314_PPIP5K2_wild_cl2,PPIP5K2_4q4cA_ADP,O43314,,PPIP5K2,wild,cl2,4q4cA,ADP,,4q4c,1,2,,phosphatase,,,Synthesis of Densely Phosphorylated Bis-1_5-Diphospho-myo-Inositol Tetrakisphosphate and its Enantiomer by Bidirectional P-Anhydride Formation.,,,0,,,,,,,,,,,,,
O43314_PPIP5K2_wild_cl1,PPIP5K2_4nzmA_0EJ,O43314,,PPIP5K2,wild,cl1,4nzmA,0EJ,,4nzm,1,2,,phosphatase,,,Synthetic Inositol Phosphate Analogs Reveal that PPIP5K2 Has a Surface-Mounted Substrate Capture Site that Is a Target for Drug Discovery.,,,0,,,,,,,,,,,,,
O43314_PPIP5K2_wild_cl1,PPIP5K2_5bybA_4WY,O43314,,PPIP5K2,wild,cl1,5bybA,4WY,,5byb,1,2,,phosphatase,,,Synthetic tools for studying the chemical biology of InsP8.,,,0,,,,,,,,,,,,,
O43426_SYNJ1_wild_cl1,SYNJ1_7a17A_IP9,O43426,,SYNJ1,wild,cl1,7a17A,IP9,,7a17,3,1,,phosphatase,,,A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations.,,,0,,,,,,,,,,,,,
O95278_EPM2A_wild_cl1,EPM2A_4rkkA_GLC,O95278,,EPM2A,wild,cl1,4rkkA,GLC,,4rkk,3,1,,phosphatase,,,Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.,,,0,,,,,,,,,,,,,
P05187_ALPP_wild_cl1,ALPP_3mk2A_PHE,P05187,,ALPP,wild,cl1,3mk2A,PHE,,3mk2,3,3,,phosphatase,,,Refined structures of placental alkaline phosphatase show a consistent pattern of interactions at the peripheral site.,,,0,,,,,,,,,,,,,
P05187_ALPP_wild_cl2,ALPP_3mk0A_NPO,P05187,,ALPP,wild,cl2,3mk0A,NPO,,3mk0,3,3,,phosphatase,,,Refined structures of placental alkaline phosphatase show a consistent pattern of interactions at the peripheral site.,,,0,,,,,,,,,,,,,
P05187_ALPP_wild_cl1,ALPP_1zefA_PHE,P05187,,ALPP,wild,cl1,1zefA,PHE,,1zef,3,3,,phosphatase,,,Structural Studies of Human Placental Alkaline Phosphatase in Complex with Functional Ligands.,,,0,,,,,,,,,,,,,
P05187_ALPP_wild_cl3,ALPP_1zedA_PNP,P05187,,ALPP,wild,cl3,1zedA,PNP,,1zed,3,3,,phosphatase,,,Structural Studies of Human Placental Alkaline Phosphatase in Complex with Functional Ligands.,,,0,,,,,,,,,,,,,
P24666_ACP1_wild_cl1,ACP1_4z9bA_B85,P24666,,ACP1,wild,cl1,4z9bA,B85,,4z9b,2,1,,phosphatase,,,Crystal structures of the apo form and a complex of human LMW-PTP with a phosphonic acid provide new evidence of a secondary site potentially related to the anchorage of natural substrates.,,,0,,,,,,,,,,,,,
P24666_ACP1_wild_cl1,ACP1_4z9aA_PMS,P24666,,ACP1,wild,cl1,4z9aA,PMS,,4z9a,2,1,,phosphatase,,,Crystal structures of the apo form and a complex of human LMW-PTP with a phosphonic acid provide new evidence of a secondary site potentially related to the anchorage of natural substrates.,,,0,,,,,,,,,,,,,
P28562_DUSP1_wild_cl1,DUSP1_6d67A_MAL,P28562,,DUSP1,wild,cl1,6d67A,MAL,,6d67,3,1,,phosphatase,,,MBP-binding DARPins facilitate the crystallization of an MBP fusion protein.,,,0,,,,,,,,,,,,,
P29218_IMPA1_wild_cl1,IMPA1_6giuA_L69,P29218,,IMPA1,wild,cl1,6giuA,L69,,6giu,3,1,,phosphatase,,,Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690_330.,,,0,,,,,,,,,,,,,
P29218_IMPA1_wild_cl1,IMPA1_1imbA_LIP,P29218,,IMPA1,wild,cl1,1imbA,LIP,,1imb,3,1,,phosphatase,,,Structural analysis of inositol monophosphatase complexes with substrates.,,,0,,,,,,,,,,,,,
P32019_INPP5B_wild_cl1,INPP5B_5a7iA_B6K,P32019,,INPP5B,wild,cl1,5a7iA,B6K,,5a7i,3,2,,phosphatase,,,Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase Inpp5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family.,,,0,,,,,,,,,,,,,
P32019_INPP5B_wild_cl1,INPP5B_5a7jA_K2Y,P32019,,INPP5B,wild,cl1,5a7jA,K2Y,,5a7j,3,2,,phosphatase,,,Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase Inpp5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family.,,,0,,,,,,,,,,,,,
P32019_INPP5B_wild_cl2,INPP5B_3mtcA_PIF,P32019,,INPP5B,wild,cl2,3mtcA,PIF,,3mtc,3,2,,phosphatase,,,Structural basis for phosphoinositide substrate recognition_ catalysis_ and membrane interactions in human inositol polyphosphate 5-phosphatases,,,0,,,,,,,,,,,,,
P36873_PPP1CC_wild_cl1,PPP1CC_1it6B_CYU,P36873,,PPP1CC,wild,cl1,1it6B,CYU,,1it6,2,1,,phosphatase,,,Crystal structure of the complex between calyculin A and the catalytic subunit of protein phosphatase 1.,,,0,,,,,,,,,,,,,
P36873_PPP1CC_wild_cl1,PPP1CC_1jk7A_OKA,P36873,,PPP1CC,wild,cl1,1jk7A,OKA,,1jk7,2,1,,phosphatase,,,Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1.,,,0,,,,,,,,,,,,,
P54829_PTPN5_wild_cl2,PTPN5_6h8rA_FWB,P54829,,PTPN5,wild,cl2,6h8rA,FWB,,6h8r,3,3,,phosphatase,,,Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP_ PTPN5) by a Fragment-like Molecule.,,allosteric,0,,,,,,,,,,,,,
Q15172_PPP2R5A_wild_cl1,PPP2R5A_6ntsB_L2J,Q15172,,PPP2R5A,wild,cl1,6ntsB,L2J,,6nts,3,1,,phosphatase,,,Selective PP2A Enhancement through Biased Heterotrimer Stabilization.,,,0,,,,,,,,,,,,,
Q6UWV6_ENPP7_wild_cl1,ENPP7_5tcdA_FUC,Q6UWV6,,ENPP7,wild,cl1,5tcdA,FUC,,5tcd,3,1,,phosphatase,,,Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition.,,,0,,,,,,,,,,,,,
Q9BVJ7_DUSP23_wild_cl1,DUSP23_2imgA_MLT,Q9BVJ7,,DUSP23,wild,cl1,2imgA,MLT,,2img,3,1,,phosphatase,,,Structure of human dual specificity protein phosphatase 23_ VHZ_ enzyme-substrate/product complex.,,,0,,,,,,,,,,,,,
O00482_NR5A2_wild_cl1,NR5A2_5syzA_71W,O00482,,NR5A2,wild,cl1,5syzA,71W,,5syz,1,2,,Receptor,,,Crystal Structures of the Nuclear Receptor_ Liver Receptor Homolog 1_ Bound to Synthetic Agonists.,agonist,,0,,,,,,,,,,,,,
O00482_NR5A2_wild_cl1,NR5A2_6or1A_N27,O00482,,NR5A2,wild,cl1,6or1A,N27,,6or1,1,2,,Receptor,,,Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design.,agonist,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl2,TRPA1_6x2jA_ULJ,O75762,,TRPA1,wild,cl2,6x2jA,ULJ,,6x2j,3,8,,Receptor,,,A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel.,agonist,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl2,TRPA1_6x2jD_ULJ,O75762,,TRPA1,wild,cl2,6x2jD,ULJ,,6x2j,3,8,,Receptor,,,A Non-covalent Ligand Reveals Biased Agonism of the TRPA1 Ion Channel.,agonist,,0,,,,,,,,,,,,,
P22736_NR4A1_wild_cl1,NR4A1_4reeA_3MZ,P22736,,NR4A1,wild,cl1,4reeA,3MZ,,4ree,1,1,,Receptor,,,Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity,agonist,,0,,,,,,,,,,,,,
P22736_NR4A1_wild_cl1,NR4A1_4whgA_3NB,P22736,,NR4A1,wild,cl1,4whgA,3NB,,4whg,1,1,,Receptor,,,Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity,agonist,,0,,,,,,,,,,,,,
P28702_RXRB_wild_cl1,RXRB_1uhlA_MEI,P28702,,RXRB,wild,cl1,1uhlA,MEI,,1uhl,3,1,,Receptor,,,Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully Agonistic conformation,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl4,RORC_5w4vF_9WA,P51449,,RORC,wild,cl4,5w4vF,9WA,,5w4v,1,6,,Receptor,,,6-Substituted quinolines as ROR gamma t inverse Agonists.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl4,RORC_5w4vA_9WA,P51449,,RORC,wild,cl4,5w4vA,9WA,,5w4v,1,6,,Receptor,,,6-Substituted quinolines as ROR gamma t inverse Agonists.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl3,RORC_6br3B_MPD,P51449,,RORC,wild,cl3,6br3B,MPD,,6br3,1,6,,Receptor,,,Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1_1-dimethyl-2_3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7_8-dihydro-1_6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent_ Selective_ and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor gamma t Inverse Agonist.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl3,RORC_6br3A_MPD,P51449,,RORC,wild,cl3,6br3A,MPD,,6br3,1,6,,Receptor,,,Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1_1-dimethyl-2_3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7_8-dihydro-1_6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent_ Selective_ and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor gamma t Inverse Agonist.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl1,RORC_4nieA_NBH,P51449,,RORC,wild,cl1,4nieA,NBH,,4nie,1,6,,Receptor,,,Discovery of Tertiary Amine and Indole Derivatives as Potent ROR gamma t Inverse Agonists.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl5,RORC_4nieA_DMX,P51449,,RORC,wild,cl5,4nieA,DMX,,4nie,1,6,,Receptor,,,Discovery of Tertiary Amine and Indole Derivatives as Potent ROR gamma t Inverse Agonists.,agonist,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl5,RORC_4nieB_DMX,P51449,,RORC,wild,cl5,4nieB,DMX,,4nie,1,6,,Receptor,,,Discovery of Tertiary Amine and Indole Derivatives as Potent ROR gamma t Inverse Agonists.,agonist,,0,,,,,,,,,,,,,
P62508_ESRRG_wild_cl1,ESRRG_6knrA_DL9,P62508,,ESRRG,wild,cl1,6knrA,DL9,,6knr,1,1,,Receptor,,,An orally available inverse Agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer.,agonist,,0,,,,,,,,,,,,,
Q15596_NCOA2_wild_cl1,NCOA2_5i4vA_67S,Q15596,,NCOA2,wild,cl1,5i4vA,67S,,5i4v,3,1,,Receptor,,,Discovery of a Novel_ Orally Efficacious Liver X Receptor (LXR) beta Agonist.,agonist,,0,,,,,,,,,,,,,
Q15788_NCOA1_wild_cl1,NCOA1_6p9fA_O5A,Q15788,,NCOA1,wild,cl1,6p9fA,O5A,,6p9f,1,1,,Receptor,,,Identification of potent_ selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as ROR gamma t inverse Agonists.,agonist,,0,,,,,,,,,,,,,
Q15788_NCOA1_wild_cl1,NCOA1_6u25A_O5B,Q15788,,NCOA1,wild,cl1,6u25A,O5B,,6u25,1,1,,Receptor,,,Rationally Designed_ Conformationally Constrained Inverse Agonists of ROR gamma t-Identification of a Potent_ Selective Series with Biologic-Like in Vivo Efficacy.,agonist,,0,,,,,,,,,,,,,
P04150_NR3C1_wild_cl1,NR3C1_6dxkA_HJ4,P04150,,NR3C1,wild,cl1,6dxkA,HJ4,,6dxk,1,1,,Receptor,,,Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor antagonist (ORIC-101).,inhibitor,,0,,,,,,,,,,,,,
P08235_NR3C2_wild_cl2,NR3C2_3vhvA_LD2,P08235,,NR3C2,wild,cl2,3vhvA,LD2,,3vhv,1,2,,Receptor,,,Identification of Benzoxazin-3-one Derivatives as Novel_ Potent_ and Selective Nonsteroidal Mineralocorticoid Receptor antagonists,inhibitor,,0,,,,,,,,,,,,,
P15328_FOLR1_wild_cl1,FOLR1_5izqC_83A,P15328,,FOLR1,wild,cl1,5izqC,83A,,5izq,2,2,,Receptor,,,Tumor Targeting with Novel 6-Substituted Pyrrolo [2_3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor alpha and the Proton-Coupled Folate Transporter and inhibition of de Novo Purine Nucleotide Biosynthesis.,inhibitor,,0,,,,,,,,,,,,,
P31639_SLC5A2_wild_cl1,SLC5A2_7vsiA_7R3,P31639,,SLC5A2,wild,cl1,7vsiA,7R3,,7vsi,3,1,,Receptor,,,Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter.,inhibitor,,0,,,,,,,,,,,,,
P31645_SC6A4_wild_cl1,SC6A4_6dzwA_8PR,P31645,,SC6A4,wild,cl1,6dzwA,8PR,,6dzw,2,3,,Receptor,,,Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.,inhibitor,,0,,,,,,,,,,,,,
P31645_SC6A4_wild_cl1,SC6A4_6dzvA_HJM,P31645,,SC6A4,wild,cl1,6dzvA,HJM,,6dzv,2,3,,Receptor,,,Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.,inhibitor,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl2,RORC_5c4tA_4Y6,P51449,,RORC,wild,cl2,5c4tA,4Y6,,5c4t,1,6,,Receptor,,,Identification of an Allosteric binding site for ROR gamma t inhibition.,inhibitor,allosteric,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl1,P2RX3_5svpA_6AT,P56373,,P2RX3,wild,cl1,5svpA,6AT,,5svp,3,4,,Receptor,,,X-ray structures define human P2X3 receptor gating cycle and antagonist action.,inhibitor,,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl1,P2RX3_5svkA_ATP,P56373,,P2RX3,wild,cl1,5svkA,ATP,,5svk,3,4,,Receptor,,,X-ray structures define human P2X3 receptor gating cycle and antagonist action.,inhibitor,,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl2,P2RX3_5svkA_MAL,P56373,,P2RX3,wild,cl2,5svkA,MAL,,5svk,3,4,,Receptor,,,X-ray structures define human P2X3 receptor gating cycle and antagonist action.,inhibitor,,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl2,P2RX3_5svlA_MAL,P56373,,P2RX3,wild,cl2,5svlA,MAL,,5svl,3,4,,Receptor,,,X-ray structures define human P2X3 receptor gating cycle and antagonist action.,inhibitor,,0,,,,,,,,,,,,,
Q9GZU1_MCOLN1_wild_cl1,MCOLN1_7mglA_ZB4,Q9GZU1,,MCOLN1,wild,cl1,7mglA,ZB4,,7mgl,3,2,,Receptor,,,Atomic insights into ML-SI3 mediated human TRPML1 inhibition.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl1,TRPV6_7k4cD_81F,Q9H1D0,,TRPV6,wild,cl1,7k4cD,81F,,7k4c,1,6,,Receptor,,,inactivation-mimicking block of the epithelial calcium channel TRPV6.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl1,TRPV6_7k4bA_VUG,Q9H1D0,,TRPV6,wild,cl1,7k4bA,VUG,,7k4b,1,6,,Receptor,,,inactivation-mimicking block of the epithelial calcium channel TRPV6.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl2,TRPV6_7k4aA_Y01,Q9H1D0,,TRPV6,wild,cl2,7k4aA,Y01,,7k4a,1,6,,Receptor,,,inactivation-mimicking block of the epithelial calcium channel TRPV6.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl3,TRPV6_7k4bC_VUG,Q9H1D0,,TRPV6,wild,cl3,7k4bC,VUG,,7k4b,1,6,,Receptor,,,inactivation-mimicking block of the epithelial calcium channel TRPV6.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl2,TRPV6_7s8bC_Y01,Q9H1D0,,TRPV6,wild,cl2,7s8bC,Y01,,7s8b,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl3,TRPV6_7s8bA_Y01,Q9H1D0,,TRPV6,wild,cl3,7s8bA,Y01,,7s8b,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl4,TRPV6_7s89A_Y01,Q9H1D0,,TRPV6,wild,cl4,7s89A,Y01,,7s89,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl4,TRPV6_7s8bB_Y01,Q9H1D0,,TRPV6,wild,cl4,7s8bB,Y01,,7s8b,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl5,TRPV6_7s8cA_ECL,Q9H1D0,,TRPV6,wild,cl5,7s8cA,ECL,,7s8c,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9H1D0_TRPV6_wild_cl6,TRPV6_7s8cA_ECL,Q9H1D0,,TRPV6,wild,cl6,7s8cA,ECL,,7s8c,1,6,,Receptor,,,Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole.,inhibitor,,0,,,,,,,,,,,,,
Q9UL62_TRPC5_wild_cl1,TRPC5_6ysnA_PJQ,Q9UL62,,TRPC5,wild,cl1,6ysnA,PJQ,,6ysn,3,1,,Receptor,,,Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.,inhibitor,,0,,,,,,,,,,,,,
O00206_TLR4_wild_cl2,TLR4_4g8aA_LP5,O00206,,TLR4,wild,cl2,4g8aA,LP5,,4g8a,3,4,,Receptor,,,Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I,,,0,,,,,,,,,,,,,
O00206_TLR4_wild_cl4,TLR4_3ulaC_E55,O00206,,TLR4,wild,cl4,3ulaC,E55,,3ula,3,4,,Receptor,,,Structure-Based Rational Design of a Toll-like Receptor 4 (TLR4) Decoy Receptor with High Binding Affinity for a Target Protein.,,,0,,,,,,,,,,,,,
O00206_TLR4_wild_cl1,TLR4_3fxiA_NAG,O00206,,TLR4,wild,cl1,3fxiA,NAG,,3fxi,3,4,,Receptor,,,The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex,,,0,,,,,,,,,,,,,
O00206_TLR4_wild_cl3,TLR4_3fxiB_NAG,O00206,,TLR4,wild,cl3,3fxiB,NAG,,3fxi,3,4,,Receptor,,,The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex,,,0,,,,,,,,,,,,,
O00482_NR5A2_wild_cl2,NR5A2_4dorA_EPH,O00482,,NR5A2,wild,cl2,4dorA,EPH,,4dor,1,2,,Receptor,,,Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.,,,0,,,,,,,,,,,,,
O00482_NR5A2_wild_cl2,NR5A2_1yucA_EPH,O00482,,NR5A2,wild,cl2,1yucA,EPH,,1yuc,1,2,,Receptor,,,Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP,,,0,,,,,,,,,,,,,
O60603_TLR2_wild_cl1,TLR2_2z7xA_PCJ,O60603,,TLR2,wild,cl1,2z7xA,PCJ,,2z7x,3,1,,Receptor,,,Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide,,,0,,,,,,,,,,,,,
O75469_NR1I2_wild_cl1,NR1I2_3r8dA_PNU,O75469,,NR1I2,wild,cl1,3r8dA,PNU,,3r8d,2,1,,Receptor,,,Activation of the human nuclear xenobiotic receptor PXR by the reverse transcriptase-targeted anti-HIV drug PNU-142721.,,,0,,,,,,,,,,,,,
O75469_NR1I2_wild_cl1,NR1I2_3hvlA_SRL,O75469,,NR1I2,wild,cl1,3hvlA,SRL,,3hvl,2,1,,Receptor,,,Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl4,TRPA1_6v9vA_QT4,O75762,,TRPA1,wild,cl4,6v9vA,QT4,,6v9v,3,8,,Receptor,,,Irritant-evoked activation and calcium modulation of the TRPA1 receptor.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl1,TRPA1_6pqoC_LBN,O75762,,TRPA1,wild,cl1,6pqoC,LBN,,6pqo,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl1,TRPA1_6pqqB_LBN,O75762,,TRPA1,wild,cl1,6pqqB,LBN,,6pqq,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl3,TRPA1_6pqoB_6OU,O75762,,TRPA1,wild,cl3,6pqoB,6OU,,6pqo,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl3,TRPA1_6pqpA_6OU,O75762,,TRPA1,wild,cl3,6pqpA,6OU,,6pqp,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl4,TRPA1_6pqpA_9BE,O75762,,TRPA1,wild,cl4,6pqpA,9BE,,6pqp,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl5,TRPA1_6pqoD_LBN,O75762,,TRPA1,wild,cl5,6pqoD,LBN,,6pqo,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl5,TRPA1_6pqqA_LBN,O75762,,TRPA1,wild,cl5,6pqqA,LBN,,6pqq,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl6,TRPA1_6pqoA_6OU,O75762,,TRPA1,wild,cl6,6pqoA,6OU,,6pqo,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl6,TRPA1_6pqqA_6OU,O75762,,TRPA1,wild,cl6,6pqqA,6OU,,6pqq,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl7,TRPA1_6pqoA_6OU,O75762,,TRPA1,wild,cl7,6pqoA,6OU,,6pqo,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl7,TRPA1_6pqpA_6OU,O75762,,TRPA1,wild,cl7,6pqpA,6OU,,6pqp,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O75762_TRPA1_wild_cl8,TRPA1_6pqpA_6OU,O75762,,TRPA1,wild,cl8,6pqpA,6OU,,6pqp,3,8,,Receptor,,,Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel.,,,0,,,,,,,,,,,,,
O95718_ESRRB_wild_cl1,ESRRB_6litA_2OH,O95718,,ESRRB,wild,cl1,6litA,2OH,,6lit,3,1,,Receptor,,,Structural Insights into the Specificity of Ligand Binding and Coactivator Assembly by Estrogen-Related Receptor beta.,,,0,,,,,,,,,,,,,
P04150_NR3C1_wild_cl1,NR3C1_6el9A_B9W,P04150,,NR3C1,wild,cl1,6el9A,B9W,,6el9,1,1,,Receptor,,,Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.,,,0,,,,,,,,,,,,,
P06401_PGR_wild_cl1,PGR_1a28B_STR,P06401,,PGR,wild,cl1,1a28B,STR,,1a28,1,1,,Receptor,,,Atomic structure of progesterone complexed with its receptor.,,,0,,,,,,,,,,,,,
P06401_PGR_wild_cl1,PGR_3d90A_NOG,P06401,,PGR,wild,cl1,3d90A,NOG,,3d90,1,1,,Receptor,,,Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins,,,0,,,,,,,,,,,,,
P08235_NR3C2_wild_cl1,NR3C2_2ab2A_SNL,P08235,,NR3C2,wild,cl1,2ab2A,SNL,,2ab2,1,2,,Receptor,,,A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor,,,0,,,,,,,,,,,,,
P08235_NR3C2_wild_cl1,NR3C2_2oaxC_SNL,P08235,,NR3C2,wild,cl1,2oaxC,SNL,,2oax,1,2,,Receptor,,,Structural basis of spirolactone recognition by the mineralocorticoid receptor,,,0,,,,,,,,,,,,,
P14207_FOLR2_wild_cl1,FOLR2_4kn2C_LYA,P14207,,FOLR2,wild,cl1,4kn2C,LYA,,4kn2,2,1,,Receptor,,,Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition.,,,0,,,,,,,,,,,,,
P14207_FOLR2_wild_cl1,FOLR2_4kn2A_LYA,P14207,,FOLR2,wild,cl1,4kn2A,LYA,,4kn2,2,1,,Receptor,,,Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition.,,,0,,,,,,,,,,,,,
P15328_FOLR1_wild_cl2,FOLR1_4kmxA_FUC,P15328,,FOLR1,wild,cl2,4kmxA,FUC,,4kmx,2,2,,Receptor,,,Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition.,,,0,,,,,,,,,,,,,
P15328_FOLR1_wild_cl1,FOLR1_4keoA_FOL,P15328,,FOLR1,wild,cl1,4keoA,FOL,,4keo,2,2,4LRH,Receptor,,,Crystal structure of human folate receptor alpha in complex with folic acid,,,0,,,,,,,,,,,,,
P17342_NPR3_wild_cl1,NPR3_1jdnA_FUC,P17342,,NPR3,wild,cl1,1jdnA,FUC,,1jdn,3,1,,Receptor,,,Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone.,,allosteric,0,,,,,,,,,,,,,
P31645_SC6A4_wild_cl2,SC6A4_6vrlA_LMT,P31645,,SC6A4,wild,cl2,6vrlA,LMT,,6vrl,2,3,,Receptor,,,Chemical and structural investigation of the paroxetine-human serotonin transporter complex.,,,0,,,,,,,,,,,,,
P31645_SC6A4_439_cl1,SC6A4_6awqA_SRE,P31645,,SC6A4,439,cl1,6awqA,SRE,,6awq,2,3,,Receptor,,,Structural basis for recognition of diverse antidepressants by the human serotonin transporter.,,,0,,,,,,,,,,,,,
P31645_SC6A4_439_cl1,SC6A4_6awpA_FVX,P31645,,SC6A4,439,cl1,6awpA,FVX,,6awp,2,3,,Receptor,,,Structural basis for recognition of diverse antidepressants by the human serotonin transporter.,,,0,,,,,,,,,,,,,
P31645_SC6A4_wild_cl2,SC6A4_5i71A_D12,P31645,,SC6A4,wild,cl2,5i71A,D12,,5i71,2,3,,Receptor,,,X-ray structures and mechanism of the human serotonin transporter.,,,0,,,,,,,,,,,,,
P35398_RORA_wild_cl1,RORA_4s15A_4D8,P35398,,RORA,wild,cl1,4s15A,4D8,,4s15,3,1,,Receptor,,,Identification of Natural ROR gamma Ligands that Regulate the Development of Lymphoid Cells.,,,0,,,,,,,,,,,,,
P35398_RORA_wild_cl1,RORA_4s15B_4D8,P35398,,RORA,wild,cl1,4s15B,4D8,,4s15,3,1,,Receptor,,,Identification of Natural ROR gamma Ligands that Regulate the Development of Lymphoid Cells.,,,0,,,,,,,,,,,,,
P43354_NR4A2_wild_cl1,NR4A2_5y41A_RPG,P43354,,NR4A2,wild,cl1,5y41A,RPG,,5y41,3,1,,Receptor,,,PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.,,,0,,,,,,,,,,,,,
P43354_NR4A2_wild_cl1,NR4A2_5yd6D_8SU,P43354,,NR4A2,wild,cl1,5yd6D,8SU,,5yd6,3,1,,Receptor,,,Structure of Nurr1 bound to cyclopentenone prostaglandin A2 and its mechanism of action in ameliorating dopaminergic neurodegeneration in Drosophila,,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl2,RORC_6t4wA_MJE,P51449,,RORC,wild,cl2,6t4wA,MJE,,6t4w,1,6,,Receptor,,,Cooperativity between the orthosteric and Allosteric ligand binding sites of ROR gamma t.,,allosteric,0,,,,,,,,,,,,,
P51449_RORC_wild_cl6,RORC_5g46A_6VD,P51449,,RORC,wild,cl6,5g46A,6VD,,5g46,1,6,,Receptor,,,Fragment Screening of Rorgammat Using Cocktail Crystallography: Identification of Simultaneous Binding of Multiple Fragments.,,,0,,,,,,,,,,,,,
P51449_RORC_wild_cl1,RORC_5ntnC_98H,P51449,,RORC,wild,cl1,5ntnC,98H,,5ntn,1,6,,Receptor,,,Structural States of ROR gamma t: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds.,,,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl3,P2RX3_5yveA_AF9,P56373,,P2RX3,wild,cl3,5yveA,AF9,,5yve,3,4,,Receptor,,,Druggable negative Allosteric site of P2X3 receptors.,,allosteric,0,,,,,,,,,,,,,
P56373_P2RX3_wild_cl4,P2RX3_6ah4B_ATP,P56373,,P2RX3,wild,cl4,6ah4B,ATP,,6ah4,3,4,,Receptor,,,Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP.,,,0,,,,,,,,,,,,,
P62508_ESRRG_wild_cl1,ESRRG_1vjbA_OHT,P62508,,ESRRG,wild,cl1,1vjbA,OHT,,1vjb,1,1,,Receptor,,,Structural Basis for the Deactivation of the Estrogen-related Receptor {gamma} by Diethylstilbestrol or 4-Hydroxytamoxifen and Determinants of Selectivity.,,,0,,,,,,,,,,,,,
Q13285_NR5A1_wild_cl1,NR5A1_1zdtB_PEF,Q13285,,NR5A1,wild,cl1,1zdtB,PEF,,1zdt,3,1,,Receptor,,,The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1,,,0,,,,,,,,,,,,,
Q13285_NR5A1_wild_cl1,NR5A1_4qk4A_PIK,Q13285,,NR5A1,wild,cl1,4qk4A,PIK,,4qk4,3,1,,Receptor,,,The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1.,,,0,,,,,,,,,,,,,
Q14541_HNF4G_wild_cl1,HNF4G_1lv2A_PLM,Q14541,,HNF4G,wild,cl1,1lv2A,PLM,,1lv2,3,1,,Receptor,,,Hepatocyte Nuclear Factor 4 Is a Transcription Factor that Constitutively Binds Fatty Acids.,,,0,,,,,,,,,,,,,
Q14995_NR1D2_wild_cl1,NR1D2_3cqvA_HEM,Q14995,,NR1D2,wild,cl1,3cqvA,HEM,,3cqv,3,1,,Receptor,,,The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta.,,,0,,,,,,,,,,,,,
Q15399_TLR1_wild_cl1,TLR1_2z7xB_PCJ,Q15399,,TLR1,wild,cl1,2z7xB,PCJ,,2z7x,3,1,,Receptor,,,Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide,,,0,,,,,,,,,,,,,
Q15413_RYR3_wild_cl1,RYR3_6uhhA_ATP,Q15413,,RYR3,wild,cl1,6uhhA,ATP,,6uhh,3,1,,Receptor,,,Crystal Structure of  Human RYR Receptor 3 ( 848-1055) in Complex with ATP,,,0,,,,,,,,,,,,,
Q8N695_SLC5A8_wild_cl1,SLC5A8_7sl9A_BUA,Q8N695,,SLC5A8,wild,cl1,7sl9A,BUA,,7sl9,3,1,,Receptor,,,Structure and mechanism of the SGLT family of glucose transporters.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl1,TRPV3_6uw4A_6OU,Q8NET8,,TRPV3,wild,cl1,6uw4A,6OU,,6uw4,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl1,TRPV3_6uw6A_6OU,Q8NET8,,TRPV3,wild,cl1,6uw6A,6OU,,6uw6,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl2,TRPV3_6uw4B_6OU,Q8NET8,,TRPV3,wild,cl2,6uw4B,6OU,,6uw4,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl2,TRPV3_6uw4A_6OU,Q8NET8,,TRPV3,wild,cl2,6uw4A,6OU,,6uw4,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl3,TRPV3_6uw6A_6OU,Q8NET8,,TRPV3,wild,cl3,6uw6A,6OU,,6uw6,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl3,TRPV3_6uw6B_6OU,Q8NET8,,TRPV3,wild,cl3,6uw6B,6OU,,6uw6,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl4,TRPV3_6uw4A_6OU,Q8NET8,,TRPV3,wild,cl4,6uw4A,6OU,,6uw4,3,5,,Receptor,,,Gating of human TRPV3 in a lipid bilayer.,,,0,,,,,,,,,,,,,
Q8NET8_TRPV3_wild_cl5,TRPV3_6ot5A_FZ4,Q8NET8,,TRPV3,wild,cl5,6ot5A,FZ4,,6ot5,3,5,,Receptor,,,Regulatory switch at the cytoplasmic interface controls TRPV channel gating.,,,0,,,,,,,,,,,,,
Q92731_ESR2_wild_cl1,ESR2_1x78A_244,Q92731,,ESR2,wild,cl1,1x78A,244,,1x78,1,1,,Receptor,,,Structure-Based Design of Estrogen Receptor-Beta Selective Ligands,,,0,,,,,,,,,,,,,
Q92731_ESR2_wild_cl1,ESR2_1u9eA_397,Q92731,,ESR2,wild,cl1,1u9eA,397,,1u9e,1,1,,Receptor,,,Structure-Based Design Of Estrogen Receptor-beta Selective Ligands,,,0,,,,,,,,,,,,,
Q9GZU1_MCOLN1_wild_cl1,MCOLN1_5wj9A_AQV,Q9GZU1,,MCOLN1,wild,cl1,5wj9A,AQV,,5wj9,3,2,,Receptor,,,Human TRPML1 channel structures in open and closed conformations.,,,0,,,,,,,,,,,,,
Q9GZU1_MCOLN1_wild_cl2,MCOLN1_6e7pA_HZ7,Q9GZU1,,MCOLN1,wild,cl2,6e7pA,HZ7,,6e7p,3,2,,Receptor,,,Structural basis for PtdInsP2-mediated human TRPML1 regulation.,,,0,,,,,,,,,,,,,
Q9GZU1_MCOLN1_wild_cl2,MCOLN1_6e7zA_HZ7,Q9GZU1,,MCOLN1,wild,cl2,6e7zA,HZ7,,6e7z,3,2,,Receptor,,,Structural basis for PtdInsP2-mediated human TRPML1 regulation.,,,0,,,,,,,,,,,,,
Q9HBA0_TRPV4_wild_cl1,TRPV4_4dx2A_BGC,Q9HBA0,,TRPV4,wild,cl1,4dx2A,BGC,,4dx2,3,1,,Receptor,,,Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel.,,,0,,,,,,,,,,,,,
Q9Y466_NR2E1_wild_cl1,NR2E1_4xajC_MAL,Q9Y466,,NR2E1,wild,cl1,4xajC,MAL,,4xaj,3,1,,Receptor,,,Structural basis for corepressor assembly by the orphan nuclear receptor TLX.,,,0,,,,,,,,,,,,,
Q9Y466_NR2E1_wild_cl1,NR2E1_4xajD_MAL,Q9Y466,,NR2E1,wild,cl1,4xajD,MAL,,4xaj,3,1,,Receptor,,,Structural basis for corepressor assembly by the orphan nuclear receptor TLX.,,,0,,,,,,,,,,,,,
O95749_GGPS1_wild_cl1,GGPS1_2q80B_GRG,O95749,,GGPS1,wild,cl1,2q80B,GRG,,2q80,1,2,,Synthase,,,The crystal structure of human geranylgeranyl pyrophosphate synthase reveals a novel hexameric arrangement and inhibitory product binding,inhibitor,,0,,,,,,,,,,,,,
O95749_GGPS1_wild_cl2,GGPS1_6c56B_VT0,O95749,,GGPS1,wild,cl2,6c56B,VT0,,6c56,1,2,,Synthase,,,Unraveling the Prenylation-Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl1,TYMS_6ojvD_2XB,P04818,,TYMS,wild,cl1,6ojvD,2XB,,6ojv,1,3,,Synthase,,,Understanding the structural basis of species selective_ stereospecific inhibition for Cryptosporidium and human thymidylate synthase.,inhibitor,,0,,,,,,,,,,,,,
P14324_FDPS_wild_cl1,FDPS_1yq7A_RIS,P14324,,FDPS,wild,cl1,1yq7A,RIS,,1yq7,1,2,,Synthase,,,Human farnesyl diphosphate complexed with clinical inhibitor risedronate,inhibitor,,0,,,,,,,,,,,,,
P14324_FDPS_wild_cl2,FDPS_5jv0F_YL5,P14324,,FDPS,wild,cl2,5jv0F,YL5,,5jv0,1,2,,Synthase,,,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) inhibitors of the Human Farnesyl Pyrophosphate Synthase.,inhibitor,,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl3,DHPS_6wkzA_8Y1,P49366,,DHPS,wild,cl3,6wkzA,8Y1,,6wkz,3,4,,Synthase,,,New Series of Potent Allosteric inhibitors of Deoxyhypusine Synthase.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl3,DHPS_6wkzB_8Y1,P49366,,DHPS,wild,cl3,6wkzB,8Y1,,6wkz,3,4,,Synthase,,,New Series of Potent Allosteric inhibitors of Deoxyhypusine Synthase.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl4,DHPS_6wkzA_8Y1,P49366,,DHPS,wild,cl4,6wkzA,8Y1,,6wkz,3,4,,Synthase,,,New Series of Potent Allosteric inhibitors of Deoxyhypusine Synthase.,inhibitor,allosteric,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl1,DHPS_1rlzA_NAD,P49366,,DHPS,wild,cl1,1rlzA,NAD,,1rlz,3,4,,Synthase,,,A New Crystal Structure of Deoxyhypusine Synthase Reveals the Configuration of the Active Enzyme and of an Enzyme-NAD-inhibitor Ternary Complex,inhibitor,,0,,,,,,,,,,,,,
Q01581_HMGCS1_wild_cl1,HMGCS1_2p8uB_COA,Q01581,,HMGCS1,wild,cl1,2p8uB,COA,,2p8u,3,1,,Synthase,,,Crystal structures of human HMG-CoA synthase isoforms provide insights into inherited ketogenesis disorders and inhibitor design.,inhibitor,,0,,,,,,,,,,,,,
O75390_CS_wild_cl1,CS_5uzpA_OAA,O75390,,CS,wild,cl1,5uzpA,OAA,,5uzp,3,1,,Synthase,,,Comparative studies of Aspergillus fumigatus 2-methylcitrate synthase and human citrate synthase.,,,0,,,,,,,,,,,,,
O95749_GGPS1_wild_cl1,GGPS1_6g31G_ZOL,O95749,,GGPS1,wild,cl1,6g31G,ZOL,,6g31,1,2,,Synthase,,,Reduced Activity of Geranylgeranyl Diphosphate Synthase Mutant Is Involved in Bisphosphonate-Induced Atypical Fractures.,,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl1,TYMS_1i00A_UMP,P04818,,TYMS,wild,cl1,1i00A,UMP,,1i00,1,3,,Synthase,,,Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.,,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl3,TYMS_1hvyA_UMP,P04818,,TYMS,wild,cl3,1hvyA,UMP,,1hvy,1,3,,Synthase,,,Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed_ an antifolate drug,,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl2,TYMS_4g2oX_TIY,P04818,,TYMS,wild,cl2,4g2oX,TIY,,4g2o,1,3,,Synthase,,,Oxidation of Cysteine 195 of Huyman Thymidylate Synthase by Purpurogallin,,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl3,TYMS_3ejlC_UFP,P04818,,TYMS,wild,cl3,3ejlC,UFP,,3ejl,1,3,,Synthase,,,Replacement of Val3 in human thymidylate synthase affects its kinetic properties and intracellular stability .,,,0,,,,,,,,,,,,,
P04818_TYMS_wild_cl2,TYMS_5x69E_7ZC,P04818,,TYMS,wild,cl2,5x69E,7ZC,,5x69,1,3,,Synthase,,,Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states,,,0,,,,,,,,,,,,,
P14324_FDPS_wild_cl1,FDPS_4lfvF_YS4,P14324,,FDPS,wild,cl1,4lfvF,YS4,,4lfv,1,2,,Synthase,,,Structure of human farnesyl pyrophosphate synthase in complex with an aminopyridine bisphosphonate and two molecules of inorganic phosphate.,,,0,,,,,,,,,,,,,
P19623_SRM_wild_cl1,SRM_2o0lA_S4M,P19623,,SRM,wild,cl1,2o0lA,S4M,,2o0l,3,1,,Synthase,,,Structure and mechanism of spermidine synthases.,,,0,,,,,,,,,,,,,
P19623_SRM_wild_cl1,SRM_2o05A_MTA,P19623,,SRM,wild,cl1,2o05A,MTA,,2o05,3,1,,Synthase,,,Structure and mechanism of spermidine synthases.,,,0,,,,,,,,,,,,,
P22102_GART_wild_cl1,GART_1rbyA_GAR,P22102,,GART,wild,cl1,1rbyA,GAR,,1rby,1,2,,Synthase,,,Human GAR Tfase complex structure,,,0,,,,,,,,,,,,,
P22102_GART_wild_cl1,GART_1rbzA_KT5,P22102,,GART,wild,cl1,1rbzA,KT5,,1rbz,1,2,,Synthase,,,Human GAR Tfase complex structure,,,0,,,,,,,,,,,,,
P22102_GART_wild_cl2,GART_2qk4A_ATP,P22102,,GART,wild,cl2,2qk4A,ATP,,2qk4,1,2,,Synthase,,,Structural studies of tri-functional human GART.,,,0,,,,,,,,,,,,,
P22102_GART_wild_cl2,GART_2qk4B_ATP,P22102,,GART,wild,cl2,2qk4B,ATP,,2qk4,1,2,,Synthase,,,Structural studies of tri-functional human GART.,,,0,,,,,,,,,,,,,
P35520_CBS_wild_cl3,CBS_4pcuB_SAM,P35520,,CBS,wild,cl3,4pcuB,SAM,,4pcu,1,6,,Synthase,,,Structural insight into the molecular mechanism of Allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine.,,allosteric,0,,,,,,,,,,,,,
P35520_CBS_wild_cl5,CBS_4pcuA_SAM,P35520,,CBS,wild,cl5,4pcuA,SAM,,4pcu,1,6,,Synthase,,,Structural insight into the molecular mechanism of Allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine.,,allosteric,0,,,,,,,,,,,,,
P35520_CBS_wild_cl6,CBS_4pcuA_SAM,P35520,,CBS,wild,cl6,4pcuA,SAM,,4pcu,1,6,,Synthase,,,Structural insight into the molecular mechanism of Allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine.,,allosteric,0,,,,,,,,,,,,,
P35520_CBS_wild_cl1,CBS_5mmsA_PLP,P35520,,CBS,wild,cl1,5mmsA,PLP,,5mms,1,6,,Synthase,,,A Clinically Relevant Variant of the Human Hydrogen Sulfide-Synthesizing Enzyme Cystathionine beta-Synthase: Increased CO Reactivity as a Novel Molecular Mechanism of Pathogenicity?,,,0,,,,,,,,,,,,,
P35520_CBS_wild_cl2,CBS_4uuuA_SAM,P35520,,CBS,wild,cl2,4uuuA,SAM,,4uuu,1,6,,Synthase,,,Inter-Domain Communication of Human Cystathionine Beta Synthase: Structural Basis of S-Adenosyl-L-Methionine Activation.,,,0,,,,,,,,,,,,,
P35520_CBS_wild_cl2,CBS_4uuuB_SAM,P35520,,CBS,wild,cl2,4uuuB,SAM,,4uuu,1,6,,Synthase,,,Inter-Domain Communication of Human Cystathionine Beta Synthase: Structural Basis of S-Adenosyl-L-Methionine Activation.,,,0,,,,,,,,,,,,,
P35520_CBS_wild_cl4,CBS_4uuuA_SAM,P35520,,CBS,wild,cl4,4uuuA,SAM,,4uuu,1,6,,Synthase,,,Inter-Domain Communication of Human Cystathionine Beta Synthase: Structural Basis of S-Adenosyl-L-Methionine Activation.,,,0,,,,,,,,,,,,,
P35520_CBS_wild_cl1,CBS_1jbqB_PLP,P35520,,CBS,wild,cl1,1jbqB,PLP,,1jbq,1,6,,Synthase,,,Structure of human cystathionine beta-synthase: a unique pyridoxal 5'-phosphate-dependent heme protein.,,,0,,,,,,,,,,,,,
P37268_FDFT1_wild_cl1,FDFT1_3wchE_8PH,P37268,,FDFT1,wild,cl1,3wchE,8PH,,3wch,1,1,,Synthase,,,Squalene synthase as a target for Chagas disease therapeutics.,,,0,,,,,,,,,,,,,
P37268_FDFT1_wild_cl1,FDFT1_3wcfB_BH8,P37268,,FDFT1,wild,cl1,3wcfB,BH8,,3wcf,1,1,,Synthase,,,Squalene synthase as a target for Chagas disease therapeutics.,,,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl1,DHPS_6xxlA_SPM,P49366,,DHPS,wild,cl1,6xxlA,SPM,,6xxl,3,4,,Synthase,,,Half Way to Hypusine-Structural Basis for Substrate Recognition by Human Deoxyhypusine Synthase.,,,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl2,DHPS_6xxlA_SPM,P49366,,DHPS,wild,cl2,6xxlA,SPM,,6xxl,3,4,,Synthase,,,Half Way to Hypusine-Structural Basis for Substrate Recognition by Human Deoxyhypusine Synthase.,,,0,,,,,,,,,,,,,
P49366_DHPS_wild_cl2,DHPS_6xxjA_SPD,P49366,,DHPS,wild,cl2,6xxjA,SPD,,6xxj,3,4,,Synthase,,,Half Way to Hypusine-Structural Basis for Substrate Recognition by Human Deoxyhypusine Synthase.,,,0,,,,,,,,,,,,,
P52788_SMS_wild_cl1,SMS_3c6mD_SPM,P52788,,SMS,wild,cl1,3c6mD,SPM,,3c6m,3,2,,Synthase,,,Crystal structure of human spermine synthase: implications of substrate binding and catalytic mechanism.,,,0,,,,,,,,,,,,,
P52788_SMS_wild_cl1,SMS_3c6mA_SPM,P52788,,SMS,wild,cl1,3c6mA,SPM,,3c6m,3,2,,Synthase,,,Crystal structure of human spermine synthase: implications of substrate binding and catalytic mechanism.,,,0,,,,,,,,,,,,,
P52788_SMS_wild_cl2,SMS_3c6kA_MTA,P52788,,SMS,wild,cl2,3c6kA,MTA,,3c6k,3,2,,Synthase,,,Crystal structure of human spermine synthase: implications of substrate binding and catalytic mechanism.,,,0,,,,,,,,,,,,,
P52788_SMS_wild_cl2,SMS_3c6kD_MTA,P52788,,SMS,wild,cl2,3c6kD,MTA,,3c6k,3,2,,Synthase,,,Crystal structure of human spermine synthase: implications of substrate binding and catalytic mechanism.,,,0,,,,,,,,,,,,,
Q99707_MTR_wild_cl1,MTR_4cczA_THG,Q99707,,MTR,wild,cl1,4cczA,THG,,4ccz,3,1,,Synthase,,,Crystal Structure of Human 5-Methyltetrahydrofolate-Homocysteine Methyltransferase_ the Homocysteine and Folate Binding Domains,,,0,,,,,,,,,,,,,
P07814_EPRS1_wild_cl1,EPRS1_5vadA_91Y,P07814,,EPRS1,wild,cl1,5vadA,91Y,,5vad,1,1,,Synthetase,,,Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.,inhibitor,,0,,,,,,,,,,,,,
P07814_EPRS1_wild_cl1,EPRS1_7ot1A_1AI,P07814,,EPRS1,wild,cl1,7ot1A,1AI,,7ot1,1,1,,Synthetase,,,Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase inhibitors: In Silico Modelling_ Thermal Shift Assay and Structural Studies.,inhibitor,,0,,,,,,,,,,,,,
P26639_TARS1_wild_cl1,TARS1_4ttvA_BC9,P26639,,TARS1,wild,cl1,4ttvA,BC9,,4ttv,2,1,,Synthetase,,,Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P26639_TARS1_wild_cl1,TARS1_4p3nA_2CR,P26639,,TARS1,wild,cl1,4p3nA,2CR,,4p3n,2,1,,Synthetase,,,Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase.,inhibitor,,0,,,,,,,,,,,,,
Q15046_KARS1_wild_cl1,KARS1_4ycwE_KRS,Q15046,,KARS1,wild,cl1,4ycwE,KRS,,4ycw,1,1,,Synthetase,,,Structural Basis for Specific inhibition of tRNA Synthetase by ATP Competitive inhibitor,inhibitor,,0,,,,,,,,,,,,,
O95363_FARS2_wild_cl1,FARS2_3tegA_DAH,O95363,,FARS2,wild,cl1,3tegA,DAH,,3teg,2,1,,Synthetase,,,Bacterial and Eukaryotic Phenylalanyl-tRNA Synthetases Catalyze Misaminoacylation of tRNA(Phe) with 3_4-Dihydroxy-L-Phenylalanine.,,,0,,,,,,,,,,,,,
O95363_FARS2_wild_cl1,FARS2_3hfvA_MTY,O95363,,FARS2,wild,cl1,3hfvA,MTY,,3hfv,2,1,,Synthetase,,,Eukaryotic cytosolic and mitochondrial phenylalanyl-tRNA synthetases catalyze the charging of tRNA with the meta-tyrosine,,,0,,,,,,,,,,,,,
P12081_HARS1_wild_cl1,HARS1_4phcA_HIS,P12081,,HARS1,wild,cl1,4phcA,HIS,,4phc,3,1,,Synthetase,,,Comparison of histidine recognition in human and trypanosomatid histidyl-tRNA synthetases.,,,0,,,,,,,,,,,,,
P15104_GLUL_wild_cl1,GLUL_2ojwA_ADP,P15104,,GLUL,wild,cl1,2ojwA,ADP,,2ojw,3,2,,Synthetase,,,Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.,,,0,,,,,,,,,,,,,
P15104_GLUL_wild_cl1,GLUL_2qc8J_ADP,P15104,,GLUL,wild,cl1,2qc8J,ADP,,2qc8,3,2,,Synthetase,,,Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.,,,0,,,,,,,,,,,,,
P15104_GLUL_wild_cl2,GLUL_2qc8A_P3S,P15104,,GLUL,wild,cl2,2qc8A,P3S,,2qc8,3,2,,Synthetase,,,Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.,,,0,,,,,,,,,,,,,
P15104_GLUL_wild_cl2,GLUL_2qc8H_P3S,P15104,,GLUL,wild,cl2,2qc8H,P3S,,2qc8,3,2,,Synthetase,,,Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.,,,0,,,,,,,,,,,,,
P22234_PAICS_wild_cl1,PAICS_6yb9A_OK8,P22234,,PAICS,wild,cl1,6yb9A,OK8,,6yb9,3,2,,Synthetase,,,Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.,,,0,,,,,,,,,,,,,
P22234_PAICS_wild_cl1,PAICS_6yb8B_C2R,P22234,,PAICS,wild,cl1,6yb8B,C2R,,6yb8,3,2,,Synthetase,,,Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.,,,0,,,,,,,,,,,,,
P22234_PAICS_wild_cl2,PAICS_6yb8A_C2R,P22234,,PAICS,wild,cl2,6yb8A,C2R,,6yb8,3,2,,Synthetase,,,Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target.,,,0,,,,,,,,,,,,,
P30520_ADSS2_wild_cl1,ADSS2_2v40A_GDP,P30520,,ADSS2,wild,cl1,2v40A,GDP,,2v40,3,1,,Synthetase,,,Human Adenylosuccinate Synthetase Isozyme 2 in Complex with Gdp,,,0,,,,,,,,,,,,,
P41250_GARS1_wild_cl1,GARS1_2zt7A_ATP,P41250,,GARS1,wild,cl1,2zt7A,ATP,,2zt7,3,1,,Synthetase,,,Crystal structures and biochemical analyses suggest unique mechanism and role for human GlyRS in Ap4A homeostasis,,,0,,,,,,,,,,,,,
P41250_GARS1_wild_cl1,GARS1_2zt8A_DRV,P41250,,GARS1,wild,cl1,2zt8A,DRV,,2zt8,3,1,,Synthetase,,,Crystal structures and biochemical analyses suggest unique mechanism and role for human GlyRS in Ap4A homeostasis,,,0,,,,,,,,,,,,,
P49588_AARS1_wild_cl1,AARS1_5v59A_8X1,P49588,,AARS1,wild,cl1,5v59A,8X1,,5v59,3,1,,Synthetase,,,Double mimicry evades tRNA synthetase editing by toxic vegetable-sourced non-proteinogenic amino acid.,,,0,,,,,,,,,,,,,
P49588_AARS1_wild_cl1,AARS1_5knnD_A5A,P49588,,AARS1,wild,cl1,5knnD,A5A,,5knn,3,1,,Synthetase,,,Evolutionary Gain of Alanine Mischarging to Noncognate tRNAs with a G4:U69 Base Pair.,,,0,,,,,,,,,,,,,
P49591_SARS1_wild_cl1,SARS1_4l87A_SSA,P49591,,SARS1,wild,cl1,4l87A,SSA,,4l87,3,1,,Synthetase,,,Crystal Structure of Human Seryl-tRNA Synthetase and Ser-SA Complex Reveals a Molecular Lever Specific to Higher Eukaryotes.,,,0,,,,,,,,,,,,,
P49591_SARS1_wild_cl1,SARS1_4rqfA_ANP,P49591,,SARS1,wild,cl1,4rqfA,ANP,,4rqf,3,1,,Synthetase,,,SerRS-tRNASec complex structures reveal mechanism of the first step in selenocysteine biosynthesis.,,,0,,,,,,,,,,,,,
P54136_RARS1_wild_cl1,RARS1_4q2tA_ARG,P54136,,RARS1,wild,cl1,4q2tA,ARG,,4q2t,3,1,,Synthetase,,,The crystal structure of arginyl-tRNA synthetase from Homo sapiens,,,0,,,,,,,,,,,,,
P56192_MARS1_wild_cl1,MARS1_5goyA_MET,P56192,,MARS1,wild,cl1,5goyA,MET,,5goy,3,1,,Synthetase,,,The crystal structure of human cytosolic methionyl-tRNA synthetase in complex with methionine,,,0,,,,,,,,,,,,,
Q15046_KARS1_wild_cl1,KARS1_6ilhA_KAA,Q15046,,KARS1,wild,cl1,6ilhA,KAA,,6ilh,1,1,,Synthetase,,,Retractile lysyl-tRNA synthetase-AIMP2 assembly in the human multi-aminoacyl-tRNA synthetase complex.,,,0,,,,,,,,,,,,,
O15382_BCAT2_wild_cl2,BCAT2_5bwuB_4VR,O15382,,BCAT2,wild,cl2,5bwuB,4VR,,5bwu,1,2,,Transferase,,,The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) inhibitors by Hybridizing Fragment and HTS Hits.,inhibitor,,0,,,,,,,,,,,,,
P00492_HPRT1_wild_cl1,HPRT1_4radC_3L5,P00492,,HPRT1,wild,cl1,4radC,3L5,,4rad,1,1,,Transferase,,,Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As inhibitors of the Human_ Plasmodium falciparum and vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents.,inhibitor,,0,,,,,,,,,,,,,
P04181_OAT_wild_cl1,OAT_2oatA_PFM,P04181,,OAT,wild,cl1,2oatA,PFM,,2oat,3,3,,Transferase,,,Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine.,inhibitor,,0,,,,,,,,,,,,,
P04181_OAT_wild_cl3,OAT_7jx9A_VLS,P04181,,OAT,wild,cl3,7jx9A,VLS,,7jx9,3,3,,Transferase,,,Structural and Kinetic Analyses Reveal the Dual inhibition Modes of Ornithine Aminotransferase by (1 S _3 S )-3-Amino-4-(hexafluoropropan-2-ylidenyl)-cyclopentane-1-carboxylic Acid (BCF 3 ).,inhibitor,,0,,,,,,,,,,,,,
P04181_OAT_wild_cl2,OAT_6oiaA_MQ4,P04181,,OAT,wild,cl2,6oiaA,MQ4,,6oia,3,3,,Transferase,,,Mechanism of inactivation of Ornithine Aminotransferase by (1S_3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid.,inhibitor,,0,,,,,,,,,,,,,
P04181_OAT_wild_cl1,OAT_7lomA_Y8P,P04181,,OAT,wild,cl1,7lomA,Y8P,,7lom,3,3,,Transferase,,,Remarkable and Unexpected Mechanism for ( S )-3-Amino-4-(difluoromethylenyl)cyclohex-1-ene-1-carboxylic Acid as a Selective inactivator of Human Ornithine Aminotransferase.,inhibitor,,0,,,,,,,,,,,,,
P17174_GOT1_wild_cl1,GOT1_6dnaD_PLP,P17174,,GOT1,wild,cl1,6dnaD,PLP,,6dna,2,2,,Transferase,,,Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
P19440_GGT1_wild_cl1,GGT1_6xpcB_GSH,P19440,,GGT1,wild,cl1,6xpcB,GSH,,6xpc,3,1,,Transferase,,,Crystal structures of glutathione- and inhibitor-bound human GGT1: critical interactions within the cysteinylglycine binding site.,inhibitor,,0,,,,,,,,,,,,,
P35610_SOAT1_wild_cl2,SOAT1_6l47A_E5L,P35610,,SOAT1,wild,cl2,6l47A,E5L,,6l47,3,2,,Transferase,,,Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor.,inhibitor,,0,,,,,,,,,,,,,
P49354_FNTA_wild_cl1,FNTA_1jcqA_739,P49354,,FNTA,wild,cl1,1jcqA,739,,1jcq,3,1,,Transferase,,,The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.,inhibitor,,0,,,,,,,,,,,,,
P49356_FNTB_wild_cl1,FNTB_1jcqB_FPP,P49356,,FNTB,wild,cl1,1jcqB,FPP,,1jcq,3,1,,Transferase,,,The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.,inhibitor,,0,,,,,,,,,,,,,
P50225_SULT1A1_wild_cl1,SULT1A1_1ls6A_NPO,P50225,,SULT1A1,wild,cl1,1ls6A,NPO,,1ls6,3,2,,Transferase,,,Structure of a human carcinogen-converting enzyme_ SULT1A1. Structural and kinetic implications of substrate inhibition.,inhibitor,,0,,,,,,,,,,,,,
P50225_SULT1A1_wild_cl2,SULT1A1_2d06A_A3P,P50225,,SULT1A1,wild,cl2,2d06A,A3P,,2d06,3,2,,Transferase,,,The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates,inhibitor,,0,,,,,,,,,,,,,
P54687_BCAT1_wild_cl2,BCAT1_2cogA_4MV,P54687,,BCAT1,wild,cl2,2cogA,4MV,,2cog,3,2,,Transferase,,,Structural determinants for branched-chain aminotransferase isozyme-specific inhibition by the anticonvulsant drug gabapentin,inhibitor,,0,,,,,,,,,,,,,
P54687_BCAT1_wild_cl1,BCAT1_2abjA_CBC,P54687,,BCAT1,wild,cl1,2abjA,CBC,,2abj,3,2,,Transferase,,,The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.,inhibitor,,0,,,,,,,,,,,,,
P54687_BCAT1_wild_cl1,BCAT1_2abjD_CBC,P54687,,BCAT1,wild,cl1,2abjD,CBC,,2abj,3,2,,Transferase,,,The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.,inhibitor,,0,,,,,,,,,,,,,
P54687_BCAT1_wild_cl2,BCAT1_2abjA_CBC,P54687,,BCAT1,wild,cl2,2abjA,CBC,,2abj,3,2,,Transferase,,,The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.,inhibitor,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl3,GALNT2_5ndfA_LU2,Q10471,,GALNT2,wild,cl3,5ndfA,LU2,,5ndf,1,3,,Transferase,,,The small molecule luteolin inhibits N-acetyl-alpha-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.,inhibitor,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl3,GALNT2_5ndfB_LU2,Q10471,,GALNT2,wild,cl3,5ndfB,LU2,,5ndf,1,3,,Transferase,,,The small molecule luteolin inhibits N-acetyl-alpha-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.,inhibitor,,0,,,,,,,,,,,,,
Q16769_QPCT_wild_cl1,QPCT_7cozB_Q39,Q16769,,QPCT,wild,cl1,7cozB,Q39,,7coz,1,2,,Transferase,,,Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q16773_KYAT1_wild_cl1,KYAT1_3fvuB_IAC,Q16773,,KYAT1,wild,cl1,3fvuB,IAC,,3fvu,2,2,,Transferase,,,Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K,inhibitor,,0,,,,,,,,,,,,,
Q16773_KYAT1_wild_cl2,KYAT1_3fvuA_GOL,Q16773,,KYAT1,wild,cl2,3fvuA,GOL,,3fvu,2,2,,Transferase,,,Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K,inhibitor,,0,,,,,,,,,,,,,
Q8N5Z0_AADAT_wild_cl1,AADAT_3ue8A_09M,Q8N5Z0,,AADAT,wild,cl1,3ue8A,09M,,3ue8,3,2,,Transferase,,,Discovery of Brain-Penetrant_ Irreversible Kynurenine Aminotransferase II inhibitors for Schizophrenia.,inhibitor,,0,,,,,,,,,,,,,
Q8N5Z0_AADAT_wild_cl1,AADAT_4gdyA_0X1,Q8N5Z0,,AADAT,wild,cl1,4gdyA,0X1,,4gdy,3,2,,Transferase,,,Discovery of Hydroxamate Bioisosteres as KATII inhibitors with Improved Oral Bioavailability and Pharmacokinetics,inhibitor,,0,,,,,,,,,,,,,
Q8N5Z0_AADAT_wild_cl2,AADAT_4gebA_0LD,Q8N5Z0,,AADAT,wild,cl2,4gebA,0LD,,4geb,3,2,,Transferase,,,PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency.,inhibitor,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl1,DPAGT1_6bw5D_PGW,Q9H3H5,,DPAGT1,wild,cl1,6bw5D,PGW,,6bw5,3,4,,Transferase,,,GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.,inhibitor,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl1,DPAGT1_6bw6C_PGW,Q9H3H5,,DPAGT1,wild,cl1,6bw6C,PGW,,6bw6,3,4,,Transferase,,,GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.,inhibitor,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl2,DPAGT1_6bw6A_TUM,Q9H3H5,,DPAGT1,wild,cl2,6bw6A,TUM,,6bw6,3,4,,Transferase,,,GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.,inhibitor,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl3,DPAGT1_6bw5C_PGW,Q9H3H5,,DPAGT1,wild,cl3,6bw5C,PGW,,6bw5,3,4,,Transferase,,,GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.,inhibitor,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl3,DPAGT1_6bw5A_PGW,Q9H3H5,,DPAGT1,wild,cl3,6bw5A,PGW,,6bw5,3,4,,Transferase,,,GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.,inhibitor,,0,,,,,,,,,,,,,
Q9NXS2_QPCTL_wild_cl1,QPCTL_3pb7A_PBD,Q9NXS2,,QPCTL,wild,cl1,3pb7A,PBD,,3pb7,3,1,,Transferase,,,Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding,inhibitor,,0,,,,,,,,,,,,,
O00204_SULT2B1_wild_cl1,SULT2B1_1q20A_PLO,O00204,,SULT2B1,wild,cl1,1q20A,PLO,,1q20,3,2,,Transferase,,,Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenoloneand 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypicalSULT2A1 and the SULT2BG1 isoforms.,,,0,,,,,,,,,,,,,
O00204_SULT2B1_wild_cl2,SULT2B1_1q1qA_A3P,O00204,,SULT2B1,wild,cl2,1q1qA,A3P,,1q1q,3,2,,Transferase,,,Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenoloneand 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypicalSULT2A1 and the SULT2BG1 isoforms.,,,0,,,,,,,,,,,,,
O00338_SULT1C2_wild_cl1,SULT1C2_3bfxA_A3P,O00338,,SULT1C2,wild,cl1,3bfxA,A3P,,3bfx,3,1,,Transferase,,,Crystal Structures of Human Sulfotransferases Sult1B1 and Sult1C1 Complexed with the Cofactor Product Adenosine-3'-5'-Diphosphate (Pap).,,,0,,,,,,,,,,,,,
O15382_BCAT2_wild_cl2,BCAT2_1kt8A_ILP,O15382,,BCAT2,wild,cl2,1kt8A,ILP,,1kt8,1,2,,Transferase,,,Crystal structures of human mitochondrial branched chain aminotransferase reaction intermediates: ketimine and pyridoxamine phosphate forms,,,0,,,,,,,,,,,,,
O15382_BCAT2_wild_cl1,BCAT2_5i5wA_68B,O15382,,BCAT2,wild,cl1,5i5wA,68B,,5i5w,1,2,,Transferase,,,Structurally Diverse Mitochondrial Branched Chain Aminotransferase (BCATm) Leads with Varying Binding Modes Identified by Fragment Screening.,,,0,,,,,,,,,,,,,
O15382_BCAT2_wild_cl1,BCAT2_1ekvA_PLP,O15382,,BCAT2,wild,cl1,1ekvA,PLP,,1ekv,1,2,,Transferase,,,The structure of human mitochondrial branched-chain aminotransferase.,,,0,,,,,,,,,,,,,
O43704_SULT1B1_wild_cl2,SULT1B1_3cklB_STL,O43704,,SULT1B1,wild,cl2,3cklB,STL,,3ckl,3,2,,Transferase,,,Crystal structure of human cytosolic sulfotransferase SULT1B1 in complex with PAP and resveratrol.,,,0,,,,,,,,,,,,,
O43704_SULT1B1_wild_cl1,SULT1B1_2z5fA_A3P,O43704,,SULT1B1,wild,cl1,2z5fA,A3P,,2z5f,3,2,,Transferase,,,Crystal structures of human sulfotransferases SULT1B1 and SULT1C1 complexed with the cofactor product adenosine-3'-5'-diphosphate (PAP),,,0,,,,,,,,,,,,,
O60704_TPST2_wild_cl1,TPST2_3ap1A_A3P,O60704,,TPST2,wild,cl1,3ap1A,A3P,,3ap1,3,1,,Transferase,,,Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction.,,,0,,,,,,,,,,,,,
O60704_TPST2_wild_cl1,TPST2_3ap2A_A3P,O60704,,TPST2,wild,cl1,3ap2A,A3P,,3ap2,3,1,,Transferase,,,Crystal structure of human tyrosylprotein sulfotransferase-2: Insights into substrate-binding and catalysis of post-translational protein tyrosine sulfation,,,0,,,,,,,,,,,,,
O75897_SULT1C4_wild_cl1,SULT1C4_2gwhA_PCI,O75897,,SULT1C4,wild,cl1,2gwhA,PCI,,2gwh,3,2,,Transferase,,,Structural and chemical profiling of the human cytosolic sulfotransferases.,,,0,,,,,,,,,,,,,
O75897_SULT1C4_wild_cl1,SULT1C4_2gwhB_PCI,O75897,,SULT1C4,wild,cl1,2gwhB,PCI,,2gwh,3,2,,Transferase,,,Structural and chemical profiling of the human cytosolic sulfotransferases.,,,0,,,,,,,,,,,,,
O75897_SULT1C4_wild_cl2,SULT1C4_2gwhA_A3P,O75897,,SULT1C4,wild,cl2,2gwhA,A3P,,2gwh,3,2,,Transferase,,,Structural and chemical profiling of the human cytosolic sulfotransferases.,,,0,,,,,,,,,,,,,
O75908_SOAT2_wild_cl1,SOAT2_7n6rA_ROV,O75908,,SOAT2,wild,cl1,7n6rA,ROV,,7n6r,3,1,,Transferase,,,Structure of nevanimibe bound human ACAT2,,,0,,,,,,,,,,,,,
P00480_OTC_wild_cl1,OTC_1othA_PAO,P00480,,OTC,wild,cl1,1othA,PAO,,1oth,3,1,,Transferase,,,1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency.,,,0,,,,,,,,,,,,,
P00480_OTC_wild_cl1,OTC_1c9yA_CP,P00480,,OTC,wild,cl1,1c9yA,CP,,1c9y,3,1,,Transferase,,,Crystal structure of human ornithine transcarbamylase complexed with carbamoyl phosphate and L-norvaline at 1.9 A resolution.,,,0,,,,,,,,,,,,,
P00492_HPRT1_wild_cl1,HPRT1_1hmpB_5GP,P00492,,HPRT1,wild,cl1,1hmpB,5GP,,1hmp,1,1,,Transferase,,,The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP.,,,0,,,,,,,,,,,,,
P04181_OAT_wild_cl2,OAT_1gbnA_GBC,P04181,,OAT,wild,cl2,1gbnA,GBC,,1gbn,3,3,,Transferase,,,Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition.,,,0,,,,,,,,,,,,,
P07741_APRT_wild_cl1,APRT_6hgqA_PRP,P07741,,APRT,wild,cl1,6hgqA,PRP,,6hgq,3,2,,Transferase,,,Structural basis for substrate selectivity and nucleophilic substitution mechanisms in human adenine phosphoribosyltransferase catalyzed reaction.,,,0,,,,,,,,,,,,,
P07741_APRT_wild_cl2,APRT_1zn7A_PRP,P07741,,APRT,wild,cl2,1zn7A,PRP,,1zn7,3,2,,Transferase,,,Structural Complexes of Human Adenine Phosphoribosyltransferase Reveal Novel Features of the APRT Catalytic Mechanism,,,0,,,,,,,,,,,,,
P07741_APRT_wild_cl1,APRT_6fclA_AMP,P07741,,APRT,wild,cl1,6fclA,AMP,,6fcl,3,2,,Transferase,,,Structural Insights into the Forward and Reverse Enzymatic Reactions in Human Adenine Phosphoribosyltransferase.,,,0,,,,,,,,,,,,,
P12277_CKB_wild_cl1,CKB_3b6rB_CRN,P12277,,CKB,wild,cl1,3b6rB,CRN,,3b6r,3,2,,Transferase,,,Structural studies of human brain-type creatine kinase complexed with the ADP-Mg2+-NO3- -creatine transition-state analogue complex,,,0,,,,,,,,,,,,,
P12277_CKB_wild_cl2,CKB_3drbB_ADP,P12277,,CKB,wild,cl2,3drbB,ADP,,3drb,3,2,,Transferase,,,Structural studies of human brain-type creatine kinase complexed with the ADP-Mg2+-NO3- -creatine transition-state analogue complex,,,0,,,,,,,,,,,,,
P15291_B4GALT1_wild_cl1,B4GALT1_4eeoC_NAG,P15291,,B4GALT1,wild,cl1,4eeoC,NAG,,4eeo,1,2,,Transferase,,,Binding of N-acetylglucosamine (GlcNAc) beta 1-6-branched oligosaccharide acceptors to beta 4-galactosyltransferase I reveals a new ligand binding mode.,,,0,,,,,,,,,,,,,
P15291_B4GALT1_wild_cl1,B4GALT1_4eemC_MMA,P15291,,B4GALT1,wild,cl1,4eemC,MMA,,4eem,1,2,,Transferase,,,Binding of N-acetylglucosamine (GlcNAc) beta 1-6-branched oligosaccharide acceptors to beta 4-galactosyltransferase I reveals a new ligand binding mode.,,,0,,,,,,,,,,,,,
P15291_B4GALT1_wild_cl2,B4GALT1_4ee4A_UDP,P15291,,B4GALT1,wild,cl2,4ee4A,UDP,,4ee4,1,2,,Transferase,,,Binding of N-acetylglucosamine (GlcNAc) beta 1-6-branched oligosaccharide acceptors to beta 4-galactosyltransferase I reveals a new ligand binding mode.,,,0,,,,,,,,,,,,,
P15291_B4GALT1_wild_cl2,B4GALT1_4ee5C_UDP,P15291,,B4GALT1,wild,cl2,4ee5C,UDP,,4ee5,1,2,,Transferase,,,Binding of N-acetylglucosamine (GlcNAc) beta 1-6-branched oligosaccharide acceptors to beta 4-galactosyltransferase I reveals a new ligand binding mode.,,,0,,,,,,,,,,,,,
P15907_ST6GAL1_wild_cl1,ST6GAL1_4js1A_CTN,P15907,,ST6GAL1,wild,cl1,4js1A,CTN,,4js1,3,1,,Transferase,,,The structure of human alpha-2_6-sialyltransferase reveals the binding mode of complex glycans.,,,0,,,,,,,,,,,,,
P15907_ST6GAL1_wild_cl1,ST6GAL1_6qvtA_NCC,P15907,,ST6GAL1,wild,cl1,6qvtA,NCC,,6qvt,3,1,,Transferase,,,Unliganded and CMP-Neu5Ac bound structures of human alpha-2_6-sialyltransferase ST6Gal I at high resolution.,,,0,,,,,,,,,,,,,
P16442_ABO_wild_cl1,ABO_5c1gA_GDU,P16442,,ABO,wild,cl1,5c1gA,GDU,,5c1g,1,1,,Transferase,,,High Resolution Structures of the Human ABO(H) Blood Group Enzymes in Complex with Donor Analogs Reveal That the Enzymes Utilize Multiple Donor Conformations to Bind Substrates in a Stepwise Manner.,,,0,,,,,,,,,,,,,
P16442_ABO_wild_cl1,ABO_2y7aA_UDP,P16442,,ABO,wild,cl1,2y7aA,UDP,,2y7a,1,1,,Transferase,,,Structural and Biochemical Characterization of the Human Blood Group a and B Galactosyltransferases Possessing the Pro156Leu Mutation,,,0,,,,,,,,,,,,,
P17174_GOT1_wild_cl1,GOT1_3ii0A_PLP,P17174,,GOT1,wild,cl1,3ii0A,PLP,,3ii0,2,2,,Transferase,,,Crystal structure of human Glutamate oxaloacetate transaminase 1 (GOT1),,,0,,,,,,,,,,,,,
P17174_GOT1_wild_cl2,GOT1_6ligB_EE6,P17174,,GOT1,wild,cl2,6ligB,EE6,,6lig,2,2,,Transferase,,,Crystal structure of human Glutamate oxaloacetate transaminase 1 (GOT1) in complex with AH,,,0,,,,,,,,,,,,,
P17735_TAT_wild_cl1,TAT_3dydA_PLP,P17735,,TAT,wild,cl1,3dydA,PLP,,3dyd,3,1,,Transferase,,,Human Tyrosine Aminotransferase,,,0,,,,,,,,,,,,,
P19440_GGT1_wild_cl1,GGT1_7ld9B_XUJ,P19440,,GGT1,wild,cl1,7ld9B,XUJ,,7ld9,3,1,,Transferase,,,Structure of human GGT1 in complex with ABBA,,,0,,,,,,,,,,,,,
P35610_SOAT1_wild_cl1,SOAT1_6p2pA_3VV,P35610,,SOAT1,wild,cl1,6p2pA,3VV,,6p2p,3,2,,Transferase,,,Structural basis for catalysis and substrate specificity of human ACAT1.,,,0,,,,,,,,,,,,,
P35610_SOAT1_wild_cl1,SOAT1_6p2pB_3VV,P35610,,SOAT1,wild,cl1,6p2pB,3VV,,6p2p,3,2,,Transferase,,,Structural basis for catalysis and substrate specificity of human ACAT1.,,,0,,,,,,,,,,,,,
P49354_FNTA_wild_cl1,FNTA_2iejA_FII,P49354,,FNTA,wild,cl1,2iejA,FII,,2iej,3,1,,Transferase,,,Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.,,,0,,,,,,,,,,,,,
P49356_FNTB_wild_cl1,FNTB_2h6hB_FAR,P49356,,FNTB,wild,cl1,2h6hB,FAR,,2h6h,3,1,,Transferase,,,Conversion of protein farnesyltransferase to a geranylgeranyltransferase.,,,0,,,,,,,,,,,,,
P49888_SULT1E1_wild_cl2,SULT1E1_1hy3A_PPS,P49888,,SULT1E1,wild,cl2,1hy3A,PPS,,1hy3,3,2,,Transferase,,,Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reaction.,,,0,,,,,,,,,,,,,
P49888_SULT1E1_wild_cl2,SULT1E1_1g3mA_A3P,P49888,,SULT1E1,wild,cl2,1g3mA,A3P,,1g3m,3,2,,Transferase,,,Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase.,,,0,,,,,,,,,,,,,
P49888_SULT1E1_wild_cl1,SULT1E1_4jvlA_EST,P49888,,SULT1E1,wild,cl1,4jvlA,EST,,4jvl,3,2,,Transferase,,,Mimicking of Estradiol Binding by Flame Retardants and Their Metabolites: A Crystallographic Analysis.,,,0,,,,,,,,,,,,,
P49888_SULT1E1_wild_cl1,SULT1E1_4jvlB_EST,P49888,,SULT1E1,wild,cl1,4jvlB,EST,,4jvl,3,2,,Transferase,,,Mimicking of Estradiol Binding by Flame Retardants and Their Metabolites: A Crystallographic Analysis.,,,0,,,,,,,,,,,,,
P50225_SULT1A1_wild_cl1,SULT1A1_3qvuB_NPO,P50225,,SULT1A1,wild,cl1,3qvuB,NPO,,3qvu,3,2,,Transferase,,,Directed evolution of sulfotransferases and paraoxonases by ancestral libraries.,,,0,,,,,,,,,,,,,
P50225_SULT1A1_wild_cl2,SULT1A1_3qvuB_A3P,P50225,,SULT1A1,wild,cl2,3qvuB,A3P,,3qvu,3,2,,Transferase,,,Directed evolution of sulfotransferases and paraoxonases by ancestral libraries.,,,0,,,,,,,,,,,,,
Q06520_SULT2A1_wild_cl1,SULT2A1_1efhA_A3P,Q06520,,SULT2A1,wild,cl1,1efhA,A3P,,1efh,3,2,,Transferase,,,Crystal structure of SULT2A3_ human hydroxysteroid sulfotransferase.,,,0,,,,,,,,,,,,,
Q06520_SULT2A1_wild_cl2,SULT2A1_3f3yA_4OA,Q06520,,SULT2A1,wild,cl2,3f3yA,4OA,,3f3y,3,2,,Transferase,,,rystal structure of human cytosolic sulfotransferase SULT2A1 in complex with PAP and lithocholic acid,,,0,,,,,,,,,,,,,
Q06520_SULT2A1_wild_cl2,SULT2A1_3f3yD_4OA,Q06520,,SULT2A1,wild,cl2,3f3yD,4OA,,3f3y,3,2,,Transferase,,,rystal structure of human cytosolic sulfotransferase SULT2A1 in complex with PAP and lithocholic acid,,,0,,,,,,,,,,,,,
Q06520_SULT2A1_wild_cl1,SULT2A1_4ifbA_PPS,Q06520,,SULT2A1,wild,cl1,4ifbA,PPS,,4ifb,3,2,,Transferase,,,Sulfotransferase Selectivity at the Molecular level,,,0,,,,,,,,,,,,,
Q09328_MGAT5_wild_cl1,MGAT5_5zicA_Z4Y,Q09328,,MGAT5,wild,cl1,5zicA,Z4Y,,5zic,3,1,,Transferase,,,Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.,,,0,,,,,,,,,,,,,
Q10469_MGAT2_wild_cl1,MGAT2_5vcmA_UDP,Q10469,,MGAT2,wild,cl1,5vcmA,UDP,,5vcm,3,1,,Transferase,,,HumanN-acetylglucosaminyltransferase II substrate recognition uses a modular architecture that includes a convergent exosite.,,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl1,GALNT2_6nqtD_LR7,Q10471,,GALNT2,wild,cl1,6nqtD,LR7,,6nqt,1,3,,Transferase,,,Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells.,,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl1,GALNT2_4d11F_UDP,Q10471,,GALNT2,wild,cl1,4d11F,UDP,,4d11,1,3,,Transferase,,,Substrate-Guided Front-Face Reaction Revealed by Combined Structural Snapshots and Metadynamics for the Polypeptide N- Acetylgalactosaminyltransferase 2.,,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl2,GALNT2_4d0zA_BBK,Q10471,,GALNT2,wild,cl2,4d0zA,BBK,,4d0z,1,3,,Transferase,,,Substrate-Guided Front-Face Reaction Revealed by Combined Structural Snapshots and Metadynamics for the Polypeptide N- Acetylgalactosaminyltransferase 2.,,,0,,,,,,,,,,,,,
Q10471_GALNT2_wild_cl2,GALNT2_4d11B_BBK,Q10471,,GALNT2,wild,cl2,4d11B,BBK,,4d11,1,3,,Transferase,,,Substrate-Guided Front-Face Reaction Revealed by Combined Structural Snapshots and Metadynamics for the Polypeptide N- Acetylgalactosaminyltransferase 2.,,,0,,,,,,,,,,,,,
Q16769_QPCT_wild_cl1,QPCT_2afwA_AHN,Q16769,,QPCT,wild,cl1,2afwA,AHN,,2afw,1,2,,Transferase,,,Crystal structures of human glutaminyl cyclase_ an enzyme responsible for protein N-terminal pyroglutamate formation,,,0,,,,,,,,,,,,,
Q16769_QPCT_wild_cl2,QPCT_6yi1A_PHE,Q16769,,QPCT,wild,cl2,6yi1A,PHE,,6yi1,1,2,,Transferase,,,Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease.,,,0,,,,,,,,,,,,,
Q16773_KYAT1_wild_cl1,KYAT1_1w7nA_PMP,Q16773,,KYAT1,wild,cl1,1w7nA,PMP,,1w7n,2,2,,Transferase,,,Crystal Structure of Human Kynurenine Aminotransferase I,,,0,,,,,,,,,,,,,
Q5VTY9_HHAT_wild_cl1,HHAT_7mhyA_HEM,Q5VTY9,,HHAT,wild,cl1,7mhyA,HEM,,7mhy,3,4,,Transferase,,,Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT.,,,0,,,,,,,,,,,,,
Q5VTY9_HHAT_wild_cl1,HHAT_7mhzA_HEM,Q5VTY9,,HHAT,wild,cl1,7mhzA,HEM,,7mhz,3,4,,Transferase,,,Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT.,,,0,,,,,,,,,,,,,
Q5VTY9_HHAT_wild_cl2,HHAT_7mhzA_PKZ,Q5VTY9,,HHAT,wild,cl2,7mhzA,PKZ,,7mhz,3,4,,Transferase,,,Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT.,,,0,,,,,,,,,,,,,
Q5VTY9_HHAT_wild_cl3,HHAT_7mhzA_AJP,Q5VTY9,,HHAT,wild,cl3,7mhzA,AJP,,7mhz,3,4,,Transferase,,,Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT.,,,0,,,,,,,,,,,,,
Q5VTY9_HHAT_wild_cl4,HHAT_7mhyA_PKZ,Q5VTY9,,HHAT,wild,cl4,7mhyA,PKZ,,7mhy,3,4,,Transferase,,,Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT.,,,0,,,,,,,,,,,,,
Q86SR1_GALNT10_wild_cl1,GALNT10_2d7iA_NGA,Q86SR1,,GALNT10,wild,cl1,2d7iA,NGA,,2d7i,3,2,,Transferase,,,Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10),,,0,,,,,,,,,,,,,
Q86SR1_GALNT10_wild_cl1,GALNT10_2d7iA_UDP,Q86SR1,,GALNT10,wild,cl1,2d7iA,UDP,,2d7i,3,2,,Transferase,,,Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10),,,0,,,,,,,,,,,,,
Q86SR1_GALNT10_wild_cl2,GALNT10_2d7rA_TNR,Q86SR1,,GALNT10,wild,cl2,2d7rA,TNR,,2d7r,3,2,,Transferase,,,Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10),,,0,,,,,,,,,,,,,
Q8N5Y8_PARP16_wild_cl1,PARP16_6hxsA_CNA,Q8N5Y8,,PARP16,wild,cl1,6hxsA,CNA,,6hxs,3,1,,Transferase,,,Human PARP16 (ARTD15) IN COMPLEX WITH CARBA-NAD,,,0,,,,,,,,,,,,,
Q8N5Y8_PARP16_wild_cl1,PARP16_6hxsB_CNA,Q8N5Y8,,PARP16,wild,cl1,6hxsB,CNA,,6hxs,3,1,,Transferase,,,Human PARP16 (ARTD15) IN COMPLEX WITH CARBA-NAD,,,0,,,,,,,,,,,,,
Q8N5Z0_AADAT_wild_cl2,AADAT_2r2nA_PMP,Q8N5Z0,,AADAT,wild,cl2,2r2nA,PMP,,2r2n,3,2,,Transferase,,,Crystal structure of human kynurenine aminotransferase II.,,,0,,,,,,,,,,,,,
Q8TD30_GPT2_wild_cl1,GPT2_3ihjA_PLP,Q8TD30,,GPT2,wild,cl1,3ihjA,PLP,,3ihj,3,1,,Transferase,,,Human glutamate pyruvate transaminase 2,,,0,,,,,,,,,,,,,
Q8WZA1_POMGNT1_wild_cl1,POMGNT1_5ggjA_PNA,Q8WZA1,,POMGNT1,wild,cl1,5ggjA,PNA,,5ggj,3,3,,Transferase,,,Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan,,,0,,,,,,,,,,,,,
Q8WZA1_POMGNT1_wild_cl1,POMGNT1_5gglA_6ZC,Q8WZA1,,POMGNT1,wild,cl1,5gglA,6ZC,,5ggl,3,3,,Transferase,,,Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan,,,0,,,,,,,,,,,,,
Q8WZA1_POMGNT1_wild_cl2,POMGNT1_5ggiB_MAN,Q8WZA1,,POMGNT1,wild,cl2,5ggiB,MAN,,5ggi,3,3,,Transferase,,,Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan,,,0,,,,,,,,,,,,,
Q8WZA1_POMGNT1_wild_cl3,POMGNT1_5ggiA_UDP,Q8WZA1,,POMGNT1,wild,cl3,5ggiA,UDP,,5ggi,3,3,,Transferase,,,Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan,,,0,,,,,,,,,,,,,
Q9BXR0_QTRT1_wild_cl1,QTRT1_6h45A_QEI,Q9BXR0,,QTRT1,wild,cl1,6h45A,QEI,,6h45,3,1,,Transferase,,,Crystal Structure of the Human tRNA Guanine Transglycosylase Catalytic Subunit QTRT1.,,,0,,,,,,,,,,,,,
Q9BXR0_QTRT1_wild_cl1,QTRT1_7nq4A_9DG,Q9BXR0,,QTRT1,wild,cl1,7nq4A,9DG,,7nq4,3,1,,Transferase,,,Structural and functional insights into human tRNA guanine transgylcosylase.,,,0,,,,,,,,,,,,,
Q9BYC5_FUT8_wild_cl1,FUT8_6x5tA_GDP,Q9BYC5,,FUT8,wild,cl1,6x5tA,GDP,,6x5t,3,2,,Transferase,,,Characterizing human alpha-1_6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases.,,,0,,,,,,,,,,,,,
Q9BYC5_FUT8_wild_cl1,FUT8_6x5hC_GDP,Q9BYC5,,FUT8,wild,cl1,6x5hC,GDP,,6x5h,3,2,,Transferase,,,Characterizing human alpha-1_6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases.,,,0,,,,,,,,,,,,,
Q9BYC5_FUT8_wild_cl2,FUT8_6vldG_ASN,Q9BYC5,,FUT8,wild,cl2,6vldG,ASN,,6vld,3,2,,Transferase,,,Structural basis of substrate recognition and catalysis by fucosyltransferase 8.,,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl2,DPAGT1_5o5eA_9LH,Q9H3H5,,DPAGT1,wild,cl2,5o5eA,9LH,,5o5e,3,4,,Transferase,,,Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.,,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl4,DPAGT1_6fm9A_P6L,Q9H3H5,,DPAGT1,wild,cl4,6fm9A,P6L,,6fm9,3,4,,Transferase,,,Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.,,,0,,,,,,,,,,,,,
Q9H3H5_DPAGT1_wild_cl4,DPAGT1_5o5eA_P6L,Q9H3H5,,DPAGT1,wild,cl4,5o5eA,P6L,,5o5e,3,4,,Transferase,,,Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.,,,0,,,,,,,,,,,,,
Q9NRN7_AASDHPPT_wild_cl1,AASDHPPT_2cg5A_COA,Q9NRN7,,AASDHPPT,wild,cl1,2cg5A,COA,,2cg5,3,1,,Transferase,,,Mechanism and Substrate Recognition of Human Holo Acp Synthase.,,,0,,,,,,,,,,,,,
P11166_SLC2A1_wild_cl1,SLC2A1_5eqgA_5RE,P11166,,SLC2A1,wild,cl1,5eqgA,5RE,,5eqg,3,1,,Transporter,,,Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides.,inhibitor,,0,,,,,,,,,,,,,
P11166_SLC2A1_wild_cl1,SLC2A1_5eqiA_5RH,P11166,,SLC2A1,wild,cl1,5eqiA,5RH,,5eqi,3,1,,Transporter,,,Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides.,inhibitor,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl1,SLC2A3_7crzA_F00,P11169,,SLC2A3,wild,cl1,7crzA,F00,,7crz,2,3,,Transporter,,,Orthosteric-Allosteric dual inhibitors of PfHT1 as selective antimalarial agents.,inhibitor,allosteric,0,,,,,,,,,,,,,
P43003_SLC1A3_wild_cl1,SLC1A3_5llmA_6Z6,P43003,,SLC1A3,wild,cl1,5llmA,6Z6,,5llm,2,2,,Transporter,,,Structure and Allosteric inhibition of excitatory amino acid transporter 1.,inhibitor,allosteric,0,,,,,,,,,,,,,
P43003_SLC1A3_wild_cl2,SLC1A3_5mjuA_7O9,P43003,,SLC1A3,wild,cl2,5mjuA,7O9,,5mju,2,2,,Transporter,,,Structure and Allosteric inhibition of excitatory amino acid transporter 1.,inhibitor,allosteric,0,,,,,,,,,,,,,
Q15758_SLC1A5_wild_cl1,SLC1A5_7bcsA_TJ5,Q15758,,SLC1A5,wild,cl1,7bcsA,TJ5,,7bcs,3,2,,Transporter,,,Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.,inhibitor,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl1,ABCG2_6feqA_D6T,Q9UNQ0,,ABCG2,wild,cl1,6feqA,D6T,,6feq,3,3,,Transporter,,,Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.,inhibitor,,0,,,,,,,,,,,,,
O95255_ABCC6_wild_cl1,ABCC6_6bzrB_ADP,O95255,,ABCC6,wild,cl1,6bzrB,ADP,,6bzr,3,1,,Transporter,,,Structures of human ABCC6 NBD1 and NBD2,,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl1,SLC2A3_4zwbA_MAL,P11169,,SLC2A3,wild,cl1,4zwbA,MAL,,4zwb,2,3,,Transporter,,,Molecular basis of ligand recognition and transport by glucose transporters,,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl2,SLC2A3_5c65A_37X,P11169,,SLC2A3,wild,cl2,5c65A,37X,,5c65,2,3,,Transporter,,,Structure of the human glucose transporter GLUT3 / SLC2A3,,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl2,SLC2A3_5c65B_37X,P11169,,SLC2A3,wild,cl2,5c65B,37X,,5c65,2,3,,Transporter,,,Structure of the human glucose transporter GLUT3 / SLC2A3,,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl3,SLC2A3_5c65A_Y01,P11169,,SLC2A3,wild,cl3,5c65A,Y01,,5c65,2,3,,Transporter,,,Structure of the human glucose transporter GLUT3 / SLC2A3,,,0,,,,,,,,,,,,,
P11169_SLC2A3_wild_cl3,SLC2A3_5c65B_Y01,P11169,,SLC2A3,wild,cl3,5c65B,Y01,,5c65,2,3,,Transporter,,,Structure of the human glucose transporter GLUT3 / SLC2A3,,,0,,,,,,,,,,,,,
P19634_SLC9A1_wild_cl1,SLC9A1_7dsvA_LBN,P19634,,SLC9A1,wild,cl1,7dsvA,LBN,,7dsv,3,3,,Transporter,,,Structure and mechanism of the human NHE1-CHP1 complex.,,,0,,,,,,,,,,,,,
P19634_SLC9A1_wild_cl1,SLC9A1_7dsvB_LBN,P19634,,SLC9A1,wild,cl1,7dsvB,LBN,,7dsv,3,3,,Transporter,,,Structure and mechanism of the human NHE1-CHP1 complex.,,,0,,,,,,,,,,,,,
P19634_SLC9A1_wild_cl2,SLC9A1_7dsxB_HG0,P19634,,SLC9A1,wild,cl2,7dsxB,HG0,,7dsx,3,3,,Transporter,,,Structure and mechanism of the human NHE1-CHP1 complex.,,,0,,,,,,,,,,,,,
P19634_SLC9A1_wild_cl3,SLC9A1_7dswB_LBN,P19634,,SLC9A1,wild,cl3,7dswB,LBN,,7dsw,3,3,,Transporter,,,Structure and mechanism of the human NHE1-CHP1 complex.,,,0,,,,,,,,,,,,,
P33527_ABCC1_wild_cl1,ABCC1_2cbzA_ATP,P33527,,ABCC1,wild,cl1,2cbzA,ATP,,2cbz,3,1,,Transporter,,,Structure of the Human Multidrug Resistance Protein 1 Nucleotide Binding Domain 1 Bound to Mg(2+)/ATP Reveals a Non-Productive Catalytic Site.,,,0,,,,,,,,,,,,,
P43003_SLC1A3_wild_cl1,SLC1A3_7awnA_6Z6,P43003,,SLC1A3,wild,cl1,7awnA,6Z6,,7awn,2,2,,Transporter,,,The ion-coupling mechanism of human excitatory amino acid transporters.,,,0,,,,,,,,,,,,,
P43003_SLC1A3_wild_cl2,SLC1A3_7awqA_ASP,P43003,,SLC1A3,wild,cl2,7awqA,ASP,,7awq,2,2,,Transporter,,,The ion-coupling mechanism of human excitatory amino acid transporters.,,,0,,,,,,,,,,,,,
P43005_SLC1A1_wild_cl1,SLC1A1_6s3qA_7O9,P43005,,SLC1A1,wild,cl1,6s3qA,7O9,,6s3q,3,2,,Transporter,,,Structure of human excitatory amino acid transporter 3 (EAAT3),,,0,,,,,,,,,,,,,
P43005_SLC1A1_wild_cl1,SLC1A1_7nsgA_UR5,P43005,,SLC1A1,wild,cl1,7nsgA,UR5,,7nsg,3,2,,Transporter,,,Structure of human excitatory amino acid transporter 3 (EAAT3) in complex with HIP-B,,,0,,,,,,,,,,,,,
P43005_SLC1A1_wild_cl2,SLC1A1_7nsgA_Y01,P43005,,SLC1A1,wild,cl2,7nsgA,Y01,,7nsg,3,2,,Transporter,,,Structure of human excitatory amino acid transporter 3 (EAAT3) in complex with HIP-B,,,0,,,,,,,,,,,,,
Q01650_SLC7A5_wild_cl1,SLC7A5_6irtB_AUU,Q01650,,SLC7A5,wild,cl1,6irtB,AUU,,6irt,3,2,,Transporter,,,Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.,,,0,,,,,,,,,,,,,
Q01650_SLC7A5_wild_cl2,SLC7A5_6irsB_3PH,Q01650,,SLC7A5,wild,cl2,6irsB,3PH,,6irs,3,2,,Transporter,,,Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.,,,0,,,,,,,,,,,,,
Q03518_TAP1_wild_cl1,TAP1_1jj7A_ADP,Q03518,,TAP1,wild,cl1,1jj7A,ADP,,1jj7,3,1,,Transporter,,,Structure of the ABC ATPase domain of human TAP1_ the transporter associated with antigen processing.,,,0,,,,,,,,,,,,,
Q15758_SLC1A5_wild_cl2,SLC1A5_6gctA_GLN,Q15758,,SLC1A5,wild,cl2,6gctA,GLN,,6gct,3,2,,Transporter,,,Cryo-EM structure of the human neutral amino acid transporter ASCT2.,,,0,,,,,,,,,,,,,
Q15758_SLC1A5_wild_cl1,SLC1A5_6mpbB_GLN,Q15758,,SLC1A5,wild,cl1,6mpbB,GLN,,6mpb,3,2,,Transporter,,,Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation.,,,0,,,,,,,,,,,,,
Q9NP58_ABCB6_wild_cl2,ABCB6_7eklA_ATP,Q9NP58,,ABCB6,wild,cl2,7eklA,ATP,,7ekl,3,2,,Transporter,,,Molecular insights into the human ABCB6 transporter.,,,0,,,,,,,,,,,,,
Q9NP58_ABCB6_wild_cl1,ABCB6_3nhaA_ADP,Q9NP58,,ABCB6,wild,cl1,3nhaA,ADP,,3nha,3,2,,Transporter,,,Structures of the nucleotide-binding domain of the human ABCB6 transporter and its complexes with nucleotides.,,,0,,,,,,,,,,,,,
Q9NP58_ABCB6_wild_cl1,ABCB6_3nh9A_ATP,Q9NP58,,ABCB6,wild,cl1,3nh9A,ATP,,3nh9,3,2,,Transporter,,,Structures of the nucleotide-binding domain of the human ABCB6 transporter and its complexes with nucleotides.,,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl1,ABCG2_6hcoA_FY5,Q9UNQ0,,ABCG2,wild,cl1,6hcoA,FY5,,6hco,3,3,,Transporter,,,Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.,,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl3,ABCG2_6hbuA_ATP,Q9UNQ0,,ABCG2,wild,cl3,6hbuA,ATP,,6hbu,3,3,,Transporter,,,Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.,,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl3,ABCG2_6hzmA_ATP,Q9UNQ0,,ABCG2,wild,cl3,6hzmA,ATP,,6hzm,3,3,,Transporter,,,Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.,,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl2,ABCG2_7ojiA_ATP,Q9UNQ0,,ABCG2,wild,cl2,7ojiA,ATP,,7oji,3,3,,Transporter,,,Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism.,,,0,,,,,,,,,,,,,
Q9UNQ0_ABCG2_wild_cl2,ABCG2_7ojiB_ATP,Q9UNQ0,,ABCG2,wild,cl2,7ojiB,ATP,,7oji,3,3,,Transporter,,,Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism.,,,0,,,,,,,,,,,,,
Q9UPY5_SLC7A11_wild_cl1,SLC7A11_7p9uB_GLU,Q9UPY5,,SLC7A11,wild,cl1,7p9uB,GLU,,7p9u,3,1,,Transporter,,,Molecular basis for redox control by the human cystine/glutamate antiporter system xc .,,,0,,,,,,,,,,,,,
Q99816_TSG101_wild_cl1,TSG101_5vkgA_4N1,Q99816,,TSG101,wild,cl1,5vkgA,4N1,,5vkg,3,1,,Ubiquitin,,,Tsg101 chaperone function revealed by HIV-1 assembly inhibitors.,inhibitor,,0,,,,,,,,,,,,,
Q9UBE0_SAE1_wild_cl1,SAE1_6cwyC_FHJ,Q9UBE0,,SAE1,wild,cl1,6cwyC,FHJ,,6cwy,3,1,,Ubiquitin,,,Molecular mechanism of a covalent Allosteric inhibitor of SUMO E1 activating enzyme.,inhibitor,allosteric,0,,,,,,,,,,,,,
P63165_SUMO1_wild_cl1,SUMO1_6uyzC_SEP,P63165,,SUMO1,wild,cl1,6uyzC,SEP,,6uyz,3,1,,Ubiquitin,,,Acetylation of SUMO1 Alters Interactions with the SIMs of PML and Daxx in a Protein-Specific Manner.,,,0,,,,,,,,,,,,,
Q9NR97_TLR8_wild_cl2,TLR8_3wn4A_D87,Q9NR97,,TLR8,wild,cl2,3wn4A,D87,,3wn4,#N/A,0,,#N/A,,,Structure-based design of novel human Toll-like receptor 8 Agonists.,agonist,,,,,,,,,,,,,,,
P27487_DPP4_wild_cl1,DPP4_2ripA_34Q,P27487,,DPP4,wild,cl1,2ripA,34Q,,2rip,#N/A,0,,#N/A,,,Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.,inhibitor,,,,,,,,,,,,,,,
P27487_DPP4_wild_cl1,DPP4_2g5tA_ACF,P27487,,DPP4,wild,cl1,2g5tA,ACF,,2g5t,#N/A,0,,#N/A,,,Discovery_ structure-activity relationship_ and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.,inhibitor,,,,,,,,,,,,,,,
P07288_KLK3_wild_cl1,KLK3_3qumQ_SIA,P07288,,KLK3,wild,cl1,3qumQ,SIA,,3qum,#N/A,0,,#N/A,,,Crystal structure of human prostate-specific antigen in a sandwich antibody complex.,,,,,,,,,,,,,,,,
Q14994_NR1I3_wild_cl1,NR1I3_1xv9D_CI2,Q14994,,NR1I3,wild,cl1,1xv9D,CI2,,1xv9,#N/A,0,,#N/A,,,A Structural Basis for Constitutive Activity in the Human CAR/RXRalpha Heterodimer.,,,,,,,,,,,,,,,,
